<SEC-DOCUMENT>0000927066-22-000167.txt : 20221031
<SEC-HEADER>0000927066-22-000167.hdr.sgml : 20221031
<ACCEPTANCE-DATETIME>20221028180255
ACCESSION NUMBER:		0000927066-22-000167
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		73
CONFORMED PERIOD OF REPORT:	20220930
FILED AS OF DATE:		20221031
DATE AS OF CHANGE:		20221028

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DAVITA INC.
		CENTRAL INDEX KEY:			0000927066
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
		IRS NUMBER:				510354549
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-14106
		FILM NUMBER:		221343279

	BUSINESS ADDRESS:	
		STREET 1:		2000 16TH STREET
		CITY:			DENVER
		STATE:			CO
		ZIP:			80202
		BUSINESS PHONE:		310-536-2668

	MAIL ADDRESS:	
		STREET 1:		2000 16TH STREET
		CITY:			DENVER
		STATE:			CO
		ZIP:			80202

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DAVITA HEALTHCARE PARTNERS INC.
		DATE OF NAME CHANGE:	20121107

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DAVITA INC
		DATE OF NAME CHANGE:	20001005

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TOTAL RENAL CARE HOLDINGS INC
		DATE OF NAME CHANGE:	19950524
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>dva-20220930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:3a89ce86-098c-4ec0-abc8-dda3315bf074,g:fd665bd8-0744-46ac-b10f-ff3cbe103a81,d:9311e9c566584bd9ab5dffbc9b9a605b--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2022" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dva="http://www.davita.com/20220930" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>dva-20220930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80L2ZyYWc6NGMyNjM5ZjRkYTg1NGU4ZWE5ZDY2YzUxMjIyYjhiMWEvdGFibGU6ZjY2MDMwOGZiYzQxNGNmY2EwYmY3ZTI3YWMwODAzODQvdGFibGVyYW5nZTpmNjYwMzA4ZmJjNDE0Y2ZjYTBiZjdlMjdhYzA4MDM4NF8xLTEtMS0xLTM2MTU2OQ_5eb61bad-7ebd-4964-96de-728235b6ec27">false</ix:nonNumeric><ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80L2ZyYWc6NGMyNjM5ZjRkYTg1NGU4ZWE5ZDY2YzUxMjIyYjhiMWEvdGFibGU6ZjY2MDMwOGZiYzQxNGNmY2EwYmY3ZTI3YWMwODAzODQvdGFibGVyYW5nZTpmNjYwMzA4ZmJjNDE0Y2ZjYTBiZjdlMjdhYzA4MDM4NF8yLTEtMS0xLTM2MTU2OQ_62ca2f37-ba2a-4009-bb2d-c20ddc8ebd64">2022</ix:nonNumeric><ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80L2ZyYWc6NGMyNjM5ZjRkYTg1NGU4ZWE5ZDY2YzUxMjIyYjhiMWEvdGFibGU6ZjY2MDMwOGZiYzQxNGNmY2EwYmY3ZTI3YWMwODAzODQvdGFibGVyYW5nZTpmNjYwMzA4ZmJjNDE0Y2ZjYTBiZjdlMjdhYzA4MDM4NF8zLTEtMS0xLTM2MTU2OQ_8d24d195-e21a-4c48-9d2a-51e683b04323">Q3</ix:nonNumeric><ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80L2ZyYWc6NGMyNjM5ZjRkYTg1NGU4ZWE5ZDY2YzUxMjIyYjhiMWEvdGFibGU6ZjY2MDMwOGZiYzQxNGNmY2EwYmY3ZTI3YWMwODAzODQvdGFibGVyYW5nZTpmNjYwMzA4ZmJjNDE0Y2ZjYTBiZjdlMjdhYzA4MDM4NF80LTEtMS0xLTM2MTU2OQ_dc4699d0-8a38-42bc-9cf6-a3382a4622f3">0000927066</ix:nonNumeric><ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80L2ZyYWc6NGMyNjM5ZjRkYTg1NGU4ZWE5ZDY2YzUxMjIyYjhiMWEvdGFibGU6ZjY2MDMwOGZiYzQxNGNmY2EwYmY3ZTI3YWMwODAzODQvdGFibGVyYW5nZTpmNjYwMzA4ZmJjNDE0Y2ZjYTBiZjdlMjdhYzA4MDM4NF81LTEtMS0xLTM2MTU2OQ_7dc17715-128a-4376-b130-38dbc5a7ea3d">12/31</ix:nonNumeric><ix:nonFraction unitRef="usdPerShare" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="3" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yMi9mcmFnOjQzOTY0YjliNjUzMTQ1ZmFhNWU4NDU4MzM1NWQ4Mjk1L3RhYmxlOjVlMmEwMTQyODhiZTQyNzlhZTM3NWJhYTc1MTUwZWZhL3RhYmxlcmFuZ2U6NWUyYTAxNDI4OGJlNDI3OWFlMzc1YmFhNzUxNTBlZmFfMS0yLTEtMS0zNjE1Njk_3a85514e-0a49-49b9-ad4d-7f24c1a3f929">0.001</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yMi9mcmFnOjQzOTY0YjliNjUzMTQ1ZmFhNWU4NDU4MzM1NWQ4Mjk1L3RhYmxlOjVlMmEwMTQyODhiZTQyNzlhZTM3NWJhYTc1MTUwZWZhL3RhYmxlcmFuZ2U6NWUyYTAxNDI4OGJlNDI3OWFlMzc1YmFhNzUxNTBlZmFfMi0yLTEtMS0zNjE1Njk_d066bd8e-df04-4e95-a188-1c4429bd700b">5,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yMi9mcmFnOjQzOTY0YjliNjUzMTQ1ZmFhNWU4NDU4MzM1NWQ4Mjk1L3RhYmxlOjVlMmEwMTQyODhiZTQyNzlhZTM3NWJhYTc1MTUwZWZhL3RhYmxlcmFuZ2U6NWUyYTAxNDI4OGJlNDI3OWFlMzc1YmFhNzUxNTBlZmFfMy0yLTEtMS0zNjE1Njk_2b62e92d-e1c7-43e9-a268-85c687836aa9">&#8212;</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="3" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yMi9mcmFnOjQzOTY0YjliNjUzMTQ1ZmFhNWU4NDU4MzM1NWQ4Mjk1L3RhYmxlOjVlMmEwMTQyODhiZTQyNzlhZTM3NWJhYTc1MTUwZWZhL3RhYmxlcmFuZ2U6NWUyYTAxNDI4OGJlNDI3OWFlMzc1YmFhNzUxNTBlZmFfNC0yLTEtMS0zNjE1Njk_2813ef19-a7f8-4c2a-ab3d-22df7f5433d6">0.001</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yMi9mcmFnOjQzOTY0YjliNjUzMTQ1ZmFhNWU4NDU4MzM1NWQ4Mjk1L3RhYmxlOjVlMmEwMTQyODhiZTQyNzlhZTM3NWJhYTc1MTUwZWZhL3RhYmxlcmFuZ2U6NWUyYTAxNDI4OGJlNDI3OWFlMzc1YmFhNzUxNTBlZmFfNS0yLTEtMS0zNjE1Njk_3160f2c5-0f83-46e1-bba0-f6a195d77c33">450,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yMi9mcmFnOjQzOTY0YjliNjUzMTQ1ZmFhNWU4NDU4MzM1NWQ4Mjk1L3RhYmxlOjVlMmEwMTQyODhiZTQyNzlhZTM3NWJhYTc1MTUwZWZhL3RhYmxlcmFuZ2U6NWUyYTAxNDI4OGJlNDI3OWFlMzc1YmFhNzUxNTBlZmFfNi0yLTEtMS0zNjE1Njk_c0f62812-0932-4b99-8738-ce292a3f783c">97,289</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:GoodwillImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80OS9mcmFnOjZiM2E1NTlmYTliNDRkZGRhZTdhZDA0M2E0Nzk5Mzc1L3RleHRyZWdpb246NmIzYTU1OWZhOWI0NGRkZGFlN2FkMDQzYTQ3OTkzNzVfMjk_c76c2861-0220-46c2-bcce-1e931560c297">0</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:GoodwillImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80OS9mcmFnOjZiM2E1NTlmYTliNDRkZGRhZTdhZDA0M2E0Nzk5Mzc1L3RleHRyZWdpb246NmIzYTU1OWZhOWI0NGRkZGFlN2FkMDQzYTQ3OTkzNzVfMzY_768f04ec-6cce-43ea-88c4-ebfd2438b25d">0</ix:nonFraction><ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="us-gaap:DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOjMzNDNiOGQxYjAwNzRhZWFhMGYzMWJkOTU1ZWVjYmNiL3RhYmxlcmFuZ2U6MzM0M2I4ZDFiMDA3NGFlYWEwZjMxYmQ5NTVlZWNiY2JfMi05LTEtMS0zNjE1Njk_2f37a18b-1ac9-4872-985b-d24c04e03453">http://fasb.org/us-gaap/2022#InterestAndDebtExpense</ix:nonNumeric><ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="dva:CorporateIntegrityAgreementPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81OC9mcmFnOjU5YjlmYzczNzE1ZjRlOTlhNjYyNTU2NzMzODJiNThkL3RleHRyZWdpb246NTliOWZjNzM3MTVmNGU5OWE2NjI1NTY3MzM4MmI1OGRfMjE3_4d148da3-62c8-4ba3-9b8c-ad4dbc72deac">five years</ix:nonNumeric><ix:nonNumeric contextRef="i234c9227eeee433bb5adf6ea9bcf5b0e_D20220525-20220525" name="dva:RegulatoryAndCommercialMilestonesBeginningDate" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81OC9mcmFnOjU5YjlmYzczNzE1ZjRlOTlhNjYyNTU2NzMzODJiNThkL3RleHRyZWdpb246NTliOWZjNzM3MTVmNGU5OWE2NjI1NTY3MzM4MmI1OGRfNDM2_22693c5f-277d-4571-9b25-2e23ef6147be">2024-01-01</ix:nonNumeric><ix:nonNumeric contextRef="i234c9227eeee433bb5adf6ea9bcf5b0e_D20220525-20220525" name="dva:RegulatoryAndCommercialMilestonesEndingDate" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81OC9mcmFnOjU5YjlmYzczNzE1ZjRlOTlhNjYyNTU2NzMzODJiNThkL3RleHRyZWdpb246NTliOWZjNzM3MTVmNGU5OWE2NjI1NTY3MzM4MmI1OGRfNDQz_1ba5197c-2f76-4ca5-83e0-94cff2288e09">2028-12-31</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="dva-20220930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9c8841268564112921ca0795b9110dc_I20221027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-10-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i50c63cefb9bd4106bee30b310fc866d1_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf9e89b4e598444e8b9df2b00849c30a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b171dd2fa094f0183b61386c9e24e5f_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia716f88984964a2b912c2cad0bd8a1fa_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb3363d3cbf6464faff1cbeaac015fa5_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ed815cd2c304b559653370ccc275a2b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4e48eaf91dc4c408c68dbe262d5b593_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i225bee24745a47b79c36ca66d4a0f754_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4611f48e469e4f43bc268b742f4eb3be_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i825fb40a1a3741bbb7f8ab64213ff5a9_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba35f774a92e4ef7aed7d1d87280a599_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i147789d12c114b6f8c98855d532eca0e_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbc46e0d55ea4c998cc9052010d50139_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc29ea0c8d1844d39747787ecd867dc7_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2320a27c131f4981931e8a5421b2ef7c_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i275b9f2c01bb463f9786a30fe06b1e1f_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39e9b3036c5b4d1b9dae3f82941570f9_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc82d88333724b428b3e6c8367bbaeb8_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7b08c7176c749f98f073fea08d83f2b_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d096d77a67d4147a3ff676d41c97ea4_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f6ac9def05f4546ad8e00029f29c85f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida0a3398956c428db91dfbf84211ac9d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6362305fbd044f9b9980adcadabf8f07_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36614688dae84eef869cd0e6d793fa74_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23a94ede934c4277b1d46b13e38fefd1_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cf6560db6fe433e9fe35420f78329ca_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd69c0a4b8da40a483520c9abec5ab4e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i276433c699f648cf975516d1ebf29a92_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieac6f79edec64565b9a967d39744ab16_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cbc28027ca9463d88cb9103183707e2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idde5dd2e47cc48b3b4ab52a208a0b76c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f4b7c7d62ec4f68a27cb7f3d6ee06dd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ba288d628f64e839c5eef1fa88fdd33_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03c39842d00748dab2c10d4f15c2ada9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i530e6ba6cb654ba8beab393e20b2de81_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55a696e4c43e43a084a98a9190e869b0_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07cba31e2e3b4a8ea010c559dcb43625_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8139303e818c4499a156db063aa48dba_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73664eea57554ff1a6527a1e3088909e_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2f7382dda1241aaad40dfb7cb9dd962_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i646ec415498444bd800c1444f673b411_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b36f5eee05c4272833ec6129d2e6d23_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3cc14165b1e5457b9a7d411fe7bae49e_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedd8e53afd1f49d1ab701015f45a5489_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice4bdd4f0f9347209498a13bb73d9bdc_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i663815c6d9b048f4b3e8a826a42acd72_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7507dbbe11004f8f993908a1a48afa76_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id43bdce378174edd8e02d9f9f1fd6b24_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie002b14464f24380b244cc03154fc209_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic329b3c1d74b48468770b45b930bad16_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie19f600b93854407adf4fdf1f09eee0b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia98324e3ccbe45f88cbaa562c7631b0b_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ddc0fff672e45bf957f1116d0d1cb0c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fbb95ab11e644199452dbc8220b5114_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b6ffea1a40d41068e8300270af3e5ba_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib49a7f0c10554865819c8371c13ef3f0_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i319451c323114481b97e571a89a51741_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56a34082e8604548b02c2fbf0259eb63_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81df84984de9471498896da7302e996d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60789889ae4a4336b174326b6a1f05e1_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7e948fdcd374e2ca7c81f008ef937b8_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief97099e76e34b33afd38d2bf7dd73d5_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbd4405ebc814444a73fcea7eb2d5281_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3329b37b11ef49e7a77677fc2571f273_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1113880d4c76456c96b6f30c904a98c3_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i658147170723431aa969dc4fb19ac738_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d92065342b44c7d9d67dad92df719c5_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie15a7e2f621142fbac1d6b1ed5011b9d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief046f5cbff64fe6add73a9cda0c18b2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic085ab466cee47ed81480d793624fbad_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9126810d2c5c48f49f23bdafdb65883a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75763a11d96243bca52ff93e2406ae41_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9bb890020ae4aef89eda77451ffdea8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0dd3f4def9b849c59ba37a6b37215489_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia506883f3ae0452194c6440259373c3b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d759d14a5e74d46b71f1406a364f03e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic46d32b59dd34a6085600e81cd1682bb_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0876db8d2e2343ad96bd1c5f19250ebd_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0dee44ae9bd741b79b52d5d2960b5164_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d50339b230d4224b69347fc7edc8b98_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2225f46e4614652b632ff59e99717b5_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id322319c79ee47d3b626a8d5196e3aeb_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8f9cc1fcc6d4078b72a351dab034ab2_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5499ef54bf54566bd5630bea4f2aef1_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf7c25a75aca401a8b6ff5a12f6bd14d_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if32f1f0b93b84c62b51bda92e1d098c1_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8b3d7d4ce924bcba6d96142c33584d7_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c5b3caa1262457a9e75c70467159fc4_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb08fa48ee76464ba77c6eb9d3849115_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i599d93fb67e9441eb25740b2dd06722d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c69e4f36c65438c9eeb2a106052afd5_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd8c3ea690e54b84a0a7066643e1c02b_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9536bd2eda14d9c86eba49ab480d898_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i872a4a0bd01a4a8abf1995e00bb2cf2d_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaaae7b470fbe4bbd8bd2ca4d195b6128_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if47f2932cefd49ed85a6f6caa58312cd_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7f517d406d8483b9f0bdad532070fe4_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f7d940ca97c4ae789757331795af7c0_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3129a22cf1d446319325259a77169cdd_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87e2bef651a34107b1fb5d68820aee09_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa9717ba02fb4ccab21d642ffbe4803c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i500d83fb41334d9c8de83f92f7fcc141_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icaea6e6d89084a3e93ba28323cd7e21d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff0caec10ecc40c584a977fdfabc4df8_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50355a967a4440e897b1ac183ad1a38d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb556fa3c676460aa8e66d0650f6a16e_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i346169ef5135448c9d85d98d5c086b2a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42e37dbf5c0a422e8802ffd5a383d2d8_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc81d3ad5ccf42d797d3042a95761484_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ac794762df747ec8e1cf0d69c6b0573_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c5f026f8ab94787909fcd87fcb38484_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib939af3797994ec1a4b0e56c5dd80a2a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if983cfecb2cf4615842da0fdce5d144c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c5c603e1e2c456093890ff389a4067c_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf91a124985e4d4a83d74b6648524f10_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i253b9978247749dcb47c368cdebc35ae_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6679c2baabca4cda8418d59c0fbb9fcb_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45f5523ed8e44e969d9667166a84a234_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c321d3f4f114e7a810149cebdfddf89_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i138d5ad826a74dd389b7c50d766dce89_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5743480e6048496ab58c95a14b8aaf6f_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia98746ed55ed4291881ac7bb3d451f92_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0162929ca27d43d894768f88369a32f4_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa3c42e6c11c4d0197c06f1170d1a877_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iadfbab933c6649d399f396278bf17828_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00c3f8bb1a4f4667af7c71428219d59d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff13895b80934a9aaca98d961abc2ee9_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14ce08d9f9e740ecb2b7cd9829aba3f6_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e56a6423e7a43a6baf62a95333e8692_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e7345a52a044d459fe02274fb72c840_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f6de3926b14464695343fd7abe17b26_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1bf1bb08a5eb457d8bc08821fa21a5ff_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81c073a4e6894483a6125b5544516dcf_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5928e35ff3ca4001abd1fb3f535ceaaf_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i490b21a1d5ff4920a6e5630f304c1992_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7bd462440e954143b9bd9c4c0bbcbc96_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67f9be9b51ec4692a27ebe64bb0fc0e4_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89dde34540454ca3ae8c705649ed5ed5_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf52eaa032584a8ab33ac97fcf842df5_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i137eae426cf247789d78e630f2c67da6_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ad9292cb3bb460b969ab3899aad678f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b1771b0ef284582836b473942fc9bfa_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7cae19c46a6043148cffc25a7d0efae1_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idcb2cf1f049d43e6bc397f58d8b751ab_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94d0c3e715a04876b7a0eebf725c54bb_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib29b1d2d5bb4458794f5d56da5481133_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f9af972e685431dac0f0893f94454e6_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8eef48118914482ea280b1dd3e31cd66_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iadaf73e90f7a4ef2b2effea52a4e2206_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idec28e83e6404debb93980472f318af7_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i507043f785414bbe9b5ce696f53c2c7e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0562607b4e35473ba1a511716103fdc2_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d2459b347674468b9af90ec7b6fa674_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icad3d0bdd7834605a261fa6fd56c8c78_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e58b8c89c344703bdf5b7d532cc1d0c_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b80df9aa48e4aa9a2eeabbf8c48904e_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33b19b87438e4e76aede245ac6a0c09c_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53105fdcd8b04f368d61266747f6b56e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iabe54304a7d4439d88d4c1cbb00ee5ac_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i422c6a94a816499c8310fd5a0acc841f_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie63e40be1b8c44ae852031a36cc0c1d2_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0cb049c47bd043afa9a8eb3aaf37cb95_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7870e39ec59457d85f40917f0be7b4b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iffa1899b208b434e83db21f284ea5a87_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">dva:CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e7043280f3044ae929ed9d39180bb93_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">dva:CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i762574633ee549d19d8053d43cdafb79_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">dva:MutualFundsAndCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i998926cd86174abfa8697edf79ac9a69_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">dva:MutualFundsAndCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3d961759a0d4fab9e023c8d7cc84b4d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02bde4cdadea4ac6b75aaf556e9f2418_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i483736bcec6d40ddb087fe0d0b25dbb5_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherLongTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfc94329266c4456afa05d709202b567_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherLongTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7271827c904f4e51b6526494e9342d5f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i756ef20c6d3443ab8a775b412b7acddc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i171f9689d476418d827ad1ac63f1abe2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7fe624a85b4c4310aae5c81aef699e3a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2759022dfe6d4c619bce01f379f17594_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i698d58b2d3b2468cbb119fff40dd7a93_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92fca4752e474a7bad54570de210ff8d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7093bff9492a45488822863f8f94a337_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d792edae43b4791856eea60df0b33b6_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic52ab49cab0046128e4cd38b93634c67_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:OtherReportingUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>dva:segment</xbrli:measure></xbrli:unit><xbrli:context id="i168f0cc4ee2a490ba0df4d0eb3ab2041_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f2af1cb259e4765a370d5164540acf9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fab6e21c9604971bab7725c4bfbac6f_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i302d14b3d5a44d99ac999f078c7fd0c8_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanB1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib24db8b1544e4594962862573a081569_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanB1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3eac2310025f4fc0a30a0754d743a012_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanB1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3433a7055306497a9f23d7846a707116_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d5c71dc8775496aa1ad4209bbb25af1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5034dae68d4445268ca6238ba4f28038_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia085405df9dc49bc9d8a30bf7986f78f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09d1f6ddde7148209032eb2224d201eb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i302c47dbb07447f3aa14cc9c0f845e99_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i5060f8fb53a5401181f83f0a4d6ff2a5_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04752ae989ad4df8860d74e4cad34f15_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64428b0bc4064508aa43d6d7c4cc144b_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbe11ca6fc7841578c3e48f6f74461bb_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibea5962a62cd4213b61783287c172e38_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87c41204c9904d789e0b0f9e1ef28d3d_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00a6d21c50894a1fa91ade6d03f0fffe_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:FinanceLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ebc73ef268843d2a9d4b6d4d487bd9e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:FinanceLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf4852e0d4004e5793b6d25aad62c55c_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:FinanceLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41f04bf6bfb648ff9ac2bac9337cf616_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c5c02a03c2046a284b5bbc100254ca4_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82d2dee054d74a1a9b9863ec06aedad5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c55687d402147b5b3598fcd58f4ea18_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27a76be1220a42ebb7e508e18f02f881_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:TermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i551c354ec3c64e7889df8603ed99c879_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:TermLoanFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6dcab18b6e464b478f9e7b926940407a_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3bcbd3ed4904f758f13fa1bf235728c_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2bd1edc1ab034b47a8b52b57f222a787_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dva:DebtExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c1f682df591439fa3b6fcdf674d782e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i288ec9efae5e463983828ed73eecc6fa_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf19afd02f534c9c8ffb4475417e4ce0_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e5742b805d64156889d9a58826bf40d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">dva:BilateralSecuredLetterOfCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i017440e66fea4d42af33e10727d6d8bc_D20171201-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">dva:USAttorneyPrescriptionDrugInvestigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb92eab57e66403ca68107330167cb46_D20171201-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">dva:USAttorneyPrescriptionDrugInvestigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">dva:IncrementalCashPortionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9078554660b4e04aa85a2b59269458d_D20171201-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">dva:USAttorneyPrescriptionDrugInvestigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">dva:CashPaidForPortionPreviouslyRefundedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34475a7595b24df1b1183abfd0b8bb6b_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">dva:CommitmentsToProvideOperatingCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i234c9227eeee433bb5adf6ea9bcf5b0e_D20220525-20220525"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">dva:AgreementWithMedtronicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-25</xbrli:startDate><xbrli:endDate>2022-05-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56c2b0de3ff24b87b529562972a48a8a_I20220525"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">dva:AgreementWithMedtronicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70a7c2b3d8c3425b83bdbde7adae4aed_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ccb6189ca58495499f4dbbf4481a40c_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e26a096655c4539b381dad37c3f4def_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dva:OpenMarketPurchasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1bbbb5f9079d4dc2b1bc26bc9197d8c2_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dva:OpenMarketPurchasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id88c7440116645768f677634e0f5e6d1_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dva:OpenMarketPurchasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75f2b64af109480b978f5c7a64a13687_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dva:OpenMarketPurchasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93d8bfb8799a4eb1a6cac7ed70c03ca0_D20221001-20221027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-10-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d5aa4e5434b4526a0049dce3fe3e153_I20221027"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8eadbdf6a4545af8abdecc0181aed70_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e8ea0962d7f484ab9b39cd36f1fe019_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b995987498a46b5abb6da0bb3401211_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25695481a54a456da58a8b675ea33615_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i782ad893fc0b4621a76c9a45d98be61d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98434fe450004124afb331b74fd63193_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fe95730ae644d9e881c7051751a5a76_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd10dfc3a87841eda50c4640b2db4669_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9b5ae0e296a416d8eddebe00e9bfe22_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79b1d5bcdc7c4fb0a917646f4ab14002_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c0124b9404249c4b64ad373e8c59fb9_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b7464a1b4454319b3b1a6fdfe238cef_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ddb5952c6014f42bf7ffa4d2e53fd09_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f9aa59cbd6641848230a121fb1bcaf3_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27574f6140c946159e41244ddaeb3b3d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied2f14238be74cbcab93bfce44bcf2a8_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90536d42eb7f4763bfaeebdcb028b4bb_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9ec694fa011482bba09ae1ec0527b52_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b41eec20f9949888d1d2510c252e563_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8d33af08bcf4539ad092a661c7d9f23_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibdfd5d445b04452f8439ae6973f8405c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1ee6b43a5f5462f93097ca6bbd4be00_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23adff93afc54365bb6b4b7000f67792_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6ae4d7515be40af9b5d0d99dedb6674_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d45a9c325c54f76bedad3d6dc284da2_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01dd8be0b3174c8ca7f5203f166342a4_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90261a9edf1e40d0a4d5ecc464319061_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68f578d19e7645c387c11ed14154d754_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i156a47ec55f944129c986623c6da4e76_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52c9b6f82ebb4d52b32a547426bdefa3_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95e6e28da1c64a71b6b90cda0a4d622f_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="clinic"><xbrli:measure>dva:clinic</xbrli:measure></xbrli:unit><xbrli:context id="ic959e17b2ced48048db8022f4a387ae2_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:ForeignDialysisCentersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6e87c344c514ceda105446f9b6fd9f1_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd5d82e4da8342af95e4f8a9ea99d743_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88a8225e4c1e42caaefc9c729b03c373_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dva:OtherCompaniesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">dva:EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifde433a78f5e48a7bae7190340e2eb48_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dva:OtherCompaniesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">dva:EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide4330793ff1447187183eb8ef9696b9_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dva:OtherCompaniesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01942e9636d34741abd1fb7dae3a5e7a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a9ef1628dd54bbc87ca947161e93f59_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6f218803873471383d0301f439bbb92_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c5d44642dc04d7aad80fa984ec18f13_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i200705f0b3544be7a6092cd5a931bd55_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ab035ae8c46470e89b5add1fb9a3684_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if32523db73914548b7ef72241eec1f64_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad68a7dfc7f8430c902a9ff9db916de5_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37ced70b3e714fa5b27f6d0da83e5d16_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie85a55a4b6014368afa4c77e630e85e9_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i861d396ab85f4a41a20715d925fdf77d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2281493dee746f3a9ad6ed5affc319f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i942ba5c680184d918b3750ba16f74597_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i422c441ffd274e1a8dea60fc1227cd35_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i277124343d7e4b49b6103749b88e2648_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86e50a7258fd4e0992f2a0577c97a330_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">dva:ExternalSourcesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8addd3c7916144679fc2e787249b56d9_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">dva:ExternalSourcesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide05e52cd7054762b05f224b69c2974e_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">dva:ExternalSourcesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i819e851e63e848a696a608bae9204746_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">dva:ExternalSourcesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96cb1c0878bf49cea8cfa1212cdc7aed_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36100b7124c542bd86b8f36ce7106243_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73df09631cc34d359a0ce8f26f7d7e45_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3eb7e259bf141018ef89a58189f8ba2_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8601bd20cd04c22b8e3e448c8c8a4bc_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38b206ccc4604608ab1cbaeaa6e878f5_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5947da8371ba465b929ebd233615c5fc_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc9f7a8bb84e40e581606e923ee81543_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i068759fddb5d4fbd9e32d6347d1e6d75_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b9dedef3bed43dba87b7821cb677959_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fd089f25d0742cc93cba789d7beaa24_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib561b1ec046245b58bddae941fc0daf3_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe0e63e321e945a08099e16de0785d5c_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee77a72428d248f899e78bbf60ce4cc2_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i283d80459c03449ebbe9a4d7b3746698_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibdf9f7a5de6348a2a7d0775d1ab48459_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1a93e7f4f5e4e33bffc9621d504b491_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4bcbcc0a834148c8afeb26f2a4556df3_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74c6003e725f4a6c850b011b394744f5_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i700a5ecba5cb45d1ba64cd1d25b5583e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000927066</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i9311e9c566584bd9ab5dffbc9b9a605b_1"></div><div style="min-height:9pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:3pt;text-align:center"><span><br/></span></div><div style="margin-top:3pt;text-align:center"><span><br/></span></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.419%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:15pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:15pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Washington, D.C. 20549 </span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:225.00pt"><tr><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:15pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xL2ZyYWc6NzI3ZGU2YzgxMzYzNDU0N2FjNDYwNjNkMTRkYjNkOWUvdGV4dHJlZ2lvbjo3MjdkZTZjODEzNjM0NTQ3YWM0NjA2M2QxNGRiM2Q5ZV8xODc2_70ba9b7f-2fdb-4a84-b3b8-47e1dcb14916">10-Q</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:225.00pt"><tr><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:510.00pt"><tr><td style="width:1.0pt"></td><td style="width:22.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:484.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xL2ZyYWc6NzI3ZGU2YzgxMzYzNDU0N2FjNDYwNjNkMTRkYjNkOWUvdGFibGU6Mzc1ODEyNjlmNWFhNDkwYzg5ZTI0YWU3MDNmZjkxMzcvdGFibGVyYW5nZTozNzU4MTI2OWY1YWE0OTBjODllMjRhZTcwM2ZmOTEzN18wLTAtMS0xLTM2MTU2OQ_7960352d-84c6-4a5b-8bb6-1d8ed6e2df80">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Quarterly Period Ended <ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xL2ZyYWc6NzI3ZGU2YzgxMzYzNDU0N2FjNDYwNjNkMTRkYjNkOWUvdGV4dHJlZ2lvbjo3MjdkZTZjODEzNjM0NTQ3YWM0NjA2M2QxNGRiM2Q5ZV8xMzA_b35d2cab-a5ac-4a11-95cc-a1f8dab6514f">September&#160;30, 2022</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">or</span></div><div style="margin-top:5pt;text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:510.00pt"><tr><td style="width:1.0pt"></td><td style="width:22.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:484.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xL2ZyYWc6NzI3ZGU2YzgxMzYzNDU0N2FjNDYwNjNkMTRkYjNkOWUvdGFibGU6ODkwNDg2NTcwYzE4NDIzM2E5NTZiMWRjYjg2NWI1YmMvdGFibGVyYW5nZTo4OTA0ODY1NzBjMTg0MjMzYTk1NmIxZGNiODY1YjViY18wLTAtMS0xLTM2MTU2OQ_a54e87e4-0ad8-4e0b-ae59-3f3df0ad4f3f">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from ___________ to ___________</span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xL2ZyYWc6NzI3ZGU2YzgxMzYzNDU0N2FjNDYwNjNkMTRkYjNkOWUvdGV4dHJlZ2lvbjo3MjdkZTZjODEzNjM0NTQ3YWM0NjA2M2QxNGRiM2Q5ZV8xODc5_a2d27c6f-5527-4fce-bc56-42d94cd78a16">1-14106</ix:nonNumeric> </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:225.00pt"><tr><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><img src="dva-20220930_g1.jpg" alt="dva-20220930_g1.jpg" style="height:69px;margin-bottom:5pt;vertical-align:text-bottom;width:182px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xL2ZyYWc6NzI3ZGU2YzgxMzYzNDU0N2FjNDYwNjNkMTRkYjNkOWUvdGV4dHJlZ2lvbjo3MjdkZTZjODEzNjM0NTQ3YWM0NjA2M2QxNGRiM2Q5ZV8xODgw_5c532214-3b55-4747-9a9b-5e90c60acc25">DAVITA INC.</ix:nonNumeric> </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:46.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.000%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xL2ZyYWc6NzI3ZGU2YzgxMzYzNDU0N2FjNDYwNjNkMTRkYjNkOWUvdGFibGU6MzY2NDQzZWI0ODcwNDEwMmFmNTlkN2U5ZmY1YTUwYzUvdGFibGVyYW5nZTozNjY0NDNlYjQ4NzA0MTAyYWY1OWQ3ZTlmZjVhNTBjNV8wLTAtMS0xLTM2MTU2OQ_75d04a35-cac0-4609-a952-0d0345a9425d">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xL2ZyYWc6NzI3ZGU2YzgxMzYzNDU0N2FjNDYwNjNkMTRkYjNkOWUvdGFibGU6MzY2NDQzZWI0ODcwNDEwMmFmNTlkN2U5ZmY1YTUwYzUvdGFibGVyYW5nZTozNjY0NDNlYjQ4NzA0MTAyYWY1OWQ3ZTlmZjVhNTBjNV8wLTItMS0xLTM2MTU2OQ_ffdd4746-a3c7-4b79-b208-acbc53a672c5">51-0354549</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State&#160;of incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:18.103%"><tr><td style="width:1.0%"></td><td style="width:42.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.028%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xL2ZyYWc6NzI3ZGU2YzgxMzYzNDU0N2FjNDYwNjNkMTRkYjNkOWUvdGFibGU6NzY5NWM2NDk3NDU2NGI0NTgyYTc1YjZlZmIwM2NhZDUvdGFibGVyYW5nZTo3Njk1YzY0OTc0NTY0YjQ1ODJhNzViNmVmYjAzY2FkNV8wLTAtMS0xLTM2MTU2OQ_6ab95f54-41cc-4dd8-b5e0-4f27d0ca768e">2000 16th Street</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xL2ZyYWc6NzI3ZGU2YzgxMzYzNDU0N2FjNDYwNjNkMTRkYjNkOWUvdGFibGU6NzY5NWM2NDk3NDU2NGI0NTgyYTc1YjZlZmIwM2NhZDUvdGFibGVyYW5nZTo3Njk1YzY0OTc0NTY0YjQ1ODJhNzViNmVmYjAzY2FkNV8xLTAtMS0xLTM2MTU2OQ_f6e83bd3-05c4-47f1-9ad4-3967cb897bb3">Denver,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xL2ZyYWc6NzI3ZGU2YzgxMzYzNDU0N2FjNDYwNjNkMTRkYjNkOWUvdGFibGU6NzY5NWM2NDk3NDU2NGI0NTgyYTc1YjZlZmIwM2NhZDUvdGFibGVyYW5nZTo3Njk1YzY0OTc0NTY0YjQ1ODJhNzViNmVmYjAzY2FkNV8xLTEtMS0xLTM2MTU2OQ_09de1fd5-c6c3-46b7-b9c6-a155d0649b51">CO</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xL2ZyYWc6NzI3ZGU2YzgxMzYzNDU0N2FjNDYwNjNkMTRkYjNkOWUvdGFibGU6NzY5NWM2NDk3NDU2NGI0NTgyYTc1YjZlZmIwM2NhZDUvdGFibGVyYW5nZTo3Njk1YzY0OTc0NTY0YjQ1ODJhNzViNmVmYjAzY2FkNV8xLTItMS0xLTM2MTU2OQ_6d894363-3b77-4260-8228-f769df5bdebc">80202</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Telephone number (<ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xL2ZyYWc6NzI3ZGU2YzgxMzYzNDU0N2FjNDYwNjNkMTRkYjNkOWUvdGV4dHJlZ2lvbjo3MjdkZTZjODEzNjM0NTQ3YWM0NjA2M2QxNGRiM2Q5ZV8xODgx_505dfb10-ecd6-4e8e-8b9c-ac71bacc1554">720</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xL2ZyYWc6NzI3ZGU2YzgxMzYzNDU0N2FjNDYwNjNkMTRkYjNkOWUvdGV4dHJlZ2lvbjo3MjdkZTZjODEzNjM0NTQ3YWM0NjA2M2QxNGRiM2Q5ZV8xODc3_10055c55-c824-4891-8c22-9d532790501b">631-2100</ix:nonNumeric> </span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.491%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.032%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.955%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.689%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading symbol(s):</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered:</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xL2ZyYWc6NzI3ZGU2YzgxMzYzNDU0N2FjNDYwNjNkMTRkYjNkOWUvdGFibGU6NGY3YWI1NmU1NTc4NDcwN2FlYTY5Yzk4ZDgxOTBhMGYvdGFibGVyYW5nZTo0ZjdhYjU2ZTU1Nzg0NzA3YWVhNjljOThkODE5MGEwZl8xLTAtMS0xLTM2MTU2OQ_c2b5ef65-9a33-4083-99eb-753bcb34b351">Common Stock, $0.001 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 6.62pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xL2ZyYWc6NzI3ZGU2YzgxMzYzNDU0N2FjNDYwNjNkMTRkYjNkOWUvdGFibGU6NGY3YWI1NmU1NTc4NDcwN2FlYTY5Yzk4ZDgxOTBhMGYvdGFibGVyYW5nZTo0ZjdhYjU2ZTU1Nzg0NzA3YWVhNjljOThkODE5MGEwZl8xLTItMS0xLTM2MTU2OQ_be0020ed-1d5a-4233-b834-95e4a16789e9">DVA</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xL2ZyYWc6NzI3ZGU2YzgxMzYzNDU0N2FjNDYwNjNkMTRkYjNkOWUvdGFibGU6NGY3YWI1NmU1NTc4NDcwN2FlYTY5Yzk4ZDgxOTBhMGYvdGFibGVyYW5nZTo0ZjdhYjU2ZTU1Nzg0NzA3YWVhNjljOThkODE5MGEwZl8xLTQtMS0xLTM2MTU2OQ_a0eab80f-e7f8-4cbb-b779-93c63f4a1990">NYSE</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:135.00pt"><tr><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;<ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xL2ZyYWc6NzI3ZGU2YzgxMzYzNDU0N2FjNDYwNjNkMTRkYjNkOWUvdGV4dHJlZ2lvbjo3MjdkZTZjODEzNjM0NTQ3YWM0NjA2M2QxNGRiM2Q5ZV8xODc4_27d8000a-4829-4214-ab15-07dfc295f44d">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;&#160;&#160;No&#160;&#160;&#9744; </span></div><div style="margin-top:3pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xL2ZyYWc6NzI3ZGU2YzgxMzYzNDU0N2FjNDYwNjNkMTRkYjNkOWUvdGV4dHJlZ2lvbjo3MjdkZTZjODEzNjM0NTQ3YWM0NjA2M2QxNGRiM2Q5ZV8xODgy_d58835b4-9e71-4165-9326-1421bc63a2c7">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;&#160;&#160;No&#160;&#160;&#9744;</span></div><div style="margin-top:3pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer", "accelerated filer", "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt;padding-left:72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.873%"><tr><td style="width:1.0%"></td><td style="width:31.925%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.213%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.633%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xL2ZyYWc6NzI3ZGU2YzgxMzYzNDU0N2FjNDYwNjNkMTRkYjNkOWUvdGFibGU6NmM3MWIxOTY1MmY4NGQwYWIwYmU1MGNkMmVjOThjNTcvdGFibGVyYW5nZTo2YzcxYjE5NjUyZjg0ZDBhYjBiZTUwY2QyZWM5OGM1N18wLTAtMS0xLTM2MTU2OQ_39f36f23-59fd-46f7-b8f9-94c8699116a4">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#9744;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xL2ZyYWc6NzI3ZGU2YzgxMzYzNDU0N2FjNDYwNjNkMTRkYjNkOWUvdGFibGU6NmM3MWIxOTY1MmY4NGQwYWIwYmU1MGNkMmVjOThjNTcvdGFibGVyYW5nZTo2YzcxYjE5NjUyZjg0ZDBhYjBiZTUwY2QyZWM5OGM1N18yLTMtMS0xLTM2MTU2OQ_61e61b3b-a3e3-419a-ad55-8d65c221d646">&#9744;</ix:nonNumeric></span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xL2ZyYWc6NzI3ZGU2YzgxMzYzNDU0N2FjNDYwNjNkMTRkYjNkOWUvdGFibGU6NmM3MWIxOTY1MmY4NGQwYWIwYmU1MGNkMmVjOThjNTcvdGFibGVyYW5nZTo2YzcxYjE5NjUyZjg0ZDBhYjBiZTUwY2QyZWM5OGM1N180LTEtMS0xLTM2MTU2OQ_fbe6ae31-c73d-4510-9d5a-cd0c854fb7a4">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></div><div style="margin-top:3pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act)&#160;&#160;&#160;&#160;Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xL2ZyYWc6NzI3ZGU2YzgxMzYzNDU0N2FjNDYwNjNkMTRkYjNkOWUvdGV4dHJlZ2lvbjo3MjdkZTZjODEzNjM0NTQ3YWM0NjA2M2QxNGRiM2Q5ZV8xODgz_4d48432b-7047-4f4a-8eb4-244ce7d8fd4a">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;&#9746;</span></div><div style="margin-top:5pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">As of October&#160;27, 2022, the number of shares of the registrant&#8217;s common stock outstanding was approximately <ix:nonFraction unitRef="shares" contextRef="id9c8841268564112921ca0795b9110dc_I20221027" decimals="-5" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xL2ZyYWc6NzI3ZGU2YzgxMzYzNDU0N2FjNDYwNjNkMTRkYjNkOWUvdGV4dHJlZ2lvbjo3MjdkZTZjODEzNjM0NTQ3YWM0NjA2M2QxNGRiM2Q5ZV8xODY1_80183be9-2ca0-4f47-a7e2-25d49bbf82e0">90.1</ix:nonFraction> million shares.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:18.636%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.931%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="height:31.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i9311e9c566584bd9ab5dffbc9b9a605b_7"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:7.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.225%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.259%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page&#160;No.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART I. FINANCIAL INFORMATION</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9311e9c566584bd9ab5dffbc9b9a605b_10">Condensed Consolidated Financial Statements:</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9311e9c566584bd9ab5dffbc9b9a605b_13">Consolidated Statements of Income for the three and nine months ended September 30, 2022 and</a></span></div><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9311e9c566584bd9ab5dffbc9b9a605b_13">&#160;September 30, 2021</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9311e9c566584bd9ab5dffbc9b9a605b_13">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9311e9c566584bd9ab5dffbc9b9a605b_16">Consolidated Statements of Comprehensive Income for the three and nine months ended</a></span></div><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9311e9c566584bd9ab5dffbc9b9a605b_16">&#160;September 30, 2022 and September 30, 2021</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9311e9c566584bd9ab5dffbc9b9a605b_16">2</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9311e9c566584bd9ab5dffbc9b9a605b_19">Consolidated Balance Sheets as of September 30, 2022 and December 31, 2021</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9311e9c566584bd9ab5dffbc9b9a605b_19">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9311e9c566584bd9ab5dffbc9b9a605b_25">Consolidated Statements of Cash Flow for the nine months ended September 30, 2022 and</a></span></div><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9311e9c566584bd9ab5dffbc9b9a605b_25">&#160;September 30, 2021</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9311e9c566584bd9ab5dffbc9b9a605b_25">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9311e9c566584bd9ab5dffbc9b9a605b_28">Consolidated Statements of Equity for the three and nine months ended September 30, 2022 and</a></span></div><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9311e9c566584bd9ab5dffbc9b9a605b_28">&#160;September 30, 2021</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9311e9c566584bd9ab5dffbc9b9a605b_28">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9311e9c566584bd9ab5dffbc9b9a605b_31">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9311e9c566584bd9ab5dffbc9b9a605b_31">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9311e9c566584bd9ab5dffbc9b9a605b_82">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9311e9c566584bd9ab5dffbc9b9a605b_82">21</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9311e9c566584bd9ab5dffbc9b9a605b_121">Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9311e9c566584bd9ab5dffbc9b9a605b_121">39</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9311e9c566584bd9ab5dffbc9b9a605b_127">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9311e9c566584bd9ab5dffbc9b9a605b_127">39</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART II. OTHER INFORMATION</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9311e9c566584bd9ab5dffbc9b9a605b_133">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9311e9c566584bd9ab5dffbc9b9a605b_133">41</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9311e9c566584bd9ab5dffbc9b9a605b_136">Risk Factors</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9311e9c566584bd9ab5dffbc9b9a605b_136">41</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9311e9c566584bd9ab5dffbc9b9a605b_139">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9311e9c566584bd9ab5dffbc9b9a605b_139">42</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9311e9c566584bd9ab5dffbc9b9a605b_142">Exhibits</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9311e9c566584bd9ab5dffbc9b9a605b_142">43</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i9311e9c566584bd9ab5dffbc9b9a605b_145">Signature</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i9311e9c566584bd9ab5dffbc9b9a605b_145">44</a></span></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note: Items 3, 4 and 5 of Part II are omitted because they are not applicable.&#160;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i</span></div></div></div><div id="i9311e9c566584bd9ab5dffbc9b9a605b_10"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div><span><br/></span></div><div id="i9311e9c566584bd9ab5dffbc9b9a605b_13"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dialysis patient service revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930" decimals="-3" name="dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMi0xLTEtMS0zNjE1Njk_f5b83fb2-1906-4652-be4c-3e6fd6df49b5">2,846,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930" decimals="-3" name="dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMi0zLTEtMS0zNjE1Njk_4bdcfd05-1b57-4602-b85a-74b1eafa27fe">2,837,940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMi01LTEtMS0zNjE1Njk_d2fe795c-5d4c-43ca-a22a-1a13ab8d3ae2">8,372,874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMi03LTEtMS0zNjE1Njk_6d7f3ec0-e164-4777-8cd1-5f95204e6292">8,370,484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMy0xLTEtMS0zNjE1Njk_2a148248-91ae-4076-9e32-5826ba173d16">102,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMy0zLTEtMS0zNjE1Njk_95a59f73-57ca-45be-9781-1f4a3e194493">100,379</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMy01LTEtMS0zNjE1Njk_2073c711-fdf1-453b-81c7-b785ed7998a1">320,132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMy03LTEtMS0zNjE1Njk_d3222004-f596-47aa-b16a-5fbbc35e3cdb">304,346</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfNC0xLTEtMS0zNjE1Njk_815fe73f-3d10-4d82-9b15-74ec65a6c679">2,948,694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfNC0zLTEtMS0zNjE1Njk_13fd7ded-3614-4115-bbc4-4ef2082bf1e5">2,938,319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfNC01LTEtMS0zNjE1Njk_2335690a-f714-41af-b07d-1da153fce60b">8,693,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfNC03LTEtMS0zNjE1Njk_f20aad33-27b1-484a-91f9-4240fc68db89">8,674,830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Patient care costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930" decimals="-3" name="dva:PatientCareCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfNi0xLTEtMS0zNjE1Njk_63344b0d-aba8-43d6-bbd5-dd2f2c0a0583">2,085,555</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930" decimals="-3" name="dva:PatientCareCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfNi0zLTEtMS0zNjE1Njk_044f75d8-ca1d-43f3-a956-5f1dc55b3037">2,008,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="dva:PatientCareCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfNi01LTEtMS0zNjE1Njk_3aac9313-844e-48e5-b8e9-ad841f5903d2">6,120,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="dva:PatientCareCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfNi03LTEtMS0zNjE1Njk_d805ced2-00c7-401d-bcb4-645ca9e09485">5,912,196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfNy0xLTEtMS0zNjE1Njk_bb00af36-2af7-422c-b9fe-48ae8918910f">365,447</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfNy0zLTEtMS0zNjE1Njk_763db518-fe23-4ab6-8fc9-aecabe767bc9">293,095</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfNy01LTEtMS0zNjE1Njk_d6d54c23-39df-4c61-ba8c-3ad574bb518d">975,486</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfNy03LTEtMS0zNjE1Njk_66d35dc0-5d00-43b3-811f-c76206b737ba">872,612</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfOC0xLTEtMS0zNjE1Njk_736d4a07-b868-4b1a-9417-ae7ac148e3e8">194,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfOC0zLTEtMS0zNjE1Njk_00f29fb5-2ef3-4ce6-a6db-b7ee34121814">170,462</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfOC01LTEtMS0zNjE1Njk_b0ebb452-fe59-4f27-9bae-b698228861b1">538,534</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfOC03LTEtMS0zNjE1Njk_b5f17b04-7545-4812-9ad7-a36a0c81656a">505,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity investment income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfOS0xLTEtMS0zNjE1Njk_b7610f2c-7230-4d65-9dbc-df028b67adf4">8,509</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfOS0zLTEtMS0zNjE1Njk_9d6cf254-3a86-4bed-97fc-b0b7fde58377">8,704</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfOS01LTEtMS0zNjE1Njk_ec75f2a2-aa05-4ac2-905a-e566e4ba6e42">24,696</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfOS03LTEtMS0zNjE1Njk_a1a528a5-3d2b-4608-af19-88c2bbef2133">23,785</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMTItMS0xLTEtMzYxNTY5_a81d6ac7-7ec3-4385-96bf-031f8ee519c7">2,636,907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMTItMy0xLTEtMzYxNTY5_2f39bef7-6595-49a3-9adb-a25cd5470d2f">2,463,442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMTItNS0xLTEtMzYxNTY5_45b2ae45-94db-4b27-af97-f2b4d35452ea">7,610,196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMTItNy0xLTEtMzYxNTY5_438701da-067f-45eb-835b-c12617f5caba">7,266,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMTMtMS0xLTEtMzYxNTY5_cc281aa0-e55d-466f-9cde-ee1d20827836">311,787</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMTMtMy0xLTEtMzYxNTY5_7a126112-14e4-4644-8eb2-bb7050eea784">474,877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMTMtNS0xLTEtMzYxNTY5_047c157b-6199-47c5-b9c8-e0ac9419bb2a">1,082,810</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMTMtNy0xLTEtMzYxNTY5_d40d361e-16f0-4a26-8b5b-96f3105a86ab">1,407,955</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930" decimals="-3" name="us-gaap:InterestAndDebtExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMTQtMS0xLTEtMzYxNTY5_2de35fc2-09e3-4719-baf9-ca441f7dc52f">99,680</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930" decimals="-3" name="us-gaap:InterestAndDebtExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMTQtMy0xLTEtMzYxNTY5_224053f4-c832-4dd6-bec7-7666a0973416">72,829</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:InterestAndDebtExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMTQtNS0xLTEtMzYxNTY5_d1336c6e-f884-4992-84e2-a00c8d3b2cd5">256,057</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:InterestAndDebtExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMTQtNy0xLTEtMzYxNTY5_1228b1a1-e644-44ac-b9e3-70a835ff11d3">213,167</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other (loss) income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMTYtMS0xLTEtMzYxNTY5_f79b079d-dd86-4b37-af8e-e5354d78667f">4,898</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMTYtMy0xLTEtMzYxNTY5_1c586133-bf6c-4b56-b6c4-37a33e232dd0">7,590</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMTYtNS0xLTEtMzYxNTY5_7a2e0d57-00ac-4244-8fe4-dd303a95649c">7,968</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMTYtNy0xLTEtMzYxNTY5_a9473c08-cdfd-4b50-90a0-59d9fda97411">8,766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMTctMS0xLTEtMzYxNTY5_cb9e3ee4-d25d-43f2-a1cd-5085df2f5f5f">207,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMTctMy0xLTEtMzYxNTY5_d837a93b-5021-4ca2-9cad-33342ee820f7">394,458</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMTctNS0xLTEtMzYxNTY5_a226f10c-3775-4674-99a0-bf5c37aed859">818,785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMTctNy0xLTEtMzYxNTY5_40f25322-ed2e-4382-99ca-78e2c6da9ec6">1,203,554</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMTgtMS0xLTEtMzYxNTY5_887a18a3-4fa3-444c-8488-2900998e664a">42,515</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMTgtMy0xLTEtMzYxNTY5_2fb4cf8b-2c32-48b4-a3e7-3d477fef9342">74,704</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMTgtNS0xLTEtMzYxNTY5_48de89bb-a746-4757-b8a1-c97c709fdf5c">163,757</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMTgtNy0xLTEtMzYxNTY5_fd6737b5-3c81-4960-87c6-dcc5f9eb3891">241,224</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMjEtMS0xLTEtMzYxNTY5_d8044268-4b86-4998-9b65-c8a3a9bfb808">164,694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMjEtMy0xLTEtMzYxNTY5_f7e1df7a-34be-458e-a17c-7909c275a54a">319,754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMjEtNS0xLTEtMzYxNTY5_d926e3af-db52-4f60-bb8e-ca35a75b1d41">655,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMjEtNy0xLTEtMzYxNTY5_a4041138-b48c-428c-9f91-5d134648e354">962,330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMjItMS0xLTEtMzYxNTY5_bb00e8f6-302b-4069-a5bf-9b878c00bb4b">59,328</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMjItMy0xLTEtMzYxNTY5_a37fbe72-9fd7-41a3-a582-b7abb3f5cd9a">60,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMjItNS0xLTEtMzYxNTY5_54451c68-9032-4e65-9075-2b6d3e6d5419">162,731</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMjItNy0xLTEtMzYxNTY5_bcf16ec9-e6f1-4588-9e7f-892528458be6">171,353</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to DaVita Inc.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMjMtMS0xLTEtMzYxNTY5_e6b1aec8-48de-430a-8792-f388f9a66b57">105,366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMjMtMy0xLTEtMzYxNTY5_944eb644-362b-4a94-8114-7232d077ff89">259,754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMjMtNS0xLTEtMzYxNTY5_da217910-4cd7-441e-8d62-c7cd48ffcd37">492,297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMjMtNy0xLTEtMzYxNTY5_21852a04-6ec7-4da7-8fd4-443398bff0e5">790,977</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earnings per share attributable to DaVita Inc.:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMjctMS0xLTEtMzYxNTY5_12954553-f78e-4289-aed2-15c3a64cad24">1.16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMjctMy0xLTEtMzYxNTY5_ab03cc2a-c6bb-42b3-a0c4-fdacaf5d1b43">2.48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMjctNS0xLTEtMzYxNTY5_d06d295e-a3d2-4cc3-bb25-2a05f4ca7e3b">5.24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMjctNy0xLTEtMzYxNTY5_d675baab-9f84-445a-9361-d4da000cfd0f">7.41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted net income</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMjktMS0xLTEtMzYxNTY5_c8bf3255-8841-4c94-a8db-d7143e81cf0a">1.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMjktMy0xLTEtMzYxNTY5_d3bf41d6-1bb6-41ae-b9ff-c4b142f862dc">2.36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMjktNS0xLTEtMzYxNTY5_3ef762b2-e88b-4151-aad7-73ba668b50f6">5.07</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMjktNy0xLTEtMzYxNTY5_cef55e42-c901-437c-af1d-7e1c04b1c471">7.08</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted average shares for earnings per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMzItMS0xLTEtMzYxNTY5_8d0e69dd-1f47-46ca-9933-504bef79c0b5">91,160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMzItMy0xLTEtMzYxNTY5_9c099e1d-d0d3-4918-8ec2-adf955d7b76a">104,793</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMzItNS0xLTEtMzYxNTY5_e715b69a-f76d-4191-9dfa-71c5bf116f20">93,959</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMzItNy0xLTEtMzYxNTY5_ac8a34b5-2549-4329-a2d9-fea07878c7c6">106,685</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted shares</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMzMtMS0xLTEtMzYxNTY5_7bc66e12-acbb-4e4c-98b7-9272c1aef4ad">93,263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMzMtMy0xLTEtMzYxNTY5_043dacae-3aca-415d-9d51-c00024ee452c">109,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMzMtNS0xLTEtMzYxNTY5_a203dec7-995e-4bec-8c47-17d133c730b2">97,153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMzMtNy0xLTEtMzYxNTY5_544ba2ed-e4d1-45d4-8c55-3d6e711a006c">111,666</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i9311e9c566584bd9ab5dffbc9b9a605b_16"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars in thousands)</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfMi0xLTEtMS0zNjE1Njk_d8044268-4b86-4998-9b65-c8a3a9bfb808">164,694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfMi0zLTEtMS0zNjE1Njk_f7e1df7a-34be-458e-a17c-7909c275a54a">319,754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfMi01LTEtMS0zNjE1Njk_d926e3af-db52-4f60-bb8e-ca35a75b1d41">655,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfMi03LTEtMS0zNjE1Njk_a4041138-b48c-428c-9f91-5d134648e354">962,330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gains (losses) on interest rate cap agreements:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gains (losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfNS0xLTEtMS0zNjE1Njk_f019b7bf-e7b6-4e0f-a8ee-d46c74ecfa22">41,312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfNS0zLTEtMS0zNjE1Njk_2af05015-a908-422f-b4fc-0c31c913aacb">357</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfNS01LTEtMS0zNjE1Njk_d7ff750c-1e96-41d0-b303-39cbc011d14c">95,660</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfNS03LTEtMS0zNjE1Njk_64d40dac-ebf1-4dfe-981b-0e8165b88185">2,466</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reclassifications of net realized losses into net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfNi0xLTEtMS0zNjE1Njk_3d7b81a9-6bdf-456d-9888-1dfabc736219">1,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfNi0zLTEtMS0zNjE1Njk_3bf891d8-0c38-4655-9a76-2b1b719faf6b">1,034</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfNi01LTEtMS0zNjE1Njk_3e908dd0-b30a-4e53-b520-a3064d9de9ca">3,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfNi03LTEtMS0zNjE1Njk_69527cfa-f90b-4253-ab34-47f861c0df43">3,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized losses on foreign currency translation:</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfNy0xLTEtMS0zNjE1Njk_87b80b0b-dbf4-4139-aad4-59c6dc45c9ce">66,100</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfNy0zLTEtMS0zNjE1Njk_c6ce82d7-db6d-49d5-9130-9ffcbab50850">54,528</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfNy01LTEtMS0zNjE1Njk_16534840-9205-4482-bbb0-f19d6d824070">95,064</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfNy03LTEtMS0zNjE1Njk_7df17b67-92a6-4018-b150-8299764f55ac">59,162</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfOC0xLTEtMS0zNjE1Njk_7c0e67a3-7dbd-453f-b354-51861267be75">23,755</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfOC0zLTEtMS0zNjE1Njk_115c76a5-5a67-4fff-8b45-19d8dbe1f50a">53,851</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfOC01LTEtMS0zNjE1Njk_71fe3c92-390a-4fce-8e6c-d3813159421f">3,696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfOC03LTEtMS0zNjE1Njk_7ed00d62-9d80-4220-b4e9-b228c966d5dc">53,596</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfOS0xLTEtMS0zNjE1Njk_ad17e804-25d1-4360-b423-66e0b0511dd1">140,939</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfOS0zLTEtMS0zNjE1Njk_61cac17f-9588-42bb-a73c-8852b2caa3ee">265,903</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfOS01LTEtMS0zNjE1Njk_8726716e-b1ff-4ead-9572-777cacf30567">658,724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfOS03LTEtMS0zNjE1Njk_bd6d71cc-b347-4b4d-b2d6-936e18a2321c">908,734</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Comprehensive income attributable to <br/>&#160;noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfMTAtMS0xLTEtMzYxNTY5_e5537cda-9d80-4870-b826-2cc5d6d64051">59,328</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfMTAtMy0xLTEtMzYxNTY5_3b1c101e-88a6-4126-ae54-4035a20a4079">60,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfMTAtNS0xLTEtMzYxNTY5_49837a59-8269-4aff-90d0-ded475176475">162,731</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfMTAtNy0xLTEtMzYxNTY5_b0b914fd-6ca1-4272-b1a9-d8addcd8ebd9">171,353</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive income attributable to DaVita Inc.</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfMTEtMS0xLTEtMzYxNTY5_0e6815a6-3b63-46c1-b2b0-27bc914e31c3">81,611</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfMTEtMy0xLTEtMzYxNTY5_4d25c4e6-5c07-4663-8dca-2d0a87dff4d3">205,903</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfMTEtNS0xLTEtMzYxNTY5_ae4cdb25-fb92-4aff-ab6f-7703da31f353">495,993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfMTEtNy0xLTEtMzYxNTY5_f0c094ef-6e51-4038-8655-e97fc072523b">737,381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;See notes to condensed consolidated financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i9311e9c566584bd9ab5dffbc9b9a605b_19"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.352%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMi0xLTEtMS0zNjE1Njk_8fd6d38f-7e28-495d-8338-0551eaf6df40">367,510</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMi0zLTEtMS0zNjE1Njk_b6bf89f4-f414-468c-a5bb-3fb47919d32d">461,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash and equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMy0xLTEtMS0zNjE1Njk_3c3b4968-e833-4636-97e1-238d2a07b913">94,704</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMy0zLTEtMS0zNjE1Njk_640e6604-11f5-4bcd-812b-044f87235877">93,060</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfNC0xLTEtMS0zNjE1Njk_d34eaa71-2081-4519-a2cd-3debdb1ba6a9">74,305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfNC0zLTEtMS0zNjE1Njk_e6ea2361-0516-41f6-9a0b-f6ef0927c479">22,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfNS0xLTEtMS0zNjE1Njk_16c92950-df7f-46a8-b9e6-d90277c44a8f">2,089,017</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfNS0zLTEtMS0zNjE1Njk_d07cd255-c4fc-4d37-826e-443eea1a2e2e">1,957,583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfNi0xLTEtMS0zNjE1Njk_dbceeabd-b52b-4257-b93d-b8cfe87a6e31">106,845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfNi0zLTEtMS0zNjE1Njk_eafa3999-29d6-4495-b349-50e95d8f238c">107,428</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfNy0xLTEtMS0zNjE1Njk_88f2ff10-7855-4a8f-a910-938732f83191">392,851</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfNy0zLTEtMS0zNjE1Njk_26bb0ff9-919b-42a4-8e8f-06bcc5e6ce37">427,321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfOC0xLTEtMS0zNjE1Njk_dc2e27df-2980-4d44-8ecd-301b648119fc">65,807</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfOC0zLTEtMS0zNjE1Njk_2046d2e9-438f-4535-b62a-6cf060b6e573">72,517</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:IncomeTaxesReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfOS0xLTEtMS0zNjE1Njk_41109cbb-af87-4fe6-9d7b-87b9748a9470">11,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:IncomeTaxesReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfOS0zLTEtMS0zNjE1Njk_493b5a4d-9bb6-4e0f-9bc3-bf2ce630a2a3">25,604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMTAtMS0xLTEtMzYxNTY5_d22bde8b-fabf-45e8-9a4b-a013be9dbae5">3,202,442</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMTAtMy0xLTEtMzYxNTY5_f805a555-9c5a-4d78-9aae-0ef3cc2c0adb">3,167,723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property and equipment, net of accumulated depreciation of $<ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentOwnedAccumulatedDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMTEtMC0xLTEtMzYxNTY5L3RleHRyZWdpb246MzI4NzQ3MjlhYTM2NGRiM2JlMDk3NDBiOGMxNjAwNjNfNjM_ce00ea26-9f14-4f33-84eb-e0fa77992137">5,114,579</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentOwnedAccumulatedDepreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMTEtMC0xLTEtMzYxNTY5L3RleHRyZWdpb246MzI4NzQ3MjlhYTM2NGRiM2JlMDk3NDBiOGMxNjAwNjNfNzA_a9833521-90f1-4a11-9115-4be57f198c0e">4,763,135</ix:nonFraction>, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMTEtMS0xLTEtMzYxNTY5_e3a8580d-4fba-4cd8-90e9-ec775dff6ee4">3,240,310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMTEtMy0xLTEtMzYxNTY5_40b5b375-10e4-43e1-b5c1-85796bdb027e">3,479,972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMTItMS0xLTEtMzYxNTY5_4e7f5125-faa2-4160-9085-88a3eb460c56">2,721,888</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMTItMy0xLTEtMzYxNTY5_483f27a2-6d12-4206-adca-5350c1d7ee89">2,824,787</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets, net of accumulated amortization of $<ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMTMtMC0xLTEtMzYxNTY5L3RleHRyZWdpb246N2VmMTZmNWJiNjFhNDVlNWIzY2Y2YWJmMGU4NTUwNmRfNTg_2463dea3-d35a-465a-93d3-47100c7142b4">46,907</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMTMtMC0xLTEtMzYxNTY5L3RleHRyZWdpb246N2VmMTZmNWJiNjFhNDVlNWIzY2Y2YWJmMGU4NTUwNmRfNjU_e0f068a2-9979-4426-96d6-2d5d727b1e02">60,730</ix:nonFraction>, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMTMtMS0xLTEtMzYxNTY5_0f8a2068-1efb-4416-9a7a-6e703057ccc3">179,715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMTMtMy0xLTEtMzYxNTY5_1c960d75-1a03-46a8-baf1-0872535ade1f">177,693</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity method and other investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMTQtMS0xLTEtMzYxNTY5_c7d345a8-36cb-48e7-be64-6eafb8424f17">243,554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMTQtMy0xLTEtMzYxNTY5_d623e9e9-f18f-415e-b433-3ebd1c4bf1c8">238,881</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:MarketableSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMTUtMS0xLTEtMzYxNTY5_57ea7d70-98e7-4c6a-ac50-8c17f3baad58">43,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:MarketableSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMTUtMy0xLTEtMzYxNTY5_82c761eb-b698-4683-ad54-edc5a777decb">49,514</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMTYtMS0xLTEtMzYxNTY5_12b7b264-ef08-4c2f-97ab-a5a35b677827">307,713</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMTYtMy0xLTEtMzYxNTY5_fa4985e2-5c54-441f-81b4-6c213dd552b4">136,677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMTctMS0xLTEtMzYxNTY5_26ece92d-6d7f-43e5-b1e9-b5e4377dc89a">7,022,642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMTctMy0xLTEtMzYxNTY5_8b491d00-1052-48dd-8c7b-3da7fdc40a9b">7,046,241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMTgtMS0xLTEtMzYxNTY5_216607c7-e831-44f4-8c98-8c6df64a5bf7">16,961,799</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMTgtMy0xLTEtMzYxNTY5_e1a500fb-3468-47a2-88fc-8ec1ffcd8794">17,121,488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES AND EQUITY</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMjAtMS0xLTEtMzYxNTY5_918753f9-ebd6-44ee-aa19-d82db2954aa0">417,139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMjAtMy0xLTEtMzYxNTY5_f038d23a-0506-4e91-bb8f-afb4b3071e37">402,049</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMjEtMS0xLTEtMzYxNTY5_13e7f497-8841-4b5f-9283-17312bf02fc2">796,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMjEtMy0xLTEtMzYxNTY5_488f8027-305b-4918-bee5-f2f68f313c8f">709,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMjItMS0xLTEtMzYxNTY5_43446236-7c14-4019-939d-7e2e006218e9">702,877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMjItMy0xLTEtMzYxNTY5_25b9614c-e88c-48bf-9792-27103716ddd2">659,960</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMjMtMS0xLTEtMzYxNTY5_10413e30-99f0-4b29-bf4e-e6e0a6769ba7">396,880</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMjMtMy0xLTEtMzYxNTY5_bbe8698e-d710-40b2-8813-9d75f4b55536">394,357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMjQtMS0xLTEtMzYxNTY5_cd10e0a5-51d3-4b53-b9cc-eb232b200fef">214,254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMjQtMy0xLTEtMzYxNTY5_df6dfaa6-2d85-4215-870b-605ac632fbcf">179,030</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMjUtMS0xLTEtMzYxNTY5_f6df254c-712d-4d3c-be4d-13e70fc19f12">10,059</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMjUtMy0xLTEtMzYxNTY5_8c98290f-baf0-4b85-a35f-f2c13c1e9f6d">53,792</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMjYtMS0xLTEtMzYxNTY5_aa7b78b9-9942-4eb0-875a-686fbe04a19b">2,537,409</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMjYtMy0xLTEtMzYxNTY5_a9295cf2-a4c9-4f13-ac59-b9dc8a613704">2,398,533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMjctMS0xLTEtMzYxNTY5_c7343d69-664d-4e9c-a858-7b2a93ebda74">2,558,355</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMjctMy0xLTEtMzYxNTY5_21186d91-624a-4465-80d2-b19b1a3770cc">2,672,713</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMjgtMS0xLTEtMzYxNTY5_7118b730-1df4-4bc4-9449-b2091c3a2d2a">8,867,187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMjgtMy0xLTEtMzYxNTY5_cfdd56ad-7522-43b8-a719-4863204afda5">8,729,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMjktMS0xLTEtMzYxNTY5_30d6489b-3c0f-46f1-9420-9b8ba080b5a1">106,895</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMjktMy0xLTEtMzYxNTY5_17e810b0-fda9-4161-baf5-5626b4e2cc60">119,158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzAtMS0xLTEtMzYxNTY5_021cf3ef-699f-4f52-a3cf-e158f3a435aa">819,073</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzAtMy0xLTEtMzYxNTY5_a3471c25-ee6c-4055-b0ce-19233a86f031">830,954</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzEtMS0xLTEtMzYxNTY5_6842e510-3561-4d30-a7e2-8d0e2586cd80">14,888,919</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzEtMy0xLTEtMzYxNTY5_dc205d9d-d9ac-4b39-a804-aef4d80f058a">14,750,508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests subject to put provisions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzMtMS0xLTEtMzYxNTY5_1e472794-c9bd-4f65-88fe-bb8939437957">1,370,753</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzMtMy0xLTEtMzYxNTY5_dc1a7814-29dc-4122-a6d1-ae1afa3b788b">1,434,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock ($<ix:nonFraction unitRef="usdPerShare" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="3" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzUtMC0xLTEtMzYxNTY5L3RleHRyZWdpb246NWJkYTJkMjE2NjRiNGUwZGE2MmRiMGM3NzQ5MmVjODJfMjE_ed1455a7-e3b6-47bd-864f-6b614ad20386">0.001</ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzUtMC0xLTEtMzYxNTY5L3RleHRyZWdpb246NWJkYTJkMjE2NjRiNGUwZGE2MmRiMGM3NzQ5MmVjODJfMzU_0d4b1dad-ca28-435b-9078-c86cb069cf60">5,000</ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzUtMC0xLTEtMzYxNTY5L3RleHRyZWdpb246NWJkYTJkMjE2NjRiNGUwZGE2MmRiMGM3NzQ5MmVjODJfNTc_1b8161a4-260c-4b34-ae21-439d1d1e173e">none</ix:nonFraction> issued)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#cceeff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzUtMS0xLTEtMzYxNTY5_fa8741fe-d88d-44bb-8cfc-fe242e2a6d2e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#cceeff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzUtMy0xLTEtMzYxNTY5_2721713c-18fa-447f-9acc-a0b71a97c95f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock ($<ix:nonFraction unitRef="usdPerShare" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="3" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzYtMC0xLTEtMzYxNTY5L3RleHRyZWdpb246M2VlOGQxNTk1MTQ0NDQ4MGE5YTQ5NGRjYzUwZmIxODJfMTg_8bdd1b1c-ee21-41f2-b4bb-dbeda5f3fe6d">0.001</ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzYtMC0xLTEtMzYxNTY5L3RleHRyZWdpb246M2VlOGQxNTk1MTQ0NDQ4MGE5YTQ5NGRjYzUwZmIxODJfMzI_336c80b4-4ff6-4fdb-8b61-b8e9a97ba614">450,000</ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzYtMC0xLTEtMzYxNTY5L3RleHRyZWdpb246M2VlOGQxNTk1MTQ0NDQ4MGE5YTQ5NGRjYzUwZmIxODJfNTQ_1fbd35b2-a792-4460-929f-4a6b5df739a7">98,199</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzYtMC0xLTEtMzYxNTY5L3RleHRyZWdpb246M2VlOGQxNTk1MTQ0NDQ4MGE5YTQ5NGRjYzUwZmIxODJfNjE_d20f3ba7-976b-4612-bee6-aae5e66450d3">90,104</ix:nonFraction> shares</span></div><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;issued and outstanding at September&#160;30, 2022, respectively, and <ix:nonFraction unitRef="shares" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzYtMC0xLTEtMzYxNTY5L3RleHRyZWdpb246M2VlOGQxNTk1MTQ0NDQ4MGE5YTQ5NGRjYzUwZmIxODJfMTIw_0a467bed-d226-4d4e-8d66-e33c0573815d">97,289</ix:nonFraction> shares issued and</span></div><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;outstanding at December&#160;31, 2021)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzYtMS0xLTEtMzYxNTY5_dbc192d8-099f-408e-a34c-941e3973adb9">98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzYtMy0xLTEtMzYxNTY5_7e538069-af69-49fe-aaad-60ecbb3e3c75">97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzctMS0xLTEtMzYxNTY5_4db97a25-eb9a-4074-9936-124de6d0173a">609,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzctMy0xLTEtMzYxNTY5_3d9438da-241e-4917-afee-0b0d92a500e5">540,321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzgtMS0xLTEtMzYxNTY5_612fb3c1-9f1b-4d6b-aa2a-96cf5ad4011b">846,634</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzgtMy0xLTEtMzYxNTY5_154f4d0a-867d-4d4d-bf43-a649e499a44b">354,337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury stock (<ix:nonFraction unitRef="shares" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzktMC0xLTEtMzYxNTY5L3RleHRyZWdpb246ODJhZWQ0MDZkMTkyNGQ0NDk2YmVhZDViYzZlYzhkZDJfMjA_0ba01b7b-c0c7-46f6-b43d-4cabeb5abb67">8,095</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzktMC0xLTEtMzYxNTY5L3RleHRyZWdpb246ODJhZWQ0MDZkMTkyNGQ0NDk2YmVhZDViYzZlYzhkZDJfMjc_177ff8ee-1daa-42a6-ba93-8f9c07844237">zero</ix:nonFraction> shares, respectively)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzktMS0xLTEtMzYxNTY5_7ca97934-9852-45e8-8af7-b06169e0e9f6">787,854</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:TreasuryStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzktMy0xLTEtMzYxNTY5_c24dcaee-61ce-412a-968d-9c7a1d98c02a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfNDAtMS0xLTEtMzYxNTY5_5844284f-9f4a-4c8a-b164-1f69f9e28aa2">135,551</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfNDAtMy0xLTEtMzYxNTY5_04cf669c-9d97-47f7-8f81-84930ecc6fb7">139,247</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total DaVita Inc. shareholders' equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfNDEtMS0xLTEtMzYxNTY5_c91af45b-5dc5-42f1-b6b8-0e811cd62379">532,672</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfNDEtMy0xLTEtMzYxNTY5_29ec1f33-6838-4f0d-a7ac-c5b447c4dcc3">755,508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests not subject to put provisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfNDItMS0xLTEtMzYxNTY5_2b60caf6-1a57-46be-8f05-d2c0fd5a7443">169,455</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfNDItMy0xLTEtMzYxNTY5_5043446e-c1b8-423f-9182-d0e3c2c8a055">180,640</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfNDMtMS0xLTEtMzYxNTY5_1841b84c-b208-48fe-b0de-39441adac120">702,127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfNDMtMy0xLTEtMzYxNTY5_6a51cbb6-2e11-44bd-a46b-afd889d20cdb">936,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfNDQtMS0xLTEtMzYxNTY5_cfd04daa-135f-4978-b9d4-79f3a93ff61d">16,961,799</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfNDQtMy0xLTEtMzYxNTY5_739f5e8a-e0d6-457e-8377-a21ed5f670db">17,121,488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i9311e9c566584bd9ab5dffbc9b9a605b_25"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOW</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars in thousands)</span></div><div style="margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.206%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMy0xLTEtMS0zNjE1Njk_e58e6d87-6659-4c75-a16b-ebbd55e8bae2">655,028</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMy0zLTEtMS0zNjE1Njk_9d2c0a14-42fb-431e-9470-632d23aa91e1">962,330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:DepreciationAmortizationAndAccretionNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfNS0xLTEtMS0zNjE1Njk_e4158002-ad47-407b-a1de-40cec3b62a42">538,534</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:DepreciationAmortizationAndAccretionNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfNS0zLTEtMS0zNjE1Njk_e9e75e88-ca4e-4b58-a423-f2dc673d784c">505,852</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfOC0xLTEtMS0zNjE1Njk_2aff8e89-c223-4f64-b698-ec31e241f593">77,904</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfOC0zLTEtMS0zNjE1Njk_0d186dd0-4fc0-4be2-b4c3-d1e4993a58f2">75,898</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfOS0xLTEtMS0zNjE1Njk_492ffa72-92f4-4dfd-8700-129ada2d1ad3">35,637</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfOS0zLTEtMS0zNjE1Njk_cbd1fcad-0712-4d22-9171-169bb35dd3d1">56,724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity investment income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMTAtMS0xLTEtMzYxNTY5_c1327575-31b6-4ae3-9f75-5f7969cdcb67">417</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMTAtMy0xLTEtMzYxNTY5_80f2eb20-9721-48e5-bf06-649596b2e013">1,687</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-cash charges, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMTItMS0xLTEtMzYxNTY5_abe1ee3f-b1b0-47fa-90d9-01bc3232ab51">16,035</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMTItMy0xLTEtMzYxNTY5_333dd469-d85f-470c-a97b-44dc0c2a8dab">13,418</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities, net of effect of acquisitions and divestitures:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMTQtMS0xLTEtMzYxNTY5_7ff426a6-fc0d-4896-9987-236e45a9db6d">135,632</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMTQtMy0xLTEtMzYxNTY5_1210ff26-a4de-47b9-a926-f82911894d2e">205,792</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMTUtMS0xLTEtMzYxNTY5_1999f9e7-a32c-44e6-bc94-14e6f0f39734">347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMTUtMy0xLTEtMzYxNTY5_08aec4a0-c17f-4501-ae1f-d04b67e29837">2,490</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other receivables and prepaid and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" sign="-" name="dva:IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMTYtMS0xLTEtMzYxNTY5_c0abe265-b4b4-4885-a3f9-bf5e91a6291e">43,392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" sign="-" name="dva:IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMTYtMy0xLTEtMzYxNTY5_f92e1d1d-b6d8-4b1c-a60f-d3a55d50c284">144,967</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMTctMS0xLTEtMzYxNTY5_855bc689-0c0e-4ba5-aab2-99c57af82d22">49,326</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMTctMy0xLTEtMzYxNTY5_0a6dd584-d3e1-4528-888a-0c84fcac10fb">19,663</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMTgtMS0xLTEtMzYxNTY5_fc49f7ce-476d-45fa-a97a-1a0b99d1dbba">38,870</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMTgtMy0xLTEtMzYxNTY5_c706fb44-5ad2-47ea-b671-a9b26f73b006">47,412</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMTktMS0xLTEtMzYxNTY5_493fdbb8-402e-4bd3-9827-a25da5845ea9">35,491</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMTktMy0xLTEtMzYxNTY5_b3a83746-860b-40e3-8951-6d9dd238807f">7,176</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMjAtMS0xLTEtMzYxNTY5_7c833220-a935-4fd2-8649-2898c07caf7d">87,248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMjAtMy0xLTEtMzYxNTY5_ff22b584-d2c2-4c44-9992-79ed3529bea9">87,842</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMjEtMS0xLTEtMzYxNTY5_7ae53fa9-9d8f-44a6-a9d7-6c3bc38d8edb">37,770</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMjEtMy0xLTEtMzYxNTY5_165668ac-05a2-4608-bbc7-428888bbb7c3">22,609</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMjItMS0xLTEtMzYxNTY5_eb81c7cf-7bcb-4aef-bf9f-bc31538d3f85">13,219</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMjItMy0xLTEtMzYxNTY5_5c639d8d-ffdc-4300-a779-2459da82799d">8,748</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMjMtMS0xLTEtMzYxNTY5_9689aef2-813c-4750-872c-f07d43841743">1,220,848</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMjMtMy0xLTEtMzYxNTY5_184b4a0e-9df5-4b6d-b71d-feb09eb9dd89">1,400,988</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additions of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMjUtMS0xLTEtMzYxNTY5_8eb515e9-b758-452a-9265-a446d311ad3b">409,391</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMjUtMy0xLTEtMzYxNTY5_c5f28c54-9f97-4a92-a003-d2f0e341637c">451,909</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMjYtMS0xLTEtMzYxNTY5_6b06f776-8bac-49fa-833f-0679c1aa65dc">43,811</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMjYtMy0xLTEtMzYxNTY5_7a52afaa-cc2f-45e3-a8e9-a9413f8c67bd">45,143</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from asset and business sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMjctMS0xLTEtMzYxNTY5_783d3761-612b-4aac-908a-b27978bef9b8">116,088</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMjctMy0xLTEtMzYxNTY5_a2bb463c-2695-42cd-b272-999c26d30c3b">46,578</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of debt investments held-to-maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsToAcquireHeldToMaturitySecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMjgtMS0xLTEtMzYxNTY5_23f9e9ba-1297-4d55-ac19-7083562bc4ab">94,602</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsToAcquireHeldToMaturitySecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMjgtMy0xLTEtMzYxNTY5_29afe1f4-bd70-426e-a3d8-bbe5c0a26be3">13,274</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of other debt and equity investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsToAcquireOtherInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMjktMS0xLTEtMzYxNTY5_f4bae11c-c877-4812-881a-b63ab5e894c0">3,322</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsToAcquireOtherInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMjktMy0xLTEtMzYxNTY5_81ae1c51-821d-4264-91fc-a3e278215541">2,609</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from debt investments held-to-maturity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMzAtMS0xLTEtMzYxNTY5_01024194-efa1-4ecd-97a7-ca900fdc5e0a">40,660</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMzAtMy0xLTEtMzYxNTY5_e49c8d64-210c-459d-85c4-d3205d8d1738">13,274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sale of other debt and equity investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMzEtMS0xLTEtMzYxNTY5_36593d7b-2ba1-4d63-add9-623627c11158">3,763</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMzEtMy0xLTEtMzYxNTY5_d6f6848b-d047-4190-82bb-4c9997a20018">11,976</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMzItMS0xLTEtMzYxNTY5_116c1882-cac7-48ec-bcb5-8f41b7d4edde">782</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMzItMy0xLTEtMzYxNTY5_56724271-3096-4f13-9627-64939cfeb16f">745</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of equity method investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMzMtMS0xLTEtMzYxNTY5_5b3ba405-28e4-43e8-bb2b-d7c24451a6bb">28,176</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMzMtMy0xLTEtMzYxNTY5_1d148524-1ee8-442a-ba42-4f5ce2766fbe">7,925</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distributions from equity method investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMzQtMS0xLTEtMzYxNTY5_5f2a45d9-8052-4c1e-af6e-44207c3d47a1">2,490</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMzQtMy0xLTEtMzYxNTY5_624424c3-2a1d-4235-a731-05bbfc4f720e">1,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMzUtMS0xLTEtMzYxNTY5_0d67c36d-6549-40a0-a96f-6a4b63a552e4">417,083</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMzUtMy0xLTEtMzYxNTY5_c58fa0b7-7507-476a-b19d-2200511aa517">448,185</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Borrowings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMzctMS0xLTEtMzYxNTY5_765baf7b-9ed7-45ff-be14-f9588c4507a6">1,705,913</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMzctMy0xLTEtMzYxNTY5_d005b898-6fce-4372-9f26-82be7450933a">1,613,036</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments on long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMzgtMS0xLTEtMzYxNTY5_fa71cd78-d10b-431a-a1b5-1722426a8c1d">1,557,358</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMzgtMy0xLTEtMzYxNTY5_a6c09fec-6a2b-4a1e-998e-f0449363c9f0">812,659</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred financing and debt redemption costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsOfFinancingCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMzktMS0xLTEtMzYxNTY5_cf37d5bf-3cb4-47c3-a88b-aceef2501865">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMzktMy0xLTEtMzYxNTY5_cebccbac-4ffb-40c1-b1db-5b60695de42b">9,091</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of treasury stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfNDAtMS0xLTEtMzYxNTY5_8b15fc38-578d-42af-9893-6b5b493fdb9a">802,228</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfNDAtMy0xLTEtMzYxNTY5_404e056a-2389-40b2-8e55-3e6d0f84977e">882,411</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Distributions to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsOfDistributionsToAffiliates" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfNDEtMS0xLTEtMzYxNTY5_3952fcfa-134b-4512-bb0d-ea823026ea34">188,592</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsOfDistributionsToAffiliates" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfNDEtMy0xLTEtMzYxNTY5_876f1025-2743-4c68-989d-f60c817e6af9">177,146</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net payments related to stock purchases and awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfNDItMS0xLTEtMzYxNTY5_c0f3400e-1e38-4957-847b-31ca704b9726">42,248</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfNDItMy0xLTEtMzYxNTY5_ea5404dc-5c22-4953-8618-625abbd45f3c">59,849</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contributions from noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:ProceedsFromContributionsFromAffiliates" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfNDMtMS0xLTEtMzYxNTY5_403070d7-3cb4-45e5-94a3-9b4be1be6f69">11,382</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:ProceedsFromContributionsFromAffiliates" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfNDMtMy0xLTEtMzYxNTY5_403339fc-6c63-4fdb-b151-b467001a3a71">28,295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sales of additional noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:ProceedsFromMinorityShareholders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfNDQtMS0xLTEtMzYxNTY5_c526bb80-5e19-4b54-a2a7-06349656da7b">3,673</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:ProceedsFromMinorityShareholders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfNDQtMy0xLTEtMzYxNTY5_ecedbc4a-a0c1-441a-8a67-17a07ddbd144">2,880</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfNDUtMS0xLTEtMzYxNTY5_feeaa7e4-911f-4041-99b4-4d66a037f3e1">20,770</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfNDUtMy0xLTEtMzYxNTY5_99d0ecf4-8769-44d7-a476-fbc04ed3e197">11,658</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfNDYtMS0xLTEtMzYxNTY5_1f1a2773-7b1c-443c-bfe6-9fa68df9aea5">890,228</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfNDYtMy0xLTEtMzYxNTY5_f5bf3574-d83a-42e2-9f59-8e06fd2c4f21">308,603</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfNDctMS0xLTEtMzYxNTY5_2b0bcc11-61f9-4193-a04b-3fd55e152550">6,283</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfNDctMy0xLTEtMzYxNTY5_87e7cc8d-475d-4d43-9a10-b03bd64a1e47">7,381</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (decrease) increase in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfNDgtMS0xLTEtMzYxNTY5_e0232822-6916-4234-b18d-2ecad9e61cfb">92,746</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfNDgtMy0xLTEtMzYxNTY5_e9eef995-a0cb-4204-8dc2-3ffe1bc05e88">636,819</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at beginning of the year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfNDktMS0xLTEtMzYxNTY5_ed3087db-bb09-477a-b814-cb49128f370d">554,960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf9e89b4e598444e8b9df2b00849c30a_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfNDktMy0xLTEtMzYxNTY5_b2a86d15-2a91-4917-bfcf-23d7bde7b90c">501,790</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at end of the period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfNTAtMS0xLTEtMzYxNTY5_a686d590-7261-4875-a304-242c6390ee13">462,214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b171dd2fa094f0183b61386c9e24e5f_I20210930" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfNTAtMy0xLTEtMzYxNTY5_18d5dcf0-f611-4cb1-aba2-8a582a95de6c">1,138,609</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i9311e9c566584bd9ab5dffbc9b9a605b_28"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands)</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:18.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.663%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.825%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.248%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.130%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.392%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.836%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended September 30, 2022</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-<br/>controlling<br/>interests<br/>subject to<br/>put provisions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="45" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">DaVita Inc. Shareholders&#8217; Equity</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-<br/>controlling<br/>interests not<br/>subject to<br/>put provisions</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional<br/>paid-in<br/>capital</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained<br/>earnings</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>other<br/>comprehensive<br/>loss</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance at June 30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia716f88984964a2b912c2cad0bd8a1fa_I20220630" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfNS0xLTEtMS0zNjE1Njk_483da286-368b-47ff-87f7-46c3ebad86ad">1,385,821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieb3363d3cbf6464faff1cbeaac015fa5_I20220630" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfNS0zLTEtMS0zNjE1Njk_591c1136-257e-4114-82b8-b7d30f8995fd">98,179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb3363d3cbf6464faff1cbeaac015fa5_I20220630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfNS01LTEtMS0zNjE1Njk_68c97d7a-f2da-4183-902b-101f80db9788">98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ed815cd2c304b559653370ccc275a2b_I20220630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfNS03LTEtMS0zNjE1Njk_909c410d-6e6b-4667-9445-8c0a455bb826">578,272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4e48eaf91dc4c408c68dbe262d5b593_I20220630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfNS05LTEtMS0zNjE1Njk_3dae4822-e46a-4a23-8d89-c86e7abb01e8">741,268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i225bee24745a47b79c36ca66d4a0f754_I20220630" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfNS0xMS0xLTEtMzYxNTY5_7381e814-9bef-4253-895b-ae7be2b867ac">5,973</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i225bee24745a47b79c36ca66d4a0f754_I20220630" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfNS0xMy0xLTEtMzYxNTY5_a32e832d-5ae3-42e7-8f93-05a913fabf60">603,058</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4611f48e469e4f43bc268b742f4eb3be_I20220630" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfNS0xNS0xLTEtMzYxNTY5_b0e0dfbf-b5f1-4541-b2cc-f6c59cdbac0e">111,796</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i825fb40a1a3741bbb7f8ab64213ff5a9_I20220630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfNS0xNy0xLTEtMzYxNTY5_a99bec47-bd0b-46ee-8683-4322a725d825">604,784</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba35f774a92e4ef7aed7d1d87280a599_I20220630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfNS0xOS0xLTEtMzYxNTY5_2def4a1e-35f7-40ad-adb1-8ef848664c29">170,390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Comprehensive income:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i147789d12c114b6f8c98855d532eca0e_D20220701-20220930" decimals="-3" name="us-gaap:TemporaryEquityNetIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfNy0xLTEtMS0zNjE1Njk_549c22cf-bfd3-4f34-86ce-0c92473a1878">39,205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbc46e0d55ea4c998cc9052010d50139_D20220701-20220930" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfNy05LTEtMS0zNjE1Njk_c8256001-3544-45f4-9f0b-cdd41b6eecb6">105,366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc29ea0c8d1844d39747787ecd867dc7_D20220701-20220930" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfNy0xNy0xLTEtMzYxNTY5_c6c5fe88-521b-4e2d-860b-9aa23db615f0">105,366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2320a27c131f4981931e8a5421b2ef7c_D20220701-20220930" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfNy0xOS0xLTEtMzYxNTY5_55287344-88f4-4726-a3a1-5a56ed1494b4">20,123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i275b9f2c01bb463f9786a30fe06b1e1f_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfOS0xNS0xLTEtMzYxNTY5_69e688e5-7183-4ec0-9800-57ffbb9c1803">23,755</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icc29ea0c8d1844d39747787ecd867dc7_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfOS0xNy0xLTEtMzYxNTY5_37acdec0-7d89-464d-8665-259ee4d71105">23,755</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock award plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i39e9b3036c5b4d1b9dae3f82941570f9_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMTEtMy0xLTEtMzYxNTY5_33a1e0d4-7373-4b9a-a93b-3bdaff730e2b">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc82d88333724b428b3e6c8367bbaeb8_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMTEtNy0xLTEtMzYxNTY5_1586d557-f227-4f34-944c-dd1cc5e71494">986</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icc29ea0c8d1844d39747787ecd867dc7_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMTEtMTctMS0xLTM2MTU2OQ_7c51a9bd-1261-4083-8627-7a4b8bc534f1">986</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock-settled stock-based<br/>&#160;compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc82d88333724b428b3e6c8367bbaeb8_D20220701-20220930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMTItNy0xLTEtMzYxNTY5_eb05b600-a2ac-40eb-9616-d9a00e761fd8">27,619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc29ea0c8d1844d39747787ecd867dc7_D20220701-20220930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMTItMTctMS0xLTM2MTU2OQ_e551a855-0353-4112-869e-abe2b63d2513">27,619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in noncontrolling<br/>&#160;interest from:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Distributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i147789d12c114b6f8c98855d532eca0e_D20220701-20220930" decimals="-3" name="dva:TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMTQtMS0xLTEtMzYxNTY5_3f814e1c-a2c1-4fd3-ae80-85b7f9398241">48,275</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2320a27c131f4981931e8a5421b2ef7c_D20220701-20220930" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMTQtMTktMS0xLTM2MTU2OQ_dc5fad02-65da-4744-8678-11a6ddb0c66d">22,002</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i147789d12c114b6f8c98855d532eca0e_D20220701-20220930" decimals="-3" name="dva:TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMTUtMS0xLTEtMzYxNTY5_868d9fcf-5603-409f-85d1-a9435f2b9483">1,996</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2320a27c131f4981931e8a5421b2ef7c_D20220701-20220930" decimals="-3" name="dva:NoncontrollingInterestIncreaseFromContributions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMTUtMTktMS0xLTM2MTU2OQ_17e55bf8-d812-4a25-919e-3b3fcfc48077">270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions and divestitures</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2320a27c131f4981931e8a5421b2ef7c_D20220701-20220930" decimals="-3" name="dva:NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMTYtMTktMS0xLTM2MTU2OQ_26814719-9cc6-4c5a-973b-414af49e4114">867</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Partial purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i147789d12c114b6f8c98855d532eca0e_D20220701-20220930" decimals="-3" name="dva:TemporaryEquityDecreasePurchaseOfInterests" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMTctMS0xLTEtMzYxNTY5_78406cb1-fa64-457f-afd4-588078f36473">215</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc82d88333724b428b3e6c8367bbaeb8_D20220701-20220930" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMTctNy0xLTEtMzYxNTY5_595d2c57-1c16-42ff-9e44-3e0096b6e3b2">3,339</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icc29ea0c8d1844d39747787ecd867dc7_D20220701-20220930" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMTctMTctMS0xLTM2MTU2OQ_a7abc802-0e3d-4411-aa08-d88be7f440a1">3,339</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2320a27c131f4981931e8a5421b2ef7c_D20220701-20220930" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMTctMTktMS0xLTM2MTU2OQ_7ca25372-1396-4728-abec-14e932131136">193</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value remeasurements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i147789d12c114b6f8c98855d532eca0e_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:TemporaryEquityAccretionToRedemptionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMTgtMS0xLTEtMzYxNTY5_de75d752-6bb4-4d9e-afec-d24d5deeee71">7,779</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc82d88333724b428b3e6c8367bbaeb8_D20220701-20220930" decimals="-3" name="us-gaap:MinorityInterestChangeInRedemptionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMTgtNy0xLTEtMzYxNTY5_c774f213-e67e-460d-9f9f-fc75e8dc3117">7,779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc29ea0c8d1844d39747787ecd867dc7_D20220701-20220930" decimals="-3" name="us-gaap:MinorityInterestChangeInRedemptionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMTgtMTctMS0xLTM2MTU2OQ_d97c9e0d-9b4a-4612-aece-cbdaa6fd9c9a">7,779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of treasury stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ia7b08c7176c749f98f073fea08d83f2b_D20220701-20220930" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMjAtMTEtMS0xLTM2MTU2OQ_123394bc-ffd5-4d82-b490-591a9b654e32">2,122</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia7b08c7176c749f98f073fea08d83f2b_D20220701-20220930" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMjAtMTMtMS0xLTM2MTU2OQ_40867b46-d0d5-4dd1-a9fa-34d8e4a8b836">184,796</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icc29ea0c8d1844d39747787ecd867dc7_D20220701-20220930" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMjAtMTctMS0xLTM2MTU2OQ_8fd2475c-0c57-4e3a-88ac-fcaf91461c1f">184,796</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance at September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d096d77a67d4147a3ff676d41c97ea4_I20220930" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMjEtMS0xLTEtMzYxNTY5_f17ff9f4-3b5b-4bad-95d8-c77d8627a6b5">1,370,753</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3f6ac9def05f4546ad8e00029f29c85f_I20220930" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMjEtMy0xLTEtMzYxNTY5_6c216e55-332d-4802-808f-9aaeb821be96">98,199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f6ac9def05f4546ad8e00029f29c85f_I20220930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMjEtNS0xLTEtMzYxNTY5_04ab7f0c-76ed-4cfd-9a0e-4b7727cb4412">98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida0a3398956c428db91dfbf84211ac9d_I20220930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMjEtNy0xLTEtMzYxNTY5_9addf7f3-126f-4188-84f7-de283baad348">609,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6362305fbd044f9b9980adcadabf8f07_I20220930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMjEtOS0xLTEtMzYxNTY5_45c34fde-8d6c-41f0-80fd-9cddd218deb5">846,634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i36614688dae84eef869cd0e6d793fa74_I20220930" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMjEtMTEtMS0xLTM2MTU2OQ_0732b3f9-7f81-4de1-955c-0a2a3d4c98e1">8,095</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36614688dae84eef869cd0e6d793fa74_I20220930" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMjEtMTMtMS0xLTM2MTU2OQ_eebd1a1e-e779-4387-b9ef-76928356be56">787,854</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i23a94ede934c4277b1d46b13e38fefd1_I20220930" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMjEtMTUtMS0xLTM2MTU2OQ_0d14d254-a207-4425-a0e3-944acbcbc742">135,551</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cf6560db6fe433e9fe35420f78329ca_I20220930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMjEtMTctMS0xLTM2MTU2OQ_41a896d9-bad0-421f-9e32-86823200d3e5">532,672</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd69c0a4b8da40a483520c9abec5ab4e_I20220930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMjEtMTktMS0xLTM2MTU2OQ_12e2d799-8055-44d9-b343-44fee0af0598">169,455</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:15pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:18.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.663%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.825%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.248%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.130%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.392%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.836%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended September 30, 2022</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-<br/>controlling<br/>interests<br/>subject to<br/>put provisions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="45" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">DaVita Inc. Shareholders&#8217; Equity</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-<br/>controlling<br/>interests not<br/>subject to<br/>put provisions</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional<br/>paid-in<br/>capital</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained<br/>earnings</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>other<br/>comprehensive<br/>loss</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i276433c699f648cf975516d1ebf29a92_I20211231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfNS0xLTEtMS0zNjE1Njk_302a9a3b-a26a-40cd-bf2b-e64ae6496e8a">1,434,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieac6f79edec64565b9a967d39744ab16_I20211231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfNS0zLTEtMS0zNjE1Njk_4f0a4673-440f-44a4-8bca-2c0149c6ec9e">97,289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieac6f79edec64565b9a967d39744ab16_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfNS01LTEtMS0zNjE1Njk_ea7d2d84-23f3-4ecf-81a5-e269a589401e">97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cbc28027ca9463d88cb9103183707e2_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfNS03LTEtMS0zNjE1Njk_791dd37e-8032-45f9-85a5-76acd409b3d4">540,321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idde5dd2e47cc48b3b4ab52a208a0b76c_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfNS05LTEtMS0zNjE1Njk_f5a644b3-4229-4852-8afd-3c968fdd43a3">354,337</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4f4b7c7d62ec4f68a27cb7f3d6ee06dd_I20211231" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfNS0xMS0xLTEtMzYxNTY5_755cfd41-9d17-4432-8e7d-0c9d0125b2c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f4b7c7d62ec4f68a27cb7f3d6ee06dd_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfNS0xMy0xLTEtMzYxNTY5_e82b47f9-2c33-4b99-a3b9-a2112c7d8f16">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ba288d628f64e839c5eef1fa88fdd33_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfNS0xNS0xLTEtMzYxNTY5_b28bc292-10b0-4be8-8a25-35eb05c64b67">139,247</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03c39842d00748dab2c10d4f15c2ada9_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfNS0xNy0xLTEtMzYxNTY5_d664fa39-d72d-41d0-90fd-988eb953a245">755,508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i530e6ba6cb654ba8beab393e20b2de81_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfNS0xOS0xLTEtMzYxNTY5_b793e8f6-a0f2-46eb-a8f3-c03c12117a29">180,640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Comprehensive income:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55a696e4c43e43a084a98a9190e869b0_D20220101-20220930" decimals="-3" name="us-gaap:TemporaryEquityNetIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfNy0xLTEtMS0zNjE1Njk_89b7ca05-6fbd-49e9-9435-58443addb690">113,157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07cba31e2e3b4a8ea010c559dcb43625_D20220101-20220930" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfNy05LTEtMS0zNjE1Njk_49102fa8-32b9-4c67-89ac-aef4a5d268ca">492,297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8139303e818c4499a156db063aa48dba_D20220101-20220930" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfNy0xNy0xLTEtMzYxNTY5_4c6a49e3-0cfe-4e31-b6a9-2fd0c1d6926a">492,297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73664eea57554ff1a6527a1e3088909e_D20220101-20220930" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfNy0xOS0xLTEtMzYxNTY5_cf0052b3-0f2e-4a12-b921-982fa661766f">49,574</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2f7382dda1241aaad40dfb7cb9dd962_D20220101-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfOS0xNS0xLTEtMzYxNTY5_b8549207-2b4d-449d-8dc8-e3373764f2e9">3,696</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8139303e818c4499a156db063aa48dba_D20220101-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfOS0xNy0xLTEtMzYxNTY5_d1cfe7e1-0631-4a93-a54c-ae30926f57a6">3,696</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock award plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i646ec415498444bd800c1444f673b411_D20220101-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMTEtMy0xLTEtMzYxNTY5_b8d37752-fbda-4dd2-b98b-ee73d1c55e0d">910</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i646ec415498444bd800c1444f673b411_D20220101-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMTEtNS0xLTEtMzYxNTY5_13bc27a6-d668-459f-bb3f-f1a54f26adff">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b36f5eee05c4272833ec6129d2e6d23_D20220101-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMTEtNy0xLTEtMzYxNTY5_d9997a37-04f1-4377-920e-20c49352da12">55,359</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8139303e818c4499a156db063aa48dba_D20220101-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMTEtMTctMS0xLTM2MTU2OQ_e5f7bec8-d58b-4886-b122-9de9c2ce4bc2">55,358</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock-settled stock-based<br/>&#160;compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b36f5eee05c4272833ec6129d2e6d23_D20220101-20220930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMTItNy0xLTEtMzYxNTY5_91ac1c1a-ca56-405a-abf9-bd3cb7580554">77,835</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8139303e818c4499a156db063aa48dba_D20220101-20220930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMTItMTctMS0xLTM2MTU2OQ_d6e30ef1-c95b-4c0c-bca6-fea6e5f4d89d">77,835</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in noncontrolling<br/>&#160;interest from:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Distributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55a696e4c43e43a084a98a9190e869b0_D20220101-20220930" decimals="-3" name="dva:TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMTQtMS0xLTEtMzYxNTY5_cb60ee36-e1e3-413c-9770-5441b44bd59c">125,534</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73664eea57554ff1a6527a1e3088909e_D20220101-20220930" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMTQtMTktMS0xLTM2MTU2OQ_40801b26-f83a-4f03-883b-e092ae65fb2a">63,058</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55a696e4c43e43a084a98a9190e869b0_D20220101-20220930" decimals="-3" name="dva:TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMTUtMS0xLTEtMzYxNTY5_df6a5629-74ef-477b-9508-d537a54015c6">9,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73664eea57554ff1a6527a1e3088909e_D20220101-20220930" decimals="-3" name="dva:NoncontrollingInterestIncreaseFromContributions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMTUtMTktMS0xLTM2MTU2OQ_905707b6-88cf-40e9-a414-311643d41191">2,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions and divestitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55a696e4c43e43a084a98a9190e869b0_D20220101-20220930" decimals="-3" name="dva:TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMTYtMS0xLTEtMzYxNTY5_8805ba7b-fa58-4940-8b3e-ef78645da3d4">2,392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b36f5eee05c4272833ec6129d2e6d23_D20220101-20220930" decimals="-3" name="dva:NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMTYtNy0xLTEtMzYxNTY5_778c398b-444e-4c4c-a6f9-cf56fc93bf4d">939</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8139303e818c4499a156db063aa48dba_D20220101-20220930" decimals="-3" name="dva:NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMTYtMTctMS0xLTM2MTU2OQ_24fcc1d6-31dd-4ab0-b8f0-b0a0a60df6ac">939</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73664eea57554ff1a6527a1e3088909e_D20220101-20220930" decimals="-3" name="dva:NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMTYtMTktMS0xLTM2MTU2OQ_30c16ab4-0d3e-40e7-b3a8-c197283d70fd">867</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Partial purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55a696e4c43e43a084a98a9190e869b0_D20220101-20220930" decimals="-3" name="dva:TemporaryEquityDecreasePurchaseOfInterests" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMTctMS0xLTEtMzYxNTY5_122c01da-3ded-46c1-ad16-7b59a24207f0">11,633</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b36f5eee05c4272833ec6129d2e6d23_D20220101-20220930" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMTctNy0xLTEtMzYxNTY5_952f2b2c-dffd-4adc-9f0a-0506d8144ba2">6,609</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8139303e818c4499a156db063aa48dba_D20220101-20220930" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMTctMTctMS0xLTM2MTU2OQ_1270dc22-6b13-479f-9727-3cd475aab6e7">6,609</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73664eea57554ff1a6527a1e3088909e_D20220101-20220930" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMTctMTktMS0xLTM2MTU2OQ_86af868b-f24f-48b5-9d64-ed6d0c294208">193</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value remeasurements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55a696e4c43e43a084a98a9190e869b0_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:TemporaryEquityAccretionToRedemptionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMTgtMS0xLTEtMzYxNTY5_46a867c9-0ae0-4f9d-b098-ce9f73ba0c56">52,218</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b36f5eee05c4272833ec6129d2e6d23_D20220101-20220930" decimals="-3" name="us-gaap:MinorityInterestChangeInRedemptionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMTgtNy0xLTEtMzYxNTY5_a3e5a34f-39f2-4987-835a-d24c8f38167a">52,218</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8139303e818c4499a156db063aa48dba_D20220101-20220930" decimals="-3" name="us-gaap:MinorityInterestChangeInRedemptionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMTgtMTctMS0xLTM2MTU2OQ_10548c70-e1ef-460d-8ea1-92b186167a4b">52,218</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55a696e4c43e43a084a98a9190e869b0_D20220101-20220930" decimals="-3" name="us-gaap:TemporaryEquityOtherChanges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMTktMS0xLTEtMzYxNTY5_4d409b1c-c0ca-45b7-991c-a7635ab7ac5b">457</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73664eea57554ff1a6527a1e3088909e_D20220101-20220930" decimals="-3" sign="-" name="dva:NoncontrollingInterestChangesFromOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMTktMTktMS0xLTM2MTU2OQ_a49bfaa2-6ff6-4183-8b71-fe936b733b51">457</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of treasury stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i3cc14165b1e5457b9a7d411fe7bae49e_D20220101-20220930" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMjAtMTEtMS0xLTM2MTU2OQ_c7908cf3-f266-43c8-9d57-3f6971f7f5f6">8,095</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3cc14165b1e5457b9a7d411fe7bae49e_D20220101-20220930" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMjAtMTMtMS0xLTM2MTU2OQ_52ee432d-3e30-4a38-8ad9-d5758a742a57">787,854</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8139303e818c4499a156db063aa48dba_D20220101-20220930" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMjAtMTctMS0xLTM2MTU2OQ_0980fbac-6d8c-4318-b101-3e7c6b39d8ce">787,854</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance at September 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d096d77a67d4147a3ff676d41c97ea4_I20220930" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMjEtMS0xLTEtMzYxNTY5_98561b15-9de3-4c9c-996c-ea5740ed5726">1,370,753</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3f6ac9def05f4546ad8e00029f29c85f_I20220930" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMjEtMy0xLTEtMzYxNTY5_541c5060-ec44-443b-9fde-8bcef2d19c90">98,199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f6ac9def05f4546ad8e00029f29c85f_I20220930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMjEtNS0xLTEtMzYxNTY5_fb589289-a96f-4aad-a373-6a870502cb02">98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida0a3398956c428db91dfbf84211ac9d_I20220930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMjEtNy0xLTEtMzYxNTY5_8d6a4e1a-6fd3-4bd5-9a68-033a3ccbbbcb">609,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6362305fbd044f9b9980adcadabf8f07_I20220930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMjEtOS0xLTEtMzYxNTY5_30102fbd-c18d-42b5-980a-9b2151764384">846,634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i36614688dae84eef869cd0e6d793fa74_I20220930" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMjEtMTEtMS0xLTM2MTU2OQ_9a3d3f4c-a0cd-4b1f-a054-f009e3fd4aa1">8,095</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36614688dae84eef869cd0e6d793fa74_I20220930" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMjEtMTMtMS0xLTM2MTU2OQ_09a7cbe6-1dd1-4a02-8c64-9cac65951f24">787,854</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i23a94ede934c4277b1d46b13e38fefd1_I20220930" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMjEtMTUtMS0xLTM2MTU2OQ_ace2d53f-2d44-4efe-9328-26d5c280c948">135,551</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cf6560db6fe433e9fe35420f78329ca_I20220930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMjEtMTctMS0xLTM2MTU2OQ_18c39676-24ed-44e1-9ad5-377c85f33cc9">532,672</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd69c0a4b8da40a483520c9abec5ab4e_I20220930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMjEtMTktMS0xLTM2MTU2OQ_a2b13082-6958-443c-9a6c-c12df2cdfc6c">169,455</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements.</span></div><div style="margin-top:9pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dollars and shares in thousands)</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:18.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.663%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.825%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.248%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.130%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.392%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.836%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended September 30, 2021</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-<br/>controlling<br/>interests<br/>subject to<br/>put provisions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="45" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">DaVita Inc. Shareholders&#8217; Equity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-<br/>controlling<br/>interests not<br/>subject to<br/>put provisions</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional<br/>paid-in<br/>capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained<br/>earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>other<br/>comprehensive<br/>loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedd8e53afd1f49d1ab701015f45a5489_I20210630" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfNS0xLTEtMS0zNjE1Njk_70b16edf-a9b5-409d-97d5-9616ec07ad2c">1,426,211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ice4bdd4f0f9347209498a13bb73d9bdc_I20210630" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfNS0zLTEtMS0zNjE1Njk_f2693182-55c7-4ecf-b439-773cf66b22c5">110,644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice4bdd4f0f9347209498a13bb73d9bdc_I20210630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfNS01LTEtMS0zNjE1Njk_fbde2476-e5f4-49b0-bc96-ba9666355116">111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663815c6d9b048f4b3e8a826a42acd72_I20210630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfNS03LTEtMS0zNjE1Njk_02b70938-eede-4d5d-9b4c-5846b7f3bb6e">523,038</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7507dbbe11004f8f993908a1a48afa76_I20210630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfNS05LTEtMS0zNjE1Njk_5de71b06-aaae-42a1-a145-02cbbe446b07">1,383,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="id43bdce378174edd8e02d9f9f1fd6b24_I20210630" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfNS0xMS0xLTEtMzYxNTY5_58c6938d-edb6-4f48-badb-92de22ab7104">5,019</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id43bdce378174edd8e02d9f9f1fd6b24_I20210630" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfNS0xMy0xLTEtMzYxNTY5_a12a7674-e0f1-491a-830d-d6c724c9d961">563,230</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie002b14464f24380b244cc03154fc209_I20210630" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfNS0xNS0xLTEtMzYxNTY5_619756ce-53ff-4eeb-ac0c-c1409e608761">65,899</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic329b3c1d74b48468770b45b930bad16_I20210630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfNS0xNy0xLTEtMzYxNTY5_69625fa9-fe1d-4a6e-8c52-a161bbe09f26">1,277,780</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie19f600b93854407adf4fdf1f09eee0b_I20210630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfNS0xOS0xLTEtMzYxNTY5_86ce4100-49b3-4dc5-85fa-674e4d5b6692">185,046</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Comprehensive income:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia98324e3ccbe45f88cbaa562c7631b0b_D20210701-20210930" decimals="-3" name="us-gaap:TemporaryEquityNetIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfNy0xLTEtMS0zNjE1Njk_ba478f20-7630-4bb2-b955-ec1abc8bea15">41,182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ddc0fff672e45bf957f1116d0d1cb0c_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfNy05LTEtMS0zNjE1Njk_e08b1a76-e2b6-48be-bd69-b3818db49bbd">259,754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fbb95ab11e644199452dbc8220b5114_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfNy0xNy0xLTEtMzYxNTY5_edbf14e4-641e-47e4-bb14-d86277d33ef3">259,754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b6ffea1a40d41068e8300270af3e5ba_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfNy0xOS0xLTEtMzYxNTY5_ce01a52e-3bfe-4b98-88b2-40bfafcdb774">18,818</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib49a7f0c10554865819c8371c13ef3f0_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfOC0xNS0xLTEtMzYxNTY5_1db6e7b1-5794-488c-aa05-f492960afb50">53,851</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fbb95ab11e644199452dbc8220b5114_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfOC0xNy0xLTEtMzYxNTY5_f685d1db-2703-4f2a-b590-4ac41e12bd02">53,851</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock award plans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i319451c323114481b97e571a89a51741_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMTAtMy0xLTEtMzYxNTY5_9f19163a-b626-4167-a161-179fc3331ed8">242</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i56a34082e8604548b02c2fbf0259eb63_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMTAtNy0xLTEtMzYxNTY5_82811834-07b6-4464-a578-8a10521fef33">23,584</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fbb95ab11e644199452dbc8220b5114_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMTAtMTctMS0xLTM2MTU2OQ_9d9bfd28-4e05-4316-8f9d-c198721feba3">23,584</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock-settled stock-based<br/>&#160;compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a34082e8604548b02c2fbf0259eb63_D20210701-20210930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMTEtNy0xLTEtMzYxNTY5_069cdd33-2d55-4382-a5d8-406031401ce3">24,055</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fbb95ab11e644199452dbc8220b5114_D20210701-20210930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMTEtMTctMS0xLTM2MTU2OQ_7a71333f-ead8-4b5b-800a-c1de8854fe64">24,055</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in noncontrolling<br/>&#160;interest from:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Distributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia98324e3ccbe45f88cbaa562c7631b0b_D20210701-20210930" decimals="-3" name="dva:TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMTMtMS0xLTEtMzYxNTY5_bbf61629-07b2-40d4-b516-4324dd1fd76d">49,766</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b6ffea1a40d41068e8300270af3e5ba_D20210701-20210930" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMTMtMTktMS0xLTM2MTU2OQ_e15dc76b-b237-4647-9c9b-773817022bef">28,018</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia98324e3ccbe45f88cbaa562c7631b0b_D20210701-20210930" decimals="-3" name="dva:TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMTQtMS0xLTEtMzYxNTY5_61ff7725-5296-4d77-9e54-a2a1a9adf967">9,041</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b6ffea1a40d41068e8300270af3e5ba_D20210701-20210930" decimals="-3" name="dva:NoncontrollingInterestIncreaseFromContributions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMTQtMTktMS0xLTM2MTU2OQ_dec96d8c-dcbb-45e8-9f77-f3044c2c5ba6">3,329</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions and divestitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia98324e3ccbe45f88cbaa562c7631b0b_D20210701-20210930" decimals="-3" name="dva:TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMTUtMS0xLTEtMzYzOTU1_a6f4e4d7-2233-4799-a936-a428227551a0">5,903</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i56a34082e8604548b02c2fbf0259eb63_D20210701-20210930" decimals="-3" name="dva:NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMTUtNy0xLTEtMzYzOTU1_176e713b-a700-47b0-a3de-17280815325b">351</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fbb95ab11e644199452dbc8220b5114_D20210701-20210930" decimals="-3" name="dva:NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMTUtMTctMS0xLTM2Mzk1NQ_0bebf4ac-1bf7-459d-98bb-fb1151e52c3e">351</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b6ffea1a40d41068e8300270af3e5ba_D20210701-20210930" decimals="-3" name="dva:NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMTUtMTktMS0xLTM2MTU2OQ_63c8785e-9e34-4812-a167-a32dadf92ded">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Partial purchases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i56a34082e8604548b02c2fbf0259eb63_D20210701-20210930" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMTYtNy0xLTEtMzYxNTY5_cead9b7b-89b3-453e-b471-aed0558ae001">6,803</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fbb95ab11e644199452dbc8220b5114_D20210701-20210930" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMTYtMTctMS0xLTM2MTU2OQ_52ddaf9c-1fe8-4b00-b43f-3fa51fc68056">6,803</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b6ffea1a40d41068e8300270af3e5ba_D20210701-20210930" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMTYtMTktMS0xLTM2MTU2OQ_74d81c65-d643-41da-8561-a0a239b7a01e">362</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value remeasurements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia98324e3ccbe45f88cbaa562c7631b0b_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:TemporaryEquityAccretionToRedemptionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMTctMS0xLTEtMzYxNTY5_0b515827-e3b1-47aa-ba29-aff6a2514838">8,654</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a34082e8604548b02c2fbf0259eb63_D20210701-20210930" decimals="-3" name="us-gaap:MinorityInterestChangeInRedemptionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMTctNy0xLTEtMzYxNTY5_990ecdf4-dc4d-45ef-809d-df8c28a4ee78">8,654</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fbb95ab11e644199452dbc8220b5114_D20210701-20210930" decimals="-3" name="us-gaap:MinorityInterestChangeInRedemptionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMTctMTctMS0xLTM2MTU2OQ_02d503d8-6164-40b5-8cc5-1abad39e5463">8,654</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Purchase of treasury stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i81df84984de9471498896da7302e996d_D20210701-20210930" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMTgtMTEtMS0xLTM2MTU2OQ_524d1776-770f-4620-be21-eca949d02d8b">2,731</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81df84984de9471498896da7302e996d_D20210701-20210930" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMTgtMTMtMS0xLTM2MTU2OQ_909f9c16-d307-4a6a-8985-932343290893">336,217</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fbb95ab11e644199452dbc8220b5114_D20210701-20210930" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMTgtMTctMS0xLTM2MTU2OQ_c5b3f10b-f7a3-4f26-8104-b8f2f6ac37e7">336,217</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60789889ae4a4336b174326b6a1f05e1_I20210930" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMjEtMS0xLTEtMzYxNTY5_222868e0-18f1-4bbd-b4a0-cafd0fefbee4">1,423,917</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id7e948fdcd374e2ca7c81f008ef937b8_I20210930" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMjEtMy0xLTEtMzYxNTY5_62dbddf0-a4e4-4cd3-943c-71b4a05d5113">110,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7e948fdcd374e2ca7c81f008ef937b8_I20210930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMjEtNS0xLTEtMzYxNTY5_a683046c-d2b5-48b7-a95c-9460398cb99f">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief97099e76e34b33afd38d2bf7dd73d5_I20210930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMjEtNy0xLTEtMzYxNTY5_18ae6a98-f0db-49d5-aae1-b072d16b5e99">525,009</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbd4405ebc814444a73fcea7eb2d5281_I20210930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMjEtOS0xLTEtMzYxNTY5_5124bff9-1535-46c4-9a1d-6d921cd4d95a">1,643,514</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i3329b37b11ef49e7a77677fc2571f273_I20210930" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMjEtMTEtMS0xLTM2MTU2OQ_57b9f863-59a5-4497-887f-7d216de2c5a0">7,750</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3329b37b11ef49e7a77677fc2571f273_I20210930" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMjEtMTMtMS0xLTM2MTU2OQ_9baf2a61-7665-43e7-ad7b-e338d87944b4">899,447</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1113880d4c76456c96b6f30c904a98c3_I20210930" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMjEtMTUtMS0xLTM2MTU2OQ_3268a216-c679-4f87-8df8-671a0ae63d82">119,750</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658147170723431aa969dc4fb19ac738_I20210930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMjEtMTctMS0xLTM2MTU2OQ_13b62609-8ba1-4cc4-b8ea-2f7f5be9ef7e">1,149,437</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d92065342b44c7d9d67dad92df719c5_I20210930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMjEtMTktMS0xLTM2MTU2OQ_f46b1a95-de23-4ea4-af0a-f621c5854ae4">178,814</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:15pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:18.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.663%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.825%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.248%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.130%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.392%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.836%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="57" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended September 30, 2021</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-<br/>controlling<br/>interests<br/>subject to<br/>put provisions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="45" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">DaVita Inc. Shareholders&#8217; Equity</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="4" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-<br/>controlling<br/>interests not<br/>subject to<br/>put provisions</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional<br/>paid-in<br/>capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained<br/>earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>other<br/>comprehensive<br/>loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie15a7e2f621142fbac1d6b1ed5011b9d_I20201231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfNS0xLTEtMS0zNjE1Njk_7388a7b2-080f-4762-b161-2519183962ed">1,330,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ief046f5cbff64fe6add73a9cda0c18b2_I20201231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfNS0zLTEtMS0zNjE1Njk_e8c7f4f7-cce7-4a6b-85c0-d324429a3fb3">109,933</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief046f5cbff64fe6add73a9cda0c18b2_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfNS01LTEtMS0zNjE1Njk_89f39768-5ed1-4493-a328-66a189bd0b7e">110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic085ab466cee47ed81480d793624fbad_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfNS03LTEtMS0zNjE1Njk_32ebf0e8-1c75-4323-96b6-cc0bccab0dea">597,073</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9126810d2c5c48f49f23bdafdb65883a_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfNS05LTEtMS0zNjE1Njk_a7891c8e-434e-4f0c-bfc2-6c4a6c60320d">852,537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i75763a11d96243bca52ff93e2406ae41_I20201231" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfNS0xMS0xLTEtMzYxNTY5_48635380-1c0b-4aec-8fe3-bcc0fb614ff4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75763a11d96243bca52ff93e2406ae41_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfNS0xMy0xLTEtMzYxNTY5_d5fcfbeb-088c-4009-aec1-c568caa1a0ce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9bb890020ae4aef89eda77451ffdea8_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfNS0xNS0xLTEtMzYxNTY5_d99ba3b4-4912-4353-ac63-1ef5034311ed">66,154</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dd3f4def9b849c59ba37a6b37215489_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfNS0xNy0xLTEtMzYxNTY5_c0a89fd2-d8cd-421a-8037-a729cc57a65e">1,383,566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia506883f3ae0452194c6440259373c3b_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfNS0xOS0xLTEtMzYxNTY5_8735c3b7-73a9-4c24-a271-2e85eacc34aa">183,186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Comprehensive income:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d759d14a5e74d46b71f1406a364f03e_D20210101-20210930" decimals="-3" name="us-gaap:TemporaryEquityNetIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfNy0xLTEtMS0zNjE1Njk_5f29794e-6f3c-44da-8393-f0b31a2e3436">121,774</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic46d32b59dd34a6085600e81cd1682bb_D20210101-20210930" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfNy05LTEtMS0zNjE1Njk_ca33983b-0fa6-4a87-8567-17a0245bc70a">790,977</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0876db8d2e2343ad96bd1c5f19250ebd_D20210101-20210930" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfNy0xNy0xLTEtMzYxNTY5_6c408ea6-1aeb-4149-8ee2-472742a049cd">790,977</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dee44ae9bd741b79b52d5d2960b5164_D20210101-20210930" decimals="-3" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfNy0xOS0xLTEtMzYxNTY5_bf528495-2c5d-4757-855d-996015923262">49,579</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d50339b230d4224b69347fc7edc8b98_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfOC0xNS0xLTEtMzYxNTY5_4ecd1bd5-d9bb-4532-a155-b1f6ec93aba7">53,596</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0876db8d2e2343ad96bd1c5f19250ebd_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfOC0xNy0xLTEtMzYxNTY5_578016f2-1f62-4d5c-bdef-a93b31057c1b">53,596</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock award plans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib2225f46e4614652b632ff59e99717b5_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMTAtMy0xLTEtMzYxNTY5_0b73e3b6-525f-4369-b124-b28a519ce463">953</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2225f46e4614652b632ff59e99717b5_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMTAtNS0xLTEtMzYxNTY5_b810f305-61d5-436b-83c9-d08873932961">1</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id322319c79ee47d3b626a8d5196e3aeb_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMTAtNy0xLTEtMzYxNTY5_d75364f9-3c0b-4b4d-85a2-9a10b4bbd119">74,761</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0876db8d2e2343ad96bd1c5f19250ebd_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMTAtMTctMS0xLTM2MTU2OQ_5ec6f781-5e7f-41ee-9f1a-5850bf56423b">74,760</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock-settled stock-based<br/>&#160;compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id322319c79ee47d3b626a8d5196e3aeb_D20210101-20210930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMTEtNy0xLTEtMzYxNTY5_643a447f-aaf7-4423-b5f5-256f0892caf9">74,568</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0876db8d2e2343ad96bd1c5f19250ebd_D20210101-20210930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMTEtMTctMS0xLTM2MTU2OQ_d6243f7c-7781-486a-a817-e7128ae3e1bb">74,568</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Changes in noncontrolling interest<br/>&#160;from:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Distributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d759d14a5e74d46b71f1406a364f03e_D20210101-20210930" decimals="-3" name="dva:TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMTMtMS0xLTEtMzYxNTY5_c769296b-2b7d-4d7d-8c1b-69f8d46583b0">114,008</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0dee44ae9bd741b79b52d5d2960b5164_D20210101-20210930" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMTMtMTktMS0xLTM2MTU2OQ_a7f8880f-d7d8-4ce9-82f0-d660b10e0fde">63,138</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d759d14a5e74d46b71f1406a364f03e_D20210101-20210930" decimals="-3" name="dva:TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMTQtMS0xLTEtMzYxNTY5_9d7e03b0-5b62-49c8-9eff-5944a6df9828">19,830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dee44ae9bd741b79b52d5d2960b5164_D20210101-20210930" decimals="-3" name="dva:NoncontrollingInterestIncreaseFromContributions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMTQtMTktMS0xLTM2MTU2OQ_c85344c3-cecf-43cf-b6c8-4f6d753bccf8">8,465</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisitions and divestitures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d759d14a5e74d46b71f1406a364f03e_D20210101-20210930" decimals="-3" name="dva:TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMTUtMS0xLTEtMzYzOTc4_92c81ff7-4de2-4f5b-82e4-1f7a2e19f7bf">5,903</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id322319c79ee47d3b626a8d5196e3aeb_D20210101-20210930" decimals="-3" name="dva:NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMTUtNy0xLTEtMzYzOTc4_c28b87e6-3cb4-45e1-bb79-97995e33129a">351</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0876db8d2e2343ad96bd1c5f19250ebd_D20210101-20210930" decimals="-3" name="dva:NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMTUtMTctMS0xLTM2Mzk3OA_951603c5-21c6-4189-a7a7-3597d5187523">351</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dee44ae9bd741b79b52d5d2960b5164_D20210101-20210930" decimals="-3" name="dva:NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMTUtMTktMS0xLTM2MTU2OQ_8c909f03-0a7b-4423-957c-14691154c076">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Partial purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d759d14a5e74d46b71f1406a364f03e_D20210101-20210930" decimals="-3" name="dva:TemporaryEquityDecreasePurchaseOfInterests" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMTYtMS0xLTEtMzYxNTY5_9a897139-7ff3-4f2e-a765-5cecdb3200bc">552</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id322319c79ee47d3b626a8d5196e3aeb_D20210101-20210930" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMTYtNy0xLTEtMzYxNTY5_73f502a2-d941-4f7b-957a-570046d32502">10,578</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0876db8d2e2343ad96bd1c5f19250ebd_D20210101-20210930" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMTYtMTctMS0xLTM2MTU2OQ_a2857009-aa89-4353-a8e5-14cfc5a65063">10,578</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0dee44ae9bd741b79b52d5d2960b5164_D20210101-20210930" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMTYtMTktMS0xLTM2MTU2OQ_23b64314-2c27-410d-9048-875d78ed46b8">528</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value remeasurements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d759d14a5e74d46b71f1406a364f03e_D20210101-20210930" decimals="-3" name="us-gaap:TemporaryEquityAccretionToRedemptionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMTctMS0xLTEtMzYxNTY5_aa68fcac-2a56-45d9-a7a0-627c667b7d19">60,942</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id322319c79ee47d3b626a8d5196e3aeb_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:MinorityInterestChangeInRedemptionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMTctNy0xLTEtMzYxNTY5_8ee63122-7264-4fed-966a-7e7ef89e1cd6">60,942</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0876db8d2e2343ad96bd1c5f19250ebd_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:MinorityInterestChangeInRedemptionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMTctMTctMS0xLTM2MTU2OQ_d5059beb-5c9f-43c3-b6d9-0ba57f3d39be">60,942</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Purchase of treasury stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ia8f9cc1fcc6d4078b72a351dab034ab2_D20210101-20210930" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMTgtMTEtMS0xLTM2MTU2OQ_1b67b035-7b12-4883-b625-aa711d3ade01">7,750</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia8f9cc1fcc6d4078b72a351dab034ab2_D20210101-20210930" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMTgtMTMtMS0xLTM2MTU2OQ_578333c0-ebb3-425f-b083-de22cccaefaa">899,447</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0876db8d2e2343ad96bd1c5f19250ebd_D20210101-20210930" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMTgtMTctMS0xLTM2MTU2OQ_8995994f-627f-4591-a469-578762024561">899,447</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Balance at September 30, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60789889ae4a4336b174326b6a1f05e1_I20210930" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMjEtMS0xLTEtMzYxNTY5_df3d5753-47a1-4c0d-8457-ca516ad6234a">1,423,917</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id7e948fdcd374e2ca7c81f008ef937b8_I20210930" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMjEtMy0xLTEtMzYxNTY5_0001c14f-0daa-43c6-a699-7912dcb934b8">110,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7e948fdcd374e2ca7c81f008ef937b8_I20210930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMjEtNS0xLTEtMzYxNTY5_aec3b7d4-8dab-47f7-be70-41d428679999">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief97099e76e34b33afd38d2bf7dd73d5_I20210930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMjEtNy0xLTEtMzYxNTY5_ff6744b3-dc05-4473-bc1e-3eaf0d2cf6fd">525,009</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbd4405ebc814444a73fcea7eb2d5281_I20210930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMjEtOS0xLTEtMzYxNTY5_910d2b84-7b1f-43d8-81c7-396aacd5d29b">1,643,514</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i3329b37b11ef49e7a77677fc2571f273_I20210930" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMjEtMTEtMS0xLTM2MTU2OQ_46504dc5-1e58-4422-b496-4450725f50a8">7,750</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3329b37b11ef49e7a77677fc2571f273_I20210930" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMjEtMTMtMS0xLTM2MTU2OQ_316a260b-967a-4c8b-8b30-7811893e04ca">899,447</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1113880d4c76456c96b6f30c904a98c3_I20210930" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMjEtMTUtMS0xLTM2MTU2OQ_b07db01d-8457-4a16-a70f-e14fe7ec1822">119,750</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i658147170723431aa969dc4fb19ac738_I20210930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMjEtMTctMS0xLTM2MTU2OQ_b145f924-4928-45a8-930a-a51ad8977e58">1,149,437</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d92065342b44c7d9d67dad92df719c5_I20210930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMjEtMTktMS0xLTM2MTU2OQ_fc2ddb78-8fe4-4d69-9156-bb8d8a56b668">178,814</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i9311e9c566584bd9ab5dffbc9b9a605b_31"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise indicated in this Quarterly Report on Form 10-Q, "the Company", "we", "us", "our" and similar terms refer to DaVita Inc. and its consolidated subsidiaries.</span></div><div id="i9311e9c566584bd9ab5dffbc9b9a605b_34"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNC9mcmFnOmQzYzU4NDlmYjE4YTQ3YjVhZDlhOGY2ZTMxMzc2NjZlL3RleHRyZWdpb246ZDNjNTg0OWZiMThhNDdiNWFkOWE4ZjZlMzEzNzY2NmVfMTU4Nw_4edab425-d58b-4313-9e9f-8a147ee7e2ce" continuedAt="iaaa53772055a41c88134f7087aa9f0fb" escape="true">Condensed consolidated interim financial statements</ix:nonNumeric></span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iaaa53772055a41c88134f7087aa9f0fb"><ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNC9mcmFnOmQzYzU4NDlmYjE4YTQ3YjVhZDlhOGY2ZTMxMzc2NjZlL3RleHRyZWdpb246ZDNjNTg0OWZiMThhNDdiNWFkOWE4ZjZlMzEzNzY2NmVfMTU5MA_6a31a41f-ec50-4213-b5e7-2b3c6e0abd91" escape="true">The unaudited condensed consolidated interim financial statements included in this report are prepared by the Company. In the opinion of management, all adjustments necessary for a fair presentation of the results of operations are reflected in these condensed consolidated interim financial statements. All significant intercompany accounts and transactions have been eliminated. The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of revenues, expenses, assets, liabilities, contingencies and noncontrolling interests subject to put provisions. The most significant estimates and assumptions underlying these financial statements and accompanying notes generally involve revenue recognition and accounts receivable, certain fair value estimates, accounting for income taxes and loss contingencies. The results of operations reflected in these interim financial statements may not necessarily be indicative of annual operating results. These condensed consolidated interim financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2021 (2021 10-K). Prior period classifications conform to the current period presentation. The Company has evaluated subsequent events through the date these condensed consolidated interim financial statements were issued and has included all necessary adjustments and disclosures.</ix:nonNumeric></ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div id="i9311e9c566584bd9ab5dffbc9b9a605b_37"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RleHRyZWdpb246Y2M3NTM0Y2VhYjE0NDY0NjhkODUzODQ2YjhkNjczZTBfMjcyOQ_a596d806-ceb1-4160-bc0d-c2bd660e3545" continuedAt="i1c51b12e58c145ae9e9413e4c023ce30" escape="true">Revenue recognition</ix:nonNumeric></span></div><ix:continuation id="i1c51b12e58c145ae9e9413e4c023ce30" continuedAt="i280e1f53320f4b5082d07c7af60514c9"><ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RleHRyZWdpb246Y2M3NTM0Y2VhYjE0NDY0NjhkODUzODQ2YjhkNjczZTBfMjczNQ_529f4754-7a2c-4e24-987d-c1fce11426d1" continuedAt="i4ecbf3a974ae4cab9c163ff399de9a49" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the Company's segment revenues by primary payor source:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.332%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.303%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.303%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.434%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other &#8212; Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other &#8212; Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dialysis patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5499ef54bf54566bd5630bea4f2aef1_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMy0xLTEtMS0zNjE1Njk_1d6b2835-4dd6-4e5f-8c47-7272be75b09f">1,535,680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf7c25a75aca401a8b6ff5a12f6bd14d_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMy01LTEtMS0zNjE1Njk_78365e9a-61b9-4ec1-adb9-d1f069ee53f1">1,535,680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if32f1f0b93b84c62b51bda92e1d098c1_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMy03LTEtMS0zNjE1Njk_ef3d2e90-3b89-487f-9d23-56b04382bf92">1,543,819</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8b3d7d4ce924bcba6d96142c33584d7_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMy0xMS0xLTEtMzYxNTY5_5caa70bb-80ce-47fa-9bc8-3ce2fc4c714e">1,543,819</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c5b3caa1262457a9e75c70467159fc4_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfNC0xLTEtMS0zNjE1Njk_eeeced9b-7daa-46e9-ac55-ad17f31362cf">193,853</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb08fa48ee76464ba77c6eb9d3849115_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfNC01LTEtMS0zNjE1Njk_082eaafd-6a2d-496d-bdee-c47b0d6e3446">193,853</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i599d93fb67e9441eb25740b2dd06722d_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfNC03LTEtMS0zNjE1Njk_cb281c42-e8ac-4188-9c89-f8c23de886a0">203,169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c69e4f36c65438c9eeb2a106052afd5_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfNC0xMS0xLTEtMzYxNTY5_c3c1fd76-85bf-4e70-935b-87b3fc9fb253">203,169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other government</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd8c3ea690e54b84a0a7066643e1c02b_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfNS0xLTEtMS0zNjE1Njk_7e98c4d4-9ff7-4121-a328-2f04d8eee6e4">86,852</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9536bd2eda14d9c86eba49ab480d898_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfNS0zLTEtMS0zNjE1Njk_0202cb24-ceea-416f-973a-d07a342a835c">116,084</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i872a4a0bd01a4a8abf1995e00bb2cf2d_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfNS01LTEtMS0zNjE1Njk_14ba34b1-750c-4a74-9d1d-8cc378f1875e">202,936</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaae7b470fbe4bbd8bd2ca4d195b6128_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfNS03LTEtMS0zNjE1Njk_c83ae0cc-9a8c-4679-a309-0163e1deef90">82,624</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if47f2932cefd49ed85a6f6caa58312cd_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfNS05LTEtMS0zNjE1Njk_17220042-5ce9-4d5b-859d-04424892be4d">113,260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7f517d406d8483b9f0bdad532070fe4_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfNS0xMS0xLTEtMzYxNTY5_26bb0288-32d7-4083-ab8e-7f9396bff7f2">195,884</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f7d940ca97c4ae789757331795af7c0_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfNi0xLTEtMS0zNjE1Njk_c6ae82da-7ccd-409b-abe9-92d6366a88b9">880,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3129a22cf1d446319325259a77169cdd_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfNi0zLTEtMS0zNjE1Njk_50ace003-4b2a-4a5a-9ffa-6824f7610920">56,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87e2bef651a34107b1fb5d68820aee09_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfNi01LTEtMS0zNjE1Njk_8067a375-79bf-47c8-858f-49b5a5545ee9">936,982</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa9717ba02fb4ccab21d642ffbe4803c_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfNi03LTEtMS0zNjE1Njk_3bc4e2e4-aaae-4c10-a41e-df24f8d9c846">862,218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i500d83fb41334d9c8de83f92f7fcc141_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfNi05LTEtMS0zNjE1Njk_ce6ea218-4560-441f-bbc2-8df61638431a">54,857</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaea6e6d89084a3e93ba28323cd7e21d_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfNi0xMS0xLTEtMzYxNTY5_c1c5674d-f27f-476f-898a-ca86557d2518">917,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other revenues:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff0caec10ecc40c584a977fdfabc4df8_D20220701-20220930" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfOC0zLTEtMS0zNjE1Njk_0e58308d-cd12-44e4-9c23-f97cb4d22a41">78,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf7c25a75aca401a8b6ff5a12f6bd14d_D20220701-20220930" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfOC01LTEtMS0zNjE1Njk_8d5d379a-016c-40e2-a866-27f7a28deab7">78,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50355a967a4440e897b1ac183ad1a38d_D20210701-20210930" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfOC05LTEtMS0zNjE1Njk_0608877a-2e7d-461d-893b-e04900d227b1">77,277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8b3d7d4ce924bcba6d96142c33584d7_D20210701-20210930" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfOC0xMS0xLTEtMzYxNTY5_57bce0a0-000f-46a0-ade5-5643bafab06d">77,277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb556fa3c676460aa8e66d0650f6a16e_D20220701-20220930" decimals="-3" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfOS0zLTEtMS0zNjE1Njk_0b42aabf-fe1d-416a-9e20-2452d830fbb0">412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb08fa48ee76464ba77c6eb9d3849115_D20220701-20220930" decimals="-3" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfOS01LTEtMS0zNjE1Njk_14afff92-f9f0-4e9c-81e1-aa67a68acd24">412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i346169ef5135448c9d85d98d5c086b2a_D20210701-20210930" decimals="-3" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfOS05LTEtMS0zNjE1Njk_094720ae-1056-4f19-b6c9-76b99854dc1f">377</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c69e4f36c65438c9eeb2a106052afd5_D20210701-20210930" decimals="-3" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfOS0xMS0xLTEtMzYxNTY5_410364ac-9f53-4da4-ae3e-2a4bc4be9deb">377</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3129a22cf1d446319325259a77169cdd_D20220701-20220930" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMTAtMy0xLTEtMzYxNTY5_b4c0dbf5-7516-4de5-8766-9b1b632d957b">6,484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87e2bef651a34107b1fb5d68820aee09_D20220701-20220930" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMTAtNS0xLTEtMzYxNTY5_5c84439f-dffe-40df-8b9f-e5eafd4d85ae">6,484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i500d83fb41334d9c8de83f92f7fcc141_D20210701-20210930" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMTAtOS0xLTEtMzYxNTY5_fd200d78-b68b-47ea-bf85-b7559c451c87">7,164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaea6e6d89084a3e93ba28323cd7e21d_D20210701-20210930" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMTAtMTEtMS0xLTM2MTU2OQ_1af8032b-1fa7-49b4-8992-b9b3219f9ec8">7,164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42e37dbf5c0a422e8802ffd5a383d2d8_D20220701-20220930" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMTEtMS0xLTEtMzYxNTY5_885496f5-2d65-4cc7-bfe7-e8f1a60bc313">6,056</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc81d3ad5ccf42d797d3042a95761484_D20220701-20220930" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMTEtMy0xLTEtMzYxNTY5_0ad29eeb-2d64-449a-ad4f-3f049c5d3bf0">10,903</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ac794762df747ec8e1cf0d69c6b0573_D20220701-20220930" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMTEtNS0xLTEtMzYxNTY5_228c5234-2aa6-485f-b673-d5f94e2305f7">16,959</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c5f026f8ab94787909fcd87fcb38484_D20210701-20210930" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMTEtNy0xLTEtMzYxNTY5_a43f16d3-8329-40bc-912d-082961e612fb">6,216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib939af3797994ec1a4b0e56c5dd80a2a_D20210701-20210930" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMTEtOS0xLTEtMzYxNTY5_241956b3-92f3-40c4-a6e2-4e15c8b57ad1">9,442</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if983cfecb2cf4615842da0fdce5d144c_D20210701-20210930" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMTEtMTEtMS0xLTM2MTU2OQ_49cf0a43-45f7-4b75-b01e-c88af8783bcb">15,658</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations of intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c5c603e1e2c456093890ff389a4067c_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMTItMS0xLTEtMzYxNTY5_f358e05f-3b15-4a60-beec-62e28c004be7">22,957</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="idf91a124985e4d4a83d74b6648524f10_D20220701-20220930" xsi:nil="true" name="us-gaap:Revenues" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMTItMy0xLTEtMzYxNTY5_237772c2-e8c6-40a3-9884-5d9f4eb5482d"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i253b9978247749dcb47c368cdebc35ae_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMTItNS0xLTEtMzYxNTY5_abc434c2-6b4f-433c-903d-4d7a2ac473c1">22,957</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6679c2baabca4cda8418d59c0fbb9fcb_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMTItNy0xLTEtMzYxNTY5_482dc19e-4fe4-4a9c-a481-32306c144068">22,104</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i45f5523ed8e44e969d9667166a84a234_D20210701-20210930" xsi:nil="true" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMTItOS0xLTEtMzYxNTY5_fcc113ea-7030-4a4f-9382-97cab1cb5c96"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c321d3f4f114e7a810149cebdfddf89_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMTItMTEtMS0xLTM2MTU2OQ_fd1ffe3d-58ea-4780-a168-ba32332471c2">22,104</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i138d5ad826a74dd389b7c50d766dce89_D20220701-20220930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMTMtMS0xLTEtMzYxNTY5_83b3b04a-9ae0-4459-88e7-ee7464707fb6">2,680,296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5743480e6048496ab58c95a14b8aaf6f_D20220701-20220930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMTMtMy0xLTEtMzYxNTY5_dddb964e-4cf9-47b9-9982-c5f8af3289c5">268,398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMTMtNS0xLTEtMzYxNTY5_c3fc5c76-5e93-41d3-86dd-3e2a658a72ba">2,948,694</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia98746ed55ed4291881ac7bb3d451f92_D20210701-20210930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMTMtNy0xLTEtMzYxNTY5_07ac7fb2-ce41-4f10-9267-af122c089486">2,675,942</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0162929ca27d43d894768f88369a32f4_D20210701-20210930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMTMtOS0xLTEtMzYxNTY5_869db1df-091a-49a8-9c65-ff971a3760d5">262,377</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMTMtMTEtMS0xLTM2MTU2OQ_ec552d57-6989-46c7-b99f-aca1c4e5dea2">2,938,319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Other primarily consists of management service fees earned in the respective Company line of business as well as other non-patient service revenue from the Company's U.S. ancillary services and international operations.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div><span><br/></span></div></div><ix:continuation id="i280e1f53320f4b5082d07c7af60514c9"><ix:continuation id="i4ecbf3a974ae4cab9c163ff399de9a49"><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.332%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.303%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.303%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.434%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other - Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other - Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dialysis patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa3c42e6c11c4d0197c06f1170d1a877_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMy0xLTEtMS0zNjE1Njk_e8c1e567-e2d3-4e25-8c2a-8fb690081bc5">4,529,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadfbab933c6649d399f396278bf17828_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMy01LTEtMS0zNjE1Njk_0b6a3f11-6ef2-4938-84be-ee50528d3c96">4,529,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00c3f8bb1a4f4667af7c71428219d59d_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMy03LTEtMS0zNjE1Njk_e122909b-001e-47b4-b590-ce70138d3b35">4,586,278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff13895b80934a9aaca98d961abc2ee9_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMy0xMS0xLTEtMzYxNTY5_56e76a34-8b49-4c5d-b8c6-4eb3d7a27154">4,586,278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14ce08d9f9e740ecb2b7cd9829aba3f6_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfNC0xLTEtMS0zNjE1Njk_48ae53ad-bff2-4b32-bd7e-a5e7a96fad3e">570,380</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e56a6423e7a43a6baf62a95333e8692_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfNC01LTEtMS0zNjE1Njk_b53f5913-6d43-4032-a24b-2bb9e30b924d">570,380</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e7345a52a044d459fe02274fb72c840_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfNC03LTEtMS0zNjE1Njk_f518febe-1b2d-432e-a762-bb79da571b27">585,053</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f6de3926b14464695343fd7abe17b26_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfNC0xMS0xLTEtMzYxNTY5_20efb349-4022-4c64-bf7a-585f4a9566ec">585,053</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other government</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bf1bb08a5eb457d8bc08821fa21a5ff_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfNS0xLTEtMS0zNjE1Njk_336ca3b9-95a9-46c1-96ff-79b313dd10c6">253,731</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81c073a4e6894483a6125b5544516dcf_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfNS0zLTEtMS0zNjE1Njk_95deca13-a80b-4e9e-8f12-747efe7187d7">349,633</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5928e35ff3ca4001abd1fb3f535ceaaf_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfNS01LTEtMS0zNjE1Njk_a90e21e7-0288-43c4-be35-be398a442dc1">603,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i490b21a1d5ff4920a6e5630f304c1992_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfNS03LTEtMS0zNjE1Njk_a1612f9b-24c9-48a8-a311-2b2ee630bd73">245,125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bd462440e954143b9bd9c4c0bbcbc96_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfNS05LTEtMS0zNjE1Njk_06b5036a-d01d-48f0-a7c0-5322f5e7c8ef">338,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67f9be9b51ec4692a27ebe64bb0fc0e4_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfNS0xMS0xLTEtMzYxNTY5_a1c9b8d4-2606-4696-9ba9-1134223290ea">583,678</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89dde34540454ca3ae8c705649ed5ed5_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfNi0xLTEtMS0zNjE1Njk_7e8ae916-fc79-4e70-b9db-d65343d8bd1d">2,570,054</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf52eaa032584a8ab33ac97fcf842df5_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfNi0zLTEtMS0zNjE1Njk_6e156680-b687-4698-ab8f-87db04796060">164,302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i137eae426cf247789d78e630f2c67da6_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfNi01LTEtMS0zNjE1Njk_02c697a7-376e-4eb7-9db7-3eed71f207ae">2,734,356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ad9292cb3bb460b969ab3899aad678f_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfNi03LTEtMS0zNjE1Njk_1ce4d889-afa8-4735-a0a9-578c2858d4a2">2,528,499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b1771b0ef284582836b473942fc9bfa_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfNi05LTEtMS0zNjE1Njk_71cad342-443c-4ae7-8bd2-852333843259">157,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cae19c46a6043148cffc25a7d0efae1_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfNi0xMS0xLTEtMzYxNTY5_d8ed586b-aed7-4c23-9bd3-9a6aeb577527">2,685,671</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other revenues:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcb2cf1f049d43e6bc397f58d8b751ab_D20220101-20220930" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfOC0zLTEtMS0zNjE1Njk_c5cc79cb-6313-4149-9226-6e8f92b7977a">255,204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadfbab933c6649d399f396278bf17828_D20220101-20220930" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfOC01LTEtMS0zNjE1Njk_af3c1658-98f8-4679-9107-3b7dbc16a71b">255,204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94d0c3e715a04876b7a0eebf725c54bb_D20210101-20210930" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfOC05LTEtMS0zNjE1Njk_ef99a444-e5dc-46af-8bf7-da1efc1ad2ab">243,085</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff13895b80934a9aaca98d961abc2ee9_D20210101-20210930" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfOC0xMS0xLTEtMzYxNTY5_ffc99ef9-c3f6-49ba-a049-d5f17e914041">243,085</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib29b1d2d5bb4458794f5d56da5481133_D20220101-20220930" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfOS0zLTEtMS0zNjE1Njk_840493e7-f857-4f6c-bdf7-8024cf929b15">1,181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e56a6423e7a43a6baf62a95333e8692_D20220101-20220930" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfOS01LTEtMS0zNjE1Njk_f0b06a2c-5d28-494f-9358-9ccf2020483b">1,181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f9af972e685431dac0f0893f94454e6_D20210101-20210930" decimals="-3" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfOS05LTEtMS0zNjE1Njk_0e16e33a-c19d-48ef-b339-528c2c3e01a0">981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f6de3926b14464695343fd7abe17b26_D20210101-20210930" decimals="-3" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfOS0xMS0xLTEtMzYxNTY5_36b56daa-a733-4958-8ea3-7d17036230af">981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf52eaa032584a8ab33ac97fcf842df5_D20220101-20220930" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMTAtMy0xLTEtMzYxNTY5_b4cb6ca7-3e34-49a6-b2dc-1e7c6ff69308">16,029</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i137eae426cf247789d78e630f2c67da6_D20220101-20220930" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMTAtNS0xLTEtMzYxNTY5_c77924e7-8062-4b4a-9a05-20601958161e">16,029</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b1771b0ef284582836b473942fc9bfa_D20210101-20210930" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMTAtOS0xLTEtMzYxNTY5_4e40eaab-00e1-48ba-9d53-32fd8a011586">14,387</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cae19c46a6043148cffc25a7d0efae1_D20210101-20210930" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMTAtMTEtMS0xLTM2MTU2OQ_faaf9149-a93f-4699-9a38-eab3b3c19df8">14,387</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8eef48118914482ea280b1dd3e31cd66_D20220101-20220930" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMTEtMS0xLTEtMzYxNTY5_69627619-7df6-4740-8c64-6eb9d4ff431a">18,124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadaf73e90f7a4ef2b2effea52a4e2206_D20220101-20220930" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMTEtMy0xLTEtMzYxNTY5_c9851a5f-e026-4f72-bf1d-4671e79dca1a">29,584</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idec28e83e6404debb93980472f318af7_D20220101-20220930" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMTEtNS0xLTEtMzYxNTY5_f6333569-c3de-454b-8dcf-4b987e66dcab">47,708</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i507043f785414bbe9b5ce696f53c2c7e_D20210101-20210930" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMTEtNy0xLTEtMzYxNTY5_b5e78c6c-acc6-48b3-86f2-61e115108bc7">19,308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0562607b4e35473ba1a511716103fdc2_D20210101-20210930" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMTEtOS0xLTEtMzYxNTY5_b663f157-92a4-44c4-b148-eb3d602e95e4">31,107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d2459b347674468b9af90ec7b6fa674_D20210101-20210930" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMTEtMTEtMS0xLTM2MTU2OQ_e1fe7286-2ae5-45a6-ac28-23883f9b0f33">50,415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations of intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icad3d0bdd7834605a261fa6fd56c8c78_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMTItMS0xLTEtMzYxNTY5_c78d1ee3-2d0d-4226-8992-8d438d1cf4b8">64,516</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i4e58b8c89c344703bdf5b7d532cc1d0c_D20220101-20220930" xsi:nil="true" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMTItMy0xLTEtMzYxNTY5_a74f8cd5-9d2c-4c0b-9b94-6049e5f872c2"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b80df9aa48e4aa9a2eeabbf8c48904e_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMTItNS0xLTEtMzYxNTY5_72ca5579-8373-4d98-bc7f-aff9b7f8e2e0">64,516</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33b19b87438e4e76aede245ac6a0c09c_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMTItNy0xLTEtMzYxNTY5_fc317b06-f3fa-4031-b1f1-9a1acdecf40c">70,424</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53105fdcd8b04f368d61266747f6b56e_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMTItOS0xLTEtMzYxNTY5_f8b9d35c-e7d9-4a41-88ba-d88a6861f178">4,294</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iabe54304a7d4439d88d4c1cbb00ee5ac_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMTItMTEtMS0xLTM2MTU2OQ_26c9a747-2e96-43ec-968e-33f0623a9c74">74,718</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i422c6a94a816499c8310fd5a0acc841f_D20220101-20220930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMTMtMS0xLTEtMzYxNTY5_e6e0f81e-99f4-4c16-9637-99847faf7ce5">7,877,073</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie63e40be1b8c44ae852031a36cc0c1d2_D20220101-20220930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMTMtMy0xLTEtMzYxNTY5_8f933a5b-f118-4fdd-802c-653a937e1a74">815,933</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMTMtNS0xLTEtMzYxNTY5_60efc687-0562-4bae-bd46-fb6bb39c7829">8,693,006</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb049c47bd043afa9a8eb3aaf37cb95_D20210101-20210930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMTMtNy0xLTEtMzYxNTY5_edba78a0-148d-4bb8-970b-8af21097be14">7,893,839</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7870e39ec59457d85f40917f0be7b4b_D20210101-20210930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMTMtOS0xLTEtMzYxNTY5_9dfe4401-0330-40c8-b709-34784f0b462e">780,991</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMTMtMTEtMS0xLTM2MTU2OQ_c62a7b06-f8a8-4804-b842-f12d1587c357">8,674,830</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Other primarily consists of management service fees earned in the respective Company line of business as well as other non-patient service revenue from the Company's U.S. ancillary services and international operations.</span></div></ix:continuation><ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RleHRyZWdpb246Y2M3NTM0Y2VhYjE0NDY0NjhkODUzODQ2YjhkNjczZTBfMjczNw_ada8dbd6-d52e-4e0f-a395-eaabfcd2596d" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are significant uncertainties associated with estimating revenue, which generally take several years to resolve. These estimates are subject to ongoing insurance coverage changes, geographic coverage differences, differing interpretations of contract coverage and other payor issues, as well as patient issues, including determination of applicable primary and secondary coverage, changes in patient insurance coverage and coordination of benefits. As these estimates are refined over time, both positive and negative adjustments to revenue are recognized in the current period.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dialysis patient service revenues. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues are recognized based on the Company&#8217;s estimate of the transaction price the Company expects to collect as a result of satisfying its performance obligations. Dialysis patient service revenues are recognized in the period services are provided based on these estimates. Revenues consist primarily of payments from government and commercial health plans for dialysis services provided to patients. The Company maintains a usual and customary fee schedule for its dialysis treatments and related lab services; however, actual collectible revenue is normally recognized at a discount from the fee schedule.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other revenues.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Other revenues consist of revenues earned by the Company's non-dialysis ancillary services as well as fees for management and administrative services to outpatient dialysis businesses that the Company does not consolidate. Other revenues are estimated in the period services are provided. The Company's U.S. ancillary service revenues include revenues earned under risk-based arrangements in the Company's integrated kidney care (IKC) business, including value-based care (VBC) arrangements. Under its VBC arrangements, the Company assumes full or shared financial risk for the total medical cost of care for patients below or above a benchmark. The benchmarks against which the Company incurs profit or loss on these contracts are typically based on the underlying premiums paid to the insuring entity (the Company's counterparty), with adjustments where applicable, or on trended or adjusted medical cost targets.</span></div></ix:nonNumeric></ix:continuation><div id="i9311e9c566584bd9ab5dffbc9b9a605b_40"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RleHRyZWdpb246YTAxMTcxMjEwMmViNGE1YzgwMjMyZmNkMzJjNmQ3NGZfODgy_3235ab8e-7919-4eb6-9fd9-69ccad28d0aa" continuedAt="ib5e82b9f838b4feab451180d52db5504" escape="true">Earnings per share</ix:nonNumeric></span></div><ix:continuation id="ib5e82b9f838b4feab451180d52db5504" continuedAt="i9be199852a5b449e9d97fd6f3d6d38a1"><ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RleHRyZWdpb246YTAxMTcxMjEwMmViNGE1YzgwMjMyZmNkMzJjNmQ3NGZfODg0_0c37652c-93e6-41b7-bf63-fd7b1827dc71" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is calculated by dividing net income attributable to the Company by the weighted average number of common shares outstanding. Weighted average common shares outstanding include restricted stock unit awards that are no longer subject to forfeiture because the recipients have satisfied either the explicit vesting terms or retirement eligibility requirements.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted earnings per share includes the dilutive effect of outstanding stock-settled stock appreciation rights and unvested stock units as computed under the treasury stock method.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div><span><br/></span></div></div><ix:continuation id="i9be199852a5b449e9d97fd6f3d6d38a1"><ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RleHRyZWdpb246YTAxMTcxMjEwMmViNGE1YzgwMjMyZmNkMzJjNmQ3NGZfODg5_252e9a22-00fa-4756-a8e3-8286f36bfca8" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliations of the numerators and denominators used to calculate basic and diluted earnings per share were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to DaVita Inc.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfNC0xLTEtMS0zNjE1Njk_8a62b8d1-c64c-4ae4-a298-a2a5523dee05">105,366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfNC0zLTEtMS0zNjE1Njk_25d83d35-bfbf-4592-8d59-6131c4b54623">259,754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfNC01LTEtMS0zNjE1Njk_f736e6b1-c314-466a-bb49-5d549d1d82c5">492,297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfNC03LTEtMS0zNjE1Njk_507581cb-d8dd-40f1-acab-9c2f4e64f8bd">790,977</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesIssuedBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfNy0xLTEtMS0zNjE1Njk_29604d68-2fd5-4812-acaa-fe932550f9ba">91,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesIssuedBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfNy0zLTEtMS0zNjE1Njk_850f5afe-8434-4834-b354-2169b0643d5a">104,793</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesIssuedBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfNy01LTEtMS0zNjE1Njk_99c1ee69-b5c6-4f22-b187-2eda61fd6d9f">93,959</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesIssuedBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfNy03LTEtMS0zNjE1Njk_d7573e13-441a-401e-863d-3ca9bb9601f9">106,685</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed incremental from stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfOC0xLTEtMS0zNjE1Njk_40b24df5-877a-4c05-b614-e5f37118cbf8">2,103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfOC0zLTEtMS0zNjE1Njk_ce2d8980-999a-4b25-9f67-5aff62a712c1">5,045</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfOC01LTEtMS0zNjE1Njk_84631d1c-606e-4a9f-946f-51ea03383063">3,194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfOC03LTEtMS0zNjE1Njk_ae14664e-392f-446b-b9c8-38487d1f84e8">4,981</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfOS0xLTEtMS0zNjE1Njk_31624ceb-d905-403b-8389-d66327f46916">93,263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfOS0zLTEtMS0zNjE1Njk_f82c041f-dcab-4d8b-b833-4566c605b1cb">109,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfOS01LTEtMS0zNjE1Njk_1ac5d5cd-e3a9-4583-8c51-2e5efe939679">97,153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfOS03LTEtMS0zNjE1Njk_97811e54-5e41-4080-a1fb-da6a78c1baa5">111,666</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income per share attributable to DaVita Inc.</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfMTMtMS0xLTEtMzYxNTY5_12954553-f78e-4289-aed2-15c3a64cad24">1.16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfMTMtMy0xLTEtMzYxNTY5_ab03cc2a-c6bb-42b3-a0c4-fdacaf5d1b43">2.48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfMTMtNS0xLTEtMzYxNTY5_d06d295e-a3d2-4cc3-bb25-2a05f4ca7e3b">5.24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfMTMtNy0xLTEtMzYxNTY5_d675baab-9f84-445a-9361-d4da000cfd0f">7.41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income per share attributable to DaVita Inc.</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfMTctMS0xLTEtMzYxNTY5_c8bf3255-8841-4c94-a8db-d7143e81cf0a">1.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfMTctMy0xLTEtMzYxNTY5_d3bf41d6-1bb6-41ae-b9ff-c4b142f862dc">2.36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfMTctNS0xLTEtMzYxNTY5_3ef762b2-e88b-4151-aad7-73ba668b50f6">5.07</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfMTctNy0xLTEtMzYxNTY5_cef55e42-c901-437c-af1d-7e1c04b1c471">7.08</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anti-dilutive stock-settled awards excluded from calculation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfMTktMS0xLTEtMzYxNTY5_f77a11b1-6521-4694-9589-c26fe8faaeb6">1,260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfMTktMy0xLTEtMzYxNTY5_ba918d53-cc13-42e2-ba6e-3fd2d750a2f3">141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfMTktNS0xLTEtMzYxNTY5_48db79e2-f444-4043-9c44-21f4d2b2975c">878</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfMTktNy0xLTEtMzYxNTY5_7080c56d-d526-4379-90e1-7a9951d6b670">103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Shares associated with stock awards excluded from the diluted denominator calculation because they were anti-dilutive under the treasury stock method.</span></div></ix:nonNumeric></ix:continuation><div id="i9311e9c566584bd9ab5dffbc9b9a605b_43"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RleHRyZWdpb246ZWQ1ZjU3YzQ1MzVlNGZkZmExZjI3MGU1ZDA3NTUxYjZfOTI2_77baf67b-0ab3-41ef-9651-56b7e1359bc1" continuedAt="i849bb1bef2794814894fb10f528524fe" escape="true">Short-term and long-term investments</ix:nonNumeric></span></div><ix:continuation id="i849bb1bef2794814894fb10f528524fe"><ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="us-gaap:MarketableSecuritiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RleHRyZWdpb246ZWQ1ZjU3YzQ1MzVlNGZkZmExZjI3MGU1ZDA3NTUxYjZfOTI3_5c88dec3-c77d-42cc-b40c-6fb1925518ea" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s short-term and long-term debt and equity investments, consisting of debt instruments classified as held-to-maturity and equity investments with readily determinable fair values or redemption values, were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:41.652%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.831%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.831%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.831%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.831%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.831%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.833%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Equity<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Equity<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit and other time deposits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffa1899b208b434e83db21f284ea5a87_I20220930" decimals="-3" name="us-gaap:HeldToMaturitySecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfMi0xLTEtMS0zNjE1Njk_0fa51037-3743-40b8-b674-3ac2deeaac54">77,843</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffa1899b208b434e83db21f284ea5a87_I20220930" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfMi0zLTEtMS0zNjE1Njk_0815926b-450e-477e-adcd-a33767b20c0b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffa1899b208b434e83db21f284ea5a87_I20220930" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfMi01LTEtMS0zNjE1Njk_e5fa3f8d-8354-4b8b-9177-e55d8b433240">77,843</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e7043280f3044ae929ed9d39180bb93_I20211231" decimals="-3" name="us-gaap:HeldToMaturitySecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfMi03LTEtMS0zNjE1Njk_b25ffcbd-8720-4ccf-ab2b-e80ba13069b1">23,226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e7043280f3044ae929ed9d39180bb93_I20211231" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfMi05LTEtMS0zNjE1Njk_6b15b39a-5fb0-4bde-a73c-78c864e9c327">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e7043280f3044ae929ed9d39180bb93_I20211231" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfMi0xMS0xLTEtMzYxNTY5_17cef8fe-fb92-4d25-89e5-52af0b57df84">23,226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in mutual funds and common stocks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i762574633ee549d19d8053d43cdafb79_I20220930" decimals="-3" name="us-gaap:HeldToMaturitySecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfMy0xLTEtMS0zNjE1Njk_2de2f7ef-75ac-49eb-bf72-8fe8bb1cbf0b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i762574633ee549d19d8053d43cdafb79_I20220930" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfMy0zLTEtMS0zNjE1Njk_0ce70e27-0134-4919-97d7-52c6862e547c">39,997</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i762574633ee549d19d8053d43cdafb79_I20220930" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfMy01LTEtMS0zNjE1Njk_217ec7ef-7893-46fc-b1fb-415977f8fae9">39,997</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i998926cd86174abfa8697edf79ac9a69_I20211231" decimals="-3" name="us-gaap:HeldToMaturitySecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfMy03LTEtMS0zNjE1Njk_d58b53b5-bc96-475c-9af7-f5a3d60a85a0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i998926cd86174abfa8697edf79ac9a69_I20211231" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfMy05LTEtMS0zNjE1Njk_6f1f607e-24d9-4644-9eb9-df72b8063e1d">48,598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i998926cd86174abfa8697edf79ac9a69_I20211231" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfMy0xMS0xLTEtMzYxNTY5_a6e60649-0c74-499f-a381-c798e862ed63">48,598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:HeldToMaturitySecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfNC0xLTEtMS0zNjE1Njk_3e8fc1e8-7fed-4fea-b80c-5c22462b98ed">77,843</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfNC0zLTEtMS0zNjE1Njk_64a4e020-6a66-4b85-8222-2dab187034a7">39,997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfNC01LTEtMS0zNjE1Njk_23d869ab-57f2-4863-b9af-a7831eada3b8">117,840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:HeldToMaturitySecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfNC03LTEtMS0zNjE1Njk_adee304d-4878-4ab6-97d1-8790b9536961">23,226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfNC05LTEtMS0zNjE1Njk_d04c50a3-9c87-43a1-bfe9-50f751a58f86">48,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfNC0xMS0xLTEtMzYxNTY5_737a3838-5dda-4865-82c4-54b6965497da">71,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:HeldToMaturitySecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfNS0xLTEtMS0zNjE1Njk_04ac6aa3-466e-4387-aa3c-c3d1c1cd0b74">62,832</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3d961759a0d4fab9e023c8d7cc84b4d_I20220930" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfNS0zLTEtMS0zNjE1Njk_f081c06a-8020-4539-b21f-d972f1a49698">11,473</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfNS01LTEtMS0zNjE1Njk_484ddd29-ba33-4612-842e-4c1dcf39e215">74,305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:HeldToMaturitySecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfNS03LTEtMS0zNjE1Njk_6014d81a-097f-438b-8b03-93741573dbce">8,227</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02bde4cdadea4ac6b75aaf556e9f2418_I20211231" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfNS05LTEtMS0zNjE1Njk_8b2e683e-01d0-4672-ba7d-bf63ce6eb7e6">14,083</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:MarketableSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfNS0xMS0xLTEtMzYxNTY5_d6842c6c-b4fb-42f9-973a-5ab68ae930d2">22,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:HeldToMaturitySecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfNi0xLTEtMS0zNjE1Njk_87fb9088-e92f-4b52-9225-f0a493d52c2e">15,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i483736bcec6d40ddb087fe0d0b25dbb5_I20220930" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfNi0zLTEtMS0zNjE1Njk_476dc1af-9f03-478f-9ce6-4704fd2b8249">28,524</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:MarketableSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfNi01LTEtMS0zNjE1Njk_5defef43-930e-41fe-b558-9054d476618f">43,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:HeldToMaturitySecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfNi03LTEtMS0zNjE1Njk_0be3794a-9350-496e-96e3-d4c207c00c36">14,999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfc94329266c4456afa05d709202b567_I20211231" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfNi05LTEtMS0zNjE1Njk_84de3a7f-26ab-4655-a6ca-c1c0d69ea88c">34,515</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:MarketableSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfNi0xMS0xLTEtMzYxNTY5_7e647538-a7dd-4680-8341-773b3677a129">49,514</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:HeldToMaturitySecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfNy0xLTEtMS0zNjE1Njk_e05d37a7-4ed0-4355-bd7a-ceade9f33898">77,843</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfNy0zLTEtMS0zNjE1Njk_feab66af-7bba-4f47-a4d0-70d51d533a4a">39,997</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfNy01LTEtMS0zNjE1Njk_bccf1735-1275-4acd-b4c3-105dcb594925">117,840</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:HeldToMaturitySecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfNy03LTEtMS0zNjE1Njk_6ddb51aa-871c-4a74-a9f1-dc1c4e3aef78">23,226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfNy05LTEtMS0zNjE1Njk_c5fc4ed6-25a0-40e2-9f62-a4b7229ea67a">48,598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:MarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfNy0xMS0xLTEtMzYxNTY5_386764d7-ce9c-4448-9481-76e43c8befd6">71,824</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="us-gaap:MarketableSecuritiesPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RleHRyZWdpb246ZWQ1ZjU3YzQ1MzVlNGZkZmExZjI3MGU1ZDA3NTUxYjZfOTI4_19337290-7a34-44f6-b4d0-c8622085f13a" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt securities:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company's short-term debt investments are principally bank certificates of deposit with contractual maturities longer than three months but shorter than one year. These debt securities are accounted for as held-to-maturity and recorded at amortized cost, which approximated their fair values at September&#160;30, 2022 and December&#160;31, 2021.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity securitie</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s: The Company holds certain equity investments that have readily determinable fair values from public markets. The Company's remaining short-term and long-term equity investments are held within a trust to fund existing obligations associated with the Company&#8217;s non-qualified deferred compensation plans.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><div id="i9311e9c566584bd9ab5dffbc9b9a605b_46"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="us-gaap:GoodwillDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RleHRyZWdpb246ZWY4YWQzMzU4MTliNGRmZjk4OWIwN2VlYzQyNGQ3YTBfMjgzMQ_6b811760-1603-4407-a06a-766c7c7daa36" continuedAt="i8c94115534644ae39fd8246807c92a98" escape="true">Goodwill</ix:nonNumeric></span></div><ix:continuation id="i8c94115534644ae39fd8246807c92a98" continuedAt="i9998b28c80864a509a82ae9171a51e7f"><ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RleHRyZWdpb246ZWY4YWQzMzU4MTliNGRmZjk4OWIwN2VlYzQyNGQ3YTBfMjgzMw_474a492c-6e80-4c90-ba3a-e23d0b1b7a3e" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in goodwill by reportable segments were as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.888%"><tr><td style="width:1.0%"></td><td style="width:39.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.143%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.622%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.143%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.622%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.145%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other &#8212; Ancillary services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7271827c904f4e51b6526494e9342d5f_I20201231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfMS0xLTEtMS0zNjE1Njk_3f2074a2-b410-4d4c-b5dc-a0316d6fd33c">6,309,928</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i756ef20c6d3443ab8a775b412b7acddc_I20201231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfMS0zLTEtMS0zNjE1Njk_6eba2489-0b8e-485a-86d4-d626e389c429">609,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf9e89b4e598444e8b9df2b00849c30a_I20201231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfMS01LTEtMS0zNjE1Njk_92e7e8cb-d161-419a-ad93-dbd93ee7fc59">6,919,109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i171f9689d476418d827ad1ac63f1abe2_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfMi0xLTEtMS0zNjE1Njk_3b1acf5e-0668-478c-bb13-5e472ae56da6">91,979</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe624a85b4c4310aae5c81aef699e3a_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfMi0zLTEtMS0zNjE1Njk_3a7e7dd9-36a8-4f43-940f-be69bbc420dc">81,265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2759022dfe6d4c619bce01f379f17594_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfMi01LTEtMS0zNjE1Njk_8b2e44ce-6296-41d3-bb97-c2aa75e60eb2">173,244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i171f9689d476418d827ad1ac63f1abe2_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfMy0xLTEtMS0zNjE1Njk_aa6175ab-20c1-4f85-af90-e4bd81b9ff87">1,745</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fe624a85b4c4310aae5c81aef699e3a_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfMy0zLTEtMS0zNjE1Njk_8fac4742-ba10-4b08-9c3f-3a3e3e471954">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2759022dfe6d4c619bce01f379f17594_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfMy01LTEtMS0zNjE1Njk_1eebd78a-cf13-4734-9b28-3f409135a720">1,745</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i171f9689d476418d827ad1ac63f1abe2_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfNC0xLTEtMS0zNjE1Njk_138109ac-7625-4db1-8d77-23f2d7fb6e16">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fe624a85b4c4310aae5c81aef699e3a_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfNC0zLTEtMS0zNjE1Njk_d0894849-3c76-42b8-8f23-969430cde032">44,367</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2759022dfe6d4c619bce01f379f17594_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfNC01LTEtMS0zNjE1Njk_a38cd93b-2f33-456e-989a-af4fbfd5788f">44,367</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i698d58b2d3b2468cbb119fff40dd7a93_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfNS0xLTEtMS0zNjE1Njk_cb7e1891-4df2-4060-8ba6-405e068a4ef7">6,400,162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92fca4752e474a7bad54570de210ff8d_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfNS0zLTEtMS0zNjE1Njk_cf9bd9ca-e020-4334-b9c6-8b270be2cb36">646,079</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfNS01LTEtMS0zNjE1Njk_2028a240-03bc-4507-8199-74861d0a5c82">7,046,241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i422c6a94a816499c8310fd5a0acc841f_D20220101-20220930" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfNi0xLTEtMS0zNjE1Njk_f82d8328-dd7e-4a51-a499-fed1438e2ed6">16,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie63e40be1b8c44ae852031a36cc0c1d2_D20220101-20220930" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfNi0zLTEtMS0zNjE1Njk_b9cd054b-bebe-4039-a8aa-16c0ed42b460">18,019</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfNi01LTEtMS0zNjE1Njk_e7119165-818b-4f3a-943f-55c0a24330a7">34,769</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i422c6a94a816499c8310fd5a0acc841f_D20220101-20220930" decimals="-3" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfNy0xLTEtMS0zNjE1Njk_119a59fe-5926-49c5-9a19-b2953d910335">87</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie63e40be1b8c44ae852031a36cc0c1d2_D20220101-20220930" decimals="-3" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfNy0zLTEtMS0zNjE1Njk_6e7ce42b-5824-485f-bf30-242ce8e14ed5">3,126</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfNy01LTEtMS0zNjE1Njk_de1f31fb-3103-40ef-855b-100e0a81502b">3,213</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i422c6a94a816499c8310fd5a0acc841f_D20220101-20220930" decimals="-3" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfOC0xLTEtMS0zNjE1Njk_0b2c3b2e-3923-4966-b40d-3a533050c6f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie63e40be1b8c44ae852031a36cc0c1d2_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfOC0zLTEtMS0zNjE1Njk_943e5876-353b-46a8-95c7-b513c3351474">55,155</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfOC01LTEtMS0zNjE1Njk_f1bd5ced-1181-4055-b4a0-a25e66cce126">55,155</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7093bff9492a45488822863f8f94a337_I20220930" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfOS0xLTEtMS0zNjE1Njk_54966761-25fd-4440-8b47-a82eb27728ec">6,416,825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d792edae43b4791856eea60df0b33b6_I20220930" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfOS0zLTEtMS0zNjE1Njk_c1444b93-5a4d-4767-b4f3-54e006405dbb">605,817</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfOS01LTEtMS0zNjE1Njk_3d95bddb-081e-4d9e-a22e-6479e75bc00e">7,022,642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2022:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7093bff9492a45488822863f8f94a337_I20220930" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfMTItMS0xLTEtMzYxNTY5_f644fb4b-90b1-48d6-980d-ded2de2f59e4">6,416,825</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d792edae43b4791856eea60df0b33b6_I20220930" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfMTItMy0xLTEtMzYxNTY5_7340007f-35c6-4c67-8ff7-0bbb5c445df8">715,147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:GoodwillGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfMTItNS0xLTEtMzYxNTY5_1c2e1145-f122-48d9-aed3-3382b1c910e5">7,131,972</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7093bff9492a45488822863f8f94a337_I20220930" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfMTMtMS0xLTEtMzYxNTY5_84e21a52-ce7d-48b4-b79b-f1038baa574a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d792edae43b4791856eea60df0b33b6_I20220930" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfMTMtMy0xLTEtMzYxNTY5_a11bc8f8-b426-482d-a467-12bdcfb2495a">109,330</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfMTMtNS0xLTEtMzYxNTY5_b8ff5dff-d508-424d-bc16-1a78d02233c1">109,330</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7093bff9492a45488822863f8f94a337_I20220930" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfMTQtMS0xLTEtMzYxNTY5_9708635e-1fef-4b73-aa9c-56b9f08ce6df">6,416,825</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d792edae43b4791856eea60df0b33b6_I20220930" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfMTQtMy0xLTEtMzYxNTY5_136c18cb-0b06-4eec-b5bd-f533a2eedef8">605,817</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfMTQtNS0xLTEtMzYxNTY5_4eb7c384-5ca7-4d3b-830f-12d96ed53bd8">7,022,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not recognize any goodwill impairment charges during the nine months ended September 30, 2022 and 2021.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As dialysis treatments are an essential, life-sustaining service for patients who depend on them, the Company's operations have continued and are currently expected to continue throughout the novel coronavirus (COVID-19) pandemic. However, the ultimate impact of this COVID-19 pandemic on the Company will depend on future developments that are highly uncertain and difficult to predict, including among others the ultimate severity and duration of the pandemic; further spread or resurgence of the virus, including as a result of the emergence of new strains of the virus such as the Omicron variant and its subvariants; COVID-19's impact on the chronic kidney disease (CKD) patient population and the Company's patient population, including on the mortality of these patients; the availability, acceptance, impact and efficacy of COVID-19 vaccines, treatments, and therapies; the pandemic's continuing impact on the Company's revenue and non-acquired growth due to lower treatment volumes, the U.S. and global economies, labor market conditions, interest rates, inflation and monetary policies; the Company's ability to successfully implement cost savings initiatives; the potential negative impact on the Company's commercial mix or the number of patients covered by commercial insurance plans; continued increased COVID-19-related costs; supply chain challenges and disruptions; the responses of the Company's competitors to the pandemic and related changes in the marketplace; the timing, scope and effectiveness of federal, state and local government responses to the pandemic; and any potential changes to the extensive set of federal, state and local laws, regulations and requirements that govern the Company's business. While the Company does not currently expect a material adverse impact to its business as a result of this public health crisis, there can be no assurance that the COVID-19 pandemic will not have a material adverse impact on one or more of the Company's businesses.</span></div></ix:continuation><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9998b28c80864a509a82ae9171a51e7f">Developments, events, changes in operating performance and other changes in circumstances since the dates of the Company&#8217;s last annual goodwill impairment assessments have not caused management to believe it is more likely than not that the fair values of any of the Company's reporting units would be less than their respective carrying amounts as of September&#160;30, 2022. Except for the Company's Germany kidney care reporting unit as described further in Note 10 to the Company's consolidated financial statements included in the 2021 10-K, <ix:nonFraction unitRef="segment" contextRef="ic52ab49cab0046128e4cd38b93634c67_D20220701-20220930" decimals="0" name="us-gaap:NumberOfOperatingSegments" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RleHRyZWdpb246ZWY4YWQzMzU4MTliNGRmZjk4OWIwN2VlYzQyNGQ3YTBfMjcwOQ_0c0756e8-4cec-4dd6-8998-ea1790af359f">none</ix:nonFraction> of the Company's various other reporting units were considered at risk of significant goodwill impairment as of September&#160;30, 2022.</ix:continuation>&#160;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><div id="i9311e9c566584bd9ab5dffbc9b9a605b_52"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="us-gaap:LongTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMzc5OA_0e87895a-b2e5-4491-b749-506d4dd7d9c1" continuedAt="i583ca9402bf84aeb841ad134f3d18d23" escape="true">Long-term debt</ix:nonNumeric></span></div><ix:continuation id="i583ca9402bf84aeb841ad134f3d18d23" continuedAt="i3af9d5915c5d43ae88b9ab7d2dadd355"><ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMzc4MA_d523b73b-ea36-45cb-abe3-062327949cc2" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt was comprised of the following:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.104%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.702%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">As of September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30, <br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Maturity date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest rate</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Estimated fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Secured Credit Facilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan A</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i168f0cc4ee2a490ba0df4d0eb3ab2041_I20220930" decimals="-3" name="us-gaap:SecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfMy0xLTEtMS0zNjE1Njk_273f00f9-c67d-464c-8c18-c4e8f1d84b9e">1,531,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f2af1cb259e4765a370d5164540acf9_I20211231" decimals="-3" name="us-gaap:SecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfMy0zLTEtMS0zNjE1Njk_9e01e9dd-387c-4fda-a8c7-df4980fe2635">1,596,875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5fab6e21c9604971bab7725c4bfbac6f_D20220101-20220930" name="us-gaap:DebtInstrumentMaturityDate" format="ixt:date-month-day-year" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfMy01LTEtMS0zNjE1Njk_c42d9f11-bfc2-4036-891f-9c6a9a6ff871">8/12/2024</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5fab6e21c9604971bab7725c4bfbac6f_D20220101-20220930" name="us-gaap:DebtInstrumentDescriptionOfVariableRateBasis" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfMy03LTEtMS0zNjE1Njk_b36c2ca1-392d-45e6-b876-10d35b244c5d">LIBOR+1.75%</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i168f0cc4ee2a490ba0df4d0eb3ab2041_I20220930" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfMy05LTEtMS0zNjE1Njk_5f41596e-0d8c-49bd-b391-d0c31ce601e6">1,500,625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan B-1</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i302d14b3d5a44d99ac999f078c7fd0c8_I20220930" decimals="-3" name="us-gaap:SecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfNC0xLTEtMS0zNjE1Njk_14df7330-060c-4a29-a48d-8e16ed291533">2,667,689</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib24db8b1544e4594962862573a081569_I20211231" decimals="-3" name="us-gaap:SecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfNC0zLTEtMS0zNjE1Njk_8860b2c2-3ce6-4f00-a8e2-a63a5cbde2ac">2,688,263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3eac2310025f4fc0a30a0754d743a012_D20220101-20220930" name="us-gaap:DebtInstrumentMaturityDate" format="ixt:date-month-day-year" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfNC01LTEtMS0zNjE1Njk_221b48ff-73a6-4bbe-9580-c2c64553b78d">8/12/2026</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3eac2310025f4fc0a30a0754d743a012_D20220101-20220930" name="us-gaap:DebtInstrumentDescriptionOfVariableRateBasis" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfNC03LTEtMS0zNjE1Njk_72169b61-18fd-4cf6-9f55-8100092aca86">LIBOR+1.75%</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i302d14b3d5a44d99ac999f078c7fd0c8_I20220930" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfNC05LTEtMS0zNjE1Njk_baa51206-c6ce-462c-a379-a649fba7cc68">2,530,970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving line of credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3433a7055306497a9f23d7846a707116_I20220930" decimals="-3" name="us-gaap:SecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfNS0xLTEtMS0zNjE1Njk_a4c3ac52-7693-4e4b-842f-9f380040e54c">275,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d5c71dc8775496aa1ad4209bbb25af1_I20211231" decimals="-3" name="us-gaap:SecuredDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfNS0zLTEtMS0zNjE1Njk_af283f06-ec1b-4996-9904-24fe86345e51">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5034dae68d4445268ca6238ba4f28038_D20220101-20220930" name="us-gaap:DebtInstrumentMaturityDate" format="ixt:date-month-day-year" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfNS01LTEtMS0zNjE1Njk_30a048c7-9858-45c4-9caa-5f840adbc844">8/12/2024</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5034dae68d4445268ca6238ba4f28038_D20220101-20220930" name="us-gaap:DebtInstrumentDescriptionOfVariableRateBasis" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfNS03LTEtMS0zNjE1Njk_c6981def-ce58-415a-b0d4-8066ae062c6e">LIBOR+1.75%</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3433a7055306497a9f23d7846a707116_I20220930" decimals="-6" name="us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfNS05LTEtMS0zNjE1Njk_bd7f3b65-2273-4f78-932c-df6424357ac0">275,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Notes:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.625% Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia085405df9dc49bc9d8a30bf7986f78f_I20220930" decimals="-3" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfNy0xLTEtMS0zNjE1Njk_1da7904d-fa31-4a5a-ada8-d2c8618d8b15">2,750,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09d1f6ddde7148209032eb2224d201eb_I20211231" decimals="-3" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfNy0zLTEtMS0zNjE1Njk_1a487735-c119-4e62-9d92-c873ac39f73d">2,750,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i302c47dbb07447f3aa14cc9c0f845e99_D20220101-20220930" name="us-gaap:DebtInstrumentMaturityDate" format="ixt:date-month-day-year" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfNy01LTEtMS0zNjE1Njk_c7a06f97-9a59-4ed8-8924-d4cbdf814c6d">6/1/2030</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i302c47dbb07447f3aa14cc9c0f845e99_D20220101-20220930" decimals="5" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfNy03LTEtMS0zNjE1Njk_57a7e361-0cd1-439e-85cd-f82943ee0306">4.625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia085405df9dc49bc9d8a30bf7986f78f_I20220930" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfNy05LTEtMS0zNjE1Njk_a6edab0d-51d6-45b5-a6e3-cbb8f1f62f2c">2,124,375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75% Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5060f8fb53a5401181f83f0a4d6ff2a5_I20220930" decimals="-3" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfOC0xLTEtMS0zNjE1Njk_87572ce0-9f39-4dc4-bb05-af452a0eb86b">1,500,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04752ae989ad4df8860d74e4cad34f15_I20211231" decimals="-3" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfOC0zLTEtMS0zNjE1Njk_04138a16-a017-4fc4-ae13-d5149c9a93f6">1,500,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i64428b0bc4064508aa43d6d7c4cc144b_D20220101-20220930" name="us-gaap:DebtInstrumentMaturityDate" format="ixt:date-month-day-year" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfOC01LTEtMS0zNjE1Njk_15192c0f-6bae-48ec-95da-27cbd5446375">2/15/2031</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i64428b0bc4064508aa43d6d7c4cc144b_D20220101-20220930" decimals="5" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfOC03LTEtMS0zNjE1Njk_6c788c3e-abf7-4c95-b659-b80c8879012e">3.75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5060f8fb53a5401181f83f0a4d6ff2a5_I20220930" decimals="-3" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfOC05LTEtMS0zNjE1Njk_888600c3-cc2a-4615-92e3-f4c4264eb7b8">1,068,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition obligations and other notes payable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe11ca6fc7841578c3e48f6f74461bb_I20220930" decimals="-3" name="dva:AcquisitionObligationsAndOtherNotesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfOS0xLTEtMS0zNjE1Njk_a29f72e1-db39-47bb-8220-10481ccb7fd8">125,809</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibea5962a62cd4213b61783287c172e38_I20211231" decimals="-3" name="dva:AcquisitionObligationsAndOtherNotesPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfOS0zLTEtMS0zNjE1Njk_195d2158-7828-4640-a9f9-0c03f28c4f0e">130,599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i87c41204c9904d789e0b0f9e1ef28d3d_D20220101-20220930" name="us-gaap:DebtInstrumentMaturityDateDescription" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfOS01LTEtMS0zNjE1Njk_4a097dc1-5fa2-4619-81e6-802aada5a80a">2022-2036</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibbe11ca6fc7841578c3e48f6f74461bb_I20220930" decimals="4" name="us-gaap:LongtermDebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfOS03LTEtMS0zNjE1Njk_01defd52-952f-4c52-ab71-9196f887287e">5.82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbe11ca6fc7841578c3e48f6f74461bb_I20220930" decimals="-3" name="dva:AcquisitionObligationsAndOtherNotesPayableFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfOS05LTEtMS0zNjE1Njk_df23a34c-aef8-4262-9dcb-fb294718e803">125,809</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing lease obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00a6d21c50894a1fa91ade6d03f0fffe_I20220930" decimals="-3" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfMTAtMS0xLTEtMzYxNTY5_b9d296a8-6721-4552-a213-b7592fbfdec9">279,213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ebc73ef268843d2a9d4b6d4d487bd9e_I20211231" decimals="-3" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfMTAtMy0xLTEtMzYxNTY5_97718614-5992-4b8f-a713-1873ef4b5ecd">299,128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iaf4852e0d4004e5793b6d25aad62c55c_D20220101-20220930" name="us-gaap:DebtInstrumentMaturityDateDescription" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfMTAtNS0xLTEtMzYxNTY5_ba9304b9-313e-4fb1-b957-1e680eeb2db2">2023-2038</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i00a6d21c50894a1fa91ade6d03f0fffe_I20220930" decimals="4" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfMTAtNy0xLTEtMzYxNTY5_a49783f3-7214-4469-8468-029567cf5cd3">4.53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt principal outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfMTEtMS0xLTEtMzYxNTY5_909de1d4-a374-43f7-8f0c-0a0e1adbe4a1">9,128,961</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfMTEtMy0xLTEtMzYxNTY5_3036a0ca-1524-42ed-b88c-4053397ed0d8">8,964,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount, premium and deferred financing costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="dva:DiscountPremiumAndDeferredFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfMTItMS0xLTEtMzYxNTY5_cb26637c-4b20-476c-b854-c7cecf6d407e">47,520</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="dva:DiscountPremiumAndDeferredFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfMTItMy0xLTEtMzYxNTY5_d0a8c326-db66-4134-b095-3aa84595e069">56,685</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfMTMtMS0xLTEtMzYxNTY5_e295e888-1bd5-400a-8bc8-0f5f55b751c0">9,081,441</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfMTMtMy0xLTEtMzYxNTY5_6fad3e92-ce0a-4331-8cb6-f6b6d9d51ef7">8,908,180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfMTQtMS0xLTEtMzYxNTY5_fe1e428b-0a86-4e7e-ac9a-0380c76fea02">214,254</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfMTQtMy0xLTEtMzYxNTY5_ff3ac856-a138-4b53-800e-d197401ab8ec">179,030</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfMTUtMS0xLTEtMzYxNTY5_92231fbf-9153-4c97-9a13-a7f36e42b895">8,867,187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfMTUtMy0xLTEtMzYxNTY5_54fdd840-5e24-4639-97ac-1f362fc4458c">8,729,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For the Company's senior secured credit facilities and senior notes, fair value estimates are based upon bid and ask quotes, typically a level 2 input. For acquisition obligations and other notes payable, the carrying values presented approximate their estimated fair values, based on estimates of their present values using level 2 interest rate inputs. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The interest rate presented for acquisition obligations and other notes payable is their weighted average interest rate based on the current fixed and variable interest rate components in effect as of September&#160;30, 2022.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Financing lease obligations are measured at their approximate present values at inception. The interest rate presented is the weighted average discount rate embedded in financing leases outstanding.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As of September&#160;30, 2022, the carrying amount of the Company's senior secured credit facilities have been reduced by a discount of $<ix:nonFraction unitRef="usd" contextRef="i41f04bf6bfb648ff9ac2bac9337cf616_I20220930" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfOTUy_5b6763be-97a5-4bc1-9bd0-590acd457432">3,740</ix:nonFraction> and deferred financing costs of $<ix:nonFraction unitRef="usd" contextRef="i41f04bf6bfb648ff9ac2bac9337cf616_I20220930" decimals="-3" name="us-gaap:DeferredOfferingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfOTg3_3f16c512-34aa-4a42-a0f8-203b3b585288">20,891</ix:nonFraction>, and the carrying amount of the Company's senior notes have been reduced by deferred financing costs of $<ix:nonFraction unitRef="usd" contextRef="i3c5c02a03c2046a284b5bbc100254ca4_I20220930" decimals="-3" name="us-gaap:DeferredOfferingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMTA5NA_a8c70a15-628d-443d-8455-718c9e6fe68f">37,380</ix:nonFraction> and increased by a debt premium of $<ix:nonFraction unitRef="usd" contextRef="i3c5c02a03c2046a284b5bbc100254ca4_I20220930" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedPremium" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMTEzMg_18154a22-96e0-4821-8c9b-3b41b8e06747">14,491</ix:nonFraction>. As of December&#160;31, 2021, the carrying amount of the Company's senior secured credit facilities were reduced by a discount of $<ix:nonFraction unitRef="usd" contextRef="i82d2dee054d74a1a9b9863ec06aedad5_I20211231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMTI0Ng_2ecf10f6-b81f-4d39-86ee-d642fdf43fcb">4,473</ix:nonFraction> and deferred financing costs of $<ix:nonFraction unitRef="usd" contextRef="i82d2dee054d74a1a9b9863ec06aedad5_I20211231" decimals="-3" name="us-gaap:DeferredOfferingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMTI4MQ_949370a5-366b-48f6-80bb-14117cb1b356">27,207</ix:nonFraction>, and the carrying amount of the Company's senior notes were reduced by deferred financing costs of $<ix:nonFraction unitRef="usd" contextRef="i7c55687d402147b5b3598fcd58f4ea18_I20211231" decimals="-3" name="us-gaap:DeferredOfferingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMTM4Mw_9c1ea2f5-a5bf-4034-91f7-50fd7802d468">40,914</ix:nonFraction> and increased by a debt premium of $<ix:nonFraction unitRef="usd" contextRef="i7c55687d402147b5b3598fcd58f4ea18_I20211231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedPremium" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMTQyMQ_b60bd4be-4fb7-4ce9-81cc-24c8f814113e">15,909</ix:nonFraction>.</span></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first nine months of 2022, the Company made regularly scheduled mandatory principal payments under its senior secured credit facilities totaling $<ix:nonFraction unitRef="usd" contextRef="i5fab6e21c9604971bab7725c4bfbac6f_D20220101-20220930" decimals="-3" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMTU3Nw_53baa4c9-f68d-4493-b8d4-3622cebb1f78">65,625</ix:nonFraction> on Term Loan A and $<ix:nonFraction unitRef="usd" contextRef="i3eac2310025f4fc0a30a0754d743a012_D20220101-20220930" decimals="-3" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMTU5OQ_a929c97b-6a93-4658-b3af-a692fd117514">20,574</ix:nonFraction> on Term Loan B-1.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, the Company's 2019 interest rate cap agreements have the economic effect of capping the Company's maximum exposure to LIBOR variable interest rate changes on equivalent amounts of the Company's floating rate debt, including all of Term Loan B-1 and a portion of Term Loan A. The remaining $<ix:nonFraction unitRef="usd" contextRef="i168f0cc4ee2a490ba0df4d0eb3ab2041_I20220930" decimals="-3" name="dva:SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMTkxOQ_4657231e-1e0c-46b4-9e89-b73a48a8c411">698,939</ix:nonFraction> outstanding principal balance of Term Loan A and the $<ix:nonFraction unitRef="usd" contextRef="i3433a7055306497a9f23d7846a707116_I20220930" decimals="-3" name="us-gaap:SecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMTk3NQ_a4c3ac52-7693-4e4b-842f-9f380040e54c">275,000</ix:nonFraction> balance outstanding on the revolving line of credit are subject to LIBOR-based interest rate volatility. <ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMzgwMA_39e61bc7-731d-455b-b204-4dde1dbee8d6" escape="true">These cap agreements are designated as cash flow hedges and, as a result, changes in their fair values are reported in other comprehensive income. The original premiums paid for the caps are amortized to debt expense on a straight-line basis over the term of each cap agreement starting from its effective date.</ix:nonNumeric> These cap agreements do not contain credit risk-contingent features.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div><span><br/></span></div></div><ix:continuation id="i3af9d5915c5d43ae88b9ab7d2dadd355" continuedAt="i6ae3f9d8f8e0468994ea0877c22243d2"><ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="us-gaap:ScheduleOfDerivativeInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMzc3OA_425b9d49-fffb-461a-9924-de76a8d93c7b" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s interest rate cap agreements outstanding as of September&#160;30, 2022 and December&#160;31, 2021, which are classified in "Other long-term assets" on its consolidated balance sheet:&#160;</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:17.779%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.192%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.192%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.012%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.012%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.929%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.377%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended <br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">LIBOR maximum rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Effective date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expiration date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt expense</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Recorded OCI gain</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30, <br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 cap agreements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27a76be1220a42ebb7e508e18f02f881_I20220930" decimals="-3" name="us-gaap:DerivativeAssetNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOjMzNDNiOGQxYjAwNzRhZWFhMGYzMWJkOTU1ZWVjYmNiL3RhYmxlcmFuZ2U6MzM0M2I4ZDFiMDA3NGFlYWEwZjMxYmQ5NTVlZWNiY2JfMi0xLTEtMS0zNjE1Njk_59eb4c5b-05d1-4194-8515-b0fceab86707">3,500,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i551c354ec3c64e7889df8603ed99c879_D20220101-20220930" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOjMzNDNiOGQxYjAwNzRhZWFhMGYzMWJkOTU1ZWVjYmNiL3RhYmxlcmFuZ2U6MzM0M2I4ZDFiMDA3NGFlYWEwZjMxYmQ5NTVlZWNiY2JfMi0zLTEtMS0zNjE1Njk_ff06c194-04eb-4cc0-9d41-e15d4a648560">2.00</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6dcab18b6e464b478f9e7b926940407a_D20220101-20220930" name="us-gaap:DerivativeInceptionDates" format="ixt:date-month-day-year" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOjMzNDNiOGQxYjAwNzRhZWFhMGYzMWJkOTU1ZWVjYmNiL3RhYmxlcmFuZ2U6MzM0M2I4ZDFiMDA3NGFlYWEwZjMxYmQ5NTVlZWNiY2JfMi01LTEtMS0zNjE1Njk_e53f7ab8-aba5-46f0-a806-3e93b5de7a87">6/30/2020</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6dcab18b6e464b478f9e7b926940407a_D20220101-20220930" name="us-gaap:DerivativeMaturityDates" format="ixt:date-month-day-year" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOjMzNDNiOGQxYjAwNzRhZWFhMGYzMWJkOTU1ZWVjYmNiL3RhYmxlcmFuZ2U6MzM0M2I4ZDFiMDA3NGFlYWEwZjMxYmQ5NTVlZWNiY2JfMi03LTEtMS0zNjE1Njk_ad8f197d-d0f4-41f3-bc1d-8a8729c221aa">6/30/2024</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOjMzNDNiOGQxYjAwNzRhZWFhMGYzMWJkOTU1ZWVjYmNiL3RhYmxlcmFuZ2U6MzM0M2I4ZDFiMDA3NGFlYWEwZjMxYmQ5NTVlZWNiY2JfMi05LTEtMS0zNjE1Njk_2f37a18b-1ac9-4872-985b-d24c04e03453"><ix:nonFraction unitRef="usd" contextRef="ie3bcbd3ed4904f758f13fa1bf235728c_D20220101-20220930" decimals="-3" name="us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOjMzNDNiOGQxYjAwNzRhZWFhMGYzMWJkOTU1ZWVjYmNiL3RhYmxlcmFuZ2U6MzM0M2I4ZDFiMDA3NGFlYWEwZjMxYmQ5NTVlZWNiY2JfMi05LTEtMS0zNjE1Njk_71913a8e-8fb1-47c5-bd4b-1644f1bcb45a">1,497</ix:nonFraction></span>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bd1edc1ab034b47a8b52b57f222a787_D20220101-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOjMzNDNiOGQxYjAwNzRhZWFhMGYzMWJkOTU1ZWVjYmNiL3RhYmxlcmFuZ2U6MzM0M2I4ZDFiMDA3NGFlYWEwZjMxYmQ5NTVlZWNiY2JfMi0xMS0xLTEtMzYxNTY5_78ab2f9e-0c21-4bfb-a178-cc4c7e83150a">127,460</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c1f682df591439fa3b6fcdf674d782e_I20220930" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOjMzNDNiOGQxYjAwNzRhZWFhMGYzMWJkOTU1ZWVjYmNiL3RhYmxlcmFuZ2U6MzM0M2I4ZDFiMDA3NGFlYWEwZjMxYmQ5NTVlZWNiY2JfMi0xMy0xLTEtMzYxNTY5_0c01526c-ea2d-40d4-94a4-cf2c059a37b1">139,663</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i288ec9efae5e463983828ed73eecc6fa_I20211231" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOjMzNDNiOGQxYjAwNzRhZWFhMGYzMWJkOTU1ZWVjYmNiL3RhYmxlcmFuZ2U6MzM0M2I4ZDFiMDA3NGFlYWEwZjMxYmQ5NTVlZWNiY2JfMi0xNS0xLTEtMzYxNTY5_9be32091-299d-459c-b5b5-0e821360220f">12,203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 9 for further details on amounts reclassified from accumulated other comprehensive loss and recorded as debt expense related to the Company&#8217;s interest rate cap agreements for the three and nine months ended September&#160;30, 2022 and 2021.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the LIBOR cap from our 2019 interest rate cap agreements, the Company&#8217;s weighted average effective interest rate on its senior secured credit facilities at the end of the third quarter of 2022 was <ix:nonFraction unitRef="number" contextRef="i41f04bf6bfb648ff9ac2bac9337cf616_I20220930" decimals="4" name="us-gaap:LongtermDebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMjE5OTAyMzI1OTQzNQ_b5630501-f6ad-4a39-b74e-cb1a97e3ba43">4.34</ix:nonFraction>%, based on the current margins in effect for its senior secured credit facilities as of September&#160;30, 2022, as detailed in the table above.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s overall weighted average effective interest rate for the three and nine months ended September&#160;30, 2022 was <ix:nonFraction unitRef="number" contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMzIyNw_0cf4ba20-8350-4f8c-b4c9-3915a03d796f">4.28</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="4" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMzIzNA_4ed7c9aa-b6ee-40ff-85a3-813f1db93663">3.78</ix:nonFraction>%, and as of September&#160;30, 2022 was <ix:nonFraction unitRef="number" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="4" name="us-gaap:LongtermDebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMzI1NQ_c55f8df2-1112-426e-ad76-588b58c3eb28">4.39</ix:nonFraction>%.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, the Company&#8217;s interest rates were fixed and economically fixed on approximately <ix:nonFraction unitRef="number" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="4" name="us-gaap:LongTermDebtPercentageBearingFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMzMyNg_aeecadf3-921e-4d56-af00-4799787b775c">50</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="4" name="dva:LongTermDebtPercentageBearingEconomicallyFixedInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMTY0OTI2NzQ0NzQ5OQ_c091c8d7-3172-42ef-ac74-bb2e41c8b2fa">89</ix:nonFraction>% of its total debt, respectively.</span></div></ix:continuation><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6ae3f9d8f8e0468994ea0877c22243d2">As of September&#160;30, 2022, the Company had $<ix:nonFraction unitRef="usd" contextRef="i3433a7055306497a9f23d7846a707116_I20220930" decimals="-3" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMzM3NA_10f39905-cd40-4d54-93cb-93dd9a1e489c">725,000</ix:nonFraction> available and $<ix:nonFraction unitRef="usd" contextRef="i3433a7055306497a9f23d7846a707116_I20220930" decimals="-3" name="us-gaap:SecuredDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMzM5MQ_a4c3ac52-7693-4e4b-842f-9f380040e54c">275,000</ix:nonFraction> drawn on its $<ix:nonFraction unitRef="usd" contextRef="i3433a7055306497a9f23d7846a707116_I20220930" decimals="-3" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMzQwNw_1e6d6b83-aa51-438e-a52c-73efa32fec26">1,000,000</ix:nonFraction> revolving line of credit under its senior secured credit facilities. Credit available under this facility is reduced by the amount of any letters of credit outstanding under this facility, of which there were <ix:nonFraction unitRef="usd" contextRef="icf19afd02f534c9c8ffb4475417e4ce0_I20220930" decimals="-3" name="us-gaap:LettersOfCreditOutstandingAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMzYxOQ_38600007-f52f-4b79-9d09-439bbb6df4dd">none</ix:nonFraction> as of September&#160;30, 2022. The Company also had approximately $<ix:nonFraction unitRef="usd" contextRef="i6e5742b805d64156889d9a58826bf40d_I20220930" decimals="-3" name="us-gaap:LettersOfCreditOutstandingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMzY2Nw_9b277b0c-dd77-4afb-976a-c6828331e686">108,002</ix:nonFraction> in letters of credit outstanding under a separate bilateral secured letter of credit facility as of September&#160;30, 2022.</ix:continuation> </span></div><div id="i9311e9c566584bd9ab5dffbc9b9a605b_55"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="us-gaap:LossContingencyDisclosures" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81NS9mcmFnOjhkYjQxYTc1ODQyNDRhMmU4OTRmODViYWQ3OTJhMzVhL3RleHRyZWdpb246OGRiNDFhNzU4NDI0NGEyZTg5NGY4NWJhZDc5MmEzNWFfMTQ1MDc_9efb60b5-5763-4d91-a03d-46bcd26cadef" continuedAt="i300b6ef219f64270bbf6ed52b5fb7ce5" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commitments and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">contingencies</span></ix:nonNumeric></div><ix:continuation id="i300b6ef219f64270bbf6ed52b5fb7ce5" continuedAt="id9dba9fb3d98480582425eca16ee00c8"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the Company&#8217;s revenues are from government programs and may be subject to adjustment as a result of: (i)&#160;examination by government agencies or contractors, for which the resolution of any matters raised may take extended periods of time to finalize; (ii)&#160;differing interpretations of government regulations by different Medicare contractors or regulatory authorities; (iii)&#160;differing opinions regarding a patient&#8217;s medical diagnosis or the medical necessity of services provided; and (iv)&#160;retroactive applications or interpretations of governmental requirements. In addition, the Company&#8217;s revenues from commercial payors may be subject to adjustment as a result of potential claims for refunds, as a result of government actions or as a result of other claims by commercial payors.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in a highly regulated industry and is a party to various lawsuits, demands, claims, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> suits, governmental investigations (which frequently arise from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> suits) and audits (including, without limitation, investigations or other actions resulting from its obligation to self-report suspected violations of law) and other legal proceedings, including, without limitation, those described below. The Company records accruals for certain legal proceedings and regulatory matters to the extent that the Company determines an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. As of September&#160;30, 2022 and December&#160;31, 2021, the Company&#8217;s total recorded accruals with respect to legal proceedings and regulatory matters, net of anticipated third party recoveries, were immaterial. While these accruals reflect the Company&#8217;s best estimate of the probable loss for those matters as of the dates of those accruals, the recorded amounts may differ materially from the actual amount of the losses for those matters, and any anticipated third party recoveries for any such losses may not ultimately be recoverable. Additionally, in some cases, no estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made because of the inherently unpredictable nature of legal proceedings and regulatory matters, which also may be impacted by various factors, including, without limitation, that they may involve indeterminate claims for monetary damages or may involve fines, penalties or non-monetary remedies; present novel legal theories or legal uncertainties; involve disputed facts; represent a shift in regulatory policy; are in the early stages of the proceedings; or may result in a change of business practices. Further, there may be various levels of judicial review available to the Company in connection with any such proceeding.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a description of certain lawsuits, claims, governmental investigations and audits and other legal proceedings to which the Company is subject.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div><span><br/></span></div></div><ix:continuation id="id9dba9fb3d98480582425eca16ee00c8" continuedAt="i89146d0c41c740eea25d3767aa5fe500"><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Certain Governmental Inquiries and Related Proceedings</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2016 U.S. Attorney Texas Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In February 2016, DaVita Rx, LLC (DaVita Rx), a wholly-owned subsidiary of the Company, received a Civil Investigative Demand (CID) from the U.S. Attorney&#8217;s Office, Northern District of Texas. The government is conducting a federal False Claims Act (FCA) investigation concerning allegations that DaVita Rx presented or caused to be presented false claims for payment to the government for prescription medications, as well as an investigation into the Company&#8217;s relationships with pharmaceutical manufacturers. The government&#8217;s investigation covers the period from January 1, 2006 through December 31, 2018. In December 2017, the Company finalized and executed a settlement agreement that resolved certain of the issues in the government&#8217;s investigation and that included total monetary consideration of $<ix:nonFraction unitRef="usd" contextRef="i017440e66fea4d42af33e10727d6d8bc_D20171201-20171231" decimals="-3" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81NS9mcmFnOjhkYjQxYTc1ODQyNDRhMmU4OTRmODViYWQ3OTJhMzVhL3RleHRyZWdpb246OGRiNDFhNzU4NDI0NGEyZTg5NGY4NWJhZDc5MmEzNWFfMzc5MA_2b470b52-3fea-4bcd-b7b6-0b1fbe1f030f">63,700</ix:nonFraction>, as previously disclosed, of which $<ix:nonFraction unitRef="usd" contextRef="ifb92eab57e66403ca68107330167cb46_D20171201-20171231" decimals="-3" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81NS9mcmFnOjhkYjQxYTc1ODQyNDRhMmU4OTRmODViYWQ3OTJhMzVhL3RleHRyZWdpb246OGRiNDFhNzU4NDI0NGEyZTg5NGY4NWJhZDc5MmEzNWFfMzgyOA_ff6572f5-7d49-473f-924e-260baf0b93c6">41,500</ix:nonFraction> was an incremental cash payment and $<ix:nonFraction unitRef="usd" contextRef="ie9078554660b4e04aa85a2b59269458d_D20171201-20171231" decimals="-3" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81NS9mcmFnOjhkYjQxYTc1ODQyNDRhMmU4OTRmODViYWQ3OTJhMzVhL3RleHRyZWdpb246OGRiNDFhNzU4NDI0NGEyZTg5NGY4NWJhZDc5MmEzNWFfMzg2Nw_e5f82bed-730f-4fa8-b2bf-58715d97f9d6">22,200</ix:nonFraction> was for amounts previously refunded, and all of which was previously accrued. The government&#8217;s investigation is ongoing with respect to issues related to DaVita Rx&#8217;s historic relationships with certain pharmaceutical manufacturers, and in July 2018 the Office of Inspector General (OIG) served the Company with a subpoena seeking additional documents and information relating to those relationships. On September 15, 2021, the U.S. Attorney&#8217;s Office notified the U.S. District Court, Northern District of Texas, of its decision and the decision of 31 states not to elect to intervene at this time in the matter of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. ex rel. Doe v. DaVita Inc., et al</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The court then unsealed the complaint, which alleges violations of the FCA, by order dated September 17, 2021. The complaint was not served on the Company. In December 2021, the private party relator filed a notice of voluntary dismissal of all claims and the court entered an order dismissing the claims without prejudice. The Company is continuing to cooperate with the government in this investigation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2017 U.S. Attorney Colorado Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In November 2017, the U.S. Attorney&#8217;s Office, District of Colorado informed the Company of an investigation it was conducting into possible federal healthcare offenses involving DaVita Kidney Care, as well as several of the Company&#8217;s wholly-owned subsidiaries. In addition to DaVita Kidney Care, the matter currently includes an investigation into DaVita Rx, DaVita Laboratory Services, Inc. (DaVita Labs), and RMS Lifeline Inc. (Lifeline). In each of August 2018, May 2019, and July 2021, the Company received a CID pursuant to the FCA from the U.S. Attorney's Office relating to this investigation. In May 2020, the Company sold its interest in Lifeline, but the Company retained certain liabilities of the Lifeline business, including those related to this investigation. The Company is continuing to cooperate with the government in this investigation. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2020 U.S. Attorney New Jersey Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In March 2020, the U.S. Attorney&#8217;s Office, District of New Jersey served the Company with a subpoena and a CID relating to an investigation being conducted by that office and the U.S. Attorney&#8217;s Office, Eastern District of Pennsylvania. The subpoena and CID request information on several topics, including certain of the Company&#8217;s joint venture arrangements with physicians and physician groups, medical director agreements, and compliance with its five-year Corporate Integrity Agreement, the term of which expired <ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="dva:CorporateIntegrityAgreementExpirationDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81NS9mcmFnOjhkYjQxYTc1ODQyNDRhMmU4OTRmODViYWQ3OTJhMzVhL3RleHRyZWdpb246OGRiNDFhNzU4NDI0NGEyZTg5NGY4NWJhZDc5MmEzNWFfNjM5Mw_9fa68bdf-ffab-423f-acf7-4d07ec944110">October 22, 2019</ix:nonNumeric>. On October 12, 2022, the U.S. Attorney&#8217;s Office notified the U.S. District Court, Eastern District of Pennsylvania, of its decision not to elect to intervene at this time in the matter of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. ex rel. Bayne v. DaVita Inc., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The court then unsealed a complaint, which alleges violations of federal and state False Claims Acts, by order dated October 14, 2022. The Company is continuing to cooperate with the government in this investigation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2020 California Department of Insurance Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In April 2020, the California Department of Insurance (CDI) sent the Company an Investigative Subpoena relating to an investigation being conducted by that office. CDI issued a superseding subpoena in September 2020 and an additional subpoena in September 2021. Those subpoenas request information on a number of topics, including but not limited to the Company&#8217;s communications with patients about insurance plans and financial assistance from the American Kidney Fund (AKF), analyses of the potential impact of patients&#8217; decisions to change insurance providers, and documents relating to donations or contributions to the AKF. The Company is continuing to cooperate with CDI in this investigation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2020 Department of Justice Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In October 2020, the Company received a CID from the Department of Justice pursuant to an FCA investigation concerning allegations that DaVita Medical Group (DMG) may have submitted undocumented or unsupported diagnosis codes in connection with Medicare Advantage beneficiaries. The CID covers the period from January 1, 2015 through June 19, 2019, the date the Company completed the divestiture of DMG to Collaborative Care Holdings, LLC. The Company is continuing to cooperate with the government in this investigation.</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* * *</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div><span><br/></span></div></div><ix:continuation id="i89146d0c41c740eea25d3767aa5fe500"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company cannot predict whether or when proceedings might be initiated or when these matters may be resolved (other than as may be described above), it is not unusual for inquiries such as these to continue for a considerable period of time through the various phases of document and witness requests and ongoing discussions with regulators and to develop over the course of time. In addition to the inquiries and proceedings specifically identified above, the Company frequently is subject to other inquiries by state or federal government agencies, many of which relate to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaints filed by relators. Negative findings or terms and conditions that the Company might agree to accept as part of a negotiated resolution of pending or future government inquiries or relator proceedings could result in, among other things, substantial financial penalties or awards against the Company, substantial payments made by the Company, harm to the Company&#8217;s reputation, required changes to the Company&#8217;s business practices, an impact on the Company's various relationships and/or contracts related to the Company's business, exclusion from future participation in the Medicare, Medicaid and other federal health care programs and, if criminal proceedings were initiated against the Company, members of its board of directors or management, possible criminal penalties, any of which could have a material adverse effect on the Company.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Proceedings</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2021 Antitrust Indictment and Putative Class Action Suit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: On July 14, 2021, an indictment was returned by a grand jury in the U.S. District Court, District of Colorado against the Company and its former chief executive officer in the matter of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. v. DaVita Inc., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> alleging that purported agreements entered into by DaVita's former chief executive officer not to solicit senior-level employees violated Section 1 of the Sherman Act. On April 15, 2022, a jury returned a verdict in the Company&#8217;s favor, acquitting both the Company and its former chief executive officer on all counts. On April 20, 2022, the court entered judgments of acquittal and closed the case. On August 9, 2021, DaVita and its former chief executive officer were added as defendants in a consolidated putative class action complaint in the matter of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re Outpatient Medical Center Employee Antitrust Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the U.S. District Court, Northern District of Illinois. This class action complaint asserts that the defendants violated Section 1 of the Sherman Act and seeks to bring an action on behalf of certain groups of individuals employed by the Company between February 1, 2012 and January 5, 2021. On September 26, 2022, the court denied the Company's motion to dismiss. The Company disputes the allegations in the class action complaint, as well as the asserted violations of the Sherman Act, and intends to defend this action accordingly.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Marietta Memorial Hospital Employee Health Benefit Plan, et al. v. DaVita Inc. et al. No. 20-1641</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: On November 5, 2021, the United States Supreme Court granted certiorari of an appeal by an employer group health plan, the plan sponsor, and the plan&#8217;s advisor of the U.S. Court of Appeals for the Sixth Circuit (Sixth Circuit) decision in the Company's favor. The questions presented involved whether the health plan violates the Medicare Secondary Payor Act (MSPA) by "taking into account" that plan beneficiaries are eligible for Medicare and/or by "differentiating" between the benefits that the plan offers to patients with dialysis versus others. On December 23, 2021, the Solicitor General on behalf of the United States filed an amicus brief supporting the petitioners' request to overturn the Sixth Circuit decision. On January 19, 2022, the Company filed its brief in support of the Sixth Circuit decision. On June 21, 2022, the United States Supreme Court reversed the Sixth Circuit decision and held that the employee health plan for Marietta Memorial Hospital did not violate the MSPA. The case has been remanded back to the lower court for resolution of the outstanding claims. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, from time to time the Company is subject to other lawsuits, demands, claims, governmental investigations and audits and legal proceedings that arise due to the nature of its business, including, without limitation, contractual disputes, such as with payors, suppliers and others, employee-related matters and professional and general liability claims. From time to time, the Company also initiates litigation or other legal proceedings as a plaintiff arising out of contracts or other matters.</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* * *</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than as may be described above, the Company cannot predict the ultimate outcomes of the various legal proceedings and regulatory matters to which the Company is or may be subject from time to time, including those described in this Note 7, or the timing of their resolution or the ultimate losses or impact of developments in those matters, which could have a material adverse effect on the Company&#8217;s revenues, earnings and cash flows. Further, any legal proceedings or regulatory matters involving the Company, whether meritorious or not, are time consuming, and often require management&#8217;s attention and result in significant legal expense, and may result in the diversion of significant operational resources, may impact the Company's various relationships and/or contracts related to the Company's business or otherwise harm the Company&#8217;s business, results of operations, financial condition, cash flows or reputation.</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* * *</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div><span><br/></span></div></div><ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="us-gaap:CommitmentsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81NS9mcmFnOjhkYjQxYTc1ODQyNDRhMmU4OTRmODViYWQ3OTJhMzVhL3RleHRyZWdpb246OGRiNDFhNzU4NDI0NGEyZTg5NGY4NWJhZDc5MmEzNWFfMTQ1MTA_e7b18371-f4cd-497d-8473-67a597f317ee" escape="true"><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Commitments</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has certain potential commitments to provide working capital funding, if necessary, to certain nonconsolidated outpatient dialysis businesses that the Company manages and in which the Company owns a noncontrolling equity interest or which are wholly-owned by third parties of approximately $<ix:nonFraction unitRef="usd" contextRef="i34475a7595b24df1b1183abfd0b8bb6b_I20220930" decimals="-3" name="us-gaap:OtherCommitment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81NS9mcmFnOjhkYjQxYTc1ODQyNDRhMmU4OTRmODViYWQ3OTJhMzVhL3RleHRyZWdpb246OGRiNDFhNzU4NDI0NGEyZTg5NGY4NWJhZDc5MmEzNWFfMTM2NzY_8f4e1c63-2ee5-4997-8792-24f6910d8e77">9,431</ix:nonFraction>.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, on <ix:nonNumeric contextRef="i234c9227eeee433bb5adf6ea9bcf5b0e_D20220525-20220525" name="dva:BusinessAgreementDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81NS9mcmFnOjhkYjQxYTc1ODQyNDRhMmU4OTRmODViYWQ3OTJhMzVhL3RleHRyZWdpb246OGRiNDFhNzU4NDI0NGEyZTg5NGY4NWJhZDc5MmEzNWFfMTM2OTY_d8ad2761-ea96-4f67-8edc-a023db19d541">May&#160;25, 2022</ix:nonNumeric>, the Company entered into an agreement with Medtronic, Inc. and one of its subsidiaries (collectively, Medtronic) to form a new, independent kidney care-focused medical device company (NewCo). The transaction is expected to close in 2023, subject to customary closing conditions and regulatory approvals. At close, the Company will make a cash payment to Medtronic of approximately $<ix:nonFraction unitRef="usd" contextRef="i56c2b0de3ff24b87b529562972a48a8a_I20220525" decimals="-3" name="us-gaap:OtherCommitmentDueInNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81NS9mcmFnOjhkYjQxYTc1ODQyNDRhMmU4OTRmODViYWQ3OTJhMzVhL3RleHRyZWdpb246OGRiNDFhNzU4NDI0NGEyZTg5NGY4NWJhZDc5MmEzNWFfMTQwODE_403b7f1e-c5cf-456d-a774-e08cbe44f1ab">75,000</ix:nonFraction>, subject to certain customary adjustments prior to the closing, and will contribute certain other non-cash assets to NewCo valued at approximately $<ix:nonFraction unitRef="usd" contextRef="i56c2b0de3ff24b87b529562972a48a8a_I20220525" decimals="-3" name="dva:OtherNoncashAssetsCommitment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81NS9mcmFnOjhkYjQxYTc1ODQyNDRhMmU4OTRmODViYWQ3OTJhMzVhL3RleHRyZWdpb246OGRiNDFhNzU4NDI0NGEyZTg5NGY4NWJhZDc5MmEzNWFfMTQyMzE_cddc85c3-d3fc-4e13-a114-b75b487537d0">25,000</ix:nonFraction>. Additionally, at close, the Company and Medtronic each will contribute approximately $<ix:nonFraction unitRef="usd" contextRef="i56c2b0de3ff24b87b529562972a48a8a_I20220525" decimals="-3" name="dva:AdditionalCashCommitment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81NS9mcmFnOjhkYjQxYTc1ODQyNDRhMmU4OTRmODViYWQ3OTJhMzVhL3RleHRyZWdpb246OGRiNDFhNzU4NDI0NGEyZTg5NGY4NWJhZDc5MmEzNWFfMTQzMjA_9458ba34-9924-49e8-b262-3c801b7797b2">200,000</ix:nonFraction> in cash to launch NewCo. The Company also agreed to pay Medtronic additional consideration of up to $<ix:nonFraction unitRef="usd" contextRef="i56c2b0de3ff24b87b529562972a48a8a_I20220525" decimals="-3" name="us-gaap:OtherCommitmentDueAfterFifthYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81NS9mcmFnOjhkYjQxYTc1ODQyNDRhMmU4OTRmODViYWQ3OTJhMzVhL3RleHRyZWdpb246OGRiNDFhNzU4NDI0NGEyZTg5NGY4NWJhZDc5MmEzNWFfMTQ0MjM_faadfb8a-474f-4971-a9df-7bb68bb1fe94">300,000</ix:nonFraction> if certain regulatory and commercial milestones are achieved between 2024 and 2028.</span></div></ix:nonNumeric><div id="i9311e9c566584bd9ab5dffbc9b9a605b_61"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RleHRyZWdpb246MmY5NWQ0MThhNDU3NGE3ZDk1OTY4MTlkYjRmMjAwNzNfMTYxMg_e922fdc0-231d-4093-9f66-b8b0ad4401c6" continuedAt="i6dc842211f1043b4815999456ac1914c" escape="true">Shareholders' equity</ix:nonNumeric></span></div><ix:continuation id="i6dc842211f1043b4815999456ac1914c"><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-based compensation</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2022, the Company granted <ix:nonFraction unitRef="shares" contextRef="i70a7c2b3d8c3425b83bdbde7adae4aed_D20220101-20220930" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RleHRyZWdpb246MmY5NWQ0MThhNDU3NGE3ZDk1OTY4MTlkYjRmMjAwNzNfMTA2_70f83cfd-0bab-421b-b220-6b0149a763e3">1,129</ix:nonFraction> restricted and performance stock units with an aggregate grant-date fair value of $<ix:nonFraction unitRef="usd" contextRef="i70a7c2b3d8c3425b83bdbde7adae4aed_D20220101-20220930" decimals="-3" name="dva:SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RleHRyZWdpb246MmY5NWQ0MThhNDU3NGE3ZDk1OTY4MTlkYjRmMjAwNzNfMTkx_8a964f0a-1286-4661-b6e5-99d209547a8d">122,356</ix:nonFraction> and a weighted-average expected life of approximately <ix:nonNumeric contextRef="i70a7c2b3d8c3425b83bdbde7adae4aed_D20220101-20220930" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RleHRyZWdpb246MmY5NWQ0MThhNDU3NGE3ZDk1OTY4MTlkYjRmMjAwNzNfMjQ4_77a20b36-dd8d-4d66-93f2-944b2aa202e3">3.5</ix:nonNumeric> years and <ix:nonFraction unitRef="shares" contextRef="i8ccb6189ca58495499f4dbbf4481a40c_D20220101-20220930" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RleHRyZWdpb246MmY5NWQ0MThhNDU3NGE3ZDk1OTY4MTlkYjRmMjAwNzNfMjU1_a5ddec1b-fe43-47a4-9a58-88bb7ed1b28f">130</ix:nonFraction> stock-settled stock appreciation rights with an aggregate grant-date fair value of $<ix:nonFraction unitRef="usd" contextRef="i8ccb6189ca58495499f4dbbf4481a40c_D20220101-20220930" decimals="-3" name="dva:SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RleHRyZWdpb246MmY5NWQ0MThhNDU3NGE3ZDk1OTY4MTlkYjRmMjAwNzNfMzQx_72a0ea76-e55f-42d1-b26f-8f347917be93">4,573</ix:nonFraction> and a weighted-average expected life of approximately <ix:nonNumeric contextRef="i8ccb6189ca58495499f4dbbf4481a40c_D20220101-20220930" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RleHRyZWdpb246MmY5NWQ0MThhNDU3NGE3ZDk1OTY4MTlkYjRmMjAwNzNfMzk4_4ac0ea3a-9221-44e0-bf03-dd3f8288f547">4.5</ix:nonNumeric> years.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, the Company had $<ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RleHRyZWdpb246MmY5NWQ0MThhNDU3NGE3ZDk1OTY4MTlkYjRmMjAwNzNfNDI4_d1a7680b-2258-42e8-9035-581142039ad8">182,083</ix:nonFraction> in total estimated but unrecognized stock-based compensation expense under the Company's equity compensation and employee stock purchase plans. The Company expects to recognize this expense over a weighted average remaining period of <ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RleHRyZWdpb246MmY5NWQ0MThhNDU3NGE3ZDk1OTY4MTlkYjRmMjAwNzNfNjY1_b54a3d28-6872-4069-b7e9-3844a887f33a">1.3</ix:nonNumeric> years.</span></div></ix:continuation><ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="us-gaap:TreasuryStockTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RleHRyZWdpb246MmY5NWQ0MThhNDU3NGE3ZDk1OTY4MTlkYjRmMjAwNzNfMTYxMw_81097c6d-2b78-43f8-b34e-7730bb3556de" escape="true"><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share repurchases</span></div><ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="us-gaap:ScheduleOfTreasuryStockByClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RleHRyZWdpb246MmY5NWQ0MThhNDU3NGE3ZDk1OTY4MTlkYjRmMjAwNzNfMTYwOQ_6163ba04-a5e2-4dc6-89c3-f7a1cde9f924" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's common stock repurchases during the three and nine months ended September&#160;30, 2022 and 2021: </span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.228%"><tr><td style="width:1.0%"></td><td style="width:33.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.573%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.683%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.573%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.683%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.573%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.683%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.575%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Open market repurchases:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0e26a096655c4539b381dad37c3f4def_D20220701-20220930" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RhYmxlOmFhOWQxNDJhZTczNTQ2Y2ViOTdkYTIwYTA3OWMyZTE5L3RhYmxlcmFuZ2U6YWE5ZDE0MmFlNzM1NDZjZWI5N2RhMjBhMDc5YzJlMTlfMy0xLTEtMS0zNjE1Njk_61d5f8d6-805c-4b37-afe4-be94d5fadc77">2,122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1bbbb5f9079d4dc2b1bc26bc9197d8c2_D20210701-20210930" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RhYmxlOmFhOWQxNDJhZTczNTQ2Y2ViOTdkYTIwYTA3OWMyZTE5L3RhYmxlcmFuZ2U6YWE5ZDE0MmFlNzM1NDZjZWI5N2RhMjBhMDc5YzJlMTlfMy0zLTEtMS0zNjE1Njk_7e817da5-e1ca-4775-a43c-8dc7e82c962d">2,731</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id88c7440116645768f677634e0f5e6d1_D20220101-20220930" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RhYmxlOmFhOWQxNDJhZTczNTQ2Y2ViOTdkYTIwYTA3OWMyZTE5L3RhYmxlcmFuZ2U6YWE5ZDE0MmFlNzM1NDZjZWI5N2RhMjBhMDc5YzJlMTlfMy02LTEtMS0zNjE1Njk_ce582b02-351b-4be0-9d94-05c79e9e66a9">8,095</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i75f2b64af109480b978f5c7a64a13687_D20210101-20210930" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RhYmxlOmFhOWQxNDJhZTczNTQ2Y2ViOTdkYTIwYTA3OWMyZTE5L3RhYmxlcmFuZ2U6YWE5ZDE0MmFlNzM1NDZjZWI5N2RhMjBhMDc5YzJlMTlfMy04LTEtMS0zNjE1Njk_03a526b2-2205-43f8-bb21-b26f63486d2b">7,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount paid</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e26a096655c4539b381dad37c3f4def_D20220701-20220930" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RhYmxlOmFhOWQxNDJhZTczNTQ2Y2ViOTdkYTIwYTA3OWMyZTE5L3RhYmxlcmFuZ2U6YWE5ZDE0MmFlNzM1NDZjZWI5N2RhMjBhMDc5YzJlMTlfNC0xLTEtMS0zNjE1Njk_7e9d9b29-b5ac-4d69-b838-1fc3169c839b">184,797</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bbbb5f9079d4dc2b1bc26bc9197d8c2_D20210701-20210930" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RhYmxlOmFhOWQxNDJhZTczNTQ2Y2ViOTdkYTIwYTA3OWMyZTE5L3RhYmxlcmFuZ2U6YWE5ZDE0MmFlNzM1NDZjZWI5N2RhMjBhMDc5YzJlMTlfNC0zLTEtMS0zNjE1Njk_8ef07d2c-c4cb-4406-8c81-17ab462debc6">336,217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id88c7440116645768f677634e0f5e6d1_D20220101-20220930" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RhYmxlOmFhOWQxNDJhZTczNTQ2Y2ViOTdkYTIwYTA3OWMyZTE5L3RhYmxlcmFuZ2U6YWE5ZDE0MmFlNzM1NDZjZWI5N2RhMjBhMDc5YzJlMTlfNC02LTEtMS0zNjE1Njk_83f45aa0-1d07-4d34-8232-ef63e396c43e">787,854</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75f2b64af109480b978f5c7a64a13687_D20210101-20210930" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RhYmxlOmFhOWQxNDJhZTczNTQ2Y2ViOTdkYTIwYTA3OWMyZTE5L3RhYmxlcmFuZ2U6YWE5ZDE0MmFlNzM1NDZjZWI5N2RhMjBhMDc5YzJlMTlfNC04LTEtMS0zNjE1Njk_f1788890-504f-44ba-b545-9c405cfd7781">899,447</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average paid per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0e26a096655c4539b381dad37c3f4def_D20220701-20220930" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RhYmxlOmFhOWQxNDJhZTczNTQ2Y2ViOTdkYTIwYTA3OWMyZTE5L3RhYmxlcmFuZ2U6YWE5ZDE0MmFlNzM1NDZjZWI5N2RhMjBhMDc5YzJlMTlfNS0xLTEtMS0zNjE1Njk_091b6d87-1d53-4c8a-8d12-a6e732030fe7">87.10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1bbbb5f9079d4dc2b1bc26bc9197d8c2_D20210701-20210930" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RhYmxlOmFhOWQxNDJhZTczNTQ2Y2ViOTdkYTIwYTA3OWMyZTE5L3RhYmxlcmFuZ2U6YWE5ZDE0MmFlNzM1NDZjZWI5N2RhMjBhMDc5YzJlMTlfNS0zLTEtMS0zNjE1Njk_9bd8fbcf-1cda-4ca5-8232-4d0bba294ec2">123.14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id88c7440116645768f677634e0f5e6d1_D20220101-20220930" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RhYmxlOmFhOWQxNDJhZTczNTQ2Y2ViOTdkYTIwYTA3OWMyZTE5L3RhYmxlcmFuZ2U6YWE5ZDE0MmFlNzM1NDZjZWI5N2RhMjBhMDc5YzJlMTlfNS02LTEtMS0zNjE1Njk_c6daa6e4-df51-4d87-a653-7aa1982cfedd">97.33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i75f2b64af109480b978f5c7a64a13687_D20210101-20210930" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RhYmxlOmFhOWQxNDJhZTczNTQ2Y2ViOTdkYTIwYTA3OWMyZTE5L3RhYmxlcmFuZ2U6YWE5ZDE0MmFlNzM1NDZjZWI5N2RhMjBhMDc5YzJlMTlfNS04LTEtMS0zNjE1Njk_73f9c785-d4fd-472a-a2c2-2d7aee2fc058">116.06</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did <ix:nonFraction unitRef="shares" contextRef="i93d8bfb8799a4eb1a6cac7ed70c03ca0_D20221001-20221027" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RleHRyZWdpb246MmY5NWQ0MThhNDU3NGE3ZDk1OTY4MTlkYjRmMjAwNzNfODI0NjMzNzIxMDA5Mw_908983d4-fbf3-432b-8188-36f9f1d6dd9b">not</ix:nonFraction> repurchase any shares subsequent to September&#160;30, 2022 through October&#160;27, 2022. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is authorized to make purchases from time to time in the open market or in privately negotiated transactions, including without limitation, through accelerated share repurchase transactions, derivative transactions, tender offers, Rule 10b5-1 plans or any combination of the foregoing, depending upon market conditions and other considerations.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October&#160;27, 2022, the Company had a total of $<ix:nonFraction unitRef="usd" contextRef="i7d5aa4e5434b4526a0049dce3fe3e153_I20221027" decimals="-3" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RleHRyZWdpb246MmY5NWQ0MThhNDU3NGE3ZDk1OTY4MTlkYjRmMjAwNzNfMTMxOA_c265b599-59b2-495a-beb4-93a62775ced6">1,596,085</ix:nonFraction> available under the current authorization for additional share repurchases. Although this share repurchase authorization does not have an expiration date, the Company remains subject to share repurchase limitations including under the terms of its current senior secured credit facilities.</span></div></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><div id="i9311e9c566584bd9ab5dffbc9b9a605b_64"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RleHRyZWdpb246ZTA3NTA5NmZhZmVmNDg1MGE3YzQxMzMwODk2NTcwMDlfMjYy_67db68c6-9dab-49bc-ae6d-0716c272287c" continuedAt="ia63a54a318014941ba770aa3aca3e3e3" escape="true">Accumulated other comprehensive loss</ix:nonNumeric></span></div><ix:continuation id="ia63a54a318014941ba770aa3aca3e3e3"><ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RleHRyZWdpb246ZTA3NTA5NmZhZmVmNDg1MGE3YzQxMzMwODk2NTcwMDlfMjUw_379a4a84-4002-4c1f-9c3c-faefc434670a" escape="true"><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.251%"><tr><td style="width:1.0%"></td><td style="width:27.267%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.310%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.468%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.310%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.474%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest<br/>rate cap<br/>agreements</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign<br/>currency<br/>translation<br/>adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>other<br/>comprehensive<br/>loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest<br/>rate cap<br/>agreements</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign<br/>currency<br/>translation<br/>adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>other<br/>comprehensive<br/>loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8eadbdf6a4545af8abdecc0181aed70_I20220630" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfMi0xLTEtMS0zNjE1Njk_4ea1f81b-03e4-44f6-8db1-d01c12fd971e">55,237</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e8ea0962d7f484ab9b39cd36f1fe019_I20220630" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfMi0zLTEtMS0zNjE1Njk_cbde8e64-5654-4ed9-b66a-77c8cef47e9e">167,033</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b995987498a46b5abb6da0bb3401211_I20220630" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfMi01LTEtMS0zNjE1Njk_24879e8f-627c-41c5-a436-b42e3a0c242c">111,796</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25695481a54a456da58a8b675ea33615_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfMi03LTEtMS0zNjE1Njk_b47e7a98-ba5d-4c20-b2c5-e3692491b020">1,178</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i782ad893fc0b4621a76c9a45d98be61d_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfMi05LTEtMS0zNjE1Njk_8db85996-1f54-4da7-a554-c570ca01c0e4">138,069</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98434fe450004124afb331b74fd63193_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfMi0xMS0xLTEtMzYxNTY5_8e08db28-62d6-424a-967d-76a84fbae457">139,247</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe95730ae644d9e881c7051751a5a76_D20220701-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfMy0xLTEtMS0zNjE1Njk_ddb5eed9-866c-42c6-b9b2-3bd834311fde">55,045</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifd10dfc3a87841eda50c4640b2db4669_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfMy0zLTEtMS0zNjE1Njk_ce8c28d9-8b74-4284-8613-42ff00a9e9f2">66,100</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie9b5ae0e296a416d8eddebe00e9bfe22_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfMy01LTEtMS0zNjE1Njk_f220ec00-6a6c-4982-9952-7b383ec29aed">11,055</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79b1d5bcdc7c4fb0a917646f4ab14002_D20220101-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfMy03LTEtMS0zNjE1Njk_326c5006-a490-4d6a-b6e3-62d4cc27fc06">127,460</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c0124b9404249c4b64ad373e8c59fb9_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfMy05LTEtMS0zNjE1Njk_2a589ac4-6dfb-446a-9dce-a8f54e867b1d">95,064</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b7464a1b4454319b3b1a6fdfe238cef_D20220101-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfMy0xMS0xLTEtMzYxNTY5_afc00c72-1f5f-40bd-8241-c78dd83574f9">32,396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8fe95730ae644d9e881c7051751a5a76_D20220701-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfNC0xLTEtMS0zNjE1Njk_4bccb49e-746e-4cb3-93a7-18da7e6eaacb">13,733</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd10dfc3a87841eda50c4640b2db4669_D20220701-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfNC0zLTEtMS0zNjE1Njk_455245e2-6691-49dd-aa66-6f18bf157ed0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie9b5ae0e296a416d8eddebe00e9bfe22_D20220701-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfNC01LTEtMS0zNjE1Njk_9b6bdce0-151f-43a6-a7d0-05356920c753">13,733</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i79b1d5bcdc7c4fb0a917646f4ab14002_D20220101-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfNC03LTEtMS0zNjE1Njk_bc9b2874-b03a-4790-bd9d-34ff0531f4c0">31,800</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0124b9404249c4b64ad373e8c59fb9_D20220101-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfNC05LTEtMS0zNjE1Njk_79e57aa5-0fa9-46a4-aac7-afaa00484374">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b7464a1b4454319b3b1a6fdfe238cef_D20220101-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfNC0xMS0xLTEtMzYxNTY5_6ce006f8-e770-4bec-9b28-72db25b10aeb">31,800</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe95730ae644d9e881c7051751a5a76_D20220701-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfNS0xLTEtMS0zNjE1Njk_0b2ec2da-ab0e-4839-a5fd-9cc2d4511df4">41,312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifd10dfc3a87841eda50c4640b2db4669_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfNS0zLTEtMS0zNjE1Njk_baae5396-bf3c-4d02-94b3-9234ce2fa0a1">66,100</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie9b5ae0e296a416d8eddebe00e9bfe22_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfNS01LTEtMS0zNjE1Njk_ca3abfdf-528f-4be1-88b9-a1d8191cac29">24,788</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79b1d5bcdc7c4fb0a917646f4ab14002_D20220101-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfNS03LTEtMS0zNjE1Njk_059b8ddf-9097-4f83-8977-7f0e07dd6adb">95,660</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c0124b9404249c4b64ad373e8c59fb9_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfNS05LTEtMS0zNjE1Njk_b35aa4d3-261a-46e0-9007-ea8590b435c1">95,064</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b7464a1b4454319b3b1a6fdfe238cef_D20220101-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfNS0xMS0xLTEtMzYxNTY5_7011e013-9401-4a6e-a19f-fa7fdb108dda">596</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification into net income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe95730ae644d9e881c7051751a5a76_D20220701-20220930" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfNi0xLTEtMS0zNjE1Njk_b3b0c230-511d-4b2f-a866-9a7072ce7647">1,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd10dfc3a87841eda50c4640b2db4669_D20220701-20220930" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfNi0zLTEtMS0zNjE1Njk_025419f8-1858-4bb5-8be4-52748c51b830">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9b5ae0e296a416d8eddebe00e9bfe22_D20220701-20220930" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfNi01LTEtMS0zNjE1Njk_ac9e03fe-ed07-4612-a73f-6ab06375b6e6">1,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79b1d5bcdc7c4fb0a917646f4ab14002_D20220101-20220930" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfNi03LTEtMS0zNjE1Njk_6f075142-cc3c-4d5f-97e5-5228cc487078">4,132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0124b9404249c4b64ad373e8c59fb9_D20220101-20220930" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfNi05LTEtMS0zNjE1Njk_99fa4cec-b14f-4ecd-bf5b-5174237a451c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b7464a1b4454319b3b1a6fdfe238cef_D20220101-20220930" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfNi0xMS0xLTEtMzYxNTY5_6bfffe1c-deef-47fc-b2e2-6c7d2f106c04">4,132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8fe95730ae644d9e881c7051751a5a76_D20220701-20220930" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfNy0xLTEtMS0zNjE1Njk_3a841de1-965a-4749-83c0-5d62136a125f">344</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd10dfc3a87841eda50c4640b2db4669_D20220701-20220930" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfNy0zLTEtMS0zNjE1Njk_0a119ff7-66da-4e2d-8129-4d932ccc626f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie9b5ae0e296a416d8eddebe00e9bfe22_D20220701-20220930" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfNy01LTEtMS0zNjE1Njk_d14d9605-7a9a-4798-a013-c3a1e4c84a0c">344</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i79b1d5bcdc7c4fb0a917646f4ab14002_D20220101-20220930" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfNy03LTEtMS0zNjE1Njk_e2cd43b5-e8a2-4415-93ce-07d31642f1ac">1,032</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0124b9404249c4b64ad373e8c59fb9_D20220101-20220930" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfNy05LTEtMS0zNjE1Njk_0d355bea-0d4e-4d39-a09a-da17d4919e11">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b7464a1b4454319b3b1a6fdfe238cef_D20220101-20220930" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfNy0xMS0xLTEtMzYxNTY5_03a05493-55aa-4c15-802b-1de6e118c88b">1,032</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fe95730ae644d9e881c7051751a5a76_D20220701-20220930" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfOC0xLTEtMS0zNjE1Njk_3b8429cc-ade1-4e1b-a748-d67a73bbfd91">1,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd10dfc3a87841eda50c4640b2db4669_D20220701-20220930" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfOC0zLTEtMS0zNjE1Njk_61032a90-7127-443b-addc-ec8b0218a7ce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9b5ae0e296a416d8eddebe00e9bfe22_D20220701-20220930" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfOC01LTEtMS0zNjE1Njk_e7345f33-3e5d-45d9-af17-74c07f4a9a9e">1,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79b1d5bcdc7c4fb0a917646f4ab14002_D20220101-20220930" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfOC03LTEtMS0zNjE1Njk_19577d6d-ef95-4dc7-b906-40534a5696c9">3,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c0124b9404249c4b64ad373e8c59fb9_D20220101-20220930" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfOC05LTEtMS0zNjE1Njk_1ab3868a-af81-46cc-b0d3-72fc7a16e87a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b7464a1b4454319b3b1a6fdfe238cef_D20220101-20220930" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfOC0xMS0xLTEtMzYxNTY5_e5220e9a-6a07-4be5-bb21-8eb9d501dce2">3,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ddb5952c6014f42bf7ffa4d2e53fd09_I20220930" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfOS0xLTEtMS0zNjE1Njk_028b080c-58ed-426e-ac37-fbb30eb0b8bf">97,582</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f9aa59cbd6641848230a121fb1bcaf3_I20220930" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfOS0zLTEtMS0zNjE1Njk_ebd29b08-4014-4bfe-a83c-8a405d9720c9">233,133</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27574f6140c946159e41244ddaeb3b3d_I20220930" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfOS01LTEtMS0zNjE1Njk_55749388-4aa5-4003-bf30-4f0fe3afecdf">135,551</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ddb5952c6014f42bf7ffa4d2e53fd09_I20220930" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfOS03LTEtMS0zNjE1Njk_960334fd-e778-4c70-9dcd-2885dacf4896">97,582</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f9aa59cbd6641848230a121fb1bcaf3_I20220930" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfOS05LTEtMS0zNjE1Njk_de5f8414-c288-4046-9a06-7c6b1b869269">233,133</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27574f6140c946159e41244ddaeb3b3d_I20220930" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfOS0xMS0xLTEtMzYxNTY5_372cef55-6213-44ec-9da8-9b8fb0e49200">135,551</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.251%"><tr><td style="width:1.0%"></td><td style="width:27.267%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.310%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.468%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.433%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.310%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.474%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest<br/>rate cap<br/>agreements</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign<br/>currency<br/>translation<br/>adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>other<br/>comprehensive<br/>loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest<br/>rate cap<br/>agreements</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign<br/>currency<br/>translation<br/>adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>other<br/>comprehensive<br/>loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied2f14238be74cbcab93bfce44bcf2a8_I20210630" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfMi0xLTEtMS0zNjE1Njk_69a80dc4-7ab8-4cf9-ba92-2d37c75be7c3">7,577</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i90536d42eb7f4763bfaeebdcb028b4bb_I20210630" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfMi0zLTEtMS0zNjE1Njk_7836ff35-1189-4d80-b80d-7709ec0b0ffe">58,322</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib9ec694fa011482bba09ae1ec0527b52_I20210630" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfMi01LTEtMS0zNjE1Njk_4ee2a4fb-01c2-45e4-88db-b645ad5ca422">65,899</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b41eec20f9949888d1d2510c252e563_I20201231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfMi03LTEtMS0zNjE1Njk_6b85e20a-91c8-468a-ab37-aa8d784c688c">12,466</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8d33af08bcf4539ad092a661c7d9f23_I20201231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfMi05LTEtMS0zNjE1Njk_9306d456-3df1-4170-b3e0-72dc45985463">53,688</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibdfd5d445b04452f8439ae6973f8405c_I20201231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfMi0xMS0xLTEtMzYxNTY5_d91bbe4f-ce2c-4f3e-af4f-e757ea3bd540">66,154</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized (losses) gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1ee6b43a5f5462f93097ca6bbd4be00_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfMy0xLTEtMS0zNjE1Njk_3089be24-461b-4c5e-8a82-6e2894358683">477</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i23adff93afc54365bb6b4b7000f67792_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfMy0zLTEtMS0zNjE1Njk_c6aad417-a0f3-4f6c-914d-e8f30af3b83f">54,528</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6ae4d7515be40af9b5d0d99dedb6674_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfMy01LTEtMS0zNjE1Njk_a9573828-e3a4-434a-8526-88811ff33765">55,005</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d45a9c325c54f76bedad3d6dc284da2_D20210101-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfMy03LTEtMS0zNjE1Njk_e43db0a8-dd80-45d2-8a7d-dd62ef0ca6e1">3,284</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01dd8be0b3174c8ca7f5203f166342a4_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfMy05LTEtMS0zNjE1Njk_8a08433b-1556-4072-8b68-8e1994f3456f">59,162</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i90261a9edf1e40d0a4d5ecc464319061_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfMy0xMS0xLTEtMzYxNTY5_99e70a7c-2acf-4df0-9f90-2a41c2d15dc6">55,878</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1ee6b43a5f5462f93097ca6bbd4be00_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfNC0xLTEtMS0zNjE1Njk_0d47d8d0-3d32-4534-80e3-bf1853c6f1cf">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23adff93afc54365bb6b4b7000f67792_D20210701-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfNC0zLTEtMS0zNjE1Njk_f8e2ec0e-4664-4b79-b83b-0b3766afba62">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6ae4d7515be40af9b5d0d99dedb6674_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfNC01LTEtMS0zNjE1Njk_918ddf45-75fe-4156-96a8-a00917e68cc3">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d45a9c325c54f76bedad3d6dc284da2_D20210101-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfNC03LTEtMS0zNjE1Njk_3082c4f0-1074-4107-bc3c-4c877ed0534c">818</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01dd8be0b3174c8ca7f5203f166342a4_D20210101-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfNC05LTEtMS0zNjE1Njk_275c6f35-1499-4216-9955-f52a28c60839">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i90261a9edf1e40d0a4d5ecc464319061_D20210101-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfNC0xMS0xLTEtMzYxNTY5_1ba23012-f18b-483f-86a8-91ba1eb4b785">818</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1ee6b43a5f5462f93097ca6bbd4be00_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfNS0xLTEtMS0zNjE1Njk_2759a130-6e5b-4ca5-a4c8-e1a7471ef2e7">357</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i23adff93afc54365bb6b4b7000f67792_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfNS0zLTEtMS0zNjE1Njk_8e0b63c2-384a-498e-b9d4-247b7701da58">54,528</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6ae4d7515be40af9b5d0d99dedb6674_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfNS01LTEtMS0zNjE1Njk_316b7904-3283-42ed-b741-c9611170eacc">54,885</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d45a9c325c54f76bedad3d6dc284da2_D20210101-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfNS03LTEtMS0zNjE1Njk_2a98afd5-ca76-4137-bdfb-0dab58f22f15">2,466</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01dd8be0b3174c8ca7f5203f166342a4_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfNS05LTEtMS0zNjE1Njk_105e2afb-2527-4c18-985f-bdde1bac4afe">59,162</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i90261a9edf1e40d0a4d5ecc464319061_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfNS0xMS0xLTEtMzYxNTY5_ab312072-4491-4170-b66d-8751d21f827c">56,696</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification into net income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1ee6b43a5f5462f93097ca6bbd4be00_D20210701-20210930" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfNi0xLTEtMS0zNjE1Njk_3e04763b-a049-4f90-8b51-e6a9f922aa6c">1,378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23adff93afc54365bb6b4b7000f67792_D20210701-20210930" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfNi0zLTEtMS0zNjE1Njk_c8897eea-ef12-4c22-9762-47cf51f8a61b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6ae4d7515be40af9b5d0d99dedb6674_D20210701-20210930" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfNi01LTEtMS0zNjE1Njk_95e27e16-da12-43f3-8a12-bbfdbb6d2d5c">1,378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d45a9c325c54f76bedad3d6dc284da2_D20210101-20210930" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfNi03LTEtMS0zNjE1Njk_7880846b-d4cd-4db2-b038-37817fe704bb">4,132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01dd8be0b3174c8ca7f5203f166342a4_D20210101-20210930" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfNi05LTEtMS0zNjE1Njk_7c57ac1b-2102-4602-af10-640bb7c0a98c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90261a9edf1e40d0a4d5ecc464319061_D20210101-20210930" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfNi0xMS0xLTEtMzYxNTY5_7e694812-f39f-4d0e-83ac-deb496a67618">4,132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1ee6b43a5f5462f93097ca6bbd4be00_D20210701-20210930" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfNy0xLTEtMS0zNjE1Njk_b152aaa6-f360-4dc4-9ed4-8a60b1d53c04">344</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23adff93afc54365bb6b4b7000f67792_D20210701-20210930" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfNy0zLTEtMS0zNjE1Njk_0e332056-e4cd-4fa4-80f4-f8038cd4d293">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6ae4d7515be40af9b5d0d99dedb6674_D20210701-20210930" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfNy01LTEtMS0zNjE1Njk_8c5ec353-d93a-48ea-93a1-060fe85f9f75">344</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3d45a9c325c54f76bedad3d6dc284da2_D20210101-20210930" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfNy03LTEtMS0zNjE1Njk_30ddf780-c530-4898-9086-0835504e453e">1,032</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01dd8be0b3174c8ca7f5203f166342a4_D20210101-20210930" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfNy05LTEtMS0zNjE1Njk_caac3601-4bde-4b43-b1c6-dbf8e3894c40">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i90261a9edf1e40d0a4d5ecc464319061_D20210101-20210930" decimals="-3" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfNy0xMS0xLTEtMzYxNTY5_46aaebda-be82-4924-bb83-1bf08b474be8">1,032</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1ee6b43a5f5462f93097ca6bbd4be00_D20210701-20210930" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfOC0xLTEtMS0zNjE1Njk_332a3fe4-fa99-4dea-b7b4-1b53a796bc4d">1,034</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23adff93afc54365bb6b4b7000f67792_D20210701-20210930" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfOC0zLTEtMS0zNjE1Njk_848174a0-174c-420d-bd76-657b35f2387d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6ae4d7515be40af9b5d0d99dedb6674_D20210701-20210930" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfOC01LTEtMS0zNjE1Njk_de7b6102-abd3-4147-b09d-f4f44f48bdcf">1,034</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d45a9c325c54f76bedad3d6dc284da2_D20210101-20210930" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfOC03LTEtMS0zNjE1Njk_4245e4d6-9f51-45f7-aad9-1fe3ea1f795b">3,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01dd8be0b3174c8ca7f5203f166342a4_D20210101-20210930" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfOC05LTEtMS0zNjE1Njk_b313d133-691c-4dd2-a8bb-af9a16be2bb1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90261a9edf1e40d0a4d5ecc464319061_D20210101-20210930" decimals="-3" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfOC0xMS0xLTEtMzYxNTY5_65d77034-f996-4aa8-b498-9b4d16309b33">3,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i68f578d19e7645c387c11ed14154d754_I20210930" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfOS0xLTEtMS0zNjE1Njk_85bbf070-afba-4b10-b538-b38e7475f776">6,900</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i156a47ec55f944129c986623c6da4e76_I20210930" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfOS0zLTEtMS0zNjE1Njk_e312cadf-23bc-4d62-8b4b-83fcb16c3c43">112,850</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52c9b6f82ebb4d52b32a547426bdefa3_I20210930" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfOS01LTEtMS0zNjE1Njk_ff640bf2-b8c7-439d-ad61-7f433fbc91ab">119,750</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i68f578d19e7645c387c11ed14154d754_I20210930" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfOS03LTEtMS0zNjE1Njk_35a5832b-fffe-420c-aa7b-23e4096da527">6,900</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i156a47ec55f944129c986623c6da4e76_I20210930" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfOS05LTEtMS0zNjE1Njk_7fb12775-2fbd-420c-8914-0aeadb3f02ca">112,850</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52c9b6f82ebb4d52b32a547426bdefa3_I20210930" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfOS0xMS0xLTEtMzYxNTY5_6372f58f-e945-4ab4-b990-dfbd2e06ee8b">119,750</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest rate cap agreement net realized losses reclassified into net income are recorded as debt expense in the corresponding consolidated statements of income. See Note 6 for further details.</span></div></ix:continuation><div id="i9311e9c566584bd9ab5dffbc9b9a605b_67"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RleHRyZWdpb246ODFiMWI1Zjc4NDc0NGI5Njg1NWM4YjQ0OTU5MWNjNDVfMjA4OQ_11ff3337-5949-4454-8e4b-87b0fb9aa9f5" continuedAt="i2e27f84569ef45b48536a97c00527244" escape="true">Acquisitions and divestitures</ix:nonNumeric></span></div><ix:continuation id="i2e27f84569ef45b48536a97c00527244" continuedAt="i4f8c0ed0b6d64d6b9bf934fe3861f6af"><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Routine acquisitions</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2022, the Company acquired dialysis businesses consisting of <ix:nonFraction unitRef="clinic" contextRef="i95e6e28da1c64a71b6b90cda0a4d622f_D20220101-20220930" decimals="INF" name="us-gaap:NumberOfBusinessesAcquired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RleHRyZWdpb246ODFiMWI1Zjc4NDc0NGI5Njg1NWM4YjQ0OTU5MWNjNDVfMTM3NDM4OTUzNDkzODQ_395ce8c7-1897-479f-8480-945873cae1ad">five</ix:nonFraction> dialysis centers located in the U.S. and <ix:nonFraction unitRef="clinic" contextRef="ic959e17b2ced48048db8022f4a387ae2_D20220101-20220930" decimals="INF" name="us-gaap:NumberOfBusinessesAcquired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RleHRyZWdpb246ODFiMWI1Zjc4NDc0NGI5Njg1NWM4YjQ0OTU5MWNjNDVfMTM3NDM4OTUzNDk0NzQ_08483c4e-8649-41c1-a003-5ca9e856c80a">eight</ix:nonFraction> dialysis centers located outside the U.S. for total net cash of $<ix:nonFraction unitRef="usd" contextRef="ia6e87c344c514ceda105446f9b6fd9f1_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RleHRyZWdpb246ODFiMWI1Zjc4NDc0NGI5Njg1NWM4YjQ0OTU5MWNjNDVfMjE0_780194b9-3a75-404a-9d08-c458aa834e38">43,811</ix:nonFraction>, contingent earn-out obligations of $<ix:nonFraction unitRef="usd" contextRef="ia6e87c344c514ceda105446f9b6fd9f1_D20220101-20220930" decimals="-3" name="dva:BusinessCombinationContingentConsiderationAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RleHRyZWdpb246ODFiMWI1Zjc4NDc0NGI5Njg1NWM4YjQ0OTU5MWNjNDVfMjUz_f6e8c0c5-b016-4b0e-999a-f881a03d9c7e">2,171</ix:nonFraction> and deferred purchase price and liabilities assumed of $<ix:nonFraction unitRef="usd" contextRef="ia6e87c344c514ceda105446f9b6fd9f1_D20220101-20220930" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RleHRyZWdpb246ODFiMWI1Zjc4NDc0NGI5Njg1NWM4YjQ0OTU5MWNjNDVfMzEx_b8da1f84-997d-4ad8-a29f-0916aef14380">11,726</ix:nonFraction>. The assets and liabilities for these acquisitions were recorded at their estimated fair values at the dates of the acquisitions and are included in the Company&#8217;s condensed consolidated financial statements, as are their operating results, from the designated effective dates of the acquisitions.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The initial purchase price allocations have been recorded at estimated fair values based on information available to management and will be finalized when certain information arranged to be obtained has been received. In particular, certain income tax amounts are pending final evaluation and quantification of any pre-acquisition tax contingencies. In addition, valuation of intangibles, contingent earn-outs, leases, and certain other working capital items relating to these acquisitions are pending final quantification.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of goodwill recognized or adjusted during the nine months ended September&#160;30, 2022 that is deductible for tax purposes was $<ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="dva:BusinessAcquisitionGoodwillExpectedTaxDeductibleAmountAdjustment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RleHRyZWdpb246ODFiMWI1Zjc4NDc0NGI5Njg1NWM4YjQ0OTU5MWNjNDVfMTIyOA_6a82b615-25a7-432b-b06f-a3f36cb1d330">34,769</ix:nonFraction>.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div><span><br/></span></div></div><ix:continuation id="i4f8c0ed0b6d64d6b9bf934fe3861f6af"><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent earn-out obligations</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has several contingent earn-out obligations associated with acquisitions that could result in the Company paying the former owners of acquired businesses a total of up to approximately $<ix:nonFraction unitRef="usd" contextRef="icd5d82e4da8342af95e4f8a9ea99d743_D20220101-20220930" decimals="-3" name="dva:BusinessCombinationContingentConsiderationAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RleHRyZWdpb246ODFiMWI1Zjc4NDc0NGI5Njg1NWM4YjQ0OTU5MWNjNDVfMTQ2MQ_849b7e67-3dd3-4d1d-b2e7-8df17e5a7a4b">56,815</ix:nonFraction> if certain performance targets or quality margins are met over the next <ix:nonNumeric contextRef="i88a8225e4c1e42caaefc9c729b03c373_D20220101-20220930" name="dva:BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RleHRyZWdpb246ODFiMWI1Zjc4NDc0NGI5Njg1NWM4YjQ0OTU5MWNjNDVfMTUzNg_7bb2628d-a7f9-43bc-af5c-1b82fc5fbadf">one year</ix:nonNumeric> to <ix:nonNumeric contextRef="ifde433a78f5e48a7bae7190340e2eb48_D20220101-20220930" name="dva:BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RleHRyZWdpb246ODFiMWI1Zjc4NDc0NGI5Njg1NWM4YjQ0OTU5MWNjNDVfMTU0Mg_ecfb01ac-80ef-4454-b50a-8c0b8d7980e0">five years</ix:nonNumeric>.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent earn-out obligations are remeasured to fair value at each reporting date until the contingencies are resolved with changes in the liability due to the remeasurement recognized in earnings. As of September&#160;30, 2022, the Company estimated the fair value of these contingent earn-out obligations to be $<ix:nonFraction unitRef="usd" contextRef="ide4330793ff1447187183eb8ef9696b9_I20220930" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RleHRyZWdpb246ODFiMWI1Zjc4NDc0NGI5Njg1NWM4YjQ0OTU5MWNjNDVfMTg0MA_d5756f19-e88e-4c92-992a-2d62ac824574">25,771</ix:nonFraction>, of which $<ix:nonFraction unitRef="usd" contextRef="i01942e9636d34741abd1fb7dae3a5e7a_I20220930" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RleHRyZWdpb246ODFiMWI1Zjc4NDc0NGI5Njg1NWM4YjQ0OTU5MWNjNDVfMTg1Mw_2ddb91c8-eea4-41b5-a9f0-a442684c3c05">9,461</ix:nonFraction> is included in other current liabilities and the remaining $<ix:nonFraction unitRef="usd" contextRef="i4a9ef1628dd54bbc87ca947161e93f59_I20220930" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RleHRyZWdpb246ODFiMWI1Zjc4NDc0NGI5Njg1NWM4YjQ0OTU5MWNjNDVfMTkxNQ_9f2b0f41-de6b-4c6f-83b9-296ce1c486c4">16,310</ix:nonFraction> is included in other long-term liabilities in the Company&#8217;s consolidated balance sheet.</span></div><ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RleHRyZWdpb246ODFiMWI1Zjc4NDc0NGI5Njg1NWM4YjQ0OTU5MWNjNDVfMjA5NQ_d8d2e5d3-d45e-4bb2-87e0-b135a1b84e6b" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of changes in contingent earn-out obligations: </span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.093%"><tr><td style="width:1.0%"></td><td style="width:58.604%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.678%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.679%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended<br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended <br/>September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6f218803873471383d0301f439bbb92_I20220630" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RhYmxlOmJlM2JiMTI5MmNlZjQ0YmNiZDRiZTNkNjU5NzkzOTQ1L3RhYmxlcmFuZ2U6YmUzYmIxMjkyY2VmNDRiY2JkNGJlM2Q2NTk3OTM5NDVfMS0xLTEtMS0zNjE1Njk_77299d3a-84d9-4b13-bde0-4199690a3d05">29,299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c5d44642dc04d7aad80fa984ec18f13_I20211231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RhYmxlOmJlM2JiMTI5MmNlZjQ0YmNiZDRiZTNkNjU5NzkzOTQ1L3RhYmxlcmFuZ2U6YmUzYmIxMjkyY2VmNDRiY2JkNGJlM2Q2NTk3OTM5NDVfMS0zLTEtMS0zNjE1Njk_46ac2f99-b7fa-4c75-b226-0bbb2804296a">33,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i200705f0b3544be7a6092cd5a931bd55_D20220701-20220930" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RhYmxlOmJlM2JiMTI5MmNlZjQ0YmNiZDRiZTNkNjU5NzkzOTQ1L3RhYmxlcmFuZ2U6YmUzYmIxMjkyY2VmNDRiY2JkNGJlM2Q2NTk3OTM5NDVfMi0xLTEtMS0zNjE1Njk_e777a436-7c03-4467-b26a-36b59e23bfd8">1,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6e87c344c514ceda105446f9b6fd9f1_D20220101-20220930" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RhYmxlOmJlM2JiMTI5MmNlZjQ0YmNiZDRiZTNkNjU5NzkzOTQ1L3RhYmxlcmFuZ2U6YmUzYmIxMjkyY2VmNDRiY2JkNGJlM2Q2NTk3OTM5NDVfMi0zLTEtMS0zNjE1Njk_e61478eb-2b5e-4493-a94b-2172f49ebc9c">2,171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i200705f0b3544be7a6092cd5a931bd55_D20220701-20220930" decimals="-3" sign="-" name="dva:ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RhYmxlOmJlM2JiMTI5MmNlZjQ0YmNiZDRiZTNkNjU5NzkzOTQ1L3RhYmxlcmFuZ2U6YmUzYmIxMjkyY2VmNDRiY2JkNGJlM2Q2NTk3OTM5NDVfMy0xLTEtMS0zNjE1Njk_5b45b839-da0d-4dae-8a2f-3edc6dc5c3e0">741</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6e87c344c514ceda105446f9b6fd9f1_D20220101-20220930" decimals="-3" name="dva:ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RhYmxlOmJlM2JiMTI5MmNlZjQ0YmNiZDRiZTNkNjU5NzkzOTQ1L3RhYmxlcmFuZ2U6YmUzYmIxMjkyY2VmNDRiY2JkNGJlM2Q2NTk3OTM5NDVfMy0zLTEtMS0zNjE1Njk_65019d8a-861b-41bf-a594-04c610947019">403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value remeasurements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i200705f0b3544be7a6092cd5a931bd55_D20220701-20220930" decimals="-3" name="dva:BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RhYmxlOmJlM2JiMTI5MmNlZjQ0YmNiZDRiZTNkNjU5NzkzOTQ1L3RhYmxlcmFuZ2U6YmUzYmIxMjkyY2VmNDRiY2JkNGJlM2Q2NTk3OTM5NDVfNC0xLTEtMS0zNjE1Njk_ef5de48d-5d13-4454-8b2e-90074ba85f8f">350</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia6e87c344c514ceda105446f9b6fd9f1_D20220101-20220930" decimals="-3" name="dva:BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RhYmxlOmJlM2JiMTI5MmNlZjQ0YmNiZDRiZTNkNjU5NzkzOTQ1L3RhYmxlcmFuZ2U6YmUzYmIxMjkyY2VmNDRiY2JkNGJlM2Q2NTk3OTM5NDVfNC0zLTEtMS0zNjE1Njk_bc777e12-2591-42b1-8af3-68b753eb0c65">3,129</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i200705f0b3544be7a6092cd5a931bd55_D20220701-20220930" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RhYmxlOmJlM2JiMTI5MmNlZjQ0YmNiZDRiZTNkNjU5NzkzOTQ1L3RhYmxlcmFuZ2U6YmUzYmIxMjkyY2VmNDRiY2JkNGJlM2Q2NTk3OTM5NDVfNS0xLTEtMS0zNjE1Njk_600d4830-e5a9-4a0e-9641-9926b7e452a0">4,085</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia6e87c344c514ceda105446f9b6fd9f1_D20220101-20220930" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RhYmxlOmJlM2JiMTI5MmNlZjQ0YmNiZDRiZTNkNjU5NzkzOTQ1L3RhYmxlcmFuZ2U6YmUzYmIxMjkyY2VmNDRiY2JkNGJlM2Q2NTk3OTM5NDVfNS0zLTEtMS0zNjE1Njk_25a2c74c-02f0-4a00-bfa0-d9ac6d6f1950">7,274</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ab035ae8c46470e89b5add1fb9a3684_I20220930" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RhYmxlOmJlM2JiMTI5MmNlZjQ0YmNiZDRiZTNkNjU5NzkzOTQ1L3RhYmxlcmFuZ2U6YmUzYmIxMjkyY2VmNDRiY2JkNGJlM2Q2NTk3OTM5NDVfNi0xLTEtMS0zNjE1Njk_6373c46a-e7bb-4287-9a5c-e6c74c1a098c">25,771</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ab035ae8c46470e89b5add1fb9a3684_I20220930" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RhYmxlOmJlM2JiMTI5MmNlZjQ0YmNiZDRiZTNkNjU5NzkzOTQ1L3RhYmxlcmFuZ2U6YmUzYmIxMjkyY2VmNDRiY2JkNGJlM2Q2NTk3OTM5NDVfNi0zLTEtMS0zNjE1Njk_f27cdf53-5d9c-40f3-b515-073e81db4870">25,771</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i9311e9c566584bd9ab5dffbc9b9a605b_70"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="us-gaap:VariableInterestEntityDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83MC9mcmFnOmNlOTljNTVlYzVjMDQyM2FhMzMxZWFkOGVmZWIzMTNmL3RleHRyZWdpb246Y2U5OWM1NWVjNWMwNDIzYWEzMzFlYWQ4ZWZlYjMxM2ZfNDUz_686e2e11-6b02-4073-b7a8-c5999936570a" continuedAt="ibe5d5bad54ca4a0690e2b6208909970f" escape="true">Variable interest entities (VIEs)</ix:nonNumeric></span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ibe5d5bad54ca4a0690e2b6208909970f">At September&#160;30, 2022, these condensed consolidated financial statements include total assets of consolidated VIEs of $<ix:nonFraction unitRef="usd" contextRef="if32523db73914548b7ef72241eec1f64_I20220930" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83MC9mcmFnOmNlOTljNTVlYzVjMDQyM2FhMzMxZWFkOGVmZWIzMTNmL3RleHRyZWdpb246Y2U5OWM1NWVjNWMwNDIzYWEzMzFlYWQ4ZWZlYjMxM2ZfMTMy_3e19de16-5fc8-4a8d-95c3-5f9287f06537">298,477</ix:nonFraction> and total liabilities and noncontrolling interests of consolidated VIEs to third parties of $<ix:nonFraction unitRef="usd" contextRef="if32523db73914548b7ef72241eec1f64_I20220930" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83MC9mcmFnOmNlOTljNTVlYzVjMDQyM2FhMzMxZWFkOGVmZWIzMTNmL3RleHRyZWdpb246Y2U5OWM1NWVjNWMwNDIzYWEzMzFlYWQ4ZWZlYjMxM2ZfMjE0_bbafc0b1-5f9d-4606-a980-177ecc68d861">196,159</ix:nonFraction>. There have been no material changes in the nature of the Company's arrangements with VIEs or its judgments concerning them from those described in Note 23 to the Company's consolidated financial statements included in the 2021 10-K.</ix:continuation></span></div><div id="i9311e9c566584bd9ab5dffbc9b9a605b_73"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83My9mcmFnOjg5YzhhNWVjMTBmOTQ1ZDdiZDA4NzVjODE4MTk1MDg1L3RleHRyZWdpb246ODljOGE1ZWMxMGY5NDVkN2JkMDg3NWM4MTgxOTUwODVfNDM3MQ_5e9fe5c8-fe81-40ff-a352-3a18bbd98213" continuedAt="if17c20404dcc49c0bfb7f0f09333e5b1" escape="true">Fair values of financial instruments</ix:nonNumeric></span></div><ix:continuation id="if17c20404dcc49c0bfb7f0f09333e5b1" continuedAt="i98377a3113604da19d03c5052cd394fe"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures the fair value of certain assets, liabilities and noncontrolling interests subject to put provisions (redeemable equity interests classified as temporary equity) based upon certain valuation techniques that include observable or unobservable inputs and assumptions that market participants would use in pricing these assets, liabilities, temporary equity and commitments. The Company has also classified assets, liabilities and temporary equities that are measured at fair value on a recurring basis into the appropriate fair value hierarchy levels as defined by the Financial Accounting Standards Board (FASB).</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83My9mcmFnOjg5YzhhNWVjMTBmOTQ1ZDdiZDA4NzVjODE4MTk1MDg1L3RleHRyZWdpb246ODljOGE1ZWMxMGY5NDVkN2JkMDg3NWM4MTgxOTUwODVfNDM2OQ_c8064732-5fc6-4cd2-afa2-7ea7cd942db1" continuedAt="i1277bb563cf14235aed2ecf1f9e10721" escape="true">The following table summarizes the Company&#8217;s assets, liabilities and temporary equities measured at fair value on a recurring basis as of September&#160;30, 2022:&#160;</ix:nonNumeric></span></div><div style="margin-top:6pt;padding-left:27pt"><ix:continuation id="i1277bb563cf14235aed2ecf1f9e10721"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.251%"><tr><td style="width:1.0%"></td><td style="width:44.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.638%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.638%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.947%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Quoted prices in<br/>active&#160;markets<br/>for identical assets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Significant other<br/>observable&#160;inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Significant<br/>unobservable<br/>inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in equity securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad68a7dfc7f8430c902a9ff9db916de5_I20220930" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83My9mcmFnOjg5YzhhNWVjMTBmOTQ1ZDdiZDA4NzVjODE4MTk1MDg1L3RhYmxlOjVhZWJjNmZiNDk5ZjRlMjZiYmFiYzMxZWE3Yzg5OGFmL3RhYmxlcmFuZ2U6NWFlYmM2ZmI0OTlmNGUyNmJiYWJjMzFlYTdjODk4YWZfMi0xLTEtMS0zNjE1Njk_ed63bfc7-863d-4a5c-8927-a4e3fc34df00">39,997</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37ced70b3e714fa5b27f6d0da83e5d16_I20220930" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83My9mcmFnOjg5YzhhNWVjMTBmOTQ1ZDdiZDA4NzVjODE4MTk1MDg1L3RhYmxlOjVhZWJjNmZiNDk5ZjRlMjZiYmFiYzMxZWE3Yzg5OGFmL3RhYmxlcmFuZ2U6NWFlYmM2ZmI0OTlmNGUyNmJiYWJjMzFlYTdjODk4YWZfMi0zLTEtMS0zNjE1Njk_9d65326f-4544-4974-93c9-b6272efb8cd5">39,997</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie85a55a4b6014368afa4c77e630e85e9_I20220930" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83My9mcmFnOjg5YzhhNWVjMTBmOTQ1ZDdiZDA4NzVjODE4MTk1MDg1L3RhYmxlOjVhZWJjNmZiNDk5ZjRlMjZiYmFiYzMxZWE3Yzg5OGFmL3RhYmxlcmFuZ2U6NWFlYmM2ZmI0OTlmNGUyNmJiYWJjMzFlYTdjODk4YWZfMi01LTEtMS0zNjE1Njk_7d8a198b-a8ed-474a-a821-928fc9588fec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i861d396ab85f4a41a20715d925fdf77d_I20220930" decimals="-3" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83My9mcmFnOjg5YzhhNWVjMTBmOTQ1ZDdiZDA4NzVjODE4MTk1MDg1L3RhYmxlOjVhZWJjNmZiNDk5ZjRlMjZiYmFiYzMxZWE3Yzg5OGFmL3RhYmxlcmFuZ2U6NWFlYmM2ZmI0OTlmNGUyNmJiYWJjMzFlYTdjODk4YWZfMi03LTEtMS0zNjE1Njk_33f6e64a-3d75-4286-acaf-8ad6f8328ddb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate cap agreements</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2281493dee746f3a9ad6ed5affc319f_I20220930" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83My9mcmFnOjg5YzhhNWVjMTBmOTQ1ZDdiZDA4NzVjODE4MTk1MDg1L3RhYmxlOjVhZWJjNmZiNDk5ZjRlMjZiYmFiYzMxZWE3Yzg5OGFmL3RhYmxlcmFuZ2U6NWFlYmM2ZmI0OTlmNGUyNmJiYWJjMzFlYTdjODk4YWZfMy0xLTEtMS0zNjE1Njk_57441924-8696-4e5b-8280-7cdeb11d90a9">139,663</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942ba5c680184d918b3750ba16f74597_I20220930" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83My9mcmFnOjg5YzhhNWVjMTBmOTQ1ZDdiZDA4NzVjODE4MTk1MDg1L3RhYmxlOjVhZWJjNmZiNDk5ZjRlMjZiYmFiYzMxZWE3Yzg5OGFmL3RhYmxlcmFuZ2U6NWFlYmM2ZmI0OTlmNGUyNmJiYWJjMzFlYTdjODk4YWZfMy0zLTEtMS0zNjE1Njk_3e24e8f6-8075-467a-8565-3e5f164338a1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i422c441ffd274e1a8dea60fc1227cd35_I20220930" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83My9mcmFnOjg5YzhhNWVjMTBmOTQ1ZDdiZDA4NzVjODE4MTk1MDg1L3RhYmxlOjVhZWJjNmZiNDk5ZjRlMjZiYmFiYzMxZWE3Yzg5OGFmL3RhYmxlcmFuZ2U6NWFlYmM2ZmI0OTlmNGUyNmJiYWJjMzFlYTdjODk4YWZfMy01LTEtMS0zNjE1Njk_5bb9192d-fe3d-406e-ba73-88ae150187be">139,663</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i277124343d7e4b49b6103749b88e2648_I20220930" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83My9mcmFnOjg5YzhhNWVjMTBmOTQ1ZDdiZDA4NzVjODE4MTk1MDg1L3RhYmxlOjVhZWJjNmZiNDk5ZjRlMjZiYmFiYzMxZWE3Yzg5OGFmL3RhYmxlcmFuZ2U6NWFlYmM2ZmI0OTlmNGUyNmJiYWJjMzFlYTdjODk4YWZfMy03LTEtMS0zNjE1Njk_9fc974f6-a414-45e6-9db8-12a46b1e2310">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent earn-out obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad68a7dfc7f8430c902a9ff9db916de5_I20220930" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83My9mcmFnOjg5YzhhNWVjMTBmOTQ1ZDdiZDA4NzVjODE4MTk1MDg1L3RhYmxlOjVhZWJjNmZiNDk5ZjRlMjZiYmFiYzMxZWE3Yzg5OGFmL3RhYmxlcmFuZ2U6NWFlYmM2ZmI0OTlmNGUyNmJiYWJjMzFlYTdjODk4YWZfNS0xLTEtMS0zNjE1Njk_2ede372a-cbdf-429c-a7e4-35cef0d31d32">25,771</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37ced70b3e714fa5b27f6d0da83e5d16_I20220930" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83My9mcmFnOjg5YzhhNWVjMTBmOTQ1ZDdiZDA4NzVjODE4MTk1MDg1L3RhYmxlOjVhZWJjNmZiNDk5ZjRlMjZiYmFiYzMxZWE3Yzg5OGFmL3RhYmxlcmFuZ2U6NWFlYmM2ZmI0OTlmNGUyNmJiYWJjMzFlYTdjODk4YWZfNS0zLTEtMS0zNjE1Njk_80418dcb-be01-47aa-a929-b6c9f6189210">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie85a55a4b6014368afa4c77e630e85e9_I20220930" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83My9mcmFnOjg5YzhhNWVjMTBmOTQ1ZDdiZDA4NzVjODE4MTk1MDg1L3RhYmxlOjVhZWJjNmZiNDk5ZjRlMjZiYmFiYzMxZWE3Yzg5OGFmL3RhYmxlcmFuZ2U6NWFlYmM2ZmI0OTlmNGUyNmJiYWJjMzFlYTdjODk4YWZfNS01LTEtMS0zNjE1Njk_3ee2a9a9-2895-486f-bb58-0b999d2ff176">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i861d396ab85f4a41a20715d925fdf77d_I20220930" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83My9mcmFnOjg5YzhhNWVjMTBmOTQ1ZDdiZDA4NzVjODE4MTk1MDg1L3RhYmxlOjVhZWJjNmZiNDk5ZjRlMjZiYmFiYzMxZWE3Yzg5OGFmL3RhYmxlcmFuZ2U6NWFlYmM2ZmI0OTlmNGUyNmJiYWJjMzFlYTdjODk4YWZfNS03LTEtMS0zNjE1Njk_b1f78a92-26fe-4c0e-837f-caf3c90c5f31">25,771</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Temporary equity</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests subject to put provisions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad68a7dfc7f8430c902a9ff9db916de5_I20220930" decimals="-3" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83My9mcmFnOjg5YzhhNWVjMTBmOTQ1ZDdiZDA4NzVjODE4MTk1MDg1L3RhYmxlOjVhZWJjNmZiNDk5ZjRlMjZiYmFiYzMxZWE3Yzg5OGFmL3RhYmxlcmFuZ2U6NWFlYmM2ZmI0OTlmNGUyNmJiYWJjMzFlYTdjODk4YWZfNy0xLTEtMS0zNjE1Njk_f57fa670-7106-4a2d-901a-d8cdb6dbf06a">1,370,753</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37ced70b3e714fa5b27f6d0da83e5d16_I20220930" decimals="-3" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83My9mcmFnOjg5YzhhNWVjMTBmOTQ1ZDdiZDA4NzVjODE4MTk1MDg1L3RhYmxlOjVhZWJjNmZiNDk5ZjRlMjZiYmFiYzMxZWE3Yzg5OGFmL3RhYmxlcmFuZ2U6NWFlYmM2ZmI0OTlmNGUyNmJiYWJjMzFlYTdjODk4YWZfNy0zLTEtMS0zNjE1Njk_a6f23f09-640c-41ff-9b89-65bdca403059">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie85a55a4b6014368afa4c77e630e85e9_I20220930" decimals="-3" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83My9mcmFnOjg5YzhhNWVjMTBmOTQ1ZDdiZDA4NzVjODE4MTk1MDg1L3RhYmxlOjVhZWJjNmZiNDk5ZjRlMjZiYmFiYzMxZWE3Yzg5OGFmL3RhYmxlcmFuZ2U6NWFlYmM2ZmI0OTlmNGUyNmJiYWJjMzFlYTdjODk4YWZfNy01LTEtMS0zNjE1Njk_fffdea71-4bfd-43b3-a01c-1bee246e8456">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i861d396ab85f4a41a20715d925fdf77d_I20220930" decimals="-3" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83My9mcmFnOjg5YzhhNWVjMTBmOTQ1ZDdiZDA4NzVjODE4MTk1MDg1L3RhYmxlOjVhZWJjNmZiNDk5ZjRlMjZiYmFiYzMxZWE3Yzg5OGFmL3RhYmxlcmFuZ2U6NWFlYmM2ZmI0OTlmNGUyNmJiYWJjMzFlYTdjODk4YWZfNy03LTEtMS0zNjE1Njk_b1f859ff-19e2-41be-a50c-fe08460451d7">1,370,753</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For reconciliations of changes in contingent earn-out obligations and noncontrolling interests subject to put provisions during the three and nine months ended September&#160;30, 2022, see Note 10 and the consolidated statement of equity, respectively.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div><span><br/></span></div></div><ix:continuation id="i98377a3113604da19d03c5052cd394fe"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in equity securities represent investments in various open-ended registered investment companies (mutual funds) and common stocks and are recorded at fair value estimated based on reported market prices or redemption prices, as applicable. See Note 4 for further discussion.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83My9mcmFnOjg5YzhhNWVjMTBmOTQ1ZDdiZDA4NzVjODE4MTk1MDg1L3RleHRyZWdpb246ODljOGE1ZWMxMGY5NDVkN2JkMDg3NWM4MTgxOTUwODVfNDM3NQ_b4540a62-ba37-41e3-84e8-0ff5d9f6ad76" continuedAt="i3aa8da22d7be4ff3b3e45f247cff86de" escape="true">Interest rate cap agreements are recorded at fair value estimated from valuation models utilizing the income approach and commonly accepted valuation techniques that use inputs from closing prices for similar assets and liabilities in active markets as well as other relevant observable market inputs at quoted intervals such as current interest rates, forward yield curves, implied volatility and credit default swap pricing. The Company does not believe the ultimate amount that could be realized upon settlement of these interest rate cap agreements would be materially different from the fair value estimates currently reported. See Note 6 for further discussion.</ix:nonNumeric></span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3aa8da22d7be4ff3b3e45f247cff86de">The estimated fair value measurements of contingent earn-out obligations are primarily based on unobservable inputs, including projected earnings before interest, taxes, depreciation, and amortization (EBITDA), revenue and certain operating metrics. The estimated fair values of these contingent earn-out obligations are remeasured as of each reporting date and could fluctuate based upon any significant changes in key assumptions, such as changes in the Company's credit risk adjusted rate that is used to discount obligations to present value.</ix:continuation> See Note 10 for further discussion.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of noncontrolling interests subject to put provisions is based principally on the higher of either estimated liquidation value of net assets or a multiple of earnings for each subject dialysis partnership, based on historical earnings, revenue mix, and other performance indicators that can affect future results. The multiples used for these valuations are derived from observed ownership transactions for dialysis businesses between unrelated parties in the U.S. in recent years, and the specific valuation multiple applied to each dialysis partnership is principally determined by its recent and expected revenue mix and contribution margin. As of September&#160;30, 2022, an increase or decrease in the weighted average multiple used in these valuations of one times EBITDA would change the estimated fair value of these noncontrolling interests by approximately $<ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="dva:PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83My9mcmFnOjg5YzhhNWVjMTBmOTQ1ZDdiZDA4NzVjODE4MTk1MDg1L3RleHRyZWdpb246ODljOGE1ZWMxMGY5NDVkN2JkMDg3NWM4MTgxOTUwODVfMzI5ODUzNDg4NzczNg_507df271-b51f-4774-94ab-babc97ad213b">170,000</ix:nonFraction>. See Notes 17 and 24 to the Company's consolidated financial statements included in the 2021 10-K for further discussion of the Company&#8217;s methodology for estimating the fair value of noncontrolling interests subject to put obligations.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's fair value estimates for its senior secured credit facilities and senior notes are based upon bid and ask quotes for these instruments, typically a level 2 input. See Note 6 for further discussion of the Company's debt.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other financial instruments consist primarily of cash and cash equivalents, restricted cash and cash equivalents, accounts receivable, accounts payable, other accrued liabilities, lease liabilities and debt. The balances of financial instruments other than debt and lease liabilities are presented in these condensed consolidated financial statements at September&#160;30, 2022 at their approximate fair values due to the short-term nature of their settlements.</span></div></ix:continuation><div id="i9311e9c566584bd9ab5dffbc9b9a605b_76"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RleHRyZWdpb246NzMwNWFjNzUyNWI3NDk4OGJmNzFmODQ3Mzc1NDRlZDJfMTQ4MA_7f39e421-0234-48ff-be43-e803c6abf483" continuedAt="i7ceb7461947c440baa0b6046af0b750d" escape="true">Segment reporting</ix:nonNumeric></span></div><ix:continuation id="i7ceb7461947c440baa0b6046af0b750d" continuedAt="ib4b42f197a8b4ce7981335f21cc368c4"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s operating divisions are comprised of its U.S. dialysis and related lab services business (its U.S. dialysis business), its U.S. integrated kidney care business, its U.S. other ancillary services and its international operations (collectively, its ancillary services), as well as its corporate administrative support. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s separate operating segments include its U.S. dialysis and related lab services business, its U.S. integrated kidney care business, its U.S. other ancillary services, its kidney care operations in each foreign sovereign jurisdiction, and its equity method investment in the Asia Pacific joint venture (APAC JV). The U.S. dialysis and related lab services business qualifies as a separately reportable segment, and all other operating segments have been combined and disclosed in the other segments category. See Note 25 to the Company's consolidated financial statements included in the 2021 10-K for further description of how the Company determines and measures results for its operating segments.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div><span><br/></span></div></div><ix:continuation id="ib4b42f197a8b4ce7981335f21cc368c4" continuedAt="i4766c1f096d4476db8c8c4f84223009b"><ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RleHRyZWdpb246NzMwNWFjNzUyNWI3NDk4OGJmNzFmODQ3Mzc1NDRlZDJfMTQ4Nw_438f8843-5009-4d86-af8a-5d908cd9e5b8" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of segment net revenues, segment operating margin (loss), and a reconciliation of segment operating margin to consolidated income before income taxes:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dialysis patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">External sources</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86e50a7258fd4e0992f2a0577c97a330_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfNS0xLTEtMS0zNjE1Njk_034cc8d6-2bf6-4567-9fc9-0521ba33e50e">2,674,240</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8addd3c7916144679fc2e787249b56d9_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfNS0zLTEtMS0zNjE1Njk_043a2ecd-8725-4644-90a8-5a87e4358035">2,669,823</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide05e52cd7054762b05f224b69c2974e_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfNS01LTEtMS0zNjE1Njk_510c7205-9acb-47b5-bdce-777f660588a6">7,858,939</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i819e851e63e848a696a608bae9204746_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfNS03LTEtMS0zNjE1Njk_10722d40-ac58-4b34-abf8-97d8d8ebc638">7,874,759</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96cb1c0878bf49cea8cfa1212cdc7aed_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfNi0xLTEtMS0zNjE1Njk_9256b49f-4c51-4aec-80f3-4c095a408c9c">22,957</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36100b7124c542bd86b8f36ce7106243_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfNi0zLTEtMS0zNjE1Njk_6aa38015-f741-4978-bb54-550b1a7738b4">22,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73df09631cc34d359a0ce8f26f7d7e45_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfNi01LTEtMS0zNjE1Njk_6912c4e1-aa18-464f-a59d-d6707a1aedc7">64,526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3eb7e259bf141018ef89a58189f8ba2_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfNi03LTEtMS0zNjE1Njk_18282470-0129-405a-b1b2-0d039d2d4361">70,196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis patient service revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8601bd20cd04c22b8e3e448c8c8a4bc_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfOS0xLTEtMS0zNjE1Njk_659c6391-a151-4ade-9f1a-d077e3ed5dd5">2,697,197</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38b206ccc4604608ab1cbaeaa6e878f5_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfOS0zLTEtMS0zNjE1Njk_07d1453e-2d1d-4049-bc70-6059c8d89bfe">2,691,830</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5947da8371ba465b929ebd233615c5fc_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfOS01LTEtMS0zNjE1Njk_cb56f162-ab32-4b63-a12b-4fa35b166b38">7,923,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc9f7a8bb84e40e581606e923ee81543_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfOS03LTEtMS0zNjE1Njk_291b76d7-4455-4536-afa3-949a075cbfa0">7,944,955</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">External sources</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86e50a7258fd4e0992f2a0577c97a330_D20220701-20220930" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTEtMS0xLTEtMzYxNTY5_1315cf94-9d7e-48ad-a45e-11a952f3628d">6,056</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8addd3c7916144679fc2e787249b56d9_D20210701-20210930" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTEtMy0xLTEtMzYxNTY5_3d89e3b8-d07e-47b3-a467-f57e0783672c">6,119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide05e52cd7054762b05f224b69c2974e_D20220101-20220930" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTEtNS0xLTEtMzYxNTY5_f1b69fcb-290a-4224-91a9-b1cf0e2556e0">18,134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i819e851e63e848a696a608bae9204746_D20210101-20210930" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTEtNy0xLTEtMzYxNTY5_da3c2334-a5b8-4547-b371-aad923991628">19,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96cb1c0878bf49cea8cfa1212cdc7aed_D20220701-20220930" decimals="-3" name="us-gaap:OtherIncome" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTItMS0xLTEtMzYxNTY5_b4e11dfc-e7d8-4197-803f-5cfbca289caf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36100b7124c542bd86b8f36ce7106243_D20210701-20210930" decimals="-3" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTItMy0xLTEtMzYxNTY5_efcb7ed1-bfec-40a7-83f5-96eeb6d48627">97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73df09631cc34d359a0ce8f26f7d7e45_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTItNS0xLTEtMzYxNTY5_b6cbb4a6-e81d-471c-90d5-ca295feeb037">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3eb7e259bf141018ef89a58189f8ba2_D20210101-20210930" decimals="-3" name="us-gaap:OtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTItNy0xLTEtMzYxNTY5_8d7940d5-4d32-4532-a4b5-2c4eb19c83d1">228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total U.S. dialysis revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8601bd20cd04c22b8e3e448c8c8a4bc_D20220701-20220930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTMtMS0xLTEtMzYxNTY5_9dda0074-2a68-4f01-ac25-59844dd9ff6b">2,703,253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38b206ccc4604608ab1cbaeaa6e878f5_D20210701-20210930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTMtMy0xLTEtMzYxNTY5_7dc45c72-6dfd-4f5d-a265-e3d8f0122965">2,698,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5947da8371ba465b929ebd233615c5fc_D20220101-20220930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTMtNS0xLTEtMzYxNTY5_86fc5933-b9c0-40db-b46f-9e2fc29ab4cb">7,941,589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc9f7a8bb84e40e581606e923ee81543_D20210101-20210930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTMtNy0xLTEtMzYxNTY5_64e91a21-3a58-4a89-b71c-b40762feb5dc">7,964,263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other&#8212;Ancillary services</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dialysis patient service revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i068759fddb5d4fbd9e32d6347d1e6d75_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTUtMS0xLTEtMzYxNTY5_128a0af3-c3fa-4f66-b219-7fd89e29c426">172,254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b9dedef3bed43dba87b7821cb677959_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTUtMy0xLTEtMzYxNTY5_fd7bef2f-f186-4c8c-9a4e-0ebc19f7c708">168,117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd089f25d0742cc93cba789d7beaa24_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTUtNS0xLTEtMzYxNTY5_b80282d3-52a7-4d72-a44b-11925aed9987">513,935</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib561b1ec046245b58bddae941fc0daf3_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTUtNy0xLTEtMzYxNTY5_d2e75275-f9fb-4e99-ac77-d4bd2f80f9b2">495,725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other external sources</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i068759fddb5d4fbd9e32d6347d1e6d75_D20220701-20220930" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTYtMS0xLTEtMzYxNTY5_fb536d34-2a7e-4b32-b573-10b4ba36b3a3">96,144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b9dedef3bed43dba87b7821cb677959_D20210701-20210930" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTYtMy0xLTEtMzYxNTY5_d5b2d7f2-f999-4aa3-b2c3-7edf02dd221b">94,260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd089f25d0742cc93cba789d7beaa24_D20220101-20220930" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTYtNS0xLTEtMzYxNTY5_f6fc0486-e0e9-4b35-8932-b85f8aa97633">301,998</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib561b1ec046245b58bddae941fc0daf3_D20210101-20210930" decimals="-3" name="us-gaap:OtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTYtNy0xLTEtMzYxNTY5_f3c783aa-fab3-4dd5-a764-a0616cdfeffc">285,266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe0e63e321e945a08099e16de0785d5c_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTctMS0xLTEtMzYxNTY5_4ce1a232-d8f2-41d0-b8b8-df40d5e734c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee77a72428d248f899e78bbf60ce4cc2_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTctMy0xLTEtMzYxNTY5_3a215330-6892-489f-b13f-a471589cd190">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i283d80459c03449ebbe9a4d7b3746698_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTctNS0xLTEtMzYxNTY5_47f917de-fe6d-4c5b-941a-d5f55ad4e36e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdf9f7a5de6348a2a7d0775d1ab48459_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTctNy0xLTEtMzYxNTY5_7b538fa7-e754-4b71-becf-f4edfaf215a9">4,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total ancillary services revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i068759fddb5d4fbd9e32d6347d1e6d75_D20220701-20220930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTgtMS0xLTEtMzYxNTY5_b96e5512-9b38-4bac-9133-b231b3f987df">268,398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b9dedef3bed43dba87b7821cb677959_D20210701-20210930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTgtMy0xLTEtMzYxNTY5_0452e888-e0f9-44c4-880d-8ed5d6c7e04e">262,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd089f25d0742cc93cba789d7beaa24_D20220101-20220930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTgtNS0xLTEtMzYxNTY5_349d0051-62a4-4882-ae3e-4c3dd236faee">815,933</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib561b1ec046245b58bddae941fc0daf3_D20210101-20210930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTgtNy0xLTEtMzYxNTY5_80078620-8376-4b7b-95e4-30ec8258c9d2">785,285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net segment revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1a93e7f4f5e4e33bffc9621d504b491_D20220701-20220930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTktMS0xLTEtMzYxNTY5_93bbf992-54af-4205-8e78-3f4eaa3cdf9f">2,971,651</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bcbcc0a834148c8afeb26f2a4556df3_D20210701-20210930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTktMy0xLTEtMzYxNTY5_08ef173b-e30a-4fb0-8fbc-718fdc513a73">2,960,423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74c6003e725f4a6c850b011b394744f5_D20220101-20220930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTktNS0xLTEtMzYxNTY5_9fe31f58-dc3e-4bee-9435-780189bf415a">8,757,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i700a5ecba5cb45d1ba64cd1d25b5583e_D20210101-20210930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTktNy0xLTEtMzYxNTY5_c39d0bdc-bbba-48ca-a251-a18d3e2ec90b">8,749,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elimination of intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i253b9978247749dcb47c368cdebc35ae_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjAtMS0xLTEtMzYxNTY5_17078c9c-b3e1-42e1-ac3b-20e23659e291">22,957</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c321d3f4f114e7a810149cebdfddf89_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjAtMy0xLTEtMzYxNTY5_b5579c7e-eba1-4621-942a-83c2892b984f">22,104</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b80df9aa48e4aa9a2eeabbf8c48904e_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjAtNS0xLTEtMzYxNTY5_9a8c5a0f-9ef5-4db0-b746-2b08ecbf83c3">64,516</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iabe54304a7d4439d88d4c1cbb00ee5ac_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjAtNy0xLTEtMzYxNTY5_293cb48c-b319-44b1-bee3-1829e6525656">74,718</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjEtMS0xLTEtMzYxNTY5_9eebe2df-dd7c-41c8-ac6f-25a292196ee0">2,948,694</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjEtMy0xLTEtMzYxNTY5_54a36c73-b13c-4fff-b1b9-47158808e7ae">2,938,319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjEtNS0xLTEtMzYxNTY5_b0009044-2697-4e93-97e7-0f5a9ea5801e">8,693,006</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjEtNy0xLTEtMzYxNTY5_eba44533-b2ed-4fed-86df-247be62a79e7">8,674,830</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating margin (loss):</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8601bd20cd04c22b8e3e448c8c8a4bc_D20220701-20220930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjMtMS0xLTEtMzYxNTY5_3a45a797-526e-4540-9112-c2fd5a1b74f4">351,474</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38b206ccc4604608ab1cbaeaa6e878f5_D20210701-20210930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjMtMy0xLTEtMzYxNTY5_bdba244f-b208-400c-9d2a-f521f54375b1">509,939</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5947da8371ba465b929ebd233615c5fc_D20220101-20220930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjMtNS0xLTEtMzYxNTY5_79a9eaec-7f23-4adf-9fbb-35e7ba4de8bd">1,230,715</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc9f7a8bb84e40e581606e923ee81543_D20210101-20210930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjMtNy0xLTEtMzYxNTY5_d1784739-cb8c-43bc-9e40-e5d2543c8ba9">1,523,625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other&#8212;Ancillary services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i068759fddb5d4fbd9e32d6347d1e6d75_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjQtMS0xLTEtMzYxNTY5_6606363e-f0fa-4077-b1d2-231559bec8a8">15,271</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b9dedef3bed43dba87b7821cb677959_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjQtMy0xLTEtMzYxNTY5_aec3cb7f-a151-44d4-be8b-87f73bddbf52">6,909</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fd089f25d0742cc93cba789d7beaa24_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjQtNS0xLTEtMzYxNTY5_99820d10-fbab-4287-a2ef-59666b82674a">56,689</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib561b1ec046245b58bddae941fc0daf3_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjQtNy0xLTEtMzYxNTY5_8590f310-7b9c-470b-8979-192587a72ad9">36,577</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment operating margin</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1a93e7f4f5e4e33bffc9621d504b491_D20220701-20220930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjUtMS0xLTEtMzYxNTY5_5aaf29d2-0621-476b-8ccb-dc6506a95542">336,203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bcbcc0a834148c8afeb26f2a4556df3_D20210701-20210930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjUtMy0xLTEtMzYxNTY5_f591b1cc-7d68-492a-a796-20639e357a2c">503,030</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74c6003e725f4a6c850b011b394744f5_D20220101-20220930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjUtNS0xLTEtMzYxNTY5_5a324df3-8238-40ba-8281-0bfb29e72ff5">1,174,026</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i700a5ecba5cb45d1ba64cd1d25b5583e_D20210101-20210930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjUtNy0xLTEtMzYxNTY5_b45df6af-86e1-4903-be7f-ce88ce9fdfa7">1,487,048</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation of segment operating income to<br/>&#160;consolidated income before income taxes:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate administrative support</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930" decimals="-3" name="dva:SegmentReportingInformationCorporateExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjctMS0xLTEtMzYxNTY5_9292146b-8079-49ab-89b7-3378e00d00f4">24,417</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930" decimals="-3" name="dva:SegmentReportingInformationCorporateExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjctMy0xLTEtMzYxNTY5_2066bba6-8d6a-4de7-9f4e-bbb74292ec56">28,153</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="dva:SegmentReportingInformationCorporateExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjctNS0xLTEtMzYxNTY5_15fa8c87-78b5-4da5-99f0-ef7f4e4206d2">91,217</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="dva:SegmentReportingInformationCorporateExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjctNy0xLTEtMzYxNTY5_b4b04167-1991-424b-8cc5-b8e5659fbfe3">79,093</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjgtMS0xLTEtMzYxNTY5_7c724758-ef1d-4c87-838c-155c0c0b9eaa">311,787</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjgtMy0xLTEtMzYxNTY5_c53f7e0d-bf1f-4296-bec4-2ab1f4890094">474,877</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjgtNS0xLTEtMzYxNTY5_0419790b-b0c3-4fca-b33c-c049d0399a35">1,082,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjgtNy0xLTEtMzYxNTY5_65f1a88d-cea9-481e-831b-3620f46e6800">1,407,955</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930" decimals="-3" name="us-gaap:InterestAndDebtExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjktMS0xLTEtMzYxNTY5_acf2b3c0-36da-4ddc-84ac-7464daf2f4ee">99,680</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930" decimals="-3" name="us-gaap:InterestAndDebtExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjktMy0xLTEtMzYxNTY5_224053f4-c832-4dd6-bec7-7666a0973416">72,829</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:InterestAndDebtExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjktNS0xLTEtMzYxNTY5_95ebbffa-67cb-4f0b-8da5-f6d0fb493ca2">256,057</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:InterestAndDebtExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjktNy0xLTEtMzYxNTY5_1228b1a1-e644-44ac-b9e3-70a835ff11d3">213,167</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (loss) income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMzEtMS0xLTEtMzYxNTY5_f79b079d-dd86-4b37-af8e-e5354d78667f">4,898</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMzEtMy0xLTEtMzYxNTY5_1c586133-bf6c-4b56-b6c4-37a33e232dd0">7,590</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMzEtNS0xLTEtMzYxNTY5_7a2e0d57-00ac-4244-8fe4-dd303a95649c">7,968</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMzEtNy0xLTEtMzYxNTY5_a9473c08-cdfd-4b50-90a0-59d9fda97411">8,766</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated income before income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMzItMS0xLTEtMzYxNTY5_b63ab107-851b-485c-8f32-2c6d7eff4869">207,209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMzItMy0xLTEtMzYxNTY5_af97b3af-f96e-49e2-9b2b-1940485f478a">394,458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMzItNS0xLTEtMzYxNTY5_b2708ec7-2897-4432-bb0c-06b98c15a8ff">818,785</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMzItNy0xLTEtMzYxNTY5_e1cc84e8-4baa-42d3-95e6-68ba66344994">1,203,554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" xsi:nil="true" name="us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RleHRyZWdpb246NzMwNWFjNzUyNWI3NDk4OGJmNzFmODQ3Mzc1NDRlZDJfMTQ3Nw_6fda0a3f-fc93-458d-bdca-589b7d64ccb3" escape="true"></ix:nonNumeric><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DAVITA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS&#8212;(continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dollars and shares in thousands, except per share data)</span></div><div><span><br/></span></div></div><ix:continuation id="i4766c1f096d4476db8c8c4f84223009b"><ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RleHRyZWdpb246NzMwNWFjNzUyNWI3NDk4OGJmNzFmODQ3Mzc1NDRlZDJfMTQ3MA_3e66edbf-aab7-487b-a4f1-131c4ac983aa" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense by reportable segment was as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.175%"><tr><td style="width:1.0%"></td><td style="width:44.982%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.649%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.653%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i138d5ad826a74dd389b7c50d766dce89_D20220701-20220930" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOjcwZDMzYmRjZDZlYzQ1NjM5OTU5ZjU4MjFkNWM2NjFlL3RhYmxlcmFuZ2U6NzBkMzNiZGNkNmVjNDU2Mzk5NTlmNTgyMWQ1YzY2MWVfMi0xLTEtMS0zNjE1Njk_96196e2c-1924-484f-a3b8-c6648217f1fa">184,688</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia98746ed55ed4291881ac7bb3d451f92_D20210701-20210930" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOjcwZDMzYmRjZDZlYzQ1NjM5OTU5ZjU4MjFkNWM2NjFlL3RhYmxlcmFuZ2U6NzBkMzNiZGNkNmVjNDU2Mzk5NTlmNTgyMWQ1YzY2MWVfMi0zLTEtMS0zNjE1Njk_d80eba49-b64e-4260-83bb-f65f02b7fcc8">161,252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i422c6a94a816499c8310fd5a0acc841f_D20220101-20220930" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOjcwZDMzYmRjZDZlYzQ1NjM5OTU5ZjU4MjFkNWM2NjFlL3RhYmxlcmFuZ2U6NzBkMzNiZGNkNmVjNDU2Mzk5NTlmNTgyMWQ1YzY2MWVfMi01LTEtMS0zNjE1Njk_66ca77be-5631-40bb-95bc-4812dcabbd29">507,320</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb049c47bd043afa9a8eb3aaf37cb95_D20210101-20210930" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOjcwZDMzYmRjZDZlYzQ1NjM5OTU5ZjU4MjFkNWM2NjFlL3RhYmxlcmFuZ2U6NzBkMzNiZGNkNmVjNDU2Mzk5NTlmNTgyMWQ1YzY2MWVfMi03LTEtMS0zNjE1Njk_36f10d34-b420-42dc-a4f7-a4df2a5df6ee">477,054</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other&#8212;Ancillary services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5743480e6048496ab58c95a14b8aaf6f_D20220701-20220930" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOjcwZDMzYmRjZDZlYzQ1NjM5OTU5ZjU4MjFkNWM2NjFlL3RhYmxlcmFuZ2U6NzBkMzNiZGNkNmVjNDU2Mzk5NTlmNTgyMWQ1YzY2MWVfMy0xLTEtMS0zNjE1Njk_57d5f5c9-224c-42f7-8a1a-f1fb9972f5b6">9,726</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0162929ca27d43d894768f88369a32f4_D20210701-20210930" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOjcwZDMzYmRjZDZlYzQ1NjM5OTU5ZjU4MjFkNWM2NjFlL3RhYmxlcmFuZ2U6NzBkMzNiZGNkNmVjNDU2Mzk5NTlmNTgyMWQ1YzY2MWVfMy0zLTEtMS0zNjE1Njk_4438b258-85c1-4e6f-9171-fd5ed567ac0f">9,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie63e40be1b8c44ae852031a36cc0c1d2_D20220101-20220930" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOjcwZDMzYmRjZDZlYzQ1NjM5OTU5ZjU4MjFkNWM2NjFlL3RhYmxlcmFuZ2U6NzBkMzNiZGNkNmVjNDU2Mzk5NTlmNTgyMWQ1YzY2MWVfMy01LTEtMS0zNjE1Njk_dfdca2d4-add1-45d4-bf85-0712c334a3bd">31,214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7870e39ec59457d85f40917f0be7b4b_D20210101-20210930" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOjcwZDMzYmRjZDZlYzQ1NjM5OTU5ZjU4MjFkNWM2NjFlL3RhYmxlcmFuZ2U6NzBkMzNiZGNkNmVjNDU2Mzk5NTlmNTgyMWQ1YzY2MWVfMy03LTEtMS0zNjE1Njk_a6d96d2c-6772-4c71-8942-5c47c92f4d31">28,798</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOjcwZDMzYmRjZDZlYzQ1NjM5OTU5ZjU4MjFkNWM2NjFlL3RhYmxlcmFuZ2U6NzBkMzNiZGNkNmVjNDU2Mzk5NTlmNTgyMWQ1YzY2MWVfNC0xLTEtMS0zNjE1Njk_51ff5272-22b6-4bed-9771-f26adac102b6">194,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOjcwZDMzYmRjZDZlYzQ1NjM5OTU5ZjU4MjFkNWM2NjFlL3RhYmxlcmFuZ2U6NzBkMzNiZGNkNmVjNDU2Mzk5NTlmNTgyMWQ1YzY2MWVfNC0zLTEtMS0zNjE1Njk_d1448066-3d19-46e2-a300-482db9b4f9f4">170,462</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOjcwZDMzYmRjZDZlYzQ1NjM5OTU5ZjU4MjFkNWM2NjFlL3RhYmxlcmFuZ2U6NzBkMzNiZGNkNmVjNDU2Mzk5NTlmNTgyMWQ1YzY2MWVfNC01LTEtMS0zNjE1Njk_ce0cd822-e002-437f-823a-98cc623321e1">538,534</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOjcwZDMzYmRjZDZlYzQ1NjM5OTU5ZjU4MjFkNWM2NjFlL3RhYmxlcmFuZ2U6NzBkMzNiZGNkNmVjNDU2Mzk5NTlmNTgyMWQ1YzY2MWVfNC03LTEtMS0zNjE1Njk_6277aafe-9ac2-44ae-aaeb-308dff62a9c2">505,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="dva:ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RleHRyZWdpb246NzMwNWFjNzUyNWI3NDk4OGJmNzFmODQ3Mzc1NDRlZDJfMTQ5MA_1d49cd1b-fc41-47b9-8307-c2257712dc0b" continuedAt="ia66e9b3236b74fc79a2dea0dc5783281" escape="true">Expenditures for property and equipment by reportable segment were as follows:</ix:nonNumeric></span></div><div style="margin-top:6pt;padding-left:27pt"><ix:continuation id="ia66e9b3236b74fc79a2dea0dc5783281"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.005%"><tr><td style="width:1.0%"></td><td style="width:62.459%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:16.696%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.698%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i422c6a94a816499c8310fd5a0acc841f_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmNmZjVlYzJkNWI4ZDRmM2FhNzhiYzBmOWY4MjFhYzFlL3RhYmxlcmFuZ2U6Y2ZmNWVjMmQ1YjhkNGYzYWE3OGJjMGY5ZjgyMWFjMWVfMi01LTEtMS0zNjE1Njk_752f1203-e0bf-4ff4-a83a-ad735d72119e">363,046</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cb049c47bd043afa9a8eb3aaf37cb95_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmNmZjVlYzJkNWI4ZDRmM2FhNzhiYzBmOWY4MjFhYzFlL3RhYmxlcmFuZ2U6Y2ZmNWVjMmQ1YjhkNGYzYWE3OGJjMGY5ZjgyMWFjMWVfMi03LTEtMS0zNjE1Njk_1929c4a2-cca0-467c-9662-eb1f18a0d767">415,994</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other&#8212;Ancillary services</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie63e40be1b8c44ae852031a36cc0c1d2_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmNmZjVlYzJkNWI4ZDRmM2FhNzhiYzBmOWY4MjFhYzFlL3RhYmxlcmFuZ2U6Y2ZmNWVjMmQ1YjhkNGYzYWE3OGJjMGY5ZjgyMWFjMWVfMy01LTEtMS0zNjE1Njk_410c8cd0-43f2-4af3-9e93-4914876bfd82">46,345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7870e39ec59457d85f40917f0be7b4b_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmNmZjVlYzJkNWI4ZDRmM2FhNzhiYzBmOWY4MjFhYzFlL3RhYmxlcmFuZ2U6Y2ZmNWVjMmQ1YjhkNGYzYWE3OGJjMGY5ZjgyMWFjMWVfMy03LTEtMS0zNjE1Njk_64508723-5038-4835-ade0-67304a97d4c6">35,915</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmNmZjVlYzJkNWI4ZDRmM2FhNzhiYzBmOWY4MjFhYzFlL3RhYmxlcmFuZ2U6Y2ZmNWVjMmQ1YjhkNGYzYWE3OGJjMGY5ZjgyMWFjMWVfNC01LTEtMS0zNjE1Njk_2bb87b46-aa4b-4fa5-b511-2d60104ff47c">409,391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmNmZjVlYzJkNWI4ZDRmM2FhNzhiYzBmOWY4MjFhYzFlL3RhYmxlcmFuZ2U6Y2ZmNWVjMmQ1YjhkNGYzYWE3OGJjMGY5ZjgyMWFjMWVfNC03LTEtMS0zNjE1Njk_31b79642-88aa-4b3d-8d6d-a528f17e0f64">451,909</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:700;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RleHRyZWdpb246NzMwNWFjNzUyNWI3NDk4OGJmNzFmODQ3Mzc1NDRlZDJfMTQ3Mw_27682729-b422-4058-9ac9-75e89566ed16" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of assets by reportable segment were as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.538%"><tr><td style="width:1.0%"></td><td style="width:58.542%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.581%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.583%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7093bff9492a45488822863f8f94a337_I20220930" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOjY4NjBmOTUyMDA4YTQ2NjBhYzVlN2U5OGFlNmZkOTQ1L3RhYmxlcmFuZ2U6Njg2MGY5NTIwMDhhNDY2MGFjNWU3ZTk4YWU2ZmQ5NDVfMS0xLTEtMS0zNjE1Njk_717b5cbd-fc53-42ee-95c7-72c0b00e2d8d">15,223,532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i698d58b2d3b2468cbb119fff40dd7a93_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOjY4NjBmOTUyMDA4YTQ2NjBhYzVlN2U5OGFlNmZkOTQ1L3RhYmxlcmFuZ2U6Njg2MGY5NTIwMDhhNDY2MGFjNWU3ZTk4YWU2ZmQ5NDVfMS0zLTEtMS0zNjE1Njk_cfb1b632-ae01-451e-bacc-bdc7c7bbbd02">15,375,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other&#8212;Ancillary services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d792edae43b4791856eea60df0b33b6_I20220930" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOjY4NjBmOTUyMDA4YTQ2NjBhYzVlN2U5OGFlNmZkOTQ1L3RhYmxlcmFuZ2U6Njg2MGY5NTIwMDhhNDY2MGFjNWU3ZTk4YWU2ZmQ5NDVfMi0xLTEtMS0zNjE1Njk_fe654f37-d7b3-422a-9fce-d9f2211d6729">1,738,267</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92fca4752e474a7bad54570de210ff8d_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOjY4NjBmOTUyMDA4YTQ2NjBhYzVlN2U5OGFlNmZkOTQ1L3RhYmxlcmFuZ2U6Njg2MGY5NTIwMDhhNDY2MGFjNWU3ZTk4YWU2ZmQ5NDVfMi0zLTEtMS0zNjE1Njk_36e0c437-9d5a-454b-bc90-233865d59b38">1,746,488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOjY4NjBmOTUyMDA4YTQ2NjBhYzVlN2U5OGFlNmZkOTQ1L3RhYmxlcmFuZ2U6Njg2MGY5NTIwMDhhNDY2MGFjNWU3ZTk4YWU2ZmQ5NDVfMy0xLTEtMS0zNjE1Njk_ed61ca57-bfa2-4849-9976-e5226ee6de18">16,961,799</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOjY4NjBmOTUyMDA4YTQ2NjBhYzVlN2U5OGFlNmZkOTQ1L3RhYmxlcmFuZ2U6Njg2MGY5NTIwMDhhNDY2MGFjNWU3ZTk4YWU2ZmQ5NDVfMy0zLTEtMS0zNjE1Njk_7049d100-8c73-4e3a-80df-84aa0a5f6bc6">17,121,488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i9311e9c566584bd9ab5dffbc9b9a605b_79"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83OS9mcmFnOjhlNDhiNDkxNDgwMjQxNmM5YjIyNDJiZWViMDA5YTMxL3RleHRyZWdpb246OGU0OGI0OTE0ODAyNDE2YzliMjI0MmJlZWIwMDlhMzFfMjA0OA_ea26976f-2fbc-4a67-8c32-ad50fa7161d4" continuedAt="i3af02316d1a44e18938addae5e5a12f3" escape="true">New accounting standards</ix:nonNumeric></span></div><ix:continuation id="i3af02316d1a44e18938addae5e5a12f3"><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New standards not yet adopted</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU No. 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ASU No. 2020-04 provides optional expedients and exceptions for applying U.S. generally accepted accounting principles to contract modifications and hedging relationships, subject to certain criteria, that reference LIBOR or another rate that is expected to be discontinued. The amendments in this ASU were effective beginning on March 12, 2020, and the Company may elect to apply the amendments prospectively through December 31, 2022. Effective January 1, 2022 certain LIBOR tenors that do not affect the Company, including the one-week and two-month U.S. dollar LIBOR rate, ceased or became non-representative. The remaining U.S. dollar LIBOR tenors will cease or become non-representative effective July 1, 2023. This change will have no impact on the Company's ability to borrow. The Company is currently assessing the other effects this guidance may have on its consolidated financial statements.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASU No. 2021-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations (Topic 805): Accounting for Acquired Contract Assets and Contract Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ASU 2021-08 requires application of ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to recognize and measure assets and liabilities from contracts with customers acquired in a business combination. This ASU creates an exception to the general recognition and measurement principle in ASC 805 and will result in recognition of contract assets and contract liabilities consistent with those recorded by the acquiree immediately before the acquisition date. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Early adoption is permitted for all entities. The Company does not expect the adoption of this standard to have a material impact on the Company's consolidated financial statements.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="i9311e9c566584bd9ab5dffbc9b9a605b_82"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</span></div><div id="i9311e9c566584bd9ab5dffbc9b9a605b_85"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward-looking statements</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q, including this Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations, contains statements that are forward-looking statements within the meaning of the federal securities laws and as such are intended to be covered by the safe harbor for "forward-looking statements" provided by the Private Securities Litigation Reform Act of 1995. These forward-looking statements could include, among other things, DaVita's response to and the expected future impacts of the coronavirus (COVID-19), including statements about our balance sheet and liquidity, our expenses and expense offsets, revenues, billings and collections, availability or cost of supplies, treatment volumes, mix expectation, such as the percentage or number of patients under commercial insurance, the availability, acceptance, impact, administration and efficacy of COVID-19 vaccines, treatments and therapies, the continuing impact on the U.S. and global economies, labor market conditions, and overall impact on our patients and teammates, as well as other statements regarding our future operations, financial condition and prospects, expenses, strategic initiatives, government and commercial payment rates, expectations related to value-based care, integrated kidney care and Medicare Advantage (MA) plan enrollment, and our ongoing stock repurchase program. All statements in this report, other than statements of historical fact, are forward-looking statements. Without limiting the foregoing, statements including the words "expect," "intend," "will," &#8220;could,&#8221; "plan," "anticipate," "believe" and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based on DaVita's current expectations and are based solely on information available as of the date of this report. DaVita undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of changed circumstances, new information, future events or otherwise, except as may be required by law. Actual future events and results could differ materially from any forward-looking statements due to numerous factors that involve substantial known and unknown risks and uncertainties. These risks and uncertainties include, among other things:</span></div><div style="margin-top:2pt;padding-left:22.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">the continuing impact of the dynamic and evolving COVID-19 pandemic, including, among other things, on our patients, teammates, physician partners, suppliers, business, operations, reputation, financial condition and results of operations; the government&#8217;s response to the COVID-19 pandemic, including, among other things, federal, state and local vaccine mandates or surveillance testing requirements and the extent to which they may ultimately be applicable to us; the pandemic's continuing impact on the U.S. and global economies, labor market conditions, interest rates, inflation and evolving monetary policies; the availability, acceptance, impact and efficacy of COVID-19 vaccines, treatments and therapies; further spread or resurgence of the virus, including as a result of the emergence of new strains of the virus; the continuing impact of the pandemic on our revenues and non-acquired growth due to lower treatment volumes; COVID-19's impact on the chronic kidney disease (CKD) population and our patient population including on the mortality of these patients, among other things; any potential negative impact on our commercial mix or the number of our patients covered by commercial insurance plans; continued increased COVID-19-related costs; our ability to successfully implement cost savings initiatives; supply chain challenges and disruptions; and elevated teammate turnover and training costs and higher salary and wage expense. including, among other things, increased contract wages, driven in part by persisting labor market conditions and a high demand for our clinical personnel, any of which may also have the effect of heightening many of the other risks and uncertainties discussed below, and in many cases, the impact of the pandemic and the aforementioned global economic conditions on our business may persist after the pandemic subsides; </span></div><div style="margin-top:2pt;padding-left:22.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">the extent to which the ongoing implementation of healthcare reform, or changes in or new legislation, regulations or guidance, enforcement thereof or related litigation result in a reduction in coverage or reimbursement rates for our services, a reduction in the number of patients enrolled in or that select higher-paying commercial plans, including for example Medicare Advantage plans; or other material impacts to our business or operations; or our making incorrect assumptions about how our patients will respond to any such developments;</span></div><div style="margin-top:2pt;padding-left:22.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">risks arising from potential changes in laws, regulations or requirements applicable to us, such as potential and proposed federal and/or state legislation, regulation, ballot, executive action or other initiatives, including, without limitation, those related to healthcare and/or labor matters, such as the Dialysis Clinic Requirements Initiative in California, which is scheduled to be voted on in November 2022 and AB 290 in California;</span></div><div style="margin-top:2pt;padding-left:22.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">the concentration of profits generated by higher-paying commercial payor plans for which there is continued downward pressure on average realized payment rates; a reduction in the number or percentage of our patients under such plans, including, without limitation, as a result of restrictions or prohibitions on the use and/or availability of charitable premium assistance, which may result in the loss of revenues or patients, or as a result of our making incorrect assumptions about how our patients will respond to any change in financial assistance from charitable organizations; as a result of payors' implementing restrictive plan designs, including, without limitation, actions taken in response to the U.S. Supreme Court&#8217;s decision in Marietta Memorial Hospital Employee Health Benefit Plan, et al. v. DaVita Inc. et al. (Marietta); how and whether regulators and legislators will respond to the Marietta decision including, without limitation, whether they will issue regulatory guidance or adopt new legislation; how courts will interpret other anti-discriminatory provisions that may apply to restrictive plan designs; whether there could be other potential negative impacts of the Marietta decision; and the timing of each of these items;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:2pt;padding-left:22.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">our ability to attract, retain and motivate teammates and our ability to manage operating cost increases or productivity decreases whether due to union organizing activities, legislative or other changes, demand for labor, volatility and uncertainty in the labor market, the current challenging and highly competitive labor market conditions, or other reasons;</span></div><div style="margin-top:2pt;padding-left:22.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">U.S. and global economic and marketplace conditions, interest rates, inflation, unemployment, labor market conditions, and evolving monetary policies, and our ability to respond to these changing conditions, including among other things our ability to successfully identify cost savings opportunities and to implement cost savings initiatives such as ongoing initiatives that increase our use of third party service providers to perform certain activities, initiatives that relate to clinic optimization and capacity utilization improvement, and procurement opportunities, among other things;</span></div><div style="margin-top:2pt;padding-left:22.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">our ability to successfully implement our strategies with respect to integrated kidney care and value-based care initiatives and home based dialysis in the desired time frame and in a complex, dynamic and highly regulated environment, including, among other things, maintaining our existing business; meeting growth expectations; recovering our investments; entering into agreements with payors, third party vendors and others on terms that are competitive and, as appropriate, prove actuarially sound; structuring operations, agreements and arrangements to comply with evolving rules and regulations; finding, training and retaining appropriate staff; and further developing our integrated care and other capabilities to provide competitive programs at scale; </span></div><div style="margin-top:2pt;padding-left:22.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">a reduction in government payment rates under the Medicare End Stage Renal Disease program, state Medicaid or other government-based programs and the impact of the Medicare Advantage benchmark structure;</span></div><div style="margin-top:2pt;padding-left:22.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">noncompliance by us or our business associates with any privacy or security laws or any security breach by us or a third party involving the misappropriation, loss or other unauthorized use or disclosure of confidential information;</span></div><div style="margin-top:2pt;padding-left:22.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">legal and compliance risks, such as our continued compliance with complex, and at times, evolving government regulations and requirements;</span></div><div style="margin-top:2pt;padding-left:22.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">the impact of the political environment and related developments on the current healthcare marketplace and on our business, including with respect to the Affordable Care Act, the exchanges and many other core aspects of the current healthcare marketplace, as well as the composition of the U.S. Supreme Court and the current presidential administration and congressional majority;</span></div><div style="margin-top:2pt;padding-left:22.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">changes in pharmaceutical practice patterns, reimbursement and payment policies and processes, or pharmaceutical pricing, including with respect to hypoxia inducible factors, among other things;</span></div><div style="margin-top:2pt;padding-left:22.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">our ability to develop and maintain relationships with physicians and hospitals, changing affiliation models for physicians, and the emergence of new models of care or other initiatives introduced by the government or private sector that, among other things, may erode our patient base and impact reimbursement rates;</span></div><div style="margin-top:2pt;padding-left:22.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">our ability to complete acquisitions, mergers, dispositions, joint ventures or other strategic transactions that we might announce or be considering, on terms favorable to us or at all, or to successfully integrate any acquired businesses, or to successfully operate any acquired businesses, joint ventures or other strategic transactions, or to successfully expand our operations and services in markets outside the United States, or to businesses or products outside of dialysis services;</span></div><div style="margin-top:2pt;padding-left:22.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">continued increased competition from dialysis providers and others, and other potential marketplace changes, including without limitation increased investment in and availability of funding to new entrants in the dialysis and pre-dialysis marketplace;</span></div><div style="margin-top:2pt;padding-left:22.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">the variability of our cash flows, including without limitation any extended billing or collections cycles; the risk that we may not be able to generate or access sufficient cash in the future to service our indebtedness or to fund our other liquidity needs; and the risk that we may not be able to refinance our indebtedness as it becomes due, on terms favorable to us or at all;</span></div><div style="margin-top:2pt;padding-left:22.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">factors that may impact our ability to repurchase stock under our stock repurchase program and the timing of any such stock repurchases, as well as our use of a considerable amount of available funds to repurchase stock;</span></div><div style="margin-top:2pt;padding-left:22.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">risks arising from the use of accounting estimates, judgments and interpretations in our financial statements;</span></div><div style="margin-top:2pt;padding-left:22.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">impairment of our goodwill, investments or other assets;</span></div><div style="margin-top:2pt;padding-left:22.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">our aspirations, goals and disclosures related to environmental, social and governance (ESG) matters, including, among other things, evolving regulatory requirements affecting ESG standards, measurements and reporting requirements; the availability of suppliers that can meet our sustainability standards; and our ability to recruit, develop and retain diverse talent in our labor markets; and</span></div><div style="margin-top:2pt;padding-left:22.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">the other risk factors, trends and uncertainties set forth in our Annual Report on Form 10-K for the year ended December&#160;31, 2021 (2021 10-K), our Quarterly Reports on Form 10-Q for the quarters ended March 31, 2022 and June 30, 2022 and this Quarterly Report on Form 10-Q, and the risks and uncertainties discussed in any subsequent reports that we file or furnish with the Securities and Exchange Commission (SEC) from time to time. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following should be read in conjunction with our condensed consolidated financial statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><div id="i9311e9c566584bd9ab5dffbc9b9a605b_88"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Company Overview</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal business is to provide dialysis and related lab services to patients in the United States, which we refer to as our U.S. dialysis business. We also operate our U.S. integrated kidney care (IKC) business, our U.S. other ancillary services, and our international operations, which we collectively refer to as our ancillary services, as well as our corporate administrative support. Our U.S. dialysis business is a leading provider of kidney dialysis services in the U.S. for patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD) or end stage kidney disease (ESKD).</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19, General Economic and Marketplace Conditions, and Legal and Regulatory Developments </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic continues to impact our business and operations. In addition, we continue to be impacted by general conditions in the global economy, including challenges with respect to supply chains, inflation, rising interest rates, labor market conditions and wage pressure, among other things. Certain of these impacts could be further intensified by concurrent global events such as COVID-19 lockdowns and protocols in portions of China or the ongoing conflict between Russia and Ukraine, the latter of which has continued to drive sociopolitical and economic uncertainty and volatility in Europe and across the globe. Legal and regulatory developments may also impact our business and operations, such as the June 2022 U.S. Supreme Court ruling related to the Medicare Secondary Payer Act (MSPA), as well as the commencement of price transparency regulation enforcement in July 2022.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operational and Financial Impacts</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter, treatment volumes continued to reflect the ongoing impact of COVID-19 on mortality rates, missed treatments and admissions of new dialysis patients, which, among other things, has had a negative impact on our patient census. While the mortality rates associated with the Omicron and subvariants surges in 2022 preliminarily appear to be lower than in prior surges, the magnitude of the COVID-19 case increases has resulted in an increased level of excess patient mortalities, that we expect to persist into 2023, the magnitude of which will depend on the severity of any future COVID-19 surges, among other things. The decline in patient admissions and elevated rates of missed treatments related to the Omicron and subvariant surge earlier this year have persisted through the third quarter as the surge has subsided. There is significant uncertainty, and these volume trends may continue through 2023. In addition, we expect that the impact of COVID-19 is likely to continue to negatively impact our revenue and non-acquired growth for a period of time even as the pandemic subsides due to the compounding impact of mortalities, among other things. Depending on the ultimate severity and duration of the pandemic, the magnitude of these cumulative impacts could have a material adverse impact on our results of operations, financial condition and cash flows.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our continued focus on the health, safety and well-being of our patients, teammates and physician partners, we have continued to dedicate substantial resources in response to COVID-19, including the implementation of additional protocols and initiatives to help safely maintain continuity of care for our patients and help protect our caregivers. We continue to implement dedicated care shifts for patients with confirmed or suspected COVID-19 and other enhanced clinical practices, including procuring additional equipment and clinical supplies, such as personal protective equipment (PPE). </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of 2022, COVID-19 has continued to strain staffing in an already challenging labor market. Additionally, as a result of these ongoing COVID-19-related clinical measures, in combination with general labor, supply chain and inflationary pressures, we have incurred higher incentive pay, increased utilization of contract labor, and inefficient productivity. In addition, during 2022, we have experienced and expect to continue to experience increased labor costs due to higher wage rates and increased investment in training expenses, and elevated levels of contract labor utilization. The cumulative impact of the foregoing will continue to put additional pressure on our cost structure, some of which is expected to abate with the decline of the impact of COVID-19. Potential staffing shortages or disruptions, if material, could ultimately lead to the unplanned closures of certain centers or adversely impact clinical operations, and may otherwise have a material adverse impact on our ability to provide dialysis services or the cost of providing those services, among other things. Prolonged volatility, uncertainty, labor supply shortages and other challenging labor market conditions, including, among other things, due to inflationary pressures or evolving monetary policies, each of which may be independent of the COVID-19 pandemic, could also have an adverse impact on our growth and ability to execute on our other strategic initiatives and a material adverse impact on our labor costs. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These inflationary pressures and evolving monetary policies, as well as ongoing global supply chain challenges, also have more broadly impacted our supply and other costs, and may continue to drive certain increased expenses, including, among other things, with respect to medical and other supplies and interest expense. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to implement cost savings opportunities to help mitigate these cost and volume pressures. These include, among other things, anticipated cost savings related to G&amp;A efficiencies, such as ongoing initiatives that increase our use of </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">third party service providers to perform certain activities; initiatives relating to clinic optimization and initiatives for capacity utilization improvement; and procurement opportunities. We have incurred, and expect to continue to incur charges in connection with the continued implementation of these initiatives, and there can be no assurance that we will be able to successfully execute these initiatives or that they will achieve expectations or succeed in helping offset the impact of these challenging conditions. Any failure on our part to adjust our business and operations in this manner, to adjust to other marketplace developments or dynamics or to appropriately implement these initiatives in accordance with applicable legal, regulatory or compliance requirements could impact our ability to provide dialysis services or the cost of providing those services, among other things, and ultimately could have a material adverse effect on our business, reputation, results of operations, financial condition and cash flows. Our COVID-19 response has reduced certain expenses though it remains uncertain how much of these reductions, if any, will persist as pandemic protocols continue to change over time. </span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Federal, State and Local Government COVID-19 Response</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal COVID-19 relief legislation suspended the 2% Medicare sequestration from May 1, 2020 through December 31, 2021. The Protecting Medicare and American Farmers from Sequester Cuts Act, signed into law on December 10, 2021, extended the suspension of the 2% Medicare sequestration from December 31, 2021 through March 31, 2022, with 1% Medicare sequestration in effect from April 1, 2022 through June 30, 2022 and 2% Medicare sequestration in effect beginning July 1, 2022. While in effect, the suspension of sequestration significantly increased our revenues.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the ultimate impact of the COVID-19 public health crisis on the Company will depend on future developments that are highly uncertain and difficult to predict, including among others the ultimate severity and duration of the pandemic; further spread or resurgence of the virus, including as a result of the emergence of new strains of the virus; COVID-19's impact on the chronic kidney disease (CKD) patient population and our patient population, including on the growth rate of these populations and mortality of these patients; the availability, acceptance, impact and efficacy of COVID-19 vaccines, treatments and therapies; the pandemic&#8217;s continuing impact on our revenue and non-acquired growth due to lower treatment volumes, the U.S. and global economies, labor market conditions, interest rates, inflation and evolving monetary policies; our ability to successfully implement cost-savings initiatives; the potential negative impact on our commercial mix or the number of patients covered by commercial insurance plans; continued increased COVID-19-related costs; supply chain challenges and disruptions; the responses of our competitors to the pandemic and related changes in the marketplace; the timing, scope and effectiveness of federal, state and local government responses to the continuing pandemic; and any potential changes to the extensive set of federal, state and local laws, regulations and requirements that govern our business. In many cases, the impact of the pandemic and the aforementioned global economic and marketplace conditions on our business may persist after the pandemic subsidies. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional discussion of the COVID-19 pandemic and our response, including its impact on us and related risks and uncertainties, please see the discussion in Part I Item 1. Business of the 2021 10-K under the headings, "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">COVID-19 and its impact on our business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" and "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Human Capital Management,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" as well as the risk factor in Part I Item 1A. Risk Factors of the 2021 10-K under the heading "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We face various risks related to the dynamic and evolving novel coronavirus pandemic, many of which may have a material adverse impact on us.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"</span></div><div id="i9311e9c566584bd9ab5dffbc9b9a605b_91"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Results</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discussion below includes analysis of our financial condition and results of operations for the three months ended September&#160;30, 2022 compared to the three months ended June&#160;30, 2022, and the year to date periods for nine months ended September&#160;30, 2022 compared to the nine months ended September&#160;30, 2021. The SEC amended its guidance on Management's Discussion and Analysis of Financial Condition and Results of Operations to permit companies to compare their most recently completed quarter to either the corresponding quarter of the prior year or to the immediately preceding sequential quarter to allow for flexibility in comparison of interim periods reported to help companies provide a more tailored and meaningful analysis relevant to their business cycles. Beginning with the first quarter of 2022, our Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations present our results of operations for the most recently completed fiscal year to date period compared to the corresponding year to date period of the prior year, as well as the most recently completed quarter compared to the immediately preceding sequential quarter, and otherwise exclude comparisons of the most recently completed quarter to the corresponding quarter of the prior year.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated results of operations</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize our revenues and operating income by line of business. See the discussion of our results for each line of business following the tables. When multiple drivers are identified in the following discussion of results, they are listed in order of magnitude:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q3 2022 vs. Q2 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30, <br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">June 30, <br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,703&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,663&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other &#8212; Ancillary services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elimination of intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consolidated revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,949&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,927&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income (loss):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other &#8212; Ancillary services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate administrative support</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(121)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted operating income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other &#8212; Ancillary services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate administrative support</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns, rows or percentages may not sum due to the presentation of rounded numbers.</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For a reconciliation of adjusted operating income by reportable segment, see "Reconciliations of Non-GAAP measures" section below.</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">YTD Q3 2022 vs. YTD Q3 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30, <br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30, <br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,942&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,964&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other &#8212; Ancillary services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">816&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elimination of intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total consolidated revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,693&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,675&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income (loss):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,524&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(293)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other &#8212; Ancillary services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate administrative support</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,083&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(325)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted operating income (loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,536&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(255)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other &#8212; Ancillary services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate administrative support</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,133&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,420&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(287)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns, rows or percentages may not sum due to the presentation of rounded numbers.</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For a reconciliation of adjusted operating income by reportable segment, see "Reconciliations of Non-GAAP measures" section below.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><div id="i9311e9c566584bd9ab5dffbc9b9a605b_94"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">U.S. dialysis results of operations </span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Treatment Volume:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.520%"><tr><td style="width:1.0%"></td><td style="width:47.941%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.598%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.598%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.598%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.045%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q3 2022 vs. Q2 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30, <br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">June 30, <br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dialysis treatments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,335,825&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,269,160&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,665&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average treatments per day</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,859&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(335)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treatment days</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Normalized non-acquired treatment growth</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:6pt;text-align:center;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns, rows or percentages may not sum due to the presentation of rounded numbers.</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Normalized non-acquired treatment growth reflects year over year growth in treatment volume, adjusted to exclude acquisitions and other similar transactions, and further adjusted to normalize for the number and mix of treatment days in a given quarter versus the prior year quarter.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.520%"><tr><td style="width:1.0%"></td><td style="width:47.941%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.598%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.598%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.598%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.045%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">YTD Q3 2022 vs. YTD Q3 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30, <br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30, <br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dialysis treatments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,714,773&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,166,628&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(451,855)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average treatments per day</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,798&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,931)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treatment days</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns, rows or percentages may not sum due to the presentation of rounded numbers.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. dialysis treatment volume is directly correlated with our operating revenues and expenses. The increase in our U.S. dialysis treatments for the third quarter of 2022 from the second quarter of 2022 was primarily driven by one additional treatment day, partially offset by fewer average treatments per day due to increased mortality and higher missed</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">treatment rates.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in our U.S. dialysis treatments for the nine months ended September&#160;30, 2022 from the nine months ended September&#160;30, 2021 was primarily driven by the impact of increased mortality over recent periods on our patient population, slightly offset by acquisition related growth. We believe the increased mortality is largely attributable to the impact of COVID-19 on our patient population.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.520%"><tr><td style="width:1.0%"></td><td style="width:47.941%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.598%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.598%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.598%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.045%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q3 2022 vs. Q2 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30, <br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">June 30, <br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions, except per treatment data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,703&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,663&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average patient service revenue per treatment</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367.67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365.54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns, rows or percentages may not sum due to the presentation of rounded numbers.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.520%"><tr><td style="width:1.0%"></td><td style="width:47.941%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.598%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.598%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.598%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.045%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">YTD Q3 2022 vs. YTD Q3 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30, <br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30, <br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions, except per treatment data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,942&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,964&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average patient service revenue per treatment</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364.89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358.42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns, rows or percentages may not sum due to the presentation of rounded numbers.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. dialysis average patient service revenue per treatment for the third quarter of 2022 compared to the second quarter of 2022 increased, primarily due to normal revenue fluctuations in the third quarter, increased hospital inpatient dialysis revenues and continued migration to Medicare Advantage plans. Our U.S. dialysis average patient service revenue per treatment was negatively impacted by unfavorable changes in government rates due to the reinstatement of 2% Medicare sequestration as of July 1, 2022, as well as a decrease in commercial mix.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. dialysis average patient service revenue per treatment for the nine months ended September&#160;30, 2022 increased compared to the nine months ended September&#160;30, 2021 primarily driven by an increase in commercial mix and rate, an increase in the Medicare base rate in 2022, and the continued shift to Medicare Advantage plans, partially offset by the reinstatement of 1% Medicare sequestration in each of the second and third quarters of 2022.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, CMS issued a proposed rule to update the Medicare ESRD Prospective Payment System payment rate and policies. Among other things, the proposed rule would update the Acute Kidney Injury dialysis payment rate for renal dialysis services furnished by ESRD facilities and requirements for the ESRD Quality Incentive Program, as well as refine the ESRD Treatment Choices Model. CMS estimates that the overall impact of the proposed rule will increase ESRD facilities&#8217; average reimbursement by 3.1% in 2023.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating expenses:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.520%"><tr><td style="width:1.0%"></td><td style="width:47.941%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.598%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.598%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.598%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.045%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q3 2022 vs. Q2 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30, <br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">June 30, <br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions, except per treatment data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patient care costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,877&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,796&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses and charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,352&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,190&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patient care costs per treatment</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255.86&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247.14&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.72&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns, rows or percentages may not sum or recalculate due to the presentation of rounded numbers.</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">General and administrative expenses for the three months ended September&#160;30, 2022 and June&#160;30, 2022 include advocacy costs of approximately $28 million and $23 million, respectively, to counter union policy efforts, including a California statewide ballot initiative (CA Proposition 29) that is scheduled to be voted on in November. </span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.520%"><tr><td style="width:1.0%"></td><td style="width:47.941%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.598%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.598%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.040%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.598%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.045%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">YTD Q3 2022 vs. YTD Q3 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30, <br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions, except per treatment data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patient care costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,469&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,303&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">684&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses and charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,711&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,441&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patient care costs per treatment</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251.88&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239.24&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.64&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns, rows or percentages may not sum or recalculate due to the presentation of rounded numbers.</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">General and administrative expenses for the nine months ended September&#160;30, 2022 includes advocacy costs of approximately $51 million to counter union policy efforts, including CA Proposition 29. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Charges impacting operating income - closure costs.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> During the third quarter of 2022, we incurred higher than normal charges for center capacity closures. These closures are the result of a strategic review of our outpatient clinic capacity requirements and utilization, which have been impacted both by declines in our patient census in some markets due to the COVID-19 pandemic, as well as by our initiatives toward, and advances in, increasing the proportion of our home dialysis patients.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our third quarter charges for U.S. dialysis center closures were approximately $40 million, which increased our patient care costs by $7 million, our general and administrative expenses by $12 million and our depreciation and amortization expense by $21 million. These capacity closures costs included net losses on assets retired, lease costs, asset impairments and accelerated depreciation and amortization.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will continue to optimize our U.S. dialysis center footprint through center mergers and/or closures and expect our center closure rates to remain at elevated levels over the next several quarters.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Patient care costs.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> U.S. dialysis patient care costs per treatment for the third quarter of 2022 increased from the second quarter of 2022 primarily due to increased compensation expenses from higher wage rates and training costs due to an increase in hiring. Other drivers of the increase include increases in health benefit expenses, medical supply costs, other direct operating expenses associated with our dialysis centers, costs related to travel, professional fees and center closure costs, as described above. These increases were partially offset by decreases in insurance expense and pharmaceutical costs.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. dialysis patient care costs per treatment for the nine months ended September&#160;30, 2022 increased from the nine months ended September&#160;30, 2021 primarily due to increased compensation expenses including increased wage rates and contract wages. Other drivers of the increase include increases in other direct operating expenses associated with our dialysis centers, including increases in utilities expense partially due to lower expense in the first half of 2021 related to our virtual power purchase arrangements, as well as increases in insurance expenses, center closure costs, as described above, and costs related to travel. In addition, our fixed other direct operating expenses negatively impacted patient care costs per treatment due to decreased treatments in 2022. These increases were partially offset by decreased pharmaceutical costs, health benefit expenses, and professional fees.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and administrative expenses. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. dialysis general and administrative expenses in the third quarter of 2022 increased from the second quarter of 2022 primarily due to gains recognized in the second quarter of 2022 on the sale of our self-developed properties, closure costs, as described above, and increased compensation expense including increased wage rates, and contract wages due to the deployment of IT projects. Other drivers of the change include increased professional fees and costs related to travel.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. dialysis general and administrative expenses for the nine months ended September&#160;30, 2022 increased from the nine months ended September&#160;30, 2021 primarily due to increases in advocacy costs to counter union policy efforts, compensation expenses including increased wage rates, travel costs and center closure costs, as described above. This increase in U.S. dialysis general and administrative expenses was partially offset by gains on sale, as described above, decreases in professional fees and contributions to our charitable foundation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Depreciation and amortization. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. dialysis depreciation and amortization expenses for the quarter ended September&#160;30, 2022 increased compared to the quarter ended June&#160;30, 2022 primarily due to accelerated depreciation related to expected center closures, as well as a full quarter of depreciation from the rollout of our new clinical system in May 2022.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. dialysis depreciation and amortization expenses for the nine months ended September&#160;30, 2022 compared to the nine months ended September&#160;30, 2021 increased primarily due to increased depreciation and amortization for hardware associated with our new clinical system and other corporate technology projects, as well as accelerated depreciation for expected center closures and the development of new centers.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity investment income. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. dialysis equity investment income remained relatively flat for the third quarter of 2022 compared to the second quarter of 2022. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. dialysis equity investment income decreased from the nine months ended September&#160;30, 2022 compared to the nine months ended September&#160;30, 2021, primarily due to a decline in profitability at certain joint ventures.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating income and adjusted operating income:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.122%"><tr><td style="width:1.0%"></td><td style="width:35.191%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.890%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.786%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.890%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.890%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.893%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q3 2022 vs. Q2 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30, <br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">June 30, <br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:3pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For a reconciliation of adjusted operating income by reportable segment, see "Reconciliations of Non-GAAP measures" section below.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.538%"><tr><td style="width:1.0%"></td><td style="width:34.685%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.009%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.009%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.191%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.009%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.191%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.012%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">YTD Q3 2022 vs. YTD Q3 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30, <br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,231&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,524&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(293)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,281&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,536&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(255)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:3pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:45pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For a reconciliation of adjusted operating income by reportable segment, see "Reconciliations of Non-GAAP measures" section below.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. dialysis operating income for the third quarter of 2022 compared to the second quarter of 2022 and for the nine months ended September&#160;30, 2022 compared to the nine months ended September&#160;30, 2021, was negatively impacted by closure costs, as described above.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. dialysis operating income and adjusted operating income for the third quarter of 2022 decreased from the second quarter of 2022 primarily due to increased compensation expenses, gains on sale of self developed properties recognized in the second quarter, and increases in professional fees, costs related to travel and other medical supply costs, each described above. Operating income was positively impacted by an increase in our average patient service revenue per treatment and increased dialysis treatments.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. dialysis operating income and adjusted operating income for the nine months ended September&#160;30, 2022 decreased from the nine months ended September&#160;30, 2021 primarily due to a decrease in dialysis treatments and increases in compensation expenses, advocacy costs, other direct operating expenses associated with our dialysis centers, costs related to travel and depreciation expense related to IT projects, each described above, as well as insurance expense. Operating income was positively impacted by an increase in our average patient service revenue per treatment as described above, as well as decreases in pharmaceutical unit costs, gains on sale of our self-developed properties, as described above, and decreases in professional fees and medical supply costs.</span></div><div id="i9311e9c566584bd9ab5dffbc9b9a605b_97"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other&#8212;Ancillary services</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our other operations include ancillary services that are primarily aligned with our core business of providing dialysis services to our network of patients. As of September&#160;30, 2022, these consisted principally of our U.S. integrated kidney care (IKC) business, certain U.S. other ancillary businesses (including our clinical research programs, transplant software business, and venture investment group), and our international operations. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These ancillary services generated revenues of approximately $268 million and $816 million in the third quarter of 2022 and nine months ended September 30, 2022, respectively, representing approximately 9% of our consolidated revenues in both periods. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our growth strategy, we have invested, and expect to continue to invest, significant resources in the further development of our integrated care business and value-based care initiatives. There can be no assurances that we will be able to successfully implement our strategies with respect to value-based care and integrated kidney care in the desired time frame and in a complex, dynamic and highly regulated environment, and we face risks including, among other things, those related to maintaining our existing business, recovering our investments, entering into agreements with payors, physicians, third party vendors and others on terms that are competitive, and as appropriate, that prove actuarially sound; structuring these agreements and arrangements to comply with evolving rules and regulations, including, among other things, rules and regulations related to the use of protected health information; and further developing our operational, IT and other capabilities to enable us to provide competitive programs at scale. If our value-based care and integrated kidney care programs are unsuccessful, it could result in a loss of our investments and have a material adverse effect on our growth strategy, and could have an adverse impact on our business, results of operations, financial condition and cash flows. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, if any of our other ancillary services, such as our international operations, are unsuccessful, this could have a negative impact on our business, results of operations, financial condition and cash flows, and we may determine to exit that line of business, which could result in significant termination costs or loss of investment. In addition, we have in the past and may in the future incur material restructuring, write-off or impairment charges on our investment in one or more of these ancillary services, including goodwill.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to add additional service offerings or product lines to our business and to pursue new business opportunities. While these opportunities could include, among other things, healthcare services not related to dialysis, we have focused our ongoing efforts on opportunities with strong strategic links to kidney care, dialysis or integrated dialysis kidney care. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, our international dialysis operations provided dialysis and administrative services through a total of 352 outpatient dialysis centers located in 11 countries outside of the United States. </span></div><div style="margin-top:9pt;padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Ancillary services results of operations</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.444%"><tr><td style="width:1.0%"></td><td style="width:49.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q3 2022 vs. Q2 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30, <br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">June 30, <br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integrated kidney care</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other U.S. ancillary</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total ancillary services revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating (loss) income:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integrated kidney care</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other U.S. ancillary</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total ancillary services operating loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns, rows or percentages may not sum due to the presentation of rounded numbers.</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The reported operating income for the three months ended September&#160;30, 2022 and June&#160;30, 2022 includes foreign currency gains embedded in equity method income recognized from our APAC JV of approximately $2.3 million and $2.1 million, respectively.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.444%"><tr><td style="width:1.0%"></td><td style="width:49.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.664%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">YTD Q3 2022 vs. YTD Q3 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30, <br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integrated kidney care</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other U.S. ancillary</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total ancillary services revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">816&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">785&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating (loss) income:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integrated kidney care</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other U.S. ancillary</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total ancillary services operating loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns, rows or percentages may not sum due to the presentation of rounded numbers.</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The reported operating income for the nine months ended September&#160;30, 2022 and September&#160;30, 2021 includes foreign currency gains embedded in equity method income recognized from our APAC JV of approximately $4.7 million and $4.4 million, respectively.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues:</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IKC revenues for the third quarter of 2022 decreased compared to the second quarter of 2022 due to a net decrease in shared savings as well as a decrease in revenues from our special needs plans. Other U.S. ancillary revenues for the third quarter of 2022 compared to the second quarter of 2022 increased due to an increase in revenue from our clinical research programs. International revenues for the third quarter of 2022 remained flat from the second quarter of 2022.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IKC revenues for the nine months ended September&#160;30, 2022 increased compared to the nine months ended September&#160;30, 2021 due to an increase in shared savings, including savings from new programs. Other U.S. ancillary services revenues for the nine months ended September&#160;30, 2022 increased compared to the nine months ended September&#160;30, 2021 due </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to revenues from our newly acquired transplant software business, offset by decreased revenues in our clinical research programs. Our international revenues for the nine months ended September&#160;30, 2022 increased from the nine months ended September&#160;30, 2021 primarily due to acquisition-related growth.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating loss:</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IKC operating loss for the third quarter of 2022 compared to the second quarter of 2022 increased due to the decrease in shared savings and decrease in revenues from our special needs plans. Other U.S. ancillary services operating loss for the third quarter of 2022 remained relatively flat compared to the second quarter of 2022, driven by the increase in revenue from our clinical research programs, partially offset by a benefit received from run-off of a legacy business in the second quarter. International operating income for the third quarter of 2022 increased from the second quarter of 2022 primarily due to the divestiture of one of our international businesses in the second quarter.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IKC operating loss for the nine months ended September&#160;30, 2022 compared to the nine months ended September&#160;30, 2021 increased primarily due to continued investments in our integrated care support functions, partially offset by an increase in shared savings. Other U.S. ancillary services operating loss for the nine months ended September&#160;30, 2022 compared to the nine months ended September&#160;30, 2021 increased primarily due to a benefit received from run-off of a legacy business in the prior year and decreased revenues in our clinical research programs. International operating income for the nine months ended September&#160;30, 2022 increased compared to the nine months ended September&#160;30, 2021 primarily driven by acquisition-related growth, partially offset by the impact of increased mortality over recent periods on our patient population.</span></div><div id="i9311e9c566584bd9ab5dffbc9b9a605b_100"></div><div style="margin-top:9pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate administrative support</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:43.914%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.096%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.096%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.096%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.099%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q3 2022 vs. Q2 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate administrative support</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:43.914%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.096%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.096%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.096%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.099%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">YTD Q3 2022 vs. YTD Q3 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate administrative support</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate administrative support expenses for the quarter ended September&#160;30, 2022 compared to the quarter ended June&#160;30, 2022 decreased primarily due to decreases in legal fees. Corporate administrative support expenses for the nine months ended September&#160;30, 2022 compared to the nine months ended September&#160;30, 2021 increased primarily due to an increase in legal fees.</span></div><div id="i9311e9c566584bd9ab5dffbc9b9a605b_103"></div><div style="margin-top:9pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate-level charges</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:43.914%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.096%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.096%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.096%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.099%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Q3 2022 vs. Q2 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30, <br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (loss) income, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(400.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate attributable to DaVita Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For a reconciliation of our effective income tax rate attributable to DaVita Inc., see "Reconciliations of Non-GAAP measures" section below.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:43.914%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.096%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.096%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.096%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.099%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">YTD Q3 2022 vs. YTD Q3 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30, <br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30, <br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (loss) income, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate attributable to DaVita Inc.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For a reconciliation of our effective income tax rate attributable to DaVita Inc., see "Reconciliations of Non-GAAP measures" section below.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt expense</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt expense for the third quarter of 2022 compared to the second quarter of 2022 and the nine months ended September&#160;30, 2022 compared to the nine months ended September&#160;30, 2021 increased primarily due to an increase in our weighted average effective interest rate and weighted average outstanding credit facility balance, which included draws on our revolving line of credit in the first nine months of 2022.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our overall weighted average effective interest rate for the three months ended September&#160;30, 2022 was 4.28% compared to 3.68% for the three months ended June&#160;30, 2022. See Note 6 to the condensed consolidated financial statements for further information on the components of our debt.</span></div><div style="margin-top:9pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other (loss) income, net</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other loss increased for the third quarter of 2022 from the second quarter of 2022, primarily driven by an increase in losses on investments. Other loss for the nine months ended September 30, 2022 compared to other income for the nine months ended September 30, 2021 was driven by losses on investments in 2022 compared to gains on investments in 2021, as well as losses on foreign currency transactions in 2022 compared to gains on foreign currency transactions in 2021, partially offset by an increase in interest income.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Effective income tax rate</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective income tax rate and the effective tax rate attributable to DaVita Inc. increased for the third quarter of 2022 compared to the second quarter of 2022 primarily due to tax benefits in the second quarter from both stock-based compensation and a partial settlement reached with federal tax authorities for fiscal years 2014-2015.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective income tax rate for the nine months ended September&#160;30, 2022 compared to the nine months ended September&#160;30, 2021 was relatively flat. The effective tax rate attributable to DaVita Inc. for the nine months ended September&#160;30, 2022 increased from the nine months ended September&#160;30, 2021 primarily due to an increase in forecasted non-deductible advocacy spend in 2022 and a year over year decrease in the tax benefits from stock-based compensation.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net income attributable to noncontrolling interests</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in net income attributable to noncontrolling interests for the third quarter of 2022 from the second quarter of 2022 and for the nine months ended September&#160;30, 2022 from the nine months ended September&#160;30, 2021 was due to reduced earnings at certain U.S. dialysis partnerships.</span></div><div id="i9311e9c566584bd9ab5dffbc9b9a605b_106"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accounts receivable</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated accounts receivable balances at September&#160;30, 2022 and December&#160;31, 2021 were $2.089 billion and $1.958 billion, respectively, representing approximately 66 and 62 days of revenue outstanding (DSO), respectively. Consolidated DSO increased primarily due to temporary billing holds and timing of collections. Our DSO calculation is based on the current quarter&#8217;s average revenues per day. There were no significant changes from the second quarter of 2022 to the third quarter of 2022 in the carrying amount of accounts receivable outstanding over one year old.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><div id="i9311e9c566584bd9ab5dffbc9b9a605b_109"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and capital resources</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the summary of our major sources and uses of cash, cash equivalents and restricted cash:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.431%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">YTD Q3 2022 vs. YTD Q3 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions and shares in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">655&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">962&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(307)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash items in net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other working capital changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(183)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(117.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,221&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,401&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(180)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash used in investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Routine maintenance/information technology/other</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(284)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(289)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development and relocations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition expenditures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of self-developed properties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,283.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(417)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(448)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:5pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash used in financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt issuances, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">791&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(642)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(189)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(177)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contributions from noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock award exercises and other share issuances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(802)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(882)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(890)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(309)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(581)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total number of shares repurchased</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,095&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Free cash flow</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns or rows may not sum due to the presentation of rounded numbers.</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For a reconciliation of our free cash flow, see "Reconciliations of Non-GAAP measures" section below.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated cash flows</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated cash flows from operating activities during the nine months ended September&#160;30, 2022 decreased compared to the nine months ended September&#160;30, 2021 primarily due to a decrease in operating results, timing of income tax payments partially offset by changes in total DSO, which increased approximately four days for the nine months ended September 30, 2022 compared to an increase of five days for the nine months ended September 30, 2021 as well as by changes in other working capital items.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Free cash flow during the nine months ended September&#160;30, 2022 decreased from the nine months ended September&#160;30, 2021 primarily due to a decrease in net cash provided by operating activities partially offset by an increase in proceeds on self-developed properties. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant sources of cash from financing activities included a net draw of $275 million on our revolving line of credit in the nine months ended September&#160;30, 2022. Significant uses of cash during the period included net debt payments which consisted of regularly scheduled mandatory principal payments under our senior secured credit facilities totaling approximately $66 million on Term Loan A and $21 million on Term Loan B-1, as well as additional required payments under other debt </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">arrangements. In addition, during the nine months ended September&#160;30, 2022 we used cash to repurchase 8,094,661 shares of our common stock.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By comparison, the same period in 2021 included the issuance of $1.0 billion in aggregate principal amount of senior notes as an add-on offering to our 4.625% senior notes due 2030 which were issued at an offering price of 101.750% of the principal amount in February 2021. Other net debt payments during the nine months ended September&#160;30, 2021 primarily consisted of the repayment in full of $75 million of borrowings under our revolving line of credit, net payments of regularly scheduled mandatory principal amounts due under our senior secured credit facilities totaling approximately $66 million on Term Loan A and $21 million on Term Loan B-1 and additional required payments under other debt arrangements. In addition, we incurred bond issuance costs of approximately $9 million in cash. For the nine months ended September&#160;30, 2021 we also used cash to repurchase 7,749,637 shares of our common stock.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dialysis center footprint and growth </span></div><div style="margin-top:9pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below shows the growth in our dialysis operations by number of dialysis centers owned or operated:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.689%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">International</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended<br/>September 30,</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended <br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended<br/>September 30,</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of centers operated at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,828&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,815&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,816&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired centers</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed centers</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in non-owned managed or</span></div><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;administered centers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sold and closed centers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Closed centers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of centers operated at end of period</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,776&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,822&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,776&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,822&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents dialysis centers which we manage or provide administrative services to but in which we own a noncontrolling equity interest or which are wholly-owned by third parties, including our APAC JV centers. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents dialysis centers that were sold and/or closed for which the majority of patients were not retained.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents dialysis centers that were closed for which the majority of patients were retained and transferred to one of our other existing outpatient dialysis centers.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock repurchases </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our common stock repurchases during the three and nine months ended September&#160;30, 2022 and 2021: </span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.725%"><tr><td style="width:1.0%"></td><td style="width:37.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.515%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.515%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.747%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.515%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.753%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Open market repurchases:</span></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions and shares in thousands, except for per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,731&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,095&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount paid</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">788&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">899&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average paid per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See further discussion of our stock repurchases in Note 8 to the condensed consolidated financial statements.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Available liquidity</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, we had $725 million available and $275 million drawn on our $1.0 billion revolving line of credit under our senior secured credit facilities. Credit available under this revolving line of credit is reduced by the amount of any letters of credit outstanding thereunder, of which there were none as of September&#160;30, 2022. We separately had approximately $108 million in letters of credit outstanding under a separate bilateral secured letter of credit facility.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 6 to the condensed consolidated financial statements for components of our long-term debt and their interest rates. We may from time to time seek to obtain funds or refinance existing debt through additional debt financings or other capital alternatives.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic, efforts to prevent its spread, and other government actions intended to support those efforts have dramatically impacted global economic activity and driven increased volatility in the financial markets. We are also impacted by general conditions in the global economy, such as challenges with respect to supply chains, inflation and wage pressure, as well as rising interest rates. We have maintained business process continuity during the COVID-19 pandemic, and as of the date of this report, we have not experienced material deterioration in our liquidity position as a result of the COVID-19 crisis or other developments in the general global economy. The ultimate impact of the pandemic and resultant global economic conditions will depend on future developments that remain highly uncertain and difficult to predict.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our cash flow from operations and other sources of liquidity, including from amounts available under our senior secured credit facilities and our access to the capital markets, will be sufficient to fund our scheduled debt service under the terms of our debt agreements and other obligations for the foreseeable future, including the next 12 months. Our primary recurrent sources of liquidity are cash from operations and cash from borrowings, which are subject to general, economic, financial, competitive, regulatory and other factors that are beyond our control, as described in Item 1A Risk Factors of our 2021 10-K</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span></div><div id="i9311e9c566584bd9ab5dffbc9b9a605b_112"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reconciliations of non-GAAP measures</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide reconciliations of adjusted operating income (loss) to operating income (loss) as presented on a U.S. generally accepted accounting principles (GAAP) basis for our U.S. dialysis reportable segment as well as for our U.S. IKC business, our U.S. other ancillary services, our international business, and for our total ancillary services which combines them and is disclosed as our other segments category. These non-GAAP or &#8220;adjusted&#8221; measures are presented because management believes these measures are useful adjuncts to, but not alternatives for, our GAAP results. Note that the non-GAAP measures presented for prior periods below have been conformed to the non-GAAP measures presented for the current period.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Specifically, management uses adjusted operating income (loss) to compare and evaluate our performance period over period and relative to competitors, to analyze the underlying trends in our business, to establish operational budgets and forecasts and for incentive compensation purposes. We believe this non-GAAP measure is also useful to investors and analysts in evaluating our performance over time and relative to competitors, as well as in analyzing the underlying trends in our business. We also believe this presentation enhances a user's understanding of our normal operating income by excluding certain items which we do not believe are indicative of our ordinary results of operations.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our effective income tax rate on income attributable to DaVita Inc. excludes noncontrolling owners' income, which primarily relates to non-tax paying entities. We believe this adjusted effective income tax rate is useful to management, investors and analysts in evaluating our performance and establishing expectations for income taxes incurred on our ordinary results attributable to DaVita Inc.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, our free cash flow represents net cash provided by operating activities less distributions to noncontrolling interests and all capital expenditures (including development capital expenditures, routine maintenance and information technology), plus contributions from noncontrolling interests and proceeds from the sale of self-developed properties. Management uses this measure to assess our ability to fund acquisitions and meet our debt service obligations and we believe this measure is equally useful to investors and analysts as an adjunct to cash flows from operating activities and other measures under GAAP.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is important to bear in mind that these non-GAAP &#8220;adjusted&#8221; measures are not measures of financial performance under GAAP and should not be considered in isolation from, nor as substitutes for, their most comparable GAAP measures.</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.119%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended September 30, 2022</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Corporate administration</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. IKC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="39" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Center closure charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns or rows may not sum or recalculate due to the presentation of rounded numbers.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.119%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended June 30, 2022</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Corporate administration</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. IKC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="39" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Center closure charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">479&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns or rows may not sum or recalculate due to the presentation of rounded numbers.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.119%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended September 30, 2022</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Corporate administration</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. IKC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="39" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,083&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Center closure charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,281&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,133&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns or rows may not sum or recalculate due to the presentation of rounded numbers.</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.119%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended September 30, 2021</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Corporate administration</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. IKC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. Other</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="39" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,524&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,408&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Center closure charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted operating income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,536&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,420&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns or rows may not sum or recalculate due to the presentation of rounded numbers.</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.454%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30, <br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">June 30, <br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30, <br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30, <br/>2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">819&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Noncontrolling owners' income primarily attributable to<br/>&#160;non-tax paying entities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes attributable to DaVita Inc.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">655&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,032&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Income tax attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense attributable to DaVita Inc.</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate on income attributable to DaVita Inc.</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns or rows may not sum or recalculate due to the presentation of rounded numbers.</span></div><div style="margin-top:6pt;text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30, <br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30, <br/>2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net cash provided by operating activities to free cash flow:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(189)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(177)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contributions from noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expenditures for routine maintenance and information technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(284)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(289)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expenditures for development and relocations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(125)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of self-developed properties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Free cash flow</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">742&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">843&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain columns or rows may not sum due to the presentation of rounded numbers.</span></div><div id="i9311e9c566584bd9ab5dffbc9b9a605b_115"></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Off-balance sheet arrangements and aggregate contractual obligations</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the debt obligations and operating lease liabilities reflected on our balance sheet, we have commitments associated with letters of credit, as well as certain working capital funding obligations associated with our equity investments in nonconsolidated dialysis ventures that we manage and some that we manage which are wholly-owned by third parties. For additional information see Note 7 to the condensed consolidated financial statements.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have potential obligations to purchase the noncontrolling interests held by third parties in many of our majority-owned dialysis partnerships and other nonconsolidated entities. These obligations are in the form of put provisions that are exercisable at the third-party owners&#8217; discretion within specified periods as outlined in each specific put provision. For additional information on these obligations and how we measure and report them, see Note 12 to the condensed consolidated financial statements and Notes 17 and 24 to the consolidated financial statements included in our 2021 10-K.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For information on the maturities and other terms of our long term debt, see Note 6 to the condensed consolidated financial statements.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, we have outstanding letters of credit in the aggregate amount of approximately $108 million under a bilateral secured letter of credit facility separate from our senior secured credit facilities.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the commitments listed above, in 2017 we entered into a sourcing and supply agreement with Amgen USA Inc. (Amgen) that expires on December 31, 2022, and has been amended and extended until December 31, 2023. Under the terms of this agreement, we will purchase EPOGEN (EPO) from Amgen in amounts necessary to meet no less than 90% of our requirements for erythropoiesis-stimulating agents (ESAs) through December 31, 2022. Under the terms of the amended agreement, beginning January 1, 2023, we will no longer purchase a percentage of our ESA requirements from Amgen, and instead will begin purchasing EPO from Amgen pursuant to the terms set forth in the amended agreement. As a result, in 2023 we will purchase a reduced share of our ESA requirements from Amgen. The actual amount of EPO that we will purchase will depend upon the amount of EPO administered during dialysis as prescribed by physicians and the overall number of patients that we serve.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, we have outstanding purchase agreements with various suppliers to purchase set amounts of dialysis equipment, parts, and supplies. If we fail to meet the minimum purchase commitments under these contracts during any year, we are required to pay the difference to the supplier, as described further in Note 17 to the Company's consolidated financial statements included in the 2021 10-K.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we have approximately $56 million of existing income tax liabilities for unrecognized tax benefits, including interest, penalties and other long-term tax liabilities. Income tax liabilities were reduced from $88 million as of December 31, 2021 to $56 million as of September 30, 2022, primarily due to a partial settlement reached with federal tax authorities for years 2014-2015.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, on May 25, 2022, we entered into an agreement with Medtronic, Inc. and one of its subsidiaries (collectively, Medtronic) to form a new, independent kidney care-focused medical device company (NewCo). The transaction is expected to close in 2023, subject to customary closing conditions and regulatory approvals. At close, DaVita will make a cash payment to Medtronic of approximately $75 million, subject to certain customary adjustments prior to the closing, and will contribute certain other non-cash assets to NewCo valued at approximately $25 million. Additionally, at close, each of DaVita and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medtronic will contribute approximately $200 million in cash to launch NewCo. DaVita also agreed to pay Medtronic additional consideration of up to $300 million if certain regulatory and commercial milestones are achieved between 2024 and 2028. </span></div><div id="i9311e9c566584bd9ab5dffbc9b9a605b_118"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Standards</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See discussion of new accounting standards in Note 14 to the condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><div id="i9311e9c566584bd9ab5dffbc9b9a605b_121"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quantitative and Qualitative Disclosures about Market Risk</span></div><div id="i9311e9c566584bd9ab5dffbc9b9a605b_124"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest rate and foreign currency sensitivity</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There has been no material change in the nature of the Company's interest rate risks or foreign currency exchange risks from those described in Part II Item 7A of our Annual Report on Form 10-K for the year ended December&#160;31, 2021.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below provide information about our financial instruments that are sensitive to changes in interest rates as of September&#160;30, 2022. For further information on the components of the Company's long-term debt and their interest rates, see Note 6 to the condensed consolidated interim financial statements included in this Quarterly Report on Form 10-Q at Part I Item 1. </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:13.501%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.717%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.717%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.717%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.717%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.717%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.717%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.307%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.127%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.897%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.133%"></td><td style="width:0.1%"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expected maturity date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Average interest rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="57" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long term debt:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed rate</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,416&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,608&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable rate</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,670&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,584&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,521&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Represents the fair value of the Company&#8217;s long-term debt excluding financing leases. See Note 6 to the condensed consolidated financial statements for further details.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The scheduled principal payments for all debt that bears a variable rate by its terms, including all of Term Loan B-1 and Term Loan A, have been included on the variable rate line of the schedule of expected maturities above. Additionally, the principal amounts of Term Loan B-1 and Term Loan A have been included in the calculation of the average variable interest rate presented.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">However, principal amounts of $2,668 million for Term Loan B-1 and $832 million of Term Loan A (the capped debt) are subject to LIBOR caps of 2.00% through June&#160;30, 2024. As of September&#160;30, 2022, applicable LIBOR rates were above this 2.00%, making the interest rates on this capped debt &#8220;economically fixed", unless or until applicable LIBOR rates were to fall back below 2.00% during the remaining term of the caps. As a result, as of September&#160;30, 2022, total fixed and economically fixed debt was $8,108 million, with an average interest rate of 4.28%, while total variable rate debt not subject to caps was $1,021 million with an average rate of 5.24%.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 6 for further details on the Company&#8217;s interest rate cap agreements.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"><tr><td style="width:1.0%"></td><td style="width:16.704%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.428%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.615%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.292%"></td><td style="width:0.1%"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Contract maturity date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>value</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Receive variable</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="57" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 cap agreements</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">LIBOR&#160;above 2%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div id="i9311e9c566584bd9ab5dffbc9b9a605b_127"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Controls and Procedures</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management has established and maintains disclosure controls and procedures designed to ensure that information required to be disclosed in the reports that it files or submits pursuant to the Securities Exchange Act of 1934 (Exchange Act) as amended is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission&#8217;s rules and forms, and that such information is accumulated and communicated to the Company&#8217;s management, including its Chief Executive Officer (CEO) and Chief Financial Officer (CFO) as appropriate to allow for timely decisions regarding required disclosures.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of the Company&#8217;s CEO and CFO, of the effectiveness of the design and operation of our disclosure controls and procedures in accordance with the Exchange Act requirements as of September&#160;30, 2022. Based upon that evaluation, the CEO and CFO concluded that the Company&#8217;s disclosure controls and procedures were effective as required by the Exchange Act as of such date for our Exchange Act reports, including this report. Management recognizes that these controls and procedures can provide only reasonable assurance of desired outcomes, and that estimates and judgments are still inherent in the process of maintaining effective controls and procedures.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no change in the Company's internal control over financial reporting that was identified during the evaluation that occurred during the fiscal quarter covered by this report that has materially affected, or is reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><div id="i9311e9c566584bd9ab5dffbc9b9a605b_130"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II. </span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OTHER INFORMATION</span></div><div id="i9311e9c566584bd9ab5dffbc9b9a605b_133"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Proceedings</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Part II, Item 1 is incorporated herein by reference to the information set forth under the caption &#8220;Commitments and contingencies&#8221; in Note 7 to the condensed consolidated financial statements included in this report. </span></div><div id="i9311e9c566584bd9ab5dffbc9b9a605b_136"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">There have been no material changes to the risk factors previously disclosed in Part I, Item 1A of our Annual Report on Form 10-K (2021 10-K) for the year ended December&#160;31, 2021 filed with Securities and Exchange Commission. You should carefully consider the risks included in our 2021 10-K, together with all the other information in the Quarterly Reports on Form 10-Q for the quarters ended March 31, 2022 and June&#160;30, 2022 and this Quarterly Report on Form 10-Q, including the forward-looking statements in Part I, Item 2 of this Quarterly Report on Form 10-Q under the heading "Management's Discussion and Analysis of Financial Condition and Results of Operations."</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><div id="i9311e9c566584bd9ab5dffbc9b9a605b_139"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share repurchases</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our repurchases of our common stock during the third quarter of 2022:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.830%"><tr><td style="width:1.0%"></td><td style="width:26.028%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.790%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.127%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.790%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.127%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.790%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.127%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.790%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.131%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total number<br/>of shares<br/>purchased</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Average price<br/>paid per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total number<br/>of shares<br/>purchased as<br/>part of publicly<br/>announced<br/>plans or programs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Approximate dollar<br/>value of shares that<br/>may yet be<br/>purchased under the<br/>plans or programs</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(dollars and shares in thousands, except per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 1-31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">901&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.94&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">901&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,706,120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 1-31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,676,111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 1-30, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">885&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">885&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,596,085&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,122&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.10&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,122&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is authorized to make purchases from time to time in the open market or in privately negotiated transactions, including without limitation, through accelerated share repurchase transactions, derivative transactions, tender offers, Rule 10b5-1 plans or any combination of the foregoing, depending upon market conditions and other considerations.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October&#160;27, 2022, we had a total of $1.596 billion available under the current authorization for additional share repurchases. Although this share repurchase authorization does not have an expiration date, we remain subject to share repurchase limitations including under our current senior secured credit facilities. </span></div><div style="margin-top:15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Items 3, 4 and 5 are not applicable</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><div id="i9311e9c566584bd9ab5dffbc9b9a605b_142"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exhibits</span></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.391%"><tr><td style="width:1.0%"></td><td style="width:9.004%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.583%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.013%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/ix?doc=/Archives/edgar/data/0000927066/000092706622000160/dva-20221014.htm">3.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amended and Restated Bylaws of DaVita Inc., adopted on October 14, 2022. (1)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dva-93022ex101xamno1tosour.htm">10.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment No. 1 to Agreement No. 00135085 between Amgen USA Inc. and DaVita Inc. effective as of January 1, 2023. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dva-93022ex31110xq.htm">31.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of the Chief Executive Officer, dated October&#160;28, 2022, pursuant to Rule 13a-14(a) or 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dva-93022ex31210xq.htm">31.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of the Chief Financial Officer, dated October&#160;28, 2022, pursuant to Rule 13a-14(a) or 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dva-93022ex32110xq.htm">32.1</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of the Chief Executive Officer, dated October&#160;28, 2022, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dva-93022ex32210xq.htm">32.2</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of the Chief Financial Officer, dated October&#160;28, 2022, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document - the Instance Document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation, Linkbase Document. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div></td></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.125%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.342%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed or furnished herewith.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Portions of this exhibit are subject to a request for confidential treatment and have been redacted and filed separately with the SEC.</span></td></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.152%"><tr><td style="width:1.0%"></td><td style="width:2.626%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.174%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed on October 18, 2022 as an exhibit to the Company's Current Report on Form 8-K.</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><div id="i9311e9c566584bd9ab5dffbc9b9a605b_145"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURE</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:56.293%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.188%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DAVITA INC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BY:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;JOHN D. WINSTEL</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">John D. Winstel</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Accounting Officer*</span></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date: October&#160;28, 2022</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:5.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.458%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mr.&#160;Winstel has signed both on behalf of the Registrant as a duly authorized officer and as the Registrant&#8217;s principal accounting officer.</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>dva-93022ex101xamno1tosour.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i09d77979b22a4824a8febe841ab50bba_1"></div><div style="min-height:112.32pt;width:100%"><div style="margin-bottom:6pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Note&#58; Certain identified information has been excluded from the exhibit because it is both not material and is the type that the registrant treats as private or confidential. Redacted portions have been marked with &#91;*&#93;. </font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:153%">Exhibit 10.1</font></div><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">AMENDMENT NO. 1 TO AGREEMENT NO. 00135085</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">BETWEEN AMGEN USA INC. AND DAVITA INC.</font></div></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><font><br></font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">This Amendment No. 1 (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Amendment No. 1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) to that certain Sourcing and Supply Agreement No. 00135085 (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) is made and entered into by and between Amgen USA Inc. (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Amgen</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and DaVita Inc. (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Dialysis Center</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  This Amendment No. 1 shall be effective on January 1, 2023 (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Amendment No. 1 Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). </font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS Amgen and Dialysis Center entered into the Agreement with an effective date of January 6, 2017&#59; </font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS the Agreement contains certain terms, conditions and discount options for the purchase of Amgen ESAs&#59; </font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS Amgen and Dialysis Center desire that the existing Agreement govern in all respects the terms, conditions and discount options for the purchase of Amgen ESAs prior to January 1, 2023, and that the Agreement as amended hereby govern in all respects the terms, conditions and discount options for the purchase of Amgen ESAs from January 1, 2023 to the Term End Date (as such term is amended hereby)&#59; and</font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS Amgen and Dialysis Center mutually desire to amend the Agreement as stated below&#59; </font></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NOW, THEREFORE, in consideration of the premises and of the mutual covenants, representations and warranties set forth herein, the Parties agree as follows&#58;</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">SECTION 1.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Definitions&#59; References</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  Unless otherwise specifically defined herein, each term used herein which is defined in the Agreement shall have the meaning assigned to such term in the Agreement.  </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">SECTION 2.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Effectiveness</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  Each of the amendments and other modifications set forth herein shall be effective on the Amendment No. 1 Date.  The amendments and other modifications set forth herein shall have no effect on the terms, conditions and discount options for the purchase of Amgen ESAs prior to January 1, 2023.  The rights and obligations of the Parties related to the purchase of Amgen ESAs prior to January 1, 2023 shall continue to be governed by the Agreement as it existed prior to this Amendment No. 1.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">SECTION 3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Amendment of Section 2 (Definitions)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement entitled &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall be amended such that&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.84pt">The titles and definitions for each of the following Sections are deleted and replaced with the word &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Reserved.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;&#58; </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:26.24pt;text-decoration:underline">Section 2.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8220;Added Aranesp Dialysis Center Purchaser,&#8221;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.8pt;text-decoration:underline">Section 2.10</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8220;Alternative Amgen ESA,&#8221; </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:21.36pt;text-decoration:underline">Section 2.11</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8220;Alternative Amgen ESA Cover,&#8221; </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.74pt;text-decoration:underline">Section 2.12</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8220;Alternative ESA Purchase Amount,&#8221; </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Section 2.13</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8220;Alternative ESA Purchase Event,&#8221;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(vi)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.74pt;text-decoration:underline">Section 2.16</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8220;Amgen ESA Equivalent Quantity Shortfall,&#8221;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(vii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.3pt;text-decoration:underline">Section 2.18</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8220;Amgen ESAs Share of Sales,&#8221; </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(viii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:15.86pt;text-decoration:underline">Section 2.33</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8220;Baseline Dose Equivalency Ratio,&#8221; </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(ix)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.74pt;text-decoration:underline">Section 2.34</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8220;Best Net Aranesp Price Rebate,&#8221; </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(x)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Section 2.35</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8220;Best Net EPOGEN Price Rebate,&#8221; </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xi)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:20.74pt;text-decoration:underline">Section 2.39</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8220;Committed Unit Purchases of Amgen ESAs,&#8221; </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:18.3pt;text-decoration:underline">Section 2.40</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8220;Committed Unit Purchases of Alternative ESAs,&#8221; </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xiii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:15.86pt;text-decoration:underline">Section 2.41</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8220;Compensation Data,&#8221; </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xiv)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:15.24pt;text-decoration:underline">Section 2.48</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8220;Dialysis Center Committed Purchasers,&#8221;</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:112.32pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CONFIDENTIAL TREATMENT</font></div></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xv)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt;text-decoration:underline">Section 2.49</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8220;Dialysis Center Committed Purchasers List,&#8221;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xvi)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:15.24pt;text-decoration:underline">Section 2.57</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8220;Economic Interest,&#8221; </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xvii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.8pt;text-decoration:underline">Section 2.64</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8220;Forecast Shortfall,&#8221; </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xviii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:10.36pt;text-decoration:underline">Section 2.65</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8220;Forecast Shortfall Amount,&#8221; </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xix)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:15.24pt;text-decoration:underline">Section 2.69</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8220;HIFs,&#8221; </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xx)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt;text-decoration:underline">Section 2.72</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8220;Included HIFs,&#8221; </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxi)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:15.24pt;text-decoration:underline">Section 2.76</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8220;Initial Dose Equivalency Ratio,&#8221; </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.8pt;text-decoration:underline">Section 2.79</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8220;Liquidated Damages,&#8221; </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxiii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:10.36pt;text-decoration:underline">Section 2.83</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8220;Maximum Aranesp Purchase Limit,&#8221; </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxiv)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.74pt;text-decoration:underline">Section 2.94</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8220;Purchase Commitment Percentage,&#8221;  </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxv)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.18pt;text-decoration:underline">Section 2.103</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8220;Self-Reported Data,&#8221; </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxvi)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.74pt;text-decoration:underline">Section 2.104</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8220;Shortfall Amgen ESA,&#8221; </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxvii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:7.3pt;text-decoration:underline">Section 2.105</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8220;Significant Supply Shortfall,&#8221; </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxviii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:4.86pt;text-decoration:underline">Section 2.115</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8220;Unmet HIF Conversion Volume,&#8221; </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxix)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:9.74pt;text-decoration:underline">Section 2.117</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8220;Wind-Down Period,&#8221; and </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(xxx)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:12.18pt;text-decoration:underline">Section 2.118</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> &#8220;Wind-Down Price.&#8221;</font></div><div style="padding-left:54pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.84pt;text-decoration:underline">Section 2.60</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement entitled &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">ESAs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; is amended and restated as follows&#58; </font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.60.&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">ESAs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean agents that stimulate erythropoiesis including, but not limited to, &#91;*&#93;.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.84pt;text-decoration:underline">Section 2.109</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement entitled &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term End Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; is amended and restated as follows&#58; </font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:9pt;text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.109 &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Term End Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means December 31, 2023.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.84pt">The following definitions are added to the end of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> immediately following </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.118</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:9pt;text-align:justify;text-indent:27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.119&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Amendment No. 1 Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means January 1, 2023. </font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.120&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Annual Purchase Commitment Deficiency</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the difference, if positive, given by (a) the Purchase Commitment for Calendar Year 2023 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">minus</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (b) the Qualified Aggregate Purchases of EPOGEN that Dialysis Center Purchasers purchased during Calendar Year 2023.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.121&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Calendar Year</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means a full twelve (12) month period beginning on January 1 and ending December 31 of each year that occurs during the Term.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.122&#160;&#160;&#160;&#160;&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Qualified Aggregate Purchases of EPOGEN</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; means the amount of EPOGEN purchased by Dialysis Center Purchasers during a given period from an Authorized Wholesaler (or from Amgen pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) for use in providing Dialysis Services, and confirmed by Amgen through sales tracking data, including, without limitation, chargeback data from wholesalers.  Qualified Aggregate Purchases of EPOGEN shall be in terms of IUs, net of product returns and adjustments.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">SECTION 4. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Amendment and Restatement of Section 3 (Purchase and Supply Commitments)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement shall be amended and restated as follows&#58;</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:112.32pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CONFIDENTIAL TREATMENT</font></div></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:8.84pt">PURCHASE AND SUPPLY COMMITMENTS</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt;text-decoration:underline">Purchase and Supply Commitments</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.1.1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.52pt;text-decoration:underline">Dialysis Center Purchase Commitment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Subject to the terms and conditions of this Agreement, the Dialysis Center Purchasers shall purchase Qualified Aggregate Purchases of EPOGEN during Calendar Year 2023 in an amount not less than the greater of (i)&#160;&#91;*&#93; IUs of EPOGEN and (ii) the sum of the quarterly Minimum Forecast Commitments for all Quarters in Calendar Year 2023 (such greater amount, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Purchase Commitment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:104.4pt;text-align:justify;text-indent:-32.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.1.1.1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:35.36pt;text-decoration:underline">Purchase Commitment Deficiency</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If during Calendar Year 2023 the Dialysis Center Purchasers do not purchase the quantities of EPOGEN necessary to meet the Purchase Commitment, then Amgen shall deliver to Dialysis Center a notice indicating the Annual Purchase Commitment Deficiency.  Within fourteen (14) days of receipt by Dialysis Center of notice from Amgen of the Annual Purchase Commitment Deficiency, Dialysis Center shall make a binding purchase order from one or more Authorized Wholesalers (or from Amgen pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) of EPOGEN in an amount equal to the Annual Purchase Commitment Deficiency and such purchase shall be eligible for the Discounts. Dialysis Center shall promptly provide Amgen notice of the completion of such purchase order along with a copy of the invoice for such purchase order.  In the event that Dialysis Center fails to complete such purchase order within fourteen (14) days of receipt of notice from Amgen, Amgen shall offset against any discounts or other amounts owed by Amgen to Dialysis Center an amount equal to the Annual Purchase Commitment Deficiency </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">multiplied by</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> the EPOGEN Fixed Price corresponding to the Qualified Aggregate Purchases of EPOGEN that Dialysis Center Purchasers actually purchased during Calendar Year 2023. </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.1.1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.52pt;text-decoration:underline">Amgen Supply Commitment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Subject to the terms and conditions of this Agreement, Amgen shall ensure that during each Quarter of the Term &#91;*&#93; percent (&#91;*&#93;%) of the Minimum Forecast Commitment for each such Quarter is available for purchase by the Dialysis Center Purchasers from one or more Authorized Wholesalers or from Amgen pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Supply Commitment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  Subject to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.2.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, Amgen acknowledges and agrees that nothing in this Agreement shall prohibit any Dialysis Center Purchaser from purchasing an amount of EPOGEN necessary to satisfy the Purchase Commitment in the final Quarter of the Term regardless of whether such EPOGEN is actually administered by the Dialysis Center Purchasers to their patients for the provision of Dialysis Services during such Quarter.</font><font style="color:#ff0000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.1.2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;padding-left:8.52pt">Reserved</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.1.3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;padding-left:8.52pt">Reserved</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.1.4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.52pt;text-decoration:underline">Dose Equivalency Ratio</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Parties agree that for purposes of this Agreement the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Dose Equivalency Ratio</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; between (i) EPOGEN and Mircera is 223&#58;1 such that 223 IUs of EPOGEN shall be considered equivalent to 1 mcg of Mircera, and (ii) the Dose Equivalency Ratio between EPOGEN and any biosimilar of EPOGEN is 1&#58;1.10 such that 1.10 IU of such biosimilar of EPOGEN shall be considered equivalent to 1 IU of EPOGEN.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt;text-decoration:underline">Eligible Purchases</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.2.1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.52pt;text-decoration:underline">Purchases from Authorized Wholesaler</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Only purchases of Amgen ESAs made by a Dialysis Center Purchaser from an Authorized Wholesaler or Amgen </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:112.32pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CONFIDENTIAL TREATMENT</font></div></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be eligible to receive the Discounts provided under this Agreement.  </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.2.2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.52pt;text-decoration:underline">Own Use</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Dialysis Center Purchasers shall purchase Amgen ESAs under this Agreement solely for their own use in providing Dialysis Services, and only purchases made by Dialysis Center Purchasers for such use shall be eligible for the Discounts provided under this Agreement.  Dialysis Center on behalf of itself and each other Dialysis Center Purchaser covenants that none of them shall seek to procure any of the Discounts available under this Agreement for any purchases of Amgen ESAs not for its or their use in providing Dialysis Services, and Dialysis Center shall promptly notify Amgen in the event Amgen shall have provided any Dialysis Center Purchaser with any Discounts hereunder for any Amgen ESAs that were not used by them for the provision of Dialysis Services.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt;text-decoration:underline">Quantity Forecasts and Minimum Forecast Commitment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.3.1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.52pt;text-decoration:underline">Rolling Forecast</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Each Quarter during the Term, Dialysis Center shall submit in writing to Amgen a twelve (12) month good faith forecast (or a good faith forecast for such lesser amount of time remaining in the Term) setting forth on a month-by-month basis the aggregate quantities in IUs of EPOGEN anticipated to be purchased by Dialysis Center Purchasers (each, a &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Rolling Forecast</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#34; and collectively the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Rolling Forecasts</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), each such forecast by EPOGEN SKU required for all Dialysis Center Purchasers for each month in the forecast period. The Rolling Forecasts submitted under this Agreement prior to the Amendment No. 1 Date shall continue to be binding as to their EPOGEN forecasts pertaining to Calendar Year 2023, except that if Dialysis Center delivers to Amgen an updated twelve (12) month good faith forecast within thirty (30) days of the date of execution of Amendment No. 1 (which, for the avoidance of doubt, may not update any forecasts for Calendar Year 2022 but may contain equivalent or increased forecasts for the applicable portion of Calendar Year 2023), such updated good faith forecast shall supersede the existing forecast for such portion of Calendar Year 2023 that Dialysis Center submitted to Amgen prior to the execution of Amendment No. 1.  Dialysis Center shall submit each Rolling Forecast by no later than the first day of the last month of each Quarter during the Term (e.g., by March 1, 2023 Dialysis Center shall submit a Rolling Forecast for the period from April 2023 through December 2023).  If Dialysis Center has not timely delivered a Rolling Forecast as provided above, the Rolling Forecast previously in effect shall remain in effect for the periods covered thereby.  The purpose of this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.3.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> is to allow Amgen adequate time to adjust its manufacturing planning and operations to properly reflect the anticipated mix of Available EPOGEN SKUs.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.3.2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;padding-left:8.52pt">Reserved.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.3.3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.52pt;text-decoration:underline">Minimum Forecast Commitment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Without reducing or limiting the Purchase Commitment set forth in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.1.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the forecasted quantities of each Available EPOGEN SKU for months 1-3 of each Rolling Forecast shall constitute the Dialysis Center Purchasers&#8217; aggregate minimum purchase commitment of IUs of EPOGEN by Available EPOGEN SKU for such Quarter (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Minimum Forecast Commitment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;). Any forecasted quantity of Available EPOGEN SKUs that constitutes less than one and five-tenths of a percent (1.5%) of the forecasted quantities of total EPOGEN for that Quarter shall be excluded from the Minimum Forecast Commitment and shall not be subject to the Supply Commitment. </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;padding-right:-4.5pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.3.4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;padding-left:8.52pt">Reserved.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;padding-right:-4.5pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.3.5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.52pt;text-decoration:underline">Forecast Variance.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">  Each new Rolling Forecast submitted by Dialysis Center on a Quarterly basis pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.3.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> may decrease (but not increase) quantities of each Available EPOGEN SKU for new months 1-6, and may increase or decrease quantities of each Available EPOGEN SKU in the new months 7-12, </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:112.32pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CONFIDENTIAL TREATMENT</font></div></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;padding-right:-4.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">each from the corresponding months in the immediately prior Rolling Forecast by the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Permitted Percentage Variance</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; in the table below.  The Permitted Percentage Variance for the months of each Rolling Forecast (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Permitted Variance Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) are as follows&#58; </font></div><div style="padding-left:77.41pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.455%"><tr><td style="width:1.0%"></td><td style="width:27.173%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.977%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.116%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.116%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.118%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Old Months</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">4-6</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">7-9</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">10-12</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">New Months</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">1-3</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">4-6</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">7-9</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">10-12</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">EPOGEN&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Percentage Variance Permitted in New Forecast for New Months from Old Months (Same Calendar Months) in Prior Forecast</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#91;*&#93;% (decrease only)</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#91;*&#93;% (decrease only)</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#91;*&#93;% (decrease or increase)</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Initial Rolling Forecast</font></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">If Dialysis Center submits a Rolling Forecast that contains a forecast that is not in compliance with the applicable Permitted Percentage Variance, Amgen shall have the right within thirty (30) days of receipt of such Rolling Forecast by written notice to Dialysis Center to either (a) accept such forecast for any month therein that is not in compliance with this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.3.5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#59; or (b) adjust such non-compliant forecasted quantity for any such month to increase or decrease the amount forecasted for such month by up to the minimum amount necessary to bring such forecasted quantity into compliance with this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.3.5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.    Dialysis Center may, at any time for any good faith reason, request additional variances to the Permitted Percentage Variance and, in such event, the Parties shall work in good faith to accommodate such request&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, however, that in no event shall Amgen be liable for any resulting Actual Supply Shortfall.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.3.6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;padding-left:8.52pt">Reserved.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.3.7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.52pt;text-decoration:underline">Good Faith Estimates</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Each Rolling Forecast submitted by Dialysis Center shall represent good faith estimates of the Dialysis Center Purchasers&#8217; actual anticipated purchases of EPOGEN for the treatment of dialysis patients in the Territory and reasonable inventory requirements for EPOGEN in the Territory during the relevant timeframes.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.3.8.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.52pt;text-decoration:underline">Available Amgen ESA SKUs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Available Amgen ESA SKU Schedule attached as </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">hereto sets forth the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Available Amgen ESA SKUs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; as of the Term Start Date.  Amgen may add Available Amgen ESA SKUs to, or remove Available Amgen ESA SKUs (with respect to all purchasers of Amgen ESAs for free-standing dialysis clinics) from, the Available Amgen ESA SKU Schedule upon at least six (6) months advance written notice to Dialysis Center&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that Amgen may not remove any Available Amgen ESA SKUs from the Available Amgen ESA SKU Schedule that accounted for five percent (5%) or more of the Qualified Gross Purchases of Amgen ESAs during the immediately preceding three (3) Quarters without the prior written consent of Dialysis Center, which consent may be withheld by Dialysis Center in its sole discretion, unless there is </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:112.32pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CONFIDENTIAL TREATMENT</font></div></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">an Available Amgen ESA SKU that corresponds to the same dosage, size and potency of the deleted Available Amgen ESA SKU&#59; and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that, notwithstanding the foregoing, Amgen</font><font style="color:#ff0000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">may immediately remove any Available Amgen ESA SKU should Amgen determine, in its sole discretion, that the removal of any such Available Amgen ESA SKU is for safety or quality or similar reasons. The Parties shall mutually agree upon (a) the first period for which any such new Available Amgen ESA SKU may be ordered by the Dialysis Center Purchasers and (b) any permitted adjustments to the Amgen ESA SKU mix contained in Dialysis Center's then applicable Rolling Forecast to reflect any changes in the Available Amgen ESA SKUs or as otherwise may be required due to any production shortfall applicable to all Amgen ESA customers.  </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt;text-decoration:underline">Supply Commitment Shortfalls</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.4.1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.52pt;text-decoration:underline">Amgen Shortfall Activities</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Dialysis Center shall promptly notify Amgen and the Amgen Business Representative if the Authorized Wholesalers do not have sufficient quantities of EPOGEN in the aggregate to meet firm purchase orders from the Dialysis Center Purchasers that are within the quantity of EPOGEN that constitutes the Minimum Forecast Commitment for that month, setting forth in such notice the aggregate amount of such EPOGEN that the Authorized Wholesalers are unable to supply.   Within seven (7) business days after receipt of such notice from Dialysis Center, Amgen shall use commercially reasonable efforts to (i) deliver to the Authorized Wholesalers additional amounts of EPOGEN, (ii) direct Dialysis Center to one or more Authorized Wholesalers or other wholesalers that have stock of EPOGEN and&#47;or (iii) make other arrangements with Dialysis Center to provide shipment of EPOGEN to Dialysis Center (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Amgen Shortfall Activities</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).   </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.4.2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.52pt">An &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Actual Supply Shortfall</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, after taking into account EPOGEN identified or made available through Amgen Shortfall Activities, there is not available a quantity of EPOGEN that is part of the Minimum Forecast Commitment for a particular month and constitutes &#91;*&#93; percent (&#91;*&#93;%) or more of the aggregate quantities in IUs of EPOGEN that form the Minimum Forecast Commitment for such month.</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.4.3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.52pt;text-decoration:underline">Supply Disruption Notice</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  To the extent permitted by Law and Amgen&#8217;s internal quality and compliance policies and procedures, Amgen shall provide Dialysis Center with written notice of anticipated supply disruptions for EPOGEN that would impact the Minimum Forecast Commitment.  </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:117pt;text-align:justify;text-indent:-45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.4.3.1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.36pt;text-decoration:underline">Non-Discrimination and Priority</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Subject to any existing obligations that Amgen or any Affiliate of Amgen may have, Amgen shall give Dialysis Center Purchasers&#8217; orders first priority among dialysis center purchasers when allocating available EPOGEN during an Actual Supply Shortfall.    </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:117pt;text-align:justify;text-indent:-45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.4.3.2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;padding-left:8.36pt">Reserved.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:117pt;text-align:justify;text-indent:-45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.4.3.3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.36pt;text-decoration:underline">Alternative ESA Cover Purchases</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  If there is limited availability of EPOGEN during an Actual Supply Shortfall, Dialysis Center shall use good faith efforts to procure any Alternative ESAs from a Third Party at the lowest commercially reasonable price.  Dialysis Center shall deliver to Amgen a statement setting forth the aggregate net purchase price (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">i.e.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, the aggregate list price less all applicable discounts, rebates, chargebacks and other price adjustments) actually paid by the Dialysis Center Purchasers to any such Third Party for that quantity of Alternative ESAs purchased by such Dialysis Center Purchasers during the Quarter in which the Actual Supply Shortfall occurs solely as a substitute for the Actual Supply Shortfall (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Aggregate Alternative </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:112.32pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CONFIDENTIAL TREATMENT</font></div></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:117pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">ESA Net Price</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that, should Dialysis Center be subject to any confidentiality restrictions that Dialysis Center may have with any Third Party from which it procured Alternative ESAs, then the Parties agree to send such Aggregate Alternative ESA Net Price to the Firm to be verified.  Amgen shall pay to Dialysis Center an amount of cash equal to the difference, if any, between (a) the Aggregate Alternative ESA Net Price and (b) the product of (i) (1) WAC in effect for the applicable Quarter of the Actual Supply Shortfall </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">less</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (2) the Discounts per IU of Available EPOGEN SKU earned by the Dialysis Center Purchasers in such Quarter, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">multiplied</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">by</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (ii) the amount of the Actual Supply Shortfall.  </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.4.1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;padding-left:8.52pt">Reserved.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.4.2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.52pt;text-decoration:underline">Purchase Commitment Reduction</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  In the event of an Actual Supply Shortfall, the Purchase Commitment shall be reduced by the amount of the aggregate Actual Supply Shortfall.  The foregoing shall be the sole remedy for any Actual Supply Shortfall.    </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.4.3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.52pt;text-decoration:underline">Response to Actual Supply Shortfall</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Amgen shall work in good faith to address and end any Actual Supply Shortfall as soon as possible and will use commercially reasonable efforts to make available additional manufacturing capacity.  </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt;text-decoration:underline">WAC</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The Dialysis Center Purchasers shall purchase Amgen ESAs from an Authorized Wholesaler (or from Amgen pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) at the then-prevailing WAC (subject to any wholesaler markup, discount, services fees or other charges), and any Discounts shall be applied in accordance with the schedules and terms set forth in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and this Agreement.  Amgen reserves the right to change WAC at any time, by any amount, without notice.   Subsequent to any WAC changes, Amgen shall promptly notify Dialysis Center.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt;text-decoration:underline">Authorized Wholesalers</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Prior to the Term Start Date, Dialysis Center shall select one or more Authorized Wholesalers from the Authorized Wholesaler list prepared by Amgen and set forth on </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (as such list may be amended from time to time as provided in this Agreement, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Authorized Wholesaler List</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), and only such selected Authorized Wholesalers shall be Authorized Wholesalers for purposes of this Agreement.  From and after the Term Start Date, Dialysis Center shall have the right to change its selection of Authorized Wholesalers from the Authorized Wholesaler List with ninety (90) days prior written notice to Amgen.  Dialysis Center may request Amgen to add wholesalers to the Authorized Wholesaler List, and Amgen, at its sole discretion, shall have the right to determine whether to approve of such addition to the Authorized Wholesaler List.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Amgen shall have the right to add or remove wholesalers from the Authorized Wholesaler List set forth on </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> in the exercise of its commercially reasonable discretion by ninety (90) days prior written notice to Dialysis Center, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that, for any removal, (a) Amgen removes such Authorized Wholesaler with respect to providing Amgen ESAs to all purchasers of Amgen ESAs for free standing dialysis clinics, or (b) such Authorized Wholesaler requests Amgen to remove it as an Authorized Wholesaler for Dialysis Center Purchasers.  In the event of any removal of an Authorized Wholesaler from the Authorized Wholesaler List by Amgen, Amgen shall work with Dialysis Center to transition the Dialysis Center Purchasers&#8217; purchases of Amgen ESAs to an alternative Authorized Wholesaler, and if no alternative Authorized Wholesaler exists at such time, the Parties shall use reasonable efforts to establish a direct purchasing relationship in any interim period between the removal of the removed Authorized Wholesaler and the initiation of purchases from a new Authorized Wholesaler, if no Authorized Wholesaler exists at such time.  Any such direct purchasing relationship shall be subject to credit qualification and the approval by Amgen of an application for direct ship account.  If the Dialysis Center Purchasers purchase Amgen ESAs </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:112.32pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CONFIDENTIAL TREATMENT</font></div></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:54pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">directly from Amgen as contemplated in this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, all purchases of Amgen ESAs made from Amgen by such Dialysis Center Purchasers shall be deemed Qualified Gross Purchases of Amgen ESAs and eligible for the Discounts.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:17.68pt;text-decoration:underline">Dialysis Center Purchasers</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.7.1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.52pt;text-decoration:underline">Designated Affiliates and Managed Centers</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Only the Designated Affiliates listed on </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit C</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (as such list may be amended from time to time as provided in this Agreement, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Designated Affiliates List</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) and the Managed Centers set forth on </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit D</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> (as such list may be amended from time to time as provided in this Agreement, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Managed Centers List</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) shall be Dialysis Center Purchasers for purposes of this Agreement.  Dialysis Center shall promptly update and maintain the accuracy of the Designated Affiliates List and the Managed Centers List throughout the Term, but in no event later than thirty (30) days after the addition or removal of a Dialysis Center Purchaser pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.7.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> or </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">3.7.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> below. Dialysis Center shall not acquire, divest, restructure, reorganize or reclassify its Affiliates or Managed Centers, or request any addition or removal of any Dialysis Center Purchaser, with the purpose or intent in whole or in part to avoid or eliminate its obligations or commitments, or the obligations and commitments of each of the Dialysis Center Purchasers set forth in this Agreement.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.7.2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.52pt;text-decoration:underline">Addition of Dialysis Center Purchasers</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. After the Term Start Date, subject to the terms and conditions of this Agreement, all new Affiliates that provide Dialysis Services and Managed Centers in the Territory shall be added to this Agreement and become Dialysis Center Purchasers.  Dialysis Center shall provide written notice to Amgen of each new Affiliate that provides Dialysis Services and Managed Center in the Territory (each a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Notice of Added Dialysis Center Purchaser</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), which notice shall include the proposed Added Dialysis Center Purchaser Transaction Date, plus any additional information regarding the proposed Dialysis Center Purchaser that Amgen shall reasonably request.  Subject to the terms and conditions of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.1.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> with respect to the Purchase Commitment, the Designated Affiliates List and the Managed Centers List shall be amended to include such Affiliates that provide Dialysis Services or Managed Centers effective as of (i) thirty (30) days from the date of Amgen&#8217;s receipt of a Notice of Added Dialysis Center Purchaser or (ii) the applicable Added Dialysis Center Purchaser Transaction Date if such Added Dialysis Center Purchaser Transaction Date is later than thirty (30) days after the Notice of Added Dialysis Center Purchaser (each such effective date, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Added Dialysis Center Purchaser Effective Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;, and each of the Affiliates that provide Dialysis Services and Managed Centers added by such amendments, an &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Added Dialysis Center Purchaser</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  The Designated Affiliates List and the Managed Centers List shall be amended without further action required of the Parties to reflect additions made in accordance with this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.7.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.7.3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.52pt;text-decoration:underline">Removal of Dialysis Center Purchasers</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  (A)  Dialysis Center may remove Designated Affiliates from the Designated Affiliates List and Managed Centers from the Managed Center List only (i) upon the written consent of Amgen, which consent shall not be unreasonably withheld, conditioned, and&#47;or delayed or (ii) upon thirty (30) days prior written notice to Amgen in the event such removal is a result of a (a) sale of all or substantially all of the assets or equity interests of a Designated Affiliate to a Third Party, whether by reorganization, merger, sales of assets, or sale of equity interests, (b) permanent closure of a Designated Affiliate facility or (c) termination of the relevant management agreement for a Managed Center that has ceased its management relationship with Dialysis Center and&#47;or any Affiliate of Dialysis Center (each of the events described in this clause (ii), an &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Authorized Removal Occurrence</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;).  Dialysis Center shall provide Amgen written notice describing the nature of any requested removal, including the anticipated </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:112.32pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CONFIDENTIAL TREATMENT</font></div></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">effective date of any Authorized Removal Occurrence, and such removal shall be effective thirty (30) days after Amgen has provided Dialysis Center with written consent to such removal or such earlier period as may be agreed to by Amgen or, in the event of an Authorized Removal Occurrence, the effective date of the Authorized Removal Occurrence.  </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(B)  Amgen shall also have the right to remove any Designated Affiliates from the Designated Affiliates List and any Managed Centers from the Managed Centers List upon ninety (90) days (or such shorter period as may be required by Law or any Governmental Authority) written notice to Dialysis Center (a) that such removal is required by order of a court or Governmental Authority or (b) in instances in which Amgen determines, in its reasonable discretion, that such removal is required (i) to comply with Law, based on the advice of counsel, or (ii) as a result of any such Designated Affiliate&#8217;s or Managed Center&#8217;s negligence or willful misconduct in the use or administration of Amgen ESAs.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(C)  The Designated Affiliates List and the Managed Centers List shall be amended without further action required of the Parties to reflect removals made in accordance with this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.7.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.7.4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.52pt;text-decoration:underline">Adjustments to Rolling Forecast</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Following the addition or removal of an Affiliate that provides Dialysis Services to or from the Designated Affiliates List or a Managed Center to or from the Managed Centers List, the Parties shall mutually agree in good faith to implement any reasonable and necessary adjustments to the Rolling Forecast to account for such addition or removal of an Affiliate that provides Dialysis Services to or from the Designated Affiliates List or a Managed Center to or from the Managed Centers List&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that unless otherwise agreed to by the Parties pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.3.5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, Amgen shall have no obligation under </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> for an Actual Supply Shortfall in the event that any increase to the quantities of each Available EPOGEN SKU set forth in such adjusted Rolling Forecast is in excess of the applicable Permitted Percentage Variances.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.7.5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;padding-left:8.52pt">Reserved.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.7.6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;padding-left:8.52pt">Reserved.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.7.7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.52pt;text-decoration:underline">Marketing of Amgen ESAs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:104.4pt;text-align:justify;text-indent:-32.4pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.7.7.1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:35.36pt">Amgen represents and warrants to Dialysis Center that during the Term of this Agreement, neither Amgen, nor any of its agents or representatives, including, without limitation, Amgen&#8217;s commercial representatives, &#91;*&#93; in the Territory for Amgen ESAs for Dialysis Services &#91;*&#93;.  In the event that Dialysis Center has a reasonable basis to believe that Amgen has not complied with its obligations under this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.7.7.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, Dialysis Center shall &#91;*&#93;.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">3.7.8.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:8.52pt;text-decoration:underline">Shelf Life</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  All EPOGEN purchases by Dialysis Center pursuant to this Agreement shall have a minimum of six (6) months remaining dating prior to expiration, unless otherwise agreed to in writing by the Parties.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">SECTION 5. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Amendment of Section 4.2 (Verification and Audit)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The first sentence of</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 4.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement shall be amended and restated as follows&#58; </font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Discounts (including any qualification criteria for any Discounts) specified herein and&#47;or any other amounts paid by one Party to the other Party pursuant to this Agreement are subject to verification and audit of the relevant purchase and other data (including the Data), as reasonably necessary to calculate any amounts payable hereunder.</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:112.32pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CONFIDENTIAL TREATMENT</font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">SECTION 6. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Amendment and Restatement of Section 7 (Other Data)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 7</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement shall be amended and restated as follows&#58;</font></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%;padding-left:8.84pt">Reserved.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">SECTION 7. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Amendment and Restatement of Section 8.4 (HIF Economic Interest)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8.4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement shall be amended and restated as follows&#58;</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Reserved.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">SECTION 8. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Amendment and Restatement of Section 8.5 (Data)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 8.5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement shall be amended and restated as follows&#58;</font></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:54pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">8.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Data</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Dialysis Center represents and warrants to Amgen that&#58; (a) the Data that the Dialysis Center Purchasers deliver to Amgen pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be&#58; (i) prepared and delivered in accordance with the provisions of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and (ii) as complete and accurate as is reasonably obtainable in view of the Dialysis Center Purchasers&#8217; customary method of compilation and the nature and accuracy of the Dialysis Center Purchasers&#8217; resources&#59; (b) the Dialysis Center Purchasers shall not knowingly and intentionally misrepresent or omit any of the Data provided by the Dialysis Center Purchasers to Amgen&#59; and (c) Dialysis Center shall promptly notify Amgen in the event it has actual knowledge that any of the Data is not complete and&#47;or accurate. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">SECTION 9. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Amendment and Restatement of Section 10.2 (Termination for Cause)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 10.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement shall be amended and restated as follows&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;10.2  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Termination for Cause</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Amgen or Dialysis Center may terminate this Agreement in the event of the following&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;10.2.1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Material Breach</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Either Party may terminate this Agreement upon thirty (30) days prior written notice if the other Party materially fails to fulfill any of its obligations under this Agreement when they come due and does not cure such breach within thirty (30) days of receipt of such notice.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.2.2. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Termination for Exclusion from Federal Health Care Program</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Either Amgen or Dialysis Center may immediately terminate this Agreement upon written notice to the other Party in the event there is change in the other Party&#8217;s status which excludes it from participation in any &#8220;Federal health care program&#8221; (as defined under 42 U.S.C. &#167; 1320a-7b(f)) (a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Debarred Party</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that no Party shall have the right to terminate this Agreement pursuant to this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 10.2.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> if the Debarred Party can complete its obligations through, or otherwise transfer its obligations to, an Affiliate as permitted by applicable Law. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;10.2.3.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Termination for Payment Failure</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Either Party may terminate this Agreement in the event the other Party fails to make payment of any undisputed amount due hereunder in excess of &#91;*&#93; following thirty (30) days&#8217; written notice from the Party (which termination shall be automatically effective at the end of such thirty (30) day period should such undisputed amount remain unpaid).</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline"> </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">SECTION 10.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Amendment and Restatement of Section 10.3 (Liquidated Damages)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 10.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement shall be amended and restated as follows&#58;</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.3&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Reserved.</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:112.32pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CONFIDENTIAL TREATMENT</font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">SECTION 11. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Amendment and Restatement of Section 10.4 (Effect of Termination)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 10.4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement shall be amended and restated as follows&#58;</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.4&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Effect of Termination</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Upon any termination or expiration of this Agreement, (a) any earned and vested Discounts shall be paid in accordance with the terms set forth in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> and (b) any payments by Amgen owing to Dialysis Center under </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.4.3.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> shall be paid.  All Discounts available to Dialysis Center in the particular Quarter in which such termination occurs shall be paid to Dialysis Center based on an achievement of the eligibility and vesting requirements set forth in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">SECTION 12. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Amendment and Restatement of Section 10.5 (Survival)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 10.5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement shall be amended and restated as follows&#58;</font></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">10.5&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Survival</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Any provision that, either expressly or by its nature is intended to survive this Agreement, shall survive any expiration or termination of this Agreement, including </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Sections 2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">8</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">9</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">10</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">11</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">SECTION 13.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Amendment and Restatement of Exhibit A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement entitled &#8220;Discount Terms and Conditions&#8221; shall be deleted in its entirety and replaced with the </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> attached hereto. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">SECTION 14.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Removal of Exhibit E</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit E</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement entitled &#8220;Dialysis Center Committed Purchasers List&#8221; shall be deleted in its entirety. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">SECTION 15.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Removal of Exhibit SR-1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit SR-1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement entitled &#8220;Purchase Data Submission Form&#8221; shall be deleted in its entirety. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">SECTION 16.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Amendment and Restatement of Schedule 1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement entitled &#8220;Data&#8221; shall be deleted in its entirety and replaced with the </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> attached hereto. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">SECTION 17.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Removal of Schedule 2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Schedule 2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement entitled &#8220;Compensation Data&#8221; shall be deleted in its entirety. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">All other definitions, references, terms, and conditions of the Agreement remain unchanged and in full force and effect.  </font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:112.32pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CONFIDENTIAL TREATMENT</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The Parties have executed this Amendment No. 1 by their designated representatives set forth below.   </font></div><div style="margin-top:12pt;text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.249%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.551%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 20.02pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">AMGEN USA INC.</font></td><td colspan="3" style="padding:2px 1pt 2px 20.22pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">DAVITA INC.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:19pt;padding-right:2.75pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:19pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;padding-left:19pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name (print)&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:19pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">_______________________________ </font></div><div style="padding-left:19pt;padding-right:2.75pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:19pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Date&#58;  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">      </font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:12pt;padding-left:19pt;padding-right:2.75pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:19pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;padding-left:19pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name (print)&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:18pt;padding-left:19.3pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;padding-left:19pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Date&#58;  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div></td></tr></table></div><div style="margin-top:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:112.32pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CONFIDENTIAL TREATMENT</font></div></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">EXHIBIT A</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">DISCOUNT TERMS AND CONDITIONS</font></div><div style="padding-left:21.6pt;text-indent:-21.6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:12.44pt">AMGEN ESA INVOICE DISCOUNTS</font></div><div style="padding-left:21.6pt"><font><br></font></div><div style="padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">1.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.73pt;text-decoration:underline">Base Invoice Discounts</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Subject to the terms and conditions contained in the Agreement, Dialysis Center Purchasers shall be entitled to the Base Invoice Discount set forth in the following Base Invoice Discount Table, applied to WAC in effect at the time of purchase of EPOGEN or Aranesp, as applicable, by Dialysis Center Purchasers under the Agreement, exclusive of any wholesaler markup, discount, service fees or other charges&#58;</font></div><div style="padding-left:54pt;text-align:justify"><font><br></font></div><div style="padding-left:68.41pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.416%"><tr><td style="width:1.0%"></td><td style="width:27.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.109%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="background-color:#d9d9d9;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Base Invoice Discount Table</font></td></tr><tr><td colspan="3" style="background-color:#d9d9d9;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">PRODUCT</font></td><td colspan="3" style="background-color:#d9d9d9;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">NDC</font></td><td colspan="3" style="background-color:#d9d9d9;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">BASE INVOICE DISCOUNT PERCENTAGE</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">EPOGEN</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">All NDCs</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#91;*&#93;%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Aranesp</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">All NDCs</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#91;*&#93;%</font></td></tr></table></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:21.6pt;text-indent:-21.6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%;padding-left:12.44pt">FIXED PRICE REBATE</font></div><div style="padding-left:21.6pt"><font><br></font></div><div style="padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.73pt;text-decoration:underline">Definitions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  In addition to the defined terms set forth in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement, the following terms, as used in this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, shall have the meaning ascribed below.</font></div><div style="padding-left:45pt;text-align:justify"><font><br></font></div><div style="padding-left:81pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.1.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.57pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Aranesp Fixed Price</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the applicable Aranesp Fixed Price per microgram of Aranesp as set forth in the </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Aranesp Fixed Price Table</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> below.</font></div><div style="padding-left:45pt;text-align:justify"><font><br></font></div><div style="padding-left:81pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.692%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="background-color:#d9d9d9;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;padding-left:20.75pt;padding-right:20.75pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Aranesp Fixed Price Table</font></div></td></tr><tr><td colspan="3" style="background-color:#d9d9d9;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Calendar Year</font></td><td colspan="3" style="background-color:#d9d9d9;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Aranesp Fixed Price per mcg</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2023</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">$&#91;*&#93;</font></td></tr></table></div><div style="padding-left:45pt;text-align:justify"><font><br></font></div><div style="padding-left:81pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.1.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.57pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">EPOGEN Fixed Price</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the applicable EPOGEN Fixed Price per 1,000 IUs of EPOGEN as set forth below&#58;</font></div><div style="padding-left:45pt;text-align:justify"><font><br></font></div><div style="padding-left:81pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.692%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="background-color:#d9d9d9;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;padding-left:20.75pt;padding-right:20.75pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">EPOGEN Fixed Price Table  </font></div></td></tr><tr><td colspan="3" style="background-color:#d9d9d9;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Qualified Aggregate Purchases of EPOGEN in 1,000 IUs by Dialysis Center Purchasers</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">for Calendar Year 2023 </font></div></td><td colspan="3" style="background-color:#d9d9d9;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">EPOGEN Fixed Price per 1,000 IUs</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8804;&#91;*&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#91;*&#93;</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;*&#93; to &#91;*&#93;</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#91;*&#93;</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;*&#93; to &#91;*&#93;</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#91;*&#93;</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;*&#93; to &#91;*&#93;</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#91;*&#93;</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8805;&#91;*&#93;</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#91;*&#93;</font></td></tr></table></div><div style="padding-left:45pt;text-align:justify"><font><br></font></div><div style="padding-left:81pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.1.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.57pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Aranesp Fixed Price Rebate Percentage</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, at any date of determination, an amount equal to&#58; &#91;(A minus B), divided by A&#93; minus C, where </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:112.32pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CONFIDENTIAL TREATMENT</font></div></div><div style="padding-left:81pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(i) &#8220;A&#8221; equals Aranesp WAC in effect at time of purchase&#59; (ii) &#8220;B&#8221; equals Aranesp Fixed Price, and (iii) &#8220;C&#8221; equals Aranesp Base Invoice Discount Percentage.  For example, a determination of the Aranesp Fixed Price Rebate Percentage would be as follows&#58;</font></div><div style="padding-left:50.4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.262%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:11.75pt;padding-right:11.75pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Aranesp Fixed Price Rebate Percentage Illustration&#58;</font></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:11.75pt;padding-right:11.75pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;(Aranesp WAC &#8211; Aranesp Fixed Price) &#47; Aranesp WAC&#93; &#8211; Aranesp Base Invoice Discount Percentage</font></div></td></tr></table></div><div style="padding-left:45pt;text-align:justify"><font><br></font></div><div style="padding-left:81pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.1.4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.57pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">EPOGEN Fixed Price Rebate Percentage</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean, at any date of determination, an amount equal to&#58; &#91;(A minus B), divided by A&#93; minus C, where (i) &#8220;A&#8221; equals EPOGEN WAC in effect at time of purchase&#59; (ii) &#8220;B&#8221; equals EPOGEN Fixed Price, and (iii) &#8220;C&#8221; equals EPOGEN Base Invoice Discount Percentage.  For example, a determination of the EPOGEN Fixed Price Rebate Percentage would be as follows&#58;</font></div><div style="padding-left:50.4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.262%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:11.75pt;padding-right:11.75pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">EPOGEN Fixed Price Rebate Percentage Illustration&#58;</font></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:11.75pt;padding-right:11.75pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;(EPOGEN WAC &#8211; EPOGEN Fixed Price) &#47; EPOGEN WAC&#93; &#8211; EPOGEN Base Invoice Discount Percentage</font></div></td></tr></table></div><div style="padding-left:45pt;text-align:justify"><font><br></font></div><div style="padding-left:81pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.1.5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.57pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Qualified Gross Purchases of Aranesp</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the amount of Aranesp purchased by Dialysis Center Purchasers during the Term from an Authorized Wholesaler (or from Amgen pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) for use in providing Dialysis Services, and confirmed by Amgen through sales tracking data, including, without limitation, chargeback data from wholesalers.  Qualified Gross Purchases of Aranesp shall be calculated using the WAC in effect at the time of the relevant purchase, net of product returns and adjustments.</font></div><div style="padding-left:45pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:81pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.1.6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.57pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Qualified Gross Purchases of EPOGEN</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221; shall mean the amount of EPOGEN purchased by Dialysis Center Purchasers during the Term from an Authorized Wholesaler (or from Amgen pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">) for use in providing Dialysis Services, and confirmed by Amgen through sales tracking data, including, without limitation, chargeback data from wholesalers.  Qualified Gross Purchases of EPOGEN shall be calculated using the WAC in effect at the time of the relevant purchase, net of product returns and adjustments.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.73pt;text-decoration:underline">Aranesp Fixed Price Rebate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Dialysis Center shall earn the Aranesp Fixed Price Rebate for each Calendar Year during the Term in the manner described below in this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:81pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.2.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.57pt;text-decoration:underline">Calculation of Aranesp Fixed Price Rebate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Amgen shall calculate the amount of Dialysis Center&#8217;s Aranesp Fixed Price Rebate by multiplying the Qualified Gross Purchases of Aranesp during the applicable Calendar Year by the Aranesp Fixed Price Rebate Percentage for such Calendar Year.</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:81pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.2.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.57pt;text-decoration:underline">Payment of Aranesp Fixed Price Rebate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Amgen will pay such Aranesp Fixed Price Rebate to Dialysis Center (a) in the event of no Annual Purchase Commitment Deficiency, within ninety (90) days after the end of the corresponding Calendar Year, and (b) in the event of an Annual Purchase Commitment Deficiency, within forty-five (45) days after Amgen&#8217;s receipt of Dialysis Center&#8217;s notice of completion of Dialysis Center&#8217;s purchase order of </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:112.32pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CONFIDENTIAL TREATMENT</font></div></div><div style="padding-left:81pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">EPOGEN in an amount equal to the Annual Purchase Commitment Deficiency pursuant to Section 3.1.1.1 of the Agreement. The payment of such Aranesp Fixed Price Rebate to Dialysis Center shall be subject to any offset set forth in Section 3.1.1.1 of the Agreement.</font></div><div><font><br></font></div><div style="padding-left:81pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.2.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.57pt;text-decoration:underline">Vesting of Aranesp Fixed Price Rebate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Aranesp Fixed Price Rebate for a given Calendar Year shall vest on the last day of such Calendar Year.</font></div><div><font><br></font></div><div style="padding-left:45pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.73pt;text-decoration:underline">EPOGEN Fixed Price Rebate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  Dialysis Center shall earn the EPOGEN Fixed Price Rebate for each Calendar Year during the Term in the manner described below in this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 2.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:81pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.3.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.57pt;text-decoration:underline">Calculation of EPOGEN Fixed Price Rebate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Amgen shall calculate the amount of Dialysis Center&#8217;s EPOGEN Fixed Price Rebate by multiplying the Qualified Gross Purchases of EPOGEN during the applicable Calendar Year by the EPOGEN Fixed Price Rebate Percentage for such Calendar Year.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:81pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.3.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.57pt;text-decoration:underline">Payment of EPOGEN Fixed Price Rebate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> Amgen will pay such EPOGEN Fixed Price Rebate to Dialysis Center (a) in the event of no Annual Purchase Commitment Deficiency, within ninety (90) days after the end of the corresponding Calendar Year, and (b) in the event of an Annual Purchase Commitment Deficiency, within forty-five (45) days after Amgen&#8217;s receipt of Dialysis Center&#8217;s notice of completion of Dialysis Center&#8217;s purchase order of EPOGEN in an amount equal to the Annual Purchase Commitment Deficiency pursuant to </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.1.1.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement. The payment of such EPOGEN Fixed Price Rebate to Dialysis Center shall be subject to any offset set forth in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">Section 3.1.1.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> of the Agreement.</font></div><div style="padding-left:45pt;text-align:justify"><font><br></font></div><div style="padding-left:81pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.3.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%;padding-left:11.57pt;text-decoration:underline">Vesting of EPOGEN Fixed Price Rebate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The EPOGEN Fixed Price Rebate for a given Calendar Year shall vest on the last day of such Calendar Year.</font></div><div style="padding-left:81pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:112.32pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CONFIDENTIAL TREATMENT</font></div></div><div style="margin-top:6pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Schedule 1</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Data</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.416%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:57.293%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.225%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.666%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#4f81bd;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Category</font></td><td colspan="3" style="background-color:#4f81bd;border-left:0.5pt solid #ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Data Element</font></td><td colspan="3" style="background-color:#4f81bd;border-left:0.5pt solid #ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Facility</font></td><td colspan="3" style="background-color:#4f81bd;border-left:0.5pt solid #ffffff;border-right:0.5pt solid #ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Patient</font></td></tr><tr><td colspan="3" style="background-color:#b8cce4;border-top:1.5pt solid #ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Facility Reference</font></td><td colspan="3" style="background-color:#b8cce4;border-left:0.5pt solid #ffffff;border-top:1.5pt solid #ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Facility Name</font></td><td colspan="3" style="background-color:#b8cce4;border-left:0.5pt solid #ffffff;border-top:1.5pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#b8cce4;border-left:0.5pt solid #ffffff;border-right:0.5pt solid #ffffff;border-top:1.5pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbe5f1;border-top:0.5pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#dbe5f1;border-left:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Address</font></td><td colspan="3" style="background-color:#dbe5f1;border-left:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#dbe5f1;border-left:0.5pt solid #ffffff;border-right:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#b8cce4;border-top:0.5pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#b8cce4;border-left:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">City, State, Zip</font></td><td colspan="3" style="background-color:#b8cce4;border-left:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#b8cce4;border-left:0.5pt solid #ffffff;border-right:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbe5f1;border-top:0.5pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#dbe5f1;border-left:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Phone</font></td><td colspan="3" style="background-color:#dbe5f1;border-left:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#dbe5f1;border-left:0.5pt solid #ffffff;border-right:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#b8cce4;border-top:0.5pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#b8cce4;border-left:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Facility ID (unique within account)</font></td><td colspan="3" style="background-color:#b8cce4;border-left:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#b8cce4;border-left:0.5pt solid #ffffff;border-right:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbe5f1;border-top:0.5pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#dbe5f1;border-left:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Regional ID (unique within account)</font></td><td colspan="3" style="background-color:#dbe5f1;border-left:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#dbe5f1;border-left:0.5pt solid #ffffff;border-right:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#b8cce4;border-top:0.5pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#b8cce4;border-left:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">State in which facility is located</font></td><td colspan="3" style="background-color:#b8cce4;border-left:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#b8cce4;border-left:0.5pt solid #ffffff;border-right:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:0 1pt"></td></tr><tr style="height:17pt"><td colspan="3" style="background-color:#dbe5f1;border-top:0.5pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#dbe5f1;border-left:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#dbe5f1;border-left:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#dbe5f1;border-left:0.5pt solid #ffffff;border-right:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#b8cce4;border-top:0.5pt solid #ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Patient Demographics</font></td><td colspan="3" style="background-color:#b8cce4;border-left:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">De-identified Patient ID</font></td><td colspan="3" style="background-color:#b8cce4;border-left:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#b8cce4;border-left:0.5pt solid #ffffff;border-right:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:0 1pt"></td></tr><tr style="height:17pt"><td colspan="3" style="background-color:#dbe5f1;border-top:0.5pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#dbe5f1;border-left:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#dbe5f1;border-left:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#dbe5f1;border-left:0.5pt solid #ffffff;border-right:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#b8cce4;border-top:0.5pt solid #ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Medications</font></td><td colspan="3" style="background-color:#b8cce4;border-left:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">ESA Name</font></td><td colspan="3" style="background-color:#b8cce4;border-left:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#b8cce4;border-left:0.5pt solid #ffffff;border-right:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbe5f1;border-top:0.5pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#dbe5f1;border-left:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ESA Dose (&#91;*&#93;)</font></div></td><td colspan="3" style="background-color:#dbe5f1;border-left:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#dbe5f1;border-left:0.5pt solid #ffffff;border-right:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#b8cce4;border-top:0.5pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#b8cce4;border-left:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">EPOGEN Administration Frequency (On DVA offered Protocol)</font></td><td colspan="3" style="background-color:#b8cce4;border-left:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#b8cce4;border-left:0.5pt solid #ffffff;border-right:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbe5f1;border-top:0.5pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#dbe5f1;border-left:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Aranesp Administration Frequency*</font></td><td colspan="3" style="background-color:#dbe5f1;border-left:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#dbe5f1;border-left:0.5pt solid #ffffff;border-right:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbe5f1;border-top:0.5pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#dbe5f1;border-left:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Other ESA Administration Frequency*</font></td><td colspan="3" style="background-color:#dbe5f1;border-left:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#dbe5f1;border-left:0.5pt solid #ffffff;border-right:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbe5f1;border-top:0.5pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#dbe5f1;border-left:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">ESA Route of Administration</font></td><td colspan="3" style="background-color:#dbe5f1;border-left:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#dbe5f1;border-left:0.5pt solid #ffffff;border-right:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#b8cce4;border-top:0.5pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#b8cce4;border-left:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">ESA Start Date</font></td><td colspan="3" style="background-color:#b8cce4;border-left:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#b8cce4;border-left:0.5pt solid #ffffff;border-right:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#dbe5f1;border-top:0.5pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#dbe5f1;border-left:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">ESA Stop Date (Missed dose due to held)*</font></td><td colspan="3" style="background-color:#dbe5f1;border-left:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#dbe5f1;border-left:0.5pt solid #ffffff;border-right:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="3" style="background-color:#b8cce4;border-bottom:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#b8cce4;border-bottom:0.5pt solid #ffffff;border-left:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#b8cce4;border-bottom:0.5pt solid #ffffff;border-left:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#b8cce4;border-bottom:0.5pt solid #ffffff;border-left:0.5pt solid #ffffff;border-right:0.5pt solid #ffffff;border-top:0.5pt solid #ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%">* For designated fields, Dialysis Center will provide Amgen business rules to calculate value of the field based on the submitted Data.</font></div><div style="margin-top:6pt;text-align:center"><font><br></font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>dva-93022ex31110xq.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i7d8d8f7d642a483e9e23d3153f352e86_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.1</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 302 CERTIFICATION</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Javier J. Rodriguez, certify that&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;I have reviewed this quarterly report on Form 10-Q of DaVita Inc.&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:33.75pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:17pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:279.00pt"><tr><td style="width:1.0pt"></td><td style="width:277.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47; J</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AVIER  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">J. R</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ODRIGUEZ</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Javier J. Rodriguez</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; October&#160;28, 2022 </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>dva-93022ex31210xq.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i8c1fbb014057408d861b12ca2508d3a8_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.2</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 302 CERTIFICATION</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Joel Ackerman, certify that&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;I have reviewed this quarterly report on Form 10-Q of DaVita Inc.&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:33.75pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:33.75pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:33.75pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:33.75pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:17pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:279.75pt"><tr><td style="width:1.0pt"></td><td style="width:277.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47; Joel Ackerman</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Joel Ackerman</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Financial Officer and Treasurer</font></td></tr></table></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; October&#160;28, 2022 </font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>dva-93022ex32110xq.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ie9d4f56a710648258751d769705e728e_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.1</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:10pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of DaVita Inc. (the &#8220;Company&#8221;) on Form 10-Q for the quarter ended September&#160;30, 2022 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Periodic Report&#8221;), I, Javier J. Rodriguez, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Periodic Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:17pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:279.75pt"><tr><td style="width:1.0pt"></td><td style="width:277.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47; J</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">AVIER</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> J. R</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ODRIGUEZ</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Javier J. Rodriguez</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Executive Officer</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 28, 2022</font></td></tr></table></div><div style="margin-top:10pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>6
<FILENAME>dva-93022ex32210xq.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i72a3f78a91264432896abec7563b809a_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.2</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:10pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of DaVita Inc. (the &#8220;Company&#8221;) on Form 10-Q for the quarter ended September&#160;30, 2022 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Periodic Report&#8221;), I, Joel Ackerman, Chief Financial Officer and Treasurer of the Company, certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Periodic Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:17pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:279.75pt"><tr><td style="width:1.0pt"></td><td style="width:277.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">S</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47; Joel Ackerman</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Joel Ackerman</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Financial Officer and Treasurer</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 28, 2022</font></td></tr></table></div><div style="margin-top:10pt;text-indent:27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>dva-20220930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:3a89ce86-098c-4ec0-abc8-dda3315bf074,g:fd665bd8-0744-46ac-b10f-ff3cbe103a81-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dva="http://www.davita.com/20220930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.davita.com/20220930">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dva-20220930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dva-20220930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dva-20220930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dva-20220930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="DocumentandEntityInformation" roleURI="http://www.davita.com/role/DocumentandEntityInformation">
        <link:definition>0000001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFINCOMEunaudited" roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited">
        <link:definition>0000002 - Statement - CONSOLIDATED STATEMENTS OF INCOME (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited" roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited">
        <link:definition>0000003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSunaudited" roleURI="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited">
        <link:definition>0000004 - Statement - CONSOLIDATED BALANCE SHEETS (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSunauditedParenthetical" roleURI="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunauditedParenthetical">
        <link:definition>0000005 - Statement - CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited" roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited">
        <link:definition>0000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFEQUITYunaudited" roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited">
        <link:definition>0000007 - Statement - CONSOLIDATED STATEMENTS OF EQUITY (unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedconsolidatedinterimfinancialstatementsCondensedconsolidatedinterimfinancialstatements" roleURI="http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidatedinterimfinancialstatements">
        <link:definition>0000008 - Disclosure - Condensed consolidated interim financial statements Condensed consolidated interim financial statements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionRevenueRecognition" roleURI="http://www.davita.com/role/RevenueRecognitionRevenueRecognition">
        <link:definition>0000009 - Disclosure - Revenue Recognition Revenue Recognition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningspershareNotes" roleURI="http://www.davita.com/role/EarningspershareNotes">
        <link:definition>0000010 - Disclosure - Earnings per share (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Investmentsindebtandequitysecurities" roleURI="http://www.davita.com/role/Investmentsindebtandequitysecurities">
        <link:definition>0000011 - Disclosure - Investments in debt and equity securities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Goodwill" roleURI="http://www.davita.com/role/Goodwill">
        <link:definition>0000012 - Disclosure - Goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Longtermdebt" roleURI="http://www.davita.com/role/Longtermdebt">
        <link:definition>0000013 - Disclosure - Long-term debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.davita.com/role/CommitmentsandContingencies">
        <link:definition>0000014 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Shareholdersequity" roleURI="http://www.davita.com/role/Shareholdersequity">
        <link:definition>0000015 - Disclosure - Shareholders' equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Accumulatedothercomprehensivelossincome" roleURI="http://www.davita.com/role/Accumulatedothercomprehensivelossincome">
        <link:definition>0000016 - Disclosure - Accumulated other comprehensive (loss) income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Acquisitionsanddivestitures" roleURI="http://www.davita.com/role/Acquisitionsanddivestitures">
        <link:definition>0000017 - Disclosure - Acquisitions and divestitures</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Variableinterestentities" roleURI="http://www.davita.com/role/Variableinterestentities">
        <link:definition>0000018 - Disclosure - Variable interest entities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Fairvalueoffinancialinstruments" roleURI="http://www.davita.com/role/Fairvalueoffinancialinstruments">
        <link:definition>0000019 - Disclosure - Fair value of financial instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Segmentreporting" roleURI="http://www.davita.com/role/Segmentreporting">
        <link:definition>0000020 - Disclosure - Segment reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Newaccountingstandards" roleURI="http://www.davita.com/role/Newaccountingstandards">
        <link:definition>0000021 - Disclosure - New accounting standards</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies" roleURI="http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies">
        <link:definition>0000022 - Disclosure - Condensed consolidated interim financial statements Condensed consolidaed interim financial statements (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionSegmentrevenuebymajorpayorTables" roleURI="http://www.davita.com/role/RevenueRecognitionSegmentrevenuebymajorpayorTables">
        <link:definition>0000023 - Disclosure - Revenue Recognition Segment revenue by major payor (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningspershareEarningsPerShareTables" roleURI="http://www.davita.com/role/EarningspershareEarningsPerShareTables">
        <link:definition>0000024 - Disclosure - Earnings per share Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsindebtandequitysecuritiesTables" roleURI="http://www.davita.com/role/InvestmentsindebtandequitysecuritiesTables">
        <link:definition>0000025 - Disclosure - Investments in debt and equity securities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillTables" roleURI="http://www.davita.com/role/GoodwillTables">
        <link:definition>0000026 - Disclosure - Goodwill (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongtermdebtTables" roleURI="http://www.davita.com/role/LongtermdebtTables">
        <link:definition>0000027 - Disclosure - Long-term debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharerepurchasesShareRepurchasesTables" roleURI="http://www.davita.com/role/SharerepurchasesShareRepurchasesTables">
        <link:definition>0000028 - Disclosure - Share repurchases Share Repurchases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedothercomprehensivelossincomeTables" roleURI="http://www.davita.com/role/AccumulatedothercomprehensivelossincomeTables">
        <link:definition>0000029 - Disclosure - Accumulated other comprehensive (loss) income (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsanddivestituresTables" roleURI="http://www.davita.com/role/AcquisitionsanddivestituresTables">
        <link:definition>0000030 - Disclosure - Acquisitions and divestitures (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairvalueoffinancialinstrumentsTables" roleURI="http://www.davita.com/role/FairvalueoffinancialinstrumentsTables">
        <link:definition>0000031 - Disclosure - Fair value of financial instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentreportingTables" roleURI="http://www.davita.com/role/SegmentreportingTables">
        <link:definition>0000032 - Disclosure - Segment reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionSegmentRevenuebyPayorDetails" roleURI="http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails">
        <link:definition>0000033 - Disclosure - Revenue Recognition Segment Revenue by Payor (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails" roleURI="http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails">
        <link:definition>0000034 - Disclosure - Earnings per share Earnings per share - Reconciliation of numberators and denominators used to calculate basic and diluted earnings per share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsindebtandequitysecuritiesDetail" roleURI="http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail">
        <link:definition>0000035 - Disclosure - Investments in debt and equity securities (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillChangesinGoodwillbyReportableSegmentsDetail" roleURI="http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail">
        <link:definition>0000036 - Disclosure - Goodwill - Changes in Goodwill by Reportable Segments (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillNarrativeDetails" roleURI="http://www.davita.com/role/GoodwillNarrativeDetails">
        <link:definition>0000037 - Disclosure - Goodwill - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongtermdebtDetail" roleURI="http://www.davita.com/role/LongtermdebtDetail">
        <link:definition>0000038 - Disclosure - Long-term debt (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongtermdebtScheduleofDerivativeInstrumentsDetails" roleURI="http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails">
        <link:definition>0000039 - Disclosure - Long-term debt Schedule of Derivative Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongtermdebtAdditionalInformationDetail" roleURI="http://www.davita.com/role/LongtermdebtAdditionalInformationDetail">
        <link:definition>0000040 - Disclosure - Long-term debt - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesAdditionalInformationDetail" roleURI="http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail">
        <link:definition>0000041 - Disclosure - Commitments and Contingencies - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongtermincentivecompensationDetails" roleURI="http://www.davita.com/role/LongtermincentivecompensationDetails">
        <link:definition>0000042 - Disclosure - Long-term incentive compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharerepurchasesShareRepurchaseTableDetails" roleURI="http://www.davita.com/role/SharerepurchasesShareRepurchaseTableDetails">
        <link:definition>0000043 - Disclosure - Share repurchases Share Repurchase Table (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharerepurchasesDetails" roleURI="http://www.davita.com/role/SharerepurchasesDetails">
        <link:definition>0000044 - Disclosure - Share repurchases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedothercomprehensivelossincomeDetail" roleURI="http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail">
        <link:definition>0000045 - Disclosure - Accumulated other comprehensive (loss) income (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsanddivestituresContingentEarnoutobligationsDetails" roleURI="http://www.davita.com/role/AcquisitionsanddivestituresContingentEarnoutobligationsDetails">
        <link:definition>0000046 - Disclosure - Acquisitions and divestitures Contingent Earn-out obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsanddivestituresAdditionalInformationDetail" roleURI="http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail">
        <link:definition>0000047 - Disclosure - Acquisitions and divestitures - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="VariableinterestentitiesAdditionalInformationDetail" roleURI="http://www.davita.com/role/VariableinterestentitiesAdditionalInformationDetail">
        <link:definition>0000048 - Disclosure - Variable interest entities - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail" roleURI="http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail">
        <link:definition>0000049 - Disclosure - Fair value of financial instruments - Assets, Liabilities and Temporary Equity Measured at Fair Value on Recurring Basis (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairvalueoffinancialinstrumentsFairValueofFinancialInstrumentsDetails" roleURI="http://www.davita.com/role/FairvalueoffinancialinstrumentsFairValueofFinancialInstrumentsDetails">
        <link:definition>0000050 - Disclosure - Fair value of financial instruments Fair Value of Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail" roleURI="http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail">
        <link:definition>0000051 - Disclosure - Segment reporting - Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income Before Income Taxes (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail" roleURI="http://www.davita.com/role/SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail">
        <link:definition>0000052 - Disclosure - Segment reporting - Summary of Depreciation and Amortization Expense by Segment (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail" roleURI="http://www.davita.com/role/SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail">
        <link:definition>0000053 - Disclosure - Segment reporting - Summary of Expenditures for Property and Equipment by Segment (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentreportingSummaryofAssetsbySegmentDetail" roleURI="http://www.davita.com/role/SegmentreportingSummaryofAssetsbySegmentDetail">
        <link:definition>0000054 - Disclosure - Segment reporting - Summary of Assets by Segment (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="dva_CorporateIntegrityAgreementPeriod" abstract="false" name="CorporateIntegrityAgreementPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dva_TermLoanB1Member" abstract="true" name="TermLoanB1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_OtherNoncashAssetsCommitment" abstract="false" name="OtherNoncashAssetsCommitment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember" abstract="true" name="SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_PatientCareCosts" abstract="false" name="PatientCareCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember" abstract="true" name="CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_USDialysisAndRelatedServicesMember" abstract="true" name="USDialysisAndRelatedServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_MutualFundsAndCommonStockMember" abstract="true" name="MutualFundsAndCommonStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_AcquisitionObligationsAndOtherNotesPayableFairValue" abstract="false" name="AcquisitionObligationsAndOtherNotesPayableFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_NoncontrollingInterestIncreaseFromContributions" abstract="false" name="NoncontrollingInterestIncreaseFromContributions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_SegmentRevenuebyMajorPayorAbstract" abstract="true" name="SegmentRevenuebyMajorPayorAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dva_OpenMarketPurchasesMember" abstract="true" name="OpenMarketPurchasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_OtherSourcesofRevenueMember" abstract="true" name="OtherSourcesofRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_NoncontrollingInterestChangesFromOther" abstract="false" name="NoncontrollingInterestChangesFromOther" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" abstract="false" name="BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dva_OtherGovernmentPayorsMember" abstract="true" name="OtherGovernmentPayorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_SegmentReportingInformationCorporateExpenses" abstract="false" name="SegmentReportingInformationCorporateExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_AgreementWithMedtronicMember" abstract="true" name="AgreementWithMedtronicMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_OtherReportingUnitsMember" abstract="true" name="OtherReportingUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" abstract="false" name="TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_MedicaidandManagedMedicaidMember" abstract="true" name="MedicaidandManagedMedicaidMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_DebtExpenseMember" abstract="true" name="DebtExpenseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_RegulatoryAndCommercialMilestonesBeginningDate" abstract="false" name="RegulatoryAndCommercialMilestonesBeginningDate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:dateItemType"/>
  <xs:element id="dva_TemporaryEquityDecreasePurchaseOfInterests" abstract="false" name="TemporaryEquityDecreasePurchaseOfInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" abstract="false" name="IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_AdditionalCashCommitment" abstract="false" name="AdditionalCashCommitment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_ForeignDialysisCentersMember" abstract="true" name="ForeignDialysisCentersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_RevenuesbymajorpayorAbstract" abstract="true" name="RevenuesbymajorpayorAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted" abstract="false" name="SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_CommercialPayorsMember" abstract="true" name="CommercialPayorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_BusinessCombinationContingentConsiderationAcquisitions" abstract="false" name="BusinessCombinationContingentConsiderationAcquisitions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_LongTermDebtPercentageBearingEconomicallyFixedInterestRate" abstract="false" name="LongTermDebtPercentageBearingEconomicallyFixedInterestRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" abstract="false" name="RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_FinanceLeaseMember" abstract="true" name="FinanceLeaseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_TemporaryEquityRedeemableNoncontrollingInterestsMember" abstract="true" name="TemporaryEquityRedeemableNoncontrollingInterestsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" abstract="false" name="TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple" abstract="false" name="PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_USAttorneyPrescriptionDrugInvestigationMember" abstract="true" name="USAttorneyPrescriptionDrugInvestigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember" abstract="true" name="SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_TermLoanFacilityMember" abstract="true" name="TermLoanFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_A2019InterestRateCapAgreementsEffectiveJune302020Member" abstract="true" name="A2019InterestRateCapAgreementsEffectiveJune302020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations" abstract="false" name="ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_RegulatoryAndCommercialMilestonesEndingDate" abstract="false" name="RegulatoryAndCommercialMilestonesEndingDate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:dateItemType"/>
  <xs:element id="dva_BusinessAgreementDate" abstract="false" name="BusinessAgreementDate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:dateItemType"/>
  <xs:element id="dva_NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures" abstract="false" name="NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock" abstract="false" name="ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="dva_DiscountPremiumAndDeferredFinancingCosts" abstract="false" name="DiscountPremiumAndDeferredFinancingCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_BilateralSecuredLetterOfCreditFacilityMember" abstract="true" name="BilateralSecuredLetterOfCreditFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_SeniorSecuredCreditFacilitiesMember" abstract="true" name="SeniorSecuredCreditFacilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures" abstract="false" name="TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss" abstract="false" name="BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures" abstract="false" name="NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_TermLoanAMember" abstract="true" name="TermLoanAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_ExternalSourcesMember" abstract="true" name="ExternalSourcesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_CommitmentsToProvideOperatingCapitalMember" abstract="true" name="CommitmentsToProvideOperatingCapitalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_CorporateIntegrityAgreementExpirationDate" abstract="false" name="CorporateIntegrityAgreementExpirationDate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:dateItemType"/>
  <xs:element id="dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR" abstract="false" name="SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_OtherCompaniesMember" abstract="true" name="OtherCompaniesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_MedicareandMedicareAdvantageMember" abstract="true" name="MedicareandMedicareAdvantageMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember" abstract="true" name="EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_IncrementalCashPortionMember" abstract="true" name="IncrementalCashPortionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_USDialysisAndRelatedLabServicesMember" abstract="true" name="USDialysisAndRelatedLabServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_CashPaidForPortionPreviouslyRefundedMember" abstract="true" name="CashPaidForPortionPreviouslyRefundedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dva_BusinessAcquisitionGoodwillExpectedTaxDeductibleAmountAdjustment" abstract="false" name="BusinessAcquisitionGoodwillExpectedTaxDeductibleAmountAdjustment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dva_AcquisitionObligationsAndOtherNotesPayable" abstract="false" name="AcquisitionObligationsAndOtherNotesPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>dva-20220930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:3a89ce86-098c-4ec0-abc8-dda3315bf074,g:fd665bd8-0744-46ac-b10f-ff3cbe103a81-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited" xlink:type="simple" xlink:href="dva-20220930.xsd#CONSOLIDATEDSTATEMENTSOFINCOMEunaudited"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_650bb732-8981-416c-8bee-75bb169650fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_40b0c069-bea4-487e-a609-0c099a04eda8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_650bb732-8981-416c-8bee-75bb169650fb" xlink:to="loc_us-gaap_OperatingIncomeLoss_40b0c069-bea4-487e-a609-0c099a04eda8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense_a529dd05-755f-43a5-a7de-804f66abbc9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_650bb732-8981-416c-8bee-75bb169650fb" xlink:to="loc_us-gaap_InterestAndDebtExpense_a529dd05-755f-43a5-a7de-804f66abbc9a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_9fb68fc0-c862-4f1c-8752-42261e1235ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_650bb732-8981-416c-8bee-75bb169650fb" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_9fb68fc0-c862-4f1c-8752-42261e1235ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f11ed427-9130-4cc2-a5f3-bd5b6b2207b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_b76220a4-c273-4385-93e3-442e04645b69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_f11ed427-9130-4cc2-a5f3-bd5b6b2207b0" xlink:to="loc_us-gaap_ProfitLoss_b76220a4-c273-4385-93e3-442e04645b69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8b66e1d4-1506-4f9a-bb32-307f2a61d95c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_f11ed427-9130-4cc2-a5f3-bd5b6b2207b0" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8b66e1d4-1506-4f9a-bb32-307f2a61d95c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_fcd08ff8-1082-47be-b7ac-a0b565a6e60e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PatientCareCosts_cc020f8c-64fa-4dad-b752-288149ea21ac" xlink:href="dva-20220930.xsd#dva_PatientCareCosts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_fcd08ff8-1082-47be-b7ac-a0b565a6e60e" xlink:to="loc_dva_PatientCareCosts_cc020f8c-64fa-4dad-b752-288149ea21ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_ef677c11-a1d5-4db2-8c3c-140a48d97047" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_fcd08ff8-1082-47be-b7ac-a0b565a6e60e" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_ef677c11-a1d5-4db2-8c3c-140a48d97047" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_258ec39e-0f0a-4aed-982f-4e985206a8e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_fcd08ff8-1082-47be-b7ac-a0b565a6e60e" xlink:to="loc_us-gaap_DepreciationAndAmortization_258ec39e-0f0a-4aed-982f-4e985206a8e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_b0302780-a962-47ac-bc43-2b41a0813ded" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_fcd08ff8-1082-47be-b7ac-a0b565a6e60e" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_b0302780-a962-47ac-bc43-2b41a0813ded" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_1054e57e-0bc3-4bce-bfda-1a1591da3f55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_1270affb-edb9-43d0-a954-05f74ad9615c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_1054e57e-0bc3-4bce-bfda-1a1591da3f55" xlink:to="loc_us-gaap_Revenues_1270affb-edb9-43d0-a954-05f74ad9615c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_99905e64-14d3-4a2e-a81a-f7a085043e6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_1054e57e-0bc3-4bce-bfda-1a1591da3f55" xlink:to="loc_us-gaap_CostsAndExpenses_99905e64-14d3-4a2e-a81a-f7a085043e6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c140890d-0b89-4409-aeb3-144c53e371d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_2b13ee7e-0283-4cdb-9faa-d33a364976f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_c140890d-0b89-4409-aeb3-144c53e371d4" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_2b13ee7e-0283-4cdb-9faa-d33a364976f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8b301379-979b-4ed2-93c5-7c8895d04969" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_c140890d-0b89-4409-aeb3-144c53e371d4" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8b301379-979b-4ed2-93c5-7c8895d04969" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_848ac474-2375-462a-aeff-967bb183564d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts_48ec63ac-874c-4697-a594-f764201cf4c5" xlink:href="dva-20220930.xsd#dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_848ac474-2375-462a-aeff-967bb183564d" xlink:to="loc_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts_48ec63ac-874c-4697-a594-f764201cf4c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_105c7a81-7e9c-41b6-93ed-5389f7343ac0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_848ac474-2375-462a-aeff-967bb183564d" xlink:to="loc_us-gaap_OtherIncome_105c7a81-7e9c-41b6-93ed-5389f7343ac0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited" xlink:type="simple" xlink:href="dva-20220930.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_4f20928c-a7cc-4e21-9128-5e332f350570" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b6ef36d6-2ee2-4a4b-a3da-5b27fae2d329" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_4f20928c-a7cc-4e21-9128-5e332f350570" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b6ef36d6-2ee2-4a4b-a3da-5b27fae2d329" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_e5bdf22b-e3fe-4812-9a9b-67d0d08dcd24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_4f20928c-a7cc-4e21-9128-5e332f350570" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_e5bdf22b-e3fe-4812-9a9b-67d0d08dcd24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_fef0e7af-af25-4288-9ab9-c1ad6a14a48e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_91e6c061-3a03-42c3-af02-16923fed7815" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_fef0e7af-af25-4288-9ab9-c1ad6a14a48e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_91e6c061-3a03-42c3-af02-16923fed7815" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_24c2effd-3b91-4885-b66d-5bb7f6295e0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_fef0e7af-af25-4288-9ab9-c1ad6a14a48e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_24c2effd-3b91-4885-b66d-5bb7f6295e0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_2971157a-1e67-4ec5-b452-5f6b04518946" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_fef0e7af-af25-4288-9ab9-c1ad6a14a48e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_2971157a-1e67-4ec5-b452-5f6b04518946" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_4c146bb3-3c62-4cc6-afa5-d54df3b5bcf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_390a8221-8b27-4e93-ad72-58166c901cc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_4c146bb3-3c62-4cc6-afa5-d54df3b5bcf9" xlink:to="loc_us-gaap_ProfitLoss_390a8221-8b27-4e93-ad72-58166c901cc1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3cc47196-a40f-4e90-9ece-c2044fcad4de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_4c146bb3-3c62-4cc6-afa5-d54df3b5bcf9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3cc47196-a40f-4e90-9ece-c2044fcad4de" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited" xlink:type="simple" xlink:href="dva-20220930.xsd#CONSOLIDATEDBALANCESHEETSunaudited"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_84ef427d-d9d8-4c9e-b3e0-91ffd1c1d334" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_e25ab8e0-7035-49f6-ad36-9302bfaf517f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_84ef427d-d9d8-4c9e-b3e0-91ffd1c1d334" xlink:to="loc_us-gaap_PreferredStockValue_e25ab8e0-7035-49f6-ad36-9302bfaf517f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_832b7a75-1c42-4f02-b479-ec77407b5d01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_84ef427d-d9d8-4c9e-b3e0-91ffd1c1d334" xlink:to="loc_us-gaap_CommonStockValue_832b7a75-1c42-4f02-b479-ec77407b5d01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_e61b3d77-2a45-4bed-8d98-841815c4f4e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_84ef427d-d9d8-4c9e-b3e0-91ffd1c1d334" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_e61b3d77-2a45-4bed-8d98-841815c4f4e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_fc7a67af-fe99-49ef-8d81-779570c7bdda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_84ef427d-d9d8-4c9e-b3e0-91ffd1c1d334" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_fc7a67af-fe99-49ef-8d81-779570c7bdda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_eb007381-0ab9-4b9f-a5e7-5d728e73a343" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_84ef427d-d9d8-4c9e-b3e0-91ffd1c1d334" xlink:to="loc_us-gaap_TreasuryStockValue_eb007381-0ab9-4b9f-a5e7-5d728e73a343" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9df5a526-a94f-4a3f-b299-b6fc79fbb2c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_84ef427d-d9d8-4c9e-b3e0-91ffd1c1d334" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9df5a526-a94f-4a3f-b299-b6fc79fbb2c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_696286d8-ed52-4d70-8d78-091b45991e76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_3f2edab5-3dc2-4413-a50a-4956b6e792d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_696286d8-ed52-4d70-8d78-091b45991e76" xlink:to="loc_us-gaap_Liabilities_3f2edab5-3dc2-4413-a50a-4956b6e792d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_553007f5-7d64-4a15-9472-c7cb5143d6a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_696286d8-ed52-4d70-8d78-091b45991e76" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_553007f5-7d64-4a15-9472-c7cb5143d6a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a6789341-7b2c-4dc0-883e-bdd3fc19b70c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_696286d8-ed52-4d70-8d78-091b45991e76" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a6789341-7b2c-4dc0-883e-bdd3fc19b70c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_b234aef0-aaa1-41a9-b388-c3fab071e897" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_47e08544-6ecc-4cab-a2e3-22af8fff88ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b234aef0-aaa1-41a9-b388-c3fab071e897" xlink:to="loc_us-gaap_AssetsCurrent_47e08544-6ecc-4cab-a2e3-22af8fff88ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_d447f9f0-09c0-49ad-8f08-50759adab178" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b234aef0-aaa1-41a9-b388-c3fab071e897" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_d447f9f0-09c0-49ad-8f08-50759adab178" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_151ace2d-5ef0-4509-81ad-f8908956c1e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b234aef0-aaa1-41a9-b388-c3fab071e897" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_151ace2d-5ef0-4509-81ad-f8908956c1e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_41a540d3-825c-40d2-aa79-553a95acaf3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b234aef0-aaa1-41a9-b388-c3fab071e897" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_41a540d3-825c-40d2-aa79-553a95acaf3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_6abb6690-d307-4398-92b5-41f69a65ec1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b234aef0-aaa1-41a9-b388-c3fab071e897" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_6abb6690-d307-4398-92b5-41f69a65ec1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_0a25dc6f-f527-4b68-9cc5-0d921a39b288" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b234aef0-aaa1-41a9-b388-c3fab071e897" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_0a25dc6f-f527-4b68-9cc5-0d921a39b288" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f7c206fa-2b83-4c42-92b4-b20492743c67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b234aef0-aaa1-41a9-b388-c3fab071e897" xlink:to="loc_us-gaap_Goodwill_f7c206fa-2b83-4c42-92b4-b20492743c67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_7f072fe8-9c70-44ca-a3db-6ce5f3b5a3c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b234aef0-aaa1-41a9-b388-c3fab071e897" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_7f072fe8-9c70-44ca-a3db-6ce5f3b5a3c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_ff1d3e40-2192-4394-b4ca-9ca3616ed1e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e56f55ae-d992-4591-848c-d3a2651b9b11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ff1d3e40-2192-4394-b4ca-9ca3616ed1e7" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e56f55ae-d992-4591-848c-d3a2651b9b11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_3dbffe68-cf1b-498d-b951-698ee0d074cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ff1d3e40-2192-4394-b4ca-9ca3616ed1e7" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_3dbffe68-cf1b-498d-b951-698ee0d074cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_beb59c9d-75bc-4f9e-95ba-8a55cb34f1ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ff1d3e40-2192-4394-b4ca-9ca3616ed1e7" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_beb59c9d-75bc-4f9e-95ba-8a55cb34f1ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_d21bb37e-0280-4995-94ae-ce932557c3a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ff1d3e40-2192-4394-b4ca-9ca3616ed1e7" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_d21bb37e-0280-4995-94ae-ce932557c3a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_e36ff3dc-0be3-47f6-a95b-08fa6f48fc78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ff1d3e40-2192-4394-b4ca-9ca3616ed1e7" xlink:to="loc_us-gaap_InventoryNet_e36ff3dc-0be3-47f6-a95b-08fa6f48fc78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_56c3d42e-c93e-4679-ba14-e2742d03c98a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ff1d3e40-2192-4394-b4ca-9ca3616ed1e7" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_56c3d42e-c93e-4679-ba14-e2742d03c98a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_283994ba-167c-4638-b124-ccbe3d3f7df7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ff1d3e40-2192-4394-b4ca-9ca3616ed1e7" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_283994ba-167c-4638-b124-ccbe3d3f7df7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_88e0e2d8-8de7-4fff-9c61-7b904ced058e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ff1d3e40-2192-4394-b4ca-9ca3616ed1e7" xlink:to="loc_us-gaap_IncomeTaxesReceivable_88e0e2d8-8de7-4fff-9c61-7b904ced058e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_cf7e4ff1-c61f-4dd2-8442-e523615fe8fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f8b67de0-b105-4acd-9b99-e455e5782720" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_cf7e4ff1-c61f-4dd2-8442-e523615fe8fc" xlink:to="loc_us-gaap_StockholdersEquity_f8b67de0-b105-4acd-9b99-e455e5782720" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_3558d169-1011-4283-a43f-2a64367f84d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_cf7e4ff1-c61f-4dd2-8442-e523615fe8fc" xlink:to="loc_us-gaap_MinorityInterest_3558d169-1011-4283-a43f-2a64367f84d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_5918dd75-a6dc-44f0-bb0b-b090ee61f239" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_63617ce4-7091-467e-aefa-6e323f6d7965" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_5918dd75-a6dc-44f0-bb0b-b090ee61f239" xlink:to="loc_us-gaap_AccountsPayableCurrent_63617ce4-7091-467e-aefa-6e323f6d7965" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_d5592a3e-9f08-4667-a541-5ef4765d8f8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_5918dd75-a6dc-44f0-bb0b-b090ee61f239" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_d5592a3e-9f08-4667-a541-5ef4765d8f8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_ebc57a1b-f9a2-4bde-b941-56e48bea6b9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_5918dd75-a6dc-44f0-bb0b-b090ee61f239" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_ebc57a1b-f9a2-4bde-b941-56e48bea6b9a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_a9fb646d-4c49-4610-a63c-b0e086ee4c0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_5918dd75-a6dc-44f0-bb0b-b090ee61f239" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_a9fb646d-4c49-4610-a63c-b0e086ee4c0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_58345ea9-92be-4884-98e9-c2b062685e0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_5918dd75-a6dc-44f0-bb0b-b090ee61f239" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_58345ea9-92be-4884-98e9-c2b062685e0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_7138ee41-c2db-473a-9337-07ccfec901f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_5918dd75-a6dc-44f0-bb0b-b090ee61f239" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_7138ee41-c2db-473a-9337-07ccfec901f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_a7d52e10-7607-4ee3-afa6-3ea6a7a6c200" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_780c3c6c-87bd-45cc-bf56-0a9f74bf4bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a7d52e10-7607-4ee3-afa6-3ea6a7a6c200" xlink:to="loc_us-gaap_LiabilitiesCurrent_780c3c6c-87bd-45cc-bf56-0a9f74bf4bd2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_db30cfcc-d864-4fcf-a9e3-c8976cdb17cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a7d52e10-7607-4ee3-afa6-3ea6a7a6c200" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_db30cfcc-d864-4fcf-a9e3-c8976cdb17cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_ea069a6c-e683-411d-9e2f-08bce4305a68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a7d52e10-7607-4ee3-afa6-3ea6a7a6c200" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_ea069a6c-e683-411d-9e2f-08bce4305a68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_ab29cbca-9f43-4cce-8fe2-9f1859162f1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a7d52e10-7607-4ee3-afa6-3ea6a7a6c200" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_ab29cbca-9f43-4cce-8fe2-9f1859162f1c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_f0b2bc1e-07ec-4eb4-afef-35a5d019c412" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a7d52e10-7607-4ee3-afa6-3ea6a7a6c200" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_f0b2bc1e-07ec-4eb4-afef-35a5d019c412" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited" xlink:type="simple" xlink:href="dva-20220930.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_80f1b5d9-49f3-4b66-ab13-6afc3a246cd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_bd64fac8-9c33-4f03-934e-cd7b88a41bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_80f1b5d9-49f3-4b66-ab13-6afc3a246cd2" xlink:to="loc_us-gaap_ProfitLoss_bd64fac8-9c33-4f03-934e-cd7b88a41bf9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet_3877803a-9d56-4410-8d8f-e4cf7e110958" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_80f1b5d9-49f3-4b66-ab13-6afc3a246cd2" xlink:to="loc_us-gaap_DepreciationAmortizationAndAccretionNet_3877803a-9d56-4410-8d8f-e4cf7e110958" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_b63542e0-cdb6-4c33-935f-631ec9f375c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_80f1b5d9-49f3-4b66-ab13-6afc3a246cd2" xlink:to="loc_us-gaap_ShareBasedCompensation_b63542e0-cdb6-4c33-935f-631ec9f375c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_ac72aae1-fd6e-45c9-9ae1-113470c1b0d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_80f1b5d9-49f3-4b66-ab13-6afc3a246cd2" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_ac72aae1-fd6e-45c9-9ae1-113470c1b0d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_89879987-0b45-4c30-8152-ed170ed2890c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_80f1b5d9-49f3-4b66-ab13-6afc3a246cd2" xlink:to="loc_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_89879987-0b45-4c30-8152-ed170ed2890c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_31ce5605-b30f-44de-899e-640fb96754ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_80f1b5d9-49f3-4b66-ab13-6afc3a246cd2" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_31ce5605-b30f-44de-899e-640fb96754ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_cc9ed8aa-28df-4ed2-9e0c-566af874b3b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_80f1b5d9-49f3-4b66-ab13-6afc3a246cd2" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_cc9ed8aa-28df-4ed2-9e0c-566af874b3b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_95a3a070-85be-4c9e-bc78-b30ec3a657be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_80f1b5d9-49f3-4b66-ab13-6afc3a246cd2" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_95a3a070-85be-4c9e-bc78-b30ec3a657be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets_40c8b56c-c0e1-4cfb-a426-8e75573741b3" xlink:href="dva-20220930.xsd#dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_80f1b5d9-49f3-4b66-ab13-6afc3a246cd2" xlink:to="loc_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets_40c8b56c-c0e1-4cfb-a426-8e75573741b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_af50425c-278b-40b5-88e4-50cb5d5efbcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_80f1b5d9-49f3-4b66-ab13-6afc3a246cd2" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_af50425c-278b-40b5-88e4-50cb5d5efbcc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_e559c956-bc10-42d9-ba25-6795a769194a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_80f1b5d9-49f3-4b66-ab13-6afc3a246cd2" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_e559c956-bc10-42d9-ba25-6795a769194a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_385e2af7-a418-48ba-a8f0-fd322a241cbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_80f1b5d9-49f3-4b66-ab13-6afc3a246cd2" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_385e2af7-a418-48ba-a8f0-fd322a241cbf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_2a77e295-fd02-448d-9dee-85fc62fd1c78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_80f1b5d9-49f3-4b66-ab13-6afc3a246cd2" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_2a77e295-fd02-448d-9dee-85fc62fd1c78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_f9d49dbd-09ea-4532-a0c0-feaa109b2fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_80f1b5d9-49f3-4b66-ab13-6afc3a246cd2" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_f9d49dbd-09ea-4532-a0c0-feaa109b2fcd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_f28eb358-6c2f-4495-8369-eda4de4fc0e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_80f1b5d9-49f3-4b66-ab13-6afc3a246cd2" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_f28eb358-6c2f-4495-8369-eda4de4fc0e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c53a508c-e00f-452d-a325-f6f0c78fea10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f7b90bce-40c7-49a1-9277-baa1bbcee346" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c53a508c-e00f-452d-a325-f6f0c78fea10" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f7b90bce-40c7-49a1-9277-baa1bbcee346" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2152a59e-6076-4d63-a60b-5c5d96a4126e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c53a508c-e00f-452d-a325-f6f0c78fea10" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2152a59e-6076-4d63-a60b-5c5d96a4126e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1a992638-ac43-450b-a2fb-1f8399145628" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c53a508c-e00f-452d-a325-f6f0c78fea10" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1a992638-ac43-450b-a2fb-1f8399145628" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0ed40ce8-f631-415d-934d-cef50ba7bbd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c53a508c-e00f-452d-a325-f6f0c78fea10" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0ed40ce8-f631-415d-934d-cef50ba7bbd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8e8b805a-c801-4cdc-9938-064e92b86d9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_23145ec6-b566-4361-8e91-edc029d386d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8e8b805a-c801-4cdc-9938-064e92b86d9f" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_23145ec6-b566-4361-8e91-edc029d386d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_d3279d2f-c51a-4d07-b11f-0fee2ec0c249" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8e8b805a-c801-4cdc-9938-064e92b86d9f" xlink:to="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_d3279d2f-c51a-4d07-b11f-0fee2ec0c249" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_0ef55e76-b353-453a-8667-d92522e4324f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8e8b805a-c801-4cdc-9938-064e92b86d9f" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_0ef55e76-b353-453a-8667-d92522e4324f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_00db9986-b7db-4a27-bc1a-df5bd382f954" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8e8b805a-c801-4cdc-9938-064e92b86d9f" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_00db9986-b7db-4a27-bc1a-df5bd382f954" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDistributionsToAffiliates_bf478dd9-4125-4c55-ba98-c64afb2832cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDistributionsToAffiliates"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8e8b805a-c801-4cdc-9938-064e92b86d9f" xlink:to="loc_us-gaap_PaymentsOfDistributionsToAffiliates_bf478dd9-4125-4c55-ba98-c64afb2832cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_eba1f98a-3638-4af8-a254-3cdd20141b67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8e8b805a-c801-4cdc-9938-064e92b86d9f" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_eba1f98a-3638-4af8-a254-3cdd20141b67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromContributionsFromAffiliates_95def2f8-c813-4e8e-827a-f2fc6390e5b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromContributionsFromAffiliates"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8e8b805a-c801-4cdc-9938-064e92b86d9f" xlink:to="loc_us-gaap_ProceedsFromContributionsFromAffiliates_95def2f8-c813-4e8e-827a-f2fc6390e5b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders_7bb19455-1f5e-4914-b7da-df56c2613d99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8e8b805a-c801-4cdc-9938-064e92b86d9f" xlink:to="loc_us-gaap_ProceedsFromMinorityShareholders_7bb19455-1f5e-4914-b7da-df56c2613d99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_977bf658-10fb-4b54-9fbc-86fece5dbaa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8e8b805a-c801-4cdc-9938-064e92b86d9f" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_977bf658-10fb-4b54-9fbc-86fece5dbaa2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_18bd3e09-71ba-44dd-9ef2-33c231f449aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_97494878-8b60-4879-9585-511286ea1f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_18bd3e09-71ba-44dd-9ef2-33c231f449aa" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_97494878-8b60-4879-9585-511286ea1f5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_3e46794e-eb0f-462f-8048-aaa5bc023ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_18bd3e09-71ba-44dd-9ef2-33c231f449aa" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_3e46794e-eb0f-462f-8048-aaa5bc023ed1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_10fcf42b-5842-41a3-b83d-7f42fccd552a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_18bd3e09-71ba-44dd-9ef2-33c231f449aa" xlink:to="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_10fcf42b-5842-41a3-b83d-7f42fccd552a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_db4731ff-d076-4f12-bc54-79153a702b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireHeldToMaturitySecurities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_18bd3e09-71ba-44dd-9ef2-33c231f449aa" xlink:to="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_db4731ff-d076-4f12-bc54-79153a702b2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherInvestments_226c9790-e7d9-4f43-bf4b-d14973bce57c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireOtherInvestments"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_18bd3e09-71ba-44dd-9ef2-33c231f449aa" xlink:to="loc_us-gaap_PaymentsToAcquireOtherInvestments_226c9790-e7d9-4f43-bf4b-d14973bce57c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_da9a9a98-efae-4525-8f47-a4ae83074c8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_18bd3e09-71ba-44dd-9ef2-33c231f449aa" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_da9a9a98-efae-4525-8f47-a4ae83074c8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments_f1ae0175-7539-49b2-b279-22915982f03e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_18bd3e09-71ba-44dd-9ef2-33c231f449aa" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments_f1ae0175-7539-49b2-b279-22915982f03e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_28701222-15f0-4d55-a765-db6f7f4b02f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_18bd3e09-71ba-44dd-9ef2-33c231f449aa" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_28701222-15f0-4d55-a765-db6f7f4b02f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_a0aff5fb-17e3-4bc7-8176-e5562bdab8eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_18bd3e09-71ba-44dd-9ef2-33c231f449aa" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_a0aff5fb-17e3-4bc7-8176-e5562bdab8eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_74ebb0cf-29d2-47a3-91f3-f1d713b70de6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_18bd3e09-71ba-44dd-9ef2-33c231f449aa" xlink:to="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_74ebb0cf-29d2-47a3-91f3-f1d713b70de6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails" xlink:type="simple" xlink:href="dva-20220930.xsd#EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5a902dc0-b6f7-48c9-a588-90fb31999589" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_0662e328-6549-47b8-94df-e0df3dd28766" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5a902dc0-b6f7-48c9-a588-90fb31999589" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_0662e328-6549-47b8-94df-e0df3dd28766" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_b10d2995-f712-4afc-93c7-1a0b66293c15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5a902dc0-b6f7-48c9-a588-90fb31999589" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_b10d2995-f712-4afc-93c7-1a0b66293c15" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail" xlink:type="simple" xlink:href="dva-20220930.xsd#InvestmentsindebtandequitysecuritiesDetail"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_14670670-59da-4f65-b6ed-cc8c29a26e4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities_efb245af-bb85-4b73-81b6-b32ac041dce7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_MarketableSecurities_14670670-59da-4f65-b6ed-cc8c29a26e4f" xlink:to="loc_us-gaap_HeldToMaturitySecurities_efb245af-bb85-4b73-81b6-b32ac041dce7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_66997cda-8073-4fb0-acf9-49cbe8bc59ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_MarketableSecurities_14670670-59da-4f65-b6ed-cc8c29a26e4f" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_66997cda-8073-4fb0-acf9-49cbe8bc59ac" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermdebtDetail" xlink:type="simple" xlink:href="dva-20220930.xsd#LongtermdebtDetail"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/LongtermdebtDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_e3bc20ff-7fb1-4815-9c47-0b8b172849df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_db091974-724b-47f4-ae72-a61674f7997b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_e3bc20ff-7fb1-4815-9c47-0b8b172849df" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_db091974-724b-47f4-ae72-a61674f7997b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_9e1b1fff-d93e-4deb-9935-e3a333bc1984" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_e3bc20ff-7fb1-4815-9c47-0b8b172849df" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_9e1b1fff-d93e-4deb-9935-e3a333bc1984" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail" xlink:type="simple" xlink:href="dva-20220930.xsd#AccumulatedothercomprehensivelossincomeDetail"/>
  <link:calculationLink xlink:role="http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_2afb32bd-7d3b-4d66-836f-760a2e4bb4e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_e1bc8acf-cf0a-413b-807c-59566f78bf68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_2afb32bd-7d3b-4d66-836f-760a2e4bb4e5" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_e1bc8acf-cf0a-413b-807c-59566f78bf68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_e5aea030-49f8-4881-8b2d-1ca8fccd706e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_2afb32bd-7d3b-4d66-836f-760a2e4bb4e5" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_e5aea030-49f8-4881-8b2d-1ca8fccd706e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_5c79c199-7f6e-4f5c-a914-b050261b717e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_fe650059-276d-44d2-bd25-83510363b2c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_5c79c199-7f6e-4f5c-a914-b050261b717e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_fe650059-276d-44d2-bd25-83510363b2c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_e3985419-fb2b-45d0-9668-2398cf18ad8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_5c79c199-7f6e-4f5c-a914-b050261b717e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_e3985419-fb2b-45d0-9668-2398cf18ad8f" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>dva-20220930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:3a89ce86-098c-4ec0-abc8-dda3315bf074,g:fd665bd8-0744-46ac-b10f-ff3cbe103a81-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited" xlink:type="simple" xlink:href="dva-20220930.xsd#CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited" xlink:type="extended" id="i9e7508751f574863bd02a2496d7aea2b_CONSOLIDATEDSTATEMENTSOFEQUITYunaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_d8772d2b-8cd2-46e4-8c0c-cc88b12e420a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_8045dc24-89c2-4873-8bc1-57033791957c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d8772d2b-8cd2-46e4-8c0c-cc88b12e420a" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_8045dc24-89c2-4873-8bc1-57033791957c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_3cdcd862-2cda-4f2f-9fac-fb3519c3280c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_8045dc24-89c2-4873-8bc1-57033791957c" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_3cdcd862-2cda-4f2f-9fac-fb3519c3280c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome_abd28d80-41ce-4229-bd28-bddff82b40f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_8045dc24-89c2-4873-8bc1-57033791957c" xlink:to="loc_us-gaap_TemporaryEquityNetIncome_abd28d80-41ce-4229-bd28-bddff82b40f5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders_1f3c951f-e264-44a2-b8b5-14c9c86e98a1" xlink:href="dva-20220930.xsd#dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_8045dc24-89c2-4873-8bc1-57033791957c" xlink:to="loc_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders_1f3c951f-e264-44a2-b8b5-14c9c86e98a1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders_f2e3efc2-8cc8-4cc4-b843-ed508b0f48de" xlink:href="dva-20220930.xsd#dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_8045dc24-89c2-4873-8bc1-57033791957c" xlink:to="loc_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders_f2e3efc2-8cc8-4cc4-b843-ed508b0f48de" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures_89f1ddfe-0f08-43d5-81b8-d335e1f40202" xlink:href="dva-20220930.xsd#dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_8045dc24-89c2-4873-8bc1-57033791957c" xlink:to="loc_dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures_89f1ddfe-0f08-43d5-81b8-d335e1f40202" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityDecreasePurchaseOfInterests_a6e8b315-2644-4e21-b404-4ccd33b64ffc" xlink:href="dva-20220930.xsd#dva_TemporaryEquityDecreasePurchaseOfInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_8045dc24-89c2-4873-8bc1-57033791957c" xlink:to="loc_dva_TemporaryEquityDecreasePurchaseOfInterests_a6e8b315-2644-4e21-b404-4ccd33b64ffc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue_add416e5-9eb9-41e9-8693-0a32c70ca75d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_8045dc24-89c2-4873-8bc1-57033791957c" xlink:to="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue_add416e5-9eb9-41e9-8693-0a32c70ca75d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityOtherChanges_b252fcaa-63f0-4328-992d-93b9ef557713" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityOtherChanges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_8045dc24-89c2-4873-8bc1-57033791957c" xlink:to="loc_us-gaap_TemporaryEquityOtherChanges_b252fcaa-63f0-4328-992d-93b9ef557713" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_2eb89096-78e6-4e30-8ef4-106a3b5bf9f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_59579849-d537-4920-a53d-69ca678a1a12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d8772d2b-8cd2-46e4-8c0c-cc88b12e420a" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_59579849-d537-4920-a53d-69ca678a1a12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a8330f3a-3751-4c42-9eab-c598542ba375" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_59579849-d537-4920-a53d-69ca678a1a12" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a8330f3a-3751-4c42-9eab-c598542ba375" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_2ac87f99-1fe0-4a42-9f09-b24fafce935c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_59579849-d537-4920-a53d-69ca678a1a12" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_2ac87f99-1fe0-4a42-9f09-b24fafce935c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_ca4230c8-4b7c-44e2-979d-79a86f05687d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_59579849-d537-4920-a53d-69ca678a1a12" xlink:to="loc_us-gaap_TreasuryStockShares_ca4230c8-4b7c-44e2-979d-79a86f05687d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_3416b9c8-420b-49e5-9bec-43507926040c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_59579849-d537-4920-a53d-69ca678a1a12" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_3416b9c8-420b-49e5-9bec-43507926040c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_cbdf3a62-45da-4ea3-8fc7-ed8c45efd88e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_3416b9c8-420b-49e5-9bec-43507926040c" xlink:to="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_cbdf3a62-45da-4ea3-8fc7-ed8c45efd88e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d2889d38-140d-45fa-b444-0b929915f0b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_3416b9c8-420b-49e5-9bec-43507926040c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d2889d38-140d-45fa-b444-0b929915f0b2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_c61183a4-a836-4e39-a99e-9f99a44dd2e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_59579849-d537-4920-a53d-69ca678a1a12" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_c61183a4-a836-4e39-a99e-9f99a44dd2e8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_cf9c1ded-7e75-4066-84f9-73ac142d5b4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_59579849-d537-4920-a53d-69ca678a1a12" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_cf9c1ded-7e75-4066-84f9-73ac142d5b4a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_cdee8172-bb9f-40a6-be4b-751eb9eb8e74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_59579849-d537-4920-a53d-69ca678a1a12" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_cdee8172-bb9f-40a6-be4b-751eb9eb8e74" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_55feb16a-0386-4c24-b054-cbe6b020a167" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_59579849-d537-4920-a53d-69ca678a1a12" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_55feb16a-0386-4c24-b054-cbe6b020a167" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestItemsAbstract_2284b17d-7d1f-41f9-906d-aec10f753c4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestItemsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_59579849-d537-4920-a53d-69ca678a1a12" xlink:to="loc_us-gaap_NoncontrollingInterestItemsAbstract_2284b17d-7d1f-41f9-906d-aec10f753c4f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_e5326538-de40-4d59-abd7-2630682ca172" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_2284b17d-7d1f-41f9-906d-aec10f753c4f" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_e5326538-de40-4d59-abd7-2630682ca172" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NoncontrollingInterestIncreaseFromContributions_e086b6f8-fa86-4383-8235-1c369ac15c3f" xlink:href="dva-20220930.xsd#dva_NoncontrollingInterestIncreaseFromContributions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_2284b17d-7d1f-41f9-906d-aec10f753c4f" xlink:to="loc_dva_NoncontrollingInterestIncreaseFromContributions_e086b6f8-fa86-4383-8235-1c369ac15c3f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures_3312bd4a-6d26-401d-8932-fb591d957006" xlink:href="dva-20220930.xsd#dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_2284b17d-7d1f-41f9-906d-aec10f753c4f" xlink:to="loc_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures_3312bd4a-6d26-401d-8932-fb591d957006" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures_a5c68d9d-213f-4600-8fb1-87294ae23d4b" xlink:href="dva-20220930.xsd#dva_NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_2284b17d-7d1f-41f9-906d-aec10f753c4f" xlink:to="loc_dva_NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures_a5c68d9d-213f-4600-8fb1-87294ae23d4b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_39b71623-020f-48fb-ae23-386408122e9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_2284b17d-7d1f-41f9-906d-aec10f753c4f" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_39b71623-020f-48fb-ae23-386408122e9b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestChangeInRedemptionValue_d0f5db2f-41ea-4ff0-a83d-0b10f3851198" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestChangeInRedemptionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_2284b17d-7d1f-41f9-906d-aec10f753c4f" xlink:to="loc_us-gaap_MinorityInterestChangeInRedemptionValue_d0f5db2f-41ea-4ff0-a83d-0b10f3851198" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NoncontrollingInterestChangesFromOther_c4263358-56d4-4967-b706-3a95b8d61e7d" xlink:href="dva-20220930.xsd#dva_NoncontrollingInterestChangesFromOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_2284b17d-7d1f-41f9-906d-aec10f753c4f" xlink:to="loc_dva_NoncontrollingInterestChangesFromOther_c4263358-56d4-4967-b706-3a95b8d61e7d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_09f1c0b9-75a9-4f2d-b91f-2c9d632952e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_59579849-d537-4920-a53d-69ca678a1a12" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_09f1c0b9-75a9-4f2d-b91f-2c9d632952e4" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_a9631723-d280-414c-90c8-8ebc414a9988" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_59579849-d537-4920-a53d-69ca678a1a12" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_a9631723-d280-414c-90c8-8ebc414a9988" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c035b206-9244-46ae-889a-df661e3c0289" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_ffec7646-8f10-424e-b5f1-b8c3d11fbc8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_8b650f25-91cc-4797-973a-c4853839a52f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_bd907106-f56b-4a10-a19a-8f43f3439fe7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_d8772d2b-8cd2-46e4-8c0c-cc88b12e420a" xlink:to="loc_us-gaap_StatementTable_bd907106-f56b-4a10-a19a-8f43f3439fe7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2c6dc38b-a712-48cd-af72-ae578d2e5a53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_bd907106-f56b-4a10-a19a-8f43f3439fe7" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2c6dc38b-a712-48cd-af72-ae578d2e5a53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2c6dc38b-a712-48cd-af72-ae578d2e5a53_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2c6dc38b-a712-48cd-af72-ae578d2e5a53" xlink:to="loc_us-gaap_EquityComponentDomain_2c6dc38b-a712-48cd-af72-ae578d2e5a53_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a2950e8f-75fb-4091-8f8b-3963def83732" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2c6dc38b-a712-48cd-af72-ae578d2e5a53" xlink:to="loc_us-gaap_EquityComponentDomain_a2950e8f-75fb-4091-8f8b-3963def83732" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_d6afdae9-da9f-44bd-9e5a-a40631dfaa85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a2950e8f-75fb-4091-8f8b-3963def83732" xlink:to="loc_us-gaap_ParentMember_d6afdae9-da9f-44bd-9e5a-a40631dfaa85" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember_d0150351-9c2f-425f-b52b-68abf4e28a53" xlink:href="dva-20220930.xsd#dva_TemporaryEquityRedeemableNoncontrollingInterestsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_d6afdae9-da9f-44bd-9e5a-a40631dfaa85" xlink:to="loc_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember_d0150351-9c2f-425f-b52b-68abf4e28a53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_2b365e1d-8333-4e82-86dc-57495bcd8739" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_d6afdae9-da9f-44bd-9e5a-a40631dfaa85" xlink:to="loc_us-gaap_CommonStockMember_2b365e1d-8333-4e82-86dc-57495bcd8739" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_575e6b4b-4c9d-44c8-a78a-6e162ded5d66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_d6afdae9-da9f-44bd-9e5a-a40631dfaa85" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_575e6b4b-4c9d-44c8-a78a-6e162ded5d66" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_e1694008-17c6-4a8d-9e7b-5f005380fd10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_d6afdae9-da9f-44bd-9e5a-a40631dfaa85" xlink:to="loc_us-gaap_RetainedEarningsMember_e1694008-17c6-4a8d-9e7b-5f005380fd10" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_4306c494-bfff-4c0b-bf1a-f72cf9b832c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_d6afdae9-da9f-44bd-9e5a-a40631dfaa85" xlink:to="loc_us-gaap_TreasuryStockMember_4306c494-bfff-4c0b-bf1a-f72cf9b832c5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4f073c4f-e2a3-43b6-970e-6998759845fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_d6afdae9-da9f-44bd-9e5a-a40631dfaa85" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4f073c4f-e2a3-43b6-970e-6998759845fd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_c026998b-e4a2-4761-8347-9f1756745a2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_d6afdae9-da9f-44bd-9e5a-a40631dfaa85" xlink:to="loc_us-gaap_NoncontrollingInterestMember_c026998b-e4a2-4761-8347-9f1756745a2e" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails" xlink:type="simple" xlink:href="dva-20220930.xsd#RevenueRecognitionSegmentRevenuebyPayorDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails" xlink:type="extended" id="i9c0db415a2874e95819d5c327d52aed2_RevenueRecognitionSegmentRevenuebyPayorDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_39e58e01-d67b-4960-894e-c981da69a3c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_6a595b05-a68f-4888-af53-532299541bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_39e58e01-d67b-4960-894e-c981da69a3c1" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_6a595b05-a68f-4888-af53-532299541bb5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_7d3d8953-8119-4d47-acf2-12d83a05e9bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_39e58e01-d67b-4960-894e-c981da69a3c1" xlink:to="loc_us-gaap_OtherIncome_7d3d8953-8119-4d47-acf2-12d83a05e9bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_1a15393b-774a-41d5-8a2e-9078d6ad3525" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_39e58e01-d67b-4960-894e-c981da69a3c1" xlink:to="loc_us-gaap_Revenues_1a15393b-774a-41d5-8a2e-9078d6ad3525" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_4dae8641-15fc-4680-8835-3dffb758c90a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_39e58e01-d67b-4960-894e-c981da69a3c1" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_4dae8641-15fc-4680-8835-3dffb758c90a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3477fa4b-c61e-4cb5-b048-a58d28c4d96a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_4dae8641-15fc-4680-8835-3dffb758c90a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3477fa4b-c61e-4cb5-b048-a58d28c4d96a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3477fa4b-c61e-4cb5-b048-a58d28c4d96a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3477fa4b-c61e-4cb5-b048-a58d28c4d96a" xlink:to="loc_us-gaap_SegmentDomain_3477fa4b-c61e-4cb5-b048-a58d28c4d96a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_50c3b704-d20e-4d5a-8d43-56f2c486063c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3477fa4b-c61e-4cb5-b048-a58d28c4d96a" xlink:to="loc_us-gaap_SegmentDomain_50c3b704-d20e-4d5a-8d43-56f2c486063c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_e1c6abd1-6ac3-44e0-a332-8688644db99a" xlink:href="dva-20220930.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_50c3b704-d20e-4d5a-8d43-56f2c486063c" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_e1c6abd1-6ac3-44e0-a332-8688644db99a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_de3b73b9-27d2-436d-91f8-00a4ca0d3935" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_50c3b704-d20e-4d5a-8d43-56f2c486063c" xlink:to="loc_us-gaap_AllOtherSegmentsMember_de3b73b9-27d2-436d-91f8-00a4ca0d3935" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_9ac57adb-ccc9-49d4-aba5-34e3309cad8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_4dae8641-15fc-4680-8835-3dffb758c90a" xlink:to="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_9ac57adb-ccc9-49d4-aba5-34e3309cad8c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_9ac57adb-ccc9-49d4-aba5-34e3309cad8c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_9ac57adb-ccc9-49d4-aba5-34e3309cad8c" xlink:to="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_9ac57adb-ccc9-49d4-aba5-34e3309cad8c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_cfcbcf8c-8d23-4ed5-9a1d-563bcf738145" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_9ac57adb-ccc9-49d4-aba5-34e3309cad8c" xlink:to="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_cfcbcf8c-8d23-4ed5-9a1d-563bcf738145" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MedicareandMedicareAdvantageMember_d2f88ea4-0398-4735-8c01-270218359542" xlink:href="dva-20220930.xsd#dva_MedicareandMedicareAdvantageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_cfcbcf8c-8d23-4ed5-9a1d-563bcf738145" xlink:to="loc_dva_MedicareandMedicareAdvantageMember_d2f88ea4-0398-4735-8c01-270218359542" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MedicaidandManagedMedicaidMember_c295ba00-3138-468f-a4f2-0737b14c4ff0" xlink:href="dva-20220930.xsd#dva_MedicaidandManagedMedicaidMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_cfcbcf8c-8d23-4ed5-9a1d-563bcf738145" xlink:to="loc_dva_MedicaidandManagedMedicaidMember_c295ba00-3138-468f-a4f2-0737b14c4ff0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherGovernmentPayorsMember_3e38f8d7-82d6-48c8-aff6-08bdf153362c" xlink:href="dva-20220930.xsd#dva_OtherGovernmentPayorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_cfcbcf8c-8d23-4ed5-9a1d-563bcf738145" xlink:to="loc_dva_OtherGovernmentPayorsMember_3e38f8d7-82d6-48c8-aff6-08bdf153362c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CommercialPayorsMember_5d9b24b2-7790-4937-b69e-09afc2da1c82" xlink:href="dva-20220930.xsd#dva_CommercialPayorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_cfcbcf8c-8d23-4ed5-9a1d-563bcf738145" xlink:to="loc_dva_CommercialPayorsMember_5d9b24b2-7790-4937-b69e-09afc2da1c82" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherSourcesofRevenueMember_f2b0d8f0-3bb2-441d-a53d-afecfb892a4f" xlink:href="dva-20220930.xsd#dva_OtherSourcesofRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_cfcbcf8c-8d23-4ed5-9a1d-563bcf738145" xlink:to="loc_dva_OtherSourcesofRevenueMember_f2b0d8f0-3bb2-441d-a53d-afecfb892a4f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_99f85a11-e7f4-49d0-aa8b-a59d78183293" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_4dae8641-15fc-4680-8835-3dffb758c90a" xlink:to="loc_srt_ConsolidationItemsAxis_99f85a11-e7f4-49d0-aa8b-a59d78183293" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_99f85a11-e7f4-49d0-aa8b-a59d78183293_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_99f85a11-e7f4-49d0-aa8b-a59d78183293" xlink:to="loc_srt_ConsolidationItemsDomain_99f85a11-e7f4-49d0-aa8b-a59d78183293_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_e3957ba5-fc63-4ea6-980f-e8d49e0bfbb9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_99f85a11-e7f4-49d0-aa8b-a59d78183293" xlink:to="loc_srt_ConsolidationItemsDomain_e3957ba5-fc63-4ea6-980f-e8d49e0bfbb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_d267d811-9fd0-4f85-9f4f-ed2713ce9f13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_e3957ba5-fc63-4ea6-980f-e8d49e0bfbb9" xlink:to="loc_us-gaap_IntersegmentEliminationMember_d267d811-9fd0-4f85-9f4f-ed2713ce9f13" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail" xlink:type="simple" xlink:href="dva-20220930.xsd#InvestmentsindebtandequitysecuritiesDetail"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail" xlink:type="extended" id="if4532485997a45b78eb1fb39cc3af26f_InvestmentsindebtandequitysecuritiesDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsLineItems_54e6b749-200f-490b-9af8-4a29d2cc1792" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentHoldingsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities_b4260e14-7270-4679-910b-f273fe75a6b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_54e6b749-200f-490b-9af8-4a29d2cc1792" xlink:to="loc_us-gaap_HeldToMaturitySecurities_b4260e14-7270-4679-910b-f273fe75a6b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_df37b033-654b-483d-b1f6-9bda1f584486" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_54e6b749-200f-490b-9af8-4a29d2cc1792" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_df37b033-654b-483d-b1f6-9bda1f584486" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_b4383059-08d7-4741-8967-fca29f6f6dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_54e6b749-200f-490b-9af8-4a29d2cc1792" xlink:to="loc_us-gaap_MarketableSecurities_b4383059-08d7-4741-8967-fca29f6f6dc9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesCurrent_7cf4344c-78b5-4a6f-bc7a-e9fd76c1a5e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_54e6b749-200f-490b-9af8-4a29d2cc1792" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesCurrent_7cf4344c-78b5-4a6f-bc7a-e9fd76c1a5e2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_1bcc49fd-c851-4d1f-8285-8d1a534a8d7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_54e6b749-200f-490b-9af8-4a29d2cc1792" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_1bcc49fd-c851-4d1f-8285-8d1a534a8d7f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesNoncurrent_f1873e28-440a-47c5-923f-22cee4798ddd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_54e6b749-200f-490b-9af8-4a29d2cc1792" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesNoncurrent_f1873e28-440a-47c5-923f-22cee4798ddd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_6b770ffe-260c-43f7-a46f-dc5b1347eeb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_54e6b749-200f-490b-9af8-4a29d2cc1792" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_6b770ffe-260c-43f7-a46f-dc5b1347eeb5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsTable_cfc2b999-4a85-4d1a-a59b-e86cf3544ce3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentHoldingsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_54e6b749-200f-490b-9af8-4a29d2cc1792" xlink:to="loc_us-gaap_InvestmentHoldingsTable_cfc2b999-4a85-4d1a-a59b-e86cf3544ce3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_2b3cdd0a-691b-4107-b2c3-85cb476d1a3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_InvestmentHoldingsTable_cfc2b999-4a85-4d1a-a59b-e86cf3544ce3" xlink:to="loc_us-gaap_InvestmentTypeAxis_2b3cdd0a-691b-4107-b2c3-85cb476d1a3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_2b3cdd0a-691b-4107-b2c3-85cb476d1a3f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_2b3cdd0a-691b-4107-b2c3-85cb476d1a3f" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_2b3cdd0a-691b-4107-b2c3-85cb476d1a3f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_ae40e397-5c25-436e-9ba9-6bda739b1d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_2b3cdd0a-691b-4107-b2c3-85cb476d1a3f" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_ae40e397-5c25-436e-9ba9-6bda739b1d6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember_d15ce060-0f73-49de-97dd-e952d26d2114" xlink:href="dva-20220930.xsd#dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ae40e397-5c25-436e-9ba9-6bda739b1d6c" xlink:to="loc_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember_d15ce060-0f73-49de-97dd-e952d26d2114" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MutualFundsAndCommonStockMember_560c9927-3b8f-43f8-9e40-3214721589e7" xlink:href="dva-20220930.xsd#dva_MutualFundsAndCommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ae40e397-5c25-436e-9ba9-6bda739b1d6c" xlink:to="loc_dva_MutualFundsAndCommonStockMember_560c9927-3b8f-43f8-9e40-3214721589e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_df9f2cf0-4129-4c4f-bc7f-3ee53c18f810" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ae40e397-5c25-436e-9ba9-6bda739b1d6c" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_df9f2cf0-4129-4c4f-bc7f-3ee53c18f810" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestmentsMember_f3cd7f86-1100-4c3d-9b13-5180038f5a8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ae40e397-5c25-436e-9ba9-6bda739b1d6c" xlink:to="loc_us-gaap_OtherLongTermInvestmentsMember_f3cd7f86-1100-4c3d-9b13-5180038f5a8a" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail" xlink:type="simple" xlink:href="dva-20220930.xsd#GoodwillChangesinGoodwillbyReportableSegmentsDetail"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail" xlink:type="extended" id="ib244cd0f71a748a7909df945df613462_GoodwillChangesinGoodwillbyReportableSegmentsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_5e5defc5-a5bc-4d2a-8d16-9a239c542dc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_3a1707c5-cda9-412d-b2c4-8774a3533f32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_5e5defc5-a5bc-4d2a-8d16-9a239c542dc2" xlink:to="loc_us-gaap_GoodwillRollForward_3a1707c5-cda9-412d-b2c4-8774a3533f32" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a50aeb23-78e4-45cd-806a-c9069d0ac103" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_3a1707c5-cda9-412d-b2c4-8774a3533f32" xlink:to="loc_us-gaap_Goodwill_a50aeb23-78e4-45cd-806a-c9069d0ac103" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_26f8674f-5a49-4ec5-9bfb-b3d4ca3a3180" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_3a1707c5-cda9-412d-b2c4-8774a3533f32" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_26f8674f-5a49-4ec5-9bfb-b3d4ca3a3180" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_9af969c4-99c9-4eb1-ba29-2c41d232ffe6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_3a1707c5-cda9-412d-b2c4-8774a3533f32" xlink:to="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_9af969c4-99c9-4eb1-ba29-2c41d232ffe6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_e9d3c7ef-ec9d-4a43-974f-6c7cf00803da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_3a1707c5-cda9-412d-b2c4-8774a3533f32" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_e9d3c7ef-ec9d-4a43-974f-6c7cf00803da" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b90cc4af-fbb3-4ecc-b466-90180d927c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_31b677e7-d8d3-4d15-88ed-2f964c06d411" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_5e5defc5-a5bc-4d2a-8d16-9a239c542dc2" xlink:to="loc_us-gaap_GoodwillGross_31b677e7-d8d3-4d15-88ed-2f964c06d411" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_f0e72286-8f4a-478a-82db-a48b818de93c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_5e5defc5-a5bc-4d2a-8d16-9a239c542dc2" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_f0e72286-8f4a-478a-82db-a48b818de93c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_af3797c8-500e-42ed-985b-62206a8b3106" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_9bf80ee2-a2b6-4113-9e79-9169fdd23f38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_5e5defc5-a5bc-4d2a-8d16-9a239c542dc2" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_9bf80ee2-a2b6-4113-9e79-9169fdd23f38" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_319e243c-c3f7-480f-88ce-52f79bd32e49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_9bf80ee2-a2b6-4113-9e79-9169fdd23f38" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_319e243c-c3f7-480f-88ce-52f79bd32e49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_319e243c-c3f7-480f-88ce-52f79bd32e49_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_319e243c-c3f7-480f-88ce-52f79bd32e49" xlink:to="loc_us-gaap_SegmentDomain_319e243c-c3f7-480f-88ce-52f79bd32e49_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8cfb3d70-7499-4bfc-b7c1-130788dd469c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_319e243c-c3f7-480f-88ce-52f79bd32e49" xlink:to="loc_us-gaap_SegmentDomain_8cfb3d70-7499-4bfc-b7c1-130788dd469c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_f4201478-dbe2-4272-92b8-b0a795ca5ed7" xlink:href="dva-20220930.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8cfb3d70-7499-4bfc-b7c1-130788dd469c" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_f4201478-dbe2-4272-92b8-b0a795ca5ed7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_0b0329d8-c007-48ba-b4c4-bbdeb884a801" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8cfb3d70-7499-4bfc-b7c1-130788dd469c" xlink:to="loc_us-gaap_AllOtherSegmentsMember_0b0329d8-c007-48ba-b4c4-bbdeb884a801" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/GoodwillNarrativeDetails" xlink:type="simple" xlink:href="dva-20220930.xsd#GoodwillNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/GoodwillNarrativeDetails" xlink:type="extended" id="i2c43eaec06734b2a846863e02f7a35f4_GoodwillNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_cfbe0707-8b97-4008-bea7-985ff61a4719" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_8b1a2111-0095-44c5-b0dc-af59b88507be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_cfbe0707-8b97-4008-bea7-985ff61a4719" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_8b1a2111-0095-44c5-b0dc-af59b88507be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_4ebb2b52-1767-48ef-863d-5bea597d2c7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_cfbe0707-8b97-4008-bea7-985ff61a4719" xlink:to="loc_us-gaap_NumberOfOperatingSegments_4ebb2b52-1767-48ef-863d-5bea597d2c7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_ced66a59-8577-4a52-918c-981b95fa1831" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_cfbe0707-8b97-4008-bea7-985ff61a4719" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_ced66a59-8577-4a52-918c-981b95fa1831" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_7d663181-f2fb-4327-9098-33bf02c8217a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ced66a59-8577-4a52-918c-981b95fa1831" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_7d663181-f2fb-4327-9098-33bf02c8217a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7d663181-f2fb-4327-9098-33bf02c8217a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7d663181-f2fb-4327-9098-33bf02c8217a" xlink:to="loc_us-gaap_SegmentDomain_7d663181-f2fb-4327-9098-33bf02c8217a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d7f26829-6bf0-43e1-a9e9-dee4ad8e3d44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7d663181-f2fb-4327-9098-33bf02c8217a" xlink:to="loc_us-gaap_SegmentDomain_d7f26829-6bf0-43e1-a9e9-dee4ad8e3d44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherReportingUnitsMember_34498616-3149-4522-9b16-eaae10b8bd3b" xlink:href="dva-20220930.xsd#dva_OtherReportingUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d7f26829-6bf0-43e1-a9e9-dee4ad8e3d44" xlink:to="loc_dva_OtherReportingUnitsMember_34498616-3149-4522-9b16-eaae10b8bd3b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermdebtDetail" xlink:type="simple" xlink:href="dva-20220930.xsd#LongtermdebtDetail"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/LongtermdebtDetail" xlink:type="extended" id="i52d592b8ec3e44df8260df2479826589_LongtermdebtDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d292fcc7-1777-4e0c-b0bd-aec2403b3662" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebt_4cff629a-9c60-4df2-a92b-836945ad4274" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d292fcc7-1777-4e0c-b0bd-aec2403b3662" xlink:to="loc_us-gaap_SecuredDebt_4cff629a-9c60-4df2-a92b-836945ad4274" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_a5d50a19-9807-4b28-986b-a49810a1b912" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d292fcc7-1777-4e0c-b0bd-aec2403b3662" xlink:to="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_a5d50a19-9807-4b28-986b-a49810a1b912" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_ec004b29-74f1-4de6-bb97-526f123cc646" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d292fcc7-1777-4e0c-b0bd-aec2403b3662" xlink:to="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_ec004b29-74f1-4de6-bb97-526f123cc646" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_321bcc73-26d2-4512-b8da-1dd9f59d9ce4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d292fcc7-1777-4e0c-b0bd-aec2403b3662" xlink:to="loc_us-gaap_SeniorNotes_321bcc73-26d2-4512-b8da-1dd9f59d9ce4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_27f31e86-f2f8-4fb0-9022-629d38d10d34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d292fcc7-1777-4e0c-b0bd-aec2403b3662" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_27f31e86-f2f8-4fb0-9022-629d38d10d34" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate_5deeacdf-a556-4403-9208-fd310548163f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d292fcc7-1777-4e0c-b0bd-aec2403b3662" xlink:to="loc_us-gaap_DebtInstrumentMaturityDate_5deeacdf-a556-4403-9208-fd310548163f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_e8d3ff18-31a1-4b4a-bf1b-c30841c49ba3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d292fcc7-1777-4e0c-b0bd-aec2403b3662" xlink:to="loc_us-gaap_DebtInstrumentFairValue_e8d3ff18-31a1-4b4a-bf1b-c30841c49ba3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AcquisitionObligationsAndOtherNotesPayable_1e2b8063-1736-4724-9c90-4997c699dc62" xlink:href="dva-20220930.xsd#dva_AcquisitionObligationsAndOtherNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d292fcc7-1777-4e0c-b0bd-aec2403b3662" xlink:to="loc_dva_AcquisitionObligationsAndOtherNotesPayable_1e2b8063-1736-4724-9c90-4997c699dc62" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_95a8e05e-50cc-42f5-9a9e-2e33bb1646a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d292fcc7-1777-4e0c-b0bd-aec2403b3662" xlink:to="loc_us-gaap_FinanceLeaseLiability_95a8e05e-50cc-42f5-9a9e-2e33bb1646a2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDateDescription_3b83e2dd-22c4-4b97-8481-a92ca73703ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMaturityDateDescription"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d292fcc7-1777-4e0c-b0bd-aec2403b3662" xlink:to="loc_us-gaap_DebtInstrumentMaturityDateDescription_3b83e2dd-22c4-4b97-8481-a92ca73703ca" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_06f442b2-286e-4841-b2ff-97463ea0e3d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d292fcc7-1777-4e0c-b0bd-aec2403b3662" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_06f442b2-286e-4841-b2ff-97463ea0e3d1" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AcquisitionObligationsAndOtherNotesPayableFairValue_7710916c-4dbc-4eac-b815-4bf6c93cb858" xlink:href="dva-20220930.xsd#dva_AcquisitionObligationsAndOtherNotesPayableFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d292fcc7-1777-4e0c-b0bd-aec2403b3662" xlink:to="loc_dva_AcquisitionObligationsAndOtherNotesPayableFairValue_7710916c-4dbc-4eac-b815-4bf6c93cb858" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_3f5084e6-5435-430d-918e-989a866c6ee4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d292fcc7-1777-4e0c-b0bd-aec2403b3662" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_3f5084e6-5435-430d-918e-989a866c6ee4" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_28f5a46a-8850-4a83-a28d-e1ed828008b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d292fcc7-1777-4e0c-b0bd-aec2403b3662" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_28f5a46a-8850-4a83-a28d-e1ed828008b7" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DiscountPremiumAndDeferredFinancingCosts_a0c40a47-6061-470e-9ed9-97c26a4560c5" xlink:href="dva-20220930.xsd#dva_DiscountPremiumAndDeferredFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d292fcc7-1777-4e0c-b0bd-aec2403b3662" xlink:to="loc_dva_DiscountPremiumAndDeferredFinancingCosts_a0c40a47-6061-470e-9ed9-97c26a4560c5" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_fd9cc20e-3cde-498a-be0f-276ef963235c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d292fcc7-1777-4e0c-b0bd-aec2403b3662" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_fd9cc20e-3cde-498a-be0f-276ef963235c" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_7fb46d68-c586-4742-9290-385e1941d879" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d292fcc7-1777-4e0c-b0bd-aec2403b3662" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_7fb46d68-c586-4742-9290-385e1941d879" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_a5b11e0a-e191-4f3f-a849-32348c180714" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d292fcc7-1777-4e0c-b0bd-aec2403b3662" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_a5b11e0a-e191-4f3f-a849-32348c180714" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_76a406f6-afc2-41c5-ae66-3bad46b4c2a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d292fcc7-1777-4e0c-b0bd-aec2403b3662" xlink:to="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_76a406f6-afc2-41c5-ae66-3bad46b4c2a9" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_015873a2-025e-474c-89cf-30be9d62f137" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_76a406f6-afc2-41c5-ae66-3bad46b4c2a9" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_015873a2-025e-474c-89cf-30be9d62f137" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredOfferingCosts_9aae6f4f-5f68-4d26-9918-0709ad80aac7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_76a406f6-afc2-41c5-ae66-3bad46b4c2a9" xlink:to="loc_us-gaap_DeferredOfferingCosts_9aae6f4f-5f68-4d26-9918-0709ad80aac7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_fbd51be9-56ba-409a-9fda-f9f14bcd105f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_76a406f6-afc2-41c5-ae66-3bad46b4c2a9" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_fbd51be9-56ba-409a-9fda-f9f14bcd105f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_bcbd5078-e24e-4455-9a31-f8c84f323162" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d292fcc7-1777-4e0c-b0bd-aec2403b3662" xlink:to="loc_us-gaap_DebtInstrumentTable_bcbd5078-e24e-4455-9a31-f8c84f323162" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_6ed88700-2ccc-4551-af0d-a203995108f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_bcbd5078-e24e-4455-9a31-f8c84f323162" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_6ed88700-2ccc-4551-af0d-a203995108f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6ed88700-2ccc-4551-af0d-a203995108f5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6ed88700-2ccc-4551-af0d-a203995108f5" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6ed88700-2ccc-4551-af0d-a203995108f5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_df322bd6-5cf9-477d-9cd4-f8623007e346" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6ed88700-2ccc-4551-af0d-a203995108f5" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_df322bd6-5cf9-477d-9cd4-f8623007e346" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanAMember_0c8d2f4a-ea88-492c-94a3-aed6c045a758" xlink:href="dva-20220930.xsd#dva_TermLoanAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_df322bd6-5cf9-477d-9cd4-f8623007e346" xlink:to="loc_dva_TermLoanAMember_0c8d2f4a-ea88-492c-94a3-aed6c045a758" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanB1Member_1f508d86-7627-4c08-84e1-3c888a003df8" xlink:href="dva-20220930.xsd#dva_TermLoanB1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_df322bd6-5cf9-477d-9cd4-f8623007e346" xlink:to="loc_dva_TermLoanB1Member_1f508d86-7627-4c08-84e1-3c888a003df8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorSecuredCreditFacilitiesMember_1754843e-7835-4e8f-8b51-a0f47e63694c" xlink:href="dva-20220930.xsd#dva_SeniorSecuredCreditFacilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_df322bd6-5cf9-477d-9cd4-f8623007e346" xlink:to="loc_dva_SeniorSecuredCreditFacilitiesMember_1754843e-7835-4e8f-8b51-a0f47e63694c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_167358ca-f225-4d03-851c-86b9a6d6848c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_df322bd6-5cf9-477d-9cd4-f8623007e346" xlink:to="loc_us-gaap_SeniorNotesMember_167358ca-f225-4d03-851c-86b9a6d6848c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_96076479-ff08-43aa-b66b-7f29b54667da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_bcbd5078-e24e-4455-9a31-f8c84f323162" xlink:to="loc_us-gaap_CreditFacilityAxis_96076479-ff08-43aa-b66b-7f29b54667da" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_96076479-ff08-43aa-b66b-7f29b54667da_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_96076479-ff08-43aa-b66b-7f29b54667da" xlink:to="loc_us-gaap_CreditFacilityDomain_96076479-ff08-43aa-b66b-7f29b54667da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a5734897-8aaa-444c-b859-a0d547a3e068" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_96076479-ff08-43aa-b66b-7f29b54667da" xlink:to="loc_us-gaap_CreditFacilityDomain_a5734897-8aaa-444c-b859-a0d547a3e068" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_7c33698f-d9fc-43b4-9a9e-b7defae82ff9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_a5734897-8aaa-444c-b859-a0d547a3e068" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_7c33698f-d9fc-43b4-9a9e-b7defae82ff9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_6b70d84b-e68d-469a-adad-c9a4a13a297c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_bcbd5078-e24e-4455-9a31-f8c84f323162" xlink:to="loc_us-gaap_DebtInstrumentAxis_6b70d84b-e68d-469a-adad-c9a4a13a297c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6b70d84b-e68d-469a-adad-c9a4a13a297c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_6b70d84b-e68d-469a-adad-c9a4a13a297c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6b70d84b-e68d-469a-adad-c9a4a13a297c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c43c7f14-c81a-477a-ac2f-49011a887038" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_6b70d84b-e68d-469a-adad-c9a4a13a297c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c43c7f14-c81a-477a-ac2f-49011a887038" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember_84152b14-d0d8-45ae-bd08-2ab9c46f4f47" xlink:href="dva-20220930.xsd#dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c43c7f14-c81a-477a-ac2f-49011a887038" xlink:to="loc_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember_84152b14-d0d8-45ae-bd08-2ab9c46f4f47" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember_d75ea375-7a24-482e-b0b7-bd5c7c519f7c" xlink:href="dva-20220930.xsd#dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c43c7f14-c81a-477a-ac2f-49011a887038" xlink:to="loc_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember_d75ea375-7a24-482e-b0b7-bd5c7c519f7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_651664f1-fe7d-4c21-8bb8-ba14c1b55ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c43c7f14-c81a-477a-ac2f-49011a887038" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_651664f1-fe7d-4c21-8bb8-ba14c1b55ccb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_FinanceLeaseMember_d4f7fb78-95b0-4f13-963a-7ec1f3ae4299" xlink:href="dva-20220930.xsd#dva_FinanceLeaseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c43c7f14-c81a-477a-ac2f-49011a887038" xlink:to="loc_dva_FinanceLeaseMember_d4f7fb78-95b0-4f13-963a-7ec1f3ae4299" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="dva-20220930.xsd#LongtermdebtScheduleofDerivativeInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails" xlink:type="extended" id="id1f908f3a56c44549471bbd6ffdcc757_LongtermdebtScheduleofDerivativeInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_30acf830-b64f-4984-863e-f649ae2ab32a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_bef0bb3f-b63b-4d00-8106-3b18ee029662" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_30acf830-b64f-4984-863e-f649ae2ab32a" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_bef0bb3f-b63b-4d00-8106-3b18ee029662" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_796fc387-8b67-4966-9502-cb9ff2ce1a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_30acf830-b64f-4984-863e-f649ae2ab32a" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_796fc387-8b67-4966-9502-cb9ff2ce1a1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInceptionDates_cd437e46-7593-441f-93d5-7da3cbbb5428" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInceptionDates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_30acf830-b64f-4984-863e-f649ae2ab32a" xlink:to="loc_us-gaap_DerivativeInceptionDates_cd437e46-7593-441f-93d5-7da3cbbb5428" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeMaturityDates_5298f1fc-89e5-4f74-ac24-cdf3e035adc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeMaturityDates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_30acf830-b64f-4984-863e-f649ae2ab32a" xlink:to="loc_us-gaap_DerivativeMaturityDates_5298f1fc-89e5-4f74-ac24-cdf3e035adc0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_5373aa7b-969d-44c2-b6e8-6b433b325c4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_30acf830-b64f-4984-863e-f649ae2ab32a" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_5373aa7b-969d-44c2-b6e8-6b433b325c4e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_e3265457-7559-4c13-a734-bdf3b78a6495" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_30acf830-b64f-4984-863e-f649ae2ab32a" xlink:to="loc_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_e3265457-7559-4c13-a734-bdf3b78a6495" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_78b0739a-a388-4e6a-b7ec-63b48cce22a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_30acf830-b64f-4984-863e-f649ae2ab32a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_78b0739a-a388-4e6a-b7ec-63b48cce22a8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_afc25cc5-1e0c-4e9d-8b1e-5208be05cd27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_30acf830-b64f-4984-863e-f649ae2ab32a" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_afc25cc5-1e0c-4e9d-8b1e-5208be05cd27" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_d88a6bb4-c9ce-4db2-973b-7bd2ce097922" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_30acf830-b64f-4984-863e-f649ae2ab32a" xlink:to="loc_us-gaap_DerivativeTable_d88a6bb4-c9ce-4db2-973b-7bd2ce097922" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e2d80ef0-9999-4ebc-b9d2-307969c2eacd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_d88a6bb4-c9ce-4db2-973b-7bd2ce097922" xlink:to="loc_us-gaap_DebtInstrumentAxis_e2d80ef0-9999-4ebc-b9d2-307969c2eacd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e2d80ef0-9999-4ebc-b9d2-307969c2eacd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_e2d80ef0-9999-4ebc-b9d2-307969c2eacd" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e2d80ef0-9999-4ebc-b9d2-307969c2eacd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_2cf8ae60-3fdb-4d1b-96e0-4fbc415db197" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_e2d80ef0-9999-4ebc-b9d2-307969c2eacd" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_2cf8ae60-3fdb-4d1b-96e0-4fbc415db197" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanFacilityMember_990bef0b-54d8-4971-8069-c09a482b9f4a" xlink:href="dva-20220930.xsd#dva_TermLoanFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_2cf8ae60-3fdb-4d1b-96e0-4fbc415db197" xlink:to="loc_dva_TermLoanFacilityMember_990bef0b-54d8-4971-8069-c09a482b9f4a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c71a72c8-90eb-4239-a6da-543f8e0b9496" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_d88a6bb4-c9ce-4db2-973b-7bd2ce097922" xlink:to="loc_srt_RangeAxis_c71a72c8-90eb-4239-a6da-543f8e0b9496" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c71a72c8-90eb-4239-a6da-543f8e0b9496_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_c71a72c8-90eb-4239-a6da-543f8e0b9496" xlink:to="loc_srt_RangeMember_c71a72c8-90eb-4239-a6da-543f8e0b9496_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9ccdb9f2-65f8-466d-80f6-8d27a46b18fe" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_c71a72c8-90eb-4239-a6da-543f8e0b9496" xlink:to="loc_srt_RangeMember_9ccdb9f2-65f8-466d-80f6-8d27a46b18fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_098075f1-1aea-4a69-a79a-2fadad2ebbfb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9ccdb9f2-65f8-466d-80f6-8d27a46b18fe" xlink:to="loc_srt_MaximumMember_098075f1-1aea-4a69-a79a-2fadad2ebbfb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_e838220e-3fc2-4951-82bc-1942c6086450" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_d88a6bb4-c9ce-4db2-973b-7bd2ce097922" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_e838220e-3fc2-4951-82bc-1942c6086450" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e838220e-3fc2-4951-82bc-1942c6086450_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e838220e-3fc2-4951-82bc-1942c6086450" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e838220e-3fc2-4951-82bc-1942c6086450_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_36f8cd07-1191-4817-b5d2-05e57d98f58e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e838220e-3fc2-4951-82bc-1942c6086450" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_36f8cd07-1191-4817-b5d2-05e57d98f58e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtExpenseMember_c1d8091e-d9df-4738-9486-465879fa68ab" xlink:href="dva-20220930.xsd#dva_DebtExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_36f8cd07-1191-4817-b5d2-05e57d98f58e" xlink:to="loc_dva_DebtExpenseMember_c1d8091e-d9df-4738-9486-465879fa68ab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_aff4d84f-91d1-4860-90b0-91dd360cf2a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_d88a6bb4-c9ce-4db2-973b-7bd2ce097922" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_aff4d84f-91d1-4860-90b0-91dd360cf2a3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_aff4d84f-91d1-4860-90b0-91dd360cf2a3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_aff4d84f-91d1-4860-90b0-91dd360cf2a3" xlink:to="loc_us-gaap_HedgingRelationshipDomain_aff4d84f-91d1-4860-90b0-91dd360cf2a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_a7782f38-3615-4839-8144-cb1d9e086565" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_aff4d84f-91d1-4860-90b0-91dd360cf2a3" xlink:to="loc_us-gaap_HedgingRelationshipDomain_a7782f38-3615-4839-8144-cb1d9e086565" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_8b09f814-5c24-4fd6-bf2c-ae13d2becb29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_a7782f38-3615-4839-8144-cb1d9e086565" xlink:to="loc_us-gaap_CashFlowHedgingMember_8b09f814-5c24-4fd6-bf2c-ae13d2becb29" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_fe3d9bd2-52e6-4bb1-a6f5-a8ca6b15fc43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_d88a6bb4-c9ce-4db2-973b-7bd2ce097922" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_fe3d9bd2-52e6-4bb1-a6f5-a8ca6b15fc43" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_fe3d9bd2-52e6-4bb1-a6f5-a8ca6b15fc43_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_fe3d9bd2-52e6-4bb1-a6f5-a8ca6b15fc43" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_fe3d9bd2-52e6-4bb1-a6f5-a8ca6b15fc43_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_e4b3ad5e-4e0a-465d-b430-032278cf633d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_fe3d9bd2-52e6-4bb1-a6f5-a8ca6b15fc43" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_e4b3ad5e-4e0a-465d-b430-032278cf633d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_f918d0c5-a899-4512-940d-6b8e2d61eab2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e4b3ad5e-4e0a-465d-b430-032278cf633d" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_f918d0c5-a899-4512-940d-6b8e2d61eab2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_997add32-6da6-4afc-ba4f-418f2ec99db5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_d88a6bb4-c9ce-4db2-973b-7bd2ce097922" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_997add32-6da6-4afc-ba4f-418f2ec99db5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_997add32-6da6-4afc-ba4f-418f2ec99db5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_997add32-6da6-4afc-ba4f-418f2ec99db5" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_997add32-6da6-4afc-ba4f-418f2ec99db5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b6d5cf1c-a498-4944-820f-944b21932f92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_997add32-6da6-4afc-ba4f-418f2ec99db5" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b6d5cf1c-a498-4944-820f-944b21932f92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member_34a1c4df-617d-4ece-9162-689fcd61fa10" xlink:href="dva-20220930.xsd#dva_A2019InterestRateCapAgreementsEffectiveJune302020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b6d5cf1c-a498-4944-820f-944b21932f92" xlink:to="loc_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member_34a1c4df-617d-4ece-9162-689fcd61fa10" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermdebtAdditionalInformationDetail" xlink:type="simple" xlink:href="dva-20220930.xsd#LongtermdebtAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/LongtermdebtAdditionalInformationDetail" xlink:type="extended" id="ia88811e1c0c24c1ab04535ce2c0c5ed7_LongtermdebtAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f2049e26-117b-4039-ab8d-3d0100f46c96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_4f265d60-2c15-4159-b93c-7e6d9ca359ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f2049e26-117b-4039-ab8d-3d0100f46c96" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_4f265d60-2c15-4159-b93c-7e6d9ca359ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR_0f556e4c-9a3a-444c-912e-0a4dd000dbbd" xlink:href="dva-20220930.xsd#dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f2049e26-117b-4039-ab8d-3d0100f46c96" xlink:to="loc_dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR_0f556e4c-9a3a-444c-912e-0a4dd000dbbd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebt_6696a823-fc4a-4cef-a420-6d936641fe03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f2049e26-117b-4039-ab8d-3d0100f46c96" xlink:to="loc_us-gaap_SecuredDebt_6696a823-fc4a-4cef-a420-6d936641fe03" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_7415a9a5-3da0-4227-aa2f-a4a719b0d03f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f2049e26-117b-4039-ab8d-3d0100f46c96" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_7415a9a5-3da0-4227-aa2f-a4a719b0d03f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_e09b2e75-01e1-49dd-ab9f-d7b54b9ce636" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f2049e26-117b-4039-ab8d-3d0100f46c96" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_e09b2e75-01e1-49dd-ab9f-d7b54b9ce636" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_a5f0d1ba-5aee-4ad1-b7c6-d7de308225ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtPercentageBearingFixedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f2049e26-117b-4039-ab8d-3d0100f46c96" xlink:to="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_a5f0d1ba-5aee-4ad1-b7c6-d7de308225ad" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LongTermDebtPercentageBearingEconomicallyFixedInterestRate_f01156a5-2520-41b6-bd9f-1e0813665bb8" xlink:href="dva-20220930.xsd#dva_LongTermDebtPercentageBearingEconomicallyFixedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f2049e26-117b-4039-ab8d-3d0100f46c96" xlink:to="loc_dva_LongTermDebtPercentageBearingEconomicallyFixedInterestRate_f01156a5-2520-41b6-bd9f-1e0813665bb8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_fac0f8e4-0558-471f-bc95-13fab7787c31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f2049e26-117b-4039-ab8d-3d0100f46c96" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_fac0f8e4-0558-471f-bc95-13fab7787c31" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_8b826a18-c164-4f20-a4b5-909b14c20b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f2049e26-117b-4039-ab8d-3d0100f46c96" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_8b826a18-c164-4f20-a4b5-909b14c20b7a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_6f20d5e0-2b31-490e-8b76-4ab68ef73d22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f2049e26-117b-4039-ab8d-3d0100f46c96" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_6f20d5e0-2b31-490e-8b76-4ab68ef73d22" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_0fce5ea4-6a84-4ca1-a90e-6cc06523b721" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f2049e26-117b-4039-ab8d-3d0100f46c96" xlink:to="loc_us-gaap_DebtInstrumentTable_0fce5ea4-6a84-4ca1-a90e-6cc06523b721" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_e4f65dfc-3cf2-4b5a-a612-21717ac25122" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_0fce5ea4-6a84-4ca1-a90e-6cc06523b721" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_e4f65dfc-3cf2-4b5a-a612-21717ac25122" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e4f65dfc-3cf2-4b5a-a612-21717ac25122_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e4f65dfc-3cf2-4b5a-a612-21717ac25122" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e4f65dfc-3cf2-4b5a-a612-21717ac25122_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f7773426-0355-4550-8fda-ad809ac9ccc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e4f65dfc-3cf2-4b5a-a612-21717ac25122" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f7773426-0355-4550-8fda-ad809ac9ccc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanAMember_3122c11c-b5be-41da-bbb8-5d26c2261748" xlink:href="dva-20220930.xsd#dva_TermLoanAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f7773426-0355-4550-8fda-ad809ac9ccc7" xlink:to="loc_dva_TermLoanAMember_3122c11c-b5be-41da-bbb8-5d26c2261748" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanB1Member_b8a20751-99b4-4dfd-b02d-34d9968c3b33" xlink:href="dva-20220930.xsd#dva_TermLoanB1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f7773426-0355-4550-8fda-ad809ac9ccc7" xlink:to="loc_dva_TermLoanB1Member_b8a20751-99b4-4dfd-b02d-34d9968c3b33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorSecuredCreditFacilitiesMember_a45d1dea-2e8b-468c-ab23-fbb74b878263" xlink:href="dva-20220930.xsd#dva_SeniorSecuredCreditFacilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f7773426-0355-4550-8fda-ad809ac9ccc7" xlink:to="loc_dva_SeniorSecuredCreditFacilitiesMember_a45d1dea-2e8b-468c-ab23-fbb74b878263" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_96bd7895-a76b-43b8-9375-b121a125e264" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_0fce5ea4-6a84-4ca1-a90e-6cc06523b721" xlink:to="loc_us-gaap_CreditFacilityAxis_96bd7895-a76b-43b8-9375-b121a125e264" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_96bd7895-a76b-43b8-9375-b121a125e264_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_96bd7895-a76b-43b8-9375-b121a125e264" xlink:to="loc_us-gaap_CreditFacilityDomain_96bd7895-a76b-43b8-9375-b121a125e264_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a2eb54a0-4ce5-4ea4-a45b-6933cd24c032" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_96bd7895-a76b-43b8-9375-b121a125e264" xlink:to="loc_us-gaap_CreditFacilityDomain_a2eb54a0-4ce5-4ea4-a45b-6933cd24c032" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_9c1d46dc-31c3-45e0-b985-0633ec9550c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_a2eb54a0-4ce5-4ea4-a45b-6933cd24c032" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_9c1d46dc-31c3-45e0-b985-0633ec9550c8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_d237d4f1-1daa-4259-a651-c246d73b8c4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_a2eb54a0-4ce5-4ea4-a45b-6933cd24c032" xlink:to="loc_us-gaap_LetterOfCreditMember_d237d4f1-1daa-4259-a651-c246d73b8c4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BilateralSecuredLetterOfCreditFacilityMember_44f01fc2-94a6-42c0-8fcb-2aa964c0af37" xlink:href="dva-20220930.xsd#dva_BilateralSecuredLetterOfCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_a2eb54a0-4ce5-4ea4-a45b-6933cd24c032" xlink:to="loc_dva_BilateralSecuredLetterOfCreditFacilityMember_44f01fc2-94a6-42c0-8fcb-2aa964c0af37" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail" xlink:type="simple" xlink:href="dva-20220930.xsd#CommitmentsandContingenciesAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail" xlink:type="extended" id="i6914bc4a78aa4c4582d5b82ca13d4e71_CommitmentsandContingenciesAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_625cdb65-227f-475f-8bef-9ab56d03d444" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_8b6001e0-fea3-40f6-8342-f4b97089144e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_625cdb65-227f-475f-8bef-9ab56d03d444" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_8b6001e0-fea3-40f6-8342-f4b97089144e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CorporateIntegrityAgreementPeriod_9b4dbe01-2d82-4e33-9e29-683df0ed47ca" xlink:href="dva-20220930.xsd#dva_CorporateIntegrityAgreementPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_625cdb65-227f-475f-8bef-9ab56d03d444" xlink:to="loc_dva_CorporateIntegrityAgreementPeriod_9b4dbe01-2d82-4e33-9e29-683df0ed47ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CorporateIntegrityAgreementExpirationDate_84f44e03-6ae6-40c7-965c-20d0ec81c0a4" xlink:href="dva-20220930.xsd#dva_CorporateIntegrityAgreementExpirationDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_625cdb65-227f-475f-8bef-9ab56d03d444" xlink:to="loc_dva_CorporateIntegrityAgreementExpirationDate_84f44e03-6ae6-40c7-965c-20d0ec81c0a4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitment_c11f5611-824c-4fa5-a1d2-b0345135e20a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_625cdb65-227f-475f-8bef-9ab56d03d444" xlink:to="loc_us-gaap_OtherCommitment_c11f5611-824c-4fa5-a1d2-b0345135e20a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessAgreementDate_a91cedcb-5b22-4b62-9f39-68bf0222caab" xlink:href="dva-20220930.xsd#dva_BusinessAgreementDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_625cdb65-227f-475f-8bef-9ab56d03d444" xlink:to="loc_dva_BusinessAgreementDate_a91cedcb-5b22-4b62-9f39-68bf0222caab" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentDueInNextTwelveMonths_c21ccda9-fa66-48f5-b9cc-4db277b7f170" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentDueInNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_625cdb65-227f-475f-8bef-9ab56d03d444" xlink:to="loc_us-gaap_OtherCommitmentDueInNextTwelveMonths_c21ccda9-fa66-48f5-b9cc-4db277b7f170" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherNoncashAssetsCommitment_4a348933-5617-4705-937f-bf39ec055c95" xlink:href="dva-20220930.xsd#dva_OtherNoncashAssetsCommitment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_625cdb65-227f-475f-8bef-9ab56d03d444" xlink:to="loc_dva_OtherNoncashAssetsCommitment_4a348933-5617-4705-937f-bf39ec055c95" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AdditionalCashCommitment_dceb8b68-52f1-4f8e-8b48-9abf0e0eb784" xlink:href="dva-20220930.xsd#dva_AdditionalCashCommitment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_625cdb65-227f-475f-8bef-9ab56d03d444" xlink:to="loc_dva_AdditionalCashCommitment_dceb8b68-52f1-4f8e-8b48-9abf0e0eb784" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentDueAfterFifthYear_f60359ac-601d-4d6c-a910-a016144cb5e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentDueAfterFifthYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_625cdb65-227f-475f-8bef-9ab56d03d444" xlink:to="loc_us-gaap_OtherCommitmentDueAfterFifthYear_f60359ac-601d-4d6c-a910-a016144cb5e3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RegulatoryAndCommercialMilestonesBeginningDate_d5853113-0fec-470e-a1b9-857ad8cf3716" xlink:href="dva-20220930.xsd#dva_RegulatoryAndCommercialMilestonesBeginningDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_625cdb65-227f-475f-8bef-9ab56d03d444" xlink:to="loc_dva_RegulatoryAndCommercialMilestonesBeginningDate_d5853113-0fec-470e-a1b9-857ad8cf3716" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RegulatoryAndCommercialMilestonesEndingDate_2aaed9ea-5c7d-4be3-89b8-f8de537118a9" xlink:href="dva-20220930.xsd#dva_RegulatoryAndCommercialMilestonesEndingDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_625cdb65-227f-475f-8bef-9ab56d03d444" xlink:to="loc_dva_RegulatoryAndCommercialMilestonesEndingDate_2aaed9ea-5c7d-4be3-89b8-f8de537118a9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_9b31f1dc-e1d2-4bff-98df-f1d643ed152a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_625cdb65-227f-475f-8bef-9ab56d03d444" xlink:to="loc_us-gaap_OtherCommitmentsTable_9b31f1dc-e1d2-4bff-98df-f1d643ed152a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionTypeAxis_09fe9f7b-3d57-4afc-9b3a-a5456bf77094" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransactionTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_9b31f1dc-e1d2-4bff-98df-f1d643ed152a" xlink:to="loc_us-gaap_TransactionTypeAxis_09fe9f7b-3d57-4afc-9b3a-a5456bf77094" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionDomain_09fe9f7b-3d57-4afc-9b3a-a5456bf77094_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TransactionTypeAxis_09fe9f7b-3d57-4afc-9b3a-a5456bf77094" xlink:to="loc_us-gaap_TransactionDomain_09fe9f7b-3d57-4afc-9b3a-a5456bf77094_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionDomain_72d520d5-ea2a-437d-b000-ff2c97d66159" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TransactionTypeAxis_09fe9f7b-3d57-4afc-9b3a-a5456bf77094" xlink:to="loc_us-gaap_TransactionDomain_72d520d5-ea2a-437d-b000-ff2c97d66159" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncrementalCashPortionMember_23129ef0-5d80-4b0c-bf4d-a851275f6e3a" xlink:href="dva-20220930.xsd#dva_IncrementalCashPortionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransactionDomain_72d520d5-ea2a-437d-b000-ff2c97d66159" xlink:to="loc_dva_IncrementalCashPortionMember_23129ef0-5d80-4b0c-bf4d-a851275f6e3a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CashPaidForPortionPreviouslyRefundedMember_c27bf532-3f94-46c2-996c-019692bc622a" xlink:href="dva-20220930.xsd#dva_CashPaidForPortionPreviouslyRefundedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransactionDomain_72d520d5-ea2a-437d-b000-ff2c97d66159" xlink:to="loc_dva_CashPaidForPortionPreviouslyRefundedMember_c27bf532-3f94-46c2-996c-019692bc622a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_2dabcf76-ee8f-4161-9649-81ac57840d88" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_9b31f1dc-e1d2-4bff-98df-f1d643ed152a" xlink:to="loc_srt_LitigationCaseAxis_2dabcf76-ee8f-4161-9649-81ac57840d88" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_2dabcf76-ee8f-4161-9649-81ac57840d88_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_2dabcf76-ee8f-4161-9649-81ac57840d88" xlink:to="loc_srt_LitigationCaseTypeDomain_2dabcf76-ee8f-4161-9649-81ac57840d88_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_e3d0658b-4a2e-44b7-839d-2c85cef3f627" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_2dabcf76-ee8f-4161-9649-81ac57840d88" xlink:to="loc_srt_LitigationCaseTypeDomain_e3d0658b-4a2e-44b7-839d-2c85cef3f627" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USAttorneyPrescriptionDrugInvestigationMember_1715a3e4-0340-442b-8bc9-4ec304e18835" xlink:href="dva-20220930.xsd#dva_USAttorneyPrescriptionDrugInvestigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_e3d0658b-4a2e-44b7-839d-2c85cef3f627" xlink:to="loc_dva_USAttorneyPrescriptionDrugInvestigationMember_1715a3e4-0340-442b-8bc9-4ec304e18835" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsAxis_d60889e3-0edd-4ba2-9393-3f489ba4131d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_9b31f1dc-e1d2-4bff-98df-f1d643ed152a" xlink:to="loc_us-gaap_OtherCommitmentsAxis_d60889e3-0edd-4ba2-9393-3f489ba4131d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain_d60889e3-0edd-4ba2-9393-3f489ba4131d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OtherCommitmentsAxis_d60889e3-0edd-4ba2-9393-3f489ba4131d" xlink:to="loc_us-gaap_OtherCommitmentsDomain_d60889e3-0edd-4ba2-9393-3f489ba4131d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain_9f9fc1b3-8847-4149-afc4-a958fc59d035" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OtherCommitmentsAxis_d60889e3-0edd-4ba2-9393-3f489ba4131d" xlink:to="loc_us-gaap_OtherCommitmentsDomain_9f9fc1b3-8847-4149-afc4-a958fc59d035" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CommitmentsToProvideOperatingCapitalMember_ed20bb0c-ff7a-401b-ab68-875c9eabb448" xlink:href="dva-20220930.xsd#dva_CommitmentsToProvideOperatingCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsDomain_9f9fc1b3-8847-4149-afc4-a958fc59d035" xlink:to="loc_dva_CommitmentsToProvideOperatingCapitalMember_ed20bb0c-ff7a-401b-ab68-875c9eabb448" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AgreementWithMedtronicMember_a65e329b-66bb-4c7b-b53f-09b5958ab89a" xlink:href="dva-20220930.xsd#dva_AgreementWithMedtronicMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsDomain_9f9fc1b3-8847-4149-afc4-a958fc59d035" xlink:to="loc_dva_AgreementWithMedtronicMember_a65e329b-66bb-4c7b-b53f-09b5958ab89a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermincentivecompensationDetails" xlink:type="simple" xlink:href="dva-20220930.xsd#LongtermincentivecompensationDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/LongtermincentivecompensationDetails" xlink:type="extended" id="i03f6dcde81954d469d90511919407de0_LongtermincentivecompensationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c3f0ac9c-a1c7-4397-9c4c-68c4c425d695" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_adb7bc2c-704c-45cf-be36-c574ba8fa38e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c3f0ac9c-a1c7-4397-9c4c-68c4c425d695" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_adb7bc2c-704c-45cf-be36-c574ba8fa38e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted_32a647cf-7e7a-4e4e-9f14-2feaa91d87e9" xlink:href="dva-20220930.xsd#dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c3f0ac9c-a1c7-4397-9c4c-68c4c425d695" xlink:to="loc_dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted_32a647cf-7e7a-4e4e-9f14-2feaa91d87e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_c63ae2d0-7d43-4965-a001-f6b8d160be1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c3f0ac9c-a1c7-4397-9c4c-68c4c425d695" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_c63ae2d0-7d43-4965-a001-f6b8d160be1c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_b675826f-7dc8-43cc-b9b3-beeca9ce670c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c3f0ac9c-a1c7-4397-9c4c-68c4c425d695" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_b675826f-7dc8-43cc-b9b3-beeca9ce670c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_d53d7383-cc0e-4d39-b156-2ed501caefc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c3f0ac9c-a1c7-4397-9c4c-68c4c425d695" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_d53d7383-cc0e-4d39-b156-2ed501caefc7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_968b04ec-b4cc-48c1-82e6-e712a3e81f00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c3f0ac9c-a1c7-4397-9c4c-68c4c425d695" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_968b04ec-b4cc-48c1-82e6-e712a3e81f00" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a8217c75-ffa8-4c50-af0a-84224401c068" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c3f0ac9c-a1c7-4397-9c4c-68c4c425d695" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a8217c75-ffa8-4c50-af0a-84224401c068" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_7b2652ad-71db-4f05-a43c-b19dc1d02610" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a8217c75-ffa8-4c50-af0a-84224401c068" xlink:to="loc_us-gaap_AwardTypeAxis_7b2652ad-71db-4f05-a43c-b19dc1d02610" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7b2652ad-71db-4f05-a43c-b19dc1d02610_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_7b2652ad-71db-4f05-a43c-b19dc1d02610" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7b2652ad-71db-4f05-a43c-b19dc1d02610_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_595f50e9-1404-456e-9b41-2e7a05e1c636" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_7b2652ad-71db-4f05-a43c-b19dc1d02610" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_595f50e9-1404-456e-9b41-2e7a05e1c636" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_f3fac6aa-bffb-413c-9e1c-9a19a2d3d6cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_595f50e9-1404-456e-9b41-2e7a05e1c636" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_f3fac6aa-bffb-413c-9e1c-9a19a2d3d6cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_f89dbc1f-bed0-4b1d-970c-034010e3a0af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_595f50e9-1404-456e-9b41-2e7a05e1c636" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_f89dbc1f-bed0-4b1d-970c-034010e3a0af" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/SharerepurchasesShareRepurchaseTableDetails" xlink:type="simple" xlink:href="dva-20220930.xsd#SharerepurchasesShareRepurchaseTableDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/SharerepurchasesShareRepurchaseTableDetails" xlink:type="extended" id="i81f7a6bead884a1cbab188224af4b9aa_SharerepurchasesShareRepurchaseTableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3d75bc1c-e59b-41a9-9733-6ffbdac215f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_6b44de8c-afda-4b8d-aca0-733c4dce745d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3d75bc1c-e59b-41a9-9733-6ffbdac215f2" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_6b44de8c-afda-4b8d-aca0-733c4dce745d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_76885861-8d3b-4aeb-a1d9-7e6283c1ab2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3d75bc1c-e59b-41a9-9733-6ffbdac215f2" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_76885861-8d3b-4aeb-a1d9-7e6283c1ab2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_e43c629b-a694-48c1-9557-3149a0aa7257" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3d75bc1c-e59b-41a9-9733-6ffbdac215f2" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_e43c629b-a694-48c1-9557-3149a0aa7257" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_04fbfa37-2d4f-4459-ad80-ca3e72ea5d6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3d75bc1c-e59b-41a9-9733-6ffbdac215f2" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_04fbfa37-2d4f-4459-ad80-ca3e72ea5d6d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_487cc122-c04c-4f69-acaa-57ef97c2d0b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_04fbfa37-2d4f-4459-ad80-ca3e72ea5d6d" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_487cc122-c04c-4f69-acaa-57ef97c2d0b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_487cc122-c04c-4f69-acaa-57ef97c2d0b5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_487cc122-c04c-4f69-acaa-57ef97c2d0b5" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_487cc122-c04c-4f69-acaa-57ef97c2d0b5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_18f300fd-edde-4cd9-9b13-dbb97b56e44a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_487cc122-c04c-4f69-acaa-57ef97c2d0b5" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_18f300fd-edde-4cd9-9b13-dbb97b56e44a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OpenMarketPurchasesMember_60bfe1cc-fb6b-4b67-9c9c-64e8fd2d372f" xlink:href="dva-20220930.xsd#dva_OpenMarketPurchasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_18f300fd-edde-4cd9-9b13-dbb97b56e44a" xlink:to="loc_dva_OpenMarketPurchasesMember_60bfe1cc-fb6b-4b67-9c9c-64e8fd2d372f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/SharerepurchasesDetails" xlink:type="simple" xlink:href="dva-20220930.xsd#SharerepurchasesDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/SharerepurchasesDetails" xlink:type="extended" id="i60e715bb7e0a4575b4c668e7479f6bc3_SharerepurchasesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ea104b2c-dda4-4c6a-9379-8d248231d137" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_8450be25-fc0f-43db-90fa-96a1228921ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ea104b2c-dda4-4c6a-9379-8d248231d137" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_8450be25-fc0f-43db-90fa-96a1228921ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_90fc92f9-4722-4bc9-bad2-c26e0f24a12a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ea104b2c-dda4-4c6a-9379-8d248231d137" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_90fc92f9-4722-4bc9-bad2-c26e0f24a12a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_99a3375b-c418-46b8-96f4-cf342ac05908" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ea104b2c-dda4-4c6a-9379-8d248231d137" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_99a3375b-c418-46b8-96f4-cf342ac05908" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_56ea0a0a-1bd0-4376-81c2-12242af70ffe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_99a3375b-c418-46b8-96f4-cf342ac05908" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_56ea0a0a-1bd0-4376-81c2-12242af70ffe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_56ea0a0a-1bd0-4376-81c2-12242af70ffe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_56ea0a0a-1bd0-4376-81c2-12242af70ffe" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_56ea0a0a-1bd0-4376-81c2-12242af70ffe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_39fcaed5-2f1d-488e-bc54-9773a65f9daa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_56ea0a0a-1bd0-4376-81c2-12242af70ffe" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_39fcaed5-2f1d-488e-bc54-9773a65f9daa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_d83e7426-7549-4034-89e8-0eec36068bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_39fcaed5-2f1d-488e-bc54-9773a65f9daa" xlink:to="loc_us-gaap_SubsequentEventMember_d83e7426-7549-4034-89e8-0eec36068bf6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail" xlink:type="simple" xlink:href="dva-20220930.xsd#AccumulatedothercomprehensivelossincomeDetail"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail" xlink:type="extended" id="i38ac1ab375b24abca89d2cedb48bcafa_AccumulatedothercomprehensivelossincomeDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_c8de9128-3261-49a0-8023-0a36d5c4111f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9ce832cc-e144-4c8c-b2db-d173b2c8dd17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_c8de9128-3261-49a0-8023-0a36d5c4111f" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9ce832cc-e144-4c8c-b2db-d173b2c8dd17" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3a13cad4-eacf-4c6b-964f-51779441c743" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9ce832cc-e144-4c8c-b2db-d173b2c8dd17" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3a13cad4-eacf-4c6b-964f-51779441c743" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_35987f30-a46d-4faa-ac48-9c4dc993c596" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9ce832cc-e144-4c8c-b2db-d173b2c8dd17" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_35987f30-a46d-4faa-ac48-9c4dc993c596" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_9a24d71a-2fd7-4147-9df1-cabfd419de86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9ce832cc-e144-4c8c-b2db-d173b2c8dd17" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_9a24d71a-2fd7-4147-9df1-cabfd419de86" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_9cacb4fb-03b1-4653-ac68-41c8d7538022" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9ce832cc-e144-4c8c-b2db-d173b2c8dd17" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_9cacb4fb-03b1-4653-ac68-41c8d7538022" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_0702e86b-d1f1-4ba6-acaf-26a73e36bfb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9ce832cc-e144-4c8c-b2db-d173b2c8dd17" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_0702e86b-d1f1-4ba6-acaf-26a73e36bfb6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_2a841e8d-5b0c-4f79-b8f0-761ff8dba047" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9ce832cc-e144-4c8c-b2db-d173b2c8dd17" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_2a841e8d-5b0c-4f79-b8f0-761ff8dba047" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_e76b8b5e-e184-46fe-8894-ef9954151344" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9ce832cc-e144-4c8c-b2db-d173b2c8dd17" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_e76b8b5e-e184-46fe-8894-ef9954151344" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c0627a37-7d28-4e39-a940-cf96934f1491" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_4422eb44-7dd6-40cb-bdc3-f664f908878c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_c8de9128-3261-49a0-8023-0a36d5c4111f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_4422eb44-7dd6-40cb-bdc3-f664f908878c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_62d6398d-51af-4c48-b0bf-479c02aa049e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_4422eb44-7dd6-40cb-bdc3-f664f908878c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_62d6398d-51af-4c48-b0bf-479c02aa049e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_62d6398d-51af-4c48-b0bf-479c02aa049e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_62d6398d-51af-4c48-b0bf-479c02aa049e" xlink:to="loc_us-gaap_EquityComponentDomain_62d6398d-51af-4c48-b0bf-479c02aa049e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2fd9b7ea-9c79-4b90-a49c-be01df9cd3af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_62d6398d-51af-4c48-b0bf-479c02aa049e" xlink:to="loc_us-gaap_EquityComponentDomain_2fd9b7ea-9c79-4b90-a49c-be01df9cd3af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_77910c4a-4106-4de3-bebd-00707780515b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2fd9b7ea-9c79-4b90-a49c-be01df9cd3af" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_77910c4a-4106-4de3-bebd-00707780515b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_ae3d0549-97ee-43ae-9558-63ef89543a59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2fd9b7ea-9c79-4b90-a49c-be01df9cd3af" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_ae3d0549-97ee-43ae-9558-63ef89543a59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_cc246a36-4254-49f2-a3d6-24e585454d89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2fd9b7ea-9c79-4b90-a49c-be01df9cd3af" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_cc246a36-4254-49f2-a3d6-24e585454d89" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/AcquisitionsanddivestituresContingentEarnoutobligationsDetails" xlink:type="simple" xlink:href="dva-20220930.xsd#AcquisitionsanddivestituresContingentEarnoutobligationsDetails"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/AcquisitionsanddivestituresContingentEarnoutobligationsDetails" xlink:type="extended" id="i381bf41d4b6d441c9df6df78f23c9a9e_AcquisitionsanddivestituresContingentEarnoutobligationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_1757d4fa-a3c2-4466-8279-490f2bd50beb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_6a86d4c8-7dc3-43e1-9302-f7bd5c7ae0d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1757d4fa-a3c2-4466-8279-490f2bd50beb" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_6a86d4c8-7dc3-43e1-9302-f7bd5c7ae0d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_55dcbce1-69ae-4d39-ad8d-b943450ed7b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1757d4fa-a3c2-4466-8279-490f2bd50beb" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_55dcbce1-69ae-4d39-ad8d-b943450ed7b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations_0e291574-0ea5-4a1f-a758-bf6abce9fc17" xlink:href="dva-20220930.xsd#dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1757d4fa-a3c2-4466-8279-490f2bd50beb" xlink:to="loc_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations_0e291574-0ea5-4a1f-a758-bf6abce9fc17" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss_97760bc5-a499-4f13-82b1-fe9562f4677f" xlink:href="dva-20220930.xsd#dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1757d4fa-a3c2-4466-8279-490f2bd50beb" xlink:to="loc_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss_97760bc5-a499-4f13-82b1-fe9562f4677f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_529e584f-f4ff-4e79-94e9-bb3a7ce0ed9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1757d4fa-a3c2-4466-8279-490f2bd50beb" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_529e584f-f4ff-4e79-94e9-bb3a7ce0ed9d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_dbb9bdf2-45f6-4707-9443-e5214f47309a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c500d425-d550-4e03-b55f-282da156339b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1757d4fa-a3c2-4466-8279-490f2bd50beb" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c500d425-d550-4e03-b55f-282da156339b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3904623c-c4b5-4409-8337-de7f099d7353" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c500d425-d550-4e03-b55f-282da156339b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3904623c-c4b5-4409-8337-de7f099d7353" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3904623c-c4b5-4409-8337-de7f099d7353_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3904623c-c4b5-4409-8337-de7f099d7353" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3904623c-c4b5-4409-8337-de7f099d7353_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e104ed67-dca8-4393-b1c7-1d3a61377287" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3904623c-c4b5-4409-8337-de7f099d7353" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e104ed67-dca8-4393-b1c7-1d3a61377287" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_ca8944ea-35b1-4f0b-ac2a-835864d1104b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e104ed67-dca8-4393-b1c7-1d3a61377287" xlink:to="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_ca8944ea-35b1-4f0b-ac2a-835864d1104b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail" xlink:type="simple" xlink:href="dva-20220930.xsd#AcquisitionsanddivestituresAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail" xlink:type="extended" id="i40ef08c68c4b4ed48df8a7493dfe4657_AcquisitionsanddivestituresAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_f883a1a5-b5c8-43d0-8b37-9beff2448e09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired_1683b9a1-492b-49cd-a8c5-88ac9fd5b1aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f883a1a5-b5c8-43d0-8b37-9beff2448e09" xlink:to="loc_us-gaap_NumberOfBusinessesAcquired_1683b9a1-492b-49cd-a8c5-88ac9fd5b1aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_418d510b-02c4-4abb-b249-8b7a26c1006d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f883a1a5-b5c8-43d0-8b37-9beff2448e09" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_418d510b-02c4-4abb-b249-8b7a26c1006d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessCombinationContingentConsiderationAcquisitions_7846bcbe-7971-4db8-b366-a23391ab56b6" xlink:href="dva-20220930.xsd#dva_BusinessCombinationContingentConsiderationAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f883a1a5-b5c8-43d0-8b37-9beff2448e09" xlink:to="loc_dva_BusinessCombinationContingentConsiderationAcquisitions_7846bcbe-7971-4db8-b366-a23391ab56b6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_d76c3afe-4355-422d-baa4-99441967d26a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f883a1a5-b5c8-43d0-8b37-9beff2448e09" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_d76c3afe-4355-422d-baa4-99441967d26a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessAcquisitionGoodwillExpectedTaxDeductibleAmountAdjustment_d96b2be6-dfe6-4188-bb29-c09b7625b483" xlink:href="dva-20220930.xsd#dva_BusinessAcquisitionGoodwillExpectedTaxDeductibleAmountAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f883a1a5-b5c8-43d0-8b37-9beff2448e09" xlink:to="loc_dva_BusinessAcquisitionGoodwillExpectedTaxDeductibleAmountAdjustment_d96b2be6-dfe6-4188-bb29-c09b7625b483" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod_bc800069-133d-4bca-953f-873a7d540d08" xlink:href="dva-20220930.xsd#dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f883a1a5-b5c8-43d0-8b37-9beff2448e09" xlink:to="loc_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod_bc800069-133d-4bca-953f-873a7d540d08" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_2bd5c69c-aae4-4080-b5c7-29cf3dc24a51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f883a1a5-b5c8-43d0-8b37-9beff2448e09" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_2bd5c69c-aae4-4080-b5c7-29cf3dc24a51" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_09a1f89d-e59d-4df8-abe5-088361d99383" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f883a1a5-b5c8-43d0-8b37-9beff2448e09" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_09a1f89d-e59d-4df8-abe5-088361d99383" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_7cef3876-0144-4442-9841-a5da5185f0c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_09a1f89d-e59d-4df8-abe5-088361d99383" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_7cef3876-0144-4442-9841-a5da5185f0c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7cef3876-0144-4442-9841-a5da5185f0c4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7cef3876-0144-4442-9841-a5da5185f0c4" xlink:to="loc_us-gaap_SegmentDomain_7cef3876-0144-4442-9841-a5da5185f0c4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_07769d48-39ef-4bab-a8c4-d735c07788de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7cef3876-0144-4442-9841-a5da5185f0c4" xlink:to="loc_us-gaap_SegmentDomain_07769d48-39ef-4bab-a8c4-d735c07788de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedServicesMember_a98d4688-41d7-44f8-b8ce-5b07db978071" xlink:href="dva-20220930.xsd#dva_USDialysisAndRelatedServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_07769d48-39ef-4bab-a8c4-d735c07788de" xlink:to="loc_dva_USDialysisAndRelatedServicesMember_a98d4688-41d7-44f8-b8ce-5b07db978071" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ForeignDialysisCentersMember_16197d1d-0187-47e8-a6be-eef2558d1acc" xlink:href="dva-20220930.xsd#dva_ForeignDialysisCentersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_07769d48-39ef-4bab-a8c4-d735c07788de" xlink:to="loc_dva_ForeignDialysisCentersMember_16197d1d-0187-47e8-a6be-eef2558d1acc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_c78ddc89-7f45-49bc-890d-e3e875939429" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_09a1f89d-e59d-4df8-abe5-088361d99383" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_c78ddc89-7f45-49bc-890d-e3e875939429" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c78ddc89-7f45-49bc-890d-e3e875939429_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c78ddc89-7f45-49bc-890d-e3e875939429" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c78ddc89-7f45-49bc-890d-e3e875939429_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_08de6afa-7402-4722-a029-468c91f38cc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c78ddc89-7f45-49bc-890d-e3e875939429" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_08de6afa-7402-4722-a029-468c91f38cc2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_aa2c3783-8173-420b-b3d2-0a67d45f53f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_08de6afa-7402-4722-a029-468c91f38cc2" xlink:to="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_aa2c3783-8173-420b-b3d2-0a67d45f53f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0fd8d241-e686-40d8-9ac6-e7e8339a5f89" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_09a1f89d-e59d-4df8-abe5-088361d99383" xlink:to="loc_srt_RangeAxis_0fd8d241-e686-40d8-9ac6-e7e8339a5f89" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0fd8d241-e686-40d8-9ac6-e7e8339a5f89_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_0fd8d241-e686-40d8-9ac6-e7e8339a5f89" xlink:to="loc_srt_RangeMember_0fd8d241-e686-40d8-9ac6-e7e8339a5f89_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b235a572-5756-45c2-85b0-9789de7ed25f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_0fd8d241-e686-40d8-9ac6-e7e8339a5f89" xlink:to="loc_srt_RangeMember_b235a572-5756-45c2-85b0-9789de7ed25f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_103d172d-cefa-4cc6-ac7f-e1fb12cc39b8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b235a572-5756-45c2-85b0-9789de7ed25f" xlink:to="loc_srt_MinimumMember_103d172d-cefa-4cc6-ac7f-e1fb12cc39b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_30a2c441-557b-4867-9696-60c3673807e7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b235a572-5756-45c2-85b0-9789de7ed25f" xlink:to="loc_srt_MaximumMember_30a2c441-557b-4867-9696-60c3673807e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5058759b-afed-4ca8-bf89-5e8df023e1d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_09a1f89d-e59d-4df8-abe5-088361d99383" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5058759b-afed-4ca8-bf89-5e8df023e1d4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_5058759b-afed-4ca8-bf89-5e8df023e1d4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5058759b-afed-4ca8-bf89-5e8df023e1d4" xlink:to="loc_us-gaap_RelatedPartyDomain_5058759b-afed-4ca8-bf89-5e8df023e1d4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_0e20e172-3325-4152-9c0e-a40649f2d302" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5058759b-afed-4ca8-bf89-5e8df023e1d4" xlink:to="loc_us-gaap_RelatedPartyDomain_0e20e172-3325-4152-9c0e-a40649f2d302" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherCompaniesMember_a00b72ed-930f-4a49-9675-1660f20e713d" xlink:href="dva-20220930.xsd#dva_OtherCompaniesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_0e20e172-3325-4152-9c0e-a40649f2d302" xlink:to="loc_dva_OtherCompaniesMember_a00b72ed-930f-4a49-9675-1660f20e713d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_9939132b-0587-4700-bfe1-f236beab2480" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_09a1f89d-e59d-4df8-abe5-088361d99383" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_9939132b-0587-4700-bfe1-f236beab2480" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_9939132b-0587-4700-bfe1-f236beab2480_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_9939132b-0587-4700-bfe1-f236beab2480" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_9939132b-0587-4700-bfe1-f236beab2480_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_c3a8b95f-6f38-4325-8d38-108221314738" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_9939132b-0587-4700-bfe1-f236beab2480" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_c3a8b95f-6f38-4325-8d38-108221314738" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember_064b6597-f642-456e-96ab-6ec44bede248" xlink:href="dva-20220930.xsd#dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_c3a8b95f-6f38-4325-8d38-108221314738" xlink:to="loc_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember_064b6597-f642-456e-96ab-6ec44bede248" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_7fd6d6b7-38b0-4a81-8b47-1cf5878de76f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_09a1f89d-e59d-4df8-abe5-088361d99383" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_7fd6d6b7-38b0-4a81-8b47-1cf5878de76f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_7fd6d6b7-38b0-4a81-8b47-1cf5878de76f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_7fd6d6b7-38b0-4a81-8b47-1cf5878de76f" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_7fd6d6b7-38b0-4a81-8b47-1cf5878de76f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1bb8f223-f722-4752-a513-4ae16585202f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_7fd6d6b7-38b0-4a81-8b47-1cf5878de76f" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1bb8f223-f722-4752-a513-4ae16585202f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_0c9333f0-9134-475a-8f1f-feb5f962f298" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1bb8f223-f722-4752-a513-4ae16585202f" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_0c9333f0-9134-475a-8f1f-feb5f962f298" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_3974e41d-f3ec-4c9d-8251-aaedb723391e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1bb8f223-f722-4752-a513-4ae16585202f" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_3974e41d-f3ec-4c9d-8251-aaedb723391e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/VariableinterestentitiesAdditionalInformationDetail" xlink:type="simple" xlink:href="dva-20220930.xsd#VariableinterestentitiesAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/VariableinterestentitiesAdditionalInformationDetail" xlink:type="extended" id="i7161ac31d6be458e8d6f6b26f19b5fa0_VariableinterestentitiesAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c9ec13da-794b-43be-a97b-bd1b06b9f121" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_4dd433b7-c832-41d5-b02e-76eb2cba3453" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c9ec13da-794b-43be-a97b-bd1b06b9f121" xlink:to="loc_us-gaap_Assets_4dd433b7-c832-41d5-b02e-76eb2cba3453" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_0b9c7328-2e1b-41fb-9680-edbc5f80cb2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c9ec13da-794b-43be-a97b-bd1b06b9f121" xlink:to="loc_us-gaap_Liabilities_0b9c7328-2e1b-41fb-9680-edbc5f80cb2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_163de459-4881-4ffb-8dfd-260b9af3e22b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_c9ec13da-794b-43be-a97b-bd1b06b9f121" xlink:to="loc_us-gaap_StatementTable_163de459-4881-4ffb-8dfd-260b9af3e22b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_cf2e22b7-630a-4da4-b5e1-596ea24e992d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_163de459-4881-4ffb-8dfd-260b9af3e22b" xlink:to="loc_srt_ConsolidatedEntitiesAxis_cf2e22b7-630a-4da4-b5e1-596ea24e992d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_cf2e22b7-630a-4da4-b5e1-596ea24e992d_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_cf2e22b7-630a-4da4-b5e1-596ea24e992d" xlink:to="loc_srt_ConsolidatedEntitiesDomain_cf2e22b7-630a-4da4-b5e1-596ea24e992d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_43ca09dd-0a62-42e1-bdfe-b3eee2e699f7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_cf2e22b7-630a-4da4-b5e1-596ea24e992d" xlink:to="loc_srt_ConsolidatedEntitiesDomain_43ca09dd-0a62-42e1-bdfe-b3eee2e699f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_782aa6cf-ce8f-48ac-8474-96ef79c56edc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_43ca09dd-0a62-42e1-bdfe-b3eee2e699f7" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_782aa6cf-ce8f-48ac-8474-96ef79c56edc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail" xlink:type="simple" xlink:href="dva-20220930.xsd#FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail" xlink:type="extended" id="i1c95f5b187694dc58dc6b9a3ee395918_FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_5b771519-5166-4094-bcb7-6dd29933dd9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_352d3fcf-5132-4498-bd36-9912deec54d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_5b771519-5166-4094-bcb7-6dd29933dd9f" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_352d3fcf-5132-4498-bd36-9912deec54d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_9b564b57-56a6-4cf6-9c29-628e36eb23fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_352d3fcf-5132-4498-bd36-9912deec54d8" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_9b564b57-56a6-4cf6-9c29-628e36eb23fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_a828f25b-a5d9-4010-92ae-a896333d9a8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_352d3fcf-5132-4498-bd36-9912deec54d8" xlink:to="loc_us-gaap_DerivativeAssets_a828f25b-a5d9-4010-92ae-a896333d9a8a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_4dcc8d01-565a-46a7-b2ca-77e7d1e1ed2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_5b771519-5166-4094-bcb7-6dd29933dd9f" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_4dcc8d01-565a-46a7-b2ca-77e7d1e1ed2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_bc27be25-e50b-4099-93d6-3dd737256e19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_4dcc8d01-565a-46a7-b2ca-77e7d1e1ed2f" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_bc27be25-e50b-4099-93d6-3dd737256e19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAbstract_1c5965e2-2fe7-4aed-811f-850b6c1f04b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_5b771519-5166-4094-bcb7-6dd29933dd9f" xlink:to="loc_us-gaap_TemporaryEquityAbstract_1c5965e2-2fe7-4aed-811f-850b6c1f04b8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_bfec396b-75d7-40a4-9816-2618d04a6132" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityAbstract_1c5965e2-2fe7-4aed-811f-850b6c1f04b8" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_bfec396b-75d7-40a4-9816-2618d04a6132" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_36bda6ad-71aa-4779-8ade-5991da382af0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_5b771519-5166-4094-bcb7-6dd29933dd9f" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_36bda6ad-71aa-4779-8ade-5991da382af0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7fc9b941-d28e-45cb-8473-ed37f0c643d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_36bda6ad-71aa-4779-8ade-5991da382af0" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7fc9b941-d28e-45cb-8473-ed37f0c643d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_7fc9b941-d28e-45cb-8473-ed37f0c643d2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7fc9b941-d28e-45cb-8473-ed37f0c643d2" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_7fc9b941-d28e-45cb-8473-ed37f0c643d2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_71184f03-2369-4351-9a19-998443815491" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7fc9b941-d28e-45cb-8473-ed37f0c643d2" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_71184f03-2369-4351-9a19-998443815491" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_fcb30c75-26aa-483f-92eb-7e5d0386b9a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_71184f03-2369-4351-9a19-998443815491" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_fcb30c75-26aa-483f-92eb-7e5d0386b9a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f16a88e1-2855-447d-b4b7-4816f8dd773a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_36bda6ad-71aa-4779-8ade-5991da382af0" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f16a88e1-2855-447d-b4b7-4816f8dd773a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f16a88e1-2855-447d-b4b7-4816f8dd773a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f16a88e1-2855-447d-b4b7-4816f8dd773a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f16a88e1-2855-447d-b4b7-4816f8dd773a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6047978b-afc3-4f97-a273-ee5d49ad88da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f16a88e1-2855-447d-b4b7-4816f8dd773a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6047978b-afc3-4f97-a273-ee5d49ad88da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_e24cbda0-edc1-40b0-a29a-ac33893194b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6047978b-afc3-4f97-a273-ee5d49ad88da" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_e24cbda0-edc1-40b0-a29a-ac33893194b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_9e5f967d-6795-4e0c-855f-ef42aeb78674" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6047978b-afc3-4f97-a273-ee5d49ad88da" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_9e5f967d-6795-4e0c-855f-ef42aeb78674" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_da16ff6a-06a6-435e-bbdb-c24592bc4342" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6047978b-afc3-4f97-a273-ee5d49ad88da" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_da16ff6a-06a6-435e-bbdb-c24592bc4342" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_4b1a14cf-f7c1-465c-bb27-3ee30ed5b2d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_36bda6ad-71aa-4779-8ade-5991da382af0" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_4b1a14cf-f7c1-465c-bb27-3ee30ed5b2d2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4b1a14cf-f7c1-465c-bb27-3ee30ed5b2d2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4b1a14cf-f7c1-465c-bb27-3ee30ed5b2d2" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4b1a14cf-f7c1-465c-bb27-3ee30ed5b2d2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6e51e1bd-e4a7-4f33-9445-24ced85571c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4b1a14cf-f7c1-465c-bb27-3ee30ed5b2d2" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6e51e1bd-e4a7-4f33-9445-24ced85571c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_4453ee42-8c65-408d-8072-8405827cc7a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6e51e1bd-e4a7-4f33-9445-24ced85571c4" xlink:to="loc_us-gaap_InterestRateCapMember_4453ee42-8c65-408d-8072-8405827cc7a6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail" xlink:type="simple" xlink:href="dva-20220930.xsd#SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail" xlink:type="extended" id="iecd67ab31afb47489edb5937b41ea464_SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_7c9ac539-657b-4129-b254-3445db5e18d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_b4d0eca5-ccfa-45dc-972b-68f23c21b054" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7c9ac539-657b-4129-b254-3445db5e18d9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_b4d0eca5-ccfa-45dc-972b-68f23c21b054" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_c52901b6-0f6d-4d16-a251-bb400d51b43e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7c9ac539-657b-4129-b254-3445db5e18d9" xlink:to="loc_us-gaap_OtherIncome_c52901b6-0f6d-4d16-a251-bb400d51b43e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_98c43fdf-6c34-44ba-af87-1e80b90e3518" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7c9ac539-657b-4129-b254-3445db5e18d9" xlink:to="loc_us-gaap_Revenues_98c43fdf-6c34-44ba-af87-1e80b90e3518" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_48cb5783-41c2-4138-bae8-94ba6d841206" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7c9ac539-657b-4129-b254-3445db5e18d9" xlink:to="loc_us-gaap_OperatingIncomeLoss_48cb5783-41c2-4138-bae8-94ba6d841206" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SegmentReportingInformationCorporateExpenses_8073cda6-fda8-49f6-ba50-486ea99048ea" xlink:href="dva-20220930.xsd#dva_SegmentReportingInformationCorporateExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7c9ac539-657b-4129-b254-3445db5e18d9" xlink:to="loc_dva_SegmentReportingInformationCorporateExpenses_8073cda6-fda8-49f6-ba50-486ea99048ea" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense_2f3ccaee-cdaa-49e4-8f90-2d528926a0bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7c9ac539-657b-4129-b254-3445db5e18d9" xlink:to="loc_us-gaap_InterestAndDebtExpense_2f3ccaee-cdaa-49e4-8f90-2d528926a0bc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_a93579b3-a08d-498d-ba9f-a241b37f1a5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7c9ac539-657b-4129-b254-3445db5e18d9" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_a93579b3-a08d-498d-ba9f-a241b37f1a5c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3275ce6e-f6d0-4025-9568-26ddbf2fb358" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7c9ac539-657b-4129-b254-3445db5e18d9" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3275ce6e-f6d0-4025-9568-26ddbf2fb358" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2b1a774e-8fe4-4548-a2cd-d0784051fbd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7c9ac539-657b-4129-b254-3445db5e18d9" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2b1a774e-8fe4-4548-a2cd-d0784051fbd8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_d2390a59-842d-439b-ae93-88af80a56af5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2b1a774e-8fe4-4548-a2cd-d0784051fbd8" xlink:to="loc_srt_ConsolidationItemsAxis_d2390a59-842d-439b-ae93-88af80a56af5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_d2390a59-842d-439b-ae93-88af80a56af5_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_d2390a59-842d-439b-ae93-88af80a56af5" xlink:to="loc_srt_ConsolidationItemsDomain_d2390a59-842d-439b-ae93-88af80a56af5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_95055f55-a2f0-4393-b7cf-d115b270b87e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_d2390a59-842d-439b-ae93-88af80a56af5" xlink:to="loc_srt_ConsolidationItemsDomain_95055f55-a2f0-4393-b7cf-d115b270b87e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_af4b121d-8a52-47a5-b6af-c94b054ff945" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_95055f55-a2f0-4393-b7cf-d115b270b87e" xlink:to="loc_us-gaap_OperatingSegmentsMember_af4b121d-8a52-47a5-b6af-c94b054ff945" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_5879fa5f-b006-4d74-ab16-f0a5adc80999" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_95055f55-a2f0-4393-b7cf-d115b270b87e" xlink:to="loc_us-gaap_IntersegmentEliminationMember_5879fa5f-b006-4d74-ab16-f0a5adc80999" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ebc7bb29-e69d-40ab-b86c-324b4096dba6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2b1a774e-8fe4-4548-a2cd-d0784051fbd8" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ebc7bb29-e69d-40ab-b86c-324b4096dba6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ebc7bb29-e69d-40ab-b86c-324b4096dba6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ebc7bb29-e69d-40ab-b86c-324b4096dba6" xlink:to="loc_us-gaap_SegmentDomain_ebc7bb29-e69d-40ab-b86c-324b4096dba6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_bb67842d-a33a-48de-a030-80fc45730e29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ebc7bb29-e69d-40ab-b86c-324b4096dba6" xlink:to="loc_us-gaap_SegmentDomain_bb67842d-a33a-48de-a030-80fc45730e29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_73880cb9-bb56-48f5-984d-9d8400b2116e" xlink:href="dva-20220930.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_bb67842d-a33a-48de-a030-80fc45730e29" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_73880cb9-bb56-48f5-984d-9d8400b2116e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_a6d0b3ae-95f1-400b-9e58-63bcbd7d087d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_bb67842d-a33a-48de-a030-80fc45730e29" xlink:to="loc_us-gaap_AllOtherSegmentsMember_a6d0b3ae-95f1-400b-9e58-63bcbd7d087d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsAxis_ac6be34c-c659-4764-9f5a-6d648ee92bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2b1a774e-8fe4-4548-a2cd-d0784051fbd8" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsAxis_ac6be34c-c659-4764-9f5a-6d648ee92bd2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsDomain_ac6be34c-c659-4764-9f5a-6d648ee92bd2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsAxis_ac6be34c-c659-4764-9f5a-6d648ee92bd2" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsDomain_ac6be34c-c659-4764-9f5a-6d648ee92bd2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsDomain_53c46ac3-542c-4e1e-a81b-cc6e7893db50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsAxis_ac6be34c-c659-4764-9f5a-6d648ee92bd2" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsDomain_53c46ac3-542c-4e1e-a81b-cc6e7893db50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ExternalSourcesMember_73621efb-6626-4b0a-a944-78a6aca7f95b" xlink:href="dva-20220930.xsd#dva_ExternalSourcesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsDomain_53c46ac3-542c-4e1e-a81b-cc6e7893db50" xlink:to="loc_dva_ExternalSourcesMember_73621efb-6626-4b0a-a944-78a6aca7f95b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersubsegmentEliminationsMember_e9ca150b-78b1-4feb-8586-b5f23fc76ccc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersubsegmentEliminationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsDomain_53c46ac3-542c-4e1e-a81b-cc6e7893db50" xlink:to="loc_us-gaap_IntersubsegmentEliminationsMember_e9ca150b-78b1-4feb-8586-b5f23fc76ccc" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail" xlink:type="simple" xlink:href="dva-20220930.xsd#SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail" xlink:type="extended" id="id2f94dd05b3a4e939df025d75b24b1e3_SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_94b8e61a-2e65-4dbc-b485-1d83a0875258" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_81b28093-a6f3-4312-8660-d11f697cd6c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_94b8e61a-2e65-4dbc-b485-1d83a0875258" xlink:to="loc_us-gaap_DepreciationAndAmortization_81b28093-a6f3-4312-8660-d11f697cd6c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_93e1d42d-752f-4250-a76f-6ccf2f6e4ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_94b8e61a-2e65-4dbc-b485-1d83a0875258" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_93e1d42d-752f-4250-a76f-6ccf2f6e4ff1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_eb9bf41b-18d4-42c2-8e6a-a71b71f933e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_93e1d42d-752f-4250-a76f-6ccf2f6e4ff1" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_eb9bf41b-18d4-42c2-8e6a-a71b71f933e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_eb9bf41b-18d4-42c2-8e6a-a71b71f933e7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_eb9bf41b-18d4-42c2-8e6a-a71b71f933e7" xlink:to="loc_us-gaap_SegmentDomain_eb9bf41b-18d4-42c2-8e6a-a71b71f933e7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b38e8917-1994-4db0-bd5e-3f066eaf8b2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_eb9bf41b-18d4-42c2-8e6a-a71b71f933e7" xlink:to="loc_us-gaap_SegmentDomain_b38e8917-1994-4db0-bd5e-3f066eaf8b2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_0a724e58-a438-43ce-ab0d-675a8b789319" xlink:href="dva-20220930.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b38e8917-1994-4db0-bd5e-3f066eaf8b2f" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_0a724e58-a438-43ce-ab0d-675a8b789319" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_172195e8-207c-4ef0-aa1a-e63a6ffb9e18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b38e8917-1994-4db0-bd5e-3f066eaf8b2f" xlink:to="loc_us-gaap_AllOtherSegmentsMember_172195e8-207c-4ef0-aa1a-e63a6ffb9e18" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail" xlink:type="simple" xlink:href="dva-20220930.xsd#SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail" xlink:type="extended" id="i9b20bda8a7b44578b36691fac73e0d46_SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_fe3782a5-05d5-4eb2-82f5-9d768627ed38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_237e839c-ee38-483e-b363-098aef1ead35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_fe3782a5-05d5-4eb2-82f5-9d768627ed38" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_237e839c-ee38-483e-b363-098aef1ead35" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ea1f6b47-d0fc-4903-aa84-85cd1260c2c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_fe3782a5-05d5-4eb2-82f5-9d768627ed38" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ea1f6b47-d0fc-4903-aa84-85cd1260c2c9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_1f454cd7-b4d6-4f10-a207-c55d49daea27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ea1f6b47-d0fc-4903-aa84-85cd1260c2c9" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_1f454cd7-b4d6-4f10-a207-c55d49daea27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1f454cd7-b4d6-4f10-a207-c55d49daea27_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1f454cd7-b4d6-4f10-a207-c55d49daea27" xlink:to="loc_us-gaap_SegmentDomain_1f454cd7-b4d6-4f10-a207-c55d49daea27_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7ebf11a8-9b8d-44fd-ac49-86a974568c84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1f454cd7-b4d6-4f10-a207-c55d49daea27" xlink:to="loc_us-gaap_SegmentDomain_7ebf11a8-9b8d-44fd-ac49-86a974568c84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_f03f3031-f9db-4644-8a4e-5bbd99ec9e2a" xlink:href="dva-20220930.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7ebf11a8-9b8d-44fd-ac49-86a974568c84" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_f03f3031-f9db-4644-8a4e-5bbd99ec9e2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_c3a35795-b302-4a74-888d-b383e31adbf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_7ebf11a8-9b8d-44fd-ac49-86a974568c84" xlink:to="loc_us-gaap_AllOtherSegmentsMember_c3a35795-b302-4a74-888d-b383e31adbf5" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentreportingSummaryofAssetsbySegmentDetail" xlink:type="simple" xlink:href="dva-20220930.xsd#SegmentreportingSummaryofAssetsbySegmentDetail"/>
  <link:definitionLink xlink:role="http://www.davita.com/role/SegmentreportingSummaryofAssetsbySegmentDetail" xlink:type="extended" id="i251811dedf894c8f99246d38ccc81673_SegmentreportingSummaryofAssetsbySegmentDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_65034b14-aa63-4add-a7e5-ba12ed55907b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_c6b20998-6dc2-459f-bf23-505570f08357" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_65034b14-aa63-4add-a7e5-ba12ed55907b" xlink:to="loc_us-gaap_AssetsAbstract_c6b20998-6dc2-459f-bf23-505570f08357" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_6de0a184-05a1-4ee2-8dd4-93e509e6a643" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_c6b20998-6dc2-459f-bf23-505570f08357" xlink:to="loc_us-gaap_Assets_6de0a184-05a1-4ee2-8dd4-93e509e6a643" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_94d9c5fb-cfb8-4094-bc28-1d955a5636d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_65034b14-aa63-4add-a7e5-ba12ed55907b" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_94d9c5fb-cfb8-4094-bc28-1d955a5636d0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_54575fca-fece-4a1e-9216-3e38e8b0839c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_94d9c5fb-cfb8-4094-bc28-1d955a5636d0" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_54575fca-fece-4a1e-9216-3e38e8b0839c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_54575fca-fece-4a1e-9216-3e38e8b0839c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_54575fca-fece-4a1e-9216-3e38e8b0839c" xlink:to="loc_us-gaap_SegmentDomain_54575fca-fece-4a1e-9216-3e38e8b0839c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_da2a658c-801b-496a-9d0f-8420ab4f02e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_54575fca-fece-4a1e-9216-3e38e8b0839c" xlink:to="loc_us-gaap_SegmentDomain_da2a658c-801b-496a-9d0f-8420ab4f02e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_bd7d8771-8478-4d30-b266-a9b8376ec4f3" xlink:href="dva-20220930.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_da2a658c-801b-496a-9d0f-8420ab4f02e6" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_bd7d8771-8478-4d30-b266-a9b8376ec4f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_1f548006-3a08-4691-aa27-b9be678336b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_da2a658c-801b-496a-9d0f-8420ab4f02e6" xlink:to="loc_us-gaap_AllOtherSegmentsMember_1f548006-3a08-4691-aa27-b9be678336b8" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>dva-20220930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:3a89ce86-098c-4ec0-abc8-dda3315bf074,g:fd665bd8-0744-46ac-b10f-ff3cbe103a81-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_e6c6460b-f20d-4f07-8b34-405226fd5151_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_CashPaidForPortionPreviouslyRefundedMember_990330bf-67ef-4787-b521-fc486ce26294_terseLabel_en-US" xlink:label="lab_dva_CashPaidForPortionPreviouslyRefundedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Paid For Portion Previously Refunded</link:label>
    <link:label id="lab_dva_CashPaidForPortionPreviouslyRefundedMember_label_en-US" xlink:label="lab_dva_CashPaidForPortionPreviouslyRefundedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Paid For Portion Previously Refunded [Member]</link:label>
    <link:label id="lab_dva_CashPaidForPortionPreviouslyRefundedMember_documentation_en-US" xlink:label="lab_dva_CashPaidForPortionPreviouslyRefundedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Paid For Amounts Previously Refunded [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CashPaidForPortionPreviouslyRefundedMember" xlink:href="dva-20220930.xsd#dva_CashPaidForPortionPreviouslyRefundedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_CashPaidForPortionPreviouslyRefundedMember" xlink:to="lab_dva_CashPaidForPortionPreviouslyRefundedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_2a6a673d-3440-400e-9d6a-0eb0d12384bc_totalLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from accumulated other comprehensive income into net income net of tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_dc3de368-efc9-4b8c-8831-deb99aa8570d_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_822e87b2-7282-4be4-bb27-e34e82f18252_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_95a86a3e-9190-4981-bfff-b6fe69a30014_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_290feb37-bf20-4da0-b4ff-f55a82bffbde_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_38db4a5d-d27a-42f0-aca4-6602c8455e4c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_e50c0eec-61c4-4da8-a14b-60ed14fd448b_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_1b071dc5-9d65-4afe-8212-b89e641701bf_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt principal outstanding</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_d36dd829-8542-413f-bcf3-cfe3047491de_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_SegmentRevenuebyMajorPayorAbstract_8f913ec3-4cb3-4451-b5a1-c935c6a98c54_terseLabel_en-US" xlink:label="lab_dva_SegmentRevenuebyMajorPayorAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Revenue by Major Payor [Abstract]</link:label>
    <link:label id="lab_dva_SegmentRevenuebyMajorPayorAbstract_label_en-US" xlink:label="lab_dva_SegmentRevenuebyMajorPayorAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Revenue by Major Payor [Abstract]</link:label>
    <link:label id="lab_dva_SegmentRevenuebyMajorPayorAbstract_documentation_en-US" xlink:label="lab_dva_SegmentRevenuebyMajorPayorAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Revenue by Major Payor [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SegmentRevenuebyMajorPayorAbstract" xlink:href="dva-20220930.xsd#dva_SegmentRevenuebyMajorPayorAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_SegmentRevenuebyMajorPayorAbstract" xlink:to="lab_dva_SegmentRevenuebyMajorPayorAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestChangeInRedemptionValue_d7069de1-e375-4db6-8564-c36fa594c418_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value remeasurements</link:label>
    <link:label id="lab_us-gaap_MinorityInterestChangeInRedemptionValue_label_en-US" xlink:label="lab_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Change in Redemption Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestChangeInRedemptionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:to="lab_us-gaap_MinorityInterestChangeInRedemptionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_8e00b39a-54ae-45c5-ba7f-0e25f27394e2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_96f5e390-2b05-44be-88a6-9ae6b82b33ee_verboseLabel_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other&#8212;Ancillary services</link:label>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_9fe9ed7a-3cd8-4fe9-a095-84e7cbb4455f_terseLabel_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other&#8212;Ancillary services</link:label>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_label_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllOtherSegmentsMember" xlink:to="lab_us-gaap_AllOtherSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_a249b891-1f57-42e2-8714-2f7daeece014_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing lease obligations</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_bbfeb14c-1537-4532-bd58-745ecb481ac4_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity on the revolving credit facilities</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_92cd7eec-be8e-4380-b39f-d2f78ae79ae9_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_5c5438e9-d158-4595-82a8-84a84297512b_negatedLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Lease Obligation, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_a7cd728c-8583-47c2-b686-ec61e7167863_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_098d42e1-dcfc-4723-bc57-7da56b3691ae_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized losses on foreign currency translation:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_addc7829-1ba5-45eb-8791-4119e607f9b0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures_4c822fd3-d683-4ad7-8e93-ad8aef8c4453_terseLabel_en-US" xlink:label="lab_dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions and divestitures</link:label>
    <link:label id="lab_dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures_label_en-US" xlink:label="lab_dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Increase Due To Acquisitions And Divestitures</link:label>
    <link:label id="lab_dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures_documentation_en-US" xlink:label="lab_dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Increase due to Acquisitions and Divestitures of the NCI with Put obligations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures" xlink:href="dva-20220930.xsd#dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures" xlink:to="lab_dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_282f2af3-b2cb-4efc-87f2-a721c068124c_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_d5446dfc-8859-4133-a396-d00d81a8be52_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR plus interest rate margin</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_NoncontrollingInterestChangesFromOther_746f6dfb-a703-4f6c-9318-147428339355_terseLabel_en-US" xlink:label="lab_dva_NoncontrollingInterestChangesFromOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_dva_NoncontrollingInterestChangesFromOther_label_en-US" xlink:label="lab_dva_NoncontrollingInterestChangesFromOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest Changes From Other</link:label>
    <link:label id="lab_dva_NoncontrollingInterestChangesFromOther_documentation_en-US" xlink:label="lab_dva_NoncontrollingInterestChangesFromOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest Changes From Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NoncontrollingInterestChangesFromOther" xlink:href="dva-20220930.xsd#dva_NoncontrollingInterestChangesFromOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_NoncontrollingInterestChangesFromOther" xlink:to="lab_dva_NoncontrollingInterestChangesFromOther" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_74ee4a5f-c551-4e6f-90ea-8eb381515497_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_MutualFundsAndCommonStockMember_f28f9382-52f5-41d7-807e-400a00a95042_terseLabel_en-US" xlink:label="lab_dva_MutualFundsAndCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in mutual funds and common stocks</link:label>
    <link:label id="lab_dva_MutualFundsAndCommonStockMember_label_en-US" xlink:label="lab_dva_MutualFundsAndCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual Funds And Common Stock [Member]</link:label>
    <link:label id="lab_dva_MutualFundsAndCommonStockMember_documentation_en-US" xlink:label="lab_dva_MutualFundsAndCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual Funds And Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MutualFundsAndCommonStockMember" xlink:href="dva-20220930.xsd#dva_MutualFundsAndCommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_MutualFundsAndCommonStockMember" xlink:to="lab_dva_MutualFundsAndCommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_05022f85-3115-4e20-93d0-153430fc2e6b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_e08dbc91-cca7-4604-87d4-82e528e1e769_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_OpenMarketPurchasesMember_092d4ad2-5ab7-4cba-8cfc-a5e063df2a29_terseLabel_en-US" xlink:label="lab_dva_OpenMarketPurchasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Market Purchases</link:label>
    <link:label id="lab_dva_OpenMarketPurchasesMember_label_en-US" xlink:label="lab_dva_OpenMarketPurchasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Market Purchases [Member]</link:label>
    <link:label id="lab_dva_OpenMarketPurchasesMember_documentation_en-US" xlink:label="lab_dva_OpenMarketPurchasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open Market Purchases Member.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OpenMarketPurchasesMember" xlink:href="dva-20220930.xsd#dva_OpenMarketPurchasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_OpenMarketPurchasesMember" xlink:to="lab_dva_OpenMarketPurchasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_IncrementalCashPortionMember_ceacdabe-e6b8-46cf-940a-6eb4f61f2eb7_terseLabel_en-US" xlink:label="lab_dva_IncrementalCashPortionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Cash Portion</link:label>
    <link:label id="lab_dva_IncrementalCashPortionMember_label_en-US" xlink:label="lab_dva_IncrementalCashPortionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Cash Portion [Member]</link:label>
    <link:label id="lab_dva_IncrementalCashPortionMember_documentation_en-US" xlink:label="lab_dva_IncrementalCashPortionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Cash Portion [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncrementalCashPortionMember" xlink:href="dva-20220930.xsd#dva_IncrementalCashPortionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_IncrementalCashPortionMember" xlink:to="lab_dva_IncrementalCashPortionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_d063d163-684e-48a3-95fe-e561af9304d8_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-cash charges, net</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations_b7d47888-91dd-47f7-b994-69095a20d287_terseLabel_en-US" xlink:label="lab_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations_label_en-US" xlink:label="lab_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustment For Contingent Earn Out Obligations</link:label>
    <link:label id="lab_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations_documentation_en-US" xlink:label="lab_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation Adjustment For Contingent Earn-out Obligations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations" xlink:href="dva-20220930.xsd#dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations" xlink:to="lab_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_671116d1-cbd8-4c80-a008-afcbddcb3f3b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_572134cd-d916-4c56-bbc3-5c557f854a42_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_fe8b5e32-b966-435d-9aa9-d56c967985a5_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_d7c382f9-840f-4327-926e-82d223aaa8b4_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to DaVita Inc.</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_c549df2d-2e14-4757-9072-b8c7beae8774_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_9479a356-459d-46b9-bac1-1f45dbd80f38_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-dilutive stock-settled awards excluded from calculation</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebt_8be030ea-6b95-44f8-856a-445bad2d912e_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt</link:label>
    <link:label id="lab_us-gaap_SecuredDebt_label_en-US" xlink:label="lab_us-gaap_SecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebt" xlink:to="lab_us-gaap_SecuredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_16503968-a94c-4d46-8100-67bcd0e4f7ee_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDistributionsToAffiliates_de17168a-87f9-4c3f-97c5-a04801ad5716_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDistributionsToAffiliates" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDistributionsToAffiliates_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDistributionsToAffiliates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Distributions to Affiliates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDistributionsToAffiliates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDistributionsToAffiliates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDistributionsToAffiliates" xlink:to="lab_us-gaap_PaymentsOfDistributionsToAffiliates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_c4ea4d89-d56e-4112-a330-776c62b4e6f4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_50fa186c-1edb-49a3-a818-70a0dbba03e1_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_8f03de9f-1172-40b7-9ec5-0141aab176b7_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareReconciliationAbstract_13b8ef19-6a47-4147-8bef-a0ad83a538c9_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerators:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract" xlink:to="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_OtherNoncashAssetsCommitment_ba6420f2-2bda-4f68-89fb-7d22b3144b21_terseLabel_en-US" xlink:label="lab_dva_OtherNoncashAssetsCommitment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Assets Commitment</link:label>
    <link:label id="lab_dva_OtherNoncashAssetsCommitment_label_en-US" xlink:label="lab_dva_OtherNoncashAssetsCommitment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Assets Commitment</link:label>
    <link:label id="lab_dva_OtherNoncashAssetsCommitment_documentation_en-US" xlink:label="lab_dva_OtherNoncashAssetsCommitment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Assets Commitment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherNoncashAssetsCommitment" xlink:href="dva-20220930.xsd#dva_OtherNoncashAssetsCommitment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_OtherNoncashAssetsCommitment" xlink:to="lab_dva_OtherNoncashAssetsCommitment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_f7f00756-e476-49a3-907b-af9d1d8a9ef3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfFinancingCosts_ef64433c-86cc-435f-80a1-c3c37c690883_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfFinancingCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred financing and debt redemption costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Financing Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfFinancingCosts" xlink:to="lab_us-gaap_PaymentsOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_BusinessCombinationContingentConsiderationAcquisitions_9e5f15a5-79cb-4812-b8c0-f793b2134e51_verboseLabel_en-US" xlink:label="lab_dva_BusinessCombinationContingentConsiderationAcquisitions" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent earn-out obligations and liabilities assumed associated with acquisitions</link:label>
    <link:label id="lab_dva_BusinessCombinationContingentConsiderationAcquisitions_label_en-US" xlink:label="lab_dva_BusinessCombinationContingentConsiderationAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Contingent Consideration Acquisitions</link:label>
    <link:label id="lab_dva_BusinessCombinationContingentConsiderationAcquisitions_documentation_en-US" xlink:label="lab_dva_BusinessCombinationContingentConsiderationAcquisitions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Contingent Consideration Acquisitions, Earn-out Obligations and Assumed Liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessCombinationContingentConsiderationAcquisitions" xlink:href="dva-20220930.xsd#dva_BusinessCombinationContingentConsiderationAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_BusinessCombinationContingentConsiderationAcquisitions" xlink:to="lab_dva_BusinessCombinationContingentConsiderationAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_4d7510da-94d7-42ea-a3bb-ebc25cccecf8_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentHoldingsLineItems_3c6ce44d-59d7-4d1d-80fa-c19497f07d79_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Holdings [Line Items]</link:label>
    <link:label id="lab_us-gaap_InvestmentHoldingsLineItems_label_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Holdings [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentHoldingsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems" xlink:to="lab_us-gaap_InvestmentHoldingsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_9d087f75-ee64-4d18-b627-0df280f77555_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying amount of long-term debt, net of unamortized discounts</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Lease Obligation, Including Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted_a5820023-b8a7-4afa-9e8d-655c249744cc_terseLabel_en-US" xlink:label="lab_dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate grant-date fair value</link:label>
    <link:label id="lab_dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted_label_en-US" xlink:label="lab_dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sharebased Compensation Arrangement By Sharebased Payment Award Grant Date Fair Value Of Options Granted</link:label>
    <link:label id="lab_dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted_documentation_en-US" xlink:label="lab_dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation arrangement by share-based payment award, grant date fair value of options granted.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted" xlink:href="dva-20220930.xsd#dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted" xlink:to="lab_dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_ec314fe2-4b80-42e8-8f17-40676d639273_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_799da5d1-5c43-482e-889e-969bd9599625_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_b9c83c4f-1e80-4e4b-a49d-92368433ae6e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Description of Variable Rate Basis</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Description of Variable Rate Basis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:to="lab_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_524f0ab4-410f-4575-8926-b9ace55d8ca7_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_f0bdd8f2-6a71-41c8-b8a0-257741b6da3a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_8c129234-72b1-40d7-befd-c2e5d220c89e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_57e92da9-d377-4055-a2ba-f583576e3bef_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted prices in active&#160;markets&#160;for identical assets (Level 1)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_MedicareandMedicareAdvantageMember_2ee2270f-13a3-461e-a63b-6a95a22e95c6_terseLabel_en-US" xlink:label="lab_dva_MedicareandMedicareAdvantageMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare and Medicare Advantage</link:label>
    <link:label id="lab_dva_MedicareandMedicareAdvantageMember_label_en-US" xlink:label="lab_dva_MedicareandMedicareAdvantageMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare and Medicare Advantage [Member]</link:label>
    <link:label id="lab_dva_MedicareandMedicareAdvantageMember_documentation_en-US" xlink:label="lab_dva_MedicareandMedicareAdvantageMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare and Medicare Advantage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MedicareandMedicareAdvantageMember" xlink:href="dva-20220930.xsd#dva_MedicareandMedicareAdvantageMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_MedicareandMedicareAdvantageMember" xlink:to="lab_dva_MedicareandMedicareAdvantageMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_f3677443-5dc3-4bed-b467-f7e444651b63_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income, net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_3f3548cd-40cc-4f5f-a47a-a1a486c0ae0e_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_24d62594-5e72-4eaa-853f-2baf22143432_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_NoncontrollingInterestIncreaseFromContributions_d12ba091-e9c7-4b3d-9637-294de032db25_terseLabel_en-US" xlink:label="lab_dva_NoncontrollingInterestIncreaseFromContributions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions</link:label>
    <link:label id="lab_dva_NoncontrollingInterestIncreaseFromContributions_label_en-US" xlink:label="lab_dva_NoncontrollingInterestIncreaseFromContributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest Increase From Contributions</link:label>
    <link:label id="lab_dva_NoncontrollingInterestIncreaseFromContributions_documentation_en-US" xlink:label="lab_dva_NoncontrollingInterestIncreaseFromContributions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest increase from contributions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NoncontrollingInterestIncreaseFromContributions" xlink:href="dva-20220930.xsd#dva_NoncontrollingInterestIncreaseFromContributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_NoncontrollingInterestIncreaseFromContributions" xlink:to="lab_dva_NoncontrollingInterestIncreaseFromContributions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_67b877a4-c6b8-4e61-9c00-87921a555ff2_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_aefccec2-846f-417f-8127-5f2a18a4bba6_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests subject to put provisions</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_96495fe4-9456-4c9b-8277-c90136eb41ab_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_ca87361a-b558-4fb7-aa6c-d0bba77079a0_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate cap agreements</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_6434a503-bcff-478d-a828-cf50791772f7_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpensesAbstract" xlink:to="lab_us-gaap_CostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransactionDomain_8b86f11f-31a9-43f7-8519-cc945fb37e69_terseLabel_en-US" xlink:label="lab_us-gaap_TransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_TransactionDomain_label_en-US" xlink:label="lab_us-gaap_TransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransactionDomain" xlink:to="lab_us-gaap_TransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_b8c780b7-4b84-4be4-96a0-57f2b6be1732_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of debt investments held-to-maturity</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Held-to-Maturity Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireHeldToMaturitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:to="lab_us-gaap_PaymentsToAcquireHeldToMaturitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsDomain_4e272602-99f3-4acd-81d1-c0f55720253a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsDomain_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsDomain" xlink:to="lab_us-gaap_OtherCommitmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_BilateralSecuredLetterOfCreditFacilityMember_dcb61710-febb-428a-8a66-fb4504649e0f_terseLabel_en-US" xlink:label="lab_dva_BilateralSecuredLetterOfCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bilateral Secured Letter Of Credit Facility</link:label>
    <link:label id="lab_dva_BilateralSecuredLetterOfCreditFacilityMember_label_en-US" xlink:label="lab_dva_BilateralSecuredLetterOfCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bilateral Secured Letter Of Credit Facility [Member]</link:label>
    <link:label id="lab_dva_BilateralSecuredLetterOfCreditFacilityMember_documentation_en-US" xlink:label="lab_dva_BilateralSecuredLetterOfCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bilateral Secured Letter Of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BilateralSecuredLetterOfCreditFacilityMember" xlink:href="dva-20220930.xsd#dva_BilateralSecuredLetterOfCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_BilateralSecuredLetterOfCreditFacilityMember" xlink:to="lab_dva_BilateralSecuredLetterOfCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_8dc2f673-a3c6-442b-987e-ce61fa11223d_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_bf45b847-5087-4a12-b0a6-77f0170c55c7_terseLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInceptionDates_e89b9c3b-574c-49ac-a8d7-6d0504cbb538_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInceptionDates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, effective date</link:label>
    <link:label id="lab_us-gaap_DerivativeInceptionDates_label_en-US" xlink:label="lab_us-gaap_DerivativeInceptionDates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Inception Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInceptionDates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInceptionDates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInceptionDates" xlink:to="lab_us-gaap_DerivativeInceptionDates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromContributionsFromAffiliates_182d6eeb-86d0-42c3-afd2-e0ae55aa43bc_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromContributionsFromAffiliates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions from noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ProceedsFromContributionsFromAffiliates_label_en-US" xlink:label="lab_us-gaap_ProceedsFromContributionsFromAffiliates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Contributions from Affiliates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromContributionsFromAffiliates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromContributionsFromAffiliates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromContributionsFromAffiliates" xlink:to="lab_us-gaap_ProceedsFromContributionsFromAffiliates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e5eecdd3-046b-4b73-a74f-e4b6c2671377_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_276d9b1a-2dcb-4b2a-9d6d-9dab64d93267_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average basic shares outstanding during period</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Issued, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_cafaa559-15c6-40a8-a6ea-7699fb7ce719_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Changes and Error Corrections [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Changes and Error Corrections [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:to="lab_us-gaap_AccountingChangesAndErrorCorrectionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_4d2b238f-4c60-4e49-a988-1be5f41d98a5_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TermLoanB1Member_9839d3a4-3340-479a-a488-b79bcacdca94_terseLabel_en-US" xlink:label="lab_dva_TermLoanB1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B-1</link:label>
    <link:label id="lab_dva_TermLoanB1Member_label_en-US" xlink:label="lab_dva_TermLoanB1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B-1 [Member]</link:label>
    <link:label id="lab_dva_TermLoanB1Member_documentation_en-US" xlink:label="lab_dva_TermLoanB1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan B-1.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanB1Member" xlink:href="dva-20220930.xsd#dva_TermLoanB1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TermLoanB1Member" xlink:to="lab_dva_TermLoanB1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_e908478a-88f1-4eaf-8be4-36b55433c5ed_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_fcf40de1-7d7d-4964-af3d-80da8ec4f72d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_658e4f44-63c9-4996-a27b-c212f7bf823b_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving line of credit</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_OtherCompaniesMember_94bd2c46-9d32-409e-87ed-6fe8857e175b_terseLabel_en-US" xlink:label="lab_dva_OtherCompaniesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other companies</link:label>
    <link:label id="lab_dva_OtherCompaniesMember_label_en-US" xlink:label="lab_dva_OtherCompaniesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Companies [Member]</link:label>
    <link:label id="lab_dva_OtherCompaniesMember_documentation_en-US" xlink:label="lab_dva_OtherCompaniesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other companies.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherCompaniesMember" xlink:href="dva-20220930.xsd#dva_OtherCompaniesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_OtherCompaniesMember" xlink:to="lab_dva_OtherCompaniesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_46a77c34-fc64-4599-b760-957cb9364497_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, starting balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_c5fbf50b-f2b0-4e0d-9040-60457a952561_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, ending balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_9b17980e-54e2-4dc7-bc4e-3a1e3db4f33e_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_b159dee5-46bd-4aac-90f9-e87fd66767f8_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_d7ad7ffc-cfc1-4e5e-95f5-a15e142a49e1_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTextBlock" xlink:to="lab_us-gaap_LongTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments_1ba205ff-49ba-424e-9639-b97b97334fcb_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of other debt and equity investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Other Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_33c63a7d-27e6-4561-ae61-110eef85ba33_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_de373375-f655-4397-b5bc-9aabe332050d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions from equity method investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_label_en-US" xlink:label="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Equity Method Investment, Distribution, Return of Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:to="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_635973e9-4984-4c6b-8210-24cfe3267bb4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_201a3e70-b00c-4376-b890-e0b71bf378ee_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_c619aaa3-330b-4b3c-8ba9-958e4fece981_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_6a338d30-cce7-4f40-93b6-ac40bd4413de_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_USAttorneyPrescriptionDrugInvestigationMember_1575a55f-2f1e-46c5-8732-371acc18df1f_terseLabel_en-US" xlink:label="lab_dva_USAttorneyPrescriptionDrugInvestigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Attorney Prescription Drug Investigation</link:label>
    <link:label id="lab_dva_USAttorneyPrescriptionDrugInvestigationMember_label_en-US" xlink:label="lab_dva_USAttorneyPrescriptionDrugInvestigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Attorney Prescription Drug Investigation [Member]</link:label>
    <link:label id="lab_dva_USAttorneyPrescriptionDrugInvestigationMember_documentation_en-US" xlink:label="lab_dva_USAttorneyPrescriptionDrugInvestigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Attorney Prescription Drug Investigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USAttorneyPrescriptionDrugInvestigationMember" xlink:href="dva-20220930.xsd#dva_USAttorneyPrescriptionDrugInvestigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_USAttorneyPrescriptionDrugInvestigationMember" xlink:to="lab_dva_USAttorneyPrescriptionDrugInvestigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_6105f637-0aa8-4b08-9c61-04453e51b16c_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_e2957f5a-8a44-4be7-96e1-bb3630810fd3_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_9aa98d42-c578-49ea-91d4-a2d02386d9d7_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_DebtExpenseMember_2b97f5d5-faaf-4f81-8cb0-209ab4bc5f95_terseLabel_en-US" xlink:label="lab_dva_DebtExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Expense</link:label>
    <link:label id="lab_dva_DebtExpenseMember_label_en-US" xlink:label="lab_dva_DebtExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Expense [Member]</link:label>
    <link:label id="lab_dva_DebtExpenseMember_documentation_en-US" xlink:label="lab_dva_DebtExpenseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt expense.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtExpenseMember" xlink:href="dva-20220930.xsd#dva_DebtExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_DebtExpenseMember" xlink:to="lab_dva_DebtExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_a2b34a08-0b5d-404d-b117-5cde20aea242_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_6cec7835-6ffb-4594-b421-7861535452cd_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_361caf2d-49cf-48e9-b6a1-b4bffde443cf_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_73b9b1b9-31b2-46ce-b4fe-ed530e8717f5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_e27e9c94-4afb-412d-9913-82c679c6073b_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share attributable to DaVita Inc.:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_d6a71c73-5d06-4aef-86b9-c9d501f706b6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_6f378bec-559e-4a1c-8341-45086d1b0553_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Premium</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Premium</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_7c0a0fe7-48c9-491d-b21d-6c27a4e831a1_verboseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_596bccf8-59cd-4360-b1a1-a92b6346534f_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_391588e3-6137-4abc-a1ee-5f63513ab56f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_ca941b7f-7144-4e9a-9b8a-0d47e283b8d8_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsAxis_aaa5fe65-8d1e-46cd-bbc2-ff50bf4d5e47_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsAxis_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsAxis" xlink:to="lab_us-gaap_OtherCommitmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9c536b7a-600e-4989-a846-a401bbfa85b8_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b5917360-1ca3-491d-b92a-a25a894a7445_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_7e5b9103-207f-44c6-adbc-d950da12c7cb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecurities_9b30d7cb-46bc-45e1-b4cf-fc94f80ab418_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecurities_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecurities" xlink:to="lab_us-gaap_HeldToMaturitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_5aede52b-3f87-4ebe-a279-468ce36fdc58_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_c27eeee5-e64f-4626-ad03-b459adeb6957_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_cdc44d5b-290d-4d8e-8988-65df6c4796b9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_1218fbd3-be7c-40e5-ba6f-00e8287bd972_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_acf0f631-ae0c-4be9-8d86-54e7e7734395_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_4864c146-d7af-4963-8531-da554a9420e9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCapMember_77192826-2d55-4801-9839-fe92d13c30aa_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate cap agreements</link:label>
    <link:label id="lab_us-gaap_InterestRateCapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCapMember" xlink:to="lab_us-gaap_InterestRateCapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillGross_68c0e3bd-6824-49c4-afcd-9067ece244f2_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, before accumulated impairment charges</link:label>
    <link:label id="lab_us-gaap_GoodwillGross_label_en-US" xlink:label="lab_us-gaap_GoodwillGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillGross" xlink:to="lab_us-gaap_GoodwillGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_055df27e-580f-46d8-b88c-090a745e0e05_negatedLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partial purchases</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_ad45024e-e227-41d9-8936-ebe1347b685a_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_9ad3c913-61c5-41c0-a267-f5ae012ad867_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestmentsMember" xlink:to="lab_us-gaap_ShortTermInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cc530696-6a69-497c-80fc-d9c8783504e5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Award</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_RegulatoryAndCommercialMilestonesEndingDate_5502fdf0-45b4-455b-9650-54e7e0ea595a_terseLabel_en-US" xlink:label="lab_dva_RegulatoryAndCommercialMilestonesEndingDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regulatory and Commercial Milestones Ending Date</link:label>
    <link:label id="lab_dva_RegulatoryAndCommercialMilestonesEndingDate_label_en-US" xlink:label="lab_dva_RegulatoryAndCommercialMilestonesEndingDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regulatory and Commercial Milestones Ending Date</link:label>
    <link:label id="lab_dva_RegulatoryAndCommercialMilestonesEndingDate_documentation_en-US" xlink:label="lab_dva_RegulatoryAndCommercialMilestonesEndingDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regulatory and Commercial Milestones Ending Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RegulatoryAndCommercialMilestonesEndingDate" xlink:href="dva-20220930.xsd#dva_RegulatoryAndCommercialMilestonesEndingDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_RegulatoryAndCommercialMilestonesEndingDate" xlink:to="lab_dva_RegulatoryAndCommercialMilestonesEndingDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_4702079e-9d74-4373-b4e7-b1d70e5bba83_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation cost related to nonvested stock-based compensation arrangements under stock-based component of LTIP costs, weighted average remaining period (in years)</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_e02a38d2-d410-4f83-9165-5fc5640797e7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax receivable</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivable" xlink:to="lab_us-gaap_IncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_c1f628b7-d160-4b63-95f3-c90be9151acc_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized (losses) gains net</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherInvestments_f31cce3c-3977-4d19-a3e1-ecd4f4132076_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of other debt and equity investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Other Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireOtherInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireOtherInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireOtherInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_4fe2f89a-2fb9-434b-b659-27dd7b38a8c6_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_b73e3375-ec56-43f0-a8ef-16e2a245df91_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid to acquire businesses</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_a6fceb6a-5c4b-4200-b00e-35d22cff9e94_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_04d6197d-dd47-49f3-be23-07ccd741d6bc_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient service revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_71cb5d7d-273f-4d7a-85c1-03fcb6e913e7_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dialysis patient service revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Including Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_18e3ccd5-2f3a-4e1b-9dab-8416f9125958_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_ad6e354c-91bc-469c-ba69-367fddf6b076_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesTextBlock_a819dddb-ef92-4374-b0ca-20eb937d9cfb_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesTextBlock_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesTextBlock" xlink:to="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_BusinessAgreementDate_fb83de50-557a-4dc7-a158-c8c69bf0ee46_terseLabel_en-US" xlink:label="lab_dva_BusinessAgreementDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Agreement Date</link:label>
    <link:label id="lab_dva_BusinessAgreementDate_label_en-US" xlink:label="lab_dva_BusinessAgreementDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Agreement Date</link:label>
    <link:label id="lab_dva_BusinessAgreementDate_documentation_en-US" xlink:label="lab_dva_BusinessAgreementDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Agreement Date, in YYYY-MM-DD formate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessAgreementDate" xlink:href="dva-20220930.xsd#dva_BusinessAgreementDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_BusinessAgreementDate" xlink:to="lab_dva_BusinessAgreementDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ForeignDialysisCentersMember_e3a9f0c9-c36c-487f-8ee0-4b924c7bcb13_terseLabel_en-US" xlink:label="lab_dva_ForeignDialysisCentersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Dialysis Centers</link:label>
    <link:label id="lab_dva_ForeignDialysisCentersMember_label_en-US" xlink:label="lab_dva_ForeignDialysisCentersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Dialysis Centers [Member]</link:label>
    <link:label id="lab_dva_ForeignDialysisCentersMember_documentation_en-US" xlink:label="lab_dva_ForeignDialysisCentersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign dialysis and other medical businesses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ForeignDialysisCentersMember" xlink:href="dva-20220930.xsd#dva_ForeignDialysisCentersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ForeignDialysisCentersMember" xlink:to="lab_dva_ForeignDialysisCentersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member_5087281a-9c25-40e2-92db-2af9deaef5bf_terseLabel_en-US" xlink:label="lab_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Interest Rate Cap Agreements Effective June 30, 2020</link:label>
    <link:label id="lab_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member_label_en-US" xlink:label="lab_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Interest Rate Cap Agreements Effective June 30, 2020 [Member]</link:label>
    <link:label id="lab_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member_documentation_en-US" xlink:label="lab_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Interest Rate Cap Agreements Effective June 30, 2020.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member" xlink:href="dva-20220930.xsd#dva_A2019InterestRateCapAgreementsEffectiveJune302020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member" xlink:to="lab_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_31b179e6-3a1a-411e-a158-ba95cc67674c_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dialysis and other businesses</link:label>
    <link:label id="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_label_en-US" xlink:label="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series of Individually Immaterial Business Acquisitions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:to="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_c6209643-2c94-477e-8b25-68ef72e3b3dd_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ExternalSourcesMember_acf3d729-43ca-4044-a664-7635aa13549b_terseLabel_en-US" xlink:label="lab_dva_ExternalSourcesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">External Sources</link:label>
    <link:label id="lab_dva_ExternalSourcesMember_label_en-US" xlink:label="lab_dva_ExternalSourcesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">External Sources [Member]</link:label>
    <link:label id="lab_dva_ExternalSourcesMember_documentation_en-US" xlink:label="lab_dva_ExternalSourcesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">External sources.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ExternalSourcesMember" xlink:href="dva-20220930.xsd#dva_ExternalSourcesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ExternalSourcesMember" xlink:to="lab_dva_ExternalSourcesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a9b84dd7-baed-43ad-b832-6e5ec63c0925_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e8e4ef81-ad18-4252-8f3c-58678dcafcaf_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_024a8a3b-9a49-4595-b4fd-376cd40e265e_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_bd56bb4b-d6ff-45c0-aa0b-d5143187a61e_verboseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Elimination of intersegment revenues</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_1bc29baf-2e78-453d-b0a3-fbea387aa406_terseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Elimination</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_label_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersegmentEliminationMember" xlink:to="lab_us-gaap_IntersegmentEliminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockTextBlock_1dedae32-20e1-4593-852c-37c3f21b41bd_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchases</link:label>
    <link:label id="lab_us-gaap_TreasuryStockTextBlock_label_en-US" xlink:label="lab_us-gaap_TreasuryStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockTextBlock" xlink:to="lab_us-gaap_TreasuryStockTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_3122cdfc-de52-461c-82d1-0143648f5263_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_4150fb31-4253-4632-8e2e-71ba2e04c01f_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests not subject to put provisions</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_53d1eb3c-850c-4803-80b1-65a43c879d0e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_743396d0-59c9-455c-ab2b-42bf0cd6a006_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_7a769112-e987-42ae-b9a2-2fc421b43c02_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_e51e1d4c-322f-4b43-aa96-4d46f78340c0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gains (losses)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_ef848688-f499-4ad6-bf47-1ae23187e006_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related income tax benefit</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) before Reclassifications, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_5d9b87e8-db95-47b2-aecb-5614e9026e72_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies:</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_b08a7729-10ed-4518-96f2-c2f4d5f76dee_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_bb0ae529-082d-4a38-84d7-75cfa9810bae_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of financial instruments</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders_a66eabed-15eb-4c3a-9ad8-5530faabf97d_terseLabel_en-US" xlink:label="lab_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions</link:label>
    <link:label id="lab_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders_label_en-US" xlink:label="lab_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Increase From Contributions From Noncontrolling Interest Holders</link:label>
    <link:label id="lab_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders_documentation_en-US" xlink:label="lab_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Increase From Contributions From Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" xlink:href="dva-20220930.xsd#dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" xlink:to="lab_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_f9011eef-daa3-430c-a66d-47bf24c66a7a_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_903f52c7-e3a1-40f4-87d8-ae6b43488440_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_560133aa-49aa-450e-81dd-802b9f2c5ba5_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_2f015be7-9251-4940-b7f4-05ae299faae7_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_261b90ac-d829-4e7b-aa98-5f717b8639fc_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_8761aaac-0a3e-4aa2-8929-f92e17741009_negatedLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related income tax</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_91b79a74-7c44-4c9e-8d27-c363172d2f63_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransactionTypeAxis_f18e2d70-97b9-4c8e-b2a0-65d76c89b40d_terseLabel_en-US" xlink:label="lab_us-gaap_TransactionTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction Type [Axis]</link:label>
    <link:label id="lab_us-gaap_TransactionTypeAxis_label_en-US" xlink:label="lab_us-gaap_TransactionTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransactionTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransactionTypeAxis" xlink:to="lab_us-gaap_TransactionTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_301b6594-56ab-4226-8bd5-2663737375e7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_4bceb78e-01e0-4793-a3a0-d791bc0905b3_negatedLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Comprehensive income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_3d21b094-2c7a-4f43-bdcc-d7991f1f95dd_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of debt instruments bearing fixed interest rate</link:label>
    <link:label id="lab_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_label_en-US" xlink:label="lab_us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Percentage Bearing Fixed Interest, Percentage Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtPercentageBearingFixedInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:to="lab_us-gaap_LongTermDebtPercentageBearingFixedInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_1666ce96-8870-4e81-bc4f-ee3c7ee9d742_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityDisclosureTextBlock_d5d25141-21ab-4943-9aa4-680c478c08dc_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable interest entities</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:to="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_53015648-cbb1-4583-99ea-aa292f0bba81_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash and equivalents</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c1f5250f-128e-4a1e-baac-20c411adbc04_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_aa53da2a-7b60-4551-8c08-0748abd32801_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units and Performance stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_708bbc85-0190-489d-8577-dac408748afe_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_d00a4ee9-6eb1-4cda-ab09-efeb03f34240_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_70d4f846-ee94-41d9-9922-6e5fbd0f9f1e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_4b37ba21-5bfe-4643-9e40-a9aa6df10a87_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred purchase price obligations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Liabilities Incurred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock_d8753ce7-7d6f-4a58-8cbd-f6af041d1cb3_terseLabel_en-US" xlink:label="lab_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Expenditures for Property and Equipment by Reportable Segment</link:label>
    <link:label id="lab_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock_label_en-US" xlink:label="lab_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation Of Capital Expenditures For Property And Equipment From Segment To Consolidated Table [Text Block]</link:label>
    <link:label id="lab_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock_documentation_en-US" xlink:label="lab_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of capital expenditures for property and equipment from segment to consolidated.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock" xlink:href="dva-20220930.xsd#dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock" xlink:to="lab_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_b1b5e506-1f5d-436c-8a62-513bb37d37f2_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in debt and equity securities</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_2ab38f5a-f792-40c6-bc7a-dfa35a4b348c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_eea4f129-e342-4487-940d-661421ac61a2_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income:</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_47054eb3-866b-4fb1-87a4-17a16edf7c00_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_c1aeacbd-8ad5-45f1-90d8-c047af0d253b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Goodwill by Reportable Segments [Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_d2986e27-5b76-4405-8517-300f027c1646_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net income</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_82c19ca8-f939-4e1e-b028-1b967d2ec80a_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net income per share attributable to DaVita Inc.</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_9c8979fb-2784-4430-9eea-5a6546c0c4cd_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification into net income</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_f9e508a0-baaa-4ec6-a354-60ae7d07976e_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToMinorityShareholders" xlink:to="lab_us-gaap_PaymentsToMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesCurrent_b50f6372-60d0-4965-987b-da01e7b968e9_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, short-term investments</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesCurrent" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_60df8366-bd4f-4372-a9b0-76603e040fe7_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_45193057-5f2d-459c-bf53-4b7870fa83f3_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total DaVita Inc. shareholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod_b3121c08-d258-40b6-8861-03c8b5f9a766_terseLabel_en-US" xlink:label="lab_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earn-out consideration payment period</link:label>
    <link:label id="lab_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod_label_en-US" xlink:label="lab_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition Contingent Consideration Revenue Earnout Period</link:label>
    <link:label id="lab_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod_documentation_en-US" xlink:label="lab_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition contingent consideration revenue earn-out period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" xlink:href="dva-20220930.xsd#dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" xlink:to="lab_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_OtherSourcesofRevenueMember_d0bded1c-5f68-482b-aaca-43381b35d3e0_terseLabel_en-US" xlink:label="lab_dva_OtherSourcesofRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_dva_OtherSourcesofRevenueMember_label_en-US" xlink:label="lab_dva_OtherSourcesofRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sources of Revenue [Member]</link:label>
    <link:label id="lab_dva_OtherSourcesofRevenueMember_documentation_en-US" xlink:label="lab_dva_OtherSourcesofRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other sources of revenue (management fees and revenue from the Company's ancillary services and strategic initiatives).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherSourcesofRevenueMember" xlink:href="dva-20220930.xsd#dva_OtherSourcesofRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_OtherSourcesofRevenueMember" xlink:to="lab_dva_OtherSourcesofRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_3ca6cc80-e941-4770-ae2e-42ec95ad6bbe_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6d277e13-f18d-4f81-8d54-a15cfb489ab2_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_298e5259-e761-4a8e-98b4-24d15c6fae7d_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities, net of effect of acquisitions and divestitures:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_0d09de35-ed18-4d94-8616-9724b4b14e8d_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_ed4cf494-efd5-476a-9e26-1b11de814a69_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_CorporateIntegrityAgreementPeriod_983b55b9-0747-4f31-b262-1d2cad799ee6_terseLabel_en-US" xlink:label="lab_dva_CorporateIntegrityAgreementPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Integrity Agreement Period</link:label>
    <link:label id="lab_dva_CorporateIntegrityAgreementPeriod_label_en-US" xlink:label="lab_dva_CorporateIntegrityAgreementPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Integrity Agreement Period</link:label>
    <link:label id="lab_dva_CorporateIntegrityAgreementPeriod_documentation_en-US" xlink:label="lab_dva_CorporateIntegrityAgreementPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Integrity Agreement Period, in PnYnMnDn format.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CorporateIntegrityAgreementPeriod" xlink:href="dva-20220930.xsd#dva_CorporateIntegrityAgreementPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_CorporateIntegrityAgreementPeriod" xlink:to="lab_dva_CorporateIntegrityAgreementPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_881e93b5-8925-42b3-b1e2-13f44690753e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_3bd8dfb3-fedf-4938-a72d-24ee0d05a2ba_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock award plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_cb9f2508-cc37-4230-926f-d96cb881c38c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of treasury stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_f0aa0a75-76c0-4408-9895-15d16bb2cdb2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent earn-out obligations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_13b562ef-ff42-483e-a48f-c620103b82db_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent earn-out obligations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_9b112ac6-54f0-43e6-926c-75f3fb751ce4_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_af4d06a8-bc34-4ed1-b608-76bbf30397ee_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term and Long-term Investments</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesPolicy" xlink:to="lab_us-gaap_MarketableSecuritiesPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_01aacad6-4570-4d08-809e-4f24138c3638_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_fee21c9a-51fe-4a9b-91c4-b0620a752681_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesNoncurrent_5ca71293-8c3a-4bf8-ba4e-25855e6112a6_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term investments</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesNoncurrent_c85c24ab-03c4-47f3-9a24-09b07fcd0476_totalLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total, long-term investments</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesNoncurrent" xlink:to="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_bb91721e-3884-4a34-a643-60c68109cc24_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_fd00c188-14c5-444e-982a-ac8d0c4ab1df_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_94258a75-0899-4e22-81fa-3c07ad05d8d9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_0ec2666d-bd47-4c2f-8099-5a024cc0bcc5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_18b634b9-b4f6-4ea9-96a3-363731a6f469_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple_0cea35f4-f110-45f8-8ca3-6bef81028cbb_terseLabel_en-US" xlink:label="lab_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential Increase Decrease In Fair Value Of Noncontrolling Interests Due To Change In Weighted Average EBITDA Multiple</link:label>
    <link:label id="lab_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple_label_en-US" xlink:label="lab_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential Increase Decrease In Fair Value Of Noncontrolling Interests Due To Change In Weighted Average EBITDA Multiple</link:label>
    <link:label id="lab_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple_documentation_en-US" xlink:label="lab_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential increase decrease In fair value of Noncontrolling interests related to contractual Put obligations due to the change In Weighted Average EBITDA multiple.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple" xlink:href="dva-20220930.xsd#dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple" xlink:to="lab_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_22620e2e-7f1c-450f-87e0-5a28e21af777_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_7fb3f219-6669-4a72-afd1-99708155116e_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_b2db6ad4-3990-4f95-b2d6-bcddd2715ce4_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_990b714e-e68e-43be-81eb-32bff42ffbfb_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_f72ba878-acc7-4797-bfc6-79fdd0013af5_verboseLabel_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_1f18ce0c-d337-4671-b20f-cbe19f4fc0a5_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_b707aa36-7ece-4d69-b957-cebae8ed6389_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMinorityShareholders_291a2170-20b5-47d3-b06d-0283fe136a4b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales of additional noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMinorityShareholders" xlink:to="lab_us-gaap_ProceedsFromMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_308869be-9cea-4257-816d-e3a20312fdc2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_2bbde6a8-2112-4474-a714-283ef93ef6a1_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_8c50ad26-94ee-4878-9979-925c403d027f_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_DiscountPremiumAndDeferredFinancingCosts_cbd60205-ec02-49f2-9690-77f4f45be429_negatedLabel_en-US" xlink:label="lab_dva_DiscountPremiumAndDeferredFinancingCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount, premium and deferred financing costs</link:label>
    <link:label id="lab_dva_DiscountPremiumAndDeferredFinancingCosts_label_en-US" xlink:label="lab_dva_DiscountPremiumAndDeferredFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount Premium And Deferred Financing Costs</link:label>
    <link:label id="lab_dva_DiscountPremiumAndDeferredFinancingCosts_documentation_en-US" xlink:label="lab_dva_DiscountPremiumAndDeferredFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount, premium and deferred financing costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DiscountPremiumAndDeferredFinancingCosts" xlink:href="dva-20220930.xsd#dva_DiscountPremiumAndDeferredFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_DiscountPremiumAndDeferredFinancingCosts" xlink:to="lab_dva_DiscountPremiumAndDeferredFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_d5dae376-c678-46b7-9f16-40e6524335c9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_6d263a16-f379-48c8-a139-e4ca36a2ad29_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Hierarchy</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_418b696a-928f-4abc-bee3-cf5e3ffd04cf_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillDisclosureTextBlock_8b7034b8-dee2-40e2-a2d8-9c944cc21ce4_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_d973ecde-516a-42ab-94de-f2915a0a083c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_45d27ad6-6a63-4b94-8edb-756b795913ef_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDisclosures_9db7c562-3ad5-4aff-acde-58376fb74241_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDisclosures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies</link:label>
    <link:label id="lab_us-gaap_LossContingencyDisclosures_label_en-US" xlink:label="lab_us-gaap_LossContingencyDisclosures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDisclosures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDisclosures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDisclosures" xlink:to="lab_us-gaap_LossContingencyDisclosures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_6e3c756d-ac9c-4e05-908d-0d4da328c3bc_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_USDialysisAndRelatedServicesMember_f8c1252e-1caf-4057-8d53-5f6f8a6cef35_terseLabel_en-US" xlink:label="lab_dva_USDialysisAndRelatedServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Dialysis</link:label>
    <link:label id="lab_dva_USDialysisAndRelatedServicesMember_label_en-US" xlink:label="lab_dva_USDialysisAndRelatedServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Dialysis And Related Services [Member]</link:label>
    <link:label id="lab_dva_USDialysisAndRelatedServicesMember_documentation_en-US" xlink:label="lab_dva_USDialysisAndRelatedServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Dialysis And Related Services.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedServicesMember" xlink:href="dva-20220930.xsd#dva_USDialysisAndRelatedServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_USDialysisAndRelatedServicesMember" xlink:to="lab_dva_USDialysisAndRelatedServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_fac33913-ddc5-418a-b943-ae89b3a9b160_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_766395b2-662e-42c9-8aec-76d0d4a4198c_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders_60ebe6a7-6ef7-4b28-9583-78583c94fdb6_negatedTerseLabel_en-US" xlink:label="lab_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions</link:label>
    <link:label id="lab_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders_label_en-US" xlink:label="lab_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:label id="lab_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders_documentation_en-US" xlink:label="lab_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:href="dva-20220930.xsd#dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:to="lab_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredOfferingCosts_11dc0f6f-9549-47e2-bd3a-b713ca08d03b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredOfferingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Offering Costs</link:label>
    <link:label id="lab_us-gaap_DeferredOfferingCosts_label_en-US" xlink:label="lab_us-gaap_DeferredOfferingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Offering Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredOfferingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredOfferingCosts" xlink:to="lab_us-gaap_DeferredOfferingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_0630f7dd-f811-49c2-804e-534c2e4fb6d5_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_a7947be9-fec1-461c-9f99-0f9e797f5552_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_7ff0e09c-7c51-462c-b14e-668443ade7f0_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_3829ccf1-47ae-4f64-8209-e4eb2c48490c_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Standards</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_6f819045-b9b2-49fa-96a2-7c1092829d0e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_694d9bb8-f336-486c-853f-9b828f767a40_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_881caef4-979b-4118-9dc2-9a7b839c9984_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_b5794e30-9b0d-4971-a04f-d325d5283236_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method and other investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_label_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:to="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_c5fb31d2-2a0c-4c44-9800-706d76fda894_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_7abe8468-2636-4739-ba2a-22bea01322fe_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_ccc2e882-e7eb-4823-9dbf-7ee94ee08990_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_3454d13b-c928-453f-8aa4-c9e837cbc00b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_8e544165-49d4-4e12-b451-12e345d4436b_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_fd69e1a6-be7f-4ac2-9da1-1dd805a63329_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_14d495ee-2490-4ea8-b2f0-53256d7676c8_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_89467a43-b9b3-4e5c-812f-e71bc1b5e2e6_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_95af0455-9222-4967-bbfa-9e2e96cf221f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_AgreementWithMedtronicMember_d14f9fef-dc90-4713-8334-ee9337db59b1_terseLabel_en-US" xlink:label="lab_dva_AgreementWithMedtronicMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agreement with Medtronic</link:label>
    <link:label id="lab_dva_AgreementWithMedtronicMember_label_en-US" xlink:label="lab_dva_AgreementWithMedtronicMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agreement with Medtronic [Member]</link:label>
    <link:label id="lab_dva_AgreementWithMedtronicMember_documentation_en-US" xlink:label="lab_dva_AgreementWithMedtronicMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agreement with Medtronic, Inc. and one of its subsidiaries (collectively, Medtronic) to form a new, independent kidney care-focused medical device company (NewCo).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AgreementWithMedtronicMember" xlink:href="dva-20220930.xsd#dva_AgreementWithMedtronicMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_AgreementWithMedtronicMember" xlink:to="lab_dva_AgreementWithMedtronicMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_389c8d0a-3a78-4d20-b50c-15a63eefc33b_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (usd per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_8aef6a04-1c4c-4cb7-b0cf-cc081a7a0aa0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_887b0a3f-2b81-4fd4-8480-d2756f0976e4_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_20210f8f-fbaa-4b94-90ff-4a6ba4a3b84c_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_0370eab9-96c6-4bd3-a6f8-23e79f381dca_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_6e04911d-4290-4f66-be1e-64bc387985ee_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_ce25ce92-e3ab-461e-ba87-6c3976b7e421_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b8b0bb83-c732-4155-bc5c-e82e0acddcc5_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e718ece0-20bd-4c1c-a07e-0656e797d6b7_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares for diluted earnings per share calculation</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeMaturityDates_6729b660-0085-4e45-a7e8-09543f07434a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeMaturityDates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, expiration date</link:label>
    <link:label id="lab_us-gaap_DerivativeMaturityDates_label_en-US" xlink:label="lab_us-gaap_DerivativeMaturityDates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Maturity Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeMaturityDates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeMaturityDates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeMaturityDates" xlink:to="lab_us-gaap_DerivativeMaturityDates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_3e390ba6-591d-465d-bdcf-51e169091270_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average expected life (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_CommercialPayorsMember_d4f6d447-3fd1-4212-9bde-91ba792526a6_terseLabel_en-US" xlink:label="lab_dva_CommercialPayorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Payors</link:label>
    <link:label id="lab_dva_CommercialPayorsMember_label_en-US" xlink:label="lab_dva_CommercialPayorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Payors [Member]</link:label>
    <link:label id="lab_dva_CommercialPayorsMember_documentation_en-US" xlink:label="lab_dva_CommercialPayorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Payors in healthcare industry.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CommercialPayorsMember" xlink:href="dva-20220930.xsd#dva_CommercialPayorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_CommercialPayorsMember" xlink:to="lab_dva_CommercialPayorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecurities_84f44553-ab82-49b7-82a7-43b47726f9be_totalLabel_en-US" xlink:label="lab_us-gaap_MarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_MarketableSecurities_label_en-US" xlink:label="lab_us-gaap_MarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecurities" xlink:to="lab_us-gaap_MarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_fcccc37a-0760-4086-8b2e-8fd162b48e99_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_b7f1d639-cde9-45f0-89c6-ac8627f131c7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_12781d89-3446-4a72-9134-12872b8878a8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_1944c853-2162-4e04-b1fb-a96cac5c1663_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_RegulatoryAndCommercialMilestonesBeginningDate_aacd2f2b-a96f-450d-9c1e-236496985a6e_terseLabel_en-US" xlink:label="lab_dva_RegulatoryAndCommercialMilestonesBeginningDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regulatory and Commercial Milestones Beginning Date</link:label>
    <link:label id="lab_dva_RegulatoryAndCommercialMilestonesBeginningDate_label_en-US" xlink:label="lab_dva_RegulatoryAndCommercialMilestonesBeginningDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regulatory and Commercial Milestones Beginning Date</link:label>
    <link:label id="lab_dva_RegulatoryAndCommercialMilestonesBeginningDate_documentation_en-US" xlink:label="lab_dva_RegulatoryAndCommercialMilestonesBeginningDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regulatory and Commercial Milestones Beginning Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RegulatoryAndCommercialMilestonesBeginningDate" xlink:href="dva-20220930.xsd#dva_RegulatoryAndCommercialMilestonesBeginningDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_RegulatoryAndCommercialMilestonesBeginningDate" xlink:to="lab_dva_RegulatoryAndCommercialMilestonesBeginningDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitment_6d6acc22-dd73-462f-8692-a26a0e390d99_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other potential commitments to provide operating capital to several dialysis centers</link:label>
    <link:label id="lab_us-gaap_OtherCommitment_label_en-US" xlink:label="lab_us-gaap_OtherCommitment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitment" xlink:to="lab_us-gaap_OtherCommitment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_354e1870-21c4-46c1-9ab5-63d3b80562e7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Liabilities and Temporary Equity Measured at Fair Value on a Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_5df9ade2-9583-4bc8-92c1-728b8c33fb46_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncome_e45e570e-b0ed-4fad-a712-7bac2ff2ad41_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other revenues</link:label>
    <link:label id="lab_us-gaap_OtherIncome_label_en-US" xlink:label="lab_us-gaap_OtherIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncome" xlink:to="lab_us-gaap_OtherIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_92a50e39-6c3e-4e01-bba7-648ef42469aa_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_45850b97-2815-43d0-a1b2-8cb8fce4de0f_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investment income, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:to="lab_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_04dcfe2f-303f-4990-9522-6f50306aeebd_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at beginning of the year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_59472ad5-1bd2-4310-be7e-842f719c57bb_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at end of the period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TextBlockAbstract_e0393293-8035-47e4-ba42-fd8a72576e8e_terseLabel_en-US" xlink:label="lab_us-gaap_TextBlockAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Text Block [Abstract]</link:label>
    <link:label id="lab_us-gaap_TextBlockAbstract_label_en-US" xlink:label="lab_us-gaap_TextBlockAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Text Block [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TextBlockAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TextBlockAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TextBlockAbstract" xlink:to="lab_us-gaap_TextBlockAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_7a35ff82-b19c-40c2-ba5d-19c8730357f8_negatedLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_5d69d7b9-3c7e-4352-9f61-396a88c65dde_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated impairment charges</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_d068b58c-4eec-4a7f-83d9-994233d1a762_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_6d985230-cc0a-403a-9be4-6d8bb6c2e97a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_LongTermDebtPercentageBearingEconomicallyFixedInterestRate_c12cec3e-653d-47ac-845f-6916cbe25036_terseLabel_en-US" xlink:label="lab_dva_LongTermDebtPercentageBearingEconomicallyFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Debt Percentage Bearing Economically Fixed Interest Rate</link:label>
    <link:label id="lab_dva_LongTermDebtPercentageBearingEconomicallyFixedInterestRate_label_en-US" xlink:label="lab_dva_LongTermDebtPercentageBearingEconomicallyFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Debt Percentage Bearing Economically Fixed Interest Rate</link:label>
    <link:label id="lab_dva_LongTermDebtPercentageBearingEconomicallyFixedInterestRate_documentation_en-US" xlink:label="lab_dva_LongTermDebtPercentageBearingEconomicallyFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Debt Percentage Bearing Economically Fixed Interest Rate.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LongTermDebtPercentageBearingEconomicallyFixedInterestRate" xlink:href="dva-20220930.xsd#dva_LongTermDebtPercentageBearingEconomicallyFixedInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_LongTermDebtPercentageBearingEconomicallyFixedInterestRate" xlink:to="lab_dva_LongTermDebtPercentageBearingEconomicallyFixedInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParentMember_b0675c8c-f0f3-4379-aac4-5c16e4f54576_terseLabel_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_ParentMember_label_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParentMember" xlink:to="lab_us-gaap_ParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_84979982-f687-4a60-b1c0-5b67e10ecb61_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_RevenuesbymajorpayorAbstract_bfd5688e-f434-4620-9c03-6f0ef27a7ea8_terseLabel_en-US" xlink:label="lab_dva_RevenuesbymajorpayorAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues by major payor [Abstract]</link:label>
    <link:label id="lab_dva_RevenuesbymajorpayorAbstract_label_en-US" xlink:label="lab_dva_RevenuesbymajorpayorAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues by major payor [Abstract]</link:label>
    <link:label id="lab_dva_RevenuesbymajorpayorAbstract_documentation_en-US" xlink:label="lab_dva_RevenuesbymajorpayorAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues by major payor [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RevenuesbymajorpayorAbstract" xlink:href="dva-20220930.xsd#dva_RevenuesbymajorpayorAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_RevenuesbymajorpayorAbstract" xlink:to="lab_dva_RevenuesbymajorpayorAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_0bf5e4db-0c38-4ec2-bb5c-ebbad3b4ae12_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentMaturityDateDescription_6fe26d87-08dd-471a-b95d-8bb0d14b758b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentMaturityDateDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, maturity date, description</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentMaturityDateDescription_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentMaturityDateDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maturity Date, Description</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDateDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMaturityDateDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentMaturityDateDescription" xlink:to="lab_us-gaap_DebtInstrumentMaturityDateDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_bd0b6bf0-60a0-47ca-8c30-8a14fb085720_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_76308709-208e-4599-8c17-3b9938bddc7a_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentHoldingsTable_92dd8902-3c45-4a53-9039-f2ec140ea040_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Holdings [Table]</link:label>
    <link:label id="lab_us-gaap_InvestmentHoldingsTable_label_en-US" xlink:label="lab_us-gaap_InvestmentHoldingsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Holdings [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentHoldingsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentHoldingsTable" xlink:to="lab_us-gaap_InvestmentHoldingsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthCareOrganizationRevenueSourcesDomain_f7c39ffe-4a8b-4c30-a0a6-7b681ca232e6_terseLabel_en-US" xlink:label="lab_us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Organization, Revenue Sources [Domain]</link:label>
    <link:label id="lab_us-gaap_HealthCareOrganizationRevenueSourcesDomain_label_en-US" xlink:label="lab_us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Organization, Revenue Sources [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:to="lab_us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_31c79adf-46b7-4e8e-bd31-196218068214_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_8768ed62-c86c-4165-9480-314e5ffab5a4_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_09b599eb-bfb2-4f17-84a6-b5885a4e5816_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_5bcca16e-fc96-4f0d-baa4-012c16881bf5_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to DaVita Inc.</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_56187adc-3592-4240-8dfe-83a08925e95b_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_26bcd73d-4aee-4810-af84-16c6fca76e2c_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentDueAfterFifthYear_cf90a285-493e-4b12-a55c-d2616f90af3e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentDueAfterFifthYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitment, to be Paid, after Year Five</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentDueAfterFifthYear_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentDueAfterFifthYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitment, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentDueAfterFifthYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentDueAfterFifthYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentDueAfterFifthYear" xlink:to="lab_us-gaap_OtherCommitmentDueAfterFifthYear" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_USDialysisAndRelatedLabServicesMember_6d7d03d5-5b51-4892-b1ed-d801bdc0e744_terseLabel_en-US" xlink:label="lab_dva_USDialysisAndRelatedLabServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. dialysis</link:label>
    <link:label id="lab_dva_USDialysisAndRelatedLabServicesMember_label_en-US" xlink:label="lab_dva_USDialysisAndRelatedLabServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U S Dialysis And Related Lab Services [Member]</link:label>
    <link:label id="lab_dva_USDialysisAndRelatedLabServicesMember_documentation_en-US" xlink:label="lab_dva_USDialysisAndRelatedLabServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US dialysis &#8203;and &#8203;related &#8203;lab&#8203; services&#8203;.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember" xlink:href="dva-20220930.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_USDialysisAndRelatedLabServicesMember" xlink:to="lab_dva_USDialysisAndRelatedLabServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_1cdac29a-684e-401e-b7eb-378e8a35c49f_terseLabel_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions and divestitures</link:label>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mergers, Acquisitions and Dispositions Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:to="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_5a708b76-a41b-499b-b528-e492e6a33bbc_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_205b805a-52b4-4315-867d-c61abbf00c68_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_70838cf8-028c-4695-b16c-f485c0e78fe8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_b205de34-d796-401e-966f-931ff2bf8c20_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts_5d7f712d-4a0e-4afa-acbf-e6e8292d1c73_terseLabel_en-US" xlink:label="lab_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dialysis patient service revenues</link:label>
    <link:label id="lab_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts_label_en-US" xlink:label="lab_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer Including Assessed Tax Net Of Provision For Uncollectible Accounts</link:label>
    <link:label id="lab_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts_documentation_en-US" xlink:label="lab_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer Including Assessed Tax Net Of Provision For Uncollectible Accounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" xlink:href="dva-20220930.xsd#dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" xlink:to="lab_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_312c96e1-6873-4da2-9022-13d1bafd3acc_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and benefits</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Employee Related Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_d1bcf293-35cf-4d8e-b275-a2c4c8433765_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency and other adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Translation and Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_503f06de-8b37-464e-9285-722e8a271e42_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_49645ae1-5013-4e6e-a022-66ca79e79e6d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_38896033-d253-493f-930e-94a9e41a2b9f_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income Loss [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_MedicaidandManagedMedicaidMember_91bd9741-95ac-49ba-a8a8-5f4e7fb6eee4_terseLabel_en-US" xlink:label="lab_dva_MedicaidandManagedMedicaidMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid and Managed Medicaid</link:label>
    <link:label id="lab_dva_MedicaidandManagedMedicaidMember_label_en-US" xlink:label="lab_dva_MedicaidandManagedMedicaidMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid and Managed Medicaid [Member]</link:label>
    <link:label id="lab_dva_MedicaidandManagedMedicaidMember_documentation_en-US" xlink:label="lab_dva_MedicaidandManagedMedicaidMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid and Managed Medicaid Member.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MedicaidandManagedMedicaidMember" xlink:href="dva-20220930.xsd#dva_MedicaidandManagedMedicaidMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_MedicaidandManagedMedicaidMember" xlink:to="lab_dva_MedicaidandManagedMedicaidMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_3e955848-f560-4e30-a9fe-59fdd9b8897f_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_9e8491e3-ca49-4ef1-98cc-e8df085ef7df_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed consolidated interim financial statements</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_733b9870-10ba-4253-9f29-640ccd5ede10_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_04487b01-086c-4318-a953-9868c7a1aebd_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures_f25866ca-e9e4-4333-b064-b9692b2c2778_terseLabel_en-US" xlink:label="lab_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions and divestitures</link:label>
    <link:label id="lab_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures_label_en-US" xlink:label="lab_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase Due To Acquisitions and Divestitures</link:label>
    <link:label id="lab_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures_documentation_en-US" xlink:label="lab_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase Due To Acquisitions and Divestitures without Put provisions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures" xlink:href="dva-20220930.xsd#dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures" xlink:to="lab_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAmortizationAndAccretionNet_77d3589c-f13f-4292-9613-2f6a2521e86d_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAmortizationAndAccretionNet_label_en-US" xlink:label="lab_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Amortization and Accretion, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:to="lab_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures_a65576c6-f10e-4cc3-87b2-bcaa751fa328_negatedTerseLabel_en-US" xlink:label="lab_dva_NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions and divestitures</link:label>
    <link:label id="lab_dva_NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures_label_en-US" xlink:label="lab_dva_NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease Due To Acquisitions and Divestitures</link:label>
    <link:label id="lab_dva_NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures_documentation_en-US" xlink:label="lab_dva_NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease Due To Acquisitions and Divestitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures" xlink:href="dva-20220930.xsd#dva_NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures" xlink:to="lab_dva_NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_27ebc840-880a-411b-91bb-4111125e7241_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_48971a9b-a602-4fb2-8ff2-66169b66c777_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_fe2e7a76-55dd-42b7-92f0-a72833cd9d28_periodStartLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Earn-out Obligations, Beginning balance</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_b06b9cd1-6ce6-4889-866e-eed0bf912e0d_periodEndLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Earn-out Obligations, Ending balance</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_OtherGovernmentPayorsMember_86b95203-8daa-493e-bd92-93b7d869fd6a_terseLabel_en-US" xlink:label="lab_dva_OtherGovernmentPayorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Government Payors</link:label>
    <link:label id="lab_dva_OtherGovernmentPayorsMember_label_en-US" xlink:label="lab_dva_OtherGovernmentPayorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Government Payors [Member]</link:label>
    <link:label id="lab_dva_OtherGovernmentPayorsMember_documentation_en-US" xlink:label="lab_dva_OtherGovernmentPayorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other government payors in healthcare industry.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherGovernmentPayorsMember" xlink:href="dva-20220930.xsd#dva_OtherGovernmentPayorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_OtherGovernmentPayorsMember" xlink:to="lab_dva_OtherGovernmentPayorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableOtherPayablesMember_b0e86c19-e9cc-4397-89ba-9b8ef13d2c04_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition obligations and other notes payable</link:label>
    <link:label id="lab_us-gaap_NotesPayableOtherPayablesMember_label_en-US" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Other Payables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableOtherPayablesMember" xlink:to="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_a993e78c-ce52-4126-ac85-cb5f8c16bd84_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock award plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_a8083853-b29b-4eab-addc-a0b9125cf987_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (loss) income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_585cc842-47ec-4dcc-bd34-b23a4c08128f_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_c5e17f1b-f7b2-44fe-8de7-45d2d2c49cb9_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityAbstract_f60afed9-5de0-4691-abc5-86f36a1f4845_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityAbstract_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityAbstract" xlink:to="lab_us-gaap_TemporaryEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_3748c64d-4ea2-4791-ad42-d9210071cdd6_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_ff17a25d-9047-4be9-87a2-cf4dc3106d46_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_5f745bb0-c6bd-4884-b6b0-23a472425dc4_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ec79ba22-1989-4038-b5e9-e01464210388_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ae912e3e-2202-4d71-be39-4bf5351c5a6e_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_96be047e-d73c-4c58-b41e-ef873af8966d_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_08c41913-8d94-4c90-a203-2d49dee3e35b_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving line of credit, fair value of amount outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Fair Value of Amount Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:to="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9cfc6571-f0d2-43d8-9198-004145e75464_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Business Acquisitions By Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestAndDebtExpense_1dc870e2-542b-4964-9840-2fd555189f65_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestAndDebtExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt expense</link:label>
    <link:label id="lab_us-gaap_InterestAndDebtExpense_label_en-US" xlink:label="lab_us-gaap_InterestAndDebtExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and Debt Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestAndDebtExpense" xlink:to="lab_us-gaap_InterestAndDebtExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_5415e872-d97b-4ecc-8ea4-77275a278f7b_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_26ee6732-191f-4d5f-93b8-d7a269ea4dd8_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentMaturityDate_66743f2f-27ab-4a67-92fb-be546292e6eb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentMaturityDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maturity Date</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentMaturityDate_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentMaturityDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maturity Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentMaturityDate" xlink:to="lab_us-gaap_DebtInstrumentMaturityDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersubsegmentEliminationsMember_f64910a5-5ae7-4ab4-abb5-7b80e102a639_terseLabel_en-US" xlink:label="lab_us-gaap_IntersubsegmentEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersubsegment Eliminations</link:label>
    <link:label id="lab_us-gaap_IntersubsegmentEliminationsMember_label_en-US" xlink:label="lab_us-gaap_IntersubsegmentEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersubsegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersubsegmentEliminationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersubsegmentEliminationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersubsegmentEliminationsMember" xlink:to="lab_us-gaap_IntersubsegmentEliminationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_6d5511cb-6b84-4b91-aed4-5c320611e7e8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_b087e5a9-1e14-4d93-bae8-2b88ad2ab213_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_f8f1d068-d7a3-4948-a83b-91f904293f86_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsTable" xlink:to="lab_us-gaap_OtherCommitmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_7022c058-d7a8-4e1b-ba2c-e819d1936ec9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement Frequency</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestItemsAbstract_4fd63712-8cf1-4f96-bed0-b02e17fe6983_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in noncontrolling interest from:</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract" xlink:to="lab_us-gaap_NoncontrollingInterestItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotes_8cebadb2-9daf-4c9e-a9bf-57330489faee_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotes_label_en-US" xlink:label="lab_us-gaap_SeniorNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotes" xlink:to="lab_us-gaap_SeniorNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_5bd9c46c-8472-417b-974b-52b9ada34920_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Assets by Reportable Segment</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Assets from Segment to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember_f919c9bf-fb10-4615-825f-39143c345630_terseLabel_en-US" xlink:label="lab_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EBITDA or Operating Income Performance Targets or Quality Margins</link:label>
    <link:label id="lab_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember_label_en-US" xlink:label="lab_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">E B I T D A Operating Income Performance Targets Or Quality Margins [Member]</link:label>
    <link:label id="lab_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember_documentation_en-US" xlink:label="lab_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EBITDA operating income performance targets or quality margins.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember" xlink:href="dva-20220930.xsd#dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember" xlink:to="lab_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_dbe46bc2-66aa-4056-91b5-b936fa7d09da_negatedLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss_a07153f7-14f4-4474-a041-135580539883_negatedLabel_en-US" xlink:label="lab_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value remeasurements</link:label>
    <link:label id="lab_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss_label_en-US" xlink:label="lab_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Contingent Consideration Acquisitions Fair Value Remeasurement Gain Loss</link:label>
    <link:label id="lab_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss_documentation_en-US" xlink:label="lab_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Contingent Consideration Acquisitions Fair Value Remeasurement Gain Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss" xlink:href="dva-20220930.xsd#dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss" xlink:to="lab_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember_2b02d364-a440-4178-81f7-c79802b1700d_terseLabel_en-US" xlink:label="lab_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of deposit and other time deposits</link:label>
    <link:label id="lab_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember_label_en-US" xlink:label="lab_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates Of Deposit Commercial Paper And Money Market Funds [Member]</link:label>
    <link:label id="lab_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember_documentation_en-US" xlink:label="lab_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of deposit, commercial paper, and money market funds.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember" xlink:href="dva-20220930.xsd#dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember" xlink:to="lab_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_a4209676-a564-46b0-9d38-288ebdea90e7_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation cost related to nonvested stock-based compensation arrangements under equity compensation and stock purchase plans</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_7703e5b5-7895-4cd1-859d-553975e2fc06_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amounts of interest rate agreements</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:to="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_AcquisitionObligationsAndOtherNotesPayableFairValue_2ec5d272-07ca-4600-bd88-f7d215f21da9_terseLabel_en-US" xlink:label="lab_dva_AcquisitionObligationsAndOtherNotesPayableFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition obligations and other notes payable, fair value</link:label>
    <link:label id="lab_dva_AcquisitionObligationsAndOtherNotesPayableFairValue_label_en-US" xlink:label="lab_dva_AcquisitionObligationsAndOtherNotesPayableFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition Obligations And Other Notes Payable, Fair Value</link:label>
    <link:label id="lab_dva_AcquisitionObligationsAndOtherNotesPayableFairValue_documentation_en-US" xlink:label="lab_dva_AcquisitionObligationsAndOtherNotesPayableFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition Obligations And Other Notes Payable, Fair Value.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AcquisitionObligationsAndOtherNotesPayableFairValue" xlink:href="dva-20220930.xsd#dva_AcquisitionObligationsAndOtherNotesPayableFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_AcquisitionObligationsAndOtherNotesPayableFairValue" xlink:to="lab_dva_AcquisitionObligationsAndOtherNotesPayableFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets_86ffc04f-674e-4876-93a8-3b79a26b3cce_negatedLabel_en-US" xlink:label="lab_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables and prepaid and other current assets</link:label>
    <link:label id="lab_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets_label_en-US" xlink:label="lab_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease In Other Current Receivables And Other Current Assets</link:label>
    <link:label id="lab_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets_documentation_en-US" xlink:label="lab_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The net change during the reporting period in other current receivables and other current assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" xlink:href="dva-20220930.xsd#dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" xlink:to="lab_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_19bcd3c0-2ecb-417b-9d3a-f4710da011fb_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_5e023535-b66a-4828-a506-78a2bb7c98fa_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_1f28d382-d756-47b6-9f90-8555641f547b_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue_48d3c47b-4df1-48fc-86b8-77fbb69418e9_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value remeasurements</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Accretion to Redemption Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:to="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TemporaryEquityDecreasePurchaseOfInterests_c566d6e4-8aad-482b-925c-03e9100a892d_negatedTerseLabel_en-US" xlink:label="lab_dva_TemporaryEquityDecreasePurchaseOfInterests" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partial purchases</link:label>
    <link:label id="lab_dva_TemporaryEquityDecreasePurchaseOfInterests_label_en-US" xlink:label="lab_dva_TemporaryEquityDecreasePurchaseOfInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Decrease Purchase Of Interests</link:label>
    <link:label id="lab_dva_TemporaryEquityDecreasePurchaseOfInterests_documentation_en-US" xlink:label="lab_dva_TemporaryEquityDecreasePurchaseOfInterests" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Decrease Purchase Of Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityDecreasePurchaseOfInterests" xlink:href="dva-20220930.xsd#dva_TemporaryEquityDecreasePurchaseOfInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TemporaryEquityDecreasePurchaseOfInterests" xlink:to="lab_dva_TemporaryEquityDecreasePurchaseOfInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_d568f06a-8e31-4763-90c4-d273c54662b5_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_AdditionalCashCommitment_63b54cb4-8305-4879-9d3a-a9ac18b05c0a_terseLabel_en-US" xlink:label="lab_dva_AdditionalCashCommitment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Cash Commitment</link:label>
    <link:label id="lab_dva_AdditionalCashCommitment_label_en-US" xlink:label="lab_dva_AdditionalCashCommitment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Cash Commitment</link:label>
    <link:label id="lab_dva_AdditionalCashCommitment_documentation_en-US" xlink:label="lab_dva_AdditionalCashCommitment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Cash Commitment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AdditionalCashCommitment" xlink:href="dva-20220930.xsd#dva_AdditionalCashCommitment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_AdditionalCashCommitment" xlink:to="lab_dva_AdditionalCashCommitment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_46503998-09fa-4bd2-9550-df29d8f2b309_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_3f52969b-8bc4-4684-bff6-ecb871f9925d_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_label_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable" xlink:to="lab_us-gaap_ClassOfTreasuryStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthCareOrganizationRevenueSourcesAxis_8de67c4f-1dc3-4d7f-a00f-ecff66fdaf30_terseLabel_en-US" xlink:label="lab_us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Organization, Revenue Sources [Axis]</link:label>
    <link:label id="lab_us-gaap_HealthCareOrganizationRevenueSourcesAxis_label_en-US" xlink:label="lab_us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Organization, Revenue Sources [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:to="lab_us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_be49fe7c-baa6-4a3f-bb84-10ee0f2e823e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_d18e1a75-6caf-4ba1-9eeb-7ec3033926a6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_186d52a3-0353-4968-85c2-95dfcc9114a9_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock award plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_93c36e4c-fa73-424c-91d3-f92efa732cee_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfDerivativeInstrumentsAbstract_45571054-c87d-404c-9e34-2fdccdc956c1_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfDerivativeInstrumentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Derivative Instruments [Abstract]</link:label>
    <link:label id="lab_us-gaap_SummaryOfDerivativeInstrumentsAbstract_label_en-US" xlink:label="lab_us-gaap_SummaryOfDerivativeInstrumentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Derivative Instruments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfDerivativeInstrumentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfDerivativeInstrumentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfDerivativeInstrumentsAbstract" xlink:to="lab_us-gaap_SummaryOfDerivativeInstrumentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_3868340a-ace2-45d3-b375-292c0e9c5025_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c333511b-919e-4aa4-a90c-bb230ef9c77a_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_325f13e1-889b-40fb-b9af-afc4e587769a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_bd540669-7dd2-49ea-86e2-fff79b202d37_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from debt investments held-to-maturity</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Held-to-Maturity Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_54862301-962e-451c-a077-58471968c6a7_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_f78858a3-7054-41e4-bc3e-4d6d09385ba5_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:to="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_37e00a51-ee9a-4119-8ad1-ec665c98cd98_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares for earnings per share:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock_1f0168c6-f6f5-472b-b402-47f70a4a7bd9_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Depreciation and Amortization Expense by Reportable Segment</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_eba65c7f-c6e9-4fe6-a288-091a8d6b2bea_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_e98856fe-f53d-4889-96b1-3e04a1e8d0c6_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfBusinessesAcquired_a8547569-8e58-4665-bd53-d2d0ae8177de_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfBusinessesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of businesses acquired</link:label>
    <link:label id="lab_us-gaap_NumberOfBusinessesAcquired_label_en-US" xlink:label="lab_us-gaap_NumberOfBusinessesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Businesses Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfBusinessesAcquired" xlink:to="lab_us-gaap_NumberOfBusinessesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_3c346280-a85a-4e97-9bd3-4f5503d55797_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember_40525e70-2dec-4dea-96e3-ddff65afbe86_terseLabel_en-US" xlink:label="lab_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non- controlling interests subject to put provisions</link:label>
    <link:label id="lab_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember_label_en-US" xlink:label="lab_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity Redeemable Noncontrolling Interests [Member]</link:label>
    <link:label id="lab_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember_documentation_en-US" xlink:label="lab_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interests Temporary Equity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember" xlink:href="dva-20220930.xsd#dva_TemporaryEquityRedeemableNoncontrollingInterestsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember" xlink:to="lab_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_b59a9119-a34a-4f68-935b-da1caa38dabb_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityOtherChanges_918701e7-6504-4929-8cc0-ee4504fe4687_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityOtherChanges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityOtherChanges_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityOtherChanges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Other Changes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityOtherChanges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityOtherChanges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityOtherChanges" xlink:to="lab_us-gaap_TemporaryEquityOtherChanges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_0525ed9e-b45d-410b-8dce-d879ff157fb5_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from asset and business sales</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sales of Business, Affiliate and Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:to="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_b2c261ad-4ee6-4e5e-82fe-9213b25b0c23_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_aff2d100-1c76-45c5-a2c9-2117ca819c38_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d56c7532-542c-4238-939e-6b923306dbee_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_7b3f0c40-db05-4546-b838-481a578cb028_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_1c9b290e-c4d6-44ef-91db-67cc9620ae96_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_3bc29777-b131-4829-a927-0f6aaef70c46_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_db6e8a7b-6836-441b-a12c-d83bddb19fcb_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests subject to put provisions</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_6ffc9039-f069-4694-b096-5cfdb30cba08_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications of net realized losses into net income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_c1fc37d8-31bc-4370-b099-7ac42269f778_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of credit outstanding</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TermLoanFacilityMember_d29f8646-f419-4999-824f-1941b77985e6_terseLabel_en-US" xlink:label="lab_dva_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility</link:label>
    <link:label id="lab_dva_TermLoanFacilityMember_label_en-US" xlink:label="lab_dva_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility [Member]</link:label>
    <link:label id="lab_dva_TermLoanFacilityMember_documentation_en-US" xlink:label="lab_dva_TermLoanFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanFacilityMember" xlink:href="dva-20220930.xsd#dva_TermLoanFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TermLoanFacilityMember" xlink:to="lab_dva_TermLoanFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_2c131142-e100-49ad-98c9-66f85de36d43_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_e37c3545-dfd0-4120-a5e4-177d5df92949_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Appreciation Rights</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_010a79be-eccb-4b4e-a266-c1bcfb27a3ac_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gains (losses) on interest rate cap agreements:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_9528258c-d99b-4768-a85b-80c604787a39_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_4074c183-c10f-4603-a059-969269299f3e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_f7d1376d-64ef-44d4-9fe6-d47aab995561_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_e53d0e6d-d077-41d2-bb2d-e5337527e5c4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant unobservable inputs (Level 3)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_a71ef943-0a9d-4034-9cb2-d236fa1b1241_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment charges</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_355b310c-9e86-4183-a6ad-6bb8c2215727_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_72a22b04-3203-4f30-b0c8-6d432ffb30e9_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term incentive compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_4fd9fc67-7f39-487f-80d7-2582b0034ab8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_1a939eb7-f5fd-4cbd-ad3f-2390f2845418_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease, weighted average discount rate, percent</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_994a6b40-2436-4b1d-96a0-f2ae91562831_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition [Text Block]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_a92ee414-fdb1-4a80-9073-19eb622e3aef_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesNoncurrent_bd522cbb-d88a-461e-95ca-007a09f04d4b_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities, long-term investments</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesNoncurrent" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_7838300b-4ccd-400f-9e17-cf793259a460_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_0cbee94a-94d2-4dfa-be48-fb804abd140b_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non- controlling interests not subject to put provisions</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_0d17b428-1787-4511-8ba3-96c893ef2357_negatedLabel_en-US" xlink:label="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestitures</link:label>
    <link:label id="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_label_en-US" xlink:label="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Written off Related to Sale of Business Unit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:to="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_ca77c404-1419-47db-a5ff-1bde5ff60b40_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net payments related to stock purchases and awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_06accb24-2e56-44d3-8ead-f14f015b493f_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_06b5c175-10b9-4b9e-ae13-060acab8ec63_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_41fb9eba-f623-4383-89c1-6a4ab30681cc_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_79805286-8b9b-48fd-826c-017798b8a998_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_686ecc4f-44f2-46f5-b99b-457621dfa295_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_ca983e6d-7c43-4fd3-b684-e1c30d678f67_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed incremental from stock plans</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_00cc1f73-f349-43c0-8257-0b674e323ba6_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_e352fd21-87c2-4e17-8c60-a32ab02c0a06_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant other observable&#160;inputs (Level 2)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_86bdf6b0-822c-4543-891b-934e9207f07d_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income Before Income Taxes</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember_f58ec806-c1e6-4bc9-bc2f-617c884a0f89_terseLabel_en-US" xlink:label="lab_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Three Point Seven Five Percent Due Twenty Thirty One</link:label>
    <link:label id="lab_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember_label_en-US" xlink:label="lab_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Three Point Seven Five Percent Due Twenty Thirty One [Member]</link:label>
    <link:label id="lab_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember_documentation_en-US" xlink:label="lab_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Three Point Seven Five Percent Due Twenty Thirty One.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember" xlink:href="dva-20220930.xsd#dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember" xlink:to="lab_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_faca84c9-bab5-405a-92a1-72b7a62b045c_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_b02e5932-0729-4142-a161-578f54562ffb_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_706b94f0-b967-4ad9-893a-9e0c010f9039_totalLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total, short-term investments</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesCurrent" xlink:to="lab_us-gaap_MarketableSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_d56d7fd7-e66e-4085-84ee-f3f1885a83b9_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_497678c8-e07b-4125-a11a-83cc05fa29bc_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_4d753669-a719-45fa-9fa9-798e62e494b4_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income per share attributable to DaVita Inc.</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_148a60c8-ff3a-48d7-8415-188a257397a7_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-settled stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_PatientCareCosts_136585f2-a130-446b-981a-c6a56ebb4538_terseLabel_en-US" xlink:label="lab_dva_PatientCareCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient care costs</link:label>
    <link:label id="lab_dva_PatientCareCosts_label_en-US" xlink:label="lab_dva_PatientCareCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient Care Costs</link:label>
    <link:label id="lab_dva_PatientCareCosts_documentation_en-US" xlink:label="lab_dva_PatientCareCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient care costs are costs directly associated with operating and supporting dialysis centers, medical clinics and ancillary operations and consist principally of labor, pharmaceuticals, medical supplies and facility operating costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PatientCareCosts" xlink:href="dva-20220930.xsd#dva_PatientCareCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_PatientCareCosts" xlink:to="lab_dva_PatientCareCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_782400fb-9b77-4cd6-abfd-d13909a23f02_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_c4905246-9db4-4ad9-9eb6-d6669a90594d_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_b4290838-2721-4bb3-a132-1b355b932405_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to DaVita Inc.</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_SegmentReportingInformationCorporateExpenses_30cfb2d8-4935-466c-99d6-1d14db119009_negatedLabel_en-US" xlink:label="lab_dva_SegmentReportingInformationCorporateExpenses" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate administrative support</link:label>
    <link:label id="lab_dva_SegmentReportingInformationCorporateExpenses_label_en-US" xlink:label="lab_dva_SegmentReportingInformationCorporateExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information Corporate Expenses</link:label>
    <link:label id="lab_dva_SegmentReportingInformationCorporateExpenses_documentation_en-US" xlink:label="lab_dva_SegmentReportingInformationCorporateExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of general and administrative support costs, such as labor, benefits and stock-based compensation costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SegmentReportingInformationCorporateExpenses" xlink:href="dva-20220930.xsd#dva_SegmentReportingInformationCorporateExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_SegmentReportingInformationCorporateExpenses" xlink:to="lab_dva_SegmentReportingInformationCorporateExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentDueInNextTwelveMonths_c3ee503b-1d1f-4e51-88ec-a3e47010d527_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentDueInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitment, to be Paid, Year One</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentDueInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentDueInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitment, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentDueInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentDueInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentDueInNextTwelveMonths" xlink:to="lab_us-gaap_OtherCommitmentDueInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_BusinessAcquisitionGoodwillExpectedTaxDeductibleAmountAdjustment_b94ecd0a-4408-42dd-b24e-a5e2a8d0f156_terseLabel_en-US" xlink:label="lab_dva_BusinessAcquisitionGoodwillExpectedTaxDeductibleAmountAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Goodwill, Adjustment To Expected Tax Deductible Amount</link:label>
    <link:label id="lab_dva_BusinessAcquisitionGoodwillExpectedTaxDeductibleAmountAdjustment_label_en-US" xlink:label="lab_dva_BusinessAcquisitionGoodwillExpectedTaxDeductibleAmountAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Goodwill, Expected Tax Deductible Amount, Adjustment</link:label>
    <link:label id="lab_dva_BusinessAcquisitionGoodwillExpectedTaxDeductibleAmountAdjustment_documentation_en-US" xlink:label="lab_dva_BusinessAcquisitionGoodwillExpectedTaxDeductibleAmountAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Goodwill, Expected Tax Deductible Amount, Adjustment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessAcquisitionGoodwillExpectedTaxDeductibleAmountAdjustment" xlink:href="dva-20220930.xsd#dva_BusinessAcquisitionGoodwillExpectedTaxDeductibleAmountAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_BusinessAcquisitionGoodwillExpectedTaxDeductibleAmountAdjustment" xlink:to="lab_dva_BusinessAcquisitionGoodwillExpectedTaxDeductibleAmountAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_TermLoanAMember_f179f90d-f290-4699-8de6-709a2955a506_terseLabel_en-US" xlink:label="lab_dva_TermLoanAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan A</link:label>
    <link:label id="lab_dva_TermLoanAMember_label_en-US" xlink:label="lab_dva_TermLoanAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan A [Member]</link:label>
    <link:label id="lab_dva_TermLoanAMember_documentation_en-US" xlink:label="lab_dva_TermLoanAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term loan A.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanAMember" xlink:href="dva-20220930.xsd#dva_TermLoanAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_TermLoanAMember" xlink:to="lab_dva_TermLoanAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValueDisclosureAbstract_47b065ed-68fc-4aa0-a30d-41da0edda7e7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, table footnotes</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract" xlink:to="lab_us-gaap_DebtInstrumentFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_OtherReportingUnitsMember_26fafaa0-30f8-4680-940e-0532e815dea8_terseLabel_en-US" xlink:label="lab_dva_OtherReportingUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Health Operations</link:label>
    <link:label id="lab_dva_OtherReportingUnitsMember_label_en-US" xlink:label="lab_dva_OtherReportingUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Reporting Units [Member]</link:label>
    <link:label id="lab_dva_OtherReportingUnitsMember_documentation_en-US" xlink:label="lab_dva_OtherReportingUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Reporting Units [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherReportingUnitsMember" xlink:href="dva-20220930.xsd#dva_OtherReportingUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_OtherReportingUnitsMember" xlink:to="lab_dva_OtherReportingUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_664645dc-aaa4-4966-9bbf-0e07901bd89a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_AcquisitionObligationsAndOtherNotesPayable_62db56fa-24c3-4452-921b-ac69828dccad_terseLabel_en-US" xlink:label="lab_dva_AcquisitionObligationsAndOtherNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition obligations and other notes payable</link:label>
    <link:label id="lab_dva_AcquisitionObligationsAndOtherNotesPayable_label_en-US" xlink:label="lab_dva_AcquisitionObligationsAndOtherNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition Obligations And Other Notes Payable</link:label>
    <link:label id="lab_dva_AcquisitionObligationsAndOtherNotesPayable_documentation_en-US" xlink:label="lab_dva_AcquisitionObligationsAndOtherNotesPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This represents deferred purchase price obligations associated with acquisitions as well as other notes payable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AcquisitionObligationsAndOtherNotesPayable" xlink:href="dva-20220930.xsd#dva_AcquisitionObligationsAndOtherNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_AcquisitionObligationsAndOtherNotesPayable" xlink:to="lab_dva_AcquisitionObligationsAndOtherNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_91d3ec6c-3237-4551-b4ff-3e04f7cfa837_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_cc15cbcf-70f0-4c7b-a199-435c41046e61_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gains (losses)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsConsolidationItemsDomain_2b08ea75-58c7-4a61-92cf-c533d57fbd57_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments Consolidation Items</link:label>
    <link:label id="lab_us-gaap_SubsegmentsConsolidationItemsDomain_label_en-US" xlink:label="lab_us-gaap_SubsegmentsConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsDomain" xlink:to="lab_us-gaap_SubsegmentsConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_d5015f80-827f-4fa4-b1ae-1dcd29b36d5b_terseLabel_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_label_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:to="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_255f3208-f018-4ddf-a98c-a0697ad026dd_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative asset, fair value, gross asset</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_35a4bb3a-f6d9-4826-8309-0a9cac7c03ae_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_bed42b5b-0e02-4e2e-add2-466e2b119c32_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_ad7de198-805b-49f7-ac03-d9a686c5fa11_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_36d88a95-ef1a-4fb6-9cf5-8ce90152ba79_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of debt expense reclassified from accumulated OCI into income</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_b69d3328-e89b-49c4-8d99-052aa1d51e1b_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_8c852523-9804-424e-ab39-4bb9a31feb87_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_32b1c7fd-df43-4638-b319-3c4d31896a43_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_d6809772-d3be-49a9-aa23-c830034ad8c8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_b83e939d-f455-412c-9534-0c5869be3efe_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_12f31c4c-752c-43c6-813d-58372079b234_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesNetCurrent" xlink:to="lab_us-gaap_OtherReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLongTermInvestmentsMember_136747d9-7250-494e-a9b1-a488422b5056_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLongTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Investments</link:label>
    <link:label id="lab_us-gaap_OtherLongTermInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_OtherLongTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-Term Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLongTermInvestmentsMember" xlink:to="lab_us-gaap_OtherLongTermInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_e53d4296-e250-45c5-85cf-8a76298c193c_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_b59a700c-3d5d-49a4-b2de-a535b08c2585_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-term Assets</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:to="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_827d5bee-3221-4274-8a51-19122dd8dd6e_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_SeniorSecuredCreditFacilitiesMember_6fff3cce-681c-463e-9bbd-5a512ff81ade_terseLabel_en-US" xlink:label="lab_dva_SeniorSecuredCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Credit Facilities</link:label>
    <link:label id="lab_dva_SeniorSecuredCreditFacilitiesMember_label_en-US" xlink:label="lab_dva_SeniorSecuredCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Secured Credit Facilities [Member]</link:label>
    <link:label id="lab_dva_SeniorSecuredCreditFacilitiesMember_documentation_en-US" xlink:label="lab_dva_SeniorSecuredCreditFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior secured credit facilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorSecuredCreditFacilitiesMember" xlink:href="dva-20220930.xsd#dva_SeniorSecuredCreditFacilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_SeniorSecuredCreditFacilitiesMember" xlink:to="lab_dva_SeniorSecuredCreditFacilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation_eadc9c1d-b53e-4aeb-aa3e-ce24d4fa759f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment, Owned, Accumulated Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_08813d63-7a2d-42fe-a41e-5277f1511e4d_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_923a7786-48af-4fdd-a045-8f0d179b6188_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:to="lab_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityNetIncome_7db18f97-694c-449b-97a4-b4fe261ba77a_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityNetIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityNetIncome_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityNetIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Net Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityNetIncome" xlink:to="lab_us-gaap_TemporaryEquityNetIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_14d10974-9eba-42a0-9810-e706815aea24_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt interest rate during period</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_233accd8-19c9-4d72-a979-f1e23114955d_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average effective interest rate during quarter</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR_0e26008e-8dc9-4aa6-b9f1-86cbc983902b_terseLabel_en-US" xlink:label="lab_dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt Outstanding Principal Balance Subject To LIBOR</link:label>
    <link:label id="lab_dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR_label_en-US" xlink:label="lab_dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt Outstanding Principal Balance Subject To LIBOR</link:label>
    <link:label id="lab_dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR_documentation_en-US" xlink:label="lab_dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt Outstanding Principal Balance Subject To LIBOR-based interest rate volatility.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR" xlink:href="dva-20220930.xsd#dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR" xlink:to="lab_dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_4755b03f-5a17-4e05-9081-210ba7c4801f_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate cap agreements</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges Including Portion Attributable to Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:to="lab_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_51294987-46db-4040-b5ad-abf20a78d55d_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (decrease) increase in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_CommitmentsToProvideOperatingCapitalMember_e5d473de-3f85-497d-8ba4-581b031fa91f_terseLabel_en-US" xlink:label="lab_dva_CommitmentsToProvideOperatingCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments to provide operating capital</link:label>
    <link:label id="lab_dva_CommitmentsToProvideOperatingCapitalMember_label_en-US" xlink:label="lab_dva_CommitmentsToProvideOperatingCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments To Provide Operating Capital [Member]</link:label>
    <link:label id="lab_dva_CommitmentsToProvideOperatingCapitalMember_documentation_en-US" xlink:label="lab_dva_CommitmentsToProvideOperatingCapitalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments to provide operating capital.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CommitmentsToProvideOperatingCapitalMember" xlink:href="dva-20220930.xsd#dva_CommitmentsToProvideOperatingCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_CommitmentsToProvideOperatingCapitalMember" xlink:to="lab_dva_CommitmentsToProvideOperatingCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsConsolidationItemsAxis_abb525eb-f45e-4f96-abbc-22747c81379c_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments Consolidation Items</link:label>
    <link:label id="lab_us-gaap_SubsegmentsConsolidationItemsAxis_label_en-US" xlink:label="lab_us-gaap_SubsegmentsConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsAxis" xlink:to="lab_us-gaap_SubsegmentsConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_0ed4d795-e73b-406f-8386-e13d6fc81d38_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_6adacb3a-a069-45dc-a225-45bc3ab45ed7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_FinanceLeaseMember_998c58d3-37ac-4b4c-858d-8ed5f0330ae2_verboseLabel_en-US" xlink:label="lab_dva_FinanceLeaseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing lease obligations</link:label>
    <link:label id="lab_dva_FinanceLeaseMember_label_en-US" xlink:label="lab_dva_FinanceLeaseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease [Member]</link:label>
    <link:label id="lab_dva_FinanceLeaseMember_documentation_en-US" xlink:label="lab_dva_FinanceLeaseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_FinanceLeaseMember" xlink:href="dva-20220930.xsd#dva_FinanceLeaseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_FinanceLeaseMember" xlink:to="lab_dva_FinanceLeaseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dd3ec455-79a8-45d5-9f6e-493cdc1e7510_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_1578ae40-e9a7-417f-a71f-a8d74655f103_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_fc2efdbe-5921-439e-a1a4-e3247f5d5d0f_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_5a9ee145-fbc2-49aa-a32d-5694cbbf45d3_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_4024ce57-540b-4eac-a3a7-c5f684fad26b_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_c5c291ee-db77-4548-845a-b0e0c0ef01ee_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies:</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsLineItems" xlink:to="lab_us-gaap_OtherCommitmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsDisclosureTextBlock_6dc7650d-f23f-41f5-9c96-c953b66f429a_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests subject to put provisions and other commitments</link:label>
    <link:label id="lab_us-gaap_CommitmentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_CorporateIntegrityAgreementExpirationDate_ed5b1a7a-8d94-4eef-9901-24307cf7e3bf_terseLabel_en-US" xlink:label="lab_dva_CorporateIntegrityAgreementExpirationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Integrity Agreement Expiration Date</link:label>
    <link:label id="lab_dva_CorporateIntegrityAgreementExpirationDate_label_en-US" xlink:label="lab_dva_CorporateIntegrityAgreementExpirationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Integrity Agreement Expiration Date</link:label>
    <link:label id="lab_dva_CorporateIntegrityAgreementExpirationDate_documentation_en-US" xlink:label="lab_dva_CorporateIntegrityAgreementExpirationDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Integrity Agreement Expiration Date, in CCYY-MM-DD format.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CorporateIntegrityAgreementExpirationDate" xlink:href="dva-20220930.xsd#dva_CorporateIntegrityAgreementExpirationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_CorporateIntegrityAgreementExpirationDate" xlink:to="lab_dva_CorporateIntegrityAgreementExpirationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_71a878aa-4581-46da-9e02-286a009df8f5_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_7e5d55cb-51c4-4264-9095-4b8a2980dd0a_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, weighted average interest rate, at point in time</link:label>
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_ad3c27da-9b54-45d1-a22d-93bf7e455dcb_verboseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average effective interest rate at quarter end</link:label>
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_label_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Weighted Average Interest Rate, at Point in Time</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:to="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_0f85806f-e9eb-4534-8391-64b283f1a9c3_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_ac6b98f6-a202-47bb-9f26-2bd55bb51195_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_0287dbf3-c01c-43b9-b0df-13761b585f7f_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of equity method investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember_43deebe2-eb14-4d91-af07-65556709bf83_terseLabel_en-US" xlink:label="lab_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Four Point Six Two Five Percent Due Twenty Thirty</link:label>
    <link:label id="lab_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember_label_en-US" xlink:label="lab_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Four Point Six Two Five Percent Due Twenty Thirty [Member]</link:label>
    <link:label id="lab_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember_documentation_en-US" xlink:label="lab_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes Four Point Six Two Five Percent Due Twenty Thirty member.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember" xlink:href="dva-20220930.xsd#dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember" xlink:to="lab_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_126a8e8e-d6ac-4df7-9348-ebc9c4e509f5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_34876858-4951-4e02-94cb-c14ef21010de_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investment income, net</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAbstract_5aab4af4-f45c-4cb8-b88e-698f46906354_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value [Abstract]</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAbstract_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAbstract" xlink:to="lab_us-gaap_TreasuryStockValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_08a20493-d94d-499e-a0cf-8772ef485e19_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_db73795d-cbf6-4a9a-ac68-86ef1186b777_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenditures for property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_87efbc34-409b-45fb-8cf6-b6aecd66bb08_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_d4344909-0032-4a30-b7ad-8053426f2f10_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>dva-20220930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:3a89ce86-098c-4ec0-abc8-dda3315bf074,g:fd665bd8-0744-46ac-b10f-ff3cbe103a81-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.davita.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="dva-20220930.xsd#DocumentandEntityInformation"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/DocumentandEntityInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_19476fc2-b82a-487a-a453-e0fa6ca4550b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_0a8b5b2a-e9a4-4f6c-b397-1dbc57f052f3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19476fc2-b82a-487a-a453-e0fa6ca4550b" xlink:to="loc_dei_DocumentType_0a8b5b2a-e9a4-4f6c-b397-1dbc57f052f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_2a7866cd-79f7-4665-933a-accd34b7b866" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19476fc2-b82a-487a-a453-e0fa6ca4550b" xlink:to="loc_dei_DocumentQuarterlyReport_2a7866cd-79f7-4665-933a-accd34b7b866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_39db9e48-03fd-4809-b994-c6dd9031d7d9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19476fc2-b82a-487a-a453-e0fa6ca4550b" xlink:to="loc_dei_DocumentPeriodEndDate_39db9e48-03fd-4809-b994-c6dd9031d7d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_52b08b62-c6b3-46ac-83d9-fc70a056d787" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19476fc2-b82a-487a-a453-e0fa6ca4550b" xlink:to="loc_dei_DocumentTransitionReport_52b08b62-c6b3-46ac-83d9-fc70a056d787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_ce1ea7cc-0a67-48e1-b1c7-a5de92dec916" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19476fc2-b82a-487a-a453-e0fa6ca4550b" xlink:to="loc_dei_EntityFileNumber_ce1ea7cc-0a67-48e1-b1c7-a5de92dec916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_91745aeb-9fe4-49f6-8521-d2cf5b248104" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19476fc2-b82a-487a-a453-e0fa6ca4550b" xlink:to="loc_dei_EntityRegistrantName_91745aeb-9fe4-49f6-8521-d2cf5b248104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_3a3383e6-ad5f-44ee-ba74-cde02e5b614f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19476fc2-b82a-487a-a453-e0fa6ca4550b" xlink:to="loc_dei_EntityIncorporationStateCountryCode_3a3383e6-ad5f-44ee-ba74-cde02e5b614f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_6b78bfbc-3994-491d-ba07-834752ee8686" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19476fc2-b82a-487a-a453-e0fa6ca4550b" xlink:to="loc_dei_EntityTaxIdentificationNumber_6b78bfbc-3994-491d-ba07-834752ee8686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_7103bc41-3be2-4d11-b325-4516902c03da" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19476fc2-b82a-487a-a453-e0fa6ca4550b" xlink:to="loc_dei_EntityAddressAddressLine1_7103bc41-3be2-4d11-b325-4516902c03da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_290b931f-4359-4c31-96d2-3361ed4822f7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19476fc2-b82a-487a-a453-e0fa6ca4550b" xlink:to="loc_dei_EntityAddressCityOrTown_290b931f-4359-4c31-96d2-3361ed4822f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_36450e3f-00f4-4e12-8f4f-79967f904498" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19476fc2-b82a-487a-a453-e0fa6ca4550b" xlink:to="loc_dei_EntityAddressStateOrProvince_36450e3f-00f4-4e12-8f4f-79967f904498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_c1e526ac-9501-445a-a003-72050631795f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19476fc2-b82a-487a-a453-e0fa6ca4550b" xlink:to="loc_dei_EntityAddressPostalZipCode_c1e526ac-9501-445a-a003-72050631795f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_c8dde888-cf4b-452f-bb9d-5b91a8c6bc6e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19476fc2-b82a-487a-a453-e0fa6ca4550b" xlink:to="loc_dei_CityAreaCode_c8dde888-cf4b-452f-bb9d-5b91a8c6bc6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_f98b974e-9478-4e8a-8f27-d9ef42924cbb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19476fc2-b82a-487a-a453-e0fa6ca4550b" xlink:to="loc_dei_LocalPhoneNumber_f98b974e-9478-4e8a-8f27-d9ef42924cbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_548978fb-8e5c-4f7a-8dc6-4cd171e0c3d8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19476fc2-b82a-487a-a453-e0fa6ca4550b" xlink:to="loc_dei_Security12bTitle_548978fb-8e5c-4f7a-8dc6-4cd171e0c3d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_983b8475-2b66-4288-a777-ce5aa0944c78" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19476fc2-b82a-487a-a453-e0fa6ca4550b" xlink:to="loc_dei_TradingSymbol_983b8475-2b66-4288-a777-ce5aa0944c78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_14d3d1fa-54d9-4076-9b05-779a887bcffd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19476fc2-b82a-487a-a453-e0fa6ca4550b" xlink:to="loc_dei_SecurityExchangeName_14d3d1fa-54d9-4076-9b05-779a887bcffd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_66c24145-eca4-484f-808e-5ed777d9989e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19476fc2-b82a-487a-a453-e0fa6ca4550b" xlink:to="loc_dei_EntityCurrentReportingStatus_66c24145-eca4-484f-808e-5ed777d9989e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_820906ae-37d5-4756-b0c7-32c21be2d6b4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19476fc2-b82a-487a-a453-e0fa6ca4550b" xlink:to="loc_dei_EntityInteractiveDataCurrent_820906ae-37d5-4756-b0c7-32c21be2d6b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_f907d9e5-8cac-462b-93c2-76b114598954" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19476fc2-b82a-487a-a453-e0fa6ca4550b" xlink:to="loc_dei_EntityFilerCategory_f907d9e5-8cac-462b-93c2-76b114598954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_df5422f8-3a12-4e62-bcee-8c00b866a283" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19476fc2-b82a-487a-a453-e0fa6ca4550b" xlink:to="loc_dei_EntitySmallBusiness_df5422f8-3a12-4e62-bcee-8c00b866a283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_02f01109-3bb8-44f6-a9ce-b344b619bee1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19476fc2-b82a-487a-a453-e0fa6ca4550b" xlink:to="loc_dei_EntityEmergingGrowthCompany_02f01109-3bb8-44f6-a9ce-b344b619bee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_9005887e-87ce-4c23-b043-aa4496c8ed57" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19476fc2-b82a-487a-a453-e0fa6ca4550b" xlink:to="loc_dei_EntityShellCompany_9005887e-87ce-4c23-b043-aa4496c8ed57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_297bb8e2-db01-4d9a-9e0f-e0ce1df2f3f0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19476fc2-b82a-487a-a453-e0fa6ca4550b" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_297bb8e2-db01-4d9a-9e0f-e0ce1df2f3f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_ba84caee-b3c1-47bd-a79e-7545d750c1e5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19476fc2-b82a-487a-a453-e0fa6ca4550b" xlink:to="loc_dei_AmendmentFlag_ba84caee-b3c1-47bd-a79e-7545d750c1e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_fd122c93-b206-4ffd-a45d-9c0fc26a8e00" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19476fc2-b82a-487a-a453-e0fa6ca4550b" xlink:to="loc_dei_DocumentFiscalYearFocus_fd122c93-b206-4ffd-a45d-9c0fc26a8e00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_c20d343b-b992-45fe-9ee8-5f73ee95bc4e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19476fc2-b82a-487a-a453-e0fa6ca4550b" xlink:to="loc_dei_DocumentFiscalPeriodFocus_c20d343b-b992-45fe-9ee8-5f73ee95bc4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_3ef1a07f-0d37-4879-af6d-0c3076b53325" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19476fc2-b82a-487a-a453-e0fa6ca4550b" xlink:to="loc_dei_EntityCentralIndexKey_3ef1a07f-0d37-4879-af6d-0c3076b53325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_cadbb83a-3ff7-4d2e-aceb-cf5f50dff41d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_19476fc2-b82a-487a-a453-e0fa6ca4550b" xlink:to="loc_dei_CurrentFiscalYearEndDate_cadbb83a-3ff7-4d2e-aceb-cf5f50dff41d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited" xlink:type="simple" xlink:href="dva-20220930.xsd#CONSOLIDATEDSTATEMENTSOFINCOMEunaudited"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_bde9c8b3-0b04-4407-8b04-c992ecb4dcae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts_9327254e-1da2-4767-a932-89da031eefcc" xlink:href="dva-20220930.xsd#dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_bde9c8b3-0b04-4407-8b04-c992ecb4dcae" xlink:to="loc_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts_9327254e-1da2-4767-a932-89da031eefcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_06ea5574-bbcc-45a6-9b48-aaf674379797" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_bde9c8b3-0b04-4407-8b04-c992ecb4dcae" xlink:to="loc_us-gaap_OtherIncome_06ea5574-bbcc-45a6-9b48-aaf674379797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_78cbbb74-f3b2-416a-9d99-88a579fcd4a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_bde9c8b3-0b04-4407-8b04-c992ecb4dcae" xlink:to="loc_us-gaap_Revenues_78cbbb74-f3b2-416a-9d99-88a579fcd4a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_41f2fbbf-afc7-4c6b-a98a-fd6a1343ea8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_bde9c8b3-0b04-4407-8b04-c992ecb4dcae" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_41f2fbbf-afc7-4c6b-a98a-fd6a1343ea8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PatientCareCosts_66200060-cd6e-4d61-954c-f6d9fcc59359" xlink:href="dva-20220930.xsd#dva_PatientCareCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_41f2fbbf-afc7-4c6b-a98a-fd6a1343ea8f" xlink:to="loc_dva_PatientCareCosts_66200060-cd6e-4d61-954c-f6d9fcc59359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_7a5ebbef-ee7d-4aee-a75c-11a5badc0bc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_41f2fbbf-afc7-4c6b-a98a-fd6a1343ea8f" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_7a5ebbef-ee7d-4aee-a75c-11a5badc0bc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_1164c995-4730-4c00-9013-07db0c108d36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_41f2fbbf-afc7-4c6b-a98a-fd6a1343ea8f" xlink:to="loc_us-gaap_DepreciationAndAmortization_1164c995-4730-4c00-9013-07db0c108d36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_7ca0efa3-d254-4756-b6c1-549a292b9d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_41f2fbbf-afc7-4c6b-a98a-fd6a1343ea8f" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_7ca0efa3-d254-4756-b6c1-549a292b9d3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_72d3b997-5af4-4330-ab52-3dfabc349beb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_41f2fbbf-afc7-4c6b-a98a-fd6a1343ea8f" xlink:to="loc_us-gaap_CostsAndExpenses_72d3b997-5af4-4330-ab52-3dfabc349beb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_46215c3c-9743-4359-9ea1-2ac3d7397bbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_bde9c8b3-0b04-4407-8b04-c992ecb4dcae" xlink:to="loc_us-gaap_OperatingIncomeLoss_46215c3c-9743-4359-9ea1-2ac3d7397bbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense_b57acee9-f53d-4a6a-8af2-f9d50788c628" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_bde9c8b3-0b04-4407-8b04-c992ecb4dcae" xlink:to="loc_us-gaap_InterestAndDebtExpense_b57acee9-f53d-4a6a-8af2-f9d50788c628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_048edca5-711f-4b15-bf85-ff6c10dfe9c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_bde9c8b3-0b04-4407-8b04-c992ecb4dcae" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_048edca5-711f-4b15-bf85-ff6c10dfe9c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e1d63117-fa6e-47a6-baf9-4c57e3b3a262" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_bde9c8b3-0b04-4407-8b04-c992ecb4dcae" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e1d63117-fa6e-47a6-baf9-4c57e3b3a262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ba8b6a0c-6fef-4e52-b157-64546603f3ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_bde9c8b3-0b04-4407-8b04-c992ecb4dcae" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ba8b6a0c-6fef-4e52-b157-64546603f3ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_ad281d79-3088-447d-9369-338bb03475d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_bde9c8b3-0b04-4407-8b04-c992ecb4dcae" xlink:to="loc_us-gaap_ProfitLoss_ad281d79-3088-447d-9369-338bb03475d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_50d40fb2-5039-4406-bb0b-3a0cab562f2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_bde9c8b3-0b04-4407-8b04-c992ecb4dcae" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_50d40fb2-5039-4406-bb0b-3a0cab562f2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_95e98b1f-84f5-489f-90a0-1c7dc363b07d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_bde9c8b3-0b04-4407-8b04-c992ecb4dcae" xlink:to="loc_us-gaap_NetIncomeLoss_95e98b1f-84f5-489f-90a0-1c7dc363b07d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_5049c67c-7804-4821-8302-5f6c1e2e1022" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_bde9c8b3-0b04-4407-8b04-c992ecb4dcae" xlink:to="loc_us-gaap_EarningsPerShareAbstract_5049c67c-7804-4821-8302-5f6c1e2e1022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_653acc09-a243-4879-8158-40929560dce2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5049c67c-7804-4821-8302-5f6c1e2e1022" xlink:to="loc_us-gaap_EarningsPerShareBasic_653acc09-a243-4879-8158-40929560dce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_4c53fa1b-aabe-49dd-96c1-4cfb4016a646" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5049c67c-7804-4821-8302-5f6c1e2e1022" xlink:to="loc_us-gaap_EarningsPerShareDiluted_4c53fa1b-aabe-49dd-96c1-4cfb4016a646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_3b3be86b-9441-473f-a44f-5b29c7b2b866" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_bde9c8b3-0b04-4407-8b04-c992ecb4dcae" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_3b3be86b-9441-473f-a44f-5b29c7b2b866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_59af2ea0-25cf-4592-bc50-91cb36f6cb53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_3b3be86b-9441-473f-a44f-5b29c7b2b866" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_59af2ea0-25cf-4592-bc50-91cb36f6cb53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_635ea51a-bf41-48a5-900c-1e81cb46511d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_3b3be86b-9441-473f-a44f-5b29c7b2b866" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_635ea51a-bf41-48a5-900c-1e81cb46511d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited" xlink:type="simple" xlink:href="dva-20220930.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c4489a16-cbe2-4484-b067-b5a846b4d6b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_64e55478-774b-4151-89a5-4e90a0f81368" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c4489a16-cbe2-4484-b067-b5a846b4d6b8" xlink:to="loc_us-gaap_ProfitLoss_64e55478-774b-4151-89a5-4e90a0f81368" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_f7cbea7d-4197-4823-9e37-2901f2cf8037" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c4489a16-cbe2-4484-b067-b5a846b4d6b8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_f7cbea7d-4197-4823-9e37-2901f2cf8037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_4429a8d5-6048-44cf-9fa7-c6c92db5e9f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_f7cbea7d-4197-4823-9e37-2901f2cf8037" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_4429a8d5-6048-44cf-9fa7-c6c92db5e9f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_544118ae-d3d0-48ae-9b9b-cd625c4b7dbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c4489a16-cbe2-4484-b067-b5a846b4d6b8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_544118ae-d3d0-48ae-9b9b-cd625c4b7dbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_9ff6205e-651c-45a6-929a-df3408c6f170" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c4489a16-cbe2-4484-b067-b5a846b4d6b8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_9ff6205e-651c-45a6-929a-df3408c6f170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_c81e1038-66e5-4fae-8ae5-a00d47f1fbb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c4489a16-cbe2-4484-b067-b5a846b4d6b8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_c81e1038-66e5-4fae-8ae5-a00d47f1fbb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9a2b5018-e4f4-4499-ae39-fb16776558d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c4489a16-cbe2-4484-b067-b5a846b4d6b8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9a2b5018-e4f4-4499-ae39-fb16776558d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_6355ae13-5256-46f8-ba46-b838450ac34a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c4489a16-cbe2-4484-b067-b5a846b4d6b8" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_6355ae13-5256-46f8-ba46-b838450ac34a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_b24f811a-f74c-4257-a84c-62039e3d1a25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c4489a16-cbe2-4484-b067-b5a846b4d6b8" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_b24f811a-f74c-4257-a84c-62039e3d1a25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_c24912e3-f8a3-47be-bfa4-eeee6ae42b96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c4489a16-cbe2-4484-b067-b5a846b4d6b8" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_c24912e3-f8a3-47be-bfa4-eeee6ae42b96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited" xlink:type="simple" xlink:href="dva-20220930.xsd#CONSOLIDATEDBALANCESHEETSunaudited"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_ffc2f306-dd21-4082-a44d-6d2b2faddb76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_61710709-c126-4ebe-b25e-28f9f5cb62b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ffc2f306-dd21-4082-a44d-6d2b2faddb76" xlink:to="loc_us-gaap_AssetsAbstract_61710709-c126-4ebe-b25e-28f9f5cb62b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_556955eb-ae50-4cd7-9e98-fc429a90a573" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_61710709-c126-4ebe-b25e-28f9f5cb62b1" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_556955eb-ae50-4cd7-9e98-fc429a90a573" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_69a51af1-a34d-4b89-87cc-449c74b8a328" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_61710709-c126-4ebe-b25e-28f9f5cb62b1" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_69a51af1-a34d-4b89-87cc-449c74b8a328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_22ce1326-0774-4524-9f4f-12eac6c267b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_61710709-c126-4ebe-b25e-28f9f5cb62b1" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_22ce1326-0774-4524-9f4f-12eac6c267b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_eeeee08f-f7b9-4d18-b6d1-de709f4128ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_61710709-c126-4ebe-b25e-28f9f5cb62b1" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_eeeee08f-f7b9-4d18-b6d1-de709f4128ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_d20d7327-a8c4-4130-a996-7b792ce18983" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_61710709-c126-4ebe-b25e-28f9f5cb62b1" xlink:to="loc_us-gaap_InventoryNet_d20d7327-a8c4-4130-a996-7b792ce18983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_6e36cc2e-fef0-48e9-acca-9b6b6b10e79d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_61710709-c126-4ebe-b25e-28f9f5cb62b1" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_6e36cc2e-fef0-48e9-acca-9b6b6b10e79d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_62c612e7-4e2a-441d-a773-a5c6728b33a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_61710709-c126-4ebe-b25e-28f9f5cb62b1" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_62c612e7-4e2a-441d-a773-a5c6728b33a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_93478aef-1a1a-4270-af69-861ad61ae508" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_61710709-c126-4ebe-b25e-28f9f5cb62b1" xlink:to="loc_us-gaap_IncomeTaxesReceivable_93478aef-1a1a-4270-af69-861ad61ae508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_f74094b0-336a-4565-954f-4782f1a45be1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_61710709-c126-4ebe-b25e-28f9f5cb62b1" xlink:to="loc_us-gaap_AssetsCurrent_f74094b0-336a-4565-954f-4782f1a45be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a8e4b02f-5a4c-4036-87ab-19a5760ca2f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_61710709-c126-4ebe-b25e-28f9f5cb62b1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_a8e4b02f-5a4c-4036-87ab-19a5760ca2f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_c35fd2f8-70e6-4110-b364-f06eea976044" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_61710709-c126-4ebe-b25e-28f9f5cb62b1" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_c35fd2f8-70e6-4110-b364-f06eea976044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b65145fd-97bb-43f8-ae1b-d406ed552a38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_61710709-c126-4ebe-b25e-28f9f5cb62b1" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b65145fd-97bb-43f8-ae1b-d406ed552a38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_01a56d94-bf84-4e67-b9dd-591adfdd163a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_61710709-c126-4ebe-b25e-28f9f5cb62b1" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_01a56d94-bf84-4e67-b9dd-591adfdd163a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_5b80db79-8f20-4eb8-a676-68abbb0aacac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_61710709-c126-4ebe-b25e-28f9f5cb62b1" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_5b80db79-8f20-4eb8-a676-68abbb0aacac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_0c069bc7-3ef8-436f-9242-6f17fa8cf0c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_61710709-c126-4ebe-b25e-28f9f5cb62b1" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_0c069bc7-3ef8-436f-9242-6f17fa8cf0c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ae0890af-a5bb-4c50-88ec-269d8d9e3087" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_61710709-c126-4ebe-b25e-28f9f5cb62b1" xlink:to="loc_us-gaap_Goodwill_ae0890af-a5bb-4c50-88ec-269d8d9e3087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_966aa591-f519-4878-8cb4-fd40b11b158c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_61710709-c126-4ebe-b25e-28f9f5cb62b1" xlink:to="loc_us-gaap_Assets_966aa591-f519-4878-8cb4-fd40b11b158c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_10e8298c-d5a3-4979-95d2-7406b73f236a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ffc2f306-dd21-4082-a44d-6d2b2faddb76" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_10e8298c-d5a3-4979-95d2-7406b73f236a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_88d05859-ee21-45ed-af51-ce56aa9778b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_10e8298c-d5a3-4979-95d2-7406b73f236a" xlink:to="loc_us-gaap_AccountsPayableCurrent_88d05859-ee21-45ed-af51-ce56aa9778b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_4c274f42-bb8c-4385-9bb1-af50b728b1ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_10e8298c-d5a3-4979-95d2-7406b73f236a" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_4c274f42-bb8c-4385-9bb1-af50b728b1ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_8e922b9a-6ab5-4a8a-a910-a6b6183cbe09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_10e8298c-d5a3-4979-95d2-7406b73f236a" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_8e922b9a-6ab5-4a8a-a910-a6b6183cbe09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_91273e3c-251a-498a-b4d7-7fca8de92b5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_10e8298c-d5a3-4979-95d2-7406b73f236a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_91273e3c-251a-498a-b4d7-7fca8de92b5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_4756c877-97f7-48c3-80db-de30213c5e43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_10e8298c-d5a3-4979-95d2-7406b73f236a" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_4756c877-97f7-48c3-80db-de30213c5e43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_4ee14171-4018-47bb-bb48-b644fccf7313" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_10e8298c-d5a3-4979-95d2-7406b73f236a" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_4ee14171-4018-47bb-bb48-b644fccf7313" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_d92bba8b-05df-4b4c-8f4c-d203a28b7e1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_10e8298c-d5a3-4979-95d2-7406b73f236a" xlink:to="loc_us-gaap_LiabilitiesCurrent_d92bba8b-05df-4b4c-8f4c-d203a28b7e1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b0d6ff37-63eb-445a-981f-cafb519a42a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_10e8298c-d5a3-4979-95d2-7406b73f236a" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b0d6ff37-63eb-445a-981f-cafb519a42a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_cac18906-a41b-49a9-bf32-cd370e0f8d46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_10e8298c-d5a3-4979-95d2-7406b73f236a" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_cac18906-a41b-49a9-bf32-cd370e0f8d46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_a75f4158-0deb-4023-aa36-e5c86d2df619" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_10e8298c-d5a3-4979-95d2-7406b73f236a" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_a75f4158-0deb-4023-aa36-e5c86d2df619" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_0cffb1d6-a495-4806-bbef-632b58d658c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_10e8298c-d5a3-4979-95d2-7406b73f236a" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_0cffb1d6-a495-4806-bbef-632b58d658c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_4a7b2dae-1825-4c6d-ad87-f16e48c6c91d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_10e8298c-d5a3-4979-95d2-7406b73f236a" xlink:to="loc_us-gaap_Liabilities_4a7b2dae-1825-4c6d-ad87-f16e48c6c91d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_089f2ff8-4b98-47c2-a06d-94fc010b7cd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_10e8298c-d5a3-4979-95d2-7406b73f236a" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_089f2ff8-4b98-47c2-a06d-94fc010b7cd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_f791d00d-1423-42ee-83a3-d673b58259ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_089f2ff8-4b98-47c2-a06d-94fc010b7cd3" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_f791d00d-1423-42ee-83a3-d673b58259ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_19b66fb2-475b-4a16-b6b6-866be3f2e7f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_10e8298c-d5a3-4979-95d2-7406b73f236a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_19b66fb2-475b-4a16-b6b6-866be3f2e7f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_ed892cc7-7d16-4f34-8b1c-696818831ceb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_19b66fb2-475b-4a16-b6b6-866be3f2e7f8" xlink:to="loc_us-gaap_PreferredStockValue_ed892cc7-7d16-4f34-8b1c-696818831ceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_f8dca9e9-be7e-4643-bd55-c3537bf77367" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_19b66fb2-475b-4a16-b6b6-866be3f2e7f8" xlink:to="loc_us-gaap_CommonStockValue_f8dca9e9-be7e-4643-bd55-c3537bf77367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_39633a28-1811-4544-9e94-368e296e10f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_19b66fb2-475b-4a16-b6b6-866be3f2e7f8" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_39633a28-1811-4544-9e94-368e296e10f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a1ccca6d-d1c8-49cf-ac65-a134a004931b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_19b66fb2-475b-4a16-b6b6-866be3f2e7f8" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a1ccca6d-d1c8-49cf-ac65-a134a004931b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_dcb95afb-6a98-42a0-9375-3f40bd229be9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_19b66fb2-475b-4a16-b6b6-866be3f2e7f8" xlink:to="loc_us-gaap_TreasuryStockValue_dcb95afb-6a98-42a0-9375-3f40bd229be9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b28acc8f-e215-4838-ba35-981152bcbebd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_19b66fb2-475b-4a16-b6b6-866be3f2e7f8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b28acc8f-e215-4838-ba35-981152bcbebd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_baae2d57-a3dd-4d81-bbb8-78551a45479a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_19b66fb2-475b-4a16-b6b6-866be3f2e7f8" xlink:to="loc_us-gaap_StockholdersEquity_baae2d57-a3dd-4d81-bbb8-78551a45479a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_9a3b28cf-0000-4dca-84be-f4b5b6163edf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_19b66fb2-475b-4a16-b6b6-866be3f2e7f8" xlink:to="loc_us-gaap_MinorityInterest_9a3b28cf-0000-4dca-84be-f4b5b6163edf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_17dabfa2-31de-4df7-821d-a0b569bc47d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_19b66fb2-475b-4a16-b6b6-866be3f2e7f8" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_17dabfa2-31de-4df7-821d-a0b569bc47d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_5a4f9cc7-8acd-4d0a-a254-7b2538ad07df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_10e8298c-d5a3-4979-95d2-7406b73f236a" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_5a4f9cc7-8acd-4d0a-a254-7b2538ad07df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunauditedParenthetical" xlink:type="simple" xlink:href="dva-20220930.xsd#CONSOLIDATEDBALANCESHEETSunauditedParenthetical"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_d1d55494-e1d2-46a3-a8b3-8f597062fa58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation_62f40b57-1b6f-4ae4-9636-4ea7bb31c74a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d1d55494-e1d2-46a3-a8b3-8f597062fa58" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation_62f40b57-1b6f-4ae4-9636-4ea7bb31c74a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_19dc4972-ccb4-4e68-b737-eb2a417fe4a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d1d55494-e1d2-46a3-a8b3-8f597062fa58" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_19dc4972-ccb4-4e68-b737-eb2a417fe4a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_3d22ce53-b10e-4093-b510-947f22d0f54f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d1d55494-e1d2-46a3-a8b3-8f597062fa58" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_3d22ce53-b10e-4093-b510-947f22d0f54f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_5960e90b-86b9-4617-bda7-7c6ad012254b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d1d55494-e1d2-46a3-a8b3-8f597062fa58" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_5960e90b-86b9-4617-bda7-7c6ad012254b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_00a47862-7585-4434-905a-90ef6b75a388" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d1d55494-e1d2-46a3-a8b3-8f597062fa58" xlink:to="loc_us-gaap_PreferredStockSharesIssued_00a47862-7585-4434-905a-90ef6b75a388" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_e00234df-ea9e-4001-ad26-0f53dd5b250c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d1d55494-e1d2-46a3-a8b3-8f597062fa58" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_e00234df-ea9e-4001-ad26-0f53dd5b250c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_41998aab-c6b4-421a-ad39-0055fa60097b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d1d55494-e1d2-46a3-a8b3-8f597062fa58" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_41998aab-c6b4-421a-ad39-0055fa60097b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_2b6ad449-83f2-4987-b834-f23d8b08aea1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d1d55494-e1d2-46a3-a8b3-8f597062fa58" xlink:to="loc_us-gaap_CommonStockSharesIssued_2b6ad449-83f2-4987-b834-f23d8b08aea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_391d7395-e502-49ec-996a-d063bcf7ae6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d1d55494-e1d2-46a3-a8b3-8f597062fa58" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_391d7395-e502-49ec-996a-d063bcf7ae6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_f23f9c99-0ec9-43a0-889e-7f47ad35e08c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d1d55494-e1d2-46a3-a8b3-8f597062fa58" xlink:to="loc_us-gaap_TreasuryStockCommonShares_f23f9c99-0ec9-43a0-889e-7f47ad35e08c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited" xlink:type="simple" xlink:href="dva-20220930.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_7da3ac46-bca0-4d9d-ba39-ce8d23ab8dac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_b8baec48-f4e2-49da-9246-d29b0524d48d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7da3ac46-bca0-4d9d-ba39-ce8d23ab8dac" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_b8baec48-f4e2-49da-9246-d29b0524d48d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_1f6970f4-e072-488e-a06a-bf7ecc6f69a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_b8baec48-f4e2-49da-9246-d29b0524d48d" xlink:to="loc_us-gaap_ProfitLoss_1f6970f4-e072-488e-a06a-bf7ecc6f69a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9e8e1177-3027-49cf-b4f9-94ef1394f23f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_b8baec48-f4e2-49da-9246-d29b0524d48d" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9e8e1177-3027-49cf-b4f9-94ef1394f23f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet_319e961a-b869-450d-83f5-7e0612ae98ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9e8e1177-3027-49cf-b4f9-94ef1394f23f" xlink:to="loc_us-gaap_DepreciationAmortizationAndAccretionNet_319e961a-b869-450d-83f5-7e0612ae98ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_d543ea71-4682-4010-9cfb-20ec29217560" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9e8e1177-3027-49cf-b4f9-94ef1394f23f" xlink:to="loc_us-gaap_ShareBasedCompensation_d543ea71-4682-4010-9cfb-20ec29217560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_ed111b55-654a-43f2-afd5-d1d1a7a64121" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9e8e1177-3027-49cf-b4f9-94ef1394f23f" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_ed111b55-654a-43f2-afd5-d1d1a7a64121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_416b1a4e-86f6-4272-a270-2ed4259a8ce4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9e8e1177-3027-49cf-b4f9-94ef1394f23f" xlink:to="loc_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi_416b1a4e-86f6-4272-a270-2ed4259a8ce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_6223e1c5-79fa-4508-80ee-25d72e92b6b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9e8e1177-3027-49cf-b4f9-94ef1394f23f" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_6223e1c5-79fa-4508-80ee-25d72e92b6b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ed35606f-74d6-4a3b-99f7-aac3f594d1d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_9e8e1177-3027-49cf-b4f9-94ef1394f23f" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ed35606f-74d6-4a3b-99f7-aac3f594d1d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_58ff8777-3244-4e35-a3a2-f7cb49f68a0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ed35606f-74d6-4a3b-99f7-aac3f594d1d0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_58ff8777-3244-4e35-a3a2-f7cb49f68a0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_29adefb5-2995-45cb-879d-1867c92d5548" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ed35606f-74d6-4a3b-99f7-aac3f594d1d0" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_29adefb5-2995-45cb-879d-1867c92d5548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets_42dd0655-ca09-40ed-8fba-2a5b99e31b05" xlink:href="dva-20220930.xsd#dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ed35606f-74d6-4a3b-99f7-aac3f594d1d0" xlink:to="loc_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets_42dd0655-ca09-40ed-8fba-2a5b99e31b05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_aceaa3dc-d2f8-485a-a68d-f42a3540c191" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ed35606f-74d6-4a3b-99f7-aac3f594d1d0" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_aceaa3dc-d2f8-485a-a68d-f42a3540c191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_eb37a3e4-ae36-4662-9d5a-58a9544edf1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ed35606f-74d6-4a3b-99f7-aac3f594d1d0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_eb37a3e4-ae36-4662-9d5a-58a9544edf1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_993a3c99-4196-42fe-8cb0-93e84d065cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ed35606f-74d6-4a3b-99f7-aac3f594d1d0" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_993a3c99-4196-42fe-8cb0-93e84d065cf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_5887f2dc-6f7a-43ca-9126-cd957abc769e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ed35606f-74d6-4a3b-99f7-aac3f594d1d0" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_5887f2dc-6f7a-43ca-9126-cd957abc769e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_63d4aee9-fd23-4f3e-b0c6-529199f6807d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ed35606f-74d6-4a3b-99f7-aac3f594d1d0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_63d4aee9-fd23-4f3e-b0c6-529199f6807d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_6356621c-8944-4f82-82ac-343ce04fe28c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ed35606f-74d6-4a3b-99f7-aac3f594d1d0" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_6356621c-8944-4f82-82ac-343ce04fe28c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4cdc761c-c933-43be-8171-01522c7e6594" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_b8baec48-f4e2-49da-9246-d29b0524d48d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4cdc761c-c933-43be-8171-01522c7e6594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_0f260948-3f45-4fe3-9e99-e4f681870a88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7da3ac46-bca0-4d9d-ba39-ce8d23ab8dac" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_0f260948-3f45-4fe3-9e99-e4f681870a88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d0f30315-ff59-40f4-b5c2-32ba73c16712" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_0f260948-3f45-4fe3-9e99-e4f681870a88" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d0f30315-ff59-40f4-b5c2-32ba73c16712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_a08f1cd0-d203-4dde-9d19-dee6efd7f344" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_0f260948-3f45-4fe3-9e99-e4f681870a88" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_a08f1cd0-d203-4dde-9d19-dee6efd7f344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_740f4035-fffc-4d1d-a3ac-6f6040fe40ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_0f260948-3f45-4fe3-9e99-e4f681870a88" xlink:to="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_740f4035-fffc-4d1d-a3ac-6f6040fe40ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_886e1b3f-d8da-4e46-a2f4-9925d034e463" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireHeldToMaturitySecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_0f260948-3f45-4fe3-9e99-e4f681870a88" xlink:to="loc_us-gaap_PaymentsToAcquireHeldToMaturitySecurities_886e1b3f-d8da-4e46-a2f4-9925d034e463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherInvestments_c1e400c6-6bad-47f7-a02e-c5d79cb9bd12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireOtherInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_0f260948-3f45-4fe3-9e99-e4f681870a88" xlink:to="loc_us-gaap_PaymentsToAcquireOtherInvestments_c1e400c6-6bad-47f7-a02e-c5d79cb9bd12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_101ed89e-5ca4-43b6-8c8d-acaed4effd67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_0f260948-3f45-4fe3-9e99-e4f681870a88" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities_101ed89e-5ca4-43b6-8c8d-acaed4effd67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments_83492723-fa65-40e5-abb5-3849bcc645e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_0f260948-3f45-4fe3-9e99-e4f681870a88" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments_83492723-fa65-40e5-abb5-3849bcc645e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_70ed8d57-f721-4c10-bc39-f2adfcb133bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_0f260948-3f45-4fe3-9e99-e4f681870a88" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_70ed8d57-f721-4c10-bc39-f2adfcb133bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_b7e6562b-7638-4e7e-a440-65f2a3c3fca1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_0f260948-3f45-4fe3-9e99-e4f681870a88" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_b7e6562b-7638-4e7e-a440-65f2a3c3fca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_50f40543-4280-48e9-9019-16c78f77bb65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_0f260948-3f45-4fe3-9e99-e4f681870a88" xlink:to="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_50f40543-4280-48e9-9019-16c78f77bb65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1669cb0a-76cb-417e-8c83-a5b8ea793098" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_0f260948-3f45-4fe3-9e99-e4f681870a88" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1669cb0a-76cb-417e-8c83-a5b8ea793098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_88639fab-5439-4350-8ced-c737d2924918" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7da3ac46-bca0-4d9d-ba39-ce8d23ab8dac" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_88639fab-5439-4350-8ced-c737d2924918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_823f5b6b-374d-49a1-b4a8-b506ce4a535c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_88639fab-5439-4350-8ced-c737d2924918" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_823f5b6b-374d-49a1-b4a8-b506ce4a535c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_5f0ca020-156f-4ca1-878d-6fccdca5c599" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_88639fab-5439-4350-8ced-c737d2924918" xlink:to="loc_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations_5f0ca020-156f-4ca1-878d-6fccdca5c599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_dd7038cf-5092-41d2-8561-d49c966db534" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_88639fab-5439-4350-8ced-c737d2924918" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_dd7038cf-5092-41d2-8561-d49c966db534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_3085c73e-6045-4a2b-8da5-4b437007023c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_88639fab-5439-4350-8ced-c737d2924918" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_3085c73e-6045-4a2b-8da5-4b437007023c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDistributionsToAffiliates_61926756-9515-4cb1-955b-c2deef9b77e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDistributionsToAffiliates"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_88639fab-5439-4350-8ced-c737d2924918" xlink:to="loc_us-gaap_PaymentsOfDistributionsToAffiliates_61926756-9515-4cb1-955b-c2deef9b77e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_ab16664e-4715-42a3-91a9-1c7647d9dacd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_88639fab-5439-4350-8ced-c737d2924918" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_ab16664e-4715-42a3-91a9-1c7647d9dacd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromContributionsFromAffiliates_88ab7fcf-0c03-4419-b834-738f92c31704" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromContributionsFromAffiliates"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_88639fab-5439-4350-8ced-c737d2924918" xlink:to="loc_us-gaap_ProceedsFromContributionsFromAffiliates_88ab7fcf-0c03-4419-b834-738f92c31704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders_2d384316-225e-47d8-8cb9-8c1e339ecb9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_88639fab-5439-4350-8ced-c737d2924918" xlink:to="loc_us-gaap_ProceedsFromMinorityShareholders_2d384316-225e-47d8-8cb9-8c1e339ecb9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_bbab7e52-318b-49b9-b318-d455313aff03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_88639fab-5439-4350-8ced-c737d2924918" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_bbab7e52-318b-49b9-b318-d455313aff03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a67804bf-3715-4b75-aea7-1d243ee35301" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_88639fab-5439-4350-8ced-c737d2924918" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a67804bf-3715-4b75-aea7-1d243ee35301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f891025c-e12f-46be-a5dd-77fba1d2c710" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7da3ac46-bca0-4d9d-ba39-ce8d23ab8dac" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f891025c-e12f-46be-a5dd-77fba1d2c710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_307b6c1a-1823-488d-a5c6-2c2106ea1614" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7da3ac46-bca0-4d9d-ba39-ce8d23ab8dac" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_307b6c1a-1823-488d-a5c6-2c2106ea1614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_87438bca-4728-428e-999e-b5f9d0c5bb8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7da3ac46-bca0-4d9d-ba39-ce8d23ab8dac" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_87438bca-4728-428e-999e-b5f9d0c5bb8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_47c5ec5f-2cdb-478b-9393-c67ce5d553d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_7da3ac46-bca0-4d9d-ba39-ce8d23ab8dac" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_47c5ec5f-2cdb-478b-9393-c67ce5d553d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited" xlink:type="simple" xlink:href="dva-20220930.xsd#CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_c6cee931-1070-4450-8c0b-49d19ab109fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_bd907106-f56b-4a10-a19a-8f43f3439fe7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_c6cee931-1070-4450-8c0b-49d19ab109fe" xlink:to="loc_us-gaap_StatementTable_bd907106-f56b-4a10-a19a-8f43f3439fe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_2c6dc38b-a712-48cd-af72-ae578d2e5a53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_bd907106-f56b-4a10-a19a-8f43f3439fe7" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_2c6dc38b-a712-48cd-af72-ae578d2e5a53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a2950e8f-75fb-4091-8f8b-3963def83732" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_2c6dc38b-a712-48cd-af72-ae578d2e5a53" xlink:to="loc_us-gaap_EquityComponentDomain_a2950e8f-75fb-4091-8f8b-3963def83732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_d6afdae9-da9f-44bd-9e5a-a40631dfaa85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a2950e8f-75fb-4091-8f8b-3963def83732" xlink:to="loc_us-gaap_ParentMember_d6afdae9-da9f-44bd-9e5a-a40631dfaa85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember_d0150351-9c2f-425f-b52b-68abf4e28a53" xlink:href="dva-20220930.xsd#dva_TemporaryEquityRedeemableNoncontrollingInterestsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_d6afdae9-da9f-44bd-9e5a-a40631dfaa85" xlink:to="loc_dva_TemporaryEquityRedeemableNoncontrollingInterestsMember_d0150351-9c2f-425f-b52b-68abf4e28a53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_2b365e1d-8333-4e82-86dc-57495bcd8739" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_d6afdae9-da9f-44bd-9e5a-a40631dfaa85" xlink:to="loc_us-gaap_CommonStockMember_2b365e1d-8333-4e82-86dc-57495bcd8739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_575e6b4b-4c9d-44c8-a78a-6e162ded5d66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_d6afdae9-da9f-44bd-9e5a-a40631dfaa85" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_575e6b4b-4c9d-44c8-a78a-6e162ded5d66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_e1694008-17c6-4a8d-9e7b-5f005380fd10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_d6afdae9-da9f-44bd-9e5a-a40631dfaa85" xlink:to="loc_us-gaap_RetainedEarningsMember_e1694008-17c6-4a8d-9e7b-5f005380fd10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_4306c494-bfff-4c0b-bf1a-f72cf9b832c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_d6afdae9-da9f-44bd-9e5a-a40631dfaa85" xlink:to="loc_us-gaap_TreasuryStockMember_4306c494-bfff-4c0b-bf1a-f72cf9b832c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4f073c4f-e2a3-43b6-970e-6998759845fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_d6afdae9-da9f-44bd-9e5a-a40631dfaa85" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4f073c4f-e2a3-43b6-970e-6998759845fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_c026998b-e4a2-4761-8347-9f1756745a2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_d6afdae9-da9f-44bd-9e5a-a40631dfaa85" xlink:to="loc_us-gaap_NoncontrollingInterestMember_c026998b-e4a2-4761-8347-9f1756745a2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_d8772d2b-8cd2-46e4-8c0c-cc88b12e420a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_bd907106-f56b-4a10-a19a-8f43f3439fe7" xlink:to="loc_us-gaap_StatementLineItems_d8772d2b-8cd2-46e4-8c0c-cc88b12e420a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_8045dc24-89c2-4873-8bc1-57033791957c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d8772d2b-8cd2-46e4-8c0c-cc88b12e420a" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_8045dc24-89c2-4873-8bc1-57033791957c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_3cdcd862-2cda-4f2f-9fac-fb3519c3280c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_8045dc24-89c2-4873-8bc1-57033791957c" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_3cdcd862-2cda-4f2f-9fac-fb3519c3280c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome_abd28d80-41ce-4229-bd28-bddff82b40f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_8045dc24-89c2-4873-8bc1-57033791957c" xlink:to="loc_us-gaap_TemporaryEquityNetIncome_abd28d80-41ce-4229-bd28-bddff82b40f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders_1f3c951f-e264-44a2-b8b5-14c9c86e98a1" xlink:href="dva-20220930.xsd#dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_8045dc24-89c2-4873-8bc1-57033791957c" xlink:to="loc_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders_1f3c951f-e264-44a2-b8b5-14c9c86e98a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders_f2e3efc2-8cc8-4cc4-b843-ed508b0f48de" xlink:href="dva-20220930.xsd#dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_8045dc24-89c2-4873-8bc1-57033791957c" xlink:to="loc_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders_f2e3efc2-8cc8-4cc4-b843-ed508b0f48de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures_89f1ddfe-0f08-43d5-81b8-d335e1f40202" xlink:href="dva-20220930.xsd#dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_8045dc24-89c2-4873-8bc1-57033791957c" xlink:to="loc_dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures_89f1ddfe-0f08-43d5-81b8-d335e1f40202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TemporaryEquityDecreasePurchaseOfInterests_a6e8b315-2644-4e21-b404-4ccd33b64ffc" xlink:href="dva-20220930.xsd#dva_TemporaryEquityDecreasePurchaseOfInterests"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_8045dc24-89c2-4873-8bc1-57033791957c" xlink:to="loc_dva_TemporaryEquityDecreasePurchaseOfInterests_a6e8b315-2644-4e21-b404-4ccd33b64ffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue_add416e5-9eb9-41e9-8693-0a32c70ca75d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_8045dc24-89c2-4873-8bc1-57033791957c" xlink:to="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue_add416e5-9eb9-41e9-8693-0a32c70ca75d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityOtherChanges_b252fcaa-63f0-4328-992d-93b9ef557713" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityOtherChanges"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_8045dc24-89c2-4873-8bc1-57033791957c" xlink:to="loc_us-gaap_TemporaryEquityOtherChanges_b252fcaa-63f0-4328-992d-93b9ef557713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_2eb89096-78e6-4e30-8ef4-106a3b5bf9f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_8045dc24-89c2-4873-8bc1-57033791957c" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_2eb89096-78e6-4e30-8ef4-106a3b5bf9f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_59579849-d537-4920-a53d-69ca678a1a12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d8772d2b-8cd2-46e4-8c0c-cc88b12e420a" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_59579849-d537-4920-a53d-69ca678a1a12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a8330f3a-3751-4c42-9eab-c598542ba375" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_59579849-d537-4920-a53d-69ca678a1a12" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a8330f3a-3751-4c42-9eab-c598542ba375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_2ac87f99-1fe0-4a42-9f09-b24fafce935c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_59579849-d537-4920-a53d-69ca678a1a12" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_2ac87f99-1fe0-4a42-9f09-b24fafce935c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_ca4230c8-4b7c-44e2-979d-79a86f05687d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_59579849-d537-4920-a53d-69ca678a1a12" xlink:to="loc_us-gaap_TreasuryStockShares_ca4230c8-4b7c-44e2-979d-79a86f05687d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_3416b9c8-420b-49e5-9bec-43507926040c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_59579849-d537-4920-a53d-69ca678a1a12" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_3416b9c8-420b-49e5-9bec-43507926040c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_cbdf3a62-45da-4ea3-8fc7-ed8c45efd88e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_3416b9c8-420b-49e5-9bec-43507926040c" xlink:to="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_cbdf3a62-45da-4ea3-8fc7-ed8c45efd88e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d2889d38-140d-45fa-b444-0b929915f0b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract_3416b9c8-420b-49e5-9bec-43507926040c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d2889d38-140d-45fa-b444-0b929915f0b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_c61183a4-a836-4e39-a99e-9f99a44dd2e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_59579849-d537-4920-a53d-69ca678a1a12" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_c61183a4-a836-4e39-a99e-9f99a44dd2e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_cf9c1ded-7e75-4066-84f9-73ac142d5b4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_59579849-d537-4920-a53d-69ca678a1a12" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_cf9c1ded-7e75-4066-84f9-73ac142d5b4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_cdee8172-bb9f-40a6-be4b-751eb9eb8e74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_59579849-d537-4920-a53d-69ca678a1a12" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_cdee8172-bb9f-40a6-be4b-751eb9eb8e74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_55feb16a-0386-4c24-b054-cbe6b020a167" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_59579849-d537-4920-a53d-69ca678a1a12" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_55feb16a-0386-4c24-b054-cbe6b020a167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestItemsAbstract_2284b17d-7d1f-41f9-906d-aec10f753c4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestItemsAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_59579849-d537-4920-a53d-69ca678a1a12" xlink:to="loc_us-gaap_NoncontrollingInterestItemsAbstract_2284b17d-7d1f-41f9-906d-aec10f753c4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_e5326538-de40-4d59-abd7-2630682ca172" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_2284b17d-7d1f-41f9-906d-aec10f753c4f" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_e5326538-de40-4d59-abd7-2630682ca172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NoncontrollingInterestIncreaseFromContributions_e086b6f8-fa86-4383-8235-1c369ac15c3f" xlink:href="dva-20220930.xsd#dva_NoncontrollingInterestIncreaseFromContributions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_2284b17d-7d1f-41f9-906d-aec10f753c4f" xlink:to="loc_dva_NoncontrollingInterestIncreaseFromContributions_e086b6f8-fa86-4383-8235-1c369ac15c3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures_3312bd4a-6d26-401d-8932-fb591d957006" xlink:href="dva-20220930.xsd#dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_2284b17d-7d1f-41f9-906d-aec10f753c4f" xlink:to="loc_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures_3312bd4a-6d26-401d-8932-fb591d957006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures_a5c68d9d-213f-4600-8fb1-87294ae23d4b" xlink:href="dva-20220930.xsd#dva_NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_2284b17d-7d1f-41f9-906d-aec10f753c4f" xlink:to="loc_dva_NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures_a5c68d9d-213f-4600-8fb1-87294ae23d4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_39b71623-020f-48fb-ae23-386408122e9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_2284b17d-7d1f-41f9-906d-aec10f753c4f" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_39b71623-020f-48fb-ae23-386408122e9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestChangeInRedemptionValue_d0f5db2f-41ea-4ff0-a83d-0b10f3851198" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestChangeInRedemptionValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_2284b17d-7d1f-41f9-906d-aec10f753c4f" xlink:to="loc_us-gaap_MinorityInterestChangeInRedemptionValue_d0f5db2f-41ea-4ff0-a83d-0b10f3851198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_NoncontrollingInterestChangesFromOther_c4263358-56d4-4967-b706-3a95b8d61e7d" xlink:href="dva-20220930.xsd#dva_NoncontrollingInterestChangesFromOther"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncontrollingInterestItemsAbstract_2284b17d-7d1f-41f9-906d-aec10f753c4f" xlink:to="loc_dva_NoncontrollingInterestChangesFromOther_c4263358-56d4-4967-b706-3a95b8d61e7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_09f1c0b9-75a9-4f2d-b91f-2c9d632952e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_59579849-d537-4920-a53d-69ca678a1a12" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_09f1c0b9-75a9-4f2d-b91f-2c9d632952e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_a9631723-d280-414c-90c8-8ebc414a9988" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_59579849-d537-4920-a53d-69ca678a1a12" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_a9631723-d280-414c-90c8-8ebc414a9988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c035b206-9244-46ae-889a-df661e3c0289" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d8772d2b-8cd2-46e4-8c0c-cc88b12e420a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c035b206-9244-46ae-889a-df661e3c0289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_ffec7646-8f10-424e-b5f1-b8c3d11fbc8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d8772d2b-8cd2-46e4-8c0c-cc88b12e420a" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_ffec7646-8f10-424e-b5f1-b8c3d11fbc8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_8b650f25-91cc-4797-973a-c4853839a52f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d8772d2b-8cd2-46e4-8c0c-cc88b12e420a" xlink:to="loc_us-gaap_TreasuryStockShares_8b650f25-91cc-4797-973a-c4853839a52f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidatedinterimfinancialstatements" xlink:type="simple" xlink:href="dva-20220930.xsd#CondensedconsolidatedinterimfinancialstatementsCondensedconsolidatedinterimfinancialstatements"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidatedinterimfinancialstatements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TextBlockAbstract_d2a74c8e-3ee5-4eb5-861a-730018687d53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TextBlockAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_7e597f0b-8523-4140-9a4a-1fa040bb5610" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TextBlockAbstract_d2a74c8e-3ee5-4eb5-861a-730018687d53" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_7e597f0b-8523-4140-9a4a-1fa040bb5610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/RevenueRecognitionRevenueRecognition" xlink:type="simple" xlink:href="dva-20220930.xsd#RevenueRecognitionRevenueRecognition"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/RevenueRecognitionRevenueRecognition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TextBlockAbstract_d0cecd9b-ec5d-4f70-8337-67bfc3ea7351" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TextBlockAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_298a6a87-a71c-4a6d-8b13-f56bd2262f0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TextBlockAbstract_d0cecd9b-ec5d-4f70-8337-67bfc3ea7351" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_298a6a87-a71c-4a6d-8b13-f56bd2262f0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/EarningspershareNotes" xlink:type="simple" xlink:href="dva-20220930.xsd#EarningspershareNotes"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/EarningspershareNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_7655f644-c63e-4695-bf12-6d63d75f11a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_9d9faff5-bf2c-43b2-a1c8-7d82f90b0efe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7655f644-c63e-4695-bf12-6d63d75f11a5" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_9d9faff5-bf2c-43b2-a1c8-7d82f90b0efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/Investmentsindebtandequitysecurities" xlink:type="simple" xlink:href="dva-20220930.xsd#Investmentsindebtandequitysecurities"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/Investmentsindebtandequitysecurities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_d8f95169-0699-456e-bb40-5adcbe26de2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_0ee825c8-91ac-4359-a458-e30f171c5c24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_d8f95169-0699-456e-bb40-5adcbe26de2f" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_0ee825c8-91ac-4359-a458-e30f171c5c24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/Goodwill" xlink:type="simple" xlink:href="dva-20220930.xsd#Goodwill"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/Goodwill" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f6735887-9956-4409-9df6-79a995637f77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillDisclosureTextBlock_905f383a-ef5d-4c75-89ec-11da961695db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f6735887-9956-4409-9df6-79a995637f77" xlink:to="loc_us-gaap_GoodwillDisclosureTextBlock_905f383a-ef5d-4c75-89ec-11da961695db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/Longtermdebt" xlink:type="simple" xlink:href="dva-20220930.xsd#Longtermdebt"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/Longtermdebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_b9f86936-ab2e-47a3-a2d3-37a708b7935f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock_6c453100-1314-4d80-8975-ae2b0afcc8d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b9f86936-ab2e-47a3-a2d3-37a708b7935f" xlink:to="loc_us-gaap_LongTermDebtTextBlock_6c453100-1314-4d80-8975-ae2b0afcc8d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="dva-20220930.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2b3fb0c2-006f-4873-b139-9615887a27f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDisclosures_45929bc8-56b2-4ca7-9b48-7a9e98c2dc8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDisclosures"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2b3fb0c2-006f-4873-b139-9615887a27f7" xlink:to="loc_us-gaap_LossContingencyDisclosures_45929bc8-56b2-4ca7-9b48-7a9e98c2dc8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsDisclosureTextBlock_3125bc14-e76e-44b9-929e-6a96a969f66b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsDisclosureTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2b3fb0c2-006f-4873-b139-9615887a27f7" xlink:to="loc_us-gaap_CommitmentsDisclosureTextBlock_3125bc14-e76e-44b9-929e-6a96a969f66b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/Shareholdersequity" xlink:type="simple" xlink:href="dva-20220930.xsd#Shareholdersequity"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/Shareholdersequity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_ebc34df7-57f2-45f8-ab6d-c5df5af405de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_246dd877-13f8-438e-88b3-4a6c433bb686" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ebc34df7-57f2-45f8-ab6d-c5df5af405de" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_246dd877-13f8-438e-88b3-4a6c433bb686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockTextBlock_147c869c-d2ed-4183-9b4a-3d6e1554e07c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ebc34df7-57f2-45f8-ab6d-c5df5af405de" xlink:to="loc_us-gaap_TreasuryStockTextBlock_147c869c-d2ed-4183-9b4a-3d6e1554e07c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/Accumulatedothercomprehensivelossincome" xlink:type="simple" xlink:href="dva-20220930.xsd#Accumulatedothercomprehensivelossincome"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/Accumulatedothercomprehensivelossincome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_0c723e28-662f-4828-b673-1a95baca2a76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_3531b3a7-b456-4f82-b9b4-36f3b94388f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_0c723e28-662f-4828-b673-1a95baca2a76" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_3531b3a7-b456-4f82-b9b4-36f3b94388f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/Acquisitionsanddivestitures" xlink:type="simple" xlink:href="dva-20220930.xsd#Acquisitionsanddivestitures"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/Acquisitionsanddivestitures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_3e2e7c25-4ba1-4b04-96a9-8c9b0baa8144" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_996af498-bef6-4624-90d9-6c07c354cb15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_3e2e7c25-4ba1-4b04-96a9-8c9b0baa8144" xlink:to="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_996af498-bef6-4624-90d9-6c07c354cb15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/Variableinterestentities" xlink:type="simple" xlink:href="dva-20220930.xsd#Variableinterestentities"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/Variableinterestentities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9bed4441-3604-482f-8b8b-0823dec95283" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityDisclosureTextBlock_d4e8519c-cbbf-45b4-a17b-7f81cf4967db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9bed4441-3604-482f-8b8b-0823dec95283" xlink:to="loc_us-gaap_VariableInterestEntityDisclosureTextBlock_d4e8519c-cbbf-45b4-a17b-7f81cf4967db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/Fairvalueoffinancialinstruments" xlink:type="simple" xlink:href="dva-20220930.xsd#Fairvalueoffinancialinstruments"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/Fairvalueoffinancialinstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_b5fdd899-c209-4ba5-a730-85eb775f17ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_b0878c42-0134-4916-be90-d74a4b58fc8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b5fdd899-c209-4ba5-a730-85eb775f17ae" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_b0878c42-0134-4916-be90-d74a4b58fc8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/Segmentreporting" xlink:type="simple" xlink:href="dva-20220930.xsd#Segmentreporting"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/Segmentreporting" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_3d7db13c-dc2a-4e36-9498-29b4892ab393" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_727d5df1-699c-448d-b382-6e3fa431971b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_3d7db13c-dc2a-4e36-9498-29b4892ab393" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_727d5df1-699c-448d-b382-6e3fa431971b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/Newaccountingstandards" xlink:type="simple" xlink:href="dva-20220930.xsd#Newaccountingstandards"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/Newaccountingstandards" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_d5ce25ec-b8a5-4552-ad20-8bea974d764e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingChangesAndErrorCorrectionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_3a293b91-f52a-4ba4-8c23-ca039be7287e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingChangesAndErrorCorrectionsAbstract_d5ce25ec-b8a5-4552-ad20-8bea974d764e" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_3a293b91-f52a-4ba4-8c23-ca039be7287e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies" xlink:type="simple" xlink:href="dva-20220930.xsd#CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_cf1c4a2b-b917-4c1d-af5f-fa3af287c206" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_f47ec2af-47ad-4cb0-bb19-47fa673560cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cf1c4a2b-b917-4c1d-af5f-fa3af287c206" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_f47ec2af-47ad-4cb0-bb19-47fa673560cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_ab874250-a730-4a8e-a8ac-5d1736986fb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cf1c4a2b-b917-4c1d-af5f-fa3af287c206" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_ab874250-a730-4a8e-a8ac-5d1736986fb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_95279fdd-de69-46bd-87c5-0aa18473a515" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cf1c4a2b-b917-4c1d-af5f-fa3af287c206" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_95279fdd-de69-46bd-87c5-0aa18473a515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy_878136de-c907-4510-8391-4fa09fb614ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cf1c4a2b-b917-4c1d-af5f-fa3af287c206" xlink:to="loc_us-gaap_MarketableSecuritiesPolicy_878136de-c907-4510-8391-4fa09fb614ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_de4ce5fd-a16d-48be-9408-eac57edac66b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cf1c4a2b-b917-4c1d-af5f-fa3af287c206" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_de4ce5fd-a16d-48be-9408-eac57edac66b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_64803b9f-1166-4216-a00a-813a5c8d716b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cf1c4a2b-b917-4c1d-af5f-fa3af287c206" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_64803b9f-1166-4216-a00a-813a5c8d716b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_20735cee-ec86-47a0-a4b6-1afacdc694fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cf1c4a2b-b917-4c1d-af5f-fa3af287c206" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_20735cee-ec86-47a0-a4b6-1afacdc694fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/RevenueRecognitionSegmentrevenuebymajorpayorTables" xlink:type="simple" xlink:href="dva-20220930.xsd#RevenueRecognitionSegmentrevenuebymajorpayorTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/RevenueRecognitionSegmentrevenuebymajorpayorTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dva_RevenuesbymajorpayorAbstract_a96c2511-cc96-4d17-a038-9ecf5329f569" xlink:href="dva-20220930.xsd#dva_RevenuesbymajorpayorAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_be95cda9-a4ef-450d-a761-5ca7096e873d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_RevenuesbymajorpayorAbstract_a96c2511-cc96-4d17-a038-9ecf5329f569" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_be95cda9-a4ef-450d-a761-5ca7096e873d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/EarningspershareEarningsPerShareTables" xlink:type="simple" xlink:href="dva-20220930.xsd#EarningspershareEarningsPerShareTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/EarningspershareEarningsPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_98a4c1ba-bc5c-41a9-b023-e682b225211c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_62bb0297-3b75-4dc6-b852-18f1737ac4c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_98a4c1ba-bc5c-41a9-b023-e682b225211c" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_62bb0297-3b75-4dc6-b852-18f1737ac4c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/InvestmentsindebtandequitysecuritiesTables" xlink:type="simple" xlink:href="dva-20220930.xsd#InvestmentsindebtandequitysecuritiesTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/InvestmentsindebtandequitysecuritiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_57bb38a2-7310-45ab-a9f5-3c00a0ce3963" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock_8532e8f8-141e-4468-8036-062a99a5dfc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_57bb38a2-7310-45ab-a9f5-3c00a0ce3963" xlink:to="loc_us-gaap_MarketableSecuritiesTextBlock_8532e8f8-141e-4468-8036-062a99a5dfc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/GoodwillTables" xlink:type="simple" xlink:href="dva-20220930.xsd#GoodwillTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/GoodwillTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_68f07438-adf0-47e0-be0c-2e0198aecbfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_d6ccba37-f1cc-42d0-aec8-6db3bd268d1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_68f07438-adf0-47e0-be0c-2e0198aecbfb" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_d6ccba37-f1cc-42d0-aec8-6db3bd268d1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermdebtTables" xlink:type="simple" xlink:href="dva-20220930.xsd#LongtermdebtTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LongtermdebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_a38638cf-f379-49b4-875c-edaab2c1e6b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_bf53f209-9c12-4a95-80d9-603f7271a53a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a38638cf-f379-49b4-875c-edaab2c1e6b9" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_bf53f209-9c12-4a95-80d9-603f7271a53a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_4d36e5b8-5391-40af-a9ff-b0eb4ef70834" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_a38638cf-f379-49b4-875c-edaab2c1e6b9" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_4d36e5b8-5391-40af-a9ff-b0eb4ef70834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SharerepurchasesShareRepurchasesTables" xlink:type="simple" xlink:href="dva-20220930.xsd#SharerepurchasesShareRepurchasesTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SharerepurchasesShareRepurchasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAbstract_79e36ee3-db05-43c9-a6b4-2e4412f1d927" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_fa0be840-381b-42e1-8814-a80879426818" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TreasuryStockValueAbstract_79e36ee3-db05-43c9-a6b4-2e4412f1d927" xlink:to="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_fa0be840-381b-42e1-8814-a80879426818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/AccumulatedothercomprehensivelossincomeTables" xlink:type="simple" xlink:href="dva-20220930.xsd#AccumulatedothercomprehensivelossincomeTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/AccumulatedothercomprehensivelossincomeTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f098ceba-8766-42a0-b610-c24901353b3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_b21c7711-0ecf-493a-add1-c9702d1cfa88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f098ceba-8766-42a0-b610-c24901353b3a" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_b21c7711-0ecf-493a-add1-c9702d1cfa88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/AcquisitionsanddivestituresTables" xlink:type="simple" xlink:href="dva-20220930.xsd#AcquisitionsanddivestituresTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/AcquisitionsanddivestituresTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_dfae574a-672e-454d-872b-8e02c81f2dd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_4451545e-688c-4f41-817b-f3f7d5de2b90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_dfae574a-672e-454d-872b-8e02c81f2dd2" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_4451545e-688c-4f41-817b-f3f7d5de2b90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/FairvalueoffinancialinstrumentsTables" xlink:type="simple" xlink:href="dva-20220930.xsd#FairvalueoffinancialinstrumentsTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/FairvalueoffinancialinstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_501296ca-8f5f-4c9f-8329-e54b41a18d0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_e4969bb1-28f1-492b-a3d1-4b13ad1bb575" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_501296ca-8f5f-4c9f-8329-e54b41a18d0e" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_e4969bb1-28f1-492b-a3d1-4b13ad1bb575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentreportingTables" xlink:type="simple" xlink:href="dva-20220930.xsd#SegmentreportingTables"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SegmentreportingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_ec786022-6683-4ae8-848a-a87fdd82b6fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_b22df84f-97ff-40c9-9f58-ea96d44f81a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ec786022-6683-4ae8-848a-a87fdd82b6fc" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_b22df84f-97ff-40c9-9f58-ea96d44f81a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock_b4c0df3c-7265-467f-bc4d-98e4d209ccf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ec786022-6683-4ae8-848a-a87fdd82b6fc" xlink:to="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock_b4c0df3c-7265-467f-bc4d-98e4d209ccf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock_eb2654a4-381e-42ca-8781-fe4145a50764" xlink:href="dva-20220930.xsd#dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ec786022-6683-4ae8-848a-a87fdd82b6fc" xlink:to="loc_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock_eb2654a4-381e-42ca-8781-fe4145a50764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_81236bef-d1da-4798-b422-f302294bc6e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ec786022-6683-4ae8-848a-a87fdd82b6fc" xlink:to="loc_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock_81236bef-d1da-4798-b422-f302294bc6e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails" xlink:type="simple" xlink:href="dva-20220930.xsd#RevenueRecognitionSegmentRevenuebyPayorDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dva_SegmentRevenuebyMajorPayorAbstract_d8724a4a-ee8f-4a1b-953d-5b67a573e64e" xlink:href="dva-20220930.xsd#dva_SegmentRevenuebyMajorPayorAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_4dae8641-15fc-4680-8835-3dffb758c90a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dva_SegmentRevenuebyMajorPayorAbstract_d8724a4a-ee8f-4a1b-953d-5b67a573e64e" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_4dae8641-15fc-4680-8835-3dffb758c90a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3477fa4b-c61e-4cb5-b048-a58d28c4d96a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_4dae8641-15fc-4680-8835-3dffb758c90a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3477fa4b-c61e-4cb5-b048-a58d28c4d96a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_50c3b704-d20e-4d5a-8d43-56f2c486063c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3477fa4b-c61e-4cb5-b048-a58d28c4d96a" xlink:to="loc_us-gaap_SegmentDomain_50c3b704-d20e-4d5a-8d43-56f2c486063c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_e1c6abd1-6ac3-44e0-a332-8688644db99a" xlink:href="dva-20220930.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_50c3b704-d20e-4d5a-8d43-56f2c486063c" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_e1c6abd1-6ac3-44e0-a332-8688644db99a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_de3b73b9-27d2-436d-91f8-00a4ca0d3935" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_50c3b704-d20e-4d5a-8d43-56f2c486063c" xlink:to="loc_us-gaap_AllOtherSegmentsMember_de3b73b9-27d2-436d-91f8-00a4ca0d3935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_9ac57adb-ccc9-49d4-aba5-34e3309cad8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_4dae8641-15fc-4680-8835-3dffb758c90a" xlink:to="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_9ac57adb-ccc9-49d4-aba5-34e3309cad8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_cfcbcf8c-8d23-4ed5-9a1d-563bcf738145" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesAxis_9ac57adb-ccc9-49d4-aba5-34e3309cad8c" xlink:to="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_cfcbcf8c-8d23-4ed5-9a1d-563bcf738145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MedicareandMedicareAdvantageMember_d2f88ea4-0398-4735-8c01-270218359542" xlink:href="dva-20220930.xsd#dva_MedicareandMedicareAdvantageMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_cfcbcf8c-8d23-4ed5-9a1d-563bcf738145" xlink:to="loc_dva_MedicareandMedicareAdvantageMember_d2f88ea4-0398-4735-8c01-270218359542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MedicaidandManagedMedicaidMember_c295ba00-3138-468f-a4f2-0737b14c4ff0" xlink:href="dva-20220930.xsd#dva_MedicaidandManagedMedicaidMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_cfcbcf8c-8d23-4ed5-9a1d-563bcf738145" xlink:to="loc_dva_MedicaidandManagedMedicaidMember_c295ba00-3138-468f-a4f2-0737b14c4ff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherGovernmentPayorsMember_3e38f8d7-82d6-48c8-aff6-08bdf153362c" xlink:href="dva-20220930.xsd#dva_OtherGovernmentPayorsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_cfcbcf8c-8d23-4ed5-9a1d-563bcf738145" xlink:to="loc_dva_OtherGovernmentPayorsMember_3e38f8d7-82d6-48c8-aff6-08bdf153362c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CommercialPayorsMember_5d9b24b2-7790-4937-b69e-09afc2da1c82" xlink:href="dva-20220930.xsd#dva_CommercialPayorsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_cfcbcf8c-8d23-4ed5-9a1d-563bcf738145" xlink:to="loc_dva_CommercialPayorsMember_5d9b24b2-7790-4937-b69e-09afc2da1c82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherSourcesofRevenueMember_f2b0d8f0-3bb2-441d-a53d-afecfb892a4f" xlink:href="dva-20220930.xsd#dva_OtherSourcesofRevenueMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HealthCareOrganizationRevenueSourcesDomain_cfcbcf8c-8d23-4ed5-9a1d-563bcf738145" xlink:to="loc_dva_OtherSourcesofRevenueMember_f2b0d8f0-3bb2-441d-a53d-afecfb892a4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_99f85a11-e7f4-49d0-aa8b-a59d78183293" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_4dae8641-15fc-4680-8835-3dffb758c90a" xlink:to="loc_srt_ConsolidationItemsAxis_99f85a11-e7f4-49d0-aa8b-a59d78183293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_e3957ba5-fc63-4ea6-980f-e8d49e0bfbb9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_99f85a11-e7f4-49d0-aa8b-a59d78183293" xlink:to="loc_srt_ConsolidationItemsDomain_e3957ba5-fc63-4ea6-980f-e8d49e0bfbb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_d267d811-9fd0-4f85-9f4f-ed2713ce9f13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_e3957ba5-fc63-4ea6-980f-e8d49e0bfbb9" xlink:to="loc_us-gaap_IntersegmentEliminationMember_d267d811-9fd0-4f85-9f4f-ed2713ce9f13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_39e58e01-d67b-4960-894e-c981da69a3c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_4dae8641-15fc-4680-8835-3dffb758c90a" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_39e58e01-d67b-4960-894e-c981da69a3c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_6a595b05-a68f-4888-af53-532299541bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_39e58e01-d67b-4960-894e-c981da69a3c1" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_6a595b05-a68f-4888-af53-532299541bb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_7d3d8953-8119-4d47-acf2-12d83a05e9bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_39e58e01-d67b-4960-894e-c981da69a3c1" xlink:to="loc_us-gaap_OtherIncome_7d3d8953-8119-4d47-acf2-12d83a05e9bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_1a15393b-774a-41d5-8a2e-9078d6ad3525" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_39e58e01-d67b-4960-894e-c981da69a3c1" xlink:to="loc_us-gaap_Revenues_1a15393b-774a-41d5-8a2e-9078d6ad3525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails" xlink:type="simple" xlink:href="dva-20220930.xsd#EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_a0023c7b-1fc1-4603-9367-847e003c2c6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract_92ad7c4b-841b-49c1-bb84-177fa2464c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a0023c7b-1fc1-4603-9367-847e003c2c6b" xlink:to="loc_us-gaap_EarningsPerShareReconciliationAbstract_92ad7c4b-841b-49c1-bb84-177fa2464c4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ec120c3c-3dca-44e4-ad26-3e46a2324954" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_92ad7c4b-841b-49c1-bb84-177fa2464c4a" xlink:to="loc_us-gaap_NetIncomeLoss_ec120c3c-3dca-44e4-ad26-3e46a2324954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_1e90fd74-e7c1-44b6-be5a-105ae2e575e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_92ad7c4b-841b-49c1-bb84-177fa2464c4a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_1e90fd74-e7c1-44b6-be5a-105ae2e575e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_38342d43-cfcb-4dcd-a189-75bfaa6bef78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_92ad7c4b-841b-49c1-bb84-177fa2464c4a" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_38342d43-cfcb-4dcd-a189-75bfaa6bef78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_32c1f462-37c8-46fc-80dd-8ccc5a723b49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_92ad7c4b-841b-49c1-bb84-177fa2464c4a" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_32c1f462-37c8-46fc-80dd-8ccc5a723b49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_485d62ff-b270-4af2-a7ca-81c67ad20dc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_92ad7c4b-841b-49c1-bb84-177fa2464c4a" xlink:to="loc_us-gaap_EarningsPerShareBasic_485d62ff-b270-4af2-a7ca-81c67ad20dc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_7524be49-dc15-4560-a5e6-601c4a4f7eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_92ad7c4b-841b-49c1-bb84-177fa2464c4a" xlink:to="loc_us-gaap_EarningsPerShareDiluted_7524be49-dc15-4560-a5e6-601c4a4f7eb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d8c10cbb-9e24-4b29-a296-3f5a525d5663" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_92ad7c4b-841b-49c1-bb84-177fa2464c4a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d8c10cbb-9e24-4b29-a296-3f5a525d5663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail" xlink:type="simple" xlink:href="dva-20220930.xsd#InvestmentsindebtandequitysecuritiesDetail"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_293949ee-9ea4-4dc2-be20-dcaca70c6565" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsTable_cfc2b999-4a85-4d1a-a59b-e86cf3544ce3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentHoldingsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_293949ee-9ea4-4dc2-be20-dcaca70c6565" xlink:to="loc_us-gaap_InvestmentHoldingsTable_cfc2b999-4a85-4d1a-a59b-e86cf3544ce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_2b3cdd0a-691b-4107-b2c3-85cb476d1a3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsTable_cfc2b999-4a85-4d1a-a59b-e86cf3544ce3" xlink:to="loc_us-gaap_InvestmentTypeAxis_2b3cdd0a-691b-4107-b2c3-85cb476d1a3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_ae40e397-5c25-436e-9ba9-6bda739b1d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_2b3cdd0a-691b-4107-b2c3-85cb476d1a3f" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_ae40e397-5c25-436e-9ba9-6bda739b1d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember_d15ce060-0f73-49de-97dd-e952d26d2114" xlink:href="dva-20220930.xsd#dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ae40e397-5c25-436e-9ba9-6bda739b1d6c" xlink:to="loc_dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember_d15ce060-0f73-49de-97dd-e952d26d2114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_MutualFundsAndCommonStockMember_560c9927-3b8f-43f8-9e40-3214721589e7" xlink:href="dva-20220930.xsd#dva_MutualFundsAndCommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ae40e397-5c25-436e-9ba9-6bda739b1d6c" xlink:to="loc_dva_MutualFundsAndCommonStockMember_560c9927-3b8f-43f8-9e40-3214721589e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_df9f2cf0-4129-4c4f-bc7f-3ee53c18f810" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ae40e397-5c25-436e-9ba9-6bda739b1d6c" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_df9f2cf0-4129-4c4f-bc7f-3ee53c18f810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestmentsMember_f3cd7f86-1100-4c3d-9b13-5180038f5a8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLongTermInvestmentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ae40e397-5c25-436e-9ba9-6bda739b1d6c" xlink:to="loc_us-gaap_OtherLongTermInvestmentsMember_f3cd7f86-1100-4c3d-9b13-5180038f5a8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentHoldingsLineItems_54e6b749-200f-490b-9af8-4a29d2cc1792" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentHoldingsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsTable_cfc2b999-4a85-4d1a-a59b-e86cf3544ce3" xlink:to="loc_us-gaap_InvestmentHoldingsLineItems_54e6b749-200f-490b-9af8-4a29d2cc1792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities_b4260e14-7270-4679-910b-f273fe75a6b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_54e6b749-200f-490b-9af8-4a29d2cc1792" xlink:to="loc_us-gaap_HeldToMaturitySecurities_b4260e14-7270-4679-910b-f273fe75a6b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_df37b033-654b-483d-b1f6-9bda1f584486" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_54e6b749-200f-490b-9af8-4a29d2cc1792" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_df37b033-654b-483d-b1f6-9bda1f584486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecurities_b4383059-08d7-4741-8967-fca29f6f6dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_54e6b749-200f-490b-9af8-4a29d2cc1792" xlink:to="loc_us-gaap_MarketableSecurities_b4383059-08d7-4741-8967-fca29f6f6dc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesCurrent_7cf4344c-78b5-4a6f-bc7a-e9fd76c1a5e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_54e6b749-200f-490b-9af8-4a29d2cc1792" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesCurrent_7cf4344c-78b5-4a6f-bc7a-e9fd76c1a5e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_1bcc49fd-c851-4d1f-8285-8d1a534a8d7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_54e6b749-200f-490b-9af8-4a29d2cc1792" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_1bcc49fd-c851-4d1f-8285-8d1a534a8d7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesNoncurrent_f1873e28-440a-47c5-923f-22cee4798ddd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HeldToMaturitySecuritiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_54e6b749-200f-490b-9af8-4a29d2cc1792" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesNoncurrent_f1873e28-440a-47c5-923f-22cee4798ddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_6b770ffe-260c-43f7-a46f-dc5b1347eeb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentHoldingsLineItems_54e6b749-200f-490b-9af8-4a29d2cc1792" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_6b770ffe-260c-43f7-a46f-dc5b1347eeb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail" xlink:type="simple" xlink:href="dva-20220930.xsd#GoodwillChangesinGoodwillbyReportableSegmentsDetail"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f45a8502-9726-410e-9661-0aa9c456a60f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_9bf80ee2-a2b6-4113-9e79-9169fdd23f38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f45a8502-9726-410e-9661-0aa9c456a60f" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_9bf80ee2-a2b6-4113-9e79-9169fdd23f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_319e243c-c3f7-480f-88ce-52f79bd32e49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_9bf80ee2-a2b6-4113-9e79-9169fdd23f38" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_319e243c-c3f7-480f-88ce-52f79bd32e49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8cfb3d70-7499-4bfc-b7c1-130788dd469c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_319e243c-c3f7-480f-88ce-52f79bd32e49" xlink:to="loc_us-gaap_SegmentDomain_8cfb3d70-7499-4bfc-b7c1-130788dd469c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_f4201478-dbe2-4272-92b8-b0a795ca5ed7" xlink:href="dva-20220930.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8cfb3d70-7499-4bfc-b7c1-130788dd469c" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_f4201478-dbe2-4272-92b8-b0a795ca5ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_0b0329d8-c007-48ba-b4c4-bbdeb884a801" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8cfb3d70-7499-4bfc-b7c1-130788dd469c" xlink:to="loc_us-gaap_AllOtherSegmentsMember_0b0329d8-c007-48ba-b4c4-bbdeb884a801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_5e5defc5-a5bc-4d2a-8d16-9a239c542dc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_9bf80ee2-a2b6-4113-9e79-9169fdd23f38" xlink:to="loc_us-gaap_GoodwillLineItems_5e5defc5-a5bc-4d2a-8d16-9a239c542dc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_3a1707c5-cda9-412d-b2c4-8774a3533f32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_5e5defc5-a5bc-4d2a-8d16-9a239c542dc2" xlink:to="loc_us-gaap_GoodwillRollForward_3a1707c5-cda9-412d-b2c4-8774a3533f32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a50aeb23-78e4-45cd-806a-c9069d0ac103" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_3a1707c5-cda9-412d-b2c4-8774a3533f32" xlink:to="loc_us-gaap_Goodwill_a50aeb23-78e4-45cd-806a-c9069d0ac103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_26f8674f-5a49-4ec5-9bfb-b3d4ca3a3180" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_3a1707c5-cda9-412d-b2c4-8774a3533f32" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_26f8674f-5a49-4ec5-9bfb-b3d4ca3a3180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_9af969c4-99c9-4eb1-ba29-2c41d232ffe6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_3a1707c5-cda9-412d-b2c4-8774a3533f32" xlink:to="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_9af969c4-99c9-4eb1-ba29-2c41d232ffe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_e9d3c7ef-ec9d-4a43-974f-6c7cf00803da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_3a1707c5-cda9-412d-b2c4-8774a3533f32" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_e9d3c7ef-ec9d-4a43-974f-6c7cf00803da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b90cc4af-fbb3-4ecc-b466-90180d927c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_3a1707c5-cda9-412d-b2c4-8774a3533f32" xlink:to="loc_us-gaap_Goodwill_b90cc4af-fbb3-4ecc-b466-90180d927c4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillGross_31b677e7-d8d3-4d15-88ed-2f964c06d411" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_5e5defc5-a5bc-4d2a-8d16-9a239c542dc2" xlink:to="loc_us-gaap_GoodwillGross_31b677e7-d8d3-4d15-88ed-2f964c06d411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_f0e72286-8f4a-478a-82db-a48b818de93c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_5e5defc5-a5bc-4d2a-8d16-9a239c542dc2" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_f0e72286-8f4a-478a-82db-a48b818de93c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_af3797c8-500e-42ed-985b-62206a8b3106" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_5e5defc5-a5bc-4d2a-8d16-9a239c542dc2" xlink:to="loc_us-gaap_Goodwill_af3797c8-500e-42ed-985b-62206a8b3106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/GoodwillNarrativeDetails" xlink:type="simple" xlink:href="dva-20220930.xsd#GoodwillNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/GoodwillNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9798481f-365a-4d08-8311-23f682715149" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_ced66a59-8577-4a52-918c-981b95fa1831" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9798481f-365a-4d08-8311-23f682715149" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_ced66a59-8577-4a52-918c-981b95fa1831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_7d663181-f2fb-4327-9098-33bf02c8217a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ced66a59-8577-4a52-918c-981b95fa1831" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_7d663181-f2fb-4327-9098-33bf02c8217a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d7f26829-6bf0-43e1-a9e9-dee4ad8e3d44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7d663181-f2fb-4327-9098-33bf02c8217a" xlink:to="loc_us-gaap_SegmentDomain_d7f26829-6bf0-43e1-a9e9-dee4ad8e3d44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherReportingUnitsMember_34498616-3149-4522-9b16-eaae10b8bd3b" xlink:href="dva-20220930.xsd#dva_OtherReportingUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d7f26829-6bf0-43e1-a9e9-dee4ad8e3d44" xlink:to="loc_dva_OtherReportingUnitsMember_34498616-3149-4522-9b16-eaae10b8bd3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_cfbe0707-8b97-4008-bea7-985ff61a4719" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_ced66a59-8577-4a52-918c-981b95fa1831" xlink:to="loc_us-gaap_GoodwillLineItems_cfbe0707-8b97-4008-bea7-985ff61a4719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_8b1a2111-0095-44c5-b0dc-af59b88507be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_cfbe0707-8b97-4008-bea7-985ff61a4719" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_8b1a2111-0095-44c5-b0dc-af59b88507be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_4ebb2b52-1767-48ef-863d-5bea597d2c7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_cfbe0707-8b97-4008-bea7-985ff61a4719" xlink:to="loc_us-gaap_NumberOfOperatingSegments_4ebb2b52-1767-48ef-863d-5bea597d2c7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermdebtDetail" xlink:type="simple" xlink:href="dva-20220930.xsd#LongtermdebtDetail"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LongtermdebtDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_03de9956-e574-4c73-9a4e-00e15dddd6ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_bcbd5078-e24e-4455-9a31-f8c84f323162" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_03de9956-e574-4c73-9a4e-00e15dddd6ff" xlink:to="loc_us-gaap_DebtInstrumentTable_bcbd5078-e24e-4455-9a31-f8c84f323162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_6ed88700-2ccc-4551-af0d-a203995108f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_bcbd5078-e24e-4455-9a31-f8c84f323162" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_6ed88700-2ccc-4551-af0d-a203995108f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_df322bd6-5cf9-477d-9cd4-f8623007e346" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6ed88700-2ccc-4551-af0d-a203995108f5" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_df322bd6-5cf9-477d-9cd4-f8623007e346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanAMember_0c8d2f4a-ea88-492c-94a3-aed6c045a758" xlink:href="dva-20220930.xsd#dva_TermLoanAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_df322bd6-5cf9-477d-9cd4-f8623007e346" xlink:to="loc_dva_TermLoanAMember_0c8d2f4a-ea88-492c-94a3-aed6c045a758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanB1Member_1f508d86-7627-4c08-84e1-3c888a003df8" xlink:href="dva-20220930.xsd#dva_TermLoanB1Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_df322bd6-5cf9-477d-9cd4-f8623007e346" xlink:to="loc_dva_TermLoanB1Member_1f508d86-7627-4c08-84e1-3c888a003df8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorSecuredCreditFacilitiesMember_1754843e-7835-4e8f-8b51-a0f47e63694c" xlink:href="dva-20220930.xsd#dva_SeniorSecuredCreditFacilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_df322bd6-5cf9-477d-9cd4-f8623007e346" xlink:to="loc_dva_SeniorSecuredCreditFacilitiesMember_1754843e-7835-4e8f-8b51-a0f47e63694c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_167358ca-f225-4d03-851c-86b9a6d6848c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_df322bd6-5cf9-477d-9cd4-f8623007e346" xlink:to="loc_us-gaap_SeniorNotesMember_167358ca-f225-4d03-851c-86b9a6d6848c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_96076479-ff08-43aa-b66b-7f29b54667da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_bcbd5078-e24e-4455-9a31-f8c84f323162" xlink:to="loc_us-gaap_CreditFacilityAxis_96076479-ff08-43aa-b66b-7f29b54667da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a5734897-8aaa-444c-b859-a0d547a3e068" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_96076479-ff08-43aa-b66b-7f29b54667da" xlink:to="loc_us-gaap_CreditFacilityDomain_a5734897-8aaa-444c-b859-a0d547a3e068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_7c33698f-d9fc-43b4-9a9e-b7defae82ff9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_a5734897-8aaa-444c-b859-a0d547a3e068" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_7c33698f-d9fc-43b4-9a9e-b7defae82ff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_6b70d84b-e68d-469a-adad-c9a4a13a297c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_bcbd5078-e24e-4455-9a31-f8c84f323162" xlink:to="loc_us-gaap_DebtInstrumentAxis_6b70d84b-e68d-469a-adad-c9a4a13a297c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c43c7f14-c81a-477a-ac2f-49011a887038" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_6b70d84b-e68d-469a-adad-c9a4a13a297c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c43c7f14-c81a-477a-ac2f-49011a887038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember_84152b14-d0d8-45ae-bd08-2ab9c46f4f47" xlink:href="dva-20220930.xsd#dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c43c7f14-c81a-477a-ac2f-49011a887038" xlink:to="loc_dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember_84152b14-d0d8-45ae-bd08-2ab9c46f4f47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember_d75ea375-7a24-482e-b0b7-bd5c7c519f7c" xlink:href="dva-20220930.xsd#dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c43c7f14-c81a-477a-ac2f-49011a887038" xlink:to="loc_dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember_d75ea375-7a24-482e-b0b7-bd5c7c519f7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_651664f1-fe7d-4c21-8bb8-ba14c1b55ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c43c7f14-c81a-477a-ac2f-49011a887038" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_651664f1-fe7d-4c21-8bb8-ba14c1b55ccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_FinanceLeaseMember_d4f7fb78-95b0-4f13-963a-7ec1f3ae4299" xlink:href="dva-20220930.xsd#dva_FinanceLeaseMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c43c7f14-c81a-477a-ac2f-49011a887038" xlink:to="loc_dva_FinanceLeaseMember_d4f7fb78-95b0-4f13-963a-7ec1f3ae4299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_d292fcc7-1777-4e0c-b0bd-aec2403b3662" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_bcbd5078-e24e-4455-9a31-f8c84f323162" xlink:to="loc_us-gaap_DebtInstrumentLineItems_d292fcc7-1777-4e0c-b0bd-aec2403b3662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebt_4cff629a-9c60-4df2-a92b-836945ad4274" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d292fcc7-1777-4e0c-b0bd-aec2403b3662" xlink:to="loc_us-gaap_SecuredDebt_4cff629a-9c60-4df2-a92b-836945ad4274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_a5d50a19-9807-4b28-986b-a49810a1b912" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentDescriptionOfVariableRateBasis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d292fcc7-1777-4e0c-b0bd-aec2403b3662" xlink:to="loc_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis_a5d50a19-9807-4b28-986b-a49810a1b912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_ec004b29-74f1-4de6-bb97-526f123cc646" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d292fcc7-1777-4e0c-b0bd-aec2403b3662" xlink:to="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_ec004b29-74f1-4de6-bb97-526f123cc646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_321bcc73-26d2-4512-b8da-1dd9f59d9ce4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d292fcc7-1777-4e0c-b0bd-aec2403b3662" xlink:to="loc_us-gaap_SeniorNotes_321bcc73-26d2-4512-b8da-1dd9f59d9ce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_27f31e86-f2f8-4fb0-9022-629d38d10d34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d292fcc7-1777-4e0c-b0bd-aec2403b3662" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_27f31e86-f2f8-4fb0-9022-629d38d10d34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDate_5deeacdf-a556-4403-9208-fd310548163f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMaturityDate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d292fcc7-1777-4e0c-b0bd-aec2403b3662" xlink:to="loc_us-gaap_DebtInstrumentMaturityDate_5deeacdf-a556-4403-9208-fd310548163f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_e8d3ff18-31a1-4b4a-bf1b-c30841c49ba3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d292fcc7-1777-4e0c-b0bd-aec2403b3662" xlink:to="loc_us-gaap_DebtInstrumentFairValue_e8d3ff18-31a1-4b4a-bf1b-c30841c49ba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AcquisitionObligationsAndOtherNotesPayable_1e2b8063-1736-4724-9c90-4997c699dc62" xlink:href="dva-20220930.xsd#dva_AcquisitionObligationsAndOtherNotesPayable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d292fcc7-1777-4e0c-b0bd-aec2403b3662" xlink:to="loc_dva_AcquisitionObligationsAndOtherNotesPayable_1e2b8063-1736-4724-9c90-4997c699dc62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_95a8e05e-50cc-42f5-9a9e-2e33bb1646a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d292fcc7-1777-4e0c-b0bd-aec2403b3662" xlink:to="loc_us-gaap_FinanceLeaseLiability_95a8e05e-50cc-42f5-9a9e-2e33bb1646a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMaturityDateDescription_3b83e2dd-22c4-4b97-8481-a92ca73703ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentMaturityDateDescription"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d292fcc7-1777-4e0c-b0bd-aec2403b3662" xlink:to="loc_us-gaap_DebtInstrumentMaturityDateDescription_3b83e2dd-22c4-4b97-8481-a92ca73703ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_06f442b2-286e-4841-b2ff-97463ea0e3d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d292fcc7-1777-4e0c-b0bd-aec2403b3662" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_06f442b2-286e-4841-b2ff-97463ea0e3d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AcquisitionObligationsAndOtherNotesPayableFairValue_7710916c-4dbc-4eac-b815-4bf6c93cb858" xlink:href="dva-20220930.xsd#dva_AcquisitionObligationsAndOtherNotesPayableFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d292fcc7-1777-4e0c-b0bd-aec2403b3662" xlink:to="loc_dva_AcquisitionObligationsAndOtherNotesPayableFairValue_7710916c-4dbc-4eac-b815-4bf6c93cb858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_3f5084e6-5435-430d-918e-989a866c6ee4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d292fcc7-1777-4e0c-b0bd-aec2403b3662" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_3f5084e6-5435-430d-918e-989a866c6ee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_28f5a46a-8850-4a83-a28d-e1ed828008b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d292fcc7-1777-4e0c-b0bd-aec2403b3662" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_28f5a46a-8850-4a83-a28d-e1ed828008b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DiscountPremiumAndDeferredFinancingCosts_a0c40a47-6061-470e-9ed9-97c26a4560c5" xlink:href="dva-20220930.xsd#dva_DiscountPremiumAndDeferredFinancingCosts"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d292fcc7-1777-4e0c-b0bd-aec2403b3662" xlink:to="loc_dva_DiscountPremiumAndDeferredFinancingCosts_a0c40a47-6061-470e-9ed9-97c26a4560c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_fd9cc20e-3cde-498a-be0f-276ef963235c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d292fcc7-1777-4e0c-b0bd-aec2403b3662" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities_fd9cc20e-3cde-498a-be0f-276ef963235c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_7fb46d68-c586-4742-9290-385e1941d879" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d292fcc7-1777-4e0c-b0bd-aec2403b3662" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_7fb46d68-c586-4742-9290-385e1941d879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_a5b11e0a-e191-4f3f-a849-32348c180714" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d292fcc7-1777-4e0c-b0bd-aec2403b3662" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_a5b11e0a-e191-4f3f-a849-32348c180714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_76a406f6-afc2-41c5-ae66-3bad46b4c2a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValueDisclosureAbstract"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_d292fcc7-1777-4e0c-b0bd-aec2403b3662" xlink:to="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_76a406f6-afc2-41c5-ae66-3bad46b4c2a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_015873a2-025e-474c-89cf-30be9d62f137" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_76a406f6-afc2-41c5-ae66-3bad46b4c2a9" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_015873a2-025e-474c-89cf-30be9d62f137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredOfferingCosts_9aae6f4f-5f68-4d26-9918-0709ad80aac7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredOfferingCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_76a406f6-afc2-41c5-ae66-3bad46b4c2a9" xlink:to="loc_us-gaap_DeferredOfferingCosts_9aae6f4f-5f68-4d26-9918-0709ad80aac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_fbd51be9-56ba-409a-9fda-f9f14bcd105f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentFairValueDisclosureAbstract_76a406f6-afc2-41c5-ae66-3bad46b4c2a9" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_fbd51be9-56ba-409a-9fda-f9f14bcd105f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="dva-20220930.xsd#LongtermdebtScheduleofDerivativeInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfDerivativeInstrumentsAbstract_8927ac6a-481d-4aed-a8e2-601808c9eedd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfDerivativeInstrumentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_d88a6bb4-c9ce-4db2-973b-7bd2ce097922" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SummaryOfDerivativeInstrumentsAbstract_8927ac6a-481d-4aed-a8e2-601808c9eedd" xlink:to="loc_us-gaap_DerivativeTable_d88a6bb4-c9ce-4db2-973b-7bd2ce097922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e2d80ef0-9999-4ebc-b9d2-307969c2eacd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_d88a6bb4-c9ce-4db2-973b-7bd2ce097922" xlink:to="loc_us-gaap_DebtInstrumentAxis_e2d80ef0-9999-4ebc-b9d2-307969c2eacd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_2cf8ae60-3fdb-4d1b-96e0-4fbc415db197" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_e2d80ef0-9999-4ebc-b9d2-307969c2eacd" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_2cf8ae60-3fdb-4d1b-96e0-4fbc415db197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanFacilityMember_990bef0b-54d8-4971-8069-c09a482b9f4a" xlink:href="dva-20220930.xsd#dva_TermLoanFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_2cf8ae60-3fdb-4d1b-96e0-4fbc415db197" xlink:to="loc_dva_TermLoanFacilityMember_990bef0b-54d8-4971-8069-c09a482b9f4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c71a72c8-90eb-4239-a6da-543f8e0b9496" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_d88a6bb4-c9ce-4db2-973b-7bd2ce097922" xlink:to="loc_srt_RangeAxis_c71a72c8-90eb-4239-a6da-543f8e0b9496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9ccdb9f2-65f8-466d-80f6-8d27a46b18fe" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_c71a72c8-90eb-4239-a6da-543f8e0b9496" xlink:to="loc_srt_RangeMember_9ccdb9f2-65f8-466d-80f6-8d27a46b18fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_098075f1-1aea-4a69-a79a-2fadad2ebbfb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9ccdb9f2-65f8-466d-80f6-8d27a46b18fe" xlink:to="loc_srt_MaximumMember_098075f1-1aea-4a69-a79a-2fadad2ebbfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_e838220e-3fc2-4951-82bc-1942c6086450" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_d88a6bb4-c9ce-4db2-973b-7bd2ce097922" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_e838220e-3fc2-4951-82bc-1942c6086450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_36f8cd07-1191-4817-b5d2-05e57d98f58e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_e838220e-3fc2-4951-82bc-1942c6086450" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_36f8cd07-1191-4817-b5d2-05e57d98f58e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_DebtExpenseMember_c1d8091e-d9df-4738-9486-465879fa68ab" xlink:href="dva-20220930.xsd#dva_DebtExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_36f8cd07-1191-4817-b5d2-05e57d98f58e" xlink:to="loc_dva_DebtExpenseMember_c1d8091e-d9df-4738-9486-465879fa68ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_aff4d84f-91d1-4860-90b0-91dd360cf2a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_d88a6bb4-c9ce-4db2-973b-7bd2ce097922" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_aff4d84f-91d1-4860-90b0-91dd360cf2a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_a7782f38-3615-4839-8144-cb1d9e086565" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_aff4d84f-91d1-4860-90b0-91dd360cf2a3" xlink:to="loc_us-gaap_HedgingRelationshipDomain_a7782f38-3615-4839-8144-cb1d9e086565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_8b09f814-5c24-4fd6-bf2c-ae13d2becb29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_a7782f38-3615-4839-8144-cb1d9e086565" xlink:to="loc_us-gaap_CashFlowHedgingMember_8b09f814-5c24-4fd6-bf2c-ae13d2becb29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_fe3d9bd2-52e6-4bb1-a6f5-a8ca6b15fc43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_d88a6bb4-c9ce-4db2-973b-7bd2ce097922" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_fe3d9bd2-52e6-4bb1-a6f5-a8ca6b15fc43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_e4b3ad5e-4e0a-465d-b430-032278cf633d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_fe3d9bd2-52e6-4bb1-a6f5-a8ca6b15fc43" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_e4b3ad5e-4e0a-465d-b430-032278cf633d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_f918d0c5-a899-4512-940d-6b8e2d61eab2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e4b3ad5e-4e0a-465d-b430-032278cf633d" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_f918d0c5-a899-4512-940d-6b8e2d61eab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_997add32-6da6-4afc-ba4f-418f2ec99db5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_d88a6bb4-c9ce-4db2-973b-7bd2ce097922" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_997add32-6da6-4afc-ba4f-418f2ec99db5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b6d5cf1c-a498-4944-820f-944b21932f92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_997add32-6da6-4afc-ba4f-418f2ec99db5" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b6d5cf1c-a498-4944-820f-944b21932f92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member_34a1c4df-617d-4ece-9162-689fcd61fa10" xlink:href="dva-20220930.xsd#dva_A2019InterestRateCapAgreementsEffectiveJune302020Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b6d5cf1c-a498-4944-820f-944b21932f92" xlink:to="loc_dva_A2019InterestRateCapAgreementsEffectiveJune302020Member_34a1c4df-617d-4ece-9162-689fcd61fa10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_30acf830-b64f-4984-863e-f649ae2ab32a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_d88a6bb4-c9ce-4db2-973b-7bd2ce097922" xlink:to="loc_us-gaap_DerivativeLineItems_30acf830-b64f-4984-863e-f649ae2ab32a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_bef0bb3f-b63b-4d00-8106-3b18ee029662" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_30acf830-b64f-4984-863e-f649ae2ab32a" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_bef0bb3f-b63b-4d00-8106-3b18ee029662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_796fc387-8b67-4966-9502-cb9ff2ce1a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_30acf830-b64f-4984-863e-f649ae2ab32a" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_796fc387-8b67-4966-9502-cb9ff2ce1a1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInceptionDates_cd437e46-7593-441f-93d5-7da3cbbb5428" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInceptionDates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_30acf830-b64f-4984-863e-f649ae2ab32a" xlink:to="loc_us-gaap_DerivativeInceptionDates_cd437e46-7593-441f-93d5-7da3cbbb5428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeMaturityDates_5298f1fc-89e5-4f74-ac24-cdf3e035adc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeMaturityDates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_30acf830-b64f-4984-863e-f649ae2ab32a" xlink:to="loc_us-gaap_DerivativeMaturityDates_5298f1fc-89e5-4f74-ac24-cdf3e035adc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_5373aa7b-969d-44c2-b6e8-6b433b325c4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_30acf830-b64f-4984-863e-f649ae2ab32a" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet_5373aa7b-969d-44c2-b6e8-6b433b325c4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_e3265457-7559-4c13-a734-bdf3b78a6495" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_30acf830-b64f-4984-863e-f649ae2ab32a" xlink:to="loc_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_e3265457-7559-4c13-a734-bdf3b78a6495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_78b0739a-a388-4e6a-b7ec-63b48cce22a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_30acf830-b64f-4984-863e-f649ae2ab32a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_78b0739a-a388-4e6a-b7ec-63b48cce22a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_afc25cc5-1e0c-4e9d-8b1e-5208be05cd27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_30acf830-b64f-4984-863e-f649ae2ab32a" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_afc25cc5-1e0c-4e9d-8b1e-5208be05cd27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermdebtAdditionalInformationDetail" xlink:type="simple" xlink:href="dva-20220930.xsd#LongtermdebtAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LongtermdebtAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_8259a63e-ac89-4569-9487-2a8d396f5025" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_0fce5ea4-6a84-4ca1-a90e-6cc06523b721" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8259a63e-ac89-4569-9487-2a8d396f5025" xlink:to="loc_us-gaap_DebtInstrumentTable_0fce5ea4-6a84-4ca1-a90e-6cc06523b721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_e4f65dfc-3cf2-4b5a-a612-21717ac25122" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_0fce5ea4-6a84-4ca1-a90e-6cc06523b721" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_e4f65dfc-3cf2-4b5a-a612-21717ac25122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f7773426-0355-4550-8fda-ad809ac9ccc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e4f65dfc-3cf2-4b5a-a612-21717ac25122" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f7773426-0355-4550-8fda-ad809ac9ccc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanAMember_3122c11c-b5be-41da-bbb8-5d26c2261748" xlink:href="dva-20220930.xsd#dva_TermLoanAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f7773426-0355-4550-8fda-ad809ac9ccc7" xlink:to="loc_dva_TermLoanAMember_3122c11c-b5be-41da-bbb8-5d26c2261748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_TermLoanB1Member_b8a20751-99b4-4dfd-b02d-34d9968c3b33" xlink:href="dva-20220930.xsd#dva_TermLoanB1Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f7773426-0355-4550-8fda-ad809ac9ccc7" xlink:to="loc_dva_TermLoanB1Member_b8a20751-99b4-4dfd-b02d-34d9968c3b33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SeniorSecuredCreditFacilitiesMember_a45d1dea-2e8b-468c-ab23-fbb74b878263" xlink:href="dva-20220930.xsd#dva_SeniorSecuredCreditFacilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f7773426-0355-4550-8fda-ad809ac9ccc7" xlink:to="loc_dva_SeniorSecuredCreditFacilitiesMember_a45d1dea-2e8b-468c-ab23-fbb74b878263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_96bd7895-a76b-43b8-9375-b121a125e264" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_0fce5ea4-6a84-4ca1-a90e-6cc06523b721" xlink:to="loc_us-gaap_CreditFacilityAxis_96bd7895-a76b-43b8-9375-b121a125e264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a2eb54a0-4ce5-4ea4-a45b-6933cd24c032" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_96bd7895-a76b-43b8-9375-b121a125e264" xlink:to="loc_us-gaap_CreditFacilityDomain_a2eb54a0-4ce5-4ea4-a45b-6933cd24c032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_9c1d46dc-31c3-45e0-b985-0633ec9550c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_a2eb54a0-4ce5-4ea4-a45b-6933cd24c032" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_9c1d46dc-31c3-45e0-b985-0633ec9550c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_d237d4f1-1daa-4259-a651-c246d73b8c4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_a2eb54a0-4ce5-4ea4-a45b-6933cd24c032" xlink:to="loc_us-gaap_LetterOfCreditMember_d237d4f1-1daa-4259-a651-c246d73b8c4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BilateralSecuredLetterOfCreditFacilityMember_44f01fc2-94a6-42c0-8fcb-2aa964c0af37" xlink:href="dva-20220930.xsd#dva_BilateralSecuredLetterOfCreditFacilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_a2eb54a0-4ce5-4ea4-a45b-6933cd24c032" xlink:to="loc_dva_BilateralSecuredLetterOfCreditFacilityMember_44f01fc2-94a6-42c0-8fcb-2aa964c0af37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f2049e26-117b-4039-ab8d-3d0100f46c96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_0fce5ea4-6a84-4ca1-a90e-6cc06523b721" xlink:to="loc_us-gaap_DebtInstrumentLineItems_f2049e26-117b-4039-ab8d-3d0100f46c96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_4f265d60-2c15-4159-b93c-7e6d9ca359ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f2049e26-117b-4039-ab8d-3d0100f46c96" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_4f265d60-2c15-4159-b93c-7e6d9ca359ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR_0f556e4c-9a3a-444c-912e-0a4dd000dbbd" xlink:href="dva-20220930.xsd#dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f2049e26-117b-4039-ab8d-3d0100f46c96" xlink:to="loc_dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR_0f556e4c-9a3a-444c-912e-0a4dd000dbbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebt_6696a823-fc4a-4cef-a420-6d936641fe03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SecuredDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f2049e26-117b-4039-ab8d-3d0100f46c96" xlink:to="loc_us-gaap_SecuredDebt_6696a823-fc4a-4cef-a420-6d936641fe03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_7415a9a5-3da0-4227-aa2f-a4a719b0d03f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f2049e26-117b-4039-ab8d-3d0100f46c96" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_7415a9a5-3da0-4227-aa2f-a4a719b0d03f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_e09b2e75-01e1-49dd-ab9f-d7b54b9ce636" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f2049e26-117b-4039-ab8d-3d0100f46c96" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_e09b2e75-01e1-49dd-ab9f-d7b54b9ce636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_a5f0d1ba-5aee-4ad1-b7c6-d7de308225ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtPercentageBearingFixedInterestRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f2049e26-117b-4039-ab8d-3d0100f46c96" xlink:to="loc_us-gaap_LongTermDebtPercentageBearingFixedInterestRate_a5f0d1ba-5aee-4ad1-b7c6-d7de308225ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_LongTermDebtPercentageBearingEconomicallyFixedInterestRate_f01156a5-2520-41b6-bd9f-1e0813665bb8" xlink:href="dva-20220930.xsd#dva_LongTermDebtPercentageBearingEconomicallyFixedInterestRate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f2049e26-117b-4039-ab8d-3d0100f46c96" xlink:to="loc_dva_LongTermDebtPercentageBearingEconomicallyFixedInterestRate_f01156a5-2520-41b6-bd9f-1e0813665bb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_fac0f8e4-0558-471f-bc95-13fab7787c31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f2049e26-117b-4039-ab8d-3d0100f46c96" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_fac0f8e4-0558-471f-bc95-13fab7787c31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_8b826a18-c164-4f20-a4b5-909b14c20b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f2049e26-117b-4039-ab8d-3d0100f46c96" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_8b826a18-c164-4f20-a4b5-909b14c20b7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_6f20d5e0-2b31-490e-8b76-4ab68ef73d22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f2049e26-117b-4039-ab8d-3d0100f46c96" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_6f20d5e0-2b31-490e-8b76-4ab68ef73d22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail" xlink:type="simple" xlink:href="dva-20220930.xsd#CommitmentsandContingenciesAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_01504933-f8e6-4722-b353-34e573c29d58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_9b31f1dc-e1d2-4bff-98df-f1d643ed152a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_01504933-f8e6-4722-b353-34e573c29d58" xlink:to="loc_us-gaap_OtherCommitmentsTable_9b31f1dc-e1d2-4bff-98df-f1d643ed152a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionTypeAxis_09fe9f7b-3d57-4afc-9b3a-a5456bf77094" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransactionTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_9b31f1dc-e1d2-4bff-98df-f1d643ed152a" xlink:to="loc_us-gaap_TransactionTypeAxis_09fe9f7b-3d57-4afc-9b3a-a5456bf77094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransactionDomain_72d520d5-ea2a-437d-b000-ff2c97d66159" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransactionTypeAxis_09fe9f7b-3d57-4afc-9b3a-a5456bf77094" xlink:to="loc_us-gaap_TransactionDomain_72d520d5-ea2a-437d-b000-ff2c97d66159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_IncrementalCashPortionMember_23129ef0-5d80-4b0c-bf4d-a851275f6e3a" xlink:href="dva-20220930.xsd#dva_IncrementalCashPortionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransactionDomain_72d520d5-ea2a-437d-b000-ff2c97d66159" xlink:to="loc_dva_IncrementalCashPortionMember_23129ef0-5d80-4b0c-bf4d-a851275f6e3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CashPaidForPortionPreviouslyRefundedMember_c27bf532-3f94-46c2-996c-019692bc622a" xlink:href="dva-20220930.xsd#dva_CashPaidForPortionPreviouslyRefundedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransactionDomain_72d520d5-ea2a-437d-b000-ff2c97d66159" xlink:to="loc_dva_CashPaidForPortionPreviouslyRefundedMember_c27bf532-3f94-46c2-996c-019692bc622a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_2dabcf76-ee8f-4161-9649-81ac57840d88" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_9b31f1dc-e1d2-4bff-98df-f1d643ed152a" xlink:to="loc_srt_LitigationCaseAxis_2dabcf76-ee8f-4161-9649-81ac57840d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_e3d0658b-4a2e-44b7-839d-2c85cef3f627" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_2dabcf76-ee8f-4161-9649-81ac57840d88" xlink:to="loc_srt_LitigationCaseTypeDomain_e3d0658b-4a2e-44b7-839d-2c85cef3f627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USAttorneyPrescriptionDrugInvestigationMember_1715a3e4-0340-442b-8bc9-4ec304e18835" xlink:href="dva-20220930.xsd#dva_USAttorneyPrescriptionDrugInvestigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_e3d0658b-4a2e-44b7-839d-2c85cef3f627" xlink:to="loc_dva_USAttorneyPrescriptionDrugInvestigationMember_1715a3e4-0340-442b-8bc9-4ec304e18835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsAxis_d60889e3-0edd-4ba2-9393-3f489ba4131d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_9b31f1dc-e1d2-4bff-98df-f1d643ed152a" xlink:to="loc_us-gaap_OtherCommitmentsAxis_d60889e3-0edd-4ba2-9393-3f489ba4131d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain_9f9fc1b3-8847-4149-afc4-a958fc59d035" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsAxis_d60889e3-0edd-4ba2-9393-3f489ba4131d" xlink:to="loc_us-gaap_OtherCommitmentsDomain_9f9fc1b3-8847-4149-afc4-a958fc59d035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CommitmentsToProvideOperatingCapitalMember_ed20bb0c-ff7a-401b-ab68-875c9eabb448" xlink:href="dva-20220930.xsd#dva_CommitmentsToProvideOperatingCapitalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsDomain_9f9fc1b3-8847-4149-afc4-a958fc59d035" xlink:to="loc_dva_CommitmentsToProvideOperatingCapitalMember_ed20bb0c-ff7a-401b-ab68-875c9eabb448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AgreementWithMedtronicMember_a65e329b-66bb-4c7b-b53f-09b5958ab89a" xlink:href="dva-20220930.xsd#dva_AgreementWithMedtronicMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsDomain_9f9fc1b3-8847-4149-afc4-a958fc59d035" xlink:to="loc_dva_AgreementWithMedtronicMember_a65e329b-66bb-4c7b-b53f-09b5958ab89a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_625cdb65-227f-475f-8bef-9ab56d03d444" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_9b31f1dc-e1d2-4bff-98df-f1d643ed152a" xlink:to="loc_us-gaap_OtherCommitmentsLineItems_625cdb65-227f-475f-8bef-9ab56d03d444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_8b6001e0-fea3-40f6-8342-f4b97089144e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_625cdb65-227f-475f-8bef-9ab56d03d444" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_8b6001e0-fea3-40f6-8342-f4b97089144e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CorporateIntegrityAgreementPeriod_9b4dbe01-2d82-4e33-9e29-683df0ed47ca" xlink:href="dva-20220930.xsd#dva_CorporateIntegrityAgreementPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_625cdb65-227f-475f-8bef-9ab56d03d444" xlink:to="loc_dva_CorporateIntegrityAgreementPeriod_9b4dbe01-2d82-4e33-9e29-683df0ed47ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_CorporateIntegrityAgreementExpirationDate_84f44e03-6ae6-40c7-965c-20d0ec81c0a4" xlink:href="dva-20220930.xsd#dva_CorporateIntegrityAgreementExpirationDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_625cdb65-227f-475f-8bef-9ab56d03d444" xlink:to="loc_dva_CorporateIntegrityAgreementExpirationDate_84f44e03-6ae6-40c7-965c-20d0ec81c0a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitment_c11f5611-824c-4fa5-a1d2-b0345135e20a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_625cdb65-227f-475f-8bef-9ab56d03d444" xlink:to="loc_us-gaap_OtherCommitment_c11f5611-824c-4fa5-a1d2-b0345135e20a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessAgreementDate_a91cedcb-5b22-4b62-9f39-68bf0222caab" xlink:href="dva-20220930.xsd#dva_BusinessAgreementDate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_625cdb65-227f-475f-8bef-9ab56d03d444" xlink:to="loc_dva_BusinessAgreementDate_a91cedcb-5b22-4b62-9f39-68bf0222caab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentDueInNextTwelveMonths_c21ccda9-fa66-48f5-b9cc-4db277b7f170" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentDueInNextTwelveMonths"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_625cdb65-227f-475f-8bef-9ab56d03d444" xlink:to="loc_us-gaap_OtherCommitmentDueInNextTwelveMonths_c21ccda9-fa66-48f5-b9cc-4db277b7f170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherNoncashAssetsCommitment_4a348933-5617-4705-937f-bf39ec055c95" xlink:href="dva-20220930.xsd#dva_OtherNoncashAssetsCommitment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_625cdb65-227f-475f-8bef-9ab56d03d444" xlink:to="loc_dva_OtherNoncashAssetsCommitment_4a348933-5617-4705-937f-bf39ec055c95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_AdditionalCashCommitment_dceb8b68-52f1-4f8e-8b48-9abf0e0eb784" xlink:href="dva-20220930.xsd#dva_AdditionalCashCommitment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_625cdb65-227f-475f-8bef-9ab56d03d444" xlink:to="loc_dva_AdditionalCashCommitment_dceb8b68-52f1-4f8e-8b48-9abf0e0eb784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentDueAfterFifthYear_f60359ac-601d-4d6c-a910-a016144cb5e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCommitmentDueAfterFifthYear"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_625cdb65-227f-475f-8bef-9ab56d03d444" xlink:to="loc_us-gaap_OtherCommitmentDueAfterFifthYear_f60359ac-601d-4d6c-a910-a016144cb5e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RegulatoryAndCommercialMilestonesBeginningDate_d5853113-0fec-470e-a1b9-857ad8cf3716" xlink:href="dva-20220930.xsd#dva_RegulatoryAndCommercialMilestonesBeginningDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_625cdb65-227f-475f-8bef-9ab56d03d444" xlink:to="loc_dva_RegulatoryAndCommercialMilestonesBeginningDate_d5853113-0fec-470e-a1b9-857ad8cf3716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_RegulatoryAndCommercialMilestonesEndingDate_2aaed9ea-5c7d-4be3-89b8-f8de537118a9" xlink:href="dva-20220930.xsd#dva_RegulatoryAndCommercialMilestonesEndingDate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_625cdb65-227f-475f-8bef-9ab56d03d444" xlink:to="loc_dva_RegulatoryAndCommercialMilestonesEndingDate_2aaed9ea-5c7d-4be3-89b8-f8de537118a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/LongtermincentivecompensationDetails" xlink:type="simple" xlink:href="dva-20220930.xsd#LongtermincentivecompensationDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/LongtermincentivecompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TextBlockAbstract_b3827bcc-b8e3-42a0-a65b-bb3863fd1207" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TextBlockAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a8217c75-ffa8-4c50-af0a-84224401c068" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TextBlockAbstract_b3827bcc-b8e3-42a0-a65b-bb3863fd1207" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a8217c75-ffa8-4c50-af0a-84224401c068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_7b2652ad-71db-4f05-a43c-b19dc1d02610" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a8217c75-ffa8-4c50-af0a-84224401c068" xlink:to="loc_us-gaap_AwardTypeAxis_7b2652ad-71db-4f05-a43c-b19dc1d02610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_595f50e9-1404-456e-9b41-2e7a05e1c636" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_7b2652ad-71db-4f05-a43c-b19dc1d02610" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_595f50e9-1404-456e-9b41-2e7a05e1c636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_f3fac6aa-bffb-413c-9e1c-9a19a2d3d6cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_595f50e9-1404-456e-9b41-2e7a05e1c636" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_f3fac6aa-bffb-413c-9e1c-9a19a2d3d6cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember_f89dbc1f-bed0-4b1d-970c-034010e3a0af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_595f50e9-1404-456e-9b41-2e7a05e1c636" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember_f89dbc1f-bed0-4b1d-970c-034010e3a0af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c3f0ac9c-a1c7-4397-9c4c-68c4c425d695" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a8217c75-ffa8-4c50-af0a-84224401c068" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c3f0ac9c-a1c7-4397-9c4c-68c4c425d695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_adb7bc2c-704c-45cf-be36-c574ba8fa38e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c3f0ac9c-a1c7-4397-9c4c-68c4c425d695" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_adb7bc2c-704c-45cf-be36-c574ba8fa38e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted_32a647cf-7e7a-4e4e-9f14-2feaa91d87e9" xlink:href="dva-20220930.xsd#dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c3f0ac9c-a1c7-4397-9c4c-68c4c425d695" xlink:to="loc_dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted_32a647cf-7e7a-4e4e-9f14-2feaa91d87e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_c63ae2d0-7d43-4965-a001-f6b8d160be1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c3f0ac9c-a1c7-4397-9c4c-68c4c425d695" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_c63ae2d0-7d43-4965-a001-f6b8d160be1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_b675826f-7dc8-43cc-b9b3-beeca9ce670c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c3f0ac9c-a1c7-4397-9c4c-68c4c425d695" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_b675826f-7dc8-43cc-b9b3-beeca9ce670c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_d53d7383-cc0e-4d39-b156-2ed501caefc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c3f0ac9c-a1c7-4397-9c4c-68c4c425d695" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_d53d7383-cc0e-4d39-b156-2ed501caefc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_968b04ec-b4cc-48c1-82e6-e712a3e81f00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c3f0ac9c-a1c7-4397-9c4c-68c4c425d695" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_968b04ec-b4cc-48c1-82e6-e712a3e81f00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SharerepurchasesShareRepurchaseTableDetails" xlink:type="simple" xlink:href="dva-20220930.xsd#SharerepurchasesShareRepurchaseTableDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SharerepurchasesShareRepurchaseTableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAbstract_d9620d8b-41d1-4eed-bc5d-f2275844a622" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_04fbfa37-2d4f-4459-ad80-ca3e72ea5d6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TreasuryStockValueAbstract_d9620d8b-41d1-4eed-bc5d-f2275844a622" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_04fbfa37-2d4f-4459-ad80-ca3e72ea5d6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_487cc122-c04c-4f69-acaa-57ef97c2d0b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_04fbfa37-2d4f-4459-ad80-ca3e72ea5d6d" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_487cc122-c04c-4f69-acaa-57ef97c2d0b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_18f300fd-edde-4cd9-9b13-dbb97b56e44a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_487cc122-c04c-4f69-acaa-57ef97c2d0b5" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_18f300fd-edde-4cd9-9b13-dbb97b56e44a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OpenMarketPurchasesMember_60bfe1cc-fb6b-4b67-9c9c-64e8fd2d372f" xlink:href="dva-20220930.xsd#dva_OpenMarketPurchasesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_18f300fd-edde-4cd9-9b13-dbb97b56e44a" xlink:to="loc_dva_OpenMarketPurchasesMember_60bfe1cc-fb6b-4b67-9c9c-64e8fd2d372f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3d75bc1c-e59b-41a9-9733-6ffbdac215f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_04fbfa37-2d4f-4459-ad80-ca3e72ea5d6d" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3d75bc1c-e59b-41a9-9733-6ffbdac215f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_6b44de8c-afda-4b8d-aca0-733c4dce745d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3d75bc1c-e59b-41a9-9733-6ffbdac215f2" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_6b44de8c-afda-4b8d-aca0-733c4dce745d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_76885861-8d3b-4aeb-a1d9-7e6283c1ab2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3d75bc1c-e59b-41a9-9733-6ffbdac215f2" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_76885861-8d3b-4aeb-a1d9-7e6283c1ab2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_e43c629b-a694-48c1-9557-3149a0aa7257" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_3d75bc1c-e59b-41a9-9733-6ffbdac215f2" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_e43c629b-a694-48c1-9557-3149a0aa7257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SharerepurchasesDetails" xlink:type="simple" xlink:href="dva-20220930.xsd#SharerepurchasesDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SharerepurchasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_0210b1d3-0d36-4117-a14a-f0dc19663313" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_99a3375b-c418-46b8-96f4-cf342ac05908" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0210b1d3-0d36-4117-a14a-f0dc19663313" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_99a3375b-c418-46b8-96f4-cf342ac05908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_56ea0a0a-1bd0-4376-81c2-12242af70ffe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_99a3375b-c418-46b8-96f4-cf342ac05908" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_56ea0a0a-1bd0-4376-81c2-12242af70ffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_39fcaed5-2f1d-488e-bc54-9773a65f9daa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_56ea0a0a-1bd0-4376-81c2-12242af70ffe" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_39fcaed5-2f1d-488e-bc54-9773a65f9daa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_d83e7426-7549-4034-89e8-0eec36068bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_39fcaed5-2f1d-488e-bc54-9773a65f9daa" xlink:to="loc_us-gaap_SubsequentEventMember_d83e7426-7549-4034-89e8-0eec36068bf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ea104b2c-dda4-4c6a-9379-8d248231d137" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_99a3375b-c418-46b8-96f4-cf342ac05908" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ea104b2c-dda4-4c6a-9379-8d248231d137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_8450be25-fc0f-43db-90fa-96a1228921ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ea104b2c-dda4-4c6a-9379-8d248231d137" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_8450be25-fc0f-43db-90fa-96a1228921ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_90fc92f9-4722-4bc9-bad2-c26e0f24a12a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_ea104b2c-dda4-4c6a-9379-8d248231d137" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_90fc92f9-4722-4bc9-bad2-c26e0f24a12a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail" xlink:type="simple" xlink:href="dva-20220930.xsd#AccumulatedothercomprehensivelossincomeDetail"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2583f7c7-69b1-45b8-92d2-473ff98e55ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_4422eb44-7dd6-40cb-bdc3-f664f908878c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2583f7c7-69b1-45b8-92d2-473ff98e55ba" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_4422eb44-7dd6-40cb-bdc3-f664f908878c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_62d6398d-51af-4c48-b0bf-479c02aa049e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_4422eb44-7dd6-40cb-bdc3-f664f908878c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_62d6398d-51af-4c48-b0bf-479c02aa049e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2fd9b7ea-9c79-4b90-a49c-be01df9cd3af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_62d6398d-51af-4c48-b0bf-479c02aa049e" xlink:to="loc_us-gaap_EquityComponentDomain_2fd9b7ea-9c79-4b90-a49c-be01df9cd3af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_77910c4a-4106-4de3-bebd-00707780515b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2fd9b7ea-9c79-4b90-a49c-be01df9cd3af" xlink:to="loc_us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember_77910c4a-4106-4de3-bebd-00707780515b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_ae3d0549-97ee-43ae-9558-63ef89543a59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2fd9b7ea-9c79-4b90-a49c-be01df9cd3af" xlink:to="loc_us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember_ae3d0549-97ee-43ae-9558-63ef89543a59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_cc246a36-4254-49f2-a3d6-24e585454d89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2fd9b7ea-9c79-4b90-a49c-be01df9cd3af" xlink:to="loc_us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember_cc246a36-4254-49f2-a3d6-24e585454d89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_c8de9128-3261-49a0-8023-0a36d5c4111f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_4422eb44-7dd6-40cb-bdc3-f664f908878c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_c8de9128-3261-49a0-8023-0a36d5c4111f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9ce832cc-e144-4c8c-b2db-d173b2c8dd17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_c8de9128-3261-49a0-8023-0a36d5c4111f" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9ce832cc-e144-4c8c-b2db-d173b2c8dd17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3a13cad4-eacf-4c6b-964f-51779441c743" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9ce832cc-e144-4c8c-b2db-d173b2c8dd17" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3a13cad4-eacf-4c6b-964f-51779441c743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_35987f30-a46d-4faa-ac48-9c4dc993c596" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9ce832cc-e144-4c8c-b2db-d173b2c8dd17" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_35987f30-a46d-4faa-ac48-9c4dc993c596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_9a24d71a-2fd7-4147-9df1-cabfd419de86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9ce832cc-e144-4c8c-b2db-d173b2c8dd17" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_9a24d71a-2fd7-4147-9df1-cabfd419de86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_9cacb4fb-03b1-4653-ac68-41c8d7538022" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9ce832cc-e144-4c8c-b2db-d173b2c8dd17" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_9cacb4fb-03b1-4653-ac68-41c8d7538022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_0702e86b-d1f1-4ba6-acaf-26a73e36bfb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9ce832cc-e144-4c8c-b2db-d173b2c8dd17" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_0702e86b-d1f1-4ba6-acaf-26a73e36bfb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_2a841e8d-5b0c-4f79-b8f0-761ff8dba047" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9ce832cc-e144-4c8c-b2db-d173b2c8dd17" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_2a841e8d-5b0c-4f79-b8f0-761ff8dba047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_e76b8b5e-e184-46fe-8894-ef9954151344" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9ce832cc-e144-4c8c-b2db-d173b2c8dd17" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_e76b8b5e-e184-46fe-8894-ef9954151344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c0627a37-7d28-4e39-a940-cf96934f1491" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_9ce832cc-e144-4c8c-b2db-d173b2c8dd17" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c0627a37-7d28-4e39-a940-cf96934f1491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/AcquisitionsanddivestituresContingentEarnoutobligationsDetails" xlink:type="simple" xlink:href="dva-20220930.xsd#AcquisitionsanddivestituresContingentEarnoutobligationsDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/AcquisitionsanddivestituresContingentEarnoutobligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_53cedc24-9f1b-480b-a3ee-150a4d8ffa10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c500d425-d550-4e03-b55f-282da156339b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract_53cedc24-9f1b-480b-a3ee-150a4d8ffa10" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c500d425-d550-4e03-b55f-282da156339b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3904623c-c4b5-4409-8337-de7f099d7353" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c500d425-d550-4e03-b55f-282da156339b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3904623c-c4b5-4409-8337-de7f099d7353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e104ed67-dca8-4393-b1c7-1d3a61377287" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3904623c-c4b5-4409-8337-de7f099d7353" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e104ed67-dca8-4393-b1c7-1d3a61377287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_ca8944ea-35b1-4f0b-ac2a-835864d1104b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e104ed67-dca8-4393-b1c7-1d3a61377287" xlink:to="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_ca8944ea-35b1-4f0b-ac2a-835864d1104b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_1757d4fa-a3c2-4466-8279-490f2bd50beb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c500d425-d550-4e03-b55f-282da156339b" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_1757d4fa-a3c2-4466-8279-490f2bd50beb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_6a86d4c8-7dc3-43e1-9302-f7bd5c7ae0d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1757d4fa-a3c2-4466-8279-490f2bd50beb" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_6a86d4c8-7dc3-43e1-9302-f7bd5c7ae0d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_55dcbce1-69ae-4d39-ad8d-b943450ed7b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1757d4fa-a3c2-4466-8279-490f2bd50beb" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_55dcbce1-69ae-4d39-ad8d-b943450ed7b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations_0e291574-0ea5-4a1f-a758-bf6abce9fc17" xlink:href="dva-20220930.xsd#dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1757d4fa-a3c2-4466-8279-490f2bd50beb" xlink:to="loc_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations_0e291574-0ea5-4a1f-a758-bf6abce9fc17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss_97760bc5-a499-4f13-82b1-fe9562f4677f" xlink:href="dva-20220930.xsd#dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1757d4fa-a3c2-4466-8279-490f2bd50beb" xlink:to="loc_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss_97760bc5-a499-4f13-82b1-fe9562f4677f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_529e584f-f4ff-4e79-94e9-bb3a7ce0ed9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1757d4fa-a3c2-4466-8279-490f2bd50beb" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_529e584f-f4ff-4e79-94e9-bb3a7ce0ed9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_dbb9bdf2-45f6-4707-9443-e5214f47309a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1757d4fa-a3c2-4466-8279-490f2bd50beb" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_dbb9bdf2-45f6-4707-9443-e5214f47309a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail" xlink:type="simple" xlink:href="dva-20220930.xsd#AcquisitionsanddivestituresAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_bd4fb656-28ce-4a5d-bf6a-65ab6341cc51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_09a1f89d-e59d-4df8-abe5-088361d99383" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_bd4fb656-28ce-4a5d-bf6a-65ab6341cc51" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_09a1f89d-e59d-4df8-abe5-088361d99383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_7cef3876-0144-4442-9841-a5da5185f0c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_09a1f89d-e59d-4df8-abe5-088361d99383" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_7cef3876-0144-4442-9841-a5da5185f0c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_07769d48-39ef-4bab-a8c4-d735c07788de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7cef3876-0144-4442-9841-a5da5185f0c4" xlink:to="loc_us-gaap_SegmentDomain_07769d48-39ef-4bab-a8c4-d735c07788de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedServicesMember_a98d4688-41d7-44f8-b8ce-5b07db978071" xlink:href="dva-20220930.xsd#dva_USDialysisAndRelatedServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_07769d48-39ef-4bab-a8c4-d735c07788de" xlink:to="loc_dva_USDialysisAndRelatedServicesMember_a98d4688-41d7-44f8-b8ce-5b07db978071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ForeignDialysisCentersMember_16197d1d-0187-47e8-a6be-eef2558d1acc" xlink:href="dva-20220930.xsd#dva_ForeignDialysisCentersMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_07769d48-39ef-4bab-a8c4-d735c07788de" xlink:to="loc_dva_ForeignDialysisCentersMember_16197d1d-0187-47e8-a6be-eef2558d1acc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_c78ddc89-7f45-49bc-890d-e3e875939429" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_09a1f89d-e59d-4df8-abe5-088361d99383" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_c78ddc89-7f45-49bc-890d-e3e875939429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_08de6afa-7402-4722-a029-468c91f38cc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_c78ddc89-7f45-49bc-890d-e3e875939429" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_08de6afa-7402-4722-a029-468c91f38cc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_aa2c3783-8173-420b-b3d2-0a67d45f53f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_08de6afa-7402-4722-a029-468c91f38cc2" xlink:to="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_aa2c3783-8173-420b-b3d2-0a67d45f53f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0fd8d241-e686-40d8-9ac6-e7e8339a5f89" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_09a1f89d-e59d-4df8-abe5-088361d99383" xlink:to="loc_srt_RangeAxis_0fd8d241-e686-40d8-9ac6-e7e8339a5f89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b235a572-5756-45c2-85b0-9789de7ed25f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_0fd8d241-e686-40d8-9ac6-e7e8339a5f89" xlink:to="loc_srt_RangeMember_b235a572-5756-45c2-85b0-9789de7ed25f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_103d172d-cefa-4cc6-ac7f-e1fb12cc39b8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b235a572-5756-45c2-85b0-9789de7ed25f" xlink:to="loc_srt_MinimumMember_103d172d-cefa-4cc6-ac7f-e1fb12cc39b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_30a2c441-557b-4867-9696-60c3673807e7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b235a572-5756-45c2-85b0-9789de7ed25f" xlink:to="loc_srt_MaximumMember_30a2c441-557b-4867-9696-60c3673807e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5058759b-afed-4ca8-bf89-5e8df023e1d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_09a1f89d-e59d-4df8-abe5-088361d99383" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5058759b-afed-4ca8-bf89-5e8df023e1d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_0e20e172-3325-4152-9c0e-a40649f2d302" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_5058759b-afed-4ca8-bf89-5e8df023e1d4" xlink:to="loc_us-gaap_RelatedPartyDomain_0e20e172-3325-4152-9c0e-a40649f2d302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_OtherCompaniesMember_a00b72ed-930f-4a49-9675-1660f20e713d" xlink:href="dva-20220930.xsd#dva_OtherCompaniesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_0e20e172-3325-4152-9c0e-a40649f2d302" xlink:to="loc_dva_OtherCompaniesMember_a00b72ed-930f-4a49-9675-1660f20e713d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_9939132b-0587-4700-bfe1-f236beab2480" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_09a1f89d-e59d-4df8-abe5-088361d99383" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_9939132b-0587-4700-bfe1-f236beab2480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_c3a8b95f-6f38-4325-8d38-108221314738" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_9939132b-0587-4700-bfe1-f236beab2480" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_c3a8b95f-6f38-4325-8d38-108221314738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember_064b6597-f642-456e-96ab-6ec44bede248" xlink:href="dva-20220930.xsd#dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_c3a8b95f-6f38-4325-8d38-108221314738" xlink:to="loc_dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember_064b6597-f642-456e-96ab-6ec44bede248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_7fd6d6b7-38b0-4a81-8b47-1cf5878de76f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_09a1f89d-e59d-4df8-abe5-088361d99383" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_7fd6d6b7-38b0-4a81-8b47-1cf5878de76f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1bb8f223-f722-4752-a513-4ae16585202f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_7fd6d6b7-38b0-4a81-8b47-1cf5878de76f" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1bb8f223-f722-4752-a513-4ae16585202f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_0c9333f0-9134-475a-8f1f-feb5f962f298" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1bb8f223-f722-4752-a513-4ae16585202f" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_0c9333f0-9134-475a-8f1f-feb5f962f298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_3974e41d-f3ec-4c9d-8251-aaedb723391e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1bb8f223-f722-4752-a513-4ae16585202f" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_3974e41d-f3ec-4c9d-8251-aaedb723391e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_f883a1a5-b5c8-43d0-8b37-9beff2448e09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_09a1f89d-e59d-4df8-abe5-088361d99383" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_f883a1a5-b5c8-43d0-8b37-9beff2448e09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired_1683b9a1-492b-49cd-a8c5-88ac9fd5b1aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f883a1a5-b5c8-43d0-8b37-9beff2448e09" xlink:to="loc_us-gaap_NumberOfBusinessesAcquired_1683b9a1-492b-49cd-a8c5-88ac9fd5b1aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_418d510b-02c4-4abb-b249-8b7a26c1006d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f883a1a5-b5c8-43d0-8b37-9beff2448e09" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_418d510b-02c4-4abb-b249-8b7a26c1006d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessCombinationContingentConsiderationAcquisitions_7846bcbe-7971-4db8-b366-a23391ab56b6" xlink:href="dva-20220930.xsd#dva_BusinessCombinationContingentConsiderationAcquisitions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f883a1a5-b5c8-43d0-8b37-9beff2448e09" xlink:to="loc_dva_BusinessCombinationContingentConsiderationAcquisitions_7846bcbe-7971-4db8-b366-a23391ab56b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_d76c3afe-4355-422d-baa4-99441967d26a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f883a1a5-b5c8-43d0-8b37-9beff2448e09" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_d76c3afe-4355-422d-baa4-99441967d26a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessAcquisitionGoodwillExpectedTaxDeductibleAmountAdjustment_d96b2be6-dfe6-4188-bb29-c09b7625b483" xlink:href="dva-20220930.xsd#dva_BusinessAcquisitionGoodwillExpectedTaxDeductibleAmountAdjustment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f883a1a5-b5c8-43d0-8b37-9beff2448e09" xlink:to="loc_dva_BusinessAcquisitionGoodwillExpectedTaxDeductibleAmountAdjustment_d96b2be6-dfe6-4188-bb29-c09b7625b483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod_bc800069-133d-4bca-953f-873a7d540d08" xlink:href="dva-20220930.xsd#dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f883a1a5-b5c8-43d0-8b37-9beff2448e09" xlink:to="loc_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod_bc800069-133d-4bca-953f-873a7d540d08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_2bd5c69c-aae4-4080-b5c7-29cf3dc24a51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_f883a1a5-b5c8-43d0-8b37-9beff2448e09" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_2bd5c69c-aae4-4080-b5c7-29cf3dc24a51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/VariableinterestentitiesAdditionalInformationDetail" xlink:type="simple" xlink:href="dva-20220930.xsd#VariableinterestentitiesAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/VariableinterestentitiesAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6189fb3d-0f6e-4145-8fa8-adbd50e85381" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_163de459-4881-4ffb-8dfd-260b9af3e22b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6189fb3d-0f6e-4145-8fa8-adbd50e85381" xlink:to="loc_us-gaap_StatementTable_163de459-4881-4ffb-8dfd-260b9af3e22b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_cf2e22b7-630a-4da4-b5e1-596ea24e992d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_163de459-4881-4ffb-8dfd-260b9af3e22b" xlink:to="loc_srt_ConsolidatedEntitiesAxis_cf2e22b7-630a-4da4-b5e1-596ea24e992d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_43ca09dd-0a62-42e1-bdfe-b3eee2e699f7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_cf2e22b7-630a-4da4-b5e1-596ea24e992d" xlink:to="loc_srt_ConsolidatedEntitiesDomain_43ca09dd-0a62-42e1-bdfe-b3eee2e699f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_782aa6cf-ce8f-48ac-8474-96ef79c56edc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_43ca09dd-0a62-42e1-bdfe-b3eee2e699f7" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_782aa6cf-ce8f-48ac-8474-96ef79c56edc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c9ec13da-794b-43be-a97b-bd1b06b9f121" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_163de459-4881-4ffb-8dfd-260b9af3e22b" xlink:to="loc_us-gaap_StatementLineItems_c9ec13da-794b-43be-a97b-bd1b06b9f121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_4dd433b7-c832-41d5-b02e-76eb2cba3453" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c9ec13da-794b-43be-a97b-bd1b06b9f121" xlink:to="loc_us-gaap_Assets_4dd433b7-c832-41d5-b02e-76eb2cba3453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_0b9c7328-2e1b-41fb-9680-edbc5f80cb2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c9ec13da-794b-43be-a97b-bd1b06b9f121" xlink:to="loc_us-gaap_Liabilities_0b9c7328-2e1b-41fb-9680-edbc5f80cb2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail" xlink:type="simple" xlink:href="dva-20220930.xsd#FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_96b07544-0c95-41bb-a761-4e68dbc5d5d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_36bda6ad-71aa-4779-8ade-5991da382af0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_96b07544-0c95-41bb-a761-4e68dbc5d5d4" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_36bda6ad-71aa-4779-8ade-5991da382af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7fc9b941-d28e-45cb-8473-ed37f0c643d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_36bda6ad-71aa-4779-8ade-5991da382af0" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7fc9b941-d28e-45cb-8473-ed37f0c643d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_71184f03-2369-4351-9a19-998443815491" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_7fc9b941-d28e-45cb-8473-ed37f0c643d2" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_71184f03-2369-4351-9a19-998443815491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_fcb30c75-26aa-483f-92eb-7e5d0386b9a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_71184f03-2369-4351-9a19-998443815491" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_fcb30c75-26aa-483f-92eb-7e5d0386b9a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f16a88e1-2855-447d-b4b7-4816f8dd773a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_36bda6ad-71aa-4779-8ade-5991da382af0" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f16a88e1-2855-447d-b4b7-4816f8dd773a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6047978b-afc3-4f97-a273-ee5d49ad88da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_f16a88e1-2855-447d-b4b7-4816f8dd773a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6047978b-afc3-4f97-a273-ee5d49ad88da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_e24cbda0-edc1-40b0-a29a-ac33893194b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6047978b-afc3-4f97-a273-ee5d49ad88da" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_e24cbda0-edc1-40b0-a29a-ac33893194b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_9e5f967d-6795-4e0c-855f-ef42aeb78674" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6047978b-afc3-4f97-a273-ee5d49ad88da" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_9e5f967d-6795-4e0c-855f-ef42aeb78674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_da16ff6a-06a6-435e-bbdb-c24592bc4342" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6047978b-afc3-4f97-a273-ee5d49ad88da" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_da16ff6a-06a6-435e-bbdb-c24592bc4342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_4b1a14cf-f7c1-465c-bb27-3ee30ed5b2d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_36bda6ad-71aa-4779-8ade-5991da382af0" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_4b1a14cf-f7c1-465c-bb27-3ee30ed5b2d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6e51e1bd-e4a7-4f33-9445-24ced85571c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4b1a14cf-f7c1-465c-bb27-3ee30ed5b2d2" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6e51e1bd-e4a7-4f33-9445-24ced85571c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_4453ee42-8c65-408d-8072-8405827cc7a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6e51e1bd-e4a7-4f33-9445-24ced85571c4" xlink:to="loc_us-gaap_InterestRateCapMember_4453ee42-8c65-408d-8072-8405827cc7a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_5b771519-5166-4094-bcb7-6dd29933dd9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_36bda6ad-71aa-4779-8ade-5991da382af0" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_5b771519-5166-4094-bcb7-6dd29933dd9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_352d3fcf-5132-4498-bd36-9912deec54d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_5b771519-5166-4094-bcb7-6dd29933dd9f" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_352d3fcf-5132-4498-bd36-9912deec54d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_9b564b57-56a6-4cf6-9c29-628e36eb23fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_352d3fcf-5132-4498-bd36-9912deec54d8" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_9b564b57-56a6-4cf6-9c29-628e36eb23fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_a828f25b-a5d9-4010-92ae-a896333d9a8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_352d3fcf-5132-4498-bd36-9912deec54d8" xlink:to="loc_us-gaap_DerivativeAssets_a828f25b-a5d9-4010-92ae-a896333d9a8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_4dcc8d01-565a-46a7-b2ca-77e7d1e1ed2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_5b771519-5166-4094-bcb7-6dd29933dd9f" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_4dcc8d01-565a-46a7-b2ca-77e7d1e1ed2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_bc27be25-e50b-4099-93d6-3dd737256e19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_4dcc8d01-565a-46a7-b2ca-77e7d1e1ed2f" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_bc27be25-e50b-4099-93d6-3dd737256e19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAbstract_1c5965e2-2fe7-4aed-811f-850b6c1f04b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_5b771519-5166-4094-bcb7-6dd29933dd9f" xlink:to="loc_us-gaap_TemporaryEquityAbstract_1c5965e2-2fe7-4aed-811f-850b6c1f04b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_bfec396b-75d7-40a4-9816-2618d04a6132" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityAbstract_1c5965e2-2fe7-4aed-811f-850b6c1f04b8" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_bfec396b-75d7-40a4-9816-2618d04a6132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/FairvalueoffinancialinstrumentsFairValueofFinancialInstrumentsDetails" xlink:type="simple" xlink:href="dva-20220930.xsd#FairvalueoffinancialinstrumentsFairValueofFinancialInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/FairvalueoffinancialinstrumentsFairValueofFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_6e1a8945-7b5b-4798-bb54-8a261166fe9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple_8c9bd184-48c0-4212-bfac-1758e24da7d6" xlink:href="dva-20220930.xsd#dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6e1a8945-7b5b-4798-bb54-8a261166fe9e" xlink:to="loc_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple_8c9bd184-48c0-4212-bfac-1758e24da7d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail" xlink:type="simple" xlink:href="dva-20220930.xsd#SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_2de90e99-37f4-4fc0-a9f6-c67fa62e159b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2b1a774e-8fe4-4548-a2cd-d0784051fbd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_2de90e99-37f4-4fc0-a9f6-c67fa62e159b" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2b1a774e-8fe4-4548-a2cd-d0784051fbd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_d2390a59-842d-439b-ae93-88af80a56af5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2b1a774e-8fe4-4548-a2cd-d0784051fbd8" xlink:to="loc_srt_ConsolidationItemsAxis_d2390a59-842d-439b-ae93-88af80a56af5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_95055f55-a2f0-4393-b7cf-d115b270b87e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_d2390a59-842d-439b-ae93-88af80a56af5" xlink:to="loc_srt_ConsolidationItemsDomain_95055f55-a2f0-4393-b7cf-d115b270b87e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_af4b121d-8a52-47a5-b6af-c94b054ff945" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_95055f55-a2f0-4393-b7cf-d115b270b87e" xlink:to="loc_us-gaap_OperatingSegmentsMember_af4b121d-8a52-47a5-b6af-c94b054ff945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_5879fa5f-b006-4d74-ab16-f0a5adc80999" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_95055f55-a2f0-4393-b7cf-d115b270b87e" xlink:to="loc_us-gaap_IntersegmentEliminationMember_5879fa5f-b006-4d74-ab16-f0a5adc80999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ebc7bb29-e69d-40ab-b86c-324b4096dba6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2b1a774e-8fe4-4548-a2cd-d0784051fbd8" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ebc7bb29-e69d-40ab-b86c-324b4096dba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_bb67842d-a33a-48de-a030-80fc45730e29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ebc7bb29-e69d-40ab-b86c-324b4096dba6" xlink:to="loc_us-gaap_SegmentDomain_bb67842d-a33a-48de-a030-80fc45730e29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_73880cb9-bb56-48f5-984d-9d8400b2116e" xlink:href="dva-20220930.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_bb67842d-a33a-48de-a030-80fc45730e29" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_73880cb9-bb56-48f5-984d-9d8400b2116e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_a6d0b3ae-95f1-400b-9e58-63bcbd7d087d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_bb67842d-a33a-48de-a030-80fc45730e29" xlink:to="loc_us-gaap_AllOtherSegmentsMember_a6d0b3ae-95f1-400b-9e58-63bcbd7d087d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsAxis_ac6be34c-c659-4764-9f5a-6d648ee92bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsConsolidationItemsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2b1a774e-8fe4-4548-a2cd-d0784051fbd8" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsAxis_ac6be34c-c659-4764-9f5a-6d648ee92bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsConsolidationItemsDomain_53c46ac3-542c-4e1e-a81b-cc6e7893db50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsegmentsConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsAxis_ac6be34c-c659-4764-9f5a-6d648ee92bd2" xlink:to="loc_us-gaap_SubsegmentsConsolidationItemsDomain_53c46ac3-542c-4e1e-a81b-cc6e7893db50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_ExternalSourcesMember_73621efb-6626-4b0a-a944-78a6aca7f95b" xlink:href="dva-20220930.xsd#dva_ExternalSourcesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsDomain_53c46ac3-542c-4e1e-a81b-cc6e7893db50" xlink:to="loc_dva_ExternalSourcesMember_73621efb-6626-4b0a-a944-78a6aca7f95b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersubsegmentEliminationsMember_e9ca150b-78b1-4feb-8586-b5f23fc76ccc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersubsegmentEliminationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsConsolidationItemsDomain_53c46ac3-542c-4e1e-a81b-cc6e7893db50" xlink:to="loc_us-gaap_IntersubsegmentEliminationsMember_e9ca150b-78b1-4feb-8586-b5f23fc76ccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_7c9ac539-657b-4129-b254-3445db5e18d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_2b1a774e-8fe4-4548-a2cd-d0784051fbd8" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_7c9ac539-657b-4129-b254-3445db5e18d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_b4d0eca5-ccfa-45dc-972b-68f23c21b054" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7c9ac539-657b-4129-b254-3445db5e18d9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_b4d0eca5-ccfa-45dc-972b-68f23c21b054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncome_c52901b6-0f6d-4d16-a251-bb400d51b43e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7c9ac539-657b-4129-b254-3445db5e18d9" xlink:to="loc_us-gaap_OtherIncome_c52901b6-0f6d-4d16-a251-bb400d51b43e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_98c43fdf-6c34-44ba-af87-1e80b90e3518" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7c9ac539-657b-4129-b254-3445db5e18d9" xlink:to="loc_us-gaap_Revenues_98c43fdf-6c34-44ba-af87-1e80b90e3518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_48cb5783-41c2-4138-bae8-94ba6d841206" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7c9ac539-657b-4129-b254-3445db5e18d9" xlink:to="loc_us-gaap_OperatingIncomeLoss_48cb5783-41c2-4138-bae8-94ba6d841206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_SegmentReportingInformationCorporateExpenses_8073cda6-fda8-49f6-ba50-486ea99048ea" xlink:href="dva-20220930.xsd#dva_SegmentReportingInformationCorporateExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7c9ac539-657b-4129-b254-3445db5e18d9" xlink:to="loc_dva_SegmentReportingInformationCorporateExpenses_8073cda6-fda8-49f6-ba50-486ea99048ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDebtExpense_2f3ccaee-cdaa-49e4-8f90-2d528926a0bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndDebtExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7c9ac539-657b-4129-b254-3445db5e18d9" xlink:to="loc_us-gaap_InterestAndDebtExpense_2f3ccaee-cdaa-49e4-8f90-2d528926a0bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_a93579b3-a08d-498d-ba9f-a241b37f1a5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7c9ac539-657b-4129-b254-3445db5e18d9" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_a93579b3-a08d-498d-ba9f-a241b37f1a5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3275ce6e-f6d0-4025-9568-26ddbf2fb358" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7c9ac539-657b-4129-b254-3445db5e18d9" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3275ce6e-f6d0-4025-9568-26ddbf2fb358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail" xlink:type="simple" xlink:href="dva-20220930.xsd#SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_561f8665-f0d5-403f-aacb-705a101690cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_93e1d42d-752f-4250-a76f-6ccf2f6e4ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_561f8665-f0d5-403f-aacb-705a101690cb" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_93e1d42d-752f-4250-a76f-6ccf2f6e4ff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_eb9bf41b-18d4-42c2-8e6a-a71b71f933e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_93e1d42d-752f-4250-a76f-6ccf2f6e4ff1" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_eb9bf41b-18d4-42c2-8e6a-a71b71f933e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b38e8917-1994-4db0-bd5e-3f066eaf8b2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_eb9bf41b-18d4-42c2-8e6a-a71b71f933e7" xlink:to="loc_us-gaap_SegmentDomain_b38e8917-1994-4db0-bd5e-3f066eaf8b2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_0a724e58-a438-43ce-ab0d-675a8b789319" xlink:href="dva-20220930.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b38e8917-1994-4db0-bd5e-3f066eaf8b2f" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_0a724e58-a438-43ce-ab0d-675a8b789319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_172195e8-207c-4ef0-aa1a-e63a6ffb9e18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b38e8917-1994-4db0-bd5e-3f066eaf8b2f" xlink:to="loc_us-gaap_AllOtherSegmentsMember_172195e8-207c-4ef0-aa1a-e63a6ffb9e18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_94b8e61a-2e65-4dbc-b485-1d83a0875258" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_93e1d42d-752f-4250-a76f-6ccf2f6e4ff1" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_94b8e61a-2e65-4dbc-b485-1d83a0875258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_81b28093-a6f3-4312-8660-d11f697cd6c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_94b8e61a-2e65-4dbc-b485-1d83a0875258" xlink:to="loc_us-gaap_DepreciationAndAmortization_81b28093-a6f3-4312-8660-d11f697cd6c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail" xlink:type="simple" xlink:href="dva-20220930.xsd#SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_595b4d26-ba11-4211-a539-3bde9d2b75e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ea1f6b47-d0fc-4903-aa84-85cd1260c2c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_595b4d26-ba11-4211-a539-3bde9d2b75e5" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ea1f6b47-d0fc-4903-aa84-85cd1260c2c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_1f454cd7-b4d6-4f10-a207-c55d49daea27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ea1f6b47-d0fc-4903-aa84-85cd1260c2c9" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_1f454cd7-b4d6-4f10-a207-c55d49daea27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7ebf11a8-9b8d-44fd-ac49-86a974568c84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1f454cd7-b4d6-4f10-a207-c55d49daea27" xlink:to="loc_us-gaap_SegmentDomain_7ebf11a8-9b8d-44fd-ac49-86a974568c84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_f03f3031-f9db-4644-8a4e-5bbd99ec9e2a" xlink:href="dva-20220930.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7ebf11a8-9b8d-44fd-ac49-86a974568c84" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_f03f3031-f9db-4644-8a4e-5bbd99ec9e2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_c3a35795-b302-4a74-888d-b383e31adbf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_7ebf11a8-9b8d-44fd-ac49-86a974568c84" xlink:to="loc_us-gaap_AllOtherSegmentsMember_c3a35795-b302-4a74-888d-b383e31adbf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_fe3782a5-05d5-4eb2-82f5-9d768627ed38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ea1f6b47-d0fc-4903-aa84-85cd1260c2c9" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_fe3782a5-05d5-4eb2-82f5-9d768627ed38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_237e839c-ee38-483e-b363-098aef1ead35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_fe3782a5-05d5-4eb2-82f5-9d768627ed38" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_237e839c-ee38-483e-b363-098aef1ead35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.davita.com/role/SegmentreportingSummaryofAssetsbySegmentDetail" xlink:type="simple" xlink:href="dva-20220930.xsd#SegmentreportingSummaryofAssetsbySegmentDetail"/>
  <link:presentationLink xlink:role="http://www.davita.com/role/SegmentreportingSummaryofAssetsbySegmentDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_84fad091-a300-4e4b-9103-df2d2bb28bd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_94d9c5fb-cfb8-4094-bc28-1d955a5636d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_84fad091-a300-4e4b-9103-df2d2bb28bd5" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_94d9c5fb-cfb8-4094-bc28-1d955a5636d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_54575fca-fece-4a1e-9216-3e38e8b0839c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_94d9c5fb-cfb8-4094-bc28-1d955a5636d0" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_54575fca-fece-4a1e-9216-3e38e8b0839c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_da2a658c-801b-496a-9d0f-8420ab4f02e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_54575fca-fece-4a1e-9216-3e38e8b0839c" xlink:to="loc_us-gaap_SegmentDomain_da2a658c-801b-496a-9d0f-8420ab4f02e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dva_USDialysisAndRelatedLabServicesMember_bd7d8771-8478-4d30-b266-a9b8376ec4f3" xlink:href="dva-20220930.xsd#dva_USDialysisAndRelatedLabServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_da2a658c-801b-496a-9d0f-8420ab4f02e6" xlink:to="loc_dva_USDialysisAndRelatedLabServicesMember_bd7d8771-8478-4d30-b266-a9b8376ec4f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_1f548006-3a08-4691-aa27-b9be678336b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_da2a658c-801b-496a-9d0f-8420ab4f02e6" xlink:to="loc_us-gaap_AllOtherSegmentsMember_1f548006-3a08-4691-aa27-b9be678336b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_65034b14-aa63-4add-a7e5-ba12ed55907b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_94d9c5fb-cfb8-4094-bc28-1d955a5636d0" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_65034b14-aa63-4add-a7e5-ba12ed55907b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_c6b20998-6dc2-459f-bf23-505570f08357" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_65034b14-aa63-4add-a7e5-ba12ed55907b" xlink:to="loc_us-gaap_AssetsAbstract_c6b20998-6dc2-459f-bf23-505570f08357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_6de0a184-05a1-4ee2-8dd4-93e509e6a643" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_c6b20998-6dc2-459f-bf23-505570f08357" xlink:to="loc_us-gaap_Assets_6de0a184-05a1-4ee2-8dd4-93e509e6a643" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>dva-20220930_g1.jpg
<TEXT>
begin 644 dva-20220930_g1.jpg
M_]C_X  02D9)1@ ! @$!*P$K  #_X@0>24-#7U!23T9)3$4  0$   0.5VEN
M  (0  !M;G1R4D="(%A96B 'V0 %  \ #@ >  !A8W-P35-&5     !,3E8
M                        ]M8  0    #3*TQ.5B
M                                             !%D97-C   !4
M '9D;6YD   !R    &%D;61D   !4    '9V=65D   "+    (9V:65W   "
MM    "1L=6UI   "V    !1M96%S   "[    "1R6%E:   #$    !1G6%E:
M   #)    !1B6%E:   #.    !1R5%)#   #3    !YG5%)#   #;    !YB
M5%)#   #C    !YW='!T   #K    !1B:W!T   #P    !1T96-H   #U
M  QC<')T   #X    "YD97-C         !Q,96YO=F\@5&AI;FM0860@3$-$
M($UO;FET;W(                      -BR0       _____Q$!  ",#Y<
M                          ",#Y<      (P/EP                !D
M97-C          =,96YO=F\                      -BR0       ____
M_R ,B0#X"XD                           #X"XD      /@+B0
M            9&5S8P         L4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET
M:6]N(&EN($E%0S8Q.38V+3(N,0                 T     H(     ,[M
M ' &- #-      @   #Y$@ $     /#]?R0(        )@   #B,0@#*#D,
MV;=  /AU0@   '9I97<      !.D_@ 47RX $,\4  /MRP $$PL  UR>
M 5A96B       $P)5@!0    5Q_F;65A<P         "
M     0   H\    "6%E:(        %P+   RCP  "%%865H@        =#0
M +T0   195A96B         FG   $%\  +F"8W5R=@         )   "&0PK
M'3LV>5;D?ARTZ___  !C=7)V          D   ()"[L>&3D*6U"$<[FT__\
M &-U<G8         "0   AX+VR'>/BAA\(UAP.C__P  6%E:(        /-1
M  $    !%LQ865H@                     '-I9R      04U$('1E>'0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 0D 9-+574YO)M
MI#W*X'X\5)9R>;!&WJB_RK/VL?:.G]I14ODW8KD?)S]+V^9-1116A(4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** ,7Q'_RQ_X'_P"RUG:==_9)E?/!
MX8#T]?PJ_P"(C\\8_P!EOYUC]J^;QU5TL=.I'>,H_A%'KX>"GAHP>S3_ #9V
M?6EJAHUS]HMU!/*?*?PZ?I5^OH:51581G':23/*G%PDXO=.P44459(5D:[>[
M%$"GEN6]AZ?C_GK5^]O%LHR[<GH!ZFN6DE:9V=SDDY->9FN+]E!T8/WYK7RC
M_P $[<#0YY>TE\,7IYO_ ( RNITI-EK$/]G/YDFN6(S78PIY:*OHH'Y"N;)8
MWG4GT44OO?\ P#7,9>["/=M_=_PX^BBBO</-"BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M3WI=NA'!!';(L<2A%48"J, ?@*DHHKB.X**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** &R1K,I1U#*1@@C((],&N#\2^ S$&N-/!*]
M3%U(]U/4_3\J[ZBM*-:=&5XOU71F5:A"O&TEZ/JCPPC!P:2O3?%'@V/5PUQ;
M )/CD9VK)]<=#[_G[>;W%O):NT<BE64X92,$'T(_7Z<UZ]#$0KJZT?6/4\?$
M8>=!V>L7L^C(J***V, HHHH Z7PSXQFT8K#.3)!T _B3W&>P_NG_ /7Z3:7<
M5]$LT+AT89!!R*\1K7\/^(KC0)=T?S1L<O&3@'MD<<$5Q8K!J?O4])=5T?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 V2-95*.
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MJ?\ H0KVVO-S'XH>C/4RWX9^J"BBBN ] **** "BBB@ HHHH **** "BBB@
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MU<O74?$3_D)C_KW3^;5R]>WAOX,/\)X.*_C5/\3"BBBMC$**** +%AQ<P_\
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MLT+E74\$<]>H(Z$'N/RYKU;P[KT>OVPE4;77 D3/W6Q_(]J\K$X5T7S+6#_
M]?"XM5URO2:_'T-6H+ZSCU""2WD'RR(5/X]_J.M3T5S)V=UT.EI-6>S/$KZS
M>PGD@D&&1V4^AP<9Y[=,5!7;_$;2-K1WT8X;"28]1]P_ED?E7$8KW:%3VM-2
M\M?5'A5Z7L:DH]%MZ/8****T,0HHHH *].\":P=1LO(<_/!A>O)4_=/X=/PK
MS*MCPIJW]CW\3DX1_P!V_IM/0X]C@_G7/C*7M:;MO'5?J=6"K>RJ*^TM'^AZ
MW1117C'M!1110 4444 %%%% !7)>*/&Z:<6M[/#R<AGX*H0<$#U8?D/?I1XY
M\2OIBBS@)$DB;F<'!522,#W.#SV'3DC'G).>M=V$PBFE4GMTCW]3@QF,<&Z<
M/BZOMZ$EQ<274C2RN7=CDDDDYZ=3_D5%2TE>DE966QY;=W=[A1113$:WA;3O
M[3U*",CY0V]OHGS?J<#\:]>KBOAMIVR*:\8?>(C3Z#EC]"<#\*[6O(QM3GJM
M=(Z?/J>U@:?LZ2?66ORZ!7D/BO\ Y"MU_P!=3_2O7J\A\5_\A6Z_ZZG^E7E_
M\27^']49YE_#C_C_ $9DTHXI**]0\DV="\47>A,!&=\6>8V/'X'L?\FO2]&U
MNVUR'S8&Y&-RG[RGW'\C7CG6K6F:E/I4Z3V[;6!Z=00>JD=P?3\N:Y<3A(U5
MS1TE^#.S#8R5+W9:P_%'M-%9^AZS#KMLL\7'9E/53C./\*T*\EIQ;3T:/734
MDFM4PHHHI#"BBB@#S/XB?\A,?]>Z?S:N7KJ/B)_R$Q_U[I_-JY>O;PW\&'^$
M\'%?QJG^)A1116QB%%%% !1110 4444 %%%% !72?#__ )"J_P#7*3^5<W72
M?#__ )"J_P#7*3^58XG^#/\ PF^%_C4_\1ZA1117B'NA1110 5DZ]XDMM 3,
MAW2$?+&#\Q]SZ#W_ "JUJ^I)I%I+<N,[%X'JQX4?B2*\?O;V74)GGF;<[G)/
M]!Z =A_D]6$PWMG>7P+\7V.7%XGV"48_'+\%W+VL^)KS6V(E?:F>(UX3\?4^
MYK*)S_GFDHKU8PC!6BK+R/(G.4VW)MM]PHHHJB HHHH **** "BBB@ HHHH
M*N:=JMUI4GF6\K(<\XY5OJ#P?RJG12E%2335T^C*C)Q=T[-=4>G>'/&D.K[8
M+C$<Q]_D8^Q/0^WZFNFKPP'%>A>"_%IOL6=VW[P#Y'/\0'\)_P!KT]?KU\S%
M8/V:YX;=5V/3PF,]HU"I\71]SL:***XCO"BBB@ HHHH **** "BBB@ HHHH
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M]O#M2HP:[)?=H>#B8N-::?\ ,W]^HE%%%;&(&EK1L/#NH:E@P6[D'^(C8O\
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M$QEIFQZNO/\ WRHK!XZBNK?HC>. KO=)>K/,Z*].;X?:6>@D'T?_ !!JK/\
M#:T88BN)5_W@KC\@%I+'47W7J@>7UET3]&>=T8KJM0^'M_; F%DG')P#M?\
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M_M[(9GE2/_?8+_,T)-[:B;2U>A/16%<^-M)MN//WGT16;]< ?K6;/\2;)?\
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M\D**** "MGP=_P A>U_WV_\ 0&K&K9\'?\A>U_WV_P#0&K*O_"G_ (6:X?\
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M1M-*NG'4Q[/^^R$_K7D>:]'+H:3GUV_5GFYE4=XP6UKO\A****] \T****
M9[5T?A'PN==D,LN5@C8 X_C. =H]!CK_ $/3GD4R$*!DD@ >YKV?2=/32K6*
MW0?<0 GU;JQ_$\UR8VLZ4%&.CGU\D=N"H*K-N6T+:>9/!!';(L<2A548"@8
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MRRO4_ ?_ ""(?]Z7_P!#-<>8?PE_C7Y,[LN_C/\ P/\ -'0T445Y1ZP4444
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M^E'\;#A?]U><?7D_G705Y^(QW-[M/1?S=?D>EA\#RVE4U?\ +T^8V.-845$
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MM,B!&&E)E(_WL8_\= K=KP\1/VE6;Z7T]$>]AH>SI076VOJPHHHK(V"BBB@
MHHHH *\E\91>3JUR/5E;_OI0W%>M5Y]\2-.:.XBNU'RNFQCV#+DC\P?TKKP$
MN6M9_:BU^IQYA!RHW7V9)_+;]3C****]8\<**** "MGP=_R%[7_?;_T!JQJV
M?!W_ "%[7_?;_P! :LJ_\*?^%FN'_BT_\2_,];HHHKPSWPHHHH 0@,"",@UY
M!XDTDZ+>R08^3.Z,^JMT_+D?A7L%87BSP\->MOD \Z/)C)X!]5/U_G^-=.$K
M>QJ:_#+1_HSFQE#VU/3XHZK]4>444^2-H6*.""IP0>"".O\ DTRO8WU/%M8*
M***!!1110 4444 %%%% !1110"+VALR:A:%>OVF''OEQ_.O9J\Z\!>'WN;@7
MTJ_NX\[,@_,_3/\ P'O[_0UZ+7DX^:G5LOLJS]3V,!!PI-O[3NEY!5;4;&/4
M[:6WD^[(A&>X/8_4'D59HKE3:=UNCK:333V9XI?V4FG3R6\HPR,0?3UR/7.<
MU6KT_P 8^&/[8B\^ ?OT'0<;U'\/U';\J\R=2A(8$$'!!XY''3L?6O9P]=5H
MI_:2]Y'B8F@Z$FOLMZ/R&T445N<X4444 %%%% !1110 4444 %%/CC>5U1%+
M,6   R22< 8K4UGPW<:'#;O,1F4-E1SM(P<$^N#_ )ZU+J14E%NTGLBU3DXN
M25XK=F11115$!1110 M=_P##2XW0W47]V1&_[Z!'3_@(KS^NH^'MY]GU(Q$\
M2Q,OXK\P_0&N;&1YJ,O*S.G!2Y:\?.Z^\],HHHKQSVPKS]$/C36VWG-O!G Y
MP5!P!]7/)]J[NY9EBD*]0C$?7'%<;\,POEW9_BW1?EAL?KFNBC[E.I47Q+E2
M?;FW?X'/77/4I4W\+NVN_+LB?Q7=75K>V5G93&$2@( N HRX4'&.V:6;1/$,
M"EX]0#L!G;TSQTY!%5O'+2IJ>GF%0T@*E 3@%A(-H/(X)QGFH]0\2Z]%*ME+
M##!)* %(_P!HX&&WLM;0C-PI\O)\+;YDKNS>O<PG*"G4YN?222Y6[+1678OZ
M/<KXWTZ6&[5?,C; <#H2/E<>AXY _E5?P)?RVD\^E3GF,N4&>A#8=>V1SD?B
M>];/A/P\= MV61@TDC!G*YP,# '/7O\ G6 @">,"$Z$MG'J;;)_6HO&7MH1U
M@ES1\K/H7:470G+2;:C+S33W.[HHHKD.PH:]_P @V\_Z]9__ $6U>-XKVK4K
M9KVUG@4@&2&1 3G +*0#Q]:X/_A6M[_SWA_\?_\ B:[L#6ITE+GE:[1P8^C4
MJN#A'FLF<A@T8-=?_P *UO?^>\/_ (__ /$T?\*UO?\ GO#_ ./_ /Q-=GUJ
MC_.OQ.+ZI7_D?X'(8-&#77_\*UO?^>\/_C__ ,31_P *UO?^>\/_ (__ /$T
M?6J/\Z_$/JE?^1_@<A@T8-=?_P *UO?^>\/_ (__ /$T?\*UO?\ GO#_ ./_
M /Q-'UJC_.OQ#ZI7_D?X'(8-&#77_P#"M;W_ )[P_P#C_P#\31_PK6]_Y[P_
M^/\ _P 31]:H_P Z_$/JE?\ D?X'(8-+BNN_X5K>_P#/>'_Q_P#^)H_X5K>_
M\]X?_'__ (FCZU1_G7XA]4K_ ,C_  .1I*[-/AG<'&ZYC'KA6/\ A5F+X9@?
MZR[)SU"QX_4L?Y5+QE%?:OZ)C6"KO[%O5HX.EKTJ#X=:=&<R/*_U8 ?H,_K6
MG:^%-+L\;+5"1W?,ASZ_.36<LPIK9-_@:QRZJ]VH_.YY1:V-Q?-M@B>0^BJ6
M_E70Z?\ #_4;LAIML [[CO?\E/\ ,BO2D18P%4  =@,"G5A/,*C^%*/GNSHI
MY=3C\3<O+9'/:7X'T[3L,ZF9_63!7\$''YYKH  H  P!2T5R3G*H[R;;\SLA
M3C35HI)>04445)04444 %%%% !1110 4444 17%M'=QM%*H9&&"#R#7GOB+P
M+-8[IK(&6/J4ZR+_ /%?S]1WKT>BM:->=!WB].J>QC6P\*ZM):K9K<\,P1Q2
M5Z]JWA>PUC+2Q[7/_+1/E?\ P/X@URE_\-[A"3:SJX]'RC?3(R#^GK7HT\=2
MFO>]U^>WWGFU,!5@_=]Y>6_W'&XI*U[GPGJMKPUJY]T_>>_\))JB^F7<9PUO
M*/K&P_I73&K"6TE]Z.>5*<='%_<RM15@:?<DX$,G_?#?X5/%H.HS?=M)C_VS
M8#\R,4.<5]I?>2H3>T7]Q0HK?MO VK7'6$1^[LH'Y D_I6W9?#7O=7'&>5C'
M_LS?_$UE+%48?:3]-3:&$K3^RUZZ'#JNXX'4\5TVA^!KO4R)+G,$7H0/,/T4
MYQGU/UYKNM,\.V&D_-!"-W]]OF?\ST_#%:5<=;'N2M37*N[W.VCEZAK4?,^R
MV*NG:9;Z5"(;=-JCKW8GU)/)-<I\0- ><"_A!)1=L@'7;V;\.A]L=LUVM(1G
M@URTJLJ<U-:OK?J==6C&K3<'HNENAX9UI:]'UOP!;W[M-:MY+GJI&8S].Z_A
MD>U<I=^"M5M?^6&\#H8V# _AP?TKU:>*I5%\2B^ST/(J82K3?PN2[K4PJ*NO
MHFH1_>M)AS_SR?\ PIT>@ZC)C%I/SW\I\?GBMN>'\R^\P]G/^5_<RCTYKI/
MFJC3]0\IS\LZ[#_O _*?SR/QJ"V\%ZM<$?Z/L'J[!?TSG]*W=-^&[*5:[N.A
M!VQ YSZ[V_\ B:Y\16H.$HN2=UTUU.G#T*ZG&:@U9]=-#N:*11M &2< <GJ:
M6O(/9"BBB@ HHHH *Q/&.G?VEIDH RT?[Q?JO7_QW-;=(0&&#R#50DX24ENG
M<F<%.+B]FFCPW%&*[*?X;7)D?RIHPF\[0Q;.W)QGY>N..*C_ .%:WO\ SWA_
M\?\ _B:]A8NCI[Z_$\5X.NG\#?W'(8-&#77_ /"M;W_GO#_X_P#_ !-'_"M;
MW_GO#_X__P#$T?6J/\Z_$/JE?^1_@<A@TN*Z[_A6M[_SWA_\?_\ B:/^%:WO
M_/>'_P ?_P#B:/K5'^=?B'U2O_(_P.1&:N:/IYU.\@MQ_'(,X[+U8_D#71?\
M*UO?^>\/_C__ ,36UX5\&R:'<O<3NCG850+GC)Y/('88_.HJXNFH2Y9)R:LC
M2C@ZCJ1YXM1OK?L=4JA % P , 4M%%>0>P%%%% !1110 4444 %4]6TR+6+9
M[:7HPX/4JPZ,/<5<HIIN+36C0FE)-/5,\9U?29]'F,,ZX/)4_P +#/W@>_7G
M]:HU[9>V%OJ,9BN(UD7T(Z>X/4'W%<K??#:VE.;:=X_]E@)!_-3^>:].ECX-
M)5%RONMCS*V7S3_=OF79[GGN#1@UV#_#2[!^6XB(]PP_H:3_ (5K>_\ />'_
M ,?_ /B:V^M4?YU^)S_5*_\ (_P.0P:VO!P_XF]K_OM_Z U:O_"M;W_GO#_X
M_P#_ !-7]"\"W6E7T-R\L3*C$D+NSRI'<#UJ*V)I2IS2FFW%]S2CAJT:D&X-
M)25WH=M1117D'L!1110 4444 <WXG\'Q:UF>'"3@#D_=?'0-CH?0_P Z\XO]
M/GTR3R[B-D;T/?W!Z'ZBO:ZKWEA;ZC'Y=Q&KKZ,,X]P>H/TKJH8R5)*,O>C^
M*]#DQ&"C6?-'W9?@_4\4I*]"U'X<02Y:TF,?^RXW+^8P?SS7/W?@/5;;.V-9
M!ZHX_DV#^&*]"&+HS7Q)/L]#SYX2M"_NM^:U.=HJ_+H&HP?>M)A[^6Q'Y@8J
M Z?<@X,,G_?#?X5KSQ?VE]Y@X37V7]Q7HJPNG73G"P2$^R,?Z59A\.ZE/C9:
M3>Q*,H_-@*'."WDOO!4YO:+^XSJ.E=':> =5GQO1(O=W'3_@&X@UO6'PVACP
M;J=GQ_"@V#Z9.3CZ8K&6+HP^U?TU-X8.M/[-O70X&&&2X<)&A9CT51DG\*[3
MP_\ #]W(FU'@=?*!Y/\ O$=/H#^5=CI^DVFE+MMH5CXY('S'ZL>3^)JY7'6Q
MTIZ07*OQ.ZA@(T]9OF?;H-CC6)0B*%4   #  ],"G445Q':%%%% !7.>)?!T
M.M9FAQ'/CKT5_9L?S_/-='150J2IRYHNS)J4XU(N,E=,\6U#3+G2Y/+N8RC>
M_0X[@C@_A_.JHYKVV[LX+Z,QSQJZGLPR/K[&N4U+X<6T^6M96C.<A6_>+^!R
M"/UKT:6/A))5%RONM4>95R^<7>F^9=GHSSVDKHKOP)JEL3B)90.\;C^38;]*
MRYM#OX,[[688[^6V/SQBNN-:G)>[*+^9R2HU(/6$E\BC14_V"Y_YXR?]\-_A
M4L>CWTWW+:9OI$Y_I5<\>Z^\GDE_*_N*=+BMBW\'ZM<?=M6'^^53_P!"(/Y5
ML6?PVNI"#<31QC/1<R-CTYVC]364\32CO-?+7\C6&&K3V@]>^GYG'5J:-X;O
M-;(\E,)GF1N$'X]S],UZ!IO@C3=/PS(9F]9.5_[X&%_,&M]5"@ #  X%<M7,
M-U37SE_D==++MG4?RC_F8V@>%;70@& \R7&#(1T]E'\(_7U-2^)-&&N63P#&
M\8:,GLPZ?GTK5HKA]K-SYV[RO>YW^RAR."5HM6L>(3P26[F*12KJQ!4]0<XQ
M476O6]=\+6FNC<XV2 8$B]?H1_$/\YKB]0\ :C;,3$%F7G!4A6QGNK8_0FO4
MHXRG46K4)=4]ODSR:V"J4V^5.<>C6_S1S%%:,OA[4HOO6DW?I&S#W.0"*C71
M;]_NVLY^D3G^E='M(?S+[T<_LY_RO[F4JGLKM[">*>/[R.&'X'I^-:,'A+5;
MC[MHX_WL)_Z$16O9?#B[FYN)DB'HOSM_0#\S6<Z]**:E---;+5FE+#UI-.,&
MK/=Z+\3O[.Z2^ACGC.5D16'T(S4U4=&TB/1+<6\;LRABWS$<$\D  # SVJ]7
MBRM=VVOH>Y&]E?>VOJ%>?Z3-_P (AK,UM-\L,I^5CP,$YC;/MRI_$UZ!67KW
MA^WU^())\KKG8X&2I^G<'N*THSC'FC/X)JSMT[,RK4Y2Y90^.#NK];[KYF)X
MJADDUC3'1"0)8\D D#]ZN>1[5J>+-"&MV9"#]['EHSWSW7\<?GBL&WF\0^&!
MY+0_:H5X4C+8 ]"HW ?45.?'=[*-L6F2;^<9+-]. F3^E;<E1.FX.+4%I)26
MNM];F*G3M44^:+GJXN+TTMI;T+^@^)0VFM->AD>!0'+ @M_=(SU)Z?7V(K)\
M$V\NJ7]SJDHP"SA?3<QY ]E7C\:5="U?Q3*LFI-Y,(.1&, _@O.#[L<CWKLK
M2TBL8DAA4*B#  I5)0I1G&-G*;UMJDNR95.,ZLH2E=0@M+Z-ONT34445RG4%
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663294679024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Oct. 27, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-14106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">DAVITA INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">51-0354549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2000 16th Street<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Denver,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CO<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">80202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">631-2100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">DVA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000927066<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663295519600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF INCOME (unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts', window );">Dialysis patient service revenues</a></td>
<td class="nump">$ 2,846,494<span></span>
</td>
<td class="nump">$ 2,837,940<span></span>
</td>
<td class="nump">$ 8,372,874<span></span>
</td>
<td class="nump">$ 8,370,484<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">102,200<span></span>
</td>
<td class="nump">100,379<span></span>
</td>
<td class="nump">320,132<span></span>
</td>
<td class="nump">304,346<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">2,948,694<span></span>
</td>
<td class="nump">2,938,319<span></span>
</td>
<td class="nump">8,693,006<span></span>
</td>
<td class="nump">8,674,830<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_PatientCareCosts', window );">Patient care costs</a></td>
<td class="nump">2,085,555<span></span>
</td>
<td class="nump">2,008,589<span></span>
</td>
<td class="nump">6,120,872<span></span>
</td>
<td class="nump">5,912,196<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">365,447<span></span>
</td>
<td class="nump">293,095<span></span>
</td>
<td class="nump">975,486<span></span>
</td>
<td class="nump">872,612<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">194,414<span></span>
</td>
<td class="nump">170,462<span></span>
</td>
<td class="nump">538,534<span></span>
</td>
<td class="nump">505,852<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity investment income, net</a></td>
<td class="num">(8,509)<span></span>
</td>
<td class="num">(8,704)<span></span>
</td>
<td class="num">(24,696)<span></span>
</td>
<td class="num">(23,785)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating expenses</a></td>
<td class="nump">2,636,907<span></span>
</td>
<td class="nump">2,463,442<span></span>
</td>
<td class="nump">7,610,196<span></span>
</td>
<td class="nump">7,266,875<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">311,787<span></span>
</td>
<td class="nump">474,877<span></span>
</td>
<td class="nump">1,082,810<span></span>
</td>
<td class="nump">1,407,955<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestAndDebtExpense', window );">Debt expense</a></td>
<td class="num">(99,680)<span></span>
</td>
<td class="num">(72,829)<span></span>
</td>
<td class="num">(256,057)<span></span>
</td>
<td class="num">(213,167)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (loss) income, net</a></td>
<td class="num">(4,898)<span></span>
</td>
<td class="num">(7,590)<span></span>
</td>
<td class="num">(7,968)<span></span>
</td>
<td class="nump">8,766<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">207,209<span></span>
</td>
<td class="nump">394,458<span></span>
</td>
<td class="nump">818,785<span></span>
</td>
<td class="nump">1,203,554<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">42,515<span></span>
</td>
<td class="nump">74,704<span></span>
</td>
<td class="nump">163,757<span></span>
</td>
<td class="nump">241,224<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">164,694<span></span>
</td>
<td class="nump">319,754<span></span>
</td>
<td class="nump">655,028<span></span>
</td>
<td class="nump">962,330<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net income attributable to noncontrolling interests</a></td>
<td class="num">(59,328)<span></span>
</td>
<td class="num">(60,000)<span></span>
</td>
<td class="num">(162,731)<span></span>
</td>
<td class="num">(171,353)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to DaVita Inc.</a></td>
<td class="nump">$ 105,366<span></span>
</td>
<td class="nump">$ 259,754<span></span>
</td>
<td class="nump">$ 492,297<span></span>
</td>
<td class="nump">$ 790,977<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings per share attributable to DaVita Inc.:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income</a></td>
<td class="nump">$ 1.16<span></span>
</td>
<td class="nump">$ 2.48<span></span>
</td>
<td class="nump">$ 5.24<span></span>
</td>
<td class="nump">$ 7.41<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income</a></td>
<td class="nump">$ 1.13<span></span>
</td>
<td class="nump">$ 2.36<span></span>
</td>
<td class="nump">$ 5.07<span></span>
</td>
<td class="nump">$ 7.08<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average shares for earnings per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">91,160,000<span></span>
</td>
<td class="nump">104,793,000<span></span>
</td>
<td class="nump">93,959,000<span></span>
</td>
<td class="nump">106,685,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">93,263,000<span></span>
</td>
<td class="nump">109,838,000<span></span>
</td>
<td class="nump">97,153,000<span></span>
</td>
<td class="nump">111,666,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_PatientCareCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Patient care costs are costs directly associated with operating and supporting dialysis centers, medical clinics and ancillary operations and consist principally of labor, pharmaceuticals, medical supplies and facility operating costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_PatientCareCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue From Contract With Customer Including Assessed Tax Net Of Provision For Uncollectible Accounts</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndDebtExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest and debt related expenses associated with nonoperating financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndDebtExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663384193888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 164,694<span></span>
</td>
<td class="nump">$ 319,754<span></span>
</td>
<td class="nump">$ 655,028<span></span>
</td>
<td class="nump">$ 962,330<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Unrealized gains (losses) on interest rate cap agreements:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Unrealized gains (losses)</a></td>
<td class="nump">41,312<span></span>
</td>
<td class="num">(357)<span></span>
</td>
<td class="nump">95,660<span></span>
</td>
<td class="nump">2,466<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Reclassifications of net realized losses into net income</a></td>
<td class="nump">1,033<span></span>
</td>
<td class="nump">1,034<span></span>
</td>
<td class="nump">3,100<span></span>
</td>
<td class="nump">3,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Unrealized losses on foreign currency translation:</a></td>
<td class="num">(66,100)<span></span>
</td>
<td class="num">(54,528)<span></span>
</td>
<td class="num">(95,064)<span></span>
</td>
<td class="num">(59,162)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive (loss) income</a></td>
<td class="num">(23,755)<span></span>
</td>
<td class="num">(53,851)<span></span>
</td>
<td class="nump">3,696<span></span>
</td>
<td class="num">(53,596)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Total comprehensive income</a></td>
<td class="nump">140,939<span></span>
</td>
<td class="nump">265,903<span></span>
</td>
<td class="nump">658,724<span></span>
</td>
<td class="nump">908,734<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Less: Comprehensive income attributable to noncontrolling interests</a></td>
<td class="num">(59,328)<span></span>
</td>
<td class="num">(60,000)<span></span>
</td>
<td class="num">(162,731)<span></span>
</td>
<td class="num">(171,353)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income attributable to DaVita Inc.</a></td>
<td class="nump">$ 81,611<span></span>
</td>
<td class="nump">$ 205,903<span></span>
</td>
<td class="nump">$ 495,993<span></span>
</td>
<td class="nump">$ 737,381<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126980362&amp;loc=d3e28129-110885<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663283467216">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 367,510<span></span>
</td>
<td class="nump">$ 461,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Restricted cash and equivalents</a></td>
<td class="nump">94,704<span></span>
</td>
<td class="nump">93,060<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Short-term investments</a></td>
<td class="nump">74,305<span></span>
</td>
<td class="nump">22,310<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">2,089,017<span></span>
</td>
<td class="nump">1,957,583<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">106,845<span></span>
</td>
<td class="nump">107,428<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">392,851<span></span>
</td>
<td class="nump">427,321<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid and other current assets</a></td>
<td class="nump">65,807<span></span>
</td>
<td class="nump">72,517<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Income tax receivable</a></td>
<td class="nump">11,403<span></span>
</td>
<td class="nump">25,604<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">3,202,442<span></span>
</td>
<td class="nump">3,167,723<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">3,240,310<span></span>
</td>
<td class="nump">3,479,972<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">2,721,888<span></span>
</td>
<td class="nump">2,824,787<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">179,715<span></span>
</td>
<td class="nump">177,693<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Equity method and other investments</a></td>
<td class="nump">243,554<span></span>
</td>
<td class="nump">238,881<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Long-term investments</a></td>
<td class="nump">43,535<span></span>
</td>
<td class="nump">49,514<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">307,713<span></span>
</td>
<td class="nump">136,677<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">7,022,642<span></span>
</td>
<td class="nump">7,046,241<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">16,961,799<span></span>
</td>
<td class="nump">17,121,488<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>LIABILITIES AND EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">417,139<span></span>
</td>
<td class="nump">402,049<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other liabilities</a></td>
<td class="nump">796,200<span></span>
</td>
<td class="nump">709,345<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation and benefits</a></td>
<td class="nump">702,877<span></span>
</td>
<td class="nump">659,960<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liabilities</a></td>
<td class="nump">396,880<span></span>
</td>
<td class="nump">394,357<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">214,254<span></span>
</td>
<td class="nump">179,030<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income tax payable</a></td>
<td class="nump">10,059<span></span>
</td>
<td class="nump">53,792<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">2,537,409<span></span>
</td>
<td class="nump">2,398,533<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">2,558,355<span></span>
</td>
<td class="nump">2,672,713<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">8,867,187<span></span>
</td>
<td class="nump">8,729,150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">106,895<span></span>
</td>
<td class="nump">119,158<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="nump">819,073<span></span>
</td>
<td class="nump">830,954<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">14,888,919<span></span>
</td>
<td class="nump">14,750,508<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and contingencies:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Noncontrolling interests subject to put provisions</a></td>
<td class="nump">1,370,753<span></span>
</td>
<td class="nump">1,434,832<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred Stock, Value, Issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock, Value, Issued</a></td>
<td class="nump">98<span></span>
</td>
<td class="nump">97<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">609,345<span></span>
</td>
<td class="nump">540,321<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">846,634<span></span>
</td>
<td class="nump">354,337<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury Stock, Value</a></td>
<td class="num">(787,854)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(135,551)<span></span>
</td>
<td class="num">(139,247)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total DaVita Inc. shareholders' equity</a></td>
<td class="nump">532,672<span></span>
</td>
<td class="nump">755,508<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests not subject to put provisions</a></td>
<td class="nump">169,455<span></span>
</td>
<td class="nump">180,640<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="nump">702,127<span></span>
</td>
<td class="nump">936,148<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td>
<td class="nump">$ 16,961,799<span></span>
</td>
<td class="nump">$ 17,121,488<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.5(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663294649520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation', window );">Property and equipment, accumulated depreciation</a></td>
<td class="nump">$ 5,114,579<span></span>
</td>
<td class="nump">$ 4,763,135<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, accumulated amortization</a></td>
<td class="nump">$ 46,907<span></span>
</td>
<td class="nump">$ 60,730<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (usd per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (usd per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">450,000<span></span>
</td>
<td class="nump">450,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">98,199<span></span>
</td>
<td class="nump">97,289<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">90,104<span></span>
</td>
<td class="nump">97,289<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury Stock, Common, Shares</a></td>
<td class="nump">8,095<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of depreciation (related to long-lived, depreciable flight assets owned by the entity and used in the entity's principle business operations and capitalized assets classified as property, plant and equipment that are owned by the entity) that has been recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663295569856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 655,028<span></span>
</td>
<td class="nump">$ 962,330<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">538,534<span></span>
</td>
<td class="nump">505,852<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">77,904<span></span>
</td>
<td class="nump">75,898<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(35,637)<span></span>
</td>
<td class="nump">56,724<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi', window );">Equity investment income, net</a></td>
<td class="num">(417)<span></span>
</td>
<td class="num">(1,687)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other non-cash charges, net</a></td>
<td class="nump">16,035<span></span>
</td>
<td class="nump">13,418<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities, net of effect of acquisitions and divestitures:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(135,632)<span></span>
</td>
<td class="num">(205,792)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="nump">347<span></span>
</td>
<td class="num">(2,490)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets', window );">Other receivables and prepaid and other current assets</a></td>
<td class="nump">43,392<span></span>
</td>
<td class="nump">144,967<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other long-term assets</a></td>
<td class="num">(49,326)<span></span>
</td>
<td class="num">(19,663)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">38,870<span></span>
</td>
<td class="num">(47,412)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Accrued compensation and benefits</a></td>
<td class="nump">35,491<span></span>
</td>
<td class="num">(7,176)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities', window );">Other current liabilities</a></td>
<td class="nump">87,248<span></span>
</td>
<td class="num">(87,842)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes</a></td>
<td class="num">(37,770)<span></span>
</td>
<td class="nump">22,609<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities', window );">Other long-term liabilities</a></td>
<td class="num">(13,219)<span></span>
</td>
<td class="num">(8,748)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">1,220,848<span></span>
</td>
<td class="nump">1,400,988<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Additions of property and equipment</a></td>
<td class="num">(409,391)<span></span>
</td>
<td class="num">(451,909)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Acquisitions</a></td>
<td class="num">(43,811)<span></span>
</td>
<td class="num">(45,143)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets', window );">Proceeds from asset and business sales</a></td>
<td class="nump">116,088<span></span>
</td>
<td class="nump">46,578<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireHeldToMaturitySecurities', window );">Purchase of debt investments held-to-maturity</a></td>
<td class="num">(94,602)<span></span>
</td>
<td class="num">(13,274)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireOtherInvestments', window );">Purchase of other debt and equity investments</a></td>
<td class="num">(3,322)<span></span>
</td>
<td class="num">(2,609)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities', window );">Proceeds from debt investments held-to-maturity</a></td>
<td class="nump">40,660<span></span>
</td>
<td class="nump">13,274<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments', window );">Proceeds from sale of other debt and equity investments</a></td>
<td class="nump">3,763<span></span>
</td>
<td class="nump">11,976<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Other</a></td>
<td class="num">(782)<span></span>
</td>
<td class="num">(745)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Purchase of equity method investments</a></td>
<td class="num">(28,176)<span></span>
</td>
<td class="num">(7,925)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital', window );">Distributions from equity method investments</a></td>
<td class="nump">2,490<span></span>
</td>
<td class="nump">1,592<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(417,083)<span></span>
</td>
<td class="num">(448,185)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Borrowings</a></td>
<td class="nump">1,705,913<span></span>
</td>
<td class="nump">1,613,036<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations', window );">Payments on long-term debt</a></td>
<td class="num">(1,557,358)<span></span>
</td>
<td class="num">(812,659)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfFinancingCosts', window );">Deferred financing and debt redemption costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(9,091)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchase of treasury stock</a></td>
<td class="num">(802,228)<span></span>
</td>
<td class="num">(882,411)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDistributionsToAffiliates', window );">Distributions to noncontrolling interests</a></td>
<td class="num">(188,592)<span></span>
</td>
<td class="num">(177,146)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Net payments related to stock purchases and awards</a></td>
<td class="num">(42,248)<span></span>
</td>
<td class="num">(59,849)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromContributionsFromAffiliates', window );">Contributions from noncontrolling interests</a></td>
<td class="nump">11,382<span></span>
</td>
<td class="nump">28,295<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromMinorityShareholders', window );">Proceeds from sales of additional noncontrolling interests</a></td>
<td class="nump">3,673<span></span>
</td>
<td class="nump">2,880<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Purchases of noncontrolling interests</a></td>
<td class="num">(20,770)<span></span>
</td>
<td class="num">(11,658)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(890,228)<span></span>
</td>
<td class="num">(308,603)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash, cash equivalents and restricted cash</a></td>
<td class="num">(6,283)<span></span>
</td>
<td class="num">(7,381)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net (decrease) increase in cash, cash equivalents and restricted cash</a></td>
<td class="num">(92,746)<span></span>
</td>
<td class="nump">636,819<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of the year</a></td>
<td class="nump">554,960<span></span>
</td>
<td class="nump">501,790<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of the period</a></td>
<td class="nump">$ 462,214<span></span>
</td>
<td class="nump">$ 1,138,609<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net change during the reporting period in other current receivables and other current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAmortizationAndAccretionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAmortizationAndAccretionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123583714&amp;loc=SL75117360-209713<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3444-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDistributionsToAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The distributions of earnings to an entity that is affiliated with the reporting entity by means of direct or indirect ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDistributionsToAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for loan and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireHeldToMaturitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow through purchase of long-term held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireHeldToMaturitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromContributionsFromAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from an entity that is affiliated with the entity by means of direct or indirect ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromContributionsFromAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of distribution received from equity method investee for return of investment, classified as investing activities. Excludes distribution for return on investment, classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=SL94080555-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from the sale or maturity of long-term held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale and maturity (principal being due) of other investments, prepayment and call (request of early payment) of other investments not otherwise defined in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate cash proceeds received from a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for short-term and long-term debt and lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663280552320">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF EQUITY (unaudited) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Non- controlling interests subject to put provisions</div></th>
<th class="th"><div>Common stock</div></th>
<th class="th"><div>Additional paid-in capital</div></th>
<th class="th"><div>Retained earnings</div></th>
<th class="th"><div>Treasury stock</div></th>
<th class="th"><div>Accumulated other comprehensive loss</div></th>
<th class="th"><div>Non- controlling interests not subject to put provisions</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Temporary equity, starting balance at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,330,028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">121,774<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders', window );">Distributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(114,008)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders', window );">Contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures', window );">Acquisitions and divestitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,903<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_TemporaryEquityDecreasePurchaseOfInterests', window );">Partial purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(552)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValue', window );">Fair value remeasurements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,942<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Temporary equity, ending balance at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,423,917<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,383,566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 110<span></span>
</td>
<td class="nump">$ 597,073<span></span>
</td>
<td class="nump">$ 852,537<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (66,154)<span></span>
</td>
<td class="nump">$ 183,186<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109,933<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Comprehensive income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net income attributable to DaVita Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">790,977<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">790,977<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,579<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">$ (53,596)<span></span>
</td>
<td class="num">(53,596)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(53,596)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock award plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">953<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock award plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock award plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(74,760)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(74,761)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-settled stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,568<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,568<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestItemsAbstract', window );"><strong>Changes in noncontrolling interest from:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(63,138)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_NoncontrollingInterestIncreaseFromContributions', window );">Contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,465<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures', window );">Acquisitions and divestitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures', window );">Acquisitions and divestitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(351)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(351)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Partial purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,578)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,578)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(528)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestChangeInRedemptionValue', window );">Fair value remeasurements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(60,942)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(60,942)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchase of treasury stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(899,447)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (899,447)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchase of treasury stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,750)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,149,437<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 111<span></span>
</td>
<td class="nump">525,009<span></span>
</td>
<td class="nump">1,643,514<span></span>
</td>
<td class="num">$ (899,447)<span></span>
</td>
<td class="num">(119,750)<span></span>
</td>
<td class="nump">178,814<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, Ending balance (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,886<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, ending balance (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,750)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Temporary equity, starting balance at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,426,211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,182<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders', window );">Distributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(49,766)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders', window );">Contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,041<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures', window );">Acquisitions and divestitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,903<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValue', window );">Fair value remeasurements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,654)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Temporary equity, ending balance at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,423,917<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,277,780<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 111<span></span>
</td>
<td class="nump">523,038<span></span>
</td>
<td class="nump">1,383,760<span></span>
</td>
<td class="num">$ (563,230)<span></span>
</td>
<td class="num">(65,899)<span></span>
</td>
<td class="nump">185,046<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, Beginning balance (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,644<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, Beginning balance (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,019)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Comprehensive income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net income attributable to DaVita Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">259,754<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">259,754<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,818<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(53,851)<span></span>
</td>
<td class="num">(53,851)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(53,851)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock award plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock award plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23,584)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23,584)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-settled stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,055<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,055<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestItemsAbstract', window );"><strong>Changes in noncontrolling interest from:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(28,018)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_NoncontrollingInterestIncreaseFromContributions', window );">Contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,329<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures', window );">Acquisitions and divestitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures', window );">Acquisitions and divestitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(351)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(351)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Partial purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,803)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,803)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(362)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestChangeInRedemptionValue', window );">Fair value remeasurements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,654<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,654<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchase of treasury stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(336,217)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (336,217)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchase of treasury stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,731)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,149,437<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 111<span></span>
</td>
<td class="nump">525,009<span></span>
</td>
<td class="nump">1,643,514<span></span>
</td>
<td class="num">$ (899,447)<span></span>
</td>
<td class="num">(119,750)<span></span>
</td>
<td class="nump">178,814<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, Ending balance (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,886<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, ending balance (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,750)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Temporary equity, starting balance at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,434,832<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113,157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders', window );">Distributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(125,534)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders', window );">Contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures', window );">Acquisitions and divestitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_TemporaryEquityDecreasePurchaseOfInterests', window );">Partial purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,633)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValue', window );">Fair value remeasurements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(52,218)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityOtherChanges', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">457<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Temporary equity, ending balance at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,370,753<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="nump">$ 936,148<span></span>
</td>
<td class="nump">755,508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 97<span></span>
</td>
<td class="nump">540,321<span></span>
</td>
<td class="nump">354,337<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(139,247)<span></span>
</td>
<td class="nump">180,640<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, Beginning balance (in shares) at Dec. 31, 2021</a></td>
<td class="nump">97,289<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97,289<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, Beginning balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Comprehensive income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net income attributable to DaVita Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">492,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">492,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,574<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">$ 3,696<span></span>
</td>
<td class="nump">3,696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock award plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">910<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Stock award plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock award plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(55,358)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(55,359)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-settled stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77,835<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77,835<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestItemsAbstract', window );"><strong>Changes in noncontrolling interest from:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(63,058)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_NoncontrollingInterestIncreaseFromContributions', window );">Contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,082<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures', window );">Acquisitions and divestitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">867<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Partial purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,609)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,609)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(193)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestChangeInRedemptionValue', window );">Fair value remeasurements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_NoncontrollingInterestChangesFromOther', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(457)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchase of treasury stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(787,854)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (787,854)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchase of treasury stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,095)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2022</a></td>
<td class="nump">$ 702,127<span></span>
</td>
<td class="nump">532,672<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 98<span></span>
</td>
<td class="nump">609,345<span></span>
</td>
<td class="nump">846,634<span></span>
</td>
<td class="num">$ (787,854)<span></span>
</td>
<td class="num">(135,551)<span></span>
</td>
<td class="nump">169,455<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, Ending balance (in shares) at Sep. 30, 2022</a></td>
<td class="nump">90,104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98,199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, ending balance (in shares) at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,095)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Temporary equity, starting balance at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,385,821<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders', window );">Distributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(48,275)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders', window );">Contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,996<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_TemporaryEquityDecreasePurchaseOfInterests', window );">Partial purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(215)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValue', window );">Fair value remeasurements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,779)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Temporary equity, ending balance at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,370,753<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">604,784<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 98<span></span>
</td>
<td class="nump">578,272<span></span>
</td>
<td class="nump">741,268<span></span>
</td>
<td class="num">$ (603,058)<span></span>
</td>
<td class="num">(111,796)<span></span>
</td>
<td class="nump">170,390<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, Beginning balance (in shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98,179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, Beginning balance (in shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,973)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Comprehensive income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net income attributable to DaVita Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105,366<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105,366<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,123<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">$ (23,755)<span></span>
</td>
<td class="num">(23,755)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23,755)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Stock award plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock award plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(986)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(986)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-settled stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,619<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,619<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestItemsAbstract', window );"><strong>Changes in noncontrolling interest from:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22,002)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_NoncontrollingInterestIncreaseFromContributions', window );">Contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">270<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures', window );">Acquisitions and divestitures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">867<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Partial purchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,339)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,339)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(193)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestChangeInRedemptionValue', window );">Fair value remeasurements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,779<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,779<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchase of treasury stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(184,796)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (184,796)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchase of treasury stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,122)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2022</a></td>
<td class="nump">$ 702,127<span></span>
</td>
<td class="nump">$ 532,672<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 98<span></span>
</td>
<td class="nump">$ 609,345<span></span>
</td>
<td class="nump">$ 846,634<span></span>
</td>
<td class="num">$ (787,854)<span></span>
</td>
<td class="num">$ (135,551)<span></span>
</td>
<td class="nump">$ 169,455<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, Ending balance (in shares) at Sep. 30, 2022</a></td>
<td class="nump">90,104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98,199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, ending balance (in shares) at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,095)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_NoncontrollingInterestChangesFromOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest Changes From Other</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_NoncontrollingInterestChangesFromOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Decrease Due To Acquisitions and Divestitures</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Increase Due To Acquisitions and Divestitures without Put provisions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_NoncontrollingInterestIncreaseFromContributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling interest increase from contributions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_NoncontrollingInterestIncreaseFromContributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_TemporaryEquityDecreasePurchaseOfInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Decrease Purchase Of Interests</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_TemporaryEquityDecreasePurchaseOfInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Decrease from Distributions to Noncontrolling Interest Holders</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Increase due to Acquisitions and Divestitures of the NCI with Put obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Increase From Contributions From Noncontrolling Interest Holders</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestChangeInRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in noncontrolling interest during the period as a result of a change in the redemption value of redeemable noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 16(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestChangeInRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromRedemptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569655-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4616395-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromRedemptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionToRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of accretion of temporary equity to its redemption value during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAccretionToRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.27(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityNetIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of net income or loss attributable to temporary equity interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityNetIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityOtherChanges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in temporary equity from changes classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityOtherChanges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663288995248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed consolidated interim financial statements Condensed consolidated interim financial statements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</a></td>
<td class="text">Condensed consolidated interim financial statementsThe unaudited condensed consolidated interim financial statements included in this report are prepared by the Company. In the opinion of management, all adjustments necessary for a fair presentation of the results of operations are reflected in these condensed consolidated interim financial statements. All significant intercompany accounts and transactions have been eliminated. The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of revenues, expenses, assets, liabilities, contingencies and noncontrolling interests subject to put provisions. The most significant estimates and assumptions underlying these financial statements and accompanying notes generally involve revenue recognition and accounts receivable, certain fair value estimates, accounting for income taxes and loss contingencies. The results of operations reflected in these interim financial statements may not necessarily be indicative of annual operating results. These condensed consolidated interim financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2021 (2021 10-K). Prior period classifications conform to the current period presentation. The Company has evaluated subsequent events through the date these condensed consolidated interim financial statements were issued and has included all necessary adjustments and disclosures.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663293585472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition Revenue Recognition<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TextBlockAbstract', window );"><strong>Text Block [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue Recognition [Text Block]</a></td>
<td class="text">Revenue recognition<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the Company's segment revenues by primary payor source:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.332%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.434%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other &#8212; Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other &#8212; Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dialysis patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,535,680&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,535,680&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,543,819&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,543,819&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,853&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,853&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other government</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,852&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,084&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,624&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195,884&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">880,812&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">936,982&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">862,218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,857&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">917,075&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other revenues:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,484&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,484&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,056&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,903&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,959&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,658&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations of intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,957)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,957)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,104)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,104)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,680,296&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268,398&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,948,694&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,675,942&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262,377&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,938,319&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Other primarily consists of management service fees earned in the respective Company line of business as well as other non-patient service revenue from the Company's U.S. ancillary services and international operations.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.332%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.434%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other - Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other - Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dialysis patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,529,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,529,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,586,278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,586,278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570,380&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570,380&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">585,053&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">585,053&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other government</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253,731&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349,633&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">603,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245,125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338,553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">583,678&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,570,054&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,734,356&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,528,499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,172&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,685,671&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other revenues:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255,204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255,204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243,085&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243,085&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">981&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">981&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,029&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,029&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,387&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,387&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,708&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations of intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,516)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,516)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70,424)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,294)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74,718)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,877,073&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">815,933&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,693,006&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,893,839&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">780,991&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,674,830&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Other primarily consists of management service fees earned in the respective Company line of business as well as other non-patient service revenue from the Company's U.S. ancillary services and international operations.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are significant uncertainties associated with estimating revenue, which generally take several years to resolve. These estimates are subject to ongoing insurance coverage changes, geographic coverage differences, differing interpretations of contract coverage and other payor issues, as well as patient issues, including determination of applicable primary and secondary coverage, changes in patient insurance coverage and coordination of benefits. As these estimates are refined over time, both positive and negative adjustments to revenue are recognized in the current period.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dialysis patient service revenues. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues are recognized based on the Company&#8217;s estimate of the transaction price the Company expects to collect as a result of satisfying its performance obligations. Dialysis patient service revenues are recognized in the period services are provided based on these estimates. Revenues consist primarily of payments from government and commercial health plans for dialysis services provided to patients. The Company maintains a usual and customary fee schedule for its dialysis treatments and related lab services; however, actual collectible revenue is normally recognized at a discount from the fee schedule.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other revenues.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Other revenues consist of revenues earned by the Company's non-dialysis ancillary services as well as fees for management and administrative services to outpatient dialysis businesses that the Company does not consolidate. Other revenues are estimated in the period services are provided. The Company's U.S. ancillary service revenues include revenues earned under risk-based arrangements in the Company's integrated kidney care (IKC) business, including value-based care (VBC) arrangements. Under its VBC arrangements, the Company assumes full or shared financial risk for the total medical cost of care for patients below or above a benchmark. The benchmarks against which the Company incurs profit or loss on these contracts are typically based on the underlying premiums paid to the insuring entity (the Company's counterparty), with adjustments where applicable, or on trended or adjusted medical cost targets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TextBlockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TextBlockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663293786048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per share (Notes)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share [Text Block]</a></td>
<td class="text">Earnings per share<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is calculated by dividing net income attributable to the Company by the weighted average number of common shares outstanding. Weighted average common shares outstanding include restricted stock unit awards that are no longer subject to forfeiture because the recipients have satisfied either the explicit vesting terms or retirement eligibility requirements.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted earnings per share includes the dilutive effect of outstanding stock-settled stock appreciation rights and unvested stock units as computed under the treasury stock method.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliations of the numerators and denominators used to calculate basic and diluted earnings per share were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to DaVita Inc.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,366&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259,754&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492,297&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">790,977&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,793&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,959&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,685&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed incremental from stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,981&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,263&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,838&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,153&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,666&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income per share attributable to DaVita Inc.</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.16&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.48&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.24&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.41&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income per share attributable to DaVita Inc.</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anti-dilutive stock-settled awards excluded from calculation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">878&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Shares associated with stock awards excluded from the diluted denominator calculation because they were anti-dilutive under the treasury stock method.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663289102496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in debt and equity securities<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Investments in debt and equity securities</a></td>
<td class="text">Short-term and long-term investments<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s short-term and long-term debt and equity investments, consisting of debt instruments classified as held-to-maturity and equity investments with readily determinable fair values or redemption values, were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:41.652%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.833%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Equity<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Equity<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit and other time deposits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,843&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,843&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,226&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,226&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in mutual funds and common stocks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,997&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,997&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,843&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,997&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,840&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,226&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,598&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,824&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,832&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,473&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,305&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,227&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,083&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,310&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,011&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,524&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,999&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,515&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,514&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,843&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,997&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,840&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,226&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,598&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,824&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt securities:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company's short-term debt investments are principally bank certificates of deposit with contractual maturities longer than three months but shorter than one year. These debt securities are accounted for as held-to-maturity and recorded at amortized cost, which approximated their fair values at September&#160;30, 2022 and December&#160;31, 2021.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity securitie</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s: The Company holds certain equity investments that have readily determinable fair values from public markets. The Company's remaining short-term and long-term equity investments are held within a trust to fund existing obligations associated with the Company&#8217;s non-qualified deferred compensation plans.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2176304<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663288934048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillDisclosureTextBlock', window );">Goodwill</a></td>
<td class="text">Goodwill<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in goodwill by reportable segments were as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.888%"><tr><td style="width:1.0%"/><td style="width:39.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.143%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.622%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.143%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.622%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.145%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other &#8212; Ancillary services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,309,928&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">609,181&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,919,109&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,979&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173,244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,745)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,745)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44,367)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44,367)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,400,162&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">646,079&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,046,241&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,750&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,019&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,769&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,126)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,213)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55,155)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55,155)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,416,825&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">605,817&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,022,642&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2022:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,416,825&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715,147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,131,972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109,330)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109,330)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,416,825&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">605,817&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,022,642&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not recognize any goodwill impairment charges during the nine months ended September 30, 2022 and 2021.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As dialysis treatments are an essential, life-sustaining service for patients who depend on them, the Company's operations have continued and are currently expected to continue throughout the novel coronavirus (COVID-19) pandemic. However, the ultimate impact of this COVID-19 pandemic on the Company will depend on future developments that are highly uncertain and difficult to predict, including among others the ultimate severity and duration of the pandemic; further spread or resurgence of the virus, including as a result of the emergence of new strains of the virus such as the Omicron variant and its subvariants; COVID-19's impact on the chronic kidney disease (CKD) patient population and the Company's patient population, including on the mortality of these patients; the availability, acceptance, impact and efficacy of COVID-19 vaccines, treatments, and therapies; the pandemic's continuing impact on the Company's revenue and non-acquired growth due to lower treatment volumes, the U.S. and global economies, labor market conditions, interest rates, inflation and monetary policies; the Company's ability to successfully implement cost savings initiatives; the potential negative impact on the Company's commercial mix or the number of patients covered by commercial insurance plans; continued increased COVID-19-related costs; supply chain challenges and disruptions; the responses of the Company's competitors to the pandemic and related changes in the marketplace; the timing, scope and effectiveness of federal, state and local government responses to the pandemic; and any potential changes to the extensive set of federal, state and local laws, regulations and requirements that govern the Company's business. While the Company does not currently expect a material adverse impact to its business as a result of this public health crisis, there can be no assurance that the COVID-19 pandemic will not have a material adverse impact on one or more of the Company's businesses.</span></div>Developments, events, changes in operating performance and other changes in circumstances since the dates of the Company&#8217;s last annual goodwill impairment assessments have not caused management to believe it is more likely than not that the fair values of any of the Company's reporting units would be less than their respective carrying amounts as of September&#160;30, 2022. Except for the Company's Germany kidney care reporting unit as described further in Note 10 to the Company's consolidated financial statements included in the 2021 10-K, none of the Company's various other reporting units were considered at risk of significant goodwill impairment as of September&#160;30, 2022.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2144439<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663384167488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term debt<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Long-term debt</a></td>
<td class="text">Long-term debt<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt was comprised of the following:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.702%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">As of September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30, <br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Maturity date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest rate</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Estimated fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Secured Credit Facilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan A</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,531,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,596,875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/12/2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIBOR+1.75%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500,625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan B-1</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,667,689&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,688,263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/12/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIBOR+1.75%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,530,970&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving line of credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/12/2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIBOR+1.75%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Notes:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.625% Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,750,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,750,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/1/2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,124,375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75% Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/15/2031</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,068,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition obligations and other notes payable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,809&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022-2036</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,809&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing lease obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279,213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299,128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023-2038</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt principal outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,128,961&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,964,865&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount, premium and deferred financing costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,520)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56,685)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,081,441&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,908,180&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(214,254)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179,030)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,867,187&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,729,150&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For the Company's senior secured credit facilities and senior notes, fair value estimates are based upon bid and ask quotes, typically a level 2 input. For acquisition obligations and other notes payable, the carrying values presented approximate their estimated fair values, based on estimates of their present values using level 2 interest rate inputs. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The interest rate presented for acquisition obligations and other notes payable is their weighted average interest rate based on the current fixed and variable interest rate components in effect as of September&#160;30, 2022.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Financing lease obligations are measured at their approximate present values at inception. The interest rate presented is the weighted average discount rate embedded in financing leases outstanding.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As of September&#160;30, 2022, the carrying amount of the Company's senior secured credit facilities have been reduced by a discount of $3,740 and deferred financing costs of $20,891, and the carrying amount of the Company's senior notes have been reduced by deferred financing costs of $37,380 and increased by a debt premium of $14,491. As of December&#160;31, 2021, the carrying amount of the Company's senior secured credit facilities were reduced by a discount of $4,473 and deferred financing costs of $27,207, and the carrying amount of the Company's senior notes were reduced by deferred financing costs of $40,914 and increased by a debt premium of $15,909.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first nine months of 2022, the Company made regularly scheduled mandatory principal payments under its senior secured credit facilities totaling $65,625 on Term Loan A and $20,574 on Term Loan B-1.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, the Company's 2019 interest rate cap agreements have the economic effect of capping the Company's maximum exposure to LIBOR variable interest rate changes on equivalent amounts of the Company's floating rate debt, including all of Term Loan B-1 and a portion of Term Loan A. The remaining $698,939 outstanding principal balance of Term Loan A and the $275,000 balance outstanding on the revolving line of credit are subject to LIBOR-based interest rate volatility. These cap agreements are designated as cash flow hedges and, as a result, changes in their fair values are reported in other comprehensive income. The original premiums paid for the caps are amortized to debt expense on a straight-line basis over the term of each cap agreement starting from its effective date. These cap agreements do not contain credit risk-contingent features.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s interest rate cap agreements outstanding as of September&#160;30, 2022 and December&#160;31, 2021, which are classified in "Other long-term assets" on its consolidated balance sheet:&#160;</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:17.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.192%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.192%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.012%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.012%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.377%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended <br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">LIBOR maximum rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Effective date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expiration date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt expense</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Recorded OCI gain</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30, <br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 cap agreements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,500,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/30/2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/30/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOjMzNDNiOGQxYjAwNzRhZWFhMGYzMWJkOTU1ZWVjYmNiL3RhYmxlcmFuZ2U6MzM0M2I4ZDFiMDA3NGFlYWEwZjMxYmQ5NTVlZWNiY2JfMi05LTEtMS0zNjE1Njk_2f37a18b-1ac9-4872-985b-d24c04e03453">1,497</span>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,460&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139,663&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,203&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 9 for further details on amounts reclassified from accumulated other comprehensive loss and recorded as debt expense related to the Company&#8217;s interest rate cap agreements for the three and nine months ended September&#160;30, 2022 and 2021.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the LIBOR cap from our 2019 interest rate cap agreements, the Company&#8217;s weighted average effective interest rate on its senior secured credit facilities at the end of the third quarter of 2022 was 4.34%, based on the current margins in effect for its senior secured credit facilities as of September&#160;30, 2022, as detailed in the table above.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s overall weighted average effective interest rate for the three and nine months ended September&#160;30, 2022 was 4.28% and 3.78%, and as of September&#160;30, 2022 was 4.39%.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, the Company&#8217;s interest rates were fixed and economically fixed on approximately 50% and 89% of its total debt, respectively.</span></div>As of September&#160;30, 2022, the Company had $725,000 available and $275,000 drawn on its $1,000,000 revolving line of credit under its senior secured credit facilities. Credit available under this facility is reduced by the amount of any letters of credit outstanding under this facility, of which there were none as of September&#160;30, 2022. The Company also had approximately $108,002 in letters of credit outstanding under a separate bilateral secured letter of credit facility as of September&#160;30, 2022.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663290380512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDisclosures', window );">Contingencies</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commitments and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">contingencies</span><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the Company&#8217;s revenues are from government programs and may be subject to adjustment as a result of: (i)&#160;examination by government agencies or contractors, for which the resolution of any matters raised may take extended periods of time to finalize; (ii)&#160;differing interpretations of government regulations by different Medicare contractors or regulatory authorities; (iii)&#160;differing opinions regarding a patient&#8217;s medical diagnosis or the medical necessity of services provided; and (iv)&#160;retroactive applications or interpretations of governmental requirements. In addition, the Company&#8217;s revenues from commercial payors may be subject to adjustment as a result of potential claims for refunds, as a result of government actions or as a result of other claims by commercial payors.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in a highly regulated industry and is a party to various lawsuits, demands, claims, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> suits, governmental investigations (which frequently arise from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> suits) and audits (including, without limitation, investigations or other actions resulting from its obligation to self-report suspected violations of law) and other legal proceedings, including, without limitation, those described below. The Company records accruals for certain legal proceedings and regulatory matters to the extent that the Company determines an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. As of September&#160;30, 2022 and December&#160;31, 2021, the Company&#8217;s total recorded accruals with respect to legal proceedings and regulatory matters, net of anticipated third party recoveries, were immaterial. While these accruals reflect the Company&#8217;s best estimate of the probable loss for those matters as of the dates of those accruals, the recorded amounts may differ materially from the actual amount of the losses for those matters, and any anticipated third party recoveries for any such losses may not ultimately be recoverable. Additionally, in some cases, no estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made because of the inherently unpredictable nature of legal proceedings and regulatory matters, which also may be impacted by various factors, including, without limitation, that they may involve indeterminate claims for monetary damages or may involve fines, penalties or non-monetary remedies; present novel legal theories or legal uncertainties; involve disputed facts; represent a shift in regulatory policy; are in the early stages of the proceedings; or may result in a change of business practices. Further, there may be various levels of judicial review available to the Company in connection with any such proceeding.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a description of certain lawsuits, claims, governmental investigations and audits and other legal proceedings to which the Company is subject.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Certain Governmental Inquiries and Related Proceedings</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2016 U.S. Attorney Texas Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In February 2016, DaVita Rx, LLC (DaVita Rx), a wholly-owned subsidiary of the Company, received a Civil Investigative Demand (CID) from the U.S. Attorney&#8217;s Office, Northern District of Texas. The government is conducting a federal False Claims Act (FCA) investigation concerning allegations that DaVita Rx presented or caused to be presented false claims for payment to the government for prescription medications, as well as an investigation into the Company&#8217;s relationships with pharmaceutical manufacturers. The government&#8217;s investigation covers the period from January 1, 2006 through December 31, 2018. In December 2017, the Company finalized and executed a settlement agreement that resolved certain of the issues in the government&#8217;s investigation and that included total monetary consideration of $63,700, as previously disclosed, of which $41,500 was an incremental cash payment and $22,200 was for amounts previously refunded, and all of which was previously accrued. The government&#8217;s investigation is ongoing with respect to issues related to DaVita Rx&#8217;s historic relationships with certain pharmaceutical manufacturers, and in July 2018 the Office of Inspector General (OIG) served the Company with a subpoena seeking additional documents and information relating to those relationships. On September 15, 2021, the U.S. Attorney&#8217;s Office notified the U.S. District Court, Northern District of Texas, of its decision and the decision of 31 states not to elect to intervene at this time in the matter of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. ex rel. Doe v. DaVita Inc., et al</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The court then unsealed the complaint, which alleges violations of the FCA, by order dated September 17, 2021. The complaint was not served on the Company. In December 2021, the private party relator filed a notice of voluntary dismissal of all claims and the court entered an order dismissing the claims without prejudice. The Company is continuing to cooperate with the government in this investigation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2017 U.S. Attorney Colorado Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In November 2017, the U.S. Attorney&#8217;s Office, District of Colorado informed the Company of an investigation it was conducting into possible federal healthcare offenses involving DaVita Kidney Care, as well as several of the Company&#8217;s wholly-owned subsidiaries. In addition to DaVita Kidney Care, the matter currently includes an investigation into DaVita Rx, DaVita Laboratory Services, Inc. (DaVita Labs), and RMS Lifeline Inc. (Lifeline). In each of August 2018, May 2019, and July 2021, the Company received a CID pursuant to the FCA from the U.S. Attorney's Office relating to this investigation. In May 2020, the Company sold its interest in Lifeline, but the Company retained certain liabilities of the Lifeline business, including those related to this investigation. The Company is continuing to cooperate with the government in this investigation. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2020 U.S. Attorney New Jersey Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In March 2020, the U.S. Attorney&#8217;s Office, District of New Jersey served the Company with a subpoena and a CID relating to an investigation being conducted by that office and the U.S. Attorney&#8217;s Office, Eastern District of Pennsylvania. The subpoena and CID request information on several topics, including certain of the Company&#8217;s joint venture arrangements with physicians and physician groups, medical director agreements, and compliance with its five-year Corporate Integrity Agreement, the term of which expired October 22, 2019. On October 12, 2022, the U.S. Attorney&#8217;s Office notified the U.S. District Court, Eastern District of Pennsylvania, of its decision not to elect to intervene at this time in the matter of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. ex rel. Bayne v. DaVita Inc., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The court then unsealed a complaint, which alleges violations of federal and state False Claims Acts, by order dated October 14, 2022. The Company is continuing to cooperate with the government in this investigation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2020 California Department of Insurance Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In April 2020, the California Department of Insurance (CDI) sent the Company an Investigative Subpoena relating to an investigation being conducted by that office. CDI issued a superseding subpoena in September 2020 and an additional subpoena in September 2021. Those subpoenas request information on a number of topics, including but not limited to the Company&#8217;s communications with patients about insurance plans and financial assistance from the American Kidney Fund (AKF), analyses of the potential impact of patients&#8217; decisions to change insurance providers, and documents relating to donations or contributions to the AKF. The Company is continuing to cooperate with CDI in this investigation.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2020 Department of Justice Investigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In October 2020, the Company received a CID from the Department of Justice pursuant to an FCA investigation concerning allegations that DaVita Medical Group (DMG) may have submitted undocumented or unsupported diagnosis codes in connection with Medicare Advantage beneficiaries. The CID covers the period from January 1, 2015 through June 19, 2019, the date the Company completed the divestiture of DMG to Collaborative Care Holdings, LLC. The Company is continuing to cooperate with the government in this investigation.</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* * *</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Company cannot predict whether or when proceedings might be initiated or when these matters may be resolved (other than as may be described above), it is not unusual for inquiries such as these to continue for a considerable period of time through the various phases of document and witness requests and ongoing discussions with regulators and to develop over the course of time. In addition to the inquiries and proceedings specifically identified above, the Company frequently is subject to other inquiries by state or federal government agencies, many of which relate to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> complaints filed by relators. Negative findings or terms and conditions that the Company might agree to accept as part of a negotiated resolution of pending or future government inquiries or relator proceedings could result in, among other things, substantial financial penalties or awards against the Company, substantial payments made by the Company, harm to the Company&#8217;s reputation, required changes to the Company&#8217;s business practices, an impact on the Company's various relationships and/or contracts related to the Company's business, exclusion from future participation in the Medicare, Medicaid and other federal health care programs and, if criminal proceedings were initiated against the Company, members of its board of directors or management, possible criminal penalties, any of which could have a material adverse effect on the Company.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Proceedings</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2021 Antitrust Indictment and Putative Class Action Suit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: On July 14, 2021, an indictment was returned by a grand jury in the U.S. District Court, District of Colorado against the Company and its former chief executive officer in the matter of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">U.S. v. DaVita Inc., et al.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> alleging that purported agreements entered into by DaVita's former chief executive officer not to solicit senior-level employees violated Section 1 of the Sherman Act. On April 15, 2022, a jury returned a verdict in the Company&#8217;s favor, acquitting both the Company and its former chief executive officer on all counts. On April 20, 2022, the court entered judgments of acquittal and closed the case. On August 9, 2021, DaVita and its former chief executive officer were added as defendants in a consolidated putative class action complaint in the matter of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re Outpatient Medical Center Employee Antitrust Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the U.S. District Court, Northern District of Illinois. This class action complaint asserts that the defendants violated Section 1 of the Sherman Act and seeks to bring an action on behalf of certain groups of individuals employed by the Company between February 1, 2012 and January 5, 2021. On September 26, 2022, the court denied the Company's motion to dismiss. The Company disputes the allegations in the class action complaint, as well as the asserted violations of the Sherman Act, and intends to defend this action accordingly.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Marietta Memorial Hospital Employee Health Benefit Plan, et al. v. DaVita Inc. et al. No. 20-1641</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: On November 5, 2021, the United States Supreme Court granted certiorari of an appeal by an employer group health plan, the plan sponsor, and the plan&#8217;s advisor of the U.S. Court of Appeals for the Sixth Circuit (Sixth Circuit) decision in the Company's favor. The questions presented involved whether the health plan violates the Medicare Secondary Payor Act (MSPA) by "taking into account" that plan beneficiaries are eligible for Medicare and/or by "differentiating" between the benefits that the plan offers to patients with dialysis versus others. On December 23, 2021, the Solicitor General on behalf of the United States filed an amicus brief supporting the petitioners' request to overturn the Sixth Circuit decision. On January 19, 2022, the Company filed its brief in support of the Sixth Circuit decision. On June 21, 2022, the United States Supreme Court reversed the Sixth Circuit decision and held that the employee health plan for Marietta Memorial Hospital did not violate the MSPA. The case has been remanded back to the lower court for resolution of the outstanding claims. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, from time to time the Company is subject to other lawsuits, demands, claims, governmental investigations and audits and legal proceedings that arise due to the nature of its business, including, without limitation, contractual disputes, such as with payors, suppliers and others, employee-related matters and professional and general liability claims. From time to time, the Company also initiates litigation or other legal proceedings as a plaintiff arising out of contracts or other matters.</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* * *</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than as may be described above, the Company cannot predict the ultimate outcomes of the various legal proceedings and regulatory matters to which the Company is or may be subject from time to time, including those described in this Note 7, or the timing of their resolution or the ultimate losses or impact of developments in those matters, which could have a material adverse effect on the Company&#8217;s revenues, earnings and cash flows. Further, any legal proceedings or regulatory matters involving the Company, whether meritorious or not, are time consuming, and often require management&#8217;s attention and result in significant legal expense, and may result in the diversion of significant operational resources, may impact the Company's various relationships and/or contracts related to the Company's business or otherwise harm the Company&#8217;s business, results of operations, financial condition, cash flows or reputation.</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* * *</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsDisclosureTextBlock', window );">Noncontrolling interests subject to put provisions and other commitments</a></td>
<td class="text"><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Commitments</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has certain potential commitments to provide working capital funding, if necessary, to certain nonconsolidated outpatient dialysis businesses that the Company manages and in which the Company owns a noncontrolling equity interest or which are wholly-owned by third parties of approximately $9,431.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, on May&#160;25, 2022, the Company entered into an agreement with Medtronic, Inc. and one of its subsidiaries (collectively, Medtronic) to form a new, independent kidney care-focused medical device company (NewCo). The transaction is expected to close in 2023, subject to customary closing conditions and regulatory approvals. At close, the Company will make a cash payment to Medtronic of approximately $75,000, subject to certain customary adjustments prior to the closing, and will contribute certain other non-cash assets to NewCo valued at approximately $25,000. Additionally, at close, the Company and Medtronic each will contribute approximately $200,000 in cash to launch NewCo. The Company also agreed to pay Medtronic additional consideration of up to $300,000 if certain regulatory and commercial milestones are achieved between 2024 and 2028.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2127163<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6397426&amp;loc=d3e17499-108355<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 30<br> -URI https://asc.fasb.org/subtopic&amp;trid=2127197<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.Y.Q4)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011672&amp;loc=d3e149879-122751<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.Y.Q2)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011672&amp;loc=d3e149879-122751<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663288923232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' equity<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Long-term incentive compensation</a></td>
<td class="text">Shareholders' equity<div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock-based compensation</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2022, the Company granted 1,129 restricted and performance stock units with an aggregate grant-date fair value of $122,356 and a weighted-average expected life of approximately 3.5 years and 130 stock-settled stock appreciation rights with an aggregate grant-date fair value of $4,573 and a weighted-average expected life of approximately 4.5 years.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, the Company had $182,083 in total estimated but unrecognized stock-based compensation expense under the Company's equity compensation and employee stock purchase plans. The Company expects to recognize this expense over a weighted average remaining period of 1.3 years.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockTextBlock', window );">Share repurchases</a></td>
<td class="text"><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share repurchases</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's common stock repurchases during the three and nine months ended September&#160;30, 2022 and 2021: </span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.228%"><tr><td style="width:1.0%"/><td style="width:33.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.573%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.573%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.683%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:14.573%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.575%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Open market repurchases:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,731&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,095&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount paid</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184,797&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336,217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">787,854&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">899,447&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average paid per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123.14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.06&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not repurchase any shares subsequent to September&#160;30, 2022 through October&#160;27, 2022. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is authorized to make purchases from time to time in the open market or in privately negotiated transactions, including without limitation, through accelerated share repurchase transactions, derivative transactions, tender offers, Rule 10b5-1 plans or any combination of the foregoing, depending upon market conditions and other considerations.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October&#160;27, 2022, the Company had a total of $1,596,085 available under the current authorization for additional share repurchases. Although this share repurchase authorization does not have an expiration date, the Company remains subject to share repurchase limitations including under the terms of its current senior secured credit facilities.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -URI https://asc.fasb.org/subtopic&amp;trid=2208821<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663288995952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated other comprehensive (loss) income<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Comprehensive income</a></td>
<td class="text">Accumulated other comprehensive loss<div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.251%"><tr><td style="width:1.0%"/><td style="width:27.267%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.310%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.468%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.433%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.310%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.474%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest<br/>rate cap<br/>agreements</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign<br/>currency<br/>translation<br/>adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>other<br/>comprehensive<br/>loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest<br/>rate cap<br/>agreements</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign<br/>currency<br/>translation<br/>adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>other<br/>comprehensive<br/>loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,237&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(167,033)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111,796)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,178)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(138,069)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(139,247)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66,100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,055)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,460&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95,064)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,733)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,733)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,800)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,800)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,312&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66,100)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,788)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,660&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95,064)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification into net income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,377&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,377&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,132&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,132&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(344)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(344)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,032)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,032)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,033&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,033&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,582&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(233,133)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(135,551)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,582&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(233,133)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(135,551)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.251%"><tr><td style="width:1.0%"/><td style="width:27.267%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.310%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.468%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.433%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.310%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.474%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest<br/>rate cap<br/>agreements</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign<br/>currency<br/>translation<br/>adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>other<br/>comprehensive<br/>loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest<br/>rate cap<br/>agreements</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign<br/>currency<br/>translation<br/>adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>other<br/>comprehensive<br/>loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,577)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58,322)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65,899)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,466)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53,688)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66,154)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized (losses) gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(477)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,528)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55,005)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,284&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59,162)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55,878)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(818)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(818)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(357)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,528)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,885)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,466&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59,162)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56,696)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification into net income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,378&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,378&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,132&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,132&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(344)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(344)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,032)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,032)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,034&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,034&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,900)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112,850)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(119,750)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,900)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112,850)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(119,750)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest rate cap agreement net realized losses reclassified into net income are recorded as debt expense in the corresponding consolidated statements of income. See Note 6 for further details.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI https://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663288909968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and divestitures<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock', window );">Acquisitions and divestitures</a></td>
<td class="text">Acquisitions and divestitures<div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Routine acquisitions</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2022, the Company acquired dialysis businesses consisting of five dialysis centers located in the U.S. and eight dialysis centers located outside the U.S. for total net cash of $43,811, contingent earn-out obligations of $2,171 and deferred purchase price and liabilities assumed of $11,726. The assets and liabilities for these acquisitions were recorded at their estimated fair values at the dates of the acquisitions and are included in the Company&#8217;s condensed consolidated financial statements, as are their operating results, from the designated effective dates of the acquisitions.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The initial purchase price allocations have been recorded at estimated fair values based on information available to management and will be finalized when certain information arranged to be obtained has been received. In particular, certain income tax amounts are pending final evaluation and quantification of any pre-acquisition tax contingencies. In addition, valuation of intangibles, contingent earn-outs, leases, and certain other working capital items relating to these acquisitions are pending final quantification.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of goodwill recognized or adjusted during the nine months ended September&#160;30, 2022 that is deductible for tax purposes was $34,769.</span></div><div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent earn-out obligations</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has several contingent earn-out obligations associated with acquisitions that could result in the Company paying the former owners of acquired businesses a total of up to approximately $56,815 if certain performance targets or quality margins are met over the next one year to five years.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent earn-out obligations are remeasured to fair value at each reporting date until the contingencies are resolved with changes in the liability due to the remeasurement recognized in earnings. As of September&#160;30, 2022, the Company estimated the fair value of these contingent earn-out obligations to be $25,771, of which $9,461 is included in other current liabilities and the remaining $16,310 is included in other long-term liabilities in the Company&#8217;s consolidated balance sheet.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of changes in contingent earn-out obligations: </span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.093%"><tr><td style="width:1.0%"/><td style="width:58.604%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.678%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.679%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended<br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended <br/>September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,299&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(741)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value remeasurements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(350)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,129)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,085)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,274)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,771&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,771&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2122178<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663288968464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Variable interest entities<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityDisclosureTextBlock', window );">Variable interest entities</a></td>
<td class="text">Variable interest entities (VIEs)At September&#160;30, 2022, these condensed consolidated financial statements include total assets of consolidated VIEs of $298,477 and total liabilities and noncontrolling interests of consolidated VIEs to third parties of $196,159. There have been no material changes in the nature of the Company's arrangements with VIEs or its judgments concerning them from those described in Note 23 to the Company's consolidated financial statements included in the 2021 10-K.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663289079792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair value of financial instruments<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair value of financial instruments</a></td>
<td class="text">Fair values of financial instruments<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures the fair value of certain assets, liabilities and noncontrolling interests subject to put provisions (redeemable equity interests classified as temporary equity) based upon certain valuation techniques that include observable or unobservable inputs and assumptions that market participants would use in pricing these assets, liabilities, temporary equity and commitments. The Company has also classified assets, liabilities and temporary equities that are measured at fair value on a recurring basis into the appropriate fair value hierarchy levels as defined by the Financial Accounting Standards Board (FASB).</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s assets, liabilities and temporary equities measured at fair value on a recurring basis as of September&#160;30, 2022:&#160;</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.251%"><tr><td style="width:1.0%"/><td style="width:44.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.638%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.638%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.947%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Quoted prices in<br/>active&#160;markets<br/>for identical assets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Significant other<br/>observable&#160;inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Significant<br/>unobservable<br/>inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in equity securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,997&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,997&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate cap agreements</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139,663&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139,663&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent earn-out obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,771&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,771&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Temporary equity</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests subject to put provisions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,370,753&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,370,753&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For reconciliations of changes in contingent earn-out obligations and noncontrolling interests subject to put provisions during the three and nine months ended September&#160;30, 2022, see Note 10 and the consolidated statement of equity, respectively.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in equity securities represent investments in various open-ended registered investment companies (mutual funds) and common stocks and are recorded at fair value estimated based on reported market prices or redemption prices, as applicable. See Note 4 for further discussion.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate cap agreements are recorded at fair value estimated from valuation models utilizing the income approach and commonly accepted valuation techniques that use inputs from closing prices for similar assets and liabilities in active markets as well as other relevant observable market inputs at quoted intervals such as current interest rates, forward yield curves, implied volatility and credit default swap pricing. The Company does not believe the ultimate amount that could be realized upon settlement of these interest rate cap agreements would be materially different from the fair value estimates currently reported. See Note 6 for further discussion.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value measurements of contingent earn-out obligations are primarily based on unobservable inputs, including projected earnings before interest, taxes, depreciation, and amortization (EBITDA), revenue and certain operating metrics. The estimated fair values of these contingent earn-out obligations are remeasured as of each reporting date and could fluctuate based upon any significant changes in key assumptions, such as changes in the Company's credit risk adjusted rate that is used to discount obligations to present value. See Note 10 for further discussion.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of noncontrolling interests subject to put provisions is based principally on the higher of either estimated liquidation value of net assets or a multiple of earnings for each subject dialysis partnership, based on historical earnings, revenue mix, and other performance indicators that can affect future results. The multiples used for these valuations are derived from observed ownership transactions for dialysis businesses between unrelated parties in the U.S. in recent years, and the specific valuation multiple applied to each dialysis partnership is principally determined by its recent and expected revenue mix and contribution margin. As of September&#160;30, 2022, an increase or decrease in the weighted average multiple used in these valuations of one times EBITDA would change the estimated fair value of these noncontrolling interests by approximately $170,000. See Notes 17 and 24 to the Company's consolidated financial statements included in the 2021 10-K for further discussion of the Company&#8217;s methodology for estimating the fair value of noncontrolling interests subject to put obligations.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's fair value estimates for its senior secured credit facilities and senior notes are based upon bid and ask quotes for these instruments, typically a level 2 input. See Note 6 for further discussion of the Company's debt.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other financial instruments consist primarily of cash and cash equivalents, restricted cash and cash equivalents, accounts receivable, accounts payable, other accrued liabilities, lease liabilities and debt. The balances of financial instruments other than debt and lease liabilities are presented in these condensed consolidated financial statements at September&#160;30, 2022 at their approximate fair values due to the short-term nature of their settlements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663288965232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment reporting<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting Disclosure</a></td>
<td class="text">Segment reporting<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s operating divisions are comprised of its U.S. dialysis and related lab services business (its U.S. dialysis business), its U.S. integrated kidney care business, its U.S. other ancillary services and its international operations (collectively, its ancillary services), as well as its corporate administrative support. </span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s separate operating segments include its U.S. dialysis and related lab services business, its U.S. integrated kidney care business, its U.S. other ancillary services, its kidney care operations in each foreign sovereign jurisdiction, and its equity method investment in the Asia Pacific joint venture (APAC JV). The U.S. dialysis and related lab services business qualifies as a separately reportable segment, and all other operating segments have been combined and disclosed in the other segments category. See Note 25 to the Company's consolidated financial statements included in the 2021 10-K for further description of how the Company determines and measures results for its operating segments.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of segment net revenues, segment operating margin (loss), and a reconciliation of segment operating margin to consolidated income before income taxes:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dialysis patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">External sources</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,674,240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,669,823&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,858,939&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,874,759&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,007&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,526&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis patient service revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,697,197&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,691,830&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,923,465&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,944,955&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">External sources</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,056&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,080&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total U.S. dialysis revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,703,253&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,698,046&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,941,589&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,964,263&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other&#8212;Ancillary services</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dialysis patient service revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168,117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513,935&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495,725&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other external sources</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301,998&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285,266&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total ancillary services revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268,398&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262,377&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">815,933&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">785,285&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net segment revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,971,651&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,960,423&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,757,522&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,749,548&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elimination of intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,957)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,104)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,516)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74,718)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,948,694&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,938,319&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,693,006&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,674,830&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating margin (loss):</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351,474&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">509,939&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,230,715&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,523,625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other&#8212;Ancillary services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,271)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,909)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56,689)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,577)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment operating margin</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336,203&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503,030&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,174,026&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,487,048&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation of segment operating income to<br/>&#160;consolidated income before income taxes:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate administrative support</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,417)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,153)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91,217)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79,093)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311,787&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">474,877&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,082,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,407,955&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99,680)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72,829)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(256,057)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(213,167)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (loss) income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,898)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,590)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,968)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,766&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated income before income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,209&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394,458&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">818,785&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,203,554&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense by reportable segment was as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.175%"><tr><td style="width:1.0%"/><td style="width:44.982%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.568%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.649%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.653%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184,688&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161,252&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507,320&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477,054&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other&#8212;Ancillary services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,726&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,798&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194,414&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170,462&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538,534&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505,852&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expenditures for property and equipment by reportable segment were as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.005%"><tr><td style="width:1.0%"/><td style="width:62.459%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:16.696%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.647%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.698%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363,046&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415,994&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other&#8212;Ancillary services</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,915&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409,391&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451,909&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of assets by reportable segment were as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.538%"><tr><td style="width:1.0%"/><td style="width:58.542%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.581%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.794%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.583%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,223,532&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,375,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other&#8212;Ancillary services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,738,267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,746,488&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,961,799&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,121,488&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663289001808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New accounting standards<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract', window );"><strong>Accounting Changes and Error Corrections [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Standards</a></td>
<td class="text">New accounting standards<div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New standards not yet adopted</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU No. 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ASU No. 2020-04 provides optional expedients and exceptions for applying U.S. generally accepted accounting principles to contract modifications and hedging relationships, subject to certain criteria, that reference LIBOR or another rate that is expected to be discontinued. The amendments in this ASU were effective beginning on March 12, 2020, and the Company may elect to apply the amendments prospectively through December 31, 2022. Effective January 1, 2022 certain LIBOR tenors that do not affect the Company, including the one-week and two-month U.S. dollar LIBOR rate, ceased or became non-representative. The remaining U.S. dollar LIBOR tenors will cease or become non-representative effective July 1, 2023. This change will have no impact on the Company's ability to borrow. The Company is currently assessing the other effects this guidance may have on its consolidated financial statements.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASU No. 2021-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations (Topic 805): Accounting for Acquired Contract Assets and Contract Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ASU 2021-08 requires application of ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to recognize and measure assets and liabilities from contracts with customers acquired in a business combination. This ASU creates an exception to the general recognition and measurement principle in ASC 805 and will result in recognition of contract assets and contract liabilities consistent with those recorded by the acquiree immediately before the acquisition date. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Early adoption is permitted for all entities. The Company does not expect the adoption of this standard to have a material impact on the Company's consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingChangesAndErrorCorrectionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingChangesAndErrorCorrectionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663294503200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed consolidated interim financial statements Condensed consolidaed interim financial statements (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Condensed consolidated interim financial statements</a></td>
<td class="text">The unaudited condensed consolidated interim financial statements included in this report are prepared by the Company. In the opinion of management, all adjustments necessary for a fair presentation of the results of operations are reflected in these condensed consolidated interim financial statements. All significant intercompany accounts and transactions have been eliminated. The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of revenues, expenses, assets, liabilities, contingencies and noncontrolling interests subject to put provisions. The most significant estimates and assumptions underlying these financial statements and accompanying notes generally involve revenue recognition and accounts receivable, certain fair value estimates, accounting for income taxes and loss contingencies. The results of operations reflected in these interim financial statements may not necessarily be indicative of annual operating results. These condensed consolidated interim financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2021 (2021 10-K). Prior period classifications conform to the current period presentation. The Company has evaluated subsequent events through the date these condensed consolidated interim financial statements were issued and has included all necessary adjustments and disclosures.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are significant uncertainties associated with estimating revenue, which generally take several years to resolve. These estimates are subject to ongoing insurance coverage changes, geographic coverage differences, differing interpretations of contract coverage and other payor issues, as well as patient issues, including determination of applicable primary and secondary coverage, changes in patient insurance coverage and coordination of benefits. As these estimates are refined over time, both positive and negative adjustments to revenue are recognized in the current period.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dialysis patient service revenues. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues are recognized based on the Company&#8217;s estimate of the transaction price the Company expects to collect as a result of satisfying its performance obligations. Dialysis patient service revenues are recognized in the period services are provided based on these estimates. Revenues consist primarily of payments from government and commercial health plans for dialysis services provided to patients. The Company maintains a usual and customary fee schedule for its dialysis treatments and related lab services; however, actual collectible revenue is normally recognized at a discount from the fee schedule.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other revenues.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Other revenues consist of revenues earned by the Company's non-dialysis ancillary services as well as fees for management and administrative services to outpatient dialysis businesses that the Company does not consolidate. Other revenues are estimated in the period services are provided. The Company's U.S. ancillary service revenues include revenues earned under risk-based arrangements in the Company's integrated kidney care (IKC) business, including value-based care (VBC) arrangements. Under its VBC arrangements, the Company assumes full or shared financial risk for the total medical cost of care for patients below or above a benchmark. The benchmarks against which the Company incurs profit or loss on these contracts are typically based on the underlying premiums paid to the insuring entity (the Company's counterparty), with adjustments where applicable, or on trended or adjusted medical cost targets.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share is calculated by dividing net income attributable to the Company by the weighted average number of common shares outstanding. Weighted average common shares outstanding include restricted stock unit awards that are no longer subject to forfeiture because the recipients have satisfied either the explicit vesting terms or retirement eligibility requirements.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted earnings per share includes the dilutive effect of outstanding stock-settled stock appreciation rights and unvested stock units as computed under the treasury stock method.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Short-term and Long-term Investments</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt securities:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company's short-term debt investments are principally bank certificates of deposit with contractual maturities longer than three months but shorter than one year. These debt securities are accounted for as held-to-maturity and recorded at amortized cost, which approximated their fair values at September&#160;30, 2022 and December&#160;31, 2021.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity securitie</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s: The Company holds certain equity investments that have readily determinable fair values from public markets. The Company's remaining short-term and long-term equity investments are held within a trust to fund existing obligations associated with the Company&#8217;s non-qualified deferred compensation plans.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Long-term debt</a></td>
<td class="text">These cap agreements are designated as cash flow hedges and, as a result, changes in their fair values are reported in other comprehensive income. The original premiums paid for the caps are amortized to debt expense on a straight-line basis over the term of each cap agreement starting from its effective date.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text">Interest rate cap agreements are recorded at fair value estimated from valuation models utilizing the income approach and commonly accepted valuation techniques that use inputs from closing prices for similar assets and liabilities in active markets as well as other relevant observable market inputs at quoted intervals such as current interest rates, forward yield curves, implied volatility and credit default swap pricing. The Company does not believe the ultimate amount that could be realized upon settlement of these interest rate cap agreements would be materially different from the fair value estimates currently reported. See Note 6 for further discussion.The estimated fair value measurements of contingent earn-out obligations are primarily based on unobservable inputs, including projected earnings before interest, taxes, depreciation, and amortization (EBITDA), revenue and certain operating metrics. The estimated fair values of these contingent earn-out obligations are remeasured as of each reporting date and could fluctuate based upon any significant changes in key assumptions, such as changes in the Company's credit risk adjusted rate that is used to discount obligations to present value.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Standards</a></td>
<td class="text">New accounting standards<div style="margin-top:9pt;padding-left:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New standards not yet adopted</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU No. 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ASU No. 2020-04 provides optional expedients and exceptions for applying U.S. generally accepted accounting principles to contract modifications and hedging relationships, subject to certain criteria, that reference LIBOR or another rate that is expected to be discontinued. The amendments in this ASU were effective beginning on March 12, 2020, and the Company may elect to apply the amendments prospectively through December 31, 2022. Effective January 1, 2022 certain LIBOR tenors that do not affect the Company, including the one-week and two-month U.S. dollar LIBOR rate, ceased or became non-representative. The remaining U.S. dollar LIBOR tenors will cease or become non-representative effective July 1, 2023. This change will have no impact on the Company's ability to borrow. The Company is currently assessing the other effects this guidance may have on its consolidated financial statements.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASU No. 2021-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations (Topic 805): Accounting for Acquired Contract Assets and Contract Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ASU 2021-08 requires application of ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to recognize and measure assets and liabilities from contracts with customers acquired in a business combination. This ASU creates an exception to the general recognition and measurement principle in ASC 805 and will result in recognition of contract assets and contract liabilities consistent with those recorded by the acquiree immediately before the acquisition date. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Early adoption is permitted for all entities. The Company does not expect the adoption of this standard to have a material impact on the Company's consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=d3e62652-112803<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663289288736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition Segment revenue by major payor (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_RevenuesbymajorpayorAbstract', window );"><strong>Revenues by major payor [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue [Table Text Block]</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the Company's segment revenues by primary payor source:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.332%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.434%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other &#8212; Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other &#8212; Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dialysis patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,535,680&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,535,680&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,543,819&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,543,819&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,853&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,853&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other government</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,852&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,084&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,624&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195,884&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">880,812&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">936,982&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">862,218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,857&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">917,075&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other revenues:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,484&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,484&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,056&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,903&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,959&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,658&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations of intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,957)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,957)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,104)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,104)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,680,296&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268,398&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,948,694&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,675,942&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262,377&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,938,319&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Other primarily consists of management service fees earned in the respective Company line of business as well as other non-patient service revenue from the Company's U.S. ancillary services and international operations.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.332%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.434%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other - Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other - Ancillary services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dialysis patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,529,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,529,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,586,278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,586,278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570,380&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570,380&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">585,053&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">585,053&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other government</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253,731&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349,633&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">603,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245,125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338,553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">583,678&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,570,054&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,734,356&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,528,499&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,172&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,685,671&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other revenues:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare and Medicare Advantage</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255,204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255,204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243,085&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243,085&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Managed Medicaid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">981&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">981&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,029&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,029&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,387&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,387&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,584&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,708&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eliminations of intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,516)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,516)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70,424)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,294)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74,718)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,877,073&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">815,933&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,693,006&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,893,839&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">780,991&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,674,830&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Other primarily consists of management service fees earned in the respective Company line of business as well as other non-patient service revenue from the Company's U.S. ancillary services and international operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_RevenuesbymajorpayorAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenues by major payor [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_RevenuesbymajorpayorAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663289288736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per share Earnings Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliations of the numerators and denominators used to calculate basic and diluted earnings per share were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to DaVita Inc.</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,366&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259,754&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492,297&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">790,977&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,793&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,959&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,685&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumed incremental from stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,981&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,263&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,838&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,153&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111,666&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income per share attributable to DaVita Inc.</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.16&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.48&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.24&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.41&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income per share attributable to DaVita Inc.</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anti-dilutive stock-settled awards excluded from calculation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">878&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Shares associated with stock awards excluded from the diluted denominator calculation because they were anti-dilutive under the treasury stock method.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663289087056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in debt and equity securities (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesTextBlock', window );">Schedule of Investments</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s short-term and long-term debt and equity investments, consisting of debt instruments classified as held-to-maturity and equity investments with readily determinable fair values or redemption values, were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:41.652%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.833%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Equity<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Equity<br/>securities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit and other time deposits</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,843&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,843&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,226&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,226&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in mutual funds and common stocks</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,997&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,997&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,843&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,997&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,840&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,226&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,598&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,824&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,832&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,473&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,305&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,227&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,083&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,310&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,011&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,524&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,999&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,515&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,514&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,843&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,997&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,840&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,226&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,598&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,824&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663289095184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Changes in Goodwill by Reportable Segments [Text Block]</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in goodwill by reportable segments were as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.888%"><tr><td style="width:1.0%"/><td style="width:39.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.143%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.622%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.143%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.622%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.145%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other &#8212; Ancillary services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,309,928&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">609,181&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,919,109&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,979&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,265&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173,244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,745)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,745)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44,367)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(44,367)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,400,162&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">646,079&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,046,241&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,750&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,019&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,769&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,126)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,213)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55,155)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55,155)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,416,825&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">605,817&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,022,642&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2022:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,416,825&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715,147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,131,972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109,330)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109,330)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,416,825&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">605,817&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,022,642&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663288902336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Long-term Debt</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt was comprised of the following:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.702%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">As of September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30, <br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Maturity date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest rate</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Estimated fair value</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Secured Credit Facilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan A</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,531,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,596,875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/12/2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIBOR+1.75%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500,625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan B-1</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,667,689&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,688,263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/12/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIBOR+1.75%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,530,970&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving line of credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/12/2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIBOR+1.75%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Notes:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.625% Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,750,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,750,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/1/2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,124,375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75% Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/15/2031</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,068,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition obligations and other notes payable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,809&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,599&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022-2036</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,809&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing lease obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279,213&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299,128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023-2038</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt principal outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,128,961&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,964,865&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount, premium and deferred financing costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,520)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56,685)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,081,441&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,908,180&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(214,254)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179,030)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,867,187&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,729,150&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For the Company's senior secured credit facilities and senior notes, fair value estimates are based upon bid and ask quotes, typically a level 2 input. For acquisition obligations and other notes payable, the carrying values presented approximate their estimated fair values, based on estimates of their present values using level 2 interest rate inputs. </span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">The interest rate presented for acquisition obligations and other notes payable is their weighted average interest rate based on the current fixed and variable interest rate components in effect as of September&#160;30, 2022.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">Financing lease obligations are measured at their approximate present values at inception. The interest rate presented is the weighted average discount rate embedded in financing leases outstanding.</span></div><div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">As of September&#160;30, 2022, the carrying amount of the Company's senior secured credit facilities have been reduced by a discount of $3,740 and deferred financing costs of $20,891, and the carrying amount of the Company's senior notes have been reduced by deferred financing costs of $37,380 and increased by a debt premium of $14,491. As of December&#160;31, 2021, the carrying amount of the Company's senior secured credit facilities were reduced by a discount of $4,473 and deferred financing costs of $27,207, and the carrying amount of the Company's senior notes were reduced by deferred financing costs of $40,914 and increased by a debt premium of $15,909.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock', window );">Schedule of Derivative Instruments</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company&#8217;s interest rate cap agreements outstanding as of September&#160;30, 2022 and December&#160;31, 2021, which are classified in "Other long-term assets" on its consolidated balance sheet:&#160;</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:17.779%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.192%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.192%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.012%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.012%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.377%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended <br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Notional amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">LIBOR maximum rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Effective date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Expiration date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Debt expense</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Recorded OCI gain</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30, <br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 cap agreements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,500,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/30/2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/30/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOjMzNDNiOGQxYjAwNzRhZWFhMGYzMWJkOTU1ZWVjYmNiL3RhYmxlcmFuZ2U6MzM0M2I4ZDFiMDA3NGFlYWEwZjMxYmQ5NTVlZWNiY2JfMi05LTEtMS0zNjE1Njk_2f37a18b-1ac9-4872-985b-d24c04e03453">1,497</span>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,460&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139,663&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,203&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41678-113959<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41641-113959<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663288992224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share repurchases Share Repurchases (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAbstract', window );"><strong>Treasury Stock, Value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock', window );">Class of Treasury Stock [Table Text Block]</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's common stock repurchases during the three and nine months ended September&#160;30, 2022 and 2021: </span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.228%"><tr><td style="width:1.0%"/><td style="width:33.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.573%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.573%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.683%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:14.573%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.683%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.575%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Open market repurchases:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares repurchased</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,731&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,095&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount paid</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184,797&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336,217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">787,854&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">899,447&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average paid per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123.14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.06&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23309-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfTreasuryStockByClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663289288736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated other comprehensive (loss) income (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Comprehensive income</a></td>
<td class="text"><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.251%"><tr><td style="width:1.0%"/><td style="width:27.267%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.310%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.468%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.433%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.310%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.474%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest<br/>rate cap<br/>agreements</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign<br/>currency<br/>translation<br/>adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>other<br/>comprehensive<br/>loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest<br/>rate cap<br/>agreements</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign<br/>currency<br/>translation<br/>adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>other<br/>comprehensive<br/>loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,237&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(167,033)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111,796)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,178)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(138,069)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(139,247)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66,100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,055)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,460&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95,064)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,733)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,733)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,800)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,800)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,312&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66,100)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,788)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,660&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95,064)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification into net income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,377&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,377&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,132&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,132&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(344)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(344)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,032)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,032)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,033&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,033&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,582&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(233,133)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(135,551)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,582&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(233,133)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(135,551)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.251%"><tr><td style="width:1.0%"/><td style="width:27.267%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.310%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.468%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.433%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.310%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.474%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended September 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended September 30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest<br/>rate cap<br/>agreements</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign<br/>currency<br/>translation<br/>adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>other<br/>comprehensive<br/>loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Interest<br/>rate cap<br/>agreements</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign<br/>currency<br/>translation<br/>adjustments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>other<br/>comprehensive<br/>loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,577)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58,322)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65,899)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,466)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53,688)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66,154)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized (losses) gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(477)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,528)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55,005)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,284&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59,162)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55,878)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(818)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(818)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(357)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,528)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,885)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,466&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59,162)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56,696)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification into net income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,378&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,378&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,132&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,132&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related income tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(344)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(344)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,032)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,032)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,034&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,034&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,900)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112,850)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(119,750)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,900)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112,850)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(119,750)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663294668816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and divestitures (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock', window );">Schedule of Business Acquisitions by Acquisition, Contingent Consideration</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of changes in contingent earn-out obligations: </span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.093%"><tr><td style="width:1.0%"/><td style="width:58.604%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.678%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.679%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended<br/>September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended <br/>September 30, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,299&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(741)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value remeasurements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(350)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,129)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,085)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,274)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,771&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,771&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663289288736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair value of financial instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Assets, Liabilities and Temporary Equity Measured at Fair Value on a Recurring Basis</a></td>
<td class="text">The following table summarizes the Company&#8217;s assets, liabilities and temporary equities measured at fair value on a recurring basis as of September&#160;30, 2022:&#160;<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.251%"><tr><td style="width:1.0%"/><td style="width:44.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.835%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.638%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.638%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.947%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Quoted prices in<br/>active&#160;markets<br/>for identical assets<br/>(Level 1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Significant other<br/>observable&#160;inputs<br/>(Level 2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Significant<br/>unobservable<br/>inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in equity securities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,997&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,997&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate cap agreements</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139,663&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139,663&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent earn-out obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,771&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,771&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Temporary equity</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests subject to put provisions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,370,753&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,370,753&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663288334224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income Before Income Taxes</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of segment net revenues, segment operating margin (loss), and a reconciliation of segment operating margin to consolidated income before income taxes:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dialysis patient service revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">External sources</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,674,240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,669,823&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,858,939&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,874,759&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,007&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,526&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis patient service revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,697,197&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,691,830&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,923,465&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,944,955&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">External sources</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,056&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,080&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total U.S. dialysis revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,703,253&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,698,046&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,941,589&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,964,263&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other&#8212;Ancillary services</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dialysis patient service revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168,117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513,935&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495,725&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other external sources</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301,998&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285,266&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total ancillary services revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268,398&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262,377&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">815,933&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">785,285&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net segment revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,971,651&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,960,423&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,757,522&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,749,548&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elimination of intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,957)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,104)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,516)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74,718)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,948,694&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,938,319&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,693,006&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,674,830&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment operating margin (loss):</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351,474&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">509,939&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,230,715&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,523,625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other&#8212;Ancillary services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,271)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,909)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56,689)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,577)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment operating margin</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336,203&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503,030&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,174,026&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,487,048&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation of segment operating income to<br/>&#160;consolidated income before income taxes:</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate administrative support</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,417)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,153)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91,217)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79,093)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311,787&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">474,877&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,082,810&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,407,955&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99,680)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72,829)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(256,057)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(213,167)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (loss) income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,898)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,590)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,968)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,766&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated income before income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,209&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394,458&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">818,785&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,203,554&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock', window );">Summary of Depreciation and Amortization Expense by Reportable Segment</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense by reportable segment was as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.175%"><tr><td style="width:1.0%"/><td style="width:44.982%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.568%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.649%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.653%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184,688&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161,252&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507,320&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477,054&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other&#8212;Ancillary services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,726&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,798&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194,414&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170,462&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">538,534&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505,852&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock', window );">Summary of Expenditures for Property and Equipment by Reportable Segment</a></td>
<td class="text">Expenditures for property and equipment by reportable segment were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.005%"><tr><td style="width:1.0%"/><td style="width:62.459%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:16.696%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.647%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.698%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363,046&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415,994&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other&#8212;Ancillary services</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,915&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409,391&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451,909&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock', window );">Summary of Assets by Reportable Segment</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of assets by reportable segment were as follows:</span></div><div style="margin-top:6pt;padding-left:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.538%"><tr><td style="width:1.0%"/><td style="width:58.542%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.581%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.794%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.583%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. dialysis</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,223,532&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,375,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other&#8212;Ancillary services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,738,267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,746,488&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,961,799&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,121,488&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reconciliation of capital expenditures for property and equipment from segment to consolidated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of each significant reconciling item, other than profit (loss), revenues, or assets, in the reconciliation of totals of such items in reportable segments to the entity's corresponding consolidated amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663285667584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition Segment Revenue by Payor (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">$ 102,200<span></span>
</td>
<td class="nump">$ 100,379<span></span>
</td>
<td class="nump">$ 320,132<span></span>
</td>
<td class="nump">$ 304,346<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">2,948,694<span></span>
</td>
<td class="nump">2,938,319<span></span>
</td>
<td class="nump">8,693,006<span></span>
</td>
<td class="nump">8,674,830<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Elimination of intersegment revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(22,957)<span></span>
</td>
<td class="num">(22,104)<span></span>
</td>
<td class="num">(64,516)<span></span>
</td>
<td class="num">(74,718)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_MedicareandMedicareAdvantageMember', window );">Medicare and Medicare Advantage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="nump">1,535,680<span></span>
</td>
<td class="nump">1,543,819<span></span>
</td>
<td class="nump">4,529,300<span></span>
</td>
<td class="nump">4,586,278<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">78,345<span></span>
</td>
<td class="nump">77,277<span></span>
</td>
<td class="nump">255,204<span></span>
</td>
<td class="nump">243,085<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_MedicaidandManagedMedicaidMember', window );">Medicaid and Managed Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="nump">193,853<span></span>
</td>
<td class="nump">203,169<span></span>
</td>
<td class="nump">570,380<span></span>
</td>
<td class="nump">585,053<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">412<span></span>
</td>
<td class="nump">377<span></span>
</td>
<td class="nump">1,181<span></span>
</td>
<td class="nump">981<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_OtherGovernmentPayorsMember', window );">Other Government Payors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="nump">202,936<span></span>
</td>
<td class="nump">195,884<span></span>
</td>
<td class="nump">603,364<span></span>
</td>
<td class="nump">583,678<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_CommercialPayorsMember', window );">Commercial Payors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="nump">936,982<span></span>
</td>
<td class="nump">917,075<span></span>
</td>
<td class="nump">2,734,356<span></span>
</td>
<td class="nump">2,685,671<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">6,484<span></span>
</td>
<td class="nump">7,164<span></span>
</td>
<td class="nump">16,029<span></span>
</td>
<td class="nump">14,387<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_OtherSourcesofRevenueMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">16,959<span></span>
</td>
<td class="nump">15,658<span></span>
</td>
<td class="nump">47,708<span></span>
</td>
<td class="nump">50,415<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">2,680,296<span></span>
</td>
<td class="nump">2,675,942<span></span>
</td>
<td class="nump">7,877,073<span></span>
</td>
<td class="nump">7,893,839<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis | Elimination of intersegment revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(22,957)<span></span>
</td>
<td class="num">(22,104)<span></span>
</td>
<td class="num">(64,516)<span></span>
</td>
<td class="num">(70,424)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis | Medicare and Medicare Advantage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="nump">1,535,680<span></span>
</td>
<td class="nump">1,543,819<span></span>
</td>
<td class="nump">4,529,300<span></span>
</td>
<td class="nump">4,586,278<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis | Medicaid and Managed Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="nump">193,853<span></span>
</td>
<td class="nump">203,169<span></span>
</td>
<td class="nump">570,380<span></span>
</td>
<td class="nump">585,053<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis | Other Government Payors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="nump">86,852<span></span>
</td>
<td class="nump">82,624<span></span>
</td>
<td class="nump">253,731<span></span>
</td>
<td class="nump">245,125<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis | Commercial Payors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="nump">880,812<span></span>
</td>
<td class="nump">862,218<span></span>
</td>
<td class="nump">2,570,054<span></span>
</td>
<td class="nump">2,528,499<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">6,056<span></span>
</td>
<td class="nump">6,216<span></span>
</td>
<td class="nump">18,124<span></span>
</td>
<td class="nump">19,308<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other&#8212;Ancillary services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">268,398<span></span>
</td>
<td class="nump">262,377<span></span>
</td>
<td class="nump">815,933<span></span>
</td>
<td class="nump">780,991<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other&#8212;Ancillary services | Elimination of intersegment revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(4,294)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other&#8212;Ancillary services | Medicare and Medicare Advantage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">78,345<span></span>
</td>
<td class="nump">77,277<span></span>
</td>
<td class="nump">255,204<span></span>
</td>
<td class="nump">243,085<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other&#8212;Ancillary services | Medicaid and Managed Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">412<span></span>
</td>
<td class="nump">377<span></span>
</td>
<td class="nump">1,181<span></span>
</td>
<td class="nump">981<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other&#8212;Ancillary services | Other Government Payors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="nump">116,084<span></span>
</td>
<td class="nump">113,260<span></span>
</td>
<td class="nump">349,633<span></span>
</td>
<td class="nump">338,553<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other&#8212;Ancillary services | Commercial Payors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Patient service revenues</a></td>
<td class="nump">56,170<span></span>
</td>
<td class="nump">54,857<span></span>
</td>
<td class="nump">164,302<span></span>
</td>
<td class="nump">157,172<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">6,484<span></span>
</td>
<td class="nump">7,164<span></span>
</td>
<td class="nump">16,029<span></span>
</td>
<td class="nump">14,387<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other&#8212;Ancillary services | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">$ 10,903<span></span>
</td>
<td class="nump">$ 9,442<span></span>
</td>
<td class="nump">$ 29,584<span></span>
</td>
<td class="nump">$ 31,107<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_MedicareandMedicareAdvantageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_MedicareandMedicareAdvantageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_MedicaidandManagedMedicaidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_MedicaidandManagedMedicaidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_OtherGovernmentPayorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_OtherGovernmentPayorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_CommercialPayorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_CommercialPayorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_OtherSourcesofRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=dva_OtherSourcesofRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663286414368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per share Earnings per share - Reconciliation of numberators and denominators used to calculate basic and diluted earnings per share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareReconciliationAbstract', window );"><strong>Numerators:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to DaVita Inc.</a></td>
<td class="nump">$ 105,366<span></span>
</td>
<td class="nump">$ 259,754<span></span>
</td>
<td class="nump">$ 492,297<span></span>
</td>
<td class="nump">$ 790,977<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesIssuedBasic', window );">Weighted average basic shares outstanding during period</a></td>
<td class="nump">91,160,000<span></span>
</td>
<td class="nump">104,793,000<span></span>
</td>
<td class="nump">93,959,000<span></span>
</td>
<td class="nump">106,685,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Assumed incremental from stock plans</a></td>
<td class="nump">2,103,000<span></span>
</td>
<td class="nump">5,045,000<span></span>
</td>
<td class="nump">3,194,000<span></span>
</td>
<td class="nump">4,981,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares for diluted earnings per share calculation</a></td>
<td class="nump">93,263,000<span></span>
</td>
<td class="nump">109,838,000<span></span>
</td>
<td class="nump">97,153,000<span></span>
</td>
<td class="nump">111,666,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income per share attributable to DaVita Inc.</a></td>
<td class="nump">$ 1.16<span></span>
</td>
<td class="nump">$ 2.48<span></span>
</td>
<td class="nump">$ 5.24<span></span>
</td>
<td class="nump">$ 7.41<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income per share attributable to DaVita Inc.</a></td>
<td class="nump">$ 1.13<span></span>
</td>
<td class="nump">$ 2.36<span></span>
</td>
<td class="nump">$ 5.07<span></span>
</td>
<td class="nump">$ 7.08<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive stock-settled awards excluded from calculation</a></td>
<td class="nump">1,260,000<span></span>
</td>
<td class="nump">141,000<span></span>
</td>
<td class="nump">878,000<span></span>
</td>
<td class="nump">103,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesIssuedBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the weighted average total number of shares issued throughout the period including the first (beginning balance outstanding) and last (ending balance outstanding) day of the period before considering any reductions (for instance, shares held in treasury) to arrive at the weighted average number of shares outstanding. Weighted average relates to the portion of time within a reporting period that common shares have been issued and outstanding to the total time in that period. Such concept is used in determining the weighted average number of shares outstanding for purposes of calculating earnings per share (basic).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e2646-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesIssuedBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663280505712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments in debt and equity securities (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsLineItems', window );"><strong>Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecurities', window );">Debt securities</a></td>
<td class="nump">$ 77,843<span></span>
</td>
<td class="nump">$ 23,226<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investments in equity securities</a></td>
<td class="nump">39,997<span></span>
</td>
<td class="nump">48,598<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Total</a></td>
<td class="nump">117,840<span></span>
</td>
<td class="nump">71,824<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesCurrent', window );">Debt securities, short-term investments</a></td>
<td class="nump">62,832<span></span>
</td>
<td class="nump">8,227<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Total, short-term investments</a></td>
<td class="nump">74,305<span></span>
</td>
<td class="nump">22,310<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesNoncurrent', window );">Debt securities, long-term investments</a></td>
<td class="nump">15,011<span></span>
</td>
<td class="nump">14,999<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Total, long-term investments</a></td>
<td class="nump">43,535<span></span>
</td>
<td class="nump">49,514<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember', window );">Certificates of deposit and other time deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsLineItems', window );"><strong>Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecurities', window );">Debt securities</a></td>
<td class="nump">77,843<span></span>
</td>
<td class="nump">23,226<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investments in equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Total</a></td>
<td class="nump">77,843<span></span>
</td>
<td class="nump">23,226<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=dva_MutualFundsAndCommonStockMember', window );">Investments in mutual funds and common stocks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsLineItems', window );"><strong>Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investments in equity securities</a></td>
<td class="nump">39,997<span></span>
</td>
<td class="nump">48,598<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecurities', window );">Total</a></td>
<td class="nump">39,997<span></span>
</td>
<td class="nump">48,598<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember', window );">Short-term Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsLineItems', window );"><strong>Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investments in equity securities</a></td>
<td class="nump">11,473<span></span>
</td>
<td class="nump">14,083<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_OtherLongTermInvestmentsMember', window );">Long-term Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentHoldingsLineItems', window );"><strong>Investment Holdings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investments in equity securities</a></td>
<td class="nump">$ 28,524<span></span>
</td>
<td class="nump">$ 34,515<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919253-210447<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7A<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953401-111524<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27232-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27232-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity), classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27232-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentHoldingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentHoldingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=dva_MutualFundsAndCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=dva_MutualFundsAndCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_OtherLongTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_OtherLongTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663294710160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill - Changes in Goodwill by Reportable Segments (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">$ 7,046,241<span></span>
</td>
<td class="nump">$ 6,919,109<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="nump">34,769<span></span>
</td>
<td class="nump">173,244<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Divestitures</a></td>
<td class="num">(3,213)<span></span>
</td>
<td class="num">(1,745)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign currency and other adjustments</a></td>
<td class="num">(55,155)<span></span>
</td>
<td class="num">(44,367)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">7,022,642<span></span>
</td>
<td class="nump">7,046,241<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill, before accumulated impairment charges</a></td>
<td class="nump">7,131,972<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment charges</a></td>
<td class="num">(109,330)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">7,022,642<span></span>
</td>
<td class="nump">7,046,241<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">6,400,162<span></span>
</td>
<td class="nump">6,309,928<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="nump">16,750<span></span>
</td>
<td class="nump">91,979<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Divestitures</a></td>
<td class="num">(87)<span></span>
</td>
<td class="num">(1,745)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign currency and other adjustments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">6,416,825<span></span>
</td>
<td class="nump">6,400,162<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill, before accumulated impairment charges</a></td>
<td class="nump">6,416,825<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">6,416,825<span></span>
</td>
<td class="nump">6,400,162<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other&#8212;Ancillary services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">646,079<span></span>
</td>
<td class="nump">609,181<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="nump">18,019<span></span>
</td>
<td class="nump">81,265<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Divestitures</a></td>
<td class="num">(3,126)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign currency and other adjustments</a></td>
<td class="num">(55,155)<span></span>
</td>
<td class="num">(44,367)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">605,817<span></span>
</td>
<td class="nump">646,079<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillGross', window );">Goodwill, before accumulated impairment charges</a></td>
<td class="nump">715,147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated impairment charges</a></td>
<td class="num">(109,330)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">$ 605,817<span></span>
</td>
<td class="nump">$ 646,079<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663287682160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>segment</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charges | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_OtherReportingUnitsMember', window );">Other Health Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of Reportable Segments | segment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_OtherReportingUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_OtherReportingUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663286331088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term debt (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt interest rate during period</a></td>
<td class="nump">4.28%<span></span>
</td>
<td class="nump">3.78%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Long-term debt, weighted average interest rate, at point in time</a></td>
<td class="nump">4.39%<span></span>
</td>
<td class="nump">4.39%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total debt principal outstanding</a></td>
<td class="nump">$ 9,128,961<span></span>
</td>
<td class="nump">$ 9,128,961<span></span>
</td>
<td class="nump">$ 8,964,865<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_DiscountPremiumAndDeferredFinancingCosts', window );">Discount, premium and deferred financing costs</a></td>
<td class="num">(47,520)<span></span>
</td>
<td class="num">(47,520)<span></span>
</td>
<td class="num">(56,685)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities', window );">Carrying amount of long-term debt, net of unamortized discounts</a></td>
<td class="nump">9,081,441<span></span>
</td>
<td class="nump">9,081,441<span></span>
</td>
<td class="nump">8,908,180<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Less current portion</a></td>
<td class="num">(214,254)<span></span>
</td>
<td class="num">(214,254)<span></span>
</td>
<td class="num">(179,030)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Total long-term debt</a></td>
<td class="nump">8,867,187<span></span>
</td>
<td class="nump">8,867,187<span></span>
</td>
<td class="nump">8,729,150<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember', window );">Senior Notes Four Point Six Two Five Percent Due Twenty Thirty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior Notes</a></td>
<td class="nump">2,750,000<span></span>
</td>
<td class="nump">$ 2,750,000<span></span>
</td>
<td class="nump">2,750,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt interest rate during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jun.  01,  2030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="nump">2,124,375<span></span>
</td>
<td class="nump">$ 2,124,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember', window );">Senior Notes Three Point Seven Five Percent Due Twenty Thirty One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior Notes</a></td>
<td class="nump">1,500,000<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Debt interest rate during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Feb. 15,  2031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="nump">1,068,750<span></span>
</td>
<td class="nump">$ 1,068,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Acquisition obligations and other notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_AcquisitionObligationsAndOtherNotesPayable', window );">Acquisition obligations and other notes payable</a></td>
<td class="nump">$ 125,809<span></span>
</td>
<td class="nump">$ 125,809<span></span>
</td>
<td class="nump">130,599<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDateDescription', window );">Debt instrument, maturity date, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2022-2036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Long-term debt, weighted average interest rate, at point in time</a></td>
<td class="nump">5.82%<span></span>
</td>
<td class="nump">5.82%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_AcquisitionObligationsAndOtherNotesPayableFairValue', window );">Acquisition obligations and other notes payable, fair value</a></td>
<td class="nump">$ 125,809<span></span>
</td>
<td class="nump">$ 125,809<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dva_FinanceLeaseMember', window );">Financing lease obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Financing lease obligations</a></td>
<td class="nump">$ 279,213<span></span>
</td>
<td class="nump">$ 279,213<span></span>
</td>
<td class="nump">299,128<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDateDescription', window );">Debt instrument, maturity date, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2023-2038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Finance lease, weighted average discount rate, percent</a></td>
<td class="nump">4.53%<span></span>
</td>
<td class="nump">4.53%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Secured Debt</a></td>
<td class="nump">$ 275,000<span></span>
</td>
<td class="nump">$ 275,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis', window );">Debt Instrument, Description of Variable Rate Basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">LIBOR+1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding', window );">Revolving line of credit, fair value of amount outstanding</a></td>
<td class="nump">275,000<span></span>
</td>
<td class="nump">$ 275,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 12,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanAMember', window );">Term Loan A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Secured Debt</a></td>
<td class="nump">1,531,250<span></span>
</td>
<td class="nump">$ 1,531,250<span></span>
</td>
<td class="nump">1,596,875<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis', window );">Debt Instrument, Description of Variable Rate Basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">LIBOR+1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 12,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="nump">1,500,625<span></span>
</td>
<td class="nump">$ 1,500,625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanB1Member', window );">Term Loan B-1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Secured Debt</a></td>
<td class="nump">2,667,689<span></span>
</td>
<td class="nump">$ 2,667,689<span></span>
</td>
<td class="nump">2,688,263<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis', window );">Debt Instrument, Description of Variable Rate Basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">LIBOR+1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt Instrument, Maturity Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug. 12,  2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt Instrument, Fair Value Disclosure</a></td>
<td class="nump">$ 2,530,970<span></span>
</td>
<td class="nump">$ 2,530,970<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dva_SeniorSecuredCreditFacilitiesMember', window );">Senior Secured Credit Facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Long-term debt, weighted average interest rate, at point in time</a></td>
<td class="nump">4.34%<span></span>
</td>
<td class="nump">4.34%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValueDisclosureAbstract', window );"><strong>Debt Instrument, table footnotes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt Instrument, Unamortized Discount</a></td>
<td class="nump">$ 3,740<span></span>
</td>
<td class="nump">$ 3,740<span></span>
</td>
<td class="nump">4,473<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Deferred Offering Costs</a></td>
<td class="nump">20,891<span></span>
</td>
<td class="nump">20,891<span></span>
</td>
<td class="nump">27,207<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValueDisclosureAbstract', window );"><strong>Debt Instrument, table footnotes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Deferred Offering Costs</a></td>
<td class="nump">37,380<span></span>
</td>
<td class="nump">37,380<span></span>
</td>
<td class="nump">40,914<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Debt Instrument, Unamortized Premium</a></td>
<td class="num">$ (14,491)<span></span>
</td>
<td class="num">$ (14,491)<span></span>
</td>
<td class="num">$ (15,909)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_AcquisitionObligationsAndOtherNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This represents deferred purchase price obligations associated with acquisitions as well as other notes payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_AcquisitionObligationsAndOtherNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_AcquisitionObligationsAndOtherNotesPayableFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquisition Obligations And Other Notes Payable, Fair Value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_AcquisitionObligationsAndOtherNotesPayableFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_DiscountPremiumAndDeferredFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discount, premium and deferred financing costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_DiscountPremiumAndDeferredFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentDescriptionOfVariableRateBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of reference rate used for variable rate of debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentDescriptionOfVariableRateBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDateDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDateDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.A)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040515&amp;loc=d3e105025-122735<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of the amount outstanding under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, including portion classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of long-term debt outstanding calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.16)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_NotesPayableOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_NotesPayableOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dva_FinanceLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dva_FinanceLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=dva_TermLoanAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanB1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=dva_TermLoanB1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=dva_SeniorSecuredCreditFacilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=dva_SeniorSecuredCreditFacilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663294701312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term debt Schedule of Derivative Instruments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration', window );">Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Interest and Debt Expense<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=dva_A2019InterestRateCapAgreementsEffectiveJune302020Member', window );">2019 Interest Rate Cap Agreements Effective June 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInceptionDates', window );">Derivative, effective date</a></td>
<td class="text">Jun. 30,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeMaturityDates', window );">Derivative, expiration date</a></td>
<td class="text">Jun. 30,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember', window );">Other Long-term Assets | 2019 Interest Rate Cap Agreements Effective June 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset, fair value, gross asset</a></td>
<td class="nump">$ 139,663<span></span>
</td>
<td class="nump">$ 12,203<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | 2019 Interest Rate Cap Agreements Effective June 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet', window );">Amount of debt expense reclassified from accumulated OCI into income</a></td>
<td class="nump">1,497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=dva_DebtExpenseMember', window );">Debt Expense | Cash Flow Hedging | 2019 Interest Rate Cap Agreements Effective June 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax</a></td>
<td class="nump">127,460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dva_TermLoanFacilityMember', window );">Term Loan Facility | Maximum | 2019 Interest Rate Cap Agreements Effective June 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts of interest rate agreements</a></td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">LIBOR plus interest rate margin</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInceptionDates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the entity entered into the derivative contract, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInceptionDates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of income or comprehensive income that includes gain (loss) from effective portion of derivative instrument reclassified from accumulated other comprehensive income (AOCI) into income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624177-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624177-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeMaturityDates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date the derivative contract matures, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeMaturityDates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=dva_A2019InterestRateCapAgreementsEffectiveJune302020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=dva_A2019InterestRateCapAgreementsEffectiveJune302020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=dva_DebtExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=dva_DebtExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dva_TermLoanFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dva_TermLoanFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663283399392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term debt - Additional Information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Weighted average effective interest rate at quarter end</a></td>
<td class="nump">4.39%<span></span>
</td>
<td class="nump">4.39%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Weighted average effective interest rate during quarter</a></td>
<td class="nump">4.28%<span></span>
</td>
<td class="nump">3.78%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtPercentageBearingFixedInterestRate', window );">Percentage of debt instruments bearing fixed interest rate</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_LongTermDebtPercentageBearingEconomicallyFixedInterestRate', window );">Long Term Debt Percentage Bearing Economically Fixed Interest Rate</a></td>
<td class="nump">89.00%<span></span>
</td>
<td class="nump">89.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Secured Debt</a></td>
<td class="nump">$ 275,000<span></span>
</td>
<td class="nump">$ 275,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Line of Credit Facility, Remaining Borrowing Capacity</a></td>
<td class="nump">725,000<span></span>
</td>
<td class="nump">725,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity on the revolving credit facilities</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of credit outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=dva_BilateralSecuredLetterOfCreditFacilityMember', window );">Bilateral Secured Letter Of Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of credit outstanding</a></td>
<td class="nump">108,002<span></span>
</td>
<td class="nump">108,002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanAMember', window );">Term Loan A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Debt Instrument, Periodic Payment, Principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR', window );">Secured Debt Outstanding Principal Balance Subject To LIBOR</a></td>
<td class="nump">698,939<span></span>
</td>
<td class="nump">698,939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Secured Debt</a></td>
<td class="nump">1,531,250<span></span>
</td>
<td class="nump">1,531,250<span></span>
</td>
<td class="nump">1,596,875<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanB1Member', window );">Term Loan B-1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Debt Instrument, Periodic Payment, Principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,574<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SecuredDebt', window );">Secured Debt</a></td>
<td class="nump">$ 2,667,689<span></span>
</td>
<td class="nump">$ 2,667,689<span></span>
</td>
<td class="nump">$ 2,688,263<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dva_SeniorSecuredCreditFacilitiesMember', window );">Senior Secured Credit Facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Weighted average effective interest rate at quarter end</a></td>
<td class="nump">4.34%<span></span>
</td>
<td class="nump">4.34%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_LongTermDebtPercentageBearingEconomicallyFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long Term Debt Percentage Bearing Economically Fixed Interest Rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_LongTermDebtPercentageBearingEconomicallyFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Secured Debt Outstanding Principal Balance Subject To LIBOR-based interest rate volatility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to principal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtPercentageBearingFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a set, unchanging rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtPercentageBearingFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of long-term debt outstanding calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=dva_BilateralSecuredLetterOfCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=dva_BilateralSecuredLetterOfCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=dva_TermLoanAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=dva_TermLoanB1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=dva_TermLoanB1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=dva_SeniorSecuredCreditFacilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=dva_SeniorSecuredCreditFacilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663280459904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Additional Information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 25, 2022</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Commitments and Contingencies:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_CorporateIntegrityAgreementPeriod', window );">Corporate Integrity Agreement Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_CorporateIntegrityAgreementExpirationDate', window );">Corporate Integrity Agreement Expiration Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Oct. 22,  2019<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsAxis=dva_CommitmentsToProvideOperatingCapitalMember', window );">Commitments to provide operating capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Commitments and Contingencies:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitment', window );">Other potential commitments to provide operating capital to several dialysis centers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,431<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsAxis=dva_AgreementWithMedtronicMember', window );">Agreement with Medtronic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Commitments and Contingencies:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_BusinessAgreementDate', window );">Business Agreement Date</a></td>
<td class="text">May 25,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentDueInNextTwelveMonths', window );">Other Commitment, to be Paid, Year One</a></td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_OtherNoncashAssetsCommitment', window );">Other Noncash Assets Commitment</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_AdditionalCashCommitment', window );">Additional Cash Commitment</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentDueAfterFifthYear', window );">Other Commitment, to be Paid, after Year Five</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_RegulatoryAndCommercialMilestonesBeginningDate', window );">Regulatory and Commercial Milestones Beginning Date</a></td>
<td class="text">Jan.  01,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_RegulatoryAndCommercialMilestonesEndingDate', window );">Regulatory and Commercial Milestones Ending Date</a></td>
<td class="text">Dec. 31,  2028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=dva_USAttorneyPrescriptionDrugInvestigationMember', window );">US Attorney Prescription Drug Investigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Commitments and Contingencies:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation Settlement, Amount Awarded to Other Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TransactionTypeAxis=dva_IncrementalCashPortionMember', window );">Incremental Cash Portion | US Attorney Prescription Drug Investigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Commitments and Contingencies:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation Settlement, Amount Awarded to Other Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TransactionTypeAxis=dva_CashPaidForPortionPreviouslyRefundedMember', window );">Cash Paid For Portion Previously Refunded | US Attorney Prescription Drug Investigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Commitments and Contingencies:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation Settlement, Amount Awarded to Other Party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_AdditionalCashCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional Cash Commitment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_AdditionalCashCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_BusinessAgreementDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Agreement Date, in YYYY-MM-DD formate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_BusinessAgreementDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_CorporateIntegrityAgreementExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Corporate Integrity Agreement Expiration Date, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_CorporateIntegrityAgreementExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_CorporateIntegrityAgreementPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Corporate Integrity Agreement Period, in PnYnMnDn format.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_CorporateIntegrityAgreementPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_OtherNoncashAssetsCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Noncash Assets Commitment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_OtherNoncashAssetsCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_RegulatoryAndCommercialMilestonesBeginningDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Regulatory and Commercial Milestones Beginning Date</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_RegulatoryAndCommercialMilestonesBeginningDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_RegulatoryAndCommercialMilestonesEndingDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Regulatory and Commercial Milestones Ending Date</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_RegulatoryAndCommercialMilestonesEndingDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount awarded to other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedToOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentDueAfterFifthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of commitment classified as other to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentDueAfterFifthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentDueInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of commitment classified as other to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentDueInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAxis=dva_CommitmentsToProvideOperatingCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAxis=dva_CommitmentsToProvideOperatingCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAxis=dva_AgreementWithMedtronicMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAxis=dva_AgreementWithMedtronicMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=dva_USAttorneyPrescriptionDrugInvestigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=dva_USAttorneyPrescriptionDrugInvestigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=dva_IncrementalCashPortionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=dva_IncrementalCashPortionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransactionTypeAxis=dva_CashPaidForPortionPreviouslyRefundedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransactionTypeAxis=dva_CashPaidForPortionPreviouslyRefundedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663286418144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term incentive compensation (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost related to nonvested stock-based compensation arrangements under equity compensation and stock purchase plans</a></td>
<td class="nump">$ 182,083<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation cost related to nonvested stock-based compensation arrangements under stock-based component of LTIP costs, weighted average remaining period (in years)</a></td>
<td class="text">1 year 3 months 18 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units and Performance stock units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares</a></td>
<td class="nump">1,129,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted', window );">Aggregate grant-date fair value</a></td>
<td class="nump">$ 122,356<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Weighted-average expected life (in years)</a></td>
<td class="text">3 years 6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember', window );">Stock Appreciation Rights</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted', window );">Aggregate grant-date fair value</a></td>
<td class="nump">$ 4,573<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Weighted-average expected life (in years)</a></td>
<td class="text">4 years 6 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures | shares</a></td>
<td class="nump">130,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based compensation arrangement by share-based payment award, grant date fair value of options granted.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockAppreciationRightsSARSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663283060032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share repurchases Share Repurchase Table (Details) - Open Market Purchases - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="nump">2,122<span></span>
</td>
<td class="nump">2,731<span></span>
</td>
<td class="nump">8,095<span></span>
</td>
<td class="nump">7,750<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury Stock, Value, Acquired, Cost Method</a></td>
<td class="nump">$ 184,797<span></span>
</td>
<td class="nump">$ 336,217<span></span>
</td>
<td class="nump">$ 787,854<span></span>
</td>
<td class="nump">$ 899,447<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Treasury Stock Acquired, Average Cost Per Share</a></td>
<td class="nump">$ 87.10<span></span>
</td>
<td class="nump">$ 123.14<span></span>
</td>
<td class="nump">$ 97.33<span></span>
</td>
<td class="nump">$ 116.06<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=dva_OpenMarketPurchasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=dva_OpenMarketPurchasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663288917152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share repurchases (Details) - Subsequent Event<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr><th class="th">
<div>Oct. 27, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Stock Repurchase Program, Remaining Authorized Repurchase Amount | $</a></td>
<td class="nump">$ 1,596,085<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663286273360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated other comprehensive (loss) income (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (139,247)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending balance</a></td>
<td class="num">$ (135,551)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(135,551)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember', window );">Interest rate cap agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning balance</a></td>
<td class="nump">55,237<span></span>
</td>
<td class="num">$ (7,577)<span></span>
</td>
<td class="num">(1,178)<span></span>
</td>
<td class="num">$ (12,466)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Unrealized gains (losses)</a></td>
<td class="nump">55,045<span></span>
</td>
<td class="num">(477)<span></span>
</td>
<td class="nump">127,460<span></span>
</td>
<td class="nump">3,284<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Related income tax benefit</a></td>
<td class="num">(13,733)<span></span>
</td>
<td class="nump">120<span></span>
</td>
<td class="num">(31,800)<span></span>
</td>
<td class="num">(818)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Unrealized (losses) gains net</a></td>
<td class="nump">41,312<span></span>
</td>
<td class="num">(357)<span></span>
</td>
<td class="nump">95,660<span></span>
</td>
<td class="nump">2,466<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Reclassification into net income</a></td>
<td class="nump">1,377<span></span>
</td>
<td class="nump">1,378<span></span>
</td>
<td class="nump">4,132<span></span>
</td>
<td class="nump">4,132<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Related income tax</a></td>
<td class="num">(344)<span></span>
</td>
<td class="num">(344)<span></span>
</td>
<td class="num">(1,032)<span></span>
</td>
<td class="num">(1,032)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from accumulated other comprehensive income into net income net of tax</a></td>
<td class="nump">1,033<span></span>
</td>
<td class="nump">1,034<span></span>
</td>
<td class="nump">3,100<span></span>
</td>
<td class="nump">3,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending balance</a></td>
<td class="nump">97,582<span></span>
</td>
<td class="num">(6,900)<span></span>
</td>
<td class="nump">97,582<span></span>
</td>
<td class="num">(6,900)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember', window );">Foreign currency translation adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning balance</a></td>
<td class="num">(167,033)<span></span>
</td>
<td class="num">(58,322)<span></span>
</td>
<td class="num">(138,069)<span></span>
</td>
<td class="num">(53,688)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Unrealized gains (losses)</a></td>
<td class="num">(66,100)<span></span>
</td>
<td class="num">(54,528)<span></span>
</td>
<td class="num">(95,064)<span></span>
</td>
<td class="num">(59,162)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Related income tax benefit</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Unrealized (losses) gains net</a></td>
<td class="num">(66,100)<span></span>
</td>
<td class="num">(54,528)<span></span>
</td>
<td class="num">(95,064)<span></span>
</td>
<td class="num">(59,162)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Reclassification into net income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Related income tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from accumulated other comprehensive income into net income net of tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending balance</a></td>
<td class="num">(233,133)<span></span>
</td>
<td class="num">(112,850)<span></span>
</td>
<td class="num">(233,133)<span></span>
</td>
<td class="num">(112,850)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember', window );">Accumulated other comprehensive (loss) income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Beginning balance</a></td>
<td class="num">(111,796)<span></span>
</td>
<td class="num">(65,899)<span></span>
</td>
<td class="num">(139,247)<span></span>
</td>
<td class="num">(66,154)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Unrealized gains (losses)</a></td>
<td class="num">(11,055)<span></span>
</td>
<td class="num">(55,005)<span></span>
</td>
<td class="nump">32,396<span></span>
</td>
<td class="num">(55,878)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Related income tax benefit</a></td>
<td class="num">(13,733)<span></span>
</td>
<td class="nump">120<span></span>
</td>
<td class="num">(31,800)<span></span>
</td>
<td class="num">(818)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Unrealized (losses) gains net</a></td>
<td class="num">(24,788)<span></span>
</td>
<td class="num">(54,885)<span></span>
</td>
<td class="nump">596<span></span>
</td>
<td class="num">(56,696)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Reclassification into net income</a></td>
<td class="nump">1,377<span></span>
</td>
<td class="nump">1,378<span></span>
</td>
<td class="nump">4,132<span></span>
</td>
<td class="nump">4,132<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Related income tax</a></td>
<td class="num">(344)<span></span>
</td>
<td class="num">(344)<span></span>
</td>
<td class="num">(1,032)<span></span>
</td>
<td class="num">(1,032)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification from accumulated other comprehensive income into net income net of tax</a></td>
<td class="nump">1,033<span></span>
</td>
<td class="nump">1,034<span></span>
</td>
<td class="nump">3,100<span></span>
</td>
<td class="nump">3,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Ending balance</a></td>
<td class="num">$ (135,551)<span></span>
</td>
<td class="num">$ (119,750)<span></span>
</td>
<td class="num">$ (135,551)<span></span>
</td>
<td class="num">$ (119,750)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663290202752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and divestitures Contingent Earn-out obligations (Details) - Dialysis and other businesses - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Contingent Earn-out Obligations, Beginning balance</a></td>
<td class="nump">$ 29,299<span></span>
</td>
<td class="nump">$ 33,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1', window );">Acquisitions</a></td>
<td class="nump">1,648<span></span>
</td>
<td class="nump">2,171<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations', window );">Foreign currency translation</a></td>
<td class="num">(741)<span></span>
</td>
<td class="nump">403<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss', window );">Fair value remeasurements</a></td>
<td class="num">(350)<span></span>
</td>
<td class="num">(3,129)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Payments</a></td>
<td class="num">(4,085)<span></span>
</td>
<td class="num">(7,274)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Contingent Earn-out Obligations, Ending balance</a></td>
<td class="nump">$ 25,771<span></span>
</td>
<td class="nump">$ 25,771<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination Contingent Consideration Acquisitions Fair Value Remeasurement Gain Loss</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Foreign Currency Translation Adjustment For Contingent Earn-out Obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of right to a contingent consideration asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663283325232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions and divestitures - Additional Information (Detail)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>clinic</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid to acquire businesses</a></td>
<td class="nump">$ 43,811<span></span>
</td>
<td class="nump">$ 45,143<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_BusinessAcquisitionGoodwillExpectedTaxDeductibleAmountAdjustment', window );">Business Acquisition, Goodwill, Adjustment To Expected Tax Deductible Amount</a></td>
<td class="nump">34,769<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember', window );">Other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out obligations</a></td>
<td class="nump">9,461<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out obligations</a></td>
<td class="nump">16,310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dva_OtherCompaniesMember', window );">Other companies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out obligations</a></td>
<td class="nump">$ 25,771<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Other companies | EBITDA or Operating Income Performance Targets or Quality Margins</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod', window );">Earn-out consideration payment period</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_BusinessCombinationContingentConsiderationAcquisitions', window );">Contingent earn-out obligations and liabilities assumed associated with acquisitions</a></td>
<td class="nump">$ 56,815<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Other companies | EBITDA or Operating Income Performance Targets or Quality Margins</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod', window );">Earn-out consideration payment period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember', window );">Dialysis and other businesses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash paid to acquire businesses</a></td>
<td class="nump">$ 43,811<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_BusinessCombinationContingentConsiderationAcquisitions', window );">Contingent earn-out obligations and liabilities assumed associated with acquisitions</a></td>
<td class="nump">2,171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Deferred purchase price obligations</a></td>
<td class="nump">$ 11,726<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedServicesMember', window );">US Dialysis | Dialysis and other businesses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of businesses acquired | clinic</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_ForeignDialysisCentersMember', window );">Foreign Dialysis Centers | Dialysis and other businesses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of businesses acquired | clinic</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business acquisition contingent consideration revenue earn-out period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_BusinessAcquisitionGoodwillExpectedTaxDeductibleAmountAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Goodwill, Expected Tax Deductible Amount, Adjustment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_BusinessAcquisitionGoodwillExpectedTaxDeductibleAmountAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_BusinessCombinationContingentConsiderationAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination Contingent Consideration Acquisitions, Earn-out Obligations and Assumed Liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_BusinessCombinationContingentConsiderationAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6405-128476<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfBusinessesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of businesses acquired by the entity during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfBusinessesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dva_OtherCompaniesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dva_OtherCompaniesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_ForeignDialysisCentersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_ForeignDialysisCentersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663283519408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Variable interest entities - Additional Information (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">$ 16,961,799<span></span>
</td>
<td class="nump">$ 17,121,488<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">14,888,919<span></span>
</td>
<td class="nump">$ 14,750,508<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable Interest Entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">298,477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">$ 196,159<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663286140336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair value of financial instruments - Assets, Liabilities and Temporary Equity Measured at Fair Value on Recurring Basis (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investments in equity securities</a></td>
<td class="nump">$ 39,997<span></span>
</td>
<td class="nump">$ 48,598<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investments in equity securities</a></td>
<td class="nump">39,997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out obligations</a></td>
<td class="nump">25,771<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue', window );">Noncontrolling interests subject to put provisions</a></td>
<td class="nump">1,370,753<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Interest rate cap agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Interest rate cap agreements</a></td>
<td class="nump">139,663<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Quoted prices in active&#160;markets&#160;for identical assets (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investments in equity securities</a></td>
<td class="nump">39,997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out obligations</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue', window );">Noncontrolling interests subject to put provisions</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Quoted prices in active&#160;markets&#160;for identical assets (Level 1) | Interest rate cap agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Interest rate cap agreements</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant other observable&#160;inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investments in equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out obligations</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue', window );">Noncontrolling interests subject to put provisions</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant other observable&#160;inputs (Level 2) | Interest rate cap agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Interest rate cap agreements</a></td>
<td class="nump">139,663<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant unobservable inputs (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Investments in equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent earn-out obligations</a></td>
<td class="nump">25,771<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue', window );">Noncontrolling interests subject to put provisions</a></td>
<td class="nump">1,370,753<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Measurements, Recurring | Significant unobservable inputs (Level 3) | Interest rate cap agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Interest rate cap agreements</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate fair value as of the reporting date of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663293810288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair value of financial instruments Fair Value of Financial Instruments (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple', window );">Potential Increase Decrease In Fair Value Of Noncontrolling Interests Due To Change In Weighted Average EBITDA Multiple</a></td>
<td class="nump">$ 170,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Potential increase decrease In fair value of Noncontrolling interests related to contractual Put obligations due to the change In Weighted Average EBITDA multiple.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663287382576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment reporting - Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income Before Income Taxes (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">$ 102,200<span></span>
</td>
<td class="nump">$ 100,379<span></span>
</td>
<td class="nump">$ 320,132<span></span>
</td>
<td class="nump">$ 304,346<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">2,948,694<span></span>
</td>
<td class="nump">2,938,319<span></span>
</td>
<td class="nump">8,693,006<span></span>
</td>
<td class="nump">8,674,830<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">311,787<span></span>
</td>
<td class="nump">474,877<span></span>
</td>
<td class="nump">1,082,810<span></span>
</td>
<td class="nump">1,407,955<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dva_SegmentReportingInformationCorporateExpenses', window );">Corporate administrative support</a></td>
<td class="num">(24,417)<span></span>
</td>
<td class="num">(28,153)<span></span>
</td>
<td class="num">(91,217)<span></span>
</td>
<td class="num">(79,093)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestAndDebtExpense', window );">Debt expense</a></td>
<td class="num">(99,680)<span></span>
</td>
<td class="num">(72,829)<span></span>
</td>
<td class="num">(256,057)<span></span>
</td>
<td class="num">(213,167)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (loss) income, net</a></td>
<td class="num">(4,898)<span></span>
</td>
<td class="num">(7,590)<span></span>
</td>
<td class="num">(7,968)<span></span>
</td>
<td class="nump">8,766<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">207,209<span></span>
</td>
<td class="nump">394,458<span></span>
</td>
<td class="nump">818,785<span></span>
</td>
<td class="nump">1,203,554<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">2,680,296<span></span>
</td>
<td class="nump">2,675,942<span></span>
</td>
<td class="nump">7,877,073<span></span>
</td>
<td class="nump">7,893,839<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other&#8212;Ancillary services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">268,398<span></span>
</td>
<td class="nump">262,377<span></span>
</td>
<td class="nump">815,933<span></span>
</td>
<td class="nump">780,991<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">2,971,651<span></span>
</td>
<td class="nump">2,960,423<span></span>
</td>
<td class="nump">8,757,522<span></span>
</td>
<td class="nump">8,749,548<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">336,203<span></span>
</td>
<td class="nump">503,030<span></span>
</td>
<td class="nump">1,174,026<span></span>
</td>
<td class="nump">1,487,048<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | U.S. dialysis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Dialysis patient service revenues</a></td>
<td class="nump">2,697,197<span></span>
</td>
<td class="nump">2,691,830<span></span>
</td>
<td class="nump">7,923,465<span></span>
</td>
<td class="nump">7,944,955<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">2,703,253<span></span>
</td>
<td class="nump">2,698,046<span></span>
</td>
<td class="nump">7,941,589<span></span>
</td>
<td class="nump">7,964,263<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="nump">351,474<span></span>
</td>
<td class="nump">509,939<span></span>
</td>
<td class="nump">1,230,715<span></span>
</td>
<td class="nump">1,523,625<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | U.S. dialysis | External Sources</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Dialysis patient service revenues</a></td>
<td class="nump">2,674,240<span></span>
</td>
<td class="nump">2,669,823<span></span>
</td>
<td class="nump">7,858,939<span></span>
</td>
<td class="nump">7,874,759<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">6,056<span></span>
</td>
<td class="nump">6,119<span></span>
</td>
<td class="nump">18,134<span></span>
</td>
<td class="nump">19,080<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | U.S. dialysis | Intersubsegment Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Dialysis patient service revenues</a></td>
<td class="nump">22,957<span></span>
</td>
<td class="nump">22,007<span></span>
</td>
<td class="nump">64,526<span></span>
</td>
<td class="nump">70,196<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">97<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="nump">228<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Other&#8212;Ancillary services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Dialysis patient service revenues</a></td>
<td class="nump">172,254<span></span>
</td>
<td class="nump">168,117<span></span>
</td>
<td class="nump">513,935<span></span>
</td>
<td class="nump">495,725<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncome', window );">Other revenues</a></td>
<td class="nump">96,144<span></span>
</td>
<td class="nump">94,260<span></span>
</td>
<td class="nump">301,998<span></span>
</td>
<td class="nump">285,266<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">268,398<span></span>
</td>
<td class="nump">262,377<span></span>
</td>
<td class="nump">815,933<span></span>
</td>
<td class="nump">785,285<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income (loss)</a></td>
<td class="num">(15,271)<span></span>
</td>
<td class="num">(6,909)<span></span>
</td>
<td class="num">(56,689)<span></span>
</td>
<td class="num">(36,577)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Other&#8212;Ancillary services | Intersubsegment Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Dialysis patient service revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,294<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Elimination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(22,957)<span></span>
</td>
<td class="num">(22,104)<span></span>
</td>
<td class="num">(64,516)<span></span>
</td>
<td class="num">(74,718)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Elimination | U.S. dialysis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(22,957)<span></span>
</td>
<td class="num">(22,104)<span></span>
</td>
<td class="num">(64,516)<span></span>
</td>
<td class="num">(70,424)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Elimination | Other&#8212;Ancillary services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (4,294)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dva_SegmentReportingInformationCorporateExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of general and administrative support costs, such as labor, benefits and stock-based compensation costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dva_SegmentReportingInformationCorporateExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dva_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndDebtExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest and debt related expenses associated with nonoperating financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndDebtExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue and income classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsConsolidationItemsAxis=dva_ExternalSourcesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsConsolidationItemsAxis=dva_ExternalSourcesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsConsolidationItemsAxis=us-gaap_IntersubsegmentEliminationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsConsolidationItemsAxis=us-gaap_IntersubsegmentEliminationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663384191136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment reporting - Summary of Depreciation and Amortization Expense by Segment (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">$ 194,414<span></span>
</td>
<td class="nump">$ 170,462<span></span>
</td>
<td class="nump">$ 538,534<span></span>
</td>
<td class="nump">$ 505,852<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">184,688<span></span>
</td>
<td class="nump">161,252<span></span>
</td>
<td class="nump">507,320<span></span>
</td>
<td class="nump">477,054<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other&#8212;Ancillary services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">$ 9,726<span></span>
</td>
<td class="nump">$ 9,210<span></span>
</td>
<td class="nump">$ 31,214<span></span>
</td>
<td class="nump">$ 28,798<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663280508064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment reporting - Summary of Expenditures for Property and Equipment by Segment (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Expenditures for property and equipment</a></td>
<td class="nump">$ 409,391<span></span>
</td>
<td class="nump">$ 451,909<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Expenditures for property and equipment</a></td>
<td class="nump">363,046<span></span>
</td>
<td class="nump">415,994<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other&#8212;Ancillary services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Expenditures for property and equipment</a></td>
<td class="nump">$ 46,345<span></span>
</td>
<td class="nump">$ 35,915<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140663290731632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Segment reporting - Summary of Assets by Segment (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">$ 16,961,799<span></span>
</td>
<td class="nump">$ 17,121,488<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember', window );">U.S. dialysis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">15,223,532<span></span>
</td>
<td class="nump">15,375,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other&#8212;Ancillary services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">$ 1,738,267<span></span>
</td>
<td class="nump">$ 1,746,488<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dva_USDialysisAndRelatedLabServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>dva-20220930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:dva="http://www.davita.com/20220930"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="dva-20220930.xsd" xlink:type="simple"/>
    <context id="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id9c8841268564112921ca0795b9110dc_I20221027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <instant>2022-10-27</instant>
        </period>
    </context>
    <context id="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i50c63cefb9bd4106bee30b310fc866d1_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibf9e89b4e598444e8b9df2b00849c30a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3b171dd2fa094f0183b61386c9e24e5f_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ia716f88984964a2b912c2cad0bd8a1fa_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ieb3363d3cbf6464faff1cbeaac015fa5_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i1ed815cd2c304b559653370ccc275a2b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="if4e48eaf91dc4c408c68dbe262d5b593_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i225bee24745a47b79c36ca66d4a0f754_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i4611f48e469e4f43bc268b742f4eb3be_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i825fb40a1a3741bbb7f8ab64213ff5a9_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iba35f774a92e4ef7aed7d1d87280a599_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i147789d12c114b6f8c98855d532eca0e_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="idbc46e0d55ea4c998cc9052010d50139_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="icc29ea0c8d1844d39747787ecd867dc7_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2320a27c131f4981931e8a5421b2ef7c_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i275b9f2c01bb463f9786a30fe06b1e1f_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i39e9b3036c5b4d1b9dae3f82941570f9_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ifc82d88333724b428b3e6c8367bbaeb8_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia7b08c7176c749f98f073fea08d83f2b_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5d096d77a67d4147a3ff676d41c97ea4_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i3f6ac9def05f4546ad8e00029f29c85f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ida0a3398956c428db91dfbf84211ac9d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i6362305fbd044f9b9980adcadabf8f07_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i36614688dae84eef869cd0e6d793fa74_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i23a94ede934c4277b1d46b13e38fefd1_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i2cf6560db6fe433e9fe35420f78329ca_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ibd69c0a4b8da40a483520c9abec5ab4e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i276433c699f648cf975516d1ebf29a92_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ieac6f79edec64565b9a967d39744ab16_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2cbc28027ca9463d88cb9103183707e2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idde5dd2e47cc48b3b4ab52a208a0b76c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4f4b7c7d62ec4f68a27cb7f3d6ee06dd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7ba288d628f64e839c5eef1fa88fdd33_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i03c39842d00748dab2c10d4f15c2ada9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i530e6ba6cb654ba8beab393e20b2de81_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i55a696e4c43e43a084a98a9190e869b0_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i07cba31e2e3b4a8ea010c559dcb43625_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8139303e818c4499a156db063aa48dba_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i73664eea57554ff1a6527a1e3088909e_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie2f7382dda1241aaad40dfb7cb9dd962_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i646ec415498444bd800c1444f673b411_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8b36f5eee05c4272833ec6129d2e6d23_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3cc14165b1e5457b9a7d411fe7bae49e_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iedd8e53afd1f49d1ab701015f45a5489_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ice4bdd4f0f9347209498a13bb73d9bdc_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i663815c6d9b048f4b3e8a826a42acd72_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i7507dbbe11004f8f993908a1a48afa76_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id43bdce378174edd8e02d9f9f1fd6b24_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie002b14464f24380b244cc03154fc209_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic329b3c1d74b48468770b45b930bad16_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie19f600b93854407adf4fdf1f09eee0b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia98324e3ccbe45f88cbaa562c7631b0b_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4ddc0fff672e45bf957f1116d0d1cb0c_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2fbb95ab11e644199452dbc8220b5114_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5b6ffea1a40d41068e8300270af3e5ba_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib49a7f0c10554865819c8371c13ef3f0_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i319451c323114481b97e571a89a51741_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i56a34082e8604548b02c2fbf0259eb63_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i81df84984de9471498896da7302e996d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i60789889ae4a4336b174326b6a1f05e1_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="id7e948fdcd374e2ca7c81f008ef937b8_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ief97099e76e34b33afd38d2bf7dd73d5_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="icbd4405ebc814444a73fcea7eb2d5281_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i3329b37b11ef49e7a77677fc2571f273_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i1113880d4c76456c96b6f30c904a98c3_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i658147170723431aa969dc4fb19ac738_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i7d92065342b44c7d9d67dad92df719c5_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ie15a7e2f621142fbac1d6b1ed5011b9d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ief046f5cbff64fe6add73a9cda0c18b2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic085ab466cee47ed81480d793624fbad_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9126810d2c5c48f49f23bdafdb65883a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i75763a11d96243bca52ff93e2406ae41_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia9bb890020ae4aef89eda77451ffdea8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0dd3f4def9b849c59ba37a6b37215489_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia506883f3ae0452194c6440259373c3b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0d759d14a5e74d46b71f1406a364f03e_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">dva:TemporaryEquityRedeemableNoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic46d32b59dd34a6085600e81cd1682bb_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0876db8d2e2343ad96bd1c5f19250ebd_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0dee44ae9bd741b79b52d5d2960b5164_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3d50339b230d4224b69347fc7edc8b98_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib2225f46e4614652b632ff59e99717b5_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id322319c79ee47d3b626a8d5196e3aeb_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia8f9cc1fcc6d4078b72a351dab034ab2_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia5499ef54bf54566bd5630bea4f2aef1_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iaf7c25a75aca401a8b6ff5a12f6bd14d_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if32f1f0b93b84c62b51bda92e1d098c1_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic8b3d7d4ce924bcba6d96142c33584d7_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8c5b3caa1262457a9e75c70467159fc4_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="icb08fa48ee76464ba77c6eb9d3849115_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i599d93fb67e9441eb25740b2dd06722d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9c69e4f36c65438c9eeb2a106052afd5_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icd8c3ea690e54b84a0a7066643e1c02b_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic9536bd2eda14d9c86eba49ab480d898_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i872a4a0bd01a4a8abf1995e00bb2cf2d_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iaaae7b470fbe4bbd8bd2ca4d195b6128_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if47f2932cefd49ed85a6f6caa58312cd_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ie7f517d406d8483b9f0bdad532070fe4_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8f7d940ca97c4ae789757331795af7c0_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3129a22cf1d446319325259a77169cdd_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i87e2bef651a34107b1fb5d68820aee09_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iaa9717ba02fb4ccab21d642ffbe4803c_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i500d83fb41334d9c8de83f92f7fcc141_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icaea6e6d89084a3e93ba28323cd7e21d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iff0caec10ecc40c584a977fdfabc4df8_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i50355a967a4440e897b1ac183ad1a38d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icb556fa3c676460aa8e66d0650f6a16e_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i346169ef5135448c9d85d98d5c086b2a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i42e37dbf5c0a422e8802ffd5a383d2d8_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="idc81d3ad5ccf42d797d3042a95761484_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3ac794762df747ec8e1cf0d69c6b0573_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i9c5f026f8ab94787909fcd87fcb38484_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib939af3797994ec1a4b0e56c5dd80a2a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if983cfecb2cf4615842da0fdce5d144c_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5c5c603e1e2c456093890ff389a4067c_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="idf91a124985e4d4a83d74b6648524f10_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i253b9978247749dcb47c368cdebc35ae_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6679c2baabca4cda8418d59c0fbb9fcb_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i45f5523ed8e44e969d9667166a84a234_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5c321d3f4f114e7a810149cebdfddf89_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i138d5ad826a74dd389b7c50d766dce89_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5743480e6048496ab58c95a14b8aaf6f_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia98746ed55ed4291881ac7bb3d451f92_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0162929ca27d43d894768f88369a32f4_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iaa3c42e6c11c4d0197c06f1170d1a877_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iadfbab933c6649d399f396278bf17828_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i00c3f8bb1a4f4667af7c71428219d59d_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iff13895b80934a9aaca98d961abc2ee9_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i14ce08d9f9e740ecb2b7cd9829aba3f6_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3e56a6423e7a43a6baf62a95333e8692_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1e7345a52a044d459fe02274fb72c840_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6f6de3926b14464695343fd7abe17b26_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1bf1bb08a5eb457d8bc08821fa21a5ff_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i81c073a4e6894483a6125b5544516dcf_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5928e35ff3ca4001abd1fb3f535ceaaf_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i490b21a1d5ff4920a6e5630f304c1992_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7bd462440e954143b9bd9c4c0bbcbc96_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i67f9be9b51ec4692a27ebe64bb0fc0e4_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherGovernmentPayorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i89dde34540454ca3ae8c705649ed5ed5_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ibf52eaa032584a8ab33ac97fcf842df5_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i137eae426cf247789d78e630f2c67da6_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6ad9292cb3bb460b969ab3899aad678f_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5b1771b0ef284582836b473942fc9bfa_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7cae19c46a6043148cffc25a7d0efae1_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:CommercialPayorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="idcb2cf1f049d43e6bc397f58d8b751ab_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i94d0c3e715a04876b7a0eebf725c54bb_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicareandMedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib29b1d2d5bb4458794f5d56da5481133_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i0f9af972e685431dac0f0893f94454e6_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:MedicaidandManagedMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i8eef48118914482ea280b1dd3e31cd66_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iadaf73e90f7a4ef2b2effea52a4e2206_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="idec28e83e6404debb93980472f318af7_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i507043f785414bbe9b5ce696f53c2c7e_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i0562607b4e35473ba1a511716103fdc2_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6d2459b347674468b9af90ec7b6fa674_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">dva:OtherSourcesofRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icad3d0bdd7834605a261fa6fd56c8c78_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i4e58b8c89c344703bdf5b7d532cc1d0c_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i4b80df9aa48e4aa9a2eeabbf8c48904e_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i33b19b87438e4e76aede245ac6a0c09c_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i53105fdcd8b04f368d61266747f6b56e_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iabe54304a7d4439d88d4c1cbb00ee5ac_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i422c6a94a816499c8310fd5a0acc841f_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie63e40be1b8c44ae852031a36cc0c1d2_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i0cb049c47bd043afa9a8eb3aaf37cb95_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if7870e39ec59457d85f40917f0be7b4b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iffa1899b208b434e83db21f284ea5a87_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">dva:CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i6e7043280f3044ae929ed9d39180bb93_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">dva:CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i762574633ee549d19d8053d43cdafb79_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">dva:MutualFundsAndCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i998926cd86174abfa8697edf79ac9a69_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">dva:MutualFundsAndCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if3d961759a0d4fab9e023c8d7cc84b4d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i02bde4cdadea4ac6b75aaf556e9f2418_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i483736bcec6d40ddb087fe0d0b25dbb5_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherLongTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ibfc94329266c4456afa05d709202b567_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:OtherLongTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7271827c904f4e51b6526494e9342d5f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i756ef20c6d3443ab8a775b412b7acddc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i171f9689d476418d827ad1ac63f1abe2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7fe624a85b4c4310aae5c81aef699e3a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2759022dfe6d4c619bce01f379f17594_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i698d58b2d3b2468cbb119fff40dd7a93_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i92fca4752e474a7bad54570de210ff8d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7093bff9492a45488822863f8f94a337_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i2d792edae43b4791856eea60df0b33b6_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic52ab49cab0046128e4cd38b93634c67_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:OtherReportingUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i168f0cc4ee2a490ba0df4d0eb3ab2041_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i6f2af1cb259e4765a370d5164540acf9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5fab6e21c9604971bab7725c4bfbac6f_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i302d14b3d5a44d99ac999f078c7fd0c8_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanB1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib24db8b1544e4594962862573a081569_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanB1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3eac2310025f4fc0a30a0754d743a012_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:TermLoanB1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3433a7055306497a9f23d7846a707116_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i6d5c71dc8775496aa1ad4209bbb25af1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5034dae68d4445268ca6238ba4f28038_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia085405df9dc49bc9d8a30bf7986f78f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i09d1f6ddde7148209032eb2224d201eb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i302c47dbb07447f3aa14cc9c0f845e99_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5060f8fb53a5401181f83f0a4d6ff2a5_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i04752ae989ad4df8860d74e4cad34f15_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i64428b0bc4064508aa43d6d7c4cc144b_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ibbe11ca6fc7841578c3e48f6f74461bb_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ibea5962a62cd4213b61783287c172e38_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i87c41204c9904d789e0b0f9e1ef28d3d_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i00a6d21c50894a1fa91ade6d03f0fffe_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:FinanceLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i4ebc73ef268843d2a9d4b6d4d487bd9e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:FinanceLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaf4852e0d4004e5793b6d25aad62c55c_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:FinanceLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i41f04bf6bfb648ff9ac2bac9337cf616_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i3c5c02a03c2046a284b5bbc100254ca4_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i82d2dee054d74a1a9b9863ec06aedad5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dva:SeniorSecuredCreditFacilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7c55687d402147b5b3598fcd58f4ea18_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i27a76be1220a42ebb7e508e18f02f881_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i551c354ec3c64e7889df8603ed99c879_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dva:TermLoanFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6dcab18b6e464b478f9e7b926940407a_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie3bcbd3ed4904f758f13fa1bf235728c_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2bd1edc1ab034b47a8b52b57f222a787_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">dva:DebtExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6c1f682df591439fa3b6fcdf674d782e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i288ec9efae5e463983828ed73eecc6fa_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">dva:A2019InterestRateCapAgreementsEffectiveJune302020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icf19afd02f534c9c8ffb4475417e4ce0_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i6e5742b805d64156889d9a58826bf40d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">dva:BilateralSecuredLetterOfCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i017440e66fea4d42af33e10727d6d8bc_D20171201-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">dva:USAttorneyPrescriptionDrugInvestigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="ifb92eab57e66403ca68107330167cb46_D20171201-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">dva:USAttorneyPrescriptionDrugInvestigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">dva:IncrementalCashPortionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="ie9078554660b4e04aa85a2b59269458d_D20171201-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">dva:USAttorneyPrescriptionDrugInvestigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TransactionTypeAxis">dva:CashPaidForPortionPreviouslyRefundedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i34475a7595b24df1b1183abfd0b8bb6b_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">dva:CommitmentsToProvideOperatingCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i234c9227eeee433bb5adf6ea9bcf5b0e_D20220525-20220525">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">dva:AgreementWithMedtronicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-25</startDate>
            <endDate>2022-05-25</endDate>
        </period>
    </context>
    <context id="i56c2b0de3ff24b87b529562972a48a8a_I20220525">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">dva:AgreementWithMedtronicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-25</instant>
        </period>
    </context>
    <context id="i70a7c2b3d8c3425b83bdbde7adae4aed_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8ccb6189ca58495499f4dbbf4481a40c_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockAppreciationRightsSARSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i0e26a096655c4539b381dad37c3f4def_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dva:OpenMarketPurchasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1bbbb5f9079d4dc2b1bc26bc9197d8c2_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dva:OpenMarketPurchasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id88c7440116645768f677634e0f5e6d1_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dva:OpenMarketPurchasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i75f2b64af109480b978f5c7a64a13687_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">dva:OpenMarketPurchasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i93d8bfb8799a4eb1a6cac7ed70c03ca0_D20221001-20221027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-10-27</endDate>
        </period>
    </context>
    <context id="i7d5aa4e5434b4526a0049dce3fe3e153_I20221027">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-27</instant>
        </period>
    </context>
    <context id="ib8eadbdf6a4545af8abdecc0181aed70_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i9e8ea0962d7f484ab9b39cd36f1fe019_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i0b995987498a46b5abb6da0bb3401211_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i25695481a54a456da58a8b675ea33615_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i782ad893fc0b4621a76c9a45d98be61d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i98434fe450004124afb331b74fd63193_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8fe95730ae644d9e881c7051751a5a76_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ifd10dfc3a87841eda50c4640b2db4669_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie9b5ae0e296a416d8eddebe00e9bfe22_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i79b1d5bcdc7c4fb0a917646f4ab14002_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5c0124b9404249c4b64ad373e8c59fb9_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7b7464a1b4454319b3b1a6fdfe238cef_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1ddb5952c6014f42bf7ffa4d2e53fd09_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i6f9aa59cbd6641848230a121fb1bcaf3_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i27574f6140c946159e41244ddaeb3b3d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ied2f14238be74cbcab93bfce44bcf2a8_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i90536d42eb7f4763bfaeebdcb028b4bb_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ib9ec694fa011482bba09ae1ec0527b52_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i4b41eec20f9949888d1d2510c252e563_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id8d33af08bcf4539ad092a661c7d9f23_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibdfd5d445b04452f8439ae6973f8405c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic1ee6b43a5f5462f93097ca6bbd4be00_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i23adff93afc54365bb6b4b7000f67792_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id6ae4d7515be40af9b5d0d99dedb6674_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i3d45a9c325c54f76bedad3d6dc284da2_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i01dd8be0b3174c8ca7f5203f166342a4_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i90261a9edf1e40d0a4d5ecc464319061_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i68f578d19e7645c387c11ed14154d754_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i156a47ec55f944129c986623c6da4e76_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i52c9b6f82ebb4d52b32a547426bdefa3_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i95e6e28da1c64a71b6b90cda0a4d622f_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic959e17b2ced48048db8022f4a387ae2_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:ForeignDialysisCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia6e87c344c514ceda105446f9b6fd9f1_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="icd5d82e4da8342af95e4f8a9ea99d743_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i88a8225e4c1e42caaefc9c729b03c373_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">dva:EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dva:OtherCompaniesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ifde433a78f5e48a7bae7190340e2eb48_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">dva:EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dva:OtherCompaniesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ide4330793ff1447187183eb8ef9696b9_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">dva:OtherCompaniesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i01942e9636d34741abd1fb7dae3a5e7a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i4a9ef1628dd54bbc87ca947161e93f59_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic6f218803873471383d0301f439bbb92_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i9c5d44642dc04d7aad80fa984ec18f13_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i200705f0b3544be7a6092cd5a931bd55_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7ab035ae8c46470e89b5add1fb9a3684_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if32523db73914548b7ef72241eec1f64_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iad68a7dfc7f8430c902a9ff9db916de5_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i37ced70b3e714fa5b27f6d0da83e5d16_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie85a55a4b6014368afa4c77e630e85e9_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i861d396ab85f4a41a20715d925fdf77d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie2281493dee746f3a9ad6ed5affc319f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i942ba5c680184d918b3750ba16f74597_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i422c441ffd274e1a8dea60fc1227cd35_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i277124343d7e4b49b6103749b88e2648_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i86e50a7258fd4e0992f2a0577c97a330_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">dva:ExternalSourcesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i8addd3c7916144679fc2e787249b56d9_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">dva:ExternalSourcesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ide05e52cd7054762b05f224b69c2974e_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">dva:ExternalSourcesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i819e851e63e848a696a608bae9204746_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">dva:ExternalSourcesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i96cb1c0878bf49cea8cfa1212cdc7aed_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i36100b7124c542bd86b8f36ce7106243_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i73df09631cc34d359a0ce8f26f7d7e45_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if3eb7e259bf141018ef89a58189f8ba2_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia8601bd20cd04c22b8e3e448c8c8a4bc_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i38b206ccc4604608ab1cbaeaa6e878f5_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i5947da8371ba465b929ebd233615c5fc_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="icc9f7a8bb84e40e581606e923ee81543_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dva:USDialysisAndRelatedLabServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i068759fddb5d4fbd9e32d6347d1e6d75_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i6b9dedef3bed43dba87b7821cb677959_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2fd089f25d0742cc93cba789d7beaa24_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib561b1ec046245b58bddae941fc0daf3_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibe0e63e321e945a08099e16de0785d5c_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iee77a72428d248f899e78bbf60ce4cc2_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i283d80459c03449ebbe9a4d7b3746698_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ibdf9f7a5de6348a2a7d0775d1ab48459_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsConsolidationItemsAxis">us-gaap:IntersubsegmentEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id1a93e7f4f5e4e33bffc9621d504b491_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i4bcbcc0a834148c8afeb26f2a4556df3_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i74c6003e725f4a6c850b011b394744f5_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i700a5ecba5cb45d1ba64cd1d25b5583e_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000927066</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="segment">
        <measure>dva:segment</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="clinic">
        <measure>dva:clinic</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80L2ZyYWc6NGMyNjM5ZjRkYTg1NGU4ZWE5ZDY2YzUxMjIyYjhiMWEvdGFibGU6ZjY2MDMwOGZiYzQxNGNmY2EwYmY3ZTI3YWMwODAzODQvdGFibGVyYW5nZTpmNjYwMzA4ZmJjNDE0Y2ZjYTBiZjdlMjdhYzA4MDM4NF8xLTEtMS0xLTM2MTU2OQ_5eb61bad-7ebd-4964-96de-728235b6ec27">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80L2ZyYWc6NGMyNjM5ZjRkYTg1NGU4ZWE5ZDY2YzUxMjIyYjhiMWEvdGFibGU6ZjY2MDMwOGZiYzQxNGNmY2EwYmY3ZTI3YWMwODAzODQvdGFibGVyYW5nZTpmNjYwMzA4ZmJjNDE0Y2ZjYTBiZjdlMjdhYzA4MDM4NF8yLTEtMS0xLTM2MTU2OQ_62ca2f37-ba2a-4009-bb2d-c20ddc8ebd64">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80L2ZyYWc6NGMyNjM5ZjRkYTg1NGU4ZWE5ZDY2YzUxMjIyYjhiMWEvdGFibGU6ZjY2MDMwOGZiYzQxNGNmY2EwYmY3ZTI3YWMwODAzODQvdGFibGVyYW5nZTpmNjYwMzA4ZmJjNDE0Y2ZjYTBiZjdlMjdhYzA4MDM4NF8zLTEtMS0xLTM2MTU2OQ_8d24d195-e21a-4c48-9d2a-51e683b04323">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80L2ZyYWc6NGMyNjM5ZjRkYTg1NGU4ZWE5ZDY2YzUxMjIyYjhiMWEvdGFibGU6ZjY2MDMwOGZiYzQxNGNmY2EwYmY3ZTI3YWMwODAzODQvdGFibGVyYW5nZTpmNjYwMzA4ZmJjNDE0Y2ZjYTBiZjdlMjdhYzA4MDM4NF80LTEtMS0xLTM2MTU2OQ_dc4699d0-8a38-42bc-9cf6-a3382a4622f3">0000927066</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80L2ZyYWc6NGMyNjM5ZjRkYTg1NGU4ZWE5ZDY2YzUxMjIyYjhiMWEvdGFibGU6ZjY2MDMwOGZiYzQxNGNmY2EwYmY3ZTI3YWMwODAzODQvdGFibGVyYW5nZTpmNjYwMzA4ZmJjNDE0Y2ZjYTBiZjdlMjdhYzA4MDM4NF81LTEtMS0xLTM2MTU2OQ_7dc17715-128a-4376-b130-38dbc5a7ea3d">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yMi9mcmFnOjQzOTY0YjliNjUzMTQ1ZmFhNWU4NDU4MzM1NWQ4Mjk1L3RhYmxlOjVlMmEwMTQyODhiZTQyNzlhZTM3NWJhYTc1MTUwZWZhL3RhYmxlcmFuZ2U6NWUyYTAxNDI4OGJlNDI3OWFlMzc1YmFhNzUxNTBlZmFfMS0yLTEtMS0zNjE1Njk_3a85514e-0a49-49b9-ad4d-7f24c1a3f929"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yMi9mcmFnOjQzOTY0YjliNjUzMTQ1ZmFhNWU4NDU4MzM1NWQ4Mjk1L3RhYmxlOjVlMmEwMTQyODhiZTQyNzlhZTM3NWJhYTc1MTUwZWZhL3RhYmxlcmFuZ2U6NWUyYTAxNDI4OGJlNDI3OWFlMzc1YmFhNzUxNTBlZmFfMi0yLTEtMS0zNjE1Njk_d066bd8e-df04-4e95-a188-1c4429bd700b"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yMi9mcmFnOjQzOTY0YjliNjUzMTQ1ZmFhNWU4NDU4MzM1NWQ4Mjk1L3RhYmxlOjVlMmEwMTQyODhiZTQyNzlhZTM3NWJhYTc1MTUwZWZhL3RhYmxlcmFuZ2U6NWUyYTAxNDI4OGJlNDI3OWFlMzc1YmFhNzUxNTBlZmFfMy0yLTEtMS0zNjE1Njk_2b62e92d-e1c7-43e9-a268-85c687836aa9"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yMi9mcmFnOjQzOTY0YjliNjUzMTQ1ZmFhNWU4NDU4MzM1NWQ4Mjk1L3RhYmxlOjVlMmEwMTQyODhiZTQyNzlhZTM3NWJhYTc1MTUwZWZhL3RhYmxlcmFuZ2U6NWUyYTAxNDI4OGJlNDI3OWFlMzc1YmFhNzUxNTBlZmFfNC0yLTEtMS0zNjE1Njk_2813ef19-a7f8-4c2a-ab3d-22df7f5433d6"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yMi9mcmFnOjQzOTY0YjliNjUzMTQ1ZmFhNWU4NDU4MzM1NWQ4Mjk1L3RhYmxlOjVlMmEwMTQyODhiZTQyNzlhZTM3NWJhYTc1MTUwZWZhL3RhYmxlcmFuZ2U6NWUyYTAxNDI4OGJlNDI3OWFlMzc1YmFhNzUxNTBlZmFfNS0yLTEtMS0zNjE1Njk_3160f2c5-0f83-46e1-bba0-f6a195d77c33"
      unitRef="shares">450000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yMi9mcmFnOjQzOTY0YjliNjUzMTQ1ZmFhNWU4NDU4MzM1NWQ4Mjk1L3RhYmxlOjVlMmEwMTQyODhiZTQyNzlhZTM3NWJhYTc1MTUwZWZhL3RhYmxlcmFuZ2U6NWUyYTAxNDI4OGJlNDI3OWFlMzc1YmFhNzUxNTBlZmFfNi0yLTEtMS0zNjE1Njk_c0f62812-0932-4b99-8738-ce292a3f783c"
      unitRef="shares">97289000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80OS9mcmFnOjZiM2E1NTlmYTliNDRkZGRhZTdhZDA0M2E0Nzk5Mzc1L3RleHRyZWdpb246NmIzYTU1OWZhOWI0NGRkZGFlN2FkMDQzYTQ3OTkzNzVfMjk_c76c2861-0220-46c2-bcce-1e931560c297"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80OS9mcmFnOjZiM2E1NTlmYTliNDRkZGRhZTdhZDA0M2E0Nzk5Mzc1L3RleHRyZWdpb246NmIzYTU1OWZhOWI0NGRkZGFlN2FkMDQzYTQ3OTkzNzVfMzY_768f04ec-6cce-43ea-88c4-ebfd2438b25d"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOjMzNDNiOGQxYjAwNzRhZWFhMGYzMWJkOTU1ZWVjYmNiL3RhYmxlcmFuZ2U6MzM0M2I4ZDFiMDA3NGFlYWEwZjMxYmQ5NTVlZWNiY2JfMi05LTEtMS0zNjE1Njk_2f37a18b-1ac9-4872-985b-d24c04e03453">http://fasb.org/us-gaap/2022#InterestAndDebtExpense</us-gaap:DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <dva:CorporateIntegrityAgreementPeriod
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81OC9mcmFnOjU5YjlmYzczNzE1ZjRlOTlhNjYyNTU2NzMzODJiNThkL3RleHRyZWdpb246NTliOWZjNzM3MTVmNGU5OWE2NjI1NTY3MzM4MmI1OGRfMjE3_4d148da3-62c8-4ba3-9b8c-ad4dbc72deac">P5Y</dva:CorporateIntegrityAgreementPeriod>
    <dva:RegulatoryAndCommercialMilestonesBeginningDate
      contextRef="i234c9227eeee433bb5adf6ea9bcf5b0e_D20220525-20220525"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81OC9mcmFnOjU5YjlmYzczNzE1ZjRlOTlhNjYyNTU2NzMzODJiNThkL3RleHRyZWdpb246NTliOWZjNzM3MTVmNGU5OWE2NjI1NTY3MzM4MmI1OGRfNDM2_22693c5f-277d-4571-9b25-2e23ef6147be">2024-01-01</dva:RegulatoryAndCommercialMilestonesBeginningDate>
    <dva:RegulatoryAndCommercialMilestonesEndingDate
      contextRef="i234c9227eeee433bb5adf6ea9bcf5b0e_D20220525-20220525"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81OC9mcmFnOjU5YjlmYzczNzE1ZjRlOTlhNjYyNTU2NzMzODJiNThkL3RleHRyZWdpb246NTliOWZjNzM3MTVmNGU5OWE2NjI1NTY3MzM4MmI1OGRfNDQz_1ba5197c-2f76-4ca5-83e0-94cff2288e09">2028-12-31</dva:RegulatoryAndCommercialMilestonesEndingDate>
    <dei:DocumentType
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xL2ZyYWc6NzI3ZGU2YzgxMzYzNDU0N2FjNDYwNjNkMTRkYjNkOWUvdGV4dHJlZ2lvbjo3MjdkZTZjODEzNjM0NTQ3YWM0NjA2M2QxNGRiM2Q5ZV8xODc2_70ba9b7f-2fdb-4a84-b3b8-47e1dcb14916">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xL2ZyYWc6NzI3ZGU2YzgxMzYzNDU0N2FjNDYwNjNkMTRkYjNkOWUvdGFibGU6Mzc1ODEyNjlmNWFhNDkwYzg5ZTI0YWU3MDNmZjkxMzcvdGFibGVyYW5nZTozNzU4MTI2OWY1YWE0OTBjODllMjRhZTcwM2ZmOTEzN18wLTAtMS0xLTM2MTU2OQ_7960352d-84c6-4a5b-8bb6-1d8ed6e2df80">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xL2ZyYWc6NzI3ZGU2YzgxMzYzNDU0N2FjNDYwNjNkMTRkYjNkOWUvdGV4dHJlZ2lvbjo3MjdkZTZjODEzNjM0NTQ3YWM0NjA2M2QxNGRiM2Q5ZV8xMzA_b35d2cab-a5ac-4a11-95cc-a1f8dab6514f">2022-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xL2ZyYWc6NzI3ZGU2YzgxMzYzNDU0N2FjNDYwNjNkMTRkYjNkOWUvdGFibGU6ODkwNDg2NTcwYzE4NDIzM2E5NTZiMWRjYjg2NWI1YmMvdGFibGVyYW5nZTo4OTA0ODY1NzBjMTg0MjMzYTk1NmIxZGNiODY1YjViY18wLTAtMS0xLTM2MTU2OQ_a54e87e4-0ad8-4e0b-ae59-3f3df0ad4f3f">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xL2ZyYWc6NzI3ZGU2YzgxMzYzNDU0N2FjNDYwNjNkMTRkYjNkOWUvdGV4dHJlZ2lvbjo3MjdkZTZjODEzNjM0NTQ3YWM0NjA2M2QxNGRiM2Q5ZV8xODc5_a2d27c6f-5527-4fce-bc56-42d94cd78a16">1-14106</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xL2ZyYWc6NzI3ZGU2YzgxMzYzNDU0N2FjNDYwNjNkMTRkYjNkOWUvdGV4dHJlZ2lvbjo3MjdkZTZjODEzNjM0NTQ3YWM0NjA2M2QxNGRiM2Q5ZV8xODgw_5c532214-3b55-4747-9a9b-5e90c60acc25">DAVITA INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xL2ZyYWc6NzI3ZGU2YzgxMzYzNDU0N2FjNDYwNjNkMTRkYjNkOWUvdGFibGU6MzY2NDQzZWI0ODcwNDEwMmFmNTlkN2U5ZmY1YTUwYzUvdGFibGVyYW5nZTozNjY0NDNlYjQ4NzA0MTAyYWY1OWQ3ZTlmZjVhNTBjNV8wLTAtMS0xLTM2MTU2OQ_75d04a35-cac0-4609-a952-0d0345a9425d">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xL2ZyYWc6NzI3ZGU2YzgxMzYzNDU0N2FjNDYwNjNkMTRkYjNkOWUvdGFibGU6MzY2NDQzZWI0ODcwNDEwMmFmNTlkN2U5ZmY1YTUwYzUvdGFibGVyYW5nZTozNjY0NDNlYjQ4NzA0MTAyYWY1OWQ3ZTlmZjVhNTBjNV8wLTItMS0xLTM2MTU2OQ_ffdd4746-a3c7-4b79-b208-acbc53a672c5">51-0354549</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xL2ZyYWc6NzI3ZGU2YzgxMzYzNDU0N2FjNDYwNjNkMTRkYjNkOWUvdGFibGU6NzY5NWM2NDk3NDU2NGI0NTgyYTc1YjZlZmIwM2NhZDUvdGFibGVyYW5nZTo3Njk1YzY0OTc0NTY0YjQ1ODJhNzViNmVmYjAzY2FkNV8wLTAtMS0xLTM2MTU2OQ_6ab95f54-41cc-4dd8-b5e0-4f27d0ca768e">2000 16th Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xL2ZyYWc6NzI3ZGU2YzgxMzYzNDU0N2FjNDYwNjNkMTRkYjNkOWUvdGFibGU6NzY5NWM2NDk3NDU2NGI0NTgyYTc1YjZlZmIwM2NhZDUvdGFibGVyYW5nZTo3Njk1YzY0OTc0NTY0YjQ1ODJhNzViNmVmYjAzY2FkNV8xLTAtMS0xLTM2MTU2OQ_f6e83bd3-05c4-47f1-9ad4-3967cb897bb3">Denver,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xL2ZyYWc6NzI3ZGU2YzgxMzYzNDU0N2FjNDYwNjNkMTRkYjNkOWUvdGFibGU6NzY5NWM2NDk3NDU2NGI0NTgyYTc1YjZlZmIwM2NhZDUvdGFibGVyYW5nZTo3Njk1YzY0OTc0NTY0YjQ1ODJhNzViNmVmYjAzY2FkNV8xLTEtMS0xLTM2MTU2OQ_09de1fd5-c6c3-46b7-b9c6-a155d0649b51">CO</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xL2ZyYWc6NzI3ZGU2YzgxMzYzNDU0N2FjNDYwNjNkMTRkYjNkOWUvdGFibGU6NzY5NWM2NDk3NDU2NGI0NTgyYTc1YjZlZmIwM2NhZDUvdGFibGVyYW5nZTo3Njk1YzY0OTc0NTY0YjQ1ODJhNzViNmVmYjAzY2FkNV8xLTItMS0xLTM2MTU2OQ_6d894363-3b77-4260-8228-f769df5bdebc">80202</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xL2ZyYWc6NzI3ZGU2YzgxMzYzNDU0N2FjNDYwNjNkMTRkYjNkOWUvdGV4dHJlZ2lvbjo3MjdkZTZjODEzNjM0NTQ3YWM0NjA2M2QxNGRiM2Q5ZV8xODgx_505dfb10-ecd6-4e8e-8b9c-ac71bacc1554">720</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xL2ZyYWc6NzI3ZGU2YzgxMzYzNDU0N2FjNDYwNjNkMTRkYjNkOWUvdGV4dHJlZ2lvbjo3MjdkZTZjODEzNjM0NTQ3YWM0NjA2M2QxNGRiM2Q5ZV8xODc3_10055c55-c824-4891-8c22-9d532790501b">631-2100</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xL2ZyYWc6NzI3ZGU2YzgxMzYzNDU0N2FjNDYwNjNkMTRkYjNkOWUvdGFibGU6NGY3YWI1NmU1NTc4NDcwN2FlYTY5Yzk4ZDgxOTBhMGYvdGFibGVyYW5nZTo0ZjdhYjU2ZTU1Nzg0NzA3YWVhNjljOThkODE5MGEwZl8xLTAtMS0xLTM2MTU2OQ_c2b5ef65-9a33-4083-99eb-753bcb34b351">Common Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xL2ZyYWc6NzI3ZGU2YzgxMzYzNDU0N2FjNDYwNjNkMTRkYjNkOWUvdGFibGU6NGY3YWI1NmU1NTc4NDcwN2FlYTY5Yzk4ZDgxOTBhMGYvdGFibGVyYW5nZTo0ZjdhYjU2ZTU1Nzg0NzA3YWVhNjljOThkODE5MGEwZl8xLTItMS0xLTM2MTU2OQ_be0020ed-1d5a-4233-b834-95e4a16789e9">DVA</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xL2ZyYWc6NzI3ZGU2YzgxMzYzNDU0N2FjNDYwNjNkMTRkYjNkOWUvdGFibGU6NGY3YWI1NmU1NTc4NDcwN2FlYTY5Yzk4ZDgxOTBhMGYvdGFibGVyYW5nZTo0ZjdhYjU2ZTU1Nzg0NzA3YWVhNjljOThkODE5MGEwZl8xLTQtMS0xLTM2MTU2OQ_a0eab80f-e7f8-4cbb-b779-93c63f4a1990">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xL2ZyYWc6NzI3ZGU2YzgxMzYzNDU0N2FjNDYwNjNkMTRkYjNkOWUvdGV4dHJlZ2lvbjo3MjdkZTZjODEzNjM0NTQ3YWM0NjA2M2QxNGRiM2Q5ZV8xODc4_27d8000a-4829-4214-ab15-07dfc295f44d">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xL2ZyYWc6NzI3ZGU2YzgxMzYzNDU0N2FjNDYwNjNkMTRkYjNkOWUvdGV4dHJlZ2lvbjo3MjdkZTZjODEzNjM0NTQ3YWM0NjA2M2QxNGRiM2Q5ZV8xODgy_d58835b4-9e71-4165-9326-1421bc63a2c7">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xL2ZyYWc6NzI3ZGU2YzgxMzYzNDU0N2FjNDYwNjNkMTRkYjNkOWUvdGFibGU6NmM3MWIxOTY1MmY4NGQwYWIwYmU1MGNkMmVjOThjNTcvdGFibGVyYW5nZTo2YzcxYjE5NjUyZjg0ZDBhYjBiZTUwY2QyZWM5OGM1N18wLTAtMS0xLTM2MTU2OQ_39f36f23-59fd-46f7-b8f9-94c8699116a4">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xL2ZyYWc6NzI3ZGU2YzgxMzYzNDU0N2FjNDYwNjNkMTRkYjNkOWUvdGFibGU6NmM3MWIxOTY1MmY4NGQwYWIwYmU1MGNkMmVjOThjNTcvdGFibGVyYW5nZTo2YzcxYjE5NjUyZjg0ZDBhYjBiZTUwY2QyZWM5OGM1N18yLTMtMS0xLTM2MTU2OQ_61e61b3b-a3e3-419a-ad55-8d65c221d646">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xL2ZyYWc6NzI3ZGU2YzgxMzYzNDU0N2FjNDYwNjNkMTRkYjNkOWUvdGFibGU6NmM3MWIxOTY1MmY4NGQwYWIwYmU1MGNkMmVjOThjNTcvdGFibGVyYW5nZTo2YzcxYjE5NjUyZjg0ZDBhYjBiZTUwY2QyZWM5OGM1N180LTEtMS0xLTM2MTU2OQ_fbe6ae31-c73d-4510-9d5a-cd0c854fb7a4">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xL2ZyYWc6NzI3ZGU2YzgxMzYzNDU0N2FjNDYwNjNkMTRkYjNkOWUvdGV4dHJlZ2lvbjo3MjdkZTZjODEzNjM0NTQ3YWM0NjA2M2QxNGRiM2Q5ZV8xODgz_4d48432b-7047-4f4a-8eb4-244ce7d8fd4a">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="id9c8841268564112921ca0795b9110dc_I20221027"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xL2ZyYWc6NzI3ZGU2YzgxMzYzNDU0N2FjNDYwNjNkMTRkYjNkOWUvdGV4dHJlZ2lvbjo3MjdkZTZjODEzNjM0NTQ3YWM0NjA2M2QxNGRiM2Q5ZV8xODY1_80183be9-2ca0-4f47-a7e2-25d49bbf82e0"
      unitRef="shares">90100000</dei:EntityCommonStockSharesOutstanding>
    <dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts
      contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMi0xLTEtMS0zNjE1Njk_f5b83fb2-1906-4652-be4c-3e6fd6df49b5"
      unitRef="usd">2846494000</dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts>
    <dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts
      contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMi0zLTEtMS0zNjE1Njk_4bdcfd05-1b57-4602-b85a-74b1eafa27fe"
      unitRef="usd">2837940000</dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts>
    <dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMi01LTEtMS0zNjE1Njk_d2fe795c-5d4c-43ca-a22a-1a13ab8d3ae2"
      unitRef="usd">8372874000</dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts>
    <dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMi03LTEtMS0zNjE1Njk_6d7f3ec0-e164-4777-8cd1-5f95204e6292"
      unitRef="usd">8370484000</dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts>
    <us-gaap:OtherIncome
      contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMy0xLTEtMS0zNjE1Njk_2a148248-91ae-4076-9e32-5826ba173d16"
      unitRef="usd">102200000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMy0zLTEtMS0zNjE1Njk_95a59f73-57ca-45be-9781-1f4a3e194493"
      unitRef="usd">100379000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMy01LTEtMS0zNjE1Njk_2073c711-fdf1-453b-81c7-b785ed7998a1"
      unitRef="usd">320132000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMy03LTEtMS0zNjE1Njk_d3222004-f596-47aa-b16a-5fbbc35e3cdb"
      unitRef="usd">304346000</us-gaap:OtherIncome>
    <us-gaap:Revenues
      contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfNC0xLTEtMS0zNjE1Njk_815fe73f-3d10-4d82-9b15-74ec65a6c679"
      unitRef="usd">2948694000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfNC0zLTEtMS0zNjE1Njk_13fd7ded-3614-4115-bbc4-4ef2082bf1e5"
      unitRef="usd">2938319000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfNC01LTEtMS0zNjE1Njk_2335690a-f714-41af-b07d-1da153fce60b"
      unitRef="usd">8693006000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfNC03LTEtMS0zNjE1Njk_f20aad33-27b1-484a-91f9-4240fc68db89"
      unitRef="usd">8674830000</us-gaap:Revenues>
    <dva:PatientCareCosts
      contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfNi0xLTEtMS0zNjE1Njk_63344b0d-aba8-43d6-bbd5-dd2f2c0a0583"
      unitRef="usd">2085555000</dva:PatientCareCosts>
    <dva:PatientCareCosts
      contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfNi0zLTEtMS0zNjE1Njk_044f75d8-ca1d-43f3-a956-5f1dc55b3037"
      unitRef="usd">2008589000</dva:PatientCareCosts>
    <dva:PatientCareCosts
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfNi01LTEtMS0zNjE1Njk_3aac9313-844e-48e5-b8e9-ad841f5903d2"
      unitRef="usd">6120872000</dva:PatientCareCosts>
    <dva:PatientCareCosts
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfNi03LTEtMS0zNjE1Njk_d805ced2-00c7-401d-bcb4-645ca9e09485"
      unitRef="usd">5912196000</dva:PatientCareCosts>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfNy0xLTEtMS0zNjE1Njk_bb00af36-2af7-422c-b9fe-48ae8918910f"
      unitRef="usd">365447000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfNy0zLTEtMS0zNjE1Njk_763db518-fe23-4ab6-8fc9-aecabe767bc9"
      unitRef="usd">293095000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfNy01LTEtMS0zNjE1Njk_d6d54c23-39df-4c61-ba8c-3ad574bb518d"
      unitRef="usd">975486000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfNy03LTEtMS0zNjE1Njk_66d35dc0-5d00-43b3-811f-c76206b737ba"
      unitRef="usd">872612000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:DepreciationAndAmortization
      contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfOC0xLTEtMS0zNjE1Njk_736d4a07-b868-4b1a-9417-ae7ac148e3e8"
      unitRef="usd">194414000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfOC0zLTEtMS0zNjE1Njk_00f29fb5-2ef3-4ce6-a6db-b7ee34121814"
      unitRef="usd">170462000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfOC01LTEtMS0zNjE1Njk_b0ebb452-fe59-4f27-9bae-b698228861b1"
      unitRef="usd">538534000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfOC03LTEtMS0zNjE1Njk_b5f17b04-7545-4812-9ad7-a36a0c81656a"
      unitRef="usd">505852000</us-gaap:DepreciationAndAmortization>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfOS0xLTEtMS0zNjE1Njk_b7610f2c-7230-4d65-9dbc-df028b67adf4"
      unitRef="usd">8509000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfOS0zLTEtMS0zNjE1Njk_9d6cf254-3a86-4bed-97fc-b0b7fde58377"
      unitRef="usd">8704000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfOS01LTEtMS0zNjE1Njk_ec75f2a2-aa05-4ac2-905a-e566e4ba6e42"
      unitRef="usd">24696000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfOS03LTEtMS0zNjE1Njk_a1a528a5-3d2b-4608-af19-88c2bbef2133"
      unitRef="usd">23785000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:CostsAndExpenses
      contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMTItMS0xLTEtMzYxNTY5_a81d6ac7-7ec3-4385-96bf-031f8ee519c7"
      unitRef="usd">2636907000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMTItMy0xLTEtMzYxNTY5_2f39bef7-6595-49a3-9adb-a25cd5470d2f"
      unitRef="usd">2463442000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMTItNS0xLTEtMzYxNTY5_45b2ae45-94db-4b27-af97-f2b4d35452ea"
      unitRef="usd">7610196000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMTItNy0xLTEtMzYxNTY5_438701da-067f-45eb-835b-c12617f5caba"
      unitRef="usd">7266875000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMTMtMS0xLTEtMzYxNTY5_cc281aa0-e55d-466f-9cde-ee1d20827836"
      unitRef="usd">311787000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMTMtMy0xLTEtMzYxNTY5_7a126112-14e4-4644-8eb2-bb7050eea784"
      unitRef="usd">474877000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMTMtNS0xLTEtMzYxNTY5_047c157b-6199-47c5-b9c8-e0ac9419bb2a"
      unitRef="usd">1082810000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMTMtNy0xLTEtMzYxNTY5_d40d361e-16f0-4a26-8b5b-96f3105a86ab"
      unitRef="usd">1407955000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestAndDebtExpense
      contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMTQtMS0xLTEtMzYxNTY5_2de35fc2-09e3-4719-baf9-ca441f7dc52f"
      unitRef="usd">99680000</us-gaap:InterestAndDebtExpense>
    <us-gaap:InterestAndDebtExpense
      contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMTQtMy0xLTEtMzYxNTY5_224053f4-c832-4dd6-bec7-7666a0973416"
      unitRef="usd">72829000</us-gaap:InterestAndDebtExpense>
    <us-gaap:InterestAndDebtExpense
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMTQtNS0xLTEtMzYxNTY5_d1336c6e-f884-4992-84e2-a00c8d3b2cd5"
      unitRef="usd">256057000</us-gaap:InterestAndDebtExpense>
    <us-gaap:InterestAndDebtExpense
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMTQtNy0xLTEtMzYxNTY5_1228b1a1-e644-44ac-b9e3-70a835ff11d3"
      unitRef="usd">213167000</us-gaap:InterestAndDebtExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMTYtMS0xLTEtMzYxNTY5_f79b079d-dd86-4b37-af8e-e5354d78667f"
      unitRef="usd">-4898000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMTYtMy0xLTEtMzYxNTY5_1c586133-bf6c-4b56-b6c4-37a33e232dd0"
      unitRef="usd">-7590000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMTYtNS0xLTEtMzYxNTY5_7a2e0d57-00ac-4244-8fe4-dd303a95649c"
      unitRef="usd">-7968000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMTYtNy0xLTEtMzYxNTY5_a9473c08-cdfd-4b50-90a0-59d9fda97411"
      unitRef="usd">8766000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMTctMS0xLTEtMzYxNTY5_cb9e3ee4-d25d-43f2-a1cd-5085df2f5f5f"
      unitRef="usd">207209000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMTctMy0xLTEtMzYxNTY5_d837a93b-5021-4ca2-9cad-33342ee820f7"
      unitRef="usd">394458000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMTctNS0xLTEtMzYxNTY5_a226f10c-3775-4674-99a0-bf5c37aed859"
      unitRef="usd">818785000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMTctNy0xLTEtMzYxNTY5_40f25322-ed2e-4382-99ca-78e2c6da9ec6"
      unitRef="usd">1203554000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMTgtMS0xLTEtMzYxNTY5_887a18a3-4fa3-444c-8488-2900998e664a"
      unitRef="usd">42515000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMTgtMy0xLTEtMzYxNTY5_2fb4cf8b-2c32-48b4-a3e7-3d477fef9342"
      unitRef="usd">74704000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMTgtNS0xLTEtMzYxNTY5_48de89bb-a746-4757-b8a1-c97c709fdf5c"
      unitRef="usd">163757000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMTgtNy0xLTEtMzYxNTY5_fd6737b5-3c81-4960-87c6-dcc5f9eb3891"
      unitRef="usd">241224000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMjEtMS0xLTEtMzYxNTY5_d8044268-4b86-4998-9b65-c8a3a9bfb808"
      unitRef="usd">164694000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMjEtMy0xLTEtMzYxNTY5_f7e1df7a-34be-458e-a17c-7909c275a54a"
      unitRef="usd">319754000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMjEtNS0xLTEtMzYxNTY5_d926e3af-db52-4f60-bb8e-ca35a75b1d41"
      unitRef="usd">655028000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMjEtNy0xLTEtMzYxNTY5_a4041138-b48c-428c-9f91-5d134648e354"
      unitRef="usd">962330000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMjItMS0xLTEtMzYxNTY5_bb00e8f6-302b-4069-a5bf-9b878c00bb4b"
      unitRef="usd">59328000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMjItMy0xLTEtMzYxNTY5_a37fbe72-9fd7-41a3-a582-b7abb3f5cd9a"
      unitRef="usd">60000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMjItNS0xLTEtMzYxNTY5_54451c68-9032-4e65-9075-2b6d3e6d5419"
      unitRef="usd">162731000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMjItNy0xLTEtMzYxNTY5_bcf16ec9-e6f1-4588-9e7f-892528458be6"
      unitRef="usd">171353000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMjMtMS0xLTEtMzYxNTY5_e6b1aec8-48de-430a-8792-f388f9a66b57"
      unitRef="usd">105366000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMjMtMy0xLTEtMzYxNTY5_944eb644-362b-4a94-8114-7232d077ff89"
      unitRef="usd">259754000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMjMtNS0xLTEtMzYxNTY5_da217910-4cd7-441e-8d62-c7cd48ffcd37"
      unitRef="usd">492297000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMjMtNy0xLTEtMzYxNTY5_21852a04-6ec7-4da7-8fd4-443398bff0e5"
      unitRef="usd">790977000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMjctMS0xLTEtMzYxNTY5_12954553-f78e-4289-aed2-15c3a64cad24"
      unitRef="usdPerShare">1.16</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMjctMy0xLTEtMzYxNTY5_ab03cc2a-c6bb-42b3-a0c4-fdacaf5d1b43"
      unitRef="usdPerShare">2.48</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMjctNS0xLTEtMzYxNTY5_d06d295e-a3d2-4cc3-bb25-2a05f4ca7e3b"
      unitRef="usdPerShare">5.24</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMjctNy0xLTEtMzYxNTY5_d675baab-9f84-445a-9361-d4da000cfd0f"
      unitRef="usdPerShare">7.41</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMjktMS0xLTEtMzYxNTY5_c8bf3255-8841-4c94-a8db-d7143e81cf0a"
      unitRef="usdPerShare">1.13</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMjktMy0xLTEtMzYxNTY5_d3bf41d6-1bb6-41ae-b9ff-c4b142f862dc"
      unitRef="usdPerShare">2.36</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMjktNS0xLTEtMzYxNTY5_3ef762b2-e88b-4151-aad7-73ba668b50f6"
      unitRef="usdPerShare">5.07</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMjktNy0xLTEtMzYxNTY5_cef55e42-c901-437c-af1d-7e1c04b1c471"
      unitRef="usdPerShare">7.08</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMzItMS0xLTEtMzYxNTY5_8d0e69dd-1f47-46ca-9933-504bef79c0b5"
      unitRef="shares">91160000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMzItMy0xLTEtMzYxNTY5_9c099e1d-d0d3-4918-8ec2-adf955d7b76a"
      unitRef="shares">104793000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMzItNS0xLTEtMzYxNTY5_e715b69a-f76d-4191-9dfa-71c5bf116f20"
      unitRef="shares">93959000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMzItNy0xLTEtMzYxNTY5_ac8a34b5-2549-4329-a2d9-fea07878c7c6"
      unitRef="shares">106685000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMzMtMS0xLTEtMzYxNTY5_7bc66e12-acbb-4e4c-98b7-9272c1aef4ad"
      unitRef="shares">93263000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMzMtMy0xLTEtMzYxNTY5_043dacae-3aca-415d-9d51-c00024ee452c"
      unitRef="shares">109838000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMzMtNS0xLTEtMzYxNTY5_a203dec7-995e-4bec-8c47-17d133c730b2"
      unitRef="shares">97153000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xMy9mcmFnOjU5OTQzYmNhYWQ4YzQxYTQ4NDcyNmU4YjBkZWNjNTY5L3RhYmxlOmMwZmY2OGU0NGMwODRhZTJhM2UzN2I3ZDAyZmY3NjhmL3RhYmxlcmFuZ2U6YzBmZjY4ZTQ0YzA4NGFlMmEzZTM3YjdkMDJmZjc2OGZfMzMtNy0xLTEtMzYxNTY5_544ba2ed-e4d1-45d4-8c55-3d6e711a006c"
      unitRef="shares">111666000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfMi0xLTEtMS0zNjE1Njk_d8044268-4b86-4998-9b65-c8a3a9bfb808"
      unitRef="usd">164694000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfMi0zLTEtMS0zNjE1Njk_f7e1df7a-34be-458e-a17c-7909c275a54a"
      unitRef="usd">319754000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfMi01LTEtMS0zNjE1Njk_d926e3af-db52-4f60-bb8e-ca35a75b1d41"
      unitRef="usd">655028000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfMi03LTEtMS0zNjE1Njk_a4041138-b48c-428c-9f91-5d134648e354"
      unitRef="usd">962330000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfNS0xLTEtMS0zNjE1Njk_f019b7bf-e7b6-4e0f-a8ee-d46c74ecfa22"
      unitRef="usd">41312000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfNS0zLTEtMS0zNjE1Njk_2af05015-a908-422f-b4fc-0c31c913aacb"
      unitRef="usd">-357000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfNS01LTEtMS0zNjE1Njk_d7ff750c-1e96-41d0-b303-39cbc011d14c"
      unitRef="usd">95660000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfNS03LTEtMS0zNjE1Njk_64d40dac-ebf1-4dfe-981b-0e8165b88185"
      unitRef="usd">2466000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfNi0xLTEtMS0zNjE1Njk_3d7b81a9-6bdf-456d-9888-1dfabc736219"
      unitRef="usd">-1033000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfNi0zLTEtMS0zNjE1Njk_3bf891d8-0c38-4655-9a76-2b1b719faf6b"
      unitRef="usd">-1034000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfNi01LTEtMS0zNjE1Njk_3e908dd0-b30a-4e53-b520-a3064d9de9ca"
      unitRef="usd">-3100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfNi03LTEtMS0zNjE1Njk_69527cfa-f90b-4253-ab34-47f861c0df43"
      unitRef="usd">-3100000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfNy0xLTEtMS0zNjE1Njk_87b80b0b-dbf4-4139-aad4-59c6dc45c9ce"
      unitRef="usd">-66100000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfNy0zLTEtMS0zNjE1Njk_c6ce82d7-db6d-49d5-9130-9ffcbab50850"
      unitRef="usd">-54528000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfNy01LTEtMS0zNjE1Njk_16534840-9205-4482-bbb0-f19d6d824070"
      unitRef="usd">-95064000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfNy03LTEtMS0zNjE1Njk_7df17b67-92a6-4018-b150-8299764f55ac"
      unitRef="usd">-59162000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfOC0xLTEtMS0zNjE1Njk_7c0e67a3-7dbd-453f-b354-51861267be75"
      unitRef="usd">-23755000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfOC0zLTEtMS0zNjE1Njk_115c76a5-5a67-4fff-8b45-19d8dbe1f50a"
      unitRef="usd">-53851000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfOC01LTEtMS0zNjE1Njk_71fe3c92-390a-4fce-8e6c-d3813159421f"
      unitRef="usd">3696000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfOC03LTEtMS0zNjE1Njk_7ed00d62-9d80-4220-b4e9-b228c966d5dc"
      unitRef="usd">-53596000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfOS0xLTEtMS0zNjE1Njk_ad17e804-25d1-4360-b423-66e0b0511dd1"
      unitRef="usd">140939000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfOS0zLTEtMS0zNjE1Njk_61cac17f-9588-42bb-a73c-8852b2caa3ee"
      unitRef="usd">265903000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfOS01LTEtMS0zNjE1Njk_8726716e-b1ff-4ead-9572-777cacf30567"
      unitRef="usd">658724000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfOS03LTEtMS0zNjE1Njk_bd6d71cc-b347-4b4d-b2d6-936e18a2321c"
      unitRef="usd">908734000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfMTAtMS0xLTEtMzYxNTY5_e5537cda-9d80-4870-b826-2cc5d6d64051"
      unitRef="usd">59328000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfMTAtMy0xLTEtMzYxNTY5_3b1c101e-88a6-4126-ae54-4035a20a4079"
      unitRef="usd">60000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfMTAtNS0xLTEtMzYxNTY5_49837a59-8269-4aff-90d0-ded475176475"
      unitRef="usd">162731000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfMTAtNy0xLTEtMzYxNTY5_b0b914fd-6ca1-4272-b1a9-d8addcd8ebd9"
      unitRef="usd">171353000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfMTEtMS0xLTEtMzYxNTY5_0e6815a6-3b63-46c1-b2b0-27bc914e31c3"
      unitRef="usd">81611000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfMTEtMy0xLTEtMzYxNTY5_4d25c4e6-5c07-4663-8dca-2d0a87dff4d3"
      unitRef="usd">205903000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfMTEtNS0xLTEtMzYxNTY5_ae4cdb25-fb92-4aff-ab6f-7703da31f353"
      unitRef="usd">495993000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xNi9mcmFnOmJkYTkwN2E3ZWM5MjQxZTE4MGQ2OGZkNWQ2ZTMwMDlhL3RhYmxlOmFkNjdjMjBlOTIyYjQ0MThhYzM4ZmY5YTVjOTUxODQ5L3RhYmxlcmFuZ2U6YWQ2N2MyMGU5MjJiNDQxOGFjMzhmZjlhNWM5NTE4NDlfMTEtNy0xLTEtMzYxNTY5_f0c094ef-6e51-4038-8655-e97fc072523b"
      unitRef="usd">737381000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMi0xLTEtMS0zNjE1Njk_8fd6d38f-7e28-495d-8338-0551eaf6df40"
      unitRef="usd">367510000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMi0zLTEtMS0zNjE1Njk_b6bf89f4-f414-468c-a5bb-3fb47919d32d"
      unitRef="usd">461900000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMy0xLTEtMS0zNjE1Njk_3c3b4968-e833-4636-97e1-238d2a07b913"
      unitRef="usd">94704000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMy0zLTEtMS0zNjE1Njk_640e6604-11f5-4bcd-812b-044f87235877"
      unitRef="usd">93060000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfNC0xLTEtMS0zNjE1Njk_d34eaa71-2081-4519-a2cd-3debdb1ba6a9"
      unitRef="usd">74305000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfNC0zLTEtMS0zNjE1Njk_e6ea2361-0516-41f6-9a0b-f6ef0927c479"
      unitRef="usd">22310000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfNS0xLTEtMS0zNjE1Njk_16c92950-df7f-46a8-b9e6-d90277c44a8f"
      unitRef="usd">2089017000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfNS0zLTEtMS0zNjE1Njk_d07cd255-c4fc-4d37-826e-443eea1a2e2e"
      unitRef="usd">1957583000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfNi0xLTEtMS0zNjE1Njk_dbceeabd-b52b-4257-b93d-b8cfe87a6e31"
      unitRef="usd">106845000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfNi0zLTEtMS0zNjE1Njk_eafa3999-29d6-4495-b349-50e95d8f238c"
      unitRef="usd">107428000</us-gaap:InventoryNet>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfNy0xLTEtMS0zNjE1Njk_88f2ff10-7855-4a8f-a910-938732f83191"
      unitRef="usd">392851000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfNy0zLTEtMS0zNjE1Njk_26bb0ff9-919b-42a4-8e8f-06bcc5e6ce37"
      unitRef="usd">427321000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfOC0xLTEtMS0zNjE1Njk_dc2e27df-2980-4d44-8ecd-301b648119fc"
      unitRef="usd">65807000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfOC0zLTEtMS0zNjE1Njk_2046d2e9-438f-4535-b62a-6cf060b6e573"
      unitRef="usd">72517000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:IncomeTaxesReceivable
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfOS0xLTEtMS0zNjE1Njk_41109cbb-af87-4fe6-9d7b-87b9748a9470"
      unitRef="usd">11403000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfOS0zLTEtMS0zNjE1Njk_493b5a4d-9bb6-4e0f-9bc3-bf2ce630a2a3"
      unitRef="usd">25604000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:AssetsCurrent
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMTAtMS0xLTEtMzYxNTY5_d22bde8b-fabf-45e8-9a4b-a013be9dbae5"
      unitRef="usd">3202442000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMTAtMy0xLTEtMzYxNTY5_f805a555-9c5a-4d78-9aae-0ef3cc2c0adb"
      unitRef="usd">3167723000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentOwnedAccumulatedDepreciation
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMTEtMC0xLTEtMzYxNTY5L3RleHRyZWdpb246MzI4NzQ3MjlhYTM2NGRiM2JlMDk3NDBiOGMxNjAwNjNfNjM_ce00ea26-9f14-4f33-84eb-e0fa77992137"
      unitRef="usd">5114579000</us-gaap:PropertyPlantAndEquipmentOwnedAccumulatedDepreciation>
    <us-gaap:PropertyPlantAndEquipmentOwnedAccumulatedDepreciation
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMTEtMC0xLTEtMzYxNTY5L3RleHRyZWdpb246MzI4NzQ3MjlhYTM2NGRiM2JlMDk3NDBiOGMxNjAwNjNfNzA_a9833521-90f1-4a11-9115-4be57f198c0e"
      unitRef="usd">4763135000</us-gaap:PropertyPlantAndEquipmentOwnedAccumulatedDepreciation>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMTEtMS0xLTEtMzYxNTY5_e3a8580d-4fba-4cd8-90e9-ec775dff6ee4"
      unitRef="usd">3240310000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMTEtMy0xLTEtMzYxNTY5_40b5b375-10e4-43e1-b5c1-85796bdb027e"
      unitRef="usd">3479972000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMTItMS0xLTEtMzYxNTY5_4e7f5125-faa2-4160-9085-88a3eb460c56"
      unitRef="usd">2721888000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMTItMy0xLTEtMzYxNTY5_483f27a2-6d12-4206-adca-5350c1d7ee89"
      unitRef="usd">2824787000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMTMtMC0xLTEtMzYxNTY5L3RleHRyZWdpb246N2VmMTZmNWJiNjFhNDVlNWIzY2Y2YWJmMGU4NTUwNmRfNTg_2463dea3-d35a-465a-93d3-47100c7142b4"
      unitRef="usd">46907000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMTMtMC0xLTEtMzYxNTY5L3RleHRyZWdpb246N2VmMTZmNWJiNjFhNDVlNWIzY2Y2YWJmMGU4NTUwNmRfNjU_e0f068a2-9979-4426-96d6-2d5d727b1e02"
      unitRef="usd">60730000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMTMtMS0xLTEtMzYxNTY5_0f8a2068-1efb-4416-9a7a-6e703057ccc3"
      unitRef="usd">179715000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMTMtMy0xLTEtMzYxNTY5_1c960d75-1a03-46a8-baf1-0872535ade1f"
      unitRef="usd">177693000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMTQtMS0xLTEtMzYxNTY5_c7d345a8-36cb-48e7-be64-6eafb8424f17"
      unitRef="usd">243554000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMTQtMy0xLTEtMzYxNTY5_d623e9e9-f18f-415e-b433-3ebd1c4bf1c8"
      unitRef="usd">238881000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMTUtMS0xLTEtMzYxNTY5_57ea7d70-98e7-4c6a-ac50-8c17f3baad58"
      unitRef="usd">43535000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMTUtMy0xLTEtMzYxNTY5_82c761eb-b698-4683-ad54-edc5a777decb"
      unitRef="usd">49514000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMTYtMS0xLTEtMzYxNTY5_12b7b264-ef08-4c2f-97ab-a5a35b677827"
      unitRef="usd">307713000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMTYtMy0xLTEtMzYxNTY5_fa4985e2-5c54-441f-81b4-6c213dd552b4"
      unitRef="usd">136677000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Goodwill
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMTctMS0xLTEtMzYxNTY5_26ece92d-6d7f-43e5-b1e9-b5e4377dc89a"
      unitRef="usd">7022642000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMTctMy0xLTEtMzYxNTY5_8b491d00-1052-48dd-8c7b-3da7fdc40a9b"
      unitRef="usd">7046241000</us-gaap:Goodwill>
    <us-gaap:Assets
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMTgtMS0xLTEtMzYxNTY5_216607c7-e831-44f4-8c98-8c6df64a5bf7"
      unitRef="usd">16961799000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMTgtMy0xLTEtMzYxNTY5_e1a500fb-3468-47a2-88fc-8ec1ffcd8794"
      unitRef="usd">17121488000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMjAtMS0xLTEtMzYxNTY5_918753f9-ebd6-44ee-aa19-d82db2954aa0"
      unitRef="usd">417139000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMjAtMy0xLTEtMzYxNTY5_f038d23a-0506-4e91-bb8f-afb4b3071e37"
      unitRef="usd">402049000</us-gaap:AccountsPayableCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMjEtMS0xLTEtMzYxNTY5_13e7f497-8841-4b5f-9283-17312bf02fc2"
      unitRef="usd">796200000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMjEtMy0xLTEtMzYxNTY5_488f8027-305b-4918-bee5-f2f68f313c8f"
      unitRef="usd">709345000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMjItMS0xLTEtMzYxNTY5_43446236-7c14-4019-939d-7e2e006218e9"
      unitRef="usd">702877000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMjItMy0xLTEtMzYxNTY5_25b9614c-e88c-48bf-9792-27103716ddd2"
      unitRef="usd">659960000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMjMtMS0xLTEtMzYxNTY5_10413e30-99f0-4b29-bf4e-e6e0a6769ba7"
      unitRef="usd">396880000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMjMtMy0xLTEtMzYxNTY5_bbe8698e-d710-40b2-8813-9d75f4b55536"
      unitRef="usd">394357000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMjQtMS0xLTEtMzYxNTY5_cd10e0a5-51d3-4b53-b9cc-eb232b200fef"
      unitRef="usd">214254000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMjQtMy0xLTEtMzYxNTY5_df6dfaa6-2d85-4215-870b-605ac632fbcf"
      unitRef="usd">179030000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMjUtMS0xLTEtMzYxNTY5_f6df254c-712d-4d3c-be4d-13e70fc19f12"
      unitRef="usd">10059000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMjUtMy0xLTEtMzYxNTY5_8c98290f-baf0-4b85-a35f-f2c13c1e9f6d"
      unitRef="usd">53792000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMjYtMS0xLTEtMzYxNTY5_aa7b78b9-9942-4eb0-875a-686fbe04a19b"
      unitRef="usd">2537409000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMjYtMy0xLTEtMzYxNTY5_a9295cf2-a4c9-4f13-ac59-b9dc8a613704"
      unitRef="usd">2398533000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMjctMS0xLTEtMzYxNTY5_c7343d69-664d-4e9c-a858-7b2a93ebda74"
      unitRef="usd">2558355000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMjctMy0xLTEtMzYxNTY5_21186d91-624a-4465-80d2-b19b1a3770cc"
      unitRef="usd">2672713000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMjgtMS0xLTEtMzYxNTY5_7118b730-1df4-4bc4-9449-b2091c3a2d2a"
      unitRef="usd">8867187000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMjgtMy0xLTEtMzYxNTY5_cfdd56ad-7522-43b8-a719-4863204afda5"
      unitRef="usd">8729150000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMjktMS0xLTEtMzYxNTY5_30d6489b-3c0f-46f1-9420-9b8ba080b5a1"
      unitRef="usd">106895000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMjktMy0xLTEtMzYxNTY5_17e810b0-fda9-4161-baf5-5626b4e2cc60"
      unitRef="usd">119158000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzAtMS0xLTEtMzYxNTY5_021cf3ef-699f-4f52-a3cf-e158f3a435aa"
      unitRef="usd">819073000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzAtMy0xLTEtMzYxNTY5_a3471c25-ee6c-4055-b0ce-19233a86f031"
      unitRef="usd">830954000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:Liabilities
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzEtMS0xLTEtMzYxNTY5_6842e510-3561-4d30-a7e2-8d0e2586cd80"
      unitRef="usd">14888919000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzEtMy0xLTEtMzYxNTY5_dc205d9d-d9ac-4b39-a804-aef4d80f058a"
      unitRef="usd">14750508000</us-gaap:Liabilities>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzMtMS0xLTEtMzYxNTY5_1e472794-c9bd-4f65-88fe-bb8939437957"
      unitRef="usd">1370753000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzMtMy0xLTEtMzYxNTY5_dc1a7814-29dc-4122-a6d1-ae1afa3b788b"
      unitRef="usd">1434832000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzUtMC0xLTEtMzYxNTY5L3RleHRyZWdpb246NWJkYTJkMjE2NjRiNGUwZGE2MmRiMGM3NzQ5MmVjODJfMjE_ed1455a7-e3b6-47bd-864f-6b614ad20386"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzUtMC0xLTEtMzYxNTY5L3RleHRyZWdpb246NWJkYTJkMjE2NjRiNGUwZGE2MmRiMGM3NzQ5MmVjODJfMzU_0d4b1dad-ca28-435b-9078-c86cb069cf60"
      unitRef="shares">5000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzUtMC0xLTEtMzYxNTY5L3RleHRyZWdpb246NWJkYTJkMjE2NjRiNGUwZGE2MmRiMGM3NzQ5MmVjODJfNTc_1b8161a4-260c-4b34-ae21-439d1d1e173e"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzUtMS0xLTEtMzYxNTY5_fa8741fe-d88d-44bb-8cfc-fe242e2a6d2e"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzUtMy0xLTEtMzYxNTY5_2721713c-18fa-447f-9acc-a0b71a97c95f"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzYtMC0xLTEtMzYxNTY5L3RleHRyZWdpb246M2VlOGQxNTk1MTQ0NDQ4MGE5YTQ5NGRjYzUwZmIxODJfMTg_8bdd1b1c-ee21-41f2-b4bb-dbeda5f3fe6d"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzYtMC0xLTEtMzYxNTY5L3RleHRyZWdpb246M2VlOGQxNTk1MTQ0NDQ4MGE5YTQ5NGRjYzUwZmIxODJfMzI_336c80b4-4ff6-4fdb-8b61-b8e9a97ba614"
      unitRef="shares">450000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzYtMC0xLTEtMzYxNTY5L3RleHRyZWdpb246M2VlOGQxNTk1MTQ0NDQ4MGE5YTQ5NGRjYzUwZmIxODJfNTQ_1fbd35b2-a792-4460-929f-4a6b5df739a7"
      unitRef="shares">98199000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzYtMC0xLTEtMzYxNTY5L3RleHRyZWdpb246M2VlOGQxNTk1MTQ0NDQ4MGE5YTQ5NGRjYzUwZmIxODJfNjE_d20f3ba7-976b-4612-bee6-aae5e66450d3"
      unitRef="shares">90104000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzYtMC0xLTEtMzYxNTY5L3RleHRyZWdpb246M2VlOGQxNTk1MTQ0NDQ4MGE5YTQ5NGRjYzUwZmIxODJfMTIw_0a467bed-d226-4d4e-8d66-e33c0573815d"
      unitRef="shares">97289000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzYtMS0xLTEtMzYxNTY5_dbc192d8-099f-408e-a34c-941e3973adb9"
      unitRef="usd">98000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzYtMy0xLTEtMzYxNTY5_7e538069-af69-49fe-aaad-60ecbb3e3c75"
      unitRef="usd">97000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzctMS0xLTEtMzYxNTY5_4db97a25-eb9a-4074-9936-124de6d0173a"
      unitRef="usd">609345000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzctMy0xLTEtMzYxNTY5_3d9438da-241e-4917-afee-0b0d92a500e5"
      unitRef="usd">540321000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzgtMS0xLTEtMzYxNTY5_612fb3c1-9f1b-4d6b-aa2a-96cf5ad4011b"
      unitRef="usd">846634000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzgtMy0xLTEtMzYxNTY5_154f4d0a-867d-4d4d-bf43-a649e499a44b"
      unitRef="usd">354337000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzktMC0xLTEtMzYxNTY5L3RleHRyZWdpb246ODJhZWQ0MDZkMTkyNGQ0NDk2YmVhZDViYzZlYzhkZDJfMjA_0ba01b7b-c0c7-46f6-b43d-4cabeb5abb67"
      unitRef="shares">8095000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzktMC0xLTEtMzYxNTY5L3RleHRyZWdpb246ODJhZWQ0MDZkMTkyNGQ0NDk2YmVhZDViYzZlYzhkZDJfMjc_177ff8ee-1daa-42a6-ba93-8f9c07844237"
      unitRef="shares">0</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockValue
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzktMS0xLTEtMzYxNTY5_7ca97934-9852-45e8-8af7-b06169e0e9f6"
      unitRef="usd">787854000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfMzktMy0xLTEtMzYxNTY5_c24dcaee-61ce-412a-968d-9c7a1d98c02a"
      unitRef="usd">0</us-gaap:TreasuryStockValue>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfNDAtMS0xLTEtMzYxNTY5_5844284f-9f4a-4c8a-b164-1f69f9e28aa2"
      unitRef="usd">-135551000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfNDAtMy0xLTEtMzYxNTY5_04cf669c-9d97-47f7-8f81-84930ecc6fb7"
      unitRef="usd">-139247000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfNDEtMS0xLTEtMzYxNTY5_c91af45b-5dc5-42f1-b6b8-0e811cd62379"
      unitRef="usd">532672000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfNDEtMy0xLTEtMzYxNTY5_29ec1f33-6838-4f0d-a7ac-c5b447c4dcc3"
      unitRef="usd">755508000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfNDItMS0xLTEtMzYxNTY5_2b60caf6-1a57-46be-8f05-d2c0fd5a7443"
      unitRef="usd">169455000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfNDItMy0xLTEtMzYxNTY5_5043446e-c1b8-423f-9182-d0e3c2c8a055"
      unitRef="usd">180640000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfNDMtMS0xLTEtMzYxNTY5_1841b84c-b208-48fe-b0de-39441adac120"
      unitRef="usd">702127000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfNDMtMy0xLTEtMzYxNTY5_6a51cbb6-2e11-44bd-a46b-afd889d20cdb"
      unitRef="usd">936148000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfNDQtMS0xLTEtMzYxNTY5_cfd04daa-135f-4978-b9d4-79f3a93ff61d"
      unitRef="usd">16961799000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8xOS9mcmFnOjUwMmUyZjY2NDNhNzRiY2I5NDVmMGNjNzc4MDQ0NDVmL3RhYmxlOjlhOWNhMTFkN2IyYjQyYTk5MjI0NTg5M2JjN2Q0YWYzL3RhYmxlcmFuZ2U6OWE5Y2ExMWQ3YjJiNDJhOTkyMjQ1ODkzYmM3ZDRhZjNfNDQtMy0xLTEtMzYxNTY5_739f5e8a-e0d6-457e-8377-a21ed5f670db"
      unitRef="usd">17121488000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMy0xLTEtMS0zNjE1Njk_e58e6d87-6659-4c75-a16b-ebbd55e8bae2"
      unitRef="usd">655028000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMy0zLTEtMS0zNjE1Njk_9d2c0a14-42fb-431e-9470-632d23aa91e1"
      unitRef="usd">962330000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfNS0xLTEtMS0zNjE1Njk_e4158002-ad47-407b-a1de-40cec3b62a42"
      unitRef="usd">538534000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfNS0zLTEtMS0zNjE1Njk_e9e75e88-ca4e-4b58-a423-f2dc673d784c"
      unitRef="usd">505852000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:ShareBasedCompensation
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfOC0xLTEtMS0zNjE1Njk_2aff8e89-c223-4f64-b698-ec31e241f593"
      unitRef="usd">77904000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfOC0zLTEtMS0zNjE1Njk_0d186dd0-4fc0-4be2-b4c3-d1e4993a58f2"
      unitRef="usd">75898000</us-gaap:ShareBasedCompensation>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfOS0xLTEtMS0zNjE1Njk_492ffa72-92f4-4dfd-8700-129ada2d1ad3"
      unitRef="usd">-35637000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfOS0zLTEtMS0zNjE1Njk_cbd1fcad-0712-4d22-9171-169bb35dd3d1"
      unitRef="usd">56724000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMTAtMS0xLTEtMzYxNTY5_c1327575-31b6-4ae3-9f75-5f7969cdcb67"
      unitRef="usd">417000</us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi>
    <us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMTAtMy0xLTEtMzYxNTY5_80f2eb20-9721-48e5-bf06-649596b2e013"
      unitRef="usd">1687000</us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMTItMS0xLTEtMzYxNTY5_abe1ee3f-b1b0-47fa-90d9-01bc3232ab51"
      unitRef="usd">-16035000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMTItMy0xLTEtMzYxNTY5_333dd469-d85f-470c-a97b-44dc0c2a8dab"
      unitRef="usd">-13418000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMTQtMS0xLTEtMzYxNTY5_7ff426a6-fc0d-4896-9987-236e45a9db6d"
      unitRef="usd">135632000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMTQtMy0xLTEtMzYxNTY5_1210ff26-a4de-47b9-a926-f82911894d2e"
      unitRef="usd">205792000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMTUtMS0xLTEtMzYxNTY5_1999f9e7-a32c-44e6-bc94-14e6f0f39734"
      unitRef="usd">-347000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMTUtMy0xLTEtMzYxNTY5_08aec4a0-c17f-4501-ae1f-d04b67e29837"
      unitRef="usd">2490000</us-gaap:IncreaseDecreaseInInventories>
    <dva:IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMTYtMS0xLTEtMzYxNTY5_c0abe265-b4b4-4885-a3f9-bf5e91a6291e"
      unitRef="usd">-43392000</dva:IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets>
    <dva:IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMTYtMy0xLTEtMzYxNTY5_f92e1d1d-b6d8-4b1c-a60f-d3a55d50c284"
      unitRef="usd">-144967000</dva:IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMTctMS0xLTEtMzYxNTY5_855bc689-0c0e-4ba5-aab2-99c57af82d22"
      unitRef="usd">49326000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMTctMy0xLTEtMzYxNTY5_0a6dd584-d3e1-4528-888a-0c84fcac10fb"
      unitRef="usd">19663000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMTgtMS0xLTEtMzYxNTY5_fc49f7ce-476d-45fa-a97a-1a0b99d1dbba"
      unitRef="usd">38870000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMTgtMy0xLTEtMzYxNTY5_c706fb44-5ad2-47ea-b671-a9b26f73b006"
      unitRef="usd">-47412000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMTktMS0xLTEtMzYxNTY5_493fdbb8-402e-4bd3-9827-a25da5845ea9"
      unitRef="usd">35491000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMTktMy0xLTEtMzYxNTY5_b3a83746-860b-40e3-8951-6d9dd238807f"
      unitRef="usd">-7176000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMjAtMS0xLTEtMzYxNTY5_7c833220-a935-4fd2-8649-2898c07caf7d"
      unitRef="usd">87248000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMjAtMy0xLTEtMzYxNTY5_ff22b584-d2c2-4c44-9992-79ed3529bea9"
      unitRef="usd">-87842000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMjEtMS0xLTEtMzYxNTY5_7ae53fa9-9d8f-44a6-a9d7-6c3bc38d8edb"
      unitRef="usd">-37770000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMjEtMy0xLTEtMzYxNTY5_165668ac-05a2-4608-bbc7-428888bbb7c3"
      unitRef="usd">22609000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMjItMS0xLTEtMzYxNTY5_eb81c7cf-7bcb-4aef-bf9f-bc31538d3f85"
      unitRef="usd">-13219000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMjItMy0xLTEtMzYxNTY5_5c639d8d-ffdc-4300-a779-2459da82799d"
      unitRef="usd">-8748000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMjMtMS0xLTEtMzYxNTY5_9689aef2-813c-4750-872c-f07d43841743"
      unitRef="usd">1220848000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMjMtMy0xLTEtMzYxNTY5_184b4a0e-9df5-4b6d-b71d-feb09eb9dd89"
      unitRef="usd">1400988000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMjUtMS0xLTEtMzYxNTY5_8eb515e9-b758-452a-9265-a446d311ad3b"
      unitRef="usd">409391000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMjUtMy0xLTEtMzYxNTY5_c5f28c54-9f97-4a92-a003-d2f0e341637c"
      unitRef="usd">451909000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMjYtMS0xLTEtMzYxNTY5_6b06f776-8bac-49fa-833f-0679c1aa65dc"
      unitRef="usd">43811000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMjYtMy0xLTEtMzYxNTY5_7a52afaa-cc2f-45e3-a8e9-a9413f8c67bd"
      unitRef="usd">45143000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMjctMS0xLTEtMzYxNTY5_783d3761-612b-4aac-908a-b27978bef9b8"
      unitRef="usd">116088000</us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets>
    <us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMjctMy0xLTEtMzYxNTY5_a2bb463c-2695-42cd-b272-999c26d30c3b"
      unitRef="usd">46578000</us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets>
    <us-gaap:PaymentsToAcquireHeldToMaturitySecurities
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMjgtMS0xLTEtMzYxNTY5_23f9e9ba-1297-4d55-ac19-7083562bc4ab"
      unitRef="usd">94602000</us-gaap:PaymentsToAcquireHeldToMaturitySecurities>
    <us-gaap:PaymentsToAcquireHeldToMaturitySecurities
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMjgtMy0xLTEtMzYxNTY5_29afe1f4-bd70-426e-a3d8-bbe5c0a26be3"
      unitRef="usd">13274000</us-gaap:PaymentsToAcquireHeldToMaturitySecurities>
    <us-gaap:PaymentsToAcquireOtherInvestments
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMjktMS0xLTEtMzYxNTY5_f4bae11c-c877-4812-881a-b63ab5e894c0"
      unitRef="usd">3322000</us-gaap:PaymentsToAcquireOtherInvestments>
    <us-gaap:PaymentsToAcquireOtherInvestments
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMjktMy0xLTEtMzYxNTY5_81ae1c51-821d-4264-91fc-a3e278215541"
      unitRef="usd">2609000</us-gaap:PaymentsToAcquireOtherInvestments>
    <us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMzAtMS0xLTEtMzYxNTY5_01024194-efa1-4ecd-97a7-ca900fdc5e0a"
      unitRef="usd">40660000</us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMzAtMy0xLTEtMzYxNTY5_e49c8d64-210c-459d-85c4-d3205d8d1738"
      unitRef="usd">13274000</us-gaap:ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMzEtMS0xLTEtMzYxNTY5_36593d7b-2ba1-4d63-add9-623627c11158"
      unitRef="usd">3763000</us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments>
    <us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMzEtMy0xLTEtMzYxNTY5_d6f6848b-d047-4190-82bb-4c9997a20018"
      unitRef="usd">11976000</us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMzItMS0xLTEtMzYxNTY5_116c1882-cac7-48ec-bcb5-8f41b7d4edde"
      unitRef="usd">782000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMzItMy0xLTEtMzYxNTY5_56724271-3096-4f13-9627-64939cfeb16f"
      unitRef="usd">745000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMzMtMS0xLTEtMzYxNTY5_5b3ba405-28e4-43e8-bb2b-d7c24451a6bb"
      unitRef="usd">28176000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMzMtMy0xLTEtMzYxNTY5_1d148524-1ee8-442a-ba42-4f5ce2766fbe"
      unitRef="usd">7925000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMzQtMS0xLTEtMzYxNTY5_5f2a45d9-8052-4c1e-af6e-44207c3d47a1"
      unitRef="usd">2490000</us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital>
    <us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMzQtMy0xLTEtMzYxNTY5_624424c3-2a1d-4235-a731-05bbfc4f720e"
      unitRef="usd">1592000</us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMzUtMS0xLTEtMzYxNTY5_0d67c36d-6549-40a0-a96f-6a4b63a552e4"
      unitRef="usd">-417083000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMzUtMy0xLTEtMzYxNTY5_c58fa0b7-7507-476a-b19d-2200511aa517"
      unitRef="usd">-448185000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMzctMS0xLTEtMzYxNTY5_765baf7b-9ed7-45ff-be14-f9588c4507a6"
      unitRef="usd">1705913000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMzctMy0xLTEtMzYxNTY5_d005b898-6fce-4372-9f26-82be7450933a"
      unitRef="usd">1613036000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMzgtMS0xLTEtMzYxNTY5_fa71cd78-d10b-431a-a1b5-1722426a8c1d"
      unitRef="usd">1557358000</us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations>
    <us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMzgtMy0xLTEtMzYxNTY5_a6c09fec-6a2b-4a1e-998e-f0449363c9f0"
      unitRef="usd">812659000</us-gaap:RepaymentsOfDebtAndCapitalLeaseObligations>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMzktMS0xLTEtMzYxNTY5_cf37d5bf-3cb4-47c3-a88b-aceef2501865"
      unitRef="usd">0</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfMzktMy0xLTEtMzYxNTY5_cebccbac-4ffb-40c1-b1db-5b60695de42b"
      unitRef="usd">9091000</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfNDAtMS0xLTEtMzYxNTY5_8b15fc38-578d-42af-9893-6b5b493fdb9a"
      unitRef="usd">802228000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfNDAtMy0xLTEtMzYxNTY5_404e056a-2389-40b2-8e55-3e6d0f84977e"
      unitRef="usd">882411000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfDistributionsToAffiliates
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfNDEtMS0xLTEtMzYxNTY5_3952fcfa-134b-4512-bb0d-ea823026ea34"
      unitRef="usd">188592000</us-gaap:PaymentsOfDistributionsToAffiliates>
    <us-gaap:PaymentsOfDistributionsToAffiliates
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfNDEtMy0xLTEtMzYxNTY5_876f1025-2743-4c68-989d-f60c817e6af9"
      unitRef="usd">177146000</us-gaap:PaymentsOfDistributionsToAffiliates>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfNDItMS0xLTEtMzYxNTY5_c0f3400e-1e38-4957-847b-31ca704b9726"
      unitRef="usd">42248000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfNDItMy0xLTEtMzYxNTY5_ea5404dc-5c22-4953-8618-625abbd45f3c"
      unitRef="usd">59849000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ProceedsFromContributionsFromAffiliates
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfNDMtMS0xLTEtMzYxNTY5_403070d7-3cb4-45e5-94a3-9b4be1be6f69"
      unitRef="usd">11382000</us-gaap:ProceedsFromContributionsFromAffiliates>
    <us-gaap:ProceedsFromContributionsFromAffiliates
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfNDMtMy0xLTEtMzYxNTY5_403339fc-6c63-4fdb-b151-b467001a3a71"
      unitRef="usd">28295000</us-gaap:ProceedsFromContributionsFromAffiliates>
    <us-gaap:ProceedsFromMinorityShareholders
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfNDQtMS0xLTEtMzYxNTY5_c526bb80-5e19-4b54-a2a7-06349656da7b"
      unitRef="usd">3673000</us-gaap:ProceedsFromMinorityShareholders>
    <us-gaap:ProceedsFromMinorityShareholders
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfNDQtMy0xLTEtMzYxNTY5_ecedbc4a-a0c1-441a-8a67-17a07ddbd144"
      unitRef="usd">2880000</us-gaap:ProceedsFromMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfNDUtMS0xLTEtMzYxNTY5_feeaa7e4-911f-4041-99b4-4d66a037f3e1"
      unitRef="usd">20770000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfNDUtMy0xLTEtMzYxNTY5_99d0ecf4-8769-44d7-a476-fbc04ed3e197"
      unitRef="usd">11658000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfNDYtMS0xLTEtMzYxNTY5_1f1a2773-7b1c-443c-bfe6-9fa68df9aea5"
      unitRef="usd">-890228000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfNDYtMy0xLTEtMzYxNTY5_f5bf3574-d83a-42e2-9f59-8e06fd2c4f21"
      unitRef="usd">-308603000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfNDctMS0xLTEtMzYxNTY5_2b0bcc11-61f9-4193-a04b-3fd55e152550"
      unitRef="usd">-6283000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfNDctMy0xLTEtMzYxNTY5_87e7cc8d-475d-4d43-9a10-b03bd64a1e47"
      unitRef="usd">-7381000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfNDgtMS0xLTEtMzYxNTY5_e0232822-6916-4234-b18d-2ecad9e61cfb"
      unitRef="usd">-92746000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfNDgtMy0xLTEtMzYxNTY5_e9eef995-a0cb-4204-8dc2-3ffe1bc05e88"
      unitRef="usd">636819000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfNDktMS0xLTEtMzYxNTY5_ed3087db-bb09-477a-b814-cb49128f370d"
      unitRef="usd">554960000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ibf9e89b4e598444e8b9df2b00849c30a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfNDktMy0xLTEtMzYxNTY5_b2a86d15-2a91-4917-bfcf-23d7bde7b90c"
      unitRef="usd">501790000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfNTAtMS0xLTEtMzYxNTY5_a686d590-7261-4875-a304-242c6390ee13"
      unitRef="usd">462214000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i3b171dd2fa094f0183b61386c9e24e5f_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yNS9mcmFnOjYwNTliZmExNjQzMDQxMmVhY2FkMjc0MGNiZTU2Yjk1L3RhYmxlOmYxMTBkMGE3MTQ1MzQzM2I5NzQ0NGYxYzg3MWIxMjA1L3RhYmxlcmFuZ2U6ZjExMGQwYTcxNDUzNDMzYjk3NDQ0ZjFjODcxYjEyMDVfNTAtMy0xLTEtMzYxNTY5_18d5dcf0-f611-4cb1-aba2-8a582a95de6c"
      unitRef="usd">1138609000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="ia716f88984964a2b912c2cad0bd8a1fa_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfNS0xLTEtMS0zNjE1Njk_483da286-368b-47ff-87f7-46c3ebad86ad"
      unitRef="usd">1385821000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ieb3363d3cbf6464faff1cbeaac015fa5_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfNS0zLTEtMS0zNjE1Njk_591c1136-257e-4114-82b8-b7d30f8995fd"
      unitRef="shares">98179000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ieb3363d3cbf6464faff1cbeaac015fa5_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfNS01LTEtMS0zNjE1Njk_68c97d7a-f2da-4183-902b-101f80db9788"
      unitRef="usd">98000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1ed815cd2c304b559653370ccc275a2b_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfNS03LTEtMS0zNjE1Njk_909c410d-6e6b-4667-9445-8c0a455bb826"
      unitRef="usd">578272000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if4e48eaf91dc4c408c68dbe262d5b593_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfNS05LTEtMS0zNjE1Njk_3dae4822-e46a-4a23-8d89-c86e7abb01e8"
      unitRef="usd">741268000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="i225bee24745a47b79c36ca66d4a0f754_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfNS0xMS0xLTEtMzYxNTY5_7381e814-9bef-4253-895b-ae7be2b867ac"
      unitRef="shares">5973000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i225bee24745a47b79c36ca66d4a0f754_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfNS0xMy0xLTEtMzYxNTY5_a32e832d-5ae3-42e7-8f93-05a913fabf60"
      unitRef="usd">-603058000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4611f48e469e4f43bc268b742f4eb3be_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfNS0xNS0xLTEtMzYxNTY5_b0e0dfbf-b5f1-4541-b2cc-f6c59cdbac0e"
      unitRef="usd">-111796000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i825fb40a1a3741bbb7f8ab64213ff5a9_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfNS0xNy0xLTEtMzYxNTY5_a99bec47-bd0b-46ee-8683-4322a725d825"
      unitRef="usd">604784000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iba35f774a92e4ef7aed7d1d87280a599_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfNS0xOS0xLTEtMzYxNTY5_2def4a1e-35f7-40ad-adb1-8ef848664c29"
      unitRef="usd">170390000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome
      contextRef="i147789d12c114b6f8c98855d532eca0e_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfNy0xLTEtMS0zNjE1Njk_549c22cf-bfd3-4f34-86ce-0c92473a1878"
      unitRef="usd">39205000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="idbc46e0d55ea4c998cc9052010d50139_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfNy05LTEtMS0zNjE1Njk_c8256001-3544-45f4-9f0b-cdd41b6eecb6"
      unitRef="usd">105366000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="icc29ea0c8d1844d39747787ecd867dc7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfNy0xNy0xLTEtMzYxNTY5_c6c5fe88-521b-4e2d-860b-9aa23db615f0"
      unitRef="usd">105366000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i2320a27c131f4981931e8a5421b2ef7c_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfNy0xOS0xLTEtMzYxNTY5_55287344-88f4-4726-a3a1-5a56ed1494b4"
      unitRef="usd">20123000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i275b9f2c01bb463f9786a30fe06b1e1f_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfOS0xNS0xLTEtMzYxNTY5_69e688e5-7183-4ec0-9800-57ffbb9c1803"
      unitRef="usd">-23755000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="icc29ea0c8d1844d39747787ecd867dc7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfOS0xNy0xLTEtMzYxNTY5_37acdec0-7d89-464d-8665-259ee4d71105"
      unitRef="usd">-23755000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i39e9b3036c5b4d1b9dae3f82941570f9_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMTEtMy0xLTEtMzYxNTY5_33a1e0d4-7373-4b9a-a93b-3bdaff730e2b"
      unitRef="shares">20000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ifc82d88333724b428b3e6c8367bbaeb8_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMTEtNy0xLTEtMzYxNTY5_1586d557-f227-4f34-944c-dd1cc5e71494"
      unitRef="usd">986000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="icc29ea0c8d1844d39747787ecd867dc7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMTEtMTctMS0xLTM2MTU2OQ_7c51a9bd-1261-4083-8627-7a4b8bc534f1"
      unitRef="usd">986000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ifc82d88333724b428b3e6c8367bbaeb8_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMTItNy0xLTEtMzYxNTY5_eb05b600-a2ac-40eb-9616-d9a00e761fd8"
      unitRef="usd">27619000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="icc29ea0c8d1844d39747787ecd867dc7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMTItMTctMS0xLTM2MTU2OQ_e551a855-0353-4112-869e-abe2b63d2513"
      unitRef="usd">27619000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <dva:TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders
      contextRef="i147789d12c114b6f8c98855d532eca0e_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMTQtMS0xLTEtMzYxNTY5_3f814e1c-a2c1-4fd3-ae80-85b7f9398241"
      unitRef="usd">48275000</dva:TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i2320a27c131f4981931e8a5421b2ef7c_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMTQtMTktMS0xLTM2MTU2OQ_dc5fad02-65da-4744-8678-11a6ddb0c66d"
      unitRef="usd">22002000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <dva:TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders
      contextRef="i147789d12c114b6f8c98855d532eca0e_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMTUtMS0xLTEtMzYxNTY5_868d9fcf-5603-409f-85d1-a9435f2b9483"
      unitRef="usd">1996000</dva:TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders>
    <dva:NoncontrollingInterestIncreaseFromContributions
      contextRef="i2320a27c131f4981931e8a5421b2ef7c_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMTUtMTktMS0xLTM2MTU2OQ_17e55bf8-d812-4a25-919e-3b3fcfc48077"
      unitRef="usd">270000</dva:NoncontrollingInterestIncreaseFromContributions>
    <dva:NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures
      contextRef="i2320a27c131f4981931e8a5421b2ef7c_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMTYtMTktMS0xLTM2MTU2OQ_26814719-9cc6-4c5a-973b-414af49e4114"
      unitRef="usd">867000</dva:NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures>
    <dva:TemporaryEquityDecreasePurchaseOfInterests
      contextRef="i147789d12c114b6f8c98855d532eca0e_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMTctMS0xLTEtMzYxNTY5_78406cb1-fa64-457f-afd4-588078f36473"
      unitRef="usd">215000</dva:TemporaryEquityDecreasePurchaseOfInterests>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="ifc82d88333724b428b3e6c8367bbaeb8_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMTctNy0xLTEtMzYxNTY5_595d2c57-1c16-42ff-9e44-3e0096b6e3b2"
      unitRef="usd">3339000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="icc29ea0c8d1844d39747787ecd867dc7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMTctMTctMS0xLTM2MTU2OQ_a7abc802-0e3d-4411-aa08-d88be7f440a1"
      unitRef="usd">3339000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i2320a27c131f4981931e8a5421b2ef7c_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMTctMTktMS0xLTM2MTU2OQ_7ca25372-1396-4728-abec-14e932131136"
      unitRef="usd">193000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="i147789d12c114b6f8c98855d532eca0e_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMTgtMS0xLTEtMzYxNTY5_de75d752-6bb4-4d9e-afec-d24d5deeee71"
      unitRef="usd">-7779000</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="ifc82d88333724b428b3e6c8367bbaeb8_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMTgtNy0xLTEtMzYxNTY5_c774f213-e67e-460d-9f9f-fc75e8dc3117"
      unitRef="usd">7779000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="icc29ea0c8d1844d39747787ecd867dc7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMTgtMTctMS0xLTM2MTU2OQ_d97c9e0d-9b4a-4612-aece-cbdaa6fd9c9a"
      unitRef="usd">7779000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ia7b08c7176c749f98f073fea08d83f2b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMjAtMTEtMS0xLTM2MTU2OQ_123394bc-ffd5-4d82-b490-591a9b654e32"
      unitRef="shares">2122000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ia7b08c7176c749f98f073fea08d83f2b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMjAtMTMtMS0xLTM2MTU2OQ_40867b46-d0d5-4dd1-a9fa-34d8e4a8b836"
      unitRef="usd">184796000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="icc29ea0c8d1844d39747787ecd867dc7_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMjAtMTctMS0xLTM2MTU2OQ_8fd2475c-0c57-4e3a-88ac-fcaf91461c1f"
      unitRef="usd">184796000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i5d096d77a67d4147a3ff676d41c97ea4_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMjEtMS0xLTEtMzYxNTY5_f17ff9f4-3b5b-4bad-95d8-c77d8627a6b5"
      unitRef="usd">1370753000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i3f6ac9def05f4546ad8e00029f29c85f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMjEtMy0xLTEtMzYxNTY5_6c216e55-332d-4802-808f-9aaeb821be96"
      unitRef="shares">98199000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3f6ac9def05f4546ad8e00029f29c85f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMjEtNS0xLTEtMzYxNTY5_04ab7f0c-76ed-4cfd-9a0e-4b7727cb4412"
      unitRef="usd">98000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ida0a3398956c428db91dfbf84211ac9d_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMjEtNy0xLTEtMzYxNTY5_9addf7f3-126f-4188-84f7-de283baad348"
      unitRef="usd">609345000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6362305fbd044f9b9980adcadabf8f07_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMjEtOS0xLTEtMzYxNTY5_45c34fde-8d6c-41f0-80fd-9cddd218deb5"
      unitRef="usd">846634000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="i36614688dae84eef869cd0e6d793fa74_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMjEtMTEtMS0xLTM2MTU2OQ_0732b3f9-7f81-4de1-955c-0a2a3d4c98e1"
      unitRef="shares">8095000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i36614688dae84eef869cd0e6d793fa74_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMjEtMTMtMS0xLTM2MTU2OQ_eebd1a1e-e779-4387-b9ef-76928356be56"
      unitRef="usd">-787854000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i23a94ede934c4277b1d46b13e38fefd1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMjEtMTUtMS0xLTM2MTU2OQ_0d14d254-a207-4425-a0e3-944acbcbc742"
      unitRef="usd">-135551000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2cf6560db6fe433e9fe35420f78329ca_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMjEtMTctMS0xLTM2MTU2OQ_41a896d9-bad0-421f-9e32-86823200d3e5"
      unitRef="usd">532672000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibd69c0a4b8da40a483520c9abec5ab4e_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmZlN2Y2NGIzZjg2NzQ4MDlhZTQxY2RmNzcxMTNmODkyL3RhYmxlcmFuZ2U6ZmU3ZjY0YjNmODY3NDgwOWFlNDFjZGY3NzExM2Y4OTJfMjEtMTktMS0xLTM2MTU2OQ_12e2d799-8055-44d9-b343-44fee0af0598"
      unitRef="usd">169455000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i276433c699f648cf975516d1ebf29a92_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfNS0xLTEtMS0zNjE1Njk_302a9a3b-a26a-40cd-bf2b-e64ae6496e8a"
      unitRef="usd">1434832000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ieac6f79edec64565b9a967d39744ab16_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfNS0zLTEtMS0zNjE1Njk_4f0a4673-440f-44a4-8bca-2c0149c6ec9e"
      unitRef="shares">97289000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ieac6f79edec64565b9a967d39744ab16_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfNS01LTEtMS0zNjE1Njk_ea7d2d84-23f3-4ecf-81a5-e269a589401e"
      unitRef="usd">97000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2cbc28027ca9463d88cb9103183707e2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfNS03LTEtMS0zNjE1Njk_791dd37e-8032-45f9-85a5-76acd409b3d4"
      unitRef="usd">540321000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idde5dd2e47cc48b3b4ab52a208a0b76c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfNS05LTEtMS0zNjE1Njk_f5a644b3-4229-4852-8afd-3c968fdd43a3"
      unitRef="usd">354337000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="i4f4b7c7d62ec4f68a27cb7f3d6ee06dd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfNS0xMS0xLTEtMzYxNTY5_755cfd41-9d17-4432-8e7d-0c9d0125b2c4"
      unitRef="shares">0</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4f4b7c7d62ec4f68a27cb7f3d6ee06dd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfNS0xMy0xLTEtMzYxNTY5_e82b47f9-2c33-4b99-a3b9-a2112c7d8f16"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7ba288d628f64e839c5eef1fa88fdd33_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfNS0xNS0xLTEtMzYxNTY5_b28bc292-10b0-4be8-8a25-35eb05c64b67"
      unitRef="usd">-139247000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i03c39842d00748dab2c10d4f15c2ada9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfNS0xNy0xLTEtMzYxNTY5_d664fa39-d72d-41d0-90fd-988eb953a245"
      unitRef="usd">755508000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i530e6ba6cb654ba8beab393e20b2de81_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfNS0xOS0xLTEtMzYxNTY5_b793e8f6-a0f2-46eb-a8f3-c03c12117a29"
      unitRef="usd">180640000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome
      contextRef="i55a696e4c43e43a084a98a9190e869b0_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfNy0xLTEtMS0zNjE1Njk_89b7ca05-6fbd-49e9-9435-58443addb690"
      unitRef="usd">113157000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i07cba31e2e3b4a8ea010c559dcb43625_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfNy05LTEtMS0zNjE1Njk_49102fa8-32b9-4c67-89ac-aef4a5d268ca"
      unitRef="usd">492297000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i8139303e818c4499a156db063aa48dba_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfNy0xNy0xLTEtMzYxNTY5_4c6a49e3-0cfe-4e31-b6a9-2fd0c1d6926a"
      unitRef="usd">492297000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i73664eea57554ff1a6527a1e3088909e_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfNy0xOS0xLTEtMzYxNTY5_cf0052b3-0f2e-4a12-b921-982fa661766f"
      unitRef="usd">49574000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie2f7382dda1241aaad40dfb7cb9dd962_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfOS0xNS0xLTEtMzYxNTY5_b8549207-2b4d-449d-8dc8-e3373764f2e9"
      unitRef="usd">3696000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8139303e818c4499a156db063aa48dba_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfOS0xNy0xLTEtMzYxNTY5_d1cfe7e1-0631-4a93-a54c-ae30926f57a6"
      unitRef="usd">3696000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i646ec415498444bd800c1444f673b411_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMTEtMy0xLTEtMzYxNTY5_b8d37752-fbda-4dd2-b98b-ee73d1c55e0d"
      unitRef="shares">910000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i646ec415498444bd800c1444f673b411_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMTEtNS0xLTEtMzYxNTY5_13bc27a6-d668-459f-bb3f-f1a54f26adff"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i8b36f5eee05c4272833ec6129d2e6d23_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMTEtNy0xLTEtMzYxNTY5_d9997a37-04f1-4377-920e-20c49352da12"
      unitRef="usd">55359000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i8139303e818c4499a156db063aa48dba_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMTEtMTctMS0xLTM2MTU2OQ_e5f7bec8-d58b-4886-b122-9de9c2ce4bc2"
      unitRef="usd">55358000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i8b36f5eee05c4272833ec6129d2e6d23_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMTItNy0xLTEtMzYxNTY5_91ac1c1a-ca56-405a-abf9-bd3cb7580554"
      unitRef="usd">77835000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i8139303e818c4499a156db063aa48dba_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMTItMTctMS0xLTM2MTU2OQ_d6e30ef1-c95b-4c0c-bca6-fea6e5f4d89d"
      unitRef="usd">77835000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <dva:TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders
      contextRef="i55a696e4c43e43a084a98a9190e869b0_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMTQtMS0xLTEtMzYxNTY5_cb60ee36-e1e3-413c-9770-5441b44bd59c"
      unitRef="usd">125534000</dva:TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i73664eea57554ff1a6527a1e3088909e_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMTQtMTktMS0xLTM2MTU2OQ_40801b26-f83a-4f03-883b-e092ae65fb2a"
      unitRef="usd">63058000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <dva:TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders
      contextRef="i55a696e4c43e43a084a98a9190e869b0_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMTUtMS0xLTEtMzYxNTY5_df6a5629-74ef-477b-9508-d537a54015c6"
      unitRef="usd">9300000</dva:TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders>
    <dva:NoncontrollingInterestIncreaseFromContributions
      contextRef="i73664eea57554ff1a6527a1e3088909e_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMTUtMTktMS0xLTM2MTU2OQ_905707b6-88cf-40e9-a414-311643d41191"
      unitRef="usd">2082000</dva:NoncontrollingInterestIncreaseFromContributions>
    <dva:TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures
      contextRef="i55a696e4c43e43a084a98a9190e869b0_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMTYtMS0xLTEtMzYxNTY5_8805ba7b-fa58-4940-8b3e-ef78645da3d4"
      unitRef="usd">2392000</dva:TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures>
    <dva:NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures
      contextRef="i8b36f5eee05c4272833ec6129d2e6d23_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMTYtNy0xLTEtMzYxNTY5_778c398b-444e-4c4c-a6f9-cf56fc93bf4d"
      unitRef="usd">939000</dva:NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures>
    <dva:NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures
      contextRef="i8139303e818c4499a156db063aa48dba_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMTYtMTctMS0xLTM2MTU2OQ_24fcc1d6-31dd-4ab0-b8f0-b0a0a60df6ac"
      unitRef="usd">939000</dva:NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures>
    <dva:NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures
      contextRef="i73664eea57554ff1a6527a1e3088909e_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMTYtMTktMS0xLTM2MTU2OQ_30c16ab4-0d3e-40e7-b3a8-c197283d70fd"
      unitRef="usd">867000</dva:NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures>
    <dva:TemporaryEquityDecreasePurchaseOfInterests
      contextRef="i55a696e4c43e43a084a98a9190e869b0_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMTctMS0xLTEtMzYxNTY5_122c01da-3ded-46c1-ad16-7b59a24207f0"
      unitRef="usd">11633000</dva:TemporaryEquityDecreasePurchaseOfInterests>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i8b36f5eee05c4272833ec6129d2e6d23_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMTctNy0xLTEtMzYxNTY5_952f2b2c-dffd-4adc-9f0a-0506d8144ba2"
      unitRef="usd">6609000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i8139303e818c4499a156db063aa48dba_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMTctMTctMS0xLTM2MTU2OQ_1270dc22-6b13-479f-9727-3cd475aab6e7"
      unitRef="usd">6609000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i73664eea57554ff1a6527a1e3088909e_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMTctMTktMS0xLTM2MTU2OQ_86af868b-f24f-48b5-9d64-ed6d0c294208"
      unitRef="usd">193000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="i55a696e4c43e43a084a98a9190e869b0_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMTgtMS0xLTEtMzYxNTY5_46a867c9-0ae0-4f9d-b098-ce9f73ba0c56"
      unitRef="usd">-52218000</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="i8b36f5eee05c4272833ec6129d2e6d23_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMTgtNy0xLTEtMzYxNTY5_a3e5a34f-39f2-4987-835a-d24c8f38167a"
      unitRef="usd">52218000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="i8139303e818c4499a156db063aa48dba_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMTgtMTctMS0xLTM2MTU2OQ_10548c70-e1ef-460d-8ea1-92b186167a4b"
      unitRef="usd">52218000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:TemporaryEquityOtherChanges
      contextRef="i55a696e4c43e43a084a98a9190e869b0_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMTktMS0xLTEtMzYxNTY5_4d409b1c-c0ca-45b7-991c-a7635ab7ac5b"
      unitRef="usd">457000</us-gaap:TemporaryEquityOtherChanges>
    <dva:NoncontrollingInterestChangesFromOther
      contextRef="i73664eea57554ff1a6527a1e3088909e_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMTktMTktMS0xLTM2MTU2OQ_a49bfaa2-6ff6-4183-8b71-fe936b733b51"
      unitRef="usd">-457000</dva:NoncontrollingInterestChangesFromOther>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i3cc14165b1e5457b9a7d411fe7bae49e_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMjAtMTEtMS0xLTM2MTU2OQ_c7908cf3-f266-43c8-9d57-3f6971f7f5f6"
      unitRef="shares">8095000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i3cc14165b1e5457b9a7d411fe7bae49e_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMjAtMTMtMS0xLTM2MTU2OQ_52ee432d-3e30-4a38-8ad9-d5758a742a57"
      unitRef="usd">787854000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i8139303e818c4499a156db063aa48dba_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMjAtMTctMS0xLTM2MTU2OQ_0980fbac-6d8c-4318-b101-3e7c6b39d8ce"
      unitRef="usd">787854000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i5d096d77a67d4147a3ff676d41c97ea4_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMjEtMS0xLTEtMzYxNTY5_98561b15-9de3-4c9c-996c-ea5740ed5726"
      unitRef="usd">1370753000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i3f6ac9def05f4546ad8e00029f29c85f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMjEtMy0xLTEtMzYxNTY5_541c5060-ec44-443b-9fde-8bcef2d19c90"
      unitRef="shares">98199000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3f6ac9def05f4546ad8e00029f29c85f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMjEtNS0xLTEtMzYxNTY5_fb589289-a96f-4aad-a373-6a870502cb02"
      unitRef="usd">98000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ida0a3398956c428db91dfbf84211ac9d_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMjEtNy0xLTEtMzYxNTY5_8d6a4e1a-6fd3-4bd5-9a68-033a3ccbbbcb"
      unitRef="usd">609345000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6362305fbd044f9b9980adcadabf8f07_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMjEtOS0xLTEtMzYxNTY5_30102fbd-c18d-42b5-980a-9b2151764384"
      unitRef="usd">846634000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="i36614688dae84eef869cd0e6d793fa74_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMjEtMTEtMS0xLTM2MTU2OQ_9a3d3f4c-a0cd-4b1f-a054-f009e3fd4aa1"
      unitRef="shares">8095000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i36614688dae84eef869cd0e6d793fa74_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMjEtMTMtMS0xLTM2MTU2OQ_09a7cbe6-1dd1-4a02-8c64-9cac65951f24"
      unitRef="usd">-787854000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i23a94ede934c4277b1d46b13e38fefd1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMjEtMTUtMS0xLTM2MTU2OQ_ace2d53f-2d44-4efe-9328-26d5c280c948"
      unitRef="usd">-135551000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2cf6560db6fe433e9fe35420f78329ca_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMjEtMTctMS0xLTM2MTU2OQ_18c39676-24ed-44e1-9ad5-377c85f33cc9"
      unitRef="usd">532672000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibd69c0a4b8da40a483520c9abec5ab4e_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOmY1ZWZjMDBjY2UzODQ5NDViM2E1ZWVhZmYyZTI2MzVjL3RhYmxlcmFuZ2U6ZjVlZmMwMGNjZTM4NDk0NWIzYTVlZWFmZjJlMjYzNWNfMjEtMTktMS0xLTM2MTU2OQ_a2b13082-6958-443c-9a6c-c12df2cdfc6c"
      unitRef="usd">169455000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="iedd8e53afd1f49d1ab701015f45a5489_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfNS0xLTEtMS0zNjE1Njk_70b16edf-a9b5-409d-97d5-9616ec07ad2c"
      unitRef="usd">1426211000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ice4bdd4f0f9347209498a13bb73d9bdc_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfNS0zLTEtMS0zNjE1Njk_f2693182-55c7-4ecf-b439-773cf66b22c5"
      unitRef="shares">110644000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ice4bdd4f0f9347209498a13bb73d9bdc_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfNS01LTEtMS0zNjE1Njk_fbde2476-e5f4-49b0-bc96-ba9666355116"
      unitRef="usd">111000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i663815c6d9b048f4b3e8a826a42acd72_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfNS03LTEtMS0zNjE1Njk_02b70938-eede-4d5d-9b4c-5846b7f3bb6e"
      unitRef="usd">523038000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7507dbbe11004f8f993908a1a48afa76_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfNS05LTEtMS0zNjE1Njk_5de71b06-aaae-42a1-a145-02cbbe446b07"
      unitRef="usd">1383760000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="id43bdce378174edd8e02d9f9f1fd6b24_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfNS0xMS0xLTEtMzYxNTY5_58c6938d-edb6-4f48-badb-92de22ab7104"
      unitRef="shares">5019000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id43bdce378174edd8e02d9f9f1fd6b24_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfNS0xMy0xLTEtMzYxNTY5_a12a7674-e0f1-491a-830d-d6c724c9d961"
      unitRef="usd">-563230000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie002b14464f24380b244cc03154fc209_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfNS0xNS0xLTEtMzYxNTY5_619756ce-53ff-4eeb-ac0c-c1409e608761"
      unitRef="usd">-65899000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic329b3c1d74b48468770b45b930bad16_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfNS0xNy0xLTEtMzYxNTY5_69625fa9-fe1d-4a6e-8c52-a161bbe09f26"
      unitRef="usd">1277780000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie19f600b93854407adf4fdf1f09eee0b_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfNS0xOS0xLTEtMzYxNTY5_86ce4100-49b3-4dc5-85fa-674e4d5b6692"
      unitRef="usd">185046000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome
      contextRef="ia98324e3ccbe45f88cbaa562c7631b0b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfNy0xLTEtMS0zNjE1Njk_ba478f20-7630-4bb2-b955-ec1abc8bea15"
      unitRef="usd">41182000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i4ddc0fff672e45bf957f1116d0d1cb0c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfNy05LTEtMS0zNjE1Njk_e08b1a76-e2b6-48be-bd69-b3818db49bbd"
      unitRef="usd">259754000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i2fbb95ab11e644199452dbc8220b5114_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfNy0xNy0xLTEtMzYxNTY5_edbf14e4-641e-47e4-bb14-d86277d33ef3"
      unitRef="usd">259754000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i5b6ffea1a40d41068e8300270af3e5ba_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfNy0xOS0xLTEtMzYxNTY5_ce01a52e-3bfe-4b98-88b2-40bfafcdb774"
      unitRef="usd">18818000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib49a7f0c10554865819c8371c13ef3f0_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfOC0xNS0xLTEtMzYxNTY5_1db6e7b1-5794-488c-aa05-f492960afb50"
      unitRef="usd">-53851000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i2fbb95ab11e644199452dbc8220b5114_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfOC0xNy0xLTEtMzYxNTY5_f685d1db-2703-4f2a-b590-4ac41e12bd02"
      unitRef="usd">-53851000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i319451c323114481b97e571a89a51741_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMTAtMy0xLTEtMzYxNTY5_9f19163a-b626-4167-a161-179fc3331ed8"
      unitRef="shares">242000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i56a34082e8604548b02c2fbf0259eb63_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMTAtNy0xLTEtMzYxNTY5_82811834-07b6-4464-a578-8a10521fef33"
      unitRef="usd">23584000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i2fbb95ab11e644199452dbc8220b5114_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMTAtMTctMS0xLTM2MTU2OQ_9d9bfd28-4e05-4316-8f9d-c198721feba3"
      unitRef="usd">23584000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i56a34082e8604548b02c2fbf0259eb63_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMTEtNy0xLTEtMzYxNTY5_069cdd33-2d55-4382-a5d8-406031401ce3"
      unitRef="usd">24055000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i2fbb95ab11e644199452dbc8220b5114_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMTEtMTctMS0xLTM2MTU2OQ_7a71333f-ead8-4b5b-800a-c1de8854fe64"
      unitRef="usd">24055000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <dva:TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders
      contextRef="ia98324e3ccbe45f88cbaa562c7631b0b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMTMtMS0xLTEtMzYxNTY5_bbf61629-07b2-40d4-b516-4324dd1fd76d"
      unitRef="usd">49766000</dva:TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i5b6ffea1a40d41068e8300270af3e5ba_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMTMtMTktMS0xLTM2MTU2OQ_e15dc76b-b237-4647-9c9b-773817022bef"
      unitRef="usd">28018000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <dva:TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders
      contextRef="ia98324e3ccbe45f88cbaa562c7631b0b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMTQtMS0xLTEtMzYxNTY5_61ff7725-5296-4d77-9e54-a2a1a9adf967"
      unitRef="usd">9041000</dva:TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders>
    <dva:NoncontrollingInterestIncreaseFromContributions
      contextRef="i5b6ffea1a40d41068e8300270af3e5ba_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMTQtMTktMS0xLTM2MTU2OQ_dec96d8c-dcbb-45e8-9f77-f3044c2c5ba6"
      unitRef="usd">3329000</dva:NoncontrollingInterestIncreaseFromContributions>
    <dva:TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures
      contextRef="ia98324e3ccbe45f88cbaa562c7631b0b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMTUtMS0xLTEtMzYzOTU1_a6f4e4d7-2233-4799-a936-a428227551a0"
      unitRef="usd">5903000</dva:TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures>
    <dva:NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures
      contextRef="i56a34082e8604548b02c2fbf0259eb63_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMTUtNy0xLTEtMzYzOTU1_176e713b-a700-47b0-a3de-17280815325b"
      unitRef="usd">351000</dva:NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures>
    <dva:NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures
      contextRef="i2fbb95ab11e644199452dbc8220b5114_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMTUtMTctMS0xLTM2Mzk1NQ_0bebf4ac-1bf7-459d-98bb-fb1151e52c3e"
      unitRef="usd">351000</dva:NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures>
    <dva:NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures
      contextRef="i5b6ffea1a40d41068e8300270af3e5ba_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMTUtMTktMS0xLTM2MTU2OQ_63c8785e-9e34-4812-a167-a32dadf92ded"
      unitRef="usd">1000</dva:NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i56a34082e8604548b02c2fbf0259eb63_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMTYtNy0xLTEtMzYxNTY5_cead9b7b-89b3-453e-b471-aed0558ae001"
      unitRef="usd">6803000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i2fbb95ab11e644199452dbc8220b5114_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMTYtMTctMS0xLTM2MTU2OQ_52ddaf9c-1fe8-4b00-b43f-3fa51fc68056"
      unitRef="usd">6803000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i5b6ffea1a40d41068e8300270af3e5ba_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMTYtMTktMS0xLTM2MTU2OQ_74d81c65-d643-41da-8561-a0a239b7a01e"
      unitRef="usd">362000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="ia98324e3ccbe45f88cbaa562c7631b0b_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMTctMS0xLTEtMzYxNTY5_0b515827-e3b1-47aa-ba29-aff6a2514838"
      unitRef="usd">-8654000</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="i56a34082e8604548b02c2fbf0259eb63_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMTctNy0xLTEtMzYxNTY5_990ecdf4-dc4d-45ef-809d-df8c28a4ee78"
      unitRef="usd">8654000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="i2fbb95ab11e644199452dbc8220b5114_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMTctMTctMS0xLTM2MTU2OQ_02d503d8-6164-40b5-8cc5-1abad39e5463"
      unitRef="usd">8654000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i81df84984de9471498896da7302e996d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMTgtMTEtMS0xLTM2MTU2OQ_524d1776-770f-4620-be21-eca949d02d8b"
      unitRef="shares">2731000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i81df84984de9471498896da7302e996d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMTgtMTMtMS0xLTM2MTU2OQ_909f9c16-d307-4a6a-8985-932343290893"
      unitRef="usd">336217000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i2fbb95ab11e644199452dbc8220b5114_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMTgtMTctMS0xLTM2MTU2OQ_c5b3f10b-f7a3-4f26-8104-b8f2f6ac37e7"
      unitRef="usd">336217000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i60789889ae4a4336b174326b6a1f05e1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMjEtMS0xLTEtMzYxNTY5_222868e0-18f1-4bbd-b4a0-cafd0fefbee4"
      unitRef="usd">1423917000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="id7e948fdcd374e2ca7c81f008ef937b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMjEtMy0xLTEtMzYxNTY5_62dbddf0-a4e4-4cd3-943c-71b4a05d5113"
      unitRef="shares">110886000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id7e948fdcd374e2ca7c81f008ef937b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMjEtNS0xLTEtMzYxNTY5_a683046c-d2b5-48b7-a95c-9460398cb99f"
      unitRef="usd">111000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ief97099e76e34b33afd38d2bf7dd73d5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMjEtNy0xLTEtMzYxNTY5_18ae6a98-f0db-49d5-aae1-b072d16b5e99"
      unitRef="usd">525009000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icbd4405ebc814444a73fcea7eb2d5281_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMjEtOS0xLTEtMzYxNTY5_5124bff9-1535-46c4-9a1d-6d921cd4d95a"
      unitRef="usd">1643514000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="i3329b37b11ef49e7a77677fc2571f273_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMjEtMTEtMS0xLTM2MTU2OQ_57b9f863-59a5-4497-887f-7d216de2c5a0"
      unitRef="shares">7750000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3329b37b11ef49e7a77677fc2571f273_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMjEtMTMtMS0xLTM2MTU2OQ_9baf2a61-7665-43e7-ad7b-e338d87944b4"
      unitRef="usd">-899447000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1113880d4c76456c96b6f30c904a98c3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMjEtMTUtMS0xLTM2MTU2OQ_3268a216-c679-4f87-8df8-671a0ae63d82"
      unitRef="usd">-119750000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i658147170723431aa969dc4fb19ac738_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMjEtMTctMS0xLTM2MTU2OQ_13b62609-8ba1-4cc4-b8ea-2f7f5be9ef7e"
      unitRef="usd">1149437000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7d92065342b44c7d9d67dad92df719c5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjQ2NGM3ZTYzZDkxMjQ4YzY5ZDQ1N2IwMWEyZDdhYzllL3RhYmxlcmFuZ2U6NDY0YzdlNjNkOTEyNDhjNjlkNDU3YjAxYTJkN2FjOWVfMjEtMTktMS0xLTM2MTU2OQ_f46b1a95-de23-4ea4-af0a-f621c5854ae4"
      unitRef="usd">178814000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="ie15a7e2f621142fbac1d6b1ed5011b9d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfNS0xLTEtMS0zNjE1Njk_7388a7b2-080f-4762-b161-2519183962ed"
      unitRef="usd">1330028000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ief046f5cbff64fe6add73a9cda0c18b2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfNS0zLTEtMS0zNjE1Njk_e8c7f4f7-cce7-4a6b-85c0-d324429a3fb3"
      unitRef="shares">109933000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ief046f5cbff64fe6add73a9cda0c18b2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfNS01LTEtMS0zNjE1Njk_89f39768-5ed1-4493-a328-66a189bd0b7e"
      unitRef="usd">110000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic085ab466cee47ed81480d793624fbad_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfNS03LTEtMS0zNjE1Njk_32ebf0e8-1c75-4323-96b6-cc0bccab0dea"
      unitRef="usd">597073000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9126810d2c5c48f49f23bdafdb65883a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfNS05LTEtMS0zNjE1Njk_a7891c8e-434e-4f0c-bfc2-6c4a6c60320d"
      unitRef="usd">852537000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="i75763a11d96243bca52ff93e2406ae41_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfNS0xMS0xLTEtMzYxNTY5_48635380-1c0b-4aec-8fe3-bcc0fb614ff4"
      unitRef="shares">0</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i75763a11d96243bca52ff93e2406ae41_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfNS0xMy0xLTEtMzYxNTY5_d5fcfbeb-088c-4009-aec1-c568caa1a0ce"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia9bb890020ae4aef89eda77451ffdea8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfNS0xNS0xLTEtMzYxNTY5_d99ba3b4-4912-4353-ac63-1ef5034311ed"
      unitRef="usd">-66154000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0dd3f4def9b849c59ba37a6b37215489_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfNS0xNy0xLTEtMzYxNTY5_c0a89fd2-d8cd-421a-8037-a729cc57a65e"
      unitRef="usd">1383566000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia506883f3ae0452194c6440259373c3b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfNS0xOS0xLTEtMzYxNTY5_8735c3b7-73a9-4c24-a271-2e85eacc34aa"
      unitRef="usd">183186000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome
      contextRef="i0d759d14a5e74d46b71f1406a364f03e_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfNy0xLTEtMS0zNjE1Njk_5f29794e-6f3c-44da-8393-f0b31a2e3436"
      unitRef="usd">121774000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="ic46d32b59dd34a6085600e81cd1682bb_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfNy05LTEtMS0zNjE1Njk_ca33983b-0fa6-4a87-8567-17a0245bc70a"
      unitRef="usd">790977000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i0876db8d2e2343ad96bd1c5f19250ebd_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfNy0xNy0xLTEtMzYxNTY5_6c408ea6-1aeb-4149-8ee2-472742a049cd"
      unitRef="usd">790977000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i0dee44ae9bd741b79b52d5d2960b5164_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfNy0xOS0xLTEtMzYxNTY5_bf528495-2c5d-4757-855d-996015923262"
      unitRef="usd">49579000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3d50339b230d4224b69347fc7edc8b98_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfOC0xNS0xLTEtMzYxNTY5_4ecd1bd5-d9bb-4532-a155-b1f6ec93aba7"
      unitRef="usd">-53596000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0876db8d2e2343ad96bd1c5f19250ebd_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfOC0xNy0xLTEtMzYxNTY5_578016f2-1f62-4d5c-bdef-a93b31057c1b"
      unitRef="usd">-53596000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ib2225f46e4614652b632ff59e99717b5_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMTAtMy0xLTEtMzYxNTY5_0b73e3b6-525f-4369-b124-b28a519ce463"
      unitRef="shares">953000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ib2225f46e4614652b632ff59e99717b5_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMTAtNS0xLTEtMzYxNTY5_b810f305-61d5-436b-83c9-d08873932961"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="id322319c79ee47d3b626a8d5196e3aeb_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMTAtNy0xLTEtMzYxNTY5_d75364f9-3c0b-4b4d-85a2-9a10b4bbd119"
      unitRef="usd">74761000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i0876db8d2e2343ad96bd1c5f19250ebd_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMTAtMTctMS0xLTM2MTU2OQ_5ec6f781-5e7f-41ee-9f1a-5850bf56423b"
      unitRef="usd">74760000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="id322319c79ee47d3b626a8d5196e3aeb_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMTEtNy0xLTEtMzYxNTY5_643a447f-aaf7-4423-b5f5-256f0892caf9"
      unitRef="usd">74568000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i0876db8d2e2343ad96bd1c5f19250ebd_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMTEtMTctMS0xLTM2MTU2OQ_d6243f7c-7781-486a-a817-e7128ae3e1bb"
      unitRef="usd">74568000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <dva:TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders
      contextRef="i0d759d14a5e74d46b71f1406a364f03e_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMTMtMS0xLTEtMzYxNTY5_c769296b-2b7d-4d7d-8c1b-69f8d46583b0"
      unitRef="usd">114008000</dva:TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i0dee44ae9bd741b79b52d5d2960b5164_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMTMtMTktMS0xLTM2MTU2OQ_a7f8880f-d7d8-4ce9-82f0-d660b10e0fde"
      unitRef="usd">63138000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <dva:TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders
      contextRef="i0d759d14a5e74d46b71f1406a364f03e_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMTQtMS0xLTEtMzYxNTY5_9d7e03b0-5b62-49c8-9eff-5944a6df9828"
      unitRef="usd">19830000</dva:TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders>
    <dva:NoncontrollingInterestIncreaseFromContributions
      contextRef="i0dee44ae9bd741b79b52d5d2960b5164_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMTQtMTktMS0xLTM2MTU2OQ_c85344c3-cecf-43cf-b6c8-4f6d753bccf8"
      unitRef="usd">8465000</dva:NoncontrollingInterestIncreaseFromContributions>
    <dva:TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures
      contextRef="i0d759d14a5e74d46b71f1406a364f03e_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMTUtMS0xLTEtMzYzOTc4_92c81ff7-4de2-4f5b-82e4-1f7a2e19f7bf"
      unitRef="usd">5903000</dva:TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures>
    <dva:NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures
      contextRef="id322319c79ee47d3b626a8d5196e3aeb_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMTUtNy0xLTEtMzYzOTc4_c28b87e6-3cb4-45e1-bb79-97995e33129a"
      unitRef="usd">351000</dva:NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures>
    <dva:NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures
      contextRef="i0876db8d2e2343ad96bd1c5f19250ebd_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMTUtMTctMS0xLTM2Mzk3OA_951603c5-21c6-4189-a7a7-3597d5187523"
      unitRef="usd">351000</dva:NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures>
    <dva:NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures
      contextRef="i0dee44ae9bd741b79b52d5d2960b5164_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMTUtMTktMS0xLTM2MTU2OQ_8c909f03-0a7b-4423-957c-14691154c076"
      unitRef="usd">1250000</dva:NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures>
    <dva:TemporaryEquityDecreasePurchaseOfInterests
      contextRef="i0d759d14a5e74d46b71f1406a364f03e_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMTYtMS0xLTEtMzYxNTY5_9a897139-7ff3-4f2e-a765-5cecdb3200bc"
      unitRef="usd">552000</dva:TemporaryEquityDecreasePurchaseOfInterests>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="id322319c79ee47d3b626a8d5196e3aeb_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMTYtNy0xLTEtMzYxNTY5_73f502a2-d941-4f7b-957a-570046d32502"
      unitRef="usd">10578000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i0876db8d2e2343ad96bd1c5f19250ebd_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMTYtMTctMS0xLTM2MTU2OQ_a2857009-aa89-4353-a8e5-14cfc5a65063"
      unitRef="usd">10578000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i0dee44ae9bd741b79b52d5d2960b5164_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMTYtMTktMS0xLTM2MTU2OQ_23b64314-2c27-410d-9048-875d78ed46b8"
      unitRef="usd">528000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="i0d759d14a5e74d46b71f1406a364f03e_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMTctMS0xLTEtMzYxNTY5_aa68fcac-2a56-45d9-a7a0-627c667b7d19"
      unitRef="usd">60942000</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="id322319c79ee47d3b626a8d5196e3aeb_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMTctNy0xLTEtMzYxNTY5_8ee63122-7264-4fed-966a-7e7ef89e1cd6"
      unitRef="usd">-60942000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:MinorityInterestChangeInRedemptionValue
      contextRef="i0876db8d2e2343ad96bd1c5f19250ebd_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMTctMTctMS0xLTM2MTU2OQ_d5059beb-5c9f-43c3-b6d9-0ba57f3d39be"
      unitRef="usd">-60942000</us-gaap:MinorityInterestChangeInRedemptionValue>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ia8f9cc1fcc6d4078b72a351dab034ab2_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMTgtMTEtMS0xLTM2MTU2OQ_1b67b035-7b12-4883-b625-aa711d3ade01"
      unitRef="shares">7750000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ia8f9cc1fcc6d4078b72a351dab034ab2_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMTgtMTMtMS0xLTM2MTU2OQ_578333c0-ebb3-425f-b083-de22cccaefaa"
      unitRef="usd">899447000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i0876db8d2e2343ad96bd1c5f19250ebd_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMTgtMTctMS0xLTM2MTU2OQ_8995994f-627f-4591-a469-578762024561"
      unitRef="usd">899447000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i60789889ae4a4336b174326b6a1f05e1_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMjEtMS0xLTEtMzYxNTY5_df3d5753-47a1-4c0d-8457-ca516ad6234a"
      unitRef="usd">1423917000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="id7e948fdcd374e2ca7c81f008ef937b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMjEtMy0xLTEtMzYxNTY5_0001c14f-0daa-43c6-a699-7912dcb934b8"
      unitRef="shares">110886000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id7e948fdcd374e2ca7c81f008ef937b8_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMjEtNS0xLTEtMzYxNTY5_aec3b7d4-8dab-47f7-be70-41d428679999"
      unitRef="usd">111000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ief97099e76e34b33afd38d2bf7dd73d5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMjEtNy0xLTEtMzYxNTY5_ff6744b3-dc05-4473-bc1e-3eaf0d2cf6fd"
      unitRef="usd">525009000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="icbd4405ebc814444a73fcea7eb2d5281_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMjEtOS0xLTEtMzYxNTY5_910d2b84-7b1f-43d8-81c7-396aacd5d29b"
      unitRef="usd">1643514000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockShares
      contextRef="i3329b37b11ef49e7a77677fc2571f273_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMjEtMTEtMS0xLTM2MTU2OQ_46504dc5-1e58-4422-b496-4450725f50a8"
      unitRef="shares">7750000</us-gaap:TreasuryStockShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3329b37b11ef49e7a77677fc2571f273_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMjEtMTMtMS0xLTM2MTU2OQ_316a260b-967a-4c8b-8b30-7811893e04ca"
      unitRef="usd">-899447000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1113880d4c76456c96b6f30c904a98c3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMjEtMTUtMS0xLTM2MTU2OQ_b07db01d-8457-4a16-a70f-e14fe7ec1822"
      unitRef="usd">-119750000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i658147170723431aa969dc4fb19ac738_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMjEtMTctMS0xLTM2MTU2OQ_b145f924-4928-45a8-930a-a51ad8977e58"
      unitRef="usd">1149437000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7d92065342b44c7d9d67dad92df719c5_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8yOC9mcmFnOjdlM2Q4YmZjZjM3YzQ5NjhiZjdkNDYyYTUwY2JlYmY4L3RhYmxlOjY0NzM3YWZhYTMzNzRhYjk5NTI3OWQ1OTYzNmRjNWIyL3RhYmxlcmFuZ2U6NjQ3MzdhZmFhMzM3NGFiOTk1Mjc5ZDU5NjM2ZGM1YjJfMjEtMTktMS0xLTM2MTU2OQ_fc2ddb78-8fe4-4d69-9156-bb8d8a56b668"
      unitRef="usd">178814000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNC9mcmFnOmQzYzU4NDlmYjE4YTQ3YjVhZDlhOGY2ZTMxMzc2NjZlL3RleHRyZWdpb246ZDNjNTg0OWZiMThhNDdiNWFkOWE4ZjZlMzEzNzY2NmVfMTU4Nw_4edab425-d58b-4313-9e9f-8a147ee7e2ce">Condensed consolidated interim financial statementsThe unaudited condensed consolidated interim financial statements included in this report are prepared by the Company. In the opinion of management, all adjustments necessary for a fair presentation of the results of operations are reflected in these condensed consolidated interim financial statements. All significant intercompany accounts and transactions have been eliminated. The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of revenues, expenses, assets, liabilities, contingencies and noncontrolling interests subject to put provisions. The most significant estimates and assumptions underlying these financial statements and accompanying notes generally involve revenue recognition and accounts receivable, certain fair value estimates, accounting for income taxes and loss contingencies. The results of operations reflected in these interim financial statements may not necessarily be indicative of annual operating results. These condensed consolidated interim financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2021 (2021 10-K). Prior period classifications conform to the current period presentation. The Company has evaluated subsequent events through the date these condensed consolidated interim financial statements were issued and has included all necessary adjustments and disclosures.</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNC9mcmFnOmQzYzU4NDlmYjE4YTQ3YjVhZDlhOGY2ZTMxMzc2NjZlL3RleHRyZWdpb246ZDNjNTg0OWZiMThhNDdiNWFkOWE4ZjZlMzEzNzY2NmVfMTU5MA_6a31a41f-ec50-4213-b5e7-2b3c6e0abd91">The unaudited condensed consolidated interim financial statements included in this report are prepared by the Company. In the opinion of management, all adjustments necessary for a fair presentation of the results of operations are reflected in these condensed consolidated interim financial statements. All significant intercompany accounts and transactions have been eliminated. The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of revenues, expenses, assets, liabilities, contingencies and noncontrolling interests subject to put provisions. The most significant estimates and assumptions underlying these financial statements and accompanying notes generally involve revenue recognition and accounts receivable, certain fair value estimates, accounting for income taxes and loss contingencies. The results of operations reflected in these interim financial statements may not necessarily be indicative of annual operating results. These condensed consolidated interim financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2021 (2021 10-K). Prior period classifications conform to the current period presentation. The Company has evaluated subsequent events through the date these condensed consolidated interim financial statements were issued and has included all necessary adjustments and disclosures.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RleHRyZWdpb246Y2M3NTM0Y2VhYjE0NDY0NjhkODUzODQ2YjhkNjczZTBfMjcyOQ_a596d806-ceb1-4160-bc0d-c2bd660e3545">Revenue recognition&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the Company's segment revenues by primary payor source:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.434%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other &#x2014; Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other &#x2014; Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Dialysis patient service revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare and Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,535,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,535,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,543,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,543,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid and Managed Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other government&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;880,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;936,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;862,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;917,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare and Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid and Managed Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Eliminations of intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,957)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,957)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,680,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,948,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,675,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,938,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Other primarily consists of management service fees earned in the respective Company line of business as well as other non-patient service revenue from the Company's U.S. ancillary services and international operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.434%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other - Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other - Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Dialysis patient service revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare and Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,529,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,529,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,586,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,586,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid and Managed Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;570,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;570,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;585,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;585,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other government&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;603,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;338,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;583,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,570,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,734,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,528,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,685,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare and Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid and Managed Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Eliminations of intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64,516)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64,516)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70,424)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,294)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74,718)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,877,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;815,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,693,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,893,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;780,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,674,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Other primarily consists of management service fees earned in the respective Company line of business as well as other non-patient service revenue from the Company's U.S. ancillary services and international operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There are significant uncertainties associated with estimating revenue, which generally take several years to resolve. These estimates are subject to ongoing insurance coverage changes, geographic coverage differences, differing interpretations of contract coverage and other payor issues, as well as patient issues, including determination of applicable primary and secondary coverage, changes in patient insurance coverage and coordination of benefits. As these estimates are refined over time, both positive and negative adjustments to revenue are recognized in the current period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dialysis patient service revenues. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues are recognized based on the Company&#x2019;s estimate of the transaction price the Company expects to collect as a result of satisfying its performance obligations. Dialysis patient service revenues are recognized in the period services are provided based on these estimates. Revenues consist primarily of payments from government and commercial health plans for dialysis services provided to patients. The Company maintains a usual and customary fee schedule for its dialysis treatments and related lab services; however, actual collectible revenue is normally recognized at a discount from the fee schedule.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other revenues.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Other revenues consist of revenues earned by the Company's non-dialysis ancillary services as well as fees for management and administrative services to outpatient dialysis businesses that the Company does not consolidate. Other revenues are estimated in the period services are provided. The Company's U.S. ancillary service revenues include revenues earned under risk-based arrangements in the Company's integrated kidney care (IKC) business, including value-based care (VBC) arrangements. Under its VBC arrangements, the Company assumes full or shared financial risk for the total medical cost of care for patients below or above a benchmark. The benchmarks against which the Company incurs profit or loss on these contracts are typically based on the underlying premiums paid to the insuring entity (the Company's counterparty), with adjustments where applicable, or on trended or adjusted medical cost targets.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RleHRyZWdpb246Y2M3NTM0Y2VhYjE0NDY0NjhkODUzODQ2YjhkNjczZTBfMjczNQ_529f4754-7a2c-4e24-987d-c1fce11426d1">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the Company's segment revenues by primary payor source:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.434%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other &#x2014; Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other &#x2014; Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Dialysis patient service revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare and Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,535,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,535,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,543,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,543,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid and Managed Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other government&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;880,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;936,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;862,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;917,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare and Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid and Managed Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Eliminations of intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,957)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,957)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,680,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,948,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,675,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,938,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Other primarily consists of management service fees earned in the respective Company line of business as well as other non-patient service revenue from the Company's U.S. ancillary services and international operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.434%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other - Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other - Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Dialysis patient service revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare and Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,529,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,529,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,586,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,586,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid and Managed Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;570,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;570,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;585,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;585,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other government&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;603,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;338,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;583,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,570,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,734,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,528,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,685,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare and Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid and Managed Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Eliminations of intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64,516)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64,516)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70,424)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,294)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74,718)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,877,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;815,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,693,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,893,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;780,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,674,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&#160;&#160;&#160;&#160;Other primarily consists of management service fees earned in the respective Company line of business as well as other non-patient service revenue from the Company's U.S. ancillary services and international operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ia5499ef54bf54566bd5630bea4f2aef1_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMy0xLTEtMS0zNjE1Njk_1d6b2835-4dd6-4e5f-8c47-7272be75b09f"
      unitRef="usd">1535680000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="iaf7c25a75aca401a8b6ff5a12f6bd14d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMy01LTEtMS0zNjE1Njk_78365e9a-61b9-4ec1-adb9-d1f069ee53f1"
      unitRef="usd">1535680000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="if32f1f0b93b84c62b51bda92e1d098c1_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMy03LTEtMS0zNjE1Njk_ef3d2e90-3b89-487f-9d23-56b04382bf92"
      unitRef="usd">1543819000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ic8b3d7d4ce924bcba6d96142c33584d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMy0xMS0xLTEtMzYxNTY5_5caa70bb-80ce-47fa-9bc8-3ce2fc4c714e"
      unitRef="usd">1543819000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i8c5b3caa1262457a9e75c70467159fc4_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfNC0xLTEtMS0zNjE1Njk_eeeced9b-7daa-46e9-ac55-ad17f31362cf"
      unitRef="usd">193853000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="icb08fa48ee76464ba77c6eb9d3849115_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfNC01LTEtMS0zNjE1Njk_082eaafd-6a2d-496d-bdee-c47b0d6e3446"
      unitRef="usd">193853000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i599d93fb67e9441eb25740b2dd06722d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfNC03LTEtMS0zNjE1Njk_cb281c42-e8ac-4188-9c89-f8c23de886a0"
      unitRef="usd">203169000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i9c69e4f36c65438c9eeb2a106052afd5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfNC0xMS0xLTEtMzYxNTY5_c3c1fd76-85bf-4e70-935b-87b3fc9fb253"
      unitRef="usd">203169000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="icd8c3ea690e54b84a0a7066643e1c02b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfNS0xLTEtMS0zNjE1Njk_7e98c4d4-9ff7-4121-a328-2f04d8eee6e4"
      unitRef="usd">86852000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ic9536bd2eda14d9c86eba49ab480d898_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfNS0zLTEtMS0zNjE1Njk_0202cb24-ceea-416f-973a-d07a342a835c"
      unitRef="usd">116084000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i872a4a0bd01a4a8abf1995e00bb2cf2d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfNS01LTEtMS0zNjE1Njk_14ba34b1-750c-4a74-9d1d-8cc378f1875e"
      unitRef="usd">202936000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="iaaae7b470fbe4bbd8bd2ca4d195b6128_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfNS03LTEtMS0zNjE1Njk_c83ae0cc-9a8c-4679-a309-0163e1deef90"
      unitRef="usd">82624000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="if47f2932cefd49ed85a6f6caa58312cd_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfNS05LTEtMS0zNjE1Njk_17220042-5ce9-4d5b-859d-04424892be4d"
      unitRef="usd">113260000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ie7f517d406d8483b9f0bdad532070fe4_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfNS0xMS0xLTEtMzYxNTY5_26bb0288-32d7-4083-ab8e-7f9396bff7f2"
      unitRef="usd">195884000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i8f7d940ca97c4ae789757331795af7c0_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfNi0xLTEtMS0zNjE1Njk_c6ae82da-7ccd-409b-abe9-92d6366a88b9"
      unitRef="usd">880812000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i3129a22cf1d446319325259a77169cdd_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfNi0zLTEtMS0zNjE1Njk_50ace003-4b2a-4a5a-9ffa-6824f7610920"
      unitRef="usd">56170000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i87e2bef651a34107b1fb5d68820aee09_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfNi01LTEtMS0zNjE1Njk_8067a375-79bf-47c8-858f-49b5a5545ee9"
      unitRef="usd">936982000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="iaa9717ba02fb4ccab21d642ffbe4803c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfNi03LTEtMS0zNjE1Njk_3bc4e2e4-aaae-4c10-a41e-df24f8d9c846"
      unitRef="usd">862218000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i500d83fb41334d9c8de83f92f7fcc141_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfNi05LTEtMS0zNjE1Njk_ce6ea218-4560-441f-bbc2-8df61638431a"
      unitRef="usd">54857000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="icaea6e6d89084a3e93ba28323cd7e21d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfNi0xMS0xLTEtMzYxNTY5_c1c5674d-f27f-476f-898a-ca86557d2518"
      unitRef="usd">917075000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:OtherIncome
      contextRef="iff0caec10ecc40c584a977fdfabc4df8_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfOC0zLTEtMS0zNjE1Njk_0e58308d-cd12-44e4-9c23-f97cb4d22a41"
      unitRef="usd">78345000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="iaf7c25a75aca401a8b6ff5a12f6bd14d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfOC01LTEtMS0zNjE1Njk_8d5d379a-016c-40e2-a866-27f7a28deab7"
      unitRef="usd">78345000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i50355a967a4440e897b1ac183ad1a38d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfOC05LTEtMS0zNjE1Njk_0608877a-2e7d-461d-893b-e04900d227b1"
      unitRef="usd">77277000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="ic8b3d7d4ce924bcba6d96142c33584d7_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfOC0xMS0xLTEtMzYxNTY5_57bce0a0-000f-46a0-ade5-5643bafab06d"
      unitRef="usd">77277000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="icb556fa3c676460aa8e66d0650f6a16e_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfOS0zLTEtMS0zNjE1Njk_0b42aabf-fe1d-416a-9e20-2452d830fbb0"
      unitRef="usd">412000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="icb08fa48ee76464ba77c6eb9d3849115_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfOS01LTEtMS0zNjE1Njk_14afff92-f9f0-4e9c-81e1-aa67a68acd24"
      unitRef="usd">412000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i346169ef5135448c9d85d98d5c086b2a_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfOS05LTEtMS0zNjE1Njk_094720ae-1056-4f19-b6c9-76b99854dc1f"
      unitRef="usd">377000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i9c69e4f36c65438c9eeb2a106052afd5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfOS0xMS0xLTEtMzYxNTY5_410364ac-9f53-4da4-ae3e-2a4bc4be9deb"
      unitRef="usd">377000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i3129a22cf1d446319325259a77169cdd_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMTAtMy0xLTEtMzYxNTY5_b4c0dbf5-7516-4de5-8766-9b1b632d957b"
      unitRef="usd">6484000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i87e2bef651a34107b1fb5d68820aee09_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMTAtNS0xLTEtMzYxNTY5_5c84439f-dffe-40df-8b9f-e5eafd4d85ae"
      unitRef="usd">6484000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i500d83fb41334d9c8de83f92f7fcc141_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMTAtOS0xLTEtMzYxNTY5_fd200d78-b68b-47ea-bf85-b7559c451c87"
      unitRef="usd">7164000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="icaea6e6d89084a3e93ba28323cd7e21d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMTAtMTEtMS0xLTM2MTU2OQ_1af8032b-1fa7-49b4-8992-b9b3219f9ec8"
      unitRef="usd">7164000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i42e37dbf5c0a422e8802ffd5a383d2d8_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMTEtMS0xLTEtMzYxNTY5_885496f5-2d65-4cc7-bfe7-e8f1a60bc313"
      unitRef="usd">6056000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="idc81d3ad5ccf42d797d3042a95761484_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMTEtMy0xLTEtMzYxNTY5_0ad29eeb-2d64-449a-ad4f-3f049c5d3bf0"
      unitRef="usd">10903000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i3ac794762df747ec8e1cf0d69c6b0573_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMTEtNS0xLTEtMzYxNTY5_228c5234-2aa6-485f-b673-d5f94e2305f7"
      unitRef="usd">16959000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i9c5f026f8ab94787909fcd87fcb38484_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMTEtNy0xLTEtMzYxNTY5_a43f16d3-8329-40bc-912d-082961e612fb"
      unitRef="usd">6216000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="ib939af3797994ec1a4b0e56c5dd80a2a_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMTEtOS0xLTEtMzYxNTY5_241956b3-92f3-40c4-a6e2-4e15c8b57ad1"
      unitRef="usd">9442000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="if983cfecb2cf4615842da0fdce5d144c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMTEtMTEtMS0xLTM2MTU2OQ_49cf0a43-45f7-4b75-b01e-c88af8783bcb"
      unitRef="usd">15658000</us-gaap:OtherIncome>
    <us-gaap:Revenues
      contextRef="i5c5c603e1e2c456093890ff389a4067c_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMTItMS0xLTEtMzYxNTY5_f358e05f-3b15-4a60-beec-62e28c004be7"
      unitRef="usd">-22957000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idf91a124985e4d4a83d74b6648524f10_D20220701-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMTItMy0xLTEtMzYxNTY5_237772c2-e8c6-40a3-9884-5d9f4eb5482d"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="i253b9978247749dcb47c368cdebc35ae_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMTItNS0xLTEtMzYxNTY5_abc434c2-6b4f-433c-903d-4d7a2ac473c1"
      unitRef="usd">-22957000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6679c2baabca4cda8418d59c0fbb9fcb_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMTItNy0xLTEtMzYxNTY5_482dc19e-4fe4-4a9c-a481-32306c144068"
      unitRef="usd">-22104000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i45f5523ed8e44e969d9667166a84a234_D20210701-20210930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMTItOS0xLTEtMzYxNTY5_fcc113ea-7030-4a4f-9382-97cab1cb5c96"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="i5c321d3f4f114e7a810149cebdfddf89_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMTItMTEtMS0xLTM2MTU2OQ_fd1ffe3d-58ea-4780-a168-ba32332471c2"
      unitRef="usd">-22104000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i138d5ad826a74dd389b7c50d766dce89_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMTMtMS0xLTEtMzYxNTY5_83b3b04a-9ae0-4459-88e7-ee7464707fb6"
      unitRef="usd">2680296000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5743480e6048496ab58c95a14b8aaf6f_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMTMtMy0xLTEtMzYxNTY5_dddb964e-4cf9-47b9-9982-c5f8af3289c5"
      unitRef="usd">268398000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMTMtNS0xLTEtMzYxNTY5_c3fc5c76-5e93-41d3-86dd-3e2a658a72ba"
      unitRef="usd">2948694000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia98746ed55ed4291881ac7bb3d451f92_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMTMtNy0xLTEtMzYxNTY5_07ac7fb2-ce41-4f10-9267-af122c089486"
      unitRef="usd">2675942000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0162929ca27d43d894768f88369a32f4_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMTMtOS0xLTEtMzYxNTY5_869db1df-091a-49a8-9c65-ff971a3760d5"
      unitRef="usd">262377000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjU5ZjJhOTY0NTg3NjRhYWJhM2QzNWExODI2ZDA0MmJlL3RhYmxlcmFuZ2U6NTlmMmE5NjQ1ODc2NGFhYmEzZDM1YTE4MjZkMDQyYmVfMTMtMTEtMS0xLTM2MTU2OQ_ec552d57-6989-46c7-b99f-aca1c4e5dea2"
      unitRef="usd">2938319000</us-gaap:Revenues>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="iaa3c42e6c11c4d0197c06f1170d1a877_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMy0xLTEtMS0zNjE1Njk_e8c1e567-e2d3-4e25-8c2a-8fb690081bc5"
      unitRef="usd">4529300000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="iadfbab933c6649d399f396278bf17828_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMy01LTEtMS0zNjE1Njk_0b6a3f11-6ef2-4938-84be-ee50528d3c96"
      unitRef="usd">4529300000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i00c3f8bb1a4f4667af7c71428219d59d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMy03LTEtMS0zNjE1Njk_e122909b-001e-47b4-b590-ce70138d3b35"
      unitRef="usd">4586278000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="iff13895b80934a9aaca98d961abc2ee9_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMy0xMS0xLTEtMzYxNTY5_56e76a34-8b49-4c5d-b8c6-4eb3d7a27154"
      unitRef="usd">4586278000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i14ce08d9f9e740ecb2b7cd9829aba3f6_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfNC0xLTEtMS0zNjE1Njk_48ae53ad-bff2-4b32-bd7e-a5e7a96fad3e"
      unitRef="usd">570380000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i3e56a6423e7a43a6baf62a95333e8692_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfNC01LTEtMS0zNjE1Njk_b53f5913-6d43-4032-a24b-2bb9e30b924d"
      unitRef="usd">570380000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i1e7345a52a044d459fe02274fb72c840_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfNC03LTEtMS0zNjE1Njk_f518febe-1b2d-432e-a762-bb79da571b27"
      unitRef="usd">585053000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i6f6de3926b14464695343fd7abe17b26_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfNC0xMS0xLTEtMzYxNTY5_20efb349-4022-4c64-bf7a-585f4a9566ec"
      unitRef="usd">585053000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i1bf1bb08a5eb457d8bc08821fa21a5ff_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfNS0xLTEtMS0zNjE1Njk_336ca3b9-95a9-46c1-96ff-79b313dd10c6"
      unitRef="usd">253731000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i81c073a4e6894483a6125b5544516dcf_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfNS0zLTEtMS0zNjE1Njk_95deca13-a80b-4e9e-8f12-747efe7187d7"
      unitRef="usd">349633000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i5928e35ff3ca4001abd1fb3f535ceaaf_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfNS01LTEtMS0zNjE1Njk_a90e21e7-0288-43c4-be35-be398a442dc1"
      unitRef="usd">603364000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i490b21a1d5ff4920a6e5630f304c1992_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfNS03LTEtMS0zNjE1Njk_a1612f9b-24c9-48a8-a311-2b2ee630bd73"
      unitRef="usd">245125000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i7bd462440e954143b9bd9c4c0bbcbc96_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfNS05LTEtMS0zNjE1Njk_06b5036a-d01d-48f0-a7c0-5322f5e7c8ef"
      unitRef="usd">338553000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i67f9be9b51ec4692a27ebe64bb0fc0e4_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfNS0xMS0xLTEtMzYxNTY5_a1c9b8d4-2606-4696-9ba9-1134223290ea"
      unitRef="usd">583678000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i89dde34540454ca3ae8c705649ed5ed5_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfNi0xLTEtMS0zNjE1Njk_7e8ae916-fc79-4e70-b9db-d65343d8bd1d"
      unitRef="usd">2570054000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ibf52eaa032584a8ab33ac97fcf842df5_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfNi0zLTEtMS0zNjE1Njk_6e156680-b687-4698-ab8f-87db04796060"
      unitRef="usd">164302000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i137eae426cf247789d78e630f2c67da6_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfNi01LTEtMS0zNjE1Njk_02c697a7-376e-4eb7-9db7-3eed71f207ae"
      unitRef="usd">2734356000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i6ad9292cb3bb460b969ab3899aad678f_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfNi03LTEtMS0zNjE1Njk_1ce4d889-afa8-4735-a0a9-578c2858d4a2"
      unitRef="usd">2528499000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i5b1771b0ef284582836b473942fc9bfa_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfNi05LTEtMS0zNjE1Njk_71cad342-443c-4ae7-8bd2-852333843259"
      unitRef="usd">157172000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i7cae19c46a6043148cffc25a7d0efae1_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfNi0xMS0xLTEtMzYxNTY5_d8ed586b-aed7-4c23-9bd3-9a6aeb577527"
      unitRef="usd">2685671000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:OtherIncome
      contextRef="idcb2cf1f049d43e6bc397f58d8b751ab_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfOC0zLTEtMS0zNjE1Njk_c5cc79cb-6313-4149-9226-6e8f92b7977a"
      unitRef="usd">255204000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="iadfbab933c6649d399f396278bf17828_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfOC01LTEtMS0zNjE1Njk_af3c1658-98f8-4679-9107-3b7dbc16a71b"
      unitRef="usd">255204000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i94d0c3e715a04876b7a0eebf725c54bb_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfOC05LTEtMS0zNjE1Njk_ef99a444-e5dc-46af-8bf7-da1efc1ad2ab"
      unitRef="usd">243085000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="iff13895b80934a9aaca98d961abc2ee9_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfOC0xMS0xLTEtMzYxNTY5_ffc99ef9-c3f6-49ba-a049-d5f17e914041"
      unitRef="usd">243085000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="ib29b1d2d5bb4458794f5d56da5481133_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfOS0zLTEtMS0zNjE1Njk_840493e7-f857-4f6c-bdf7-8024cf929b15"
      unitRef="usd">1181000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i3e56a6423e7a43a6baf62a95333e8692_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfOS01LTEtMS0zNjE1Njk_f0b06a2c-5d28-494f-9358-9ccf2020483b"
      unitRef="usd">1181000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i0f9af972e685431dac0f0893f94454e6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfOS05LTEtMS0zNjE1Njk_0e16e33a-c19d-48ef-b339-528c2c3e01a0"
      unitRef="usd">981000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i6f6de3926b14464695343fd7abe17b26_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfOS0xMS0xLTEtMzYxNTY5_36b56daa-a733-4958-8ea3-7d17036230af"
      unitRef="usd">981000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="ibf52eaa032584a8ab33ac97fcf842df5_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMTAtMy0xLTEtMzYxNTY5_b4cb6ca7-3e34-49a6-b2dc-1e7c6ff69308"
      unitRef="usd">16029000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i137eae426cf247789d78e630f2c67da6_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMTAtNS0xLTEtMzYxNTY5_c77924e7-8062-4b4a-9a05-20601958161e"
      unitRef="usd">16029000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i5b1771b0ef284582836b473942fc9bfa_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMTAtOS0xLTEtMzYxNTY5_4e40eaab-00e1-48ba-9d53-32fd8a011586"
      unitRef="usd">14387000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i7cae19c46a6043148cffc25a7d0efae1_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMTAtMTEtMS0xLTM2MTU2OQ_faaf9149-a93f-4699-9a38-eab3b3c19df8"
      unitRef="usd">14387000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i8eef48118914482ea280b1dd3e31cd66_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMTEtMS0xLTEtMzYxNTY5_69627619-7df6-4740-8c64-6eb9d4ff431a"
      unitRef="usd">18124000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="iadaf73e90f7a4ef2b2effea52a4e2206_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMTEtMy0xLTEtMzYxNTY5_c9851a5f-e026-4f72-bf1d-4671e79dca1a"
      unitRef="usd">29584000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="idec28e83e6404debb93980472f318af7_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMTEtNS0xLTEtMzYxNTY5_f6333569-c3de-454b-8dcf-4b987e66dcab"
      unitRef="usd">47708000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i507043f785414bbe9b5ce696f53c2c7e_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMTEtNy0xLTEtMzYxNTY5_b5e78c6c-acc6-48b3-86f2-61e115108bc7"
      unitRef="usd">19308000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i0562607b4e35473ba1a511716103fdc2_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMTEtOS0xLTEtMzYxNTY5_b663f157-92a4-44c4-b148-eb3d602e95e4"
      unitRef="usd">31107000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i6d2459b347674468b9af90ec7b6fa674_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMTEtMTEtMS0xLTM2MTU2OQ_e1fe7286-2ae5-45a6-ac28-23883f9b0f33"
      unitRef="usd">50415000</us-gaap:OtherIncome>
    <us-gaap:Revenues
      contextRef="icad3d0bdd7834605a261fa6fd56c8c78_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMTItMS0xLTEtMzYxNTY5_c78d1ee3-2d0d-4226-8992-8d438d1cf4b8"
      unitRef="usd">-64516000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4e58b8c89c344703bdf5b7d532cc1d0c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMTItMy0xLTEtMzYxNTY5_a74f8cd5-9d2c-4c0b-9b94-6049e5f872c2"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:Revenues
      contextRef="i4b80df9aa48e4aa9a2eeabbf8c48904e_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMTItNS0xLTEtMzYxNTY5_72ca5579-8373-4d98-bc7f-aff9b7f8e2e0"
      unitRef="usd">-64516000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i33b19b87438e4e76aede245ac6a0c09c_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMTItNy0xLTEtMzYxNTY5_fc317b06-f3fa-4031-b1f1-9a1acdecf40c"
      unitRef="usd">-70424000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i53105fdcd8b04f368d61266747f6b56e_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMTItOS0xLTEtMzYxNTY5_f8b9d35c-e7d9-4a41-88ba-d88a6861f178"
      unitRef="usd">-4294000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iabe54304a7d4439d88d4c1cbb00ee5ac_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMTItMTEtMS0xLTM2MTU2OQ_26c9a747-2e96-43ec-968e-33f0623a9c74"
      unitRef="usd">-74718000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i422c6a94a816499c8310fd5a0acc841f_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMTMtMS0xLTEtMzYxNTY5_e6e0f81e-99f4-4c16-9637-99847faf7ce5"
      unitRef="usd">7877073000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie63e40be1b8c44ae852031a36cc0c1d2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMTMtMy0xLTEtMzYxNTY5_8f933a5b-f118-4fdd-802c-653a937e1a74"
      unitRef="usd">815933000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMTMtNS0xLTEtMzYxNTY5_60efc687-0562-4bae-bd46-fb6bb39c7829"
      unitRef="usd">8693006000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0cb049c47bd043afa9a8eb3aaf37cb95_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMTMtNy0xLTEtMzYxNTY5_edba78a0-148d-4bb8-970b-8af21097be14"
      unitRef="usd">7893839000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if7870e39ec59457d85f40917f0be7b4b_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMTMtOS0xLTEtMzYxNTY5_9dfe4401-0330-40c8-b709-34784f0b462e"
      unitRef="usd">780991000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RhYmxlOjQ0NjRhYTg2M2FkOTQzNGI4Y2M1ZDcxNzNlYTM1NmRiL3RhYmxlcmFuZ2U6NDQ2NGFhODYzYWQ5NDM0YjhjYzVkNzE3M2VhMzU2ZGJfMTMtMTEtMS0xLTM2MTU2OQ_c62a7b06-f8a8-4804-b842-f12d1587c357"
      unitRef="usd">8674830000</us-gaap:Revenues>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl8zNy9mcmFnOmNjNzUzNGNlYWIxNDQ2NDY4ZDg1Mzg0NmI4ZDY3M2UwL3RleHRyZWdpb246Y2M3NTM0Y2VhYjE0NDY0NjhkODUzODQ2YjhkNjczZTBfMjczNw_ada8dbd6-d52e-4e0f-a395-eaabfcd2596d">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There are significant uncertainties associated with estimating revenue, which generally take several years to resolve. These estimates are subject to ongoing insurance coverage changes, geographic coverage differences, differing interpretations of contract coverage and other payor issues, as well as patient issues, including determination of applicable primary and secondary coverage, changes in patient insurance coverage and coordination of benefits. As these estimates are refined over time, both positive and negative adjustments to revenue are recognized in the current period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dialysis patient service revenues. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues are recognized based on the Company&#x2019;s estimate of the transaction price the Company expects to collect as a result of satisfying its performance obligations. Dialysis patient service revenues are recognized in the period services are provided based on these estimates. Revenues consist primarily of payments from government and commercial health plans for dialysis services provided to patients. The Company maintains a usual and customary fee schedule for its dialysis treatments and related lab services; however, actual collectible revenue is normally recognized at a discount from the fee schedule.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other revenues.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Other revenues consist of revenues earned by the Company's non-dialysis ancillary services as well as fees for management and administrative services to outpatient dialysis businesses that the Company does not consolidate. Other revenues are estimated in the period services are provided. The Company's U.S. ancillary service revenues include revenues earned under risk-based arrangements in the Company's integrated kidney care (IKC) business, including value-based care (VBC) arrangements. Under its VBC arrangements, the Company assumes full or shared financial risk for the total medical cost of care for patients below or above a benchmark. The benchmarks against which the Company incurs profit or loss on these contracts are typically based on the underlying premiums paid to the insuring entity (the Company's counterparty), with adjustments where applicable, or on trended or adjusted medical cost targets.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RleHRyZWdpb246YTAxMTcxMjEwMmViNGE1YzgwMjMyZmNkMzJjNmQ3NGZfODgy_3235ab8e-7919-4eb6-9fd9-69ccad28d0aa">Earnings per share&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings per share is calculated by dividing net income attributable to the Company by the weighted average number of common shares outstanding. Weighted average common shares outstanding include restricted stock unit awards that are no longer subject to forfeiture because the recipients have satisfied either the explicit vesting terms or retirement eligibility requirements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Diluted earnings per share includes the dilutive effect of outstanding stock-settled stock appreciation rights and unvested stock units as computed under the treasury stock method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliations of the numerators and denominators used to calculate basic and diluted earnings per share were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to DaVita Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;790,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assumed incremental from stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic net income per share attributable to DaVita Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted net income per share attributable to DaVita Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Anti-dilutive stock-settled awards excluded from calculation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Shares associated with stock awards excluded from the diluted denominator calculation because they were anti-dilutive under the treasury stock method.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RleHRyZWdpb246YTAxMTcxMjEwMmViNGE1YzgwMjMyZmNkMzJjNmQ3NGZfODg0_0c37652c-93e6-41b7-bf63-fd7b1827dc71">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings per share is calculated by dividing net income attributable to the Company by the weighted average number of common shares outstanding. Weighted average common shares outstanding include restricted stock unit awards that are no longer subject to forfeiture because the recipients have satisfied either the explicit vesting terms or retirement eligibility requirements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Diluted earnings per share includes the dilutive effect of outstanding stock-settled stock appreciation rights and unvested stock units as computed under the treasury stock method.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RleHRyZWdpb246YTAxMTcxMjEwMmViNGE1YzgwMjMyZmNkMzJjNmQ3NGZfODg5_252e9a22-00fa-4756-a8e3-8286f36bfca8">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliations of the numerators and denominators used to calculate basic and diluted earnings per share were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to DaVita Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259,754&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;790,977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assumed incremental from stock plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic net income per share attributable to DaVita Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted net income per share attributable to DaVita Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Anti-dilutive stock-settled awards excluded from calculation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Shares associated with stock awards excluded from the diluted denominator calculation because they were anti-dilutive under the treasury stock method.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfNC0xLTEtMS0zNjE1Njk_8a62b8d1-c64c-4ae4-a298-a2a5523dee05"
      unitRef="usd">105366000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfNC0zLTEtMS0zNjE1Njk_25d83d35-bfbf-4592-8d59-6131c4b54623"
      unitRef="usd">259754000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfNC01LTEtMS0zNjE1Njk_f736e6b1-c314-466a-bb49-5d549d1d82c5"
      unitRef="usd">492297000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfNC03LTEtMS0zNjE1Njk_507581cb-d8dd-40f1-acab-9c2f4e64f8bd"
      unitRef="usd">790977000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic
      contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfNy0xLTEtMS0zNjE1Njk_29604d68-2fd5-4812-acaa-fe932550f9ba"
      unitRef="shares">91160000</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic
      contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfNy0zLTEtMS0zNjE1Njk_850f5afe-8434-4834-b354-2169b0643d5a"
      unitRef="shares">104793000</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfNy01LTEtMS0zNjE1Njk_99c1ee69-b5c6-4f22-b187-2eda61fd6d9f"
      unitRef="shares">93959000</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfNy03LTEtMS0zNjE1Njk_d7573e13-441a-401e-863d-3ca9bb9601f9"
      unitRef="shares">106685000</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfOC0xLTEtMS0zNjE1Njk_40b24df5-877a-4c05-b614-e5f37118cbf8"
      unitRef="shares">2103000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfOC0zLTEtMS0zNjE1Njk_ce2d8980-999a-4b25-9f67-5aff62a712c1"
      unitRef="shares">5045000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfOC01LTEtMS0zNjE1Njk_84631d1c-606e-4a9f-946f-51ea03383063"
      unitRef="shares">3194000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfOC03LTEtMS0zNjE1Njk_ae14664e-392f-446b-b9c8-38487d1f84e8"
      unitRef="shares">4981000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfOS0xLTEtMS0zNjE1Njk_31624ceb-d905-403b-8389-d66327f46916"
      unitRef="shares">93263000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfOS0zLTEtMS0zNjE1Njk_f82c041f-dcab-4d8b-b833-4566c605b1cb"
      unitRef="shares">109838000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfOS01LTEtMS0zNjE1Njk_1ac5d5cd-e3a9-4583-8c51-2e5efe939679"
      unitRef="shares">97153000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfOS03LTEtMS0zNjE1Njk_97811e54-5e41-4080-a1fb-da6a78c1baa5"
      unitRef="shares">111666000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfMTMtMS0xLTEtMzYxNTY5_12954553-f78e-4289-aed2-15c3a64cad24"
      unitRef="usdPerShare">1.16</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfMTMtMy0xLTEtMzYxNTY5_ab03cc2a-c6bb-42b3-a0c4-fdacaf5d1b43"
      unitRef="usdPerShare">2.48</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfMTMtNS0xLTEtMzYxNTY5_d06d295e-a3d2-4cc3-bb25-2a05f4ca7e3b"
      unitRef="usdPerShare">5.24</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfMTMtNy0xLTEtMzYxNTY5_d675baab-9f84-445a-9361-d4da000cfd0f"
      unitRef="usdPerShare">7.41</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfMTctMS0xLTEtMzYxNTY5_c8bf3255-8841-4c94-a8db-d7143e81cf0a"
      unitRef="usdPerShare">1.13</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfMTctMy0xLTEtMzYxNTY5_d3bf41d6-1bb6-41ae-b9ff-c4b142f862dc"
      unitRef="usdPerShare">2.36</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfMTctNS0xLTEtMzYxNTY5_3ef762b2-e88b-4151-aad7-73ba668b50f6"
      unitRef="usdPerShare">5.07</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfMTctNy0xLTEtMzYxNTY5_cef55e42-c901-437c-af1d-7e1c04b1c471"
      unitRef="usdPerShare">7.08</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfMTktMS0xLTEtMzYxNTY5_f77a11b1-6521-4694-9589-c26fe8faaeb6"
      unitRef="shares">1260000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfMTktMy0xLTEtMzYxNTY5_ba918d53-cc13-42e2-ba6e-3fd2d750a2f3"
      unitRef="shares">141000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfMTktNS0xLTEtMzYxNTY5_48db79e2-f444-4043-9c44-21f4d2b2975c"
      unitRef="shares">878000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80MC9mcmFnOmEwMTE3MTIxMDJlYjRhNWM4MDIzMmZjZDMyYzZkNzRmL3RhYmxlOjAyYzRkZDkzOGRhMDRmNzlhMzcxOWRiNzYwNDdhODE1L3RhYmxlcmFuZ2U6MDJjNGRkOTM4ZGEwNGY3OWEzNzE5ZGI3NjA0N2E4MTVfMTktNy0xLTEtMzYxNTY5_7080c56d-d526-4379-90e1-7a9951d6b670"
      unitRef="shares">103000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RleHRyZWdpb246ZWQ1ZjU3YzQ1MzVlNGZkZmExZjI3MGU1ZDA3NTUxYjZfOTI2_77baf67b-0ab3-41ef-9651-56b7e1359bc1">Short-term and long-term investments&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s short-term and long-term debt and equity investments, consisting of debt instruments classified as held-to-maturity and equity investments with readily determinable fair values or redemption values, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.652%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Debt&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Equity&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Debt&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Equity&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit and other time deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments in mutual funds and common stocks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt securities:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company's short-term debt investments are principally bank certificates of deposit with contractual maturities longer than three months but shorter than one year. These debt securities are accounted for as held-to-maturity and recorded at amortized cost, which approximated their fair values at September&#160;30, 2022 and December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity securitie&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;s: The Company holds certain equity investments that have readily determinable fair values from public markets. The Company's remaining short-term and long-term equity investments are held within a trust to fund existing obligations associated with the Company&#x2019;s non-qualified deferred compensation plans.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:MarketableSecuritiesTextBlock
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RleHRyZWdpb246ZWQ1ZjU3YzQ1MzVlNGZkZmExZjI3MGU1ZDA3NTUxYjZfOTI3_5c88dec3-c77d-42cc-b40c-6fb1925518ea">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s short-term and long-term debt and equity investments, consisting of debt instruments classified as held-to-maturity and equity investments with readily determinable fair values or redemption values, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.652%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Debt&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Equity&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Debt&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Equity&lt;br/&gt;securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit and other time deposits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments in mutual funds and common stocks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:MarketableSecuritiesTextBlock>
    <us-gaap:HeldToMaturitySecurities
      contextRef="iffa1899b208b434e83db21f284ea5a87_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfMi0xLTEtMS0zNjE1Njk_0fa51037-3743-40b8-b674-3ac2deeaac54"
      unitRef="usd">77843000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="iffa1899b208b434e83db21f284ea5a87_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfMi0zLTEtMS0zNjE1Njk_0815926b-450e-477e-adcd-a33767b20c0b"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecurities
      contextRef="iffa1899b208b434e83db21f284ea5a87_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfMi01LTEtMS0zNjE1Njk_e5fa3f8d-8354-4b8b-9177-e55d8b433240"
      unitRef="usd">77843000</us-gaap:MarketableSecurities>
    <us-gaap:HeldToMaturitySecurities
      contextRef="i6e7043280f3044ae929ed9d39180bb93_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfMi03LTEtMS0zNjE1Njk_b25ffcbd-8720-4ccf-ab2b-e80ba13069b1"
      unitRef="usd">23226000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i6e7043280f3044ae929ed9d39180bb93_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfMi05LTEtMS0zNjE1Njk_6b15b39a-5fb0-4bde-a73c-78c864e9c327"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecurities
      contextRef="i6e7043280f3044ae929ed9d39180bb93_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfMi0xMS0xLTEtMzYxNTY5_17cef8fe-fb92-4d25-89e5-52af0b57df84"
      unitRef="usd">23226000</us-gaap:MarketableSecurities>
    <us-gaap:HeldToMaturitySecurities
      contextRef="i762574633ee549d19d8053d43cdafb79_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfMy0xLTEtMS0zNjE1Njk_2de2f7ef-75ac-49eb-bf72-8fe8bb1cbf0b"
      unitRef="usd">0</us-gaap:HeldToMaturitySecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i762574633ee549d19d8053d43cdafb79_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfMy0zLTEtMS0zNjE1Njk_0ce70e27-0134-4919-97d7-52c6862e547c"
      unitRef="usd">39997000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecurities
      contextRef="i762574633ee549d19d8053d43cdafb79_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfMy01LTEtMS0zNjE1Njk_217ec7ef-7893-46fc-b1fb-415977f8fae9"
      unitRef="usd">39997000</us-gaap:MarketableSecurities>
    <us-gaap:HeldToMaturitySecurities
      contextRef="i998926cd86174abfa8697edf79ac9a69_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfMy03LTEtMS0zNjE1Njk_d58b53b5-bc96-475c-9af7-f5a3d60a85a0"
      unitRef="usd">0</us-gaap:HeldToMaturitySecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i998926cd86174abfa8697edf79ac9a69_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfMy05LTEtMS0zNjE1Njk_6f1f607e-24d9-4644-9eb9-df72b8063e1d"
      unitRef="usd">48598000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecurities
      contextRef="i998926cd86174abfa8697edf79ac9a69_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfMy0xMS0xLTEtMzYxNTY5_a6e60649-0c74-499f-a381-c798e862ed63"
      unitRef="usd">48598000</us-gaap:MarketableSecurities>
    <us-gaap:HeldToMaturitySecurities
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfNC0xLTEtMS0zNjE1Njk_3e8fc1e8-7fed-4fea-b80c-5c22462b98ed"
      unitRef="usd">77843000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfNC0zLTEtMS0zNjE1Njk_64a4e020-6a66-4b85-8222-2dab187034a7"
      unitRef="usd">39997000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecurities
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfNC01LTEtMS0zNjE1Njk_23d869ab-57f2-4863-b9af-a7831eada3b8"
      unitRef="usd">117840000</us-gaap:MarketableSecurities>
    <us-gaap:HeldToMaturitySecurities
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfNC03LTEtMS0zNjE1Njk_adee304d-4878-4ab6-97d1-8790b9536961"
      unitRef="usd">23226000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfNC05LTEtMS0zNjE1Njk_d04c50a3-9c87-43a1-bfe9-50f751a58f86"
      unitRef="usd">48598000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecurities
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfNC0xMS0xLTEtMzYxNTY5_737a3838-5dda-4865-82c4-54b6965497da"
      unitRef="usd">71824000</us-gaap:MarketableSecurities>
    <us-gaap:HeldToMaturitySecuritiesCurrent
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfNS0xLTEtMS0zNjE1Njk_04ac6aa3-466e-4387-aa3c-c3d1c1cd0b74"
      unitRef="usd">62832000</us-gaap:HeldToMaturitySecuritiesCurrent>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="if3d961759a0d4fab9e023c8d7cc84b4d_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfNS0zLTEtMS0zNjE1Njk_f081c06a-8020-4539-b21f-d972f1a49698"
      unitRef="usd">11473000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfNS01LTEtMS0zNjE1Njk_484ddd29-ba33-4612-842e-4c1dcf39e215"
      unitRef="usd">74305000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:HeldToMaturitySecuritiesCurrent
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfNS03LTEtMS0zNjE1Njk_6014d81a-097f-438b-8b03-93741573dbce"
      unitRef="usd">8227000</us-gaap:HeldToMaturitySecuritiesCurrent>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i02bde4cdadea4ac6b75aaf556e9f2418_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfNS05LTEtMS0zNjE1Njk_8b2e683e-01d0-4672-ba7d-bf63ce6eb7e6"
      unitRef="usd">14083000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfNS0xMS0xLTEtMzYxNTY5_d6842c6c-b4fb-42f9-973a-5ab68ae930d2"
      unitRef="usd">22310000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:HeldToMaturitySecuritiesNoncurrent
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfNi0xLTEtMS0zNjE1Njk_87fb9088-e92f-4b52-9225-f0a493d52c2e"
      unitRef="usd">15011000</us-gaap:HeldToMaturitySecuritiesNoncurrent>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i483736bcec6d40ddb087fe0d0b25dbb5_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfNi0zLTEtMS0zNjE1Njk_476dc1af-9f03-478f-9ce6-4704fd2b8249"
      unitRef="usd">28524000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfNi01LTEtMS0zNjE1Njk_5defef43-930e-41fe-b558-9054d476618f"
      unitRef="usd">43535000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:HeldToMaturitySecuritiesNoncurrent
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfNi03LTEtMS0zNjE1Njk_0be3794a-9350-496e-96e3-d4c207c00c36"
      unitRef="usd">14999000</us-gaap:HeldToMaturitySecuritiesNoncurrent>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ibfc94329266c4456afa05d709202b567_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfNi05LTEtMS0zNjE1Njk_84de3a7f-26ab-4655-a6ca-c1c0d69ea88c"
      unitRef="usd">34515000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfNi0xMS0xLTEtMzYxNTY5_7e647538-a7dd-4680-8341-773b3677a129"
      unitRef="usd">49514000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:HeldToMaturitySecurities
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfNy0xLTEtMS0zNjE1Njk_e05d37a7-4ed0-4355-bd7a-ceade9f33898"
      unitRef="usd">77843000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfNy0zLTEtMS0zNjE1Njk_feab66af-7bba-4f47-a4d0-70d51d533a4a"
      unitRef="usd">39997000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecurities
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfNy01LTEtMS0zNjE1Njk_bccf1735-1275-4acd-b4c3-105dcb594925"
      unitRef="usd">117840000</us-gaap:MarketableSecurities>
    <us-gaap:HeldToMaturitySecurities
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfNy03LTEtMS0zNjE1Njk_6ddb51aa-871c-4a74-a9f1-dc1c4e3aef78"
      unitRef="usd">23226000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfNy05LTEtMS0zNjE1Njk_c5fc4ed6-25a0-40e2-9f62-a4b7229ea67a"
      unitRef="usd">48598000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:MarketableSecurities
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RhYmxlOjM3MmE3MjViNWU2NzQ2ODU4YTljODVmOTFhNTFkN2ExL3RhYmxlcmFuZ2U6MzcyYTcyNWI1ZTY3NDY4NThhOWM4NWY5MWE1MWQ3YTFfNy0xMS0xLTEtMzYxNTY5_386764d7-ce9c-4448-9481-76e43c8befd6"
      unitRef="usd">71824000</us-gaap:MarketableSecurities>
    <us-gaap:MarketableSecuritiesPolicy
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80My9mcmFnOmVkNWY1N2M0NTM1ZTRmZGZhMWYyNzBlNWQwNzU1MWI2L3RleHRyZWdpb246ZWQ1ZjU3YzQ1MzVlNGZkZmExZjI3MGU1ZDA3NTUxYjZfOTI4_19337290-7a34-44f6-b4d0-c8622085f13a">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt securities:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company's short-term debt investments are principally bank certificates of deposit with contractual maturities longer than three months but shorter than one year. These debt securities are accounted for as held-to-maturity and recorded at amortized cost, which approximated their fair values at September&#160;30, 2022 and December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity securitie&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;s: The Company holds certain equity investments that have readily determinable fair values from public markets. The Company's remaining short-term and long-term equity investments are held within a trust to fund existing obligations associated with the Company&#x2019;s non-qualified deferred compensation plans.&lt;/span&gt;&lt;/div&gt;</us-gaap:MarketableSecuritiesPolicy>
    <us-gaap:GoodwillDisclosureTextBlock
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RleHRyZWdpb246ZWY4YWQzMzU4MTliNGRmZjk4OWIwN2VlYzQyNGQ3YTBfMjgzMQ_6b811760-1603-4407-a06a-766c7c7daa36">Goodwill&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in goodwill by reportable segments were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.888%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other &#x2014; Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,309,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;609,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,919,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Divestitures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,745)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,745)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44,367)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44,367)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,400,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;646,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,046,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Divestitures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,126)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,213)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55,155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55,155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,416,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;605,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,022,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2022:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,416,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;715,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,131,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(109,330)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(109,330)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,416,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;605,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,022,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company did not recognize any goodwill impairment charges during the nine months ended September 30, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As dialysis treatments are an essential, life-sustaining service for patients who depend on them, the Company's operations have continued and are currently expected to continue throughout the novel coronavirus (COVID-19) pandemic. However, the ultimate impact of this COVID-19 pandemic on the Company will depend on future developments that are highly uncertain and difficult to predict, including among others the ultimate severity and duration of the pandemic; further spread or resurgence of the virus, including as a result of the emergence of new strains of the virus such as the Omicron variant and its subvariants; COVID-19's impact on the chronic kidney disease (CKD) patient population and the Company's patient population, including on the mortality of these patients; the availability, acceptance, impact and efficacy of COVID-19 vaccines, treatments, and therapies; the pandemic's continuing impact on the Company's revenue and non-acquired growth due to lower treatment volumes, the U.S. and global economies, labor market conditions, interest rates, inflation and monetary policies; the Company's ability to successfully implement cost savings initiatives; the potential negative impact on the Company's commercial mix or the number of patients covered by commercial insurance plans; continued increased COVID-19-related costs; supply chain challenges and disruptions; the responses of the Company's competitors to the pandemic and related changes in the marketplace; the timing, scope and effectiveness of federal, state and local government responses to the pandemic; and any potential changes to the extensive set of federal, state and local laws, regulations and requirements that govern the Company's business. While the Company does not currently expect a material adverse impact to its business as a result of this public health crisis, there can be no assurance that the COVID-19 pandemic will not have a material adverse impact on one or more of the Company's businesses.&lt;/span&gt;&lt;/div&gt;Developments, events, changes in operating performance and other changes in circumstances since the dates of the Company&#x2019;s last annual goodwill impairment assessments have not caused management to believe it is more likely than not that the fair values of any of the Company's reporting units would be less than their respective carrying amounts as of September&#160;30, 2022. Except for the Company's Germany kidney care reporting unit as described further in Note 10 to the Company's consolidated financial statements included in the 2021 10-K, none of the Company's various other reporting units were considered at risk of significant goodwill impairment as of September&#160;30, 2022.</us-gaap:GoodwillDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RleHRyZWdpb246ZWY4YWQzMzU4MTliNGRmZjk4OWIwN2VlYzQyNGQ3YTBfMjgzMw_474a492c-6e80-4c90-ba3a-e23d0b1b7a3e">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in goodwill by reportable segments were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.888%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.145%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other &#x2014; Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,309,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;609,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,919,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173,244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Divestitures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,745)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,745)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44,367)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(44,367)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,400,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;646,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,046,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Divestitures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,126)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,213)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency and other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55,155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55,155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,416,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;605,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,022,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at September 30, 2022:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,416,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;715,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,131,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated impairment charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(109,330)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(109,330)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,416,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;605,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,022,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i7271827c904f4e51b6526494e9342d5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfMS0xLTEtMS0zNjE1Njk_3f2074a2-b410-4d4c-b5dc-a0316d6fd33c"
      unitRef="usd">6309928000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i756ef20c6d3443ab8a775b412b7acddc_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfMS0zLTEtMS0zNjE1Njk_6eba2489-0b8e-485a-86d4-d626e389c429"
      unitRef="usd">609181000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ibf9e89b4e598444e8b9df2b00849c30a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfMS01LTEtMS0zNjE1Njk_92e7e8cb-d161-419a-ad93-dbd93ee7fc59"
      unitRef="usd">6919109000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i171f9689d476418d827ad1ac63f1abe2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfMi0xLTEtMS0zNjE1Njk_3b1acf5e-0668-478c-bb13-5e472ae56da6"
      unitRef="usd">91979000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i7fe624a85b4c4310aae5c81aef699e3a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfMi0zLTEtMS0zNjE1Njk_3a7e7dd9-36a8-4f43-940f-be69bbc420dc"
      unitRef="usd">81265000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i2759022dfe6d4c619bce01f379f17594_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfMi01LTEtMS0zNjE1Njk_8b2e44ce-6296-41d3-bb97-c2aa75e60eb2"
      unitRef="usd">173244000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i171f9689d476418d827ad1ac63f1abe2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfMy0xLTEtMS0zNjE1Njk_aa6175ab-20c1-4f85-af90-e4bd81b9ff87"
      unitRef="usd">1745000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i7fe624a85b4c4310aae5c81aef699e3a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfMy0zLTEtMS0zNjE1Njk_8fac4742-ba10-4b08-9c3f-3a3e3e471954"
      unitRef="usd">0</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i2759022dfe6d4c619bce01f379f17594_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfMy01LTEtMS0zNjE1Njk_1eebd78a-cf13-4734-9b28-3f409135a720"
      unitRef="usd">1745000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i171f9689d476418d827ad1ac63f1abe2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfNC0xLTEtMS0zNjE1Njk_138109ac-7625-4db1-8d77-23f2d7fb6e16"
      unitRef="usd">0</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i7fe624a85b4c4310aae5c81aef699e3a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfNC0zLTEtMS0zNjE1Njk_d0894849-3c76-42b8-8f23-969430cde032"
      unitRef="usd">-44367000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i2759022dfe6d4c619bce01f379f17594_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfNC01LTEtMS0zNjE1Njk_a38cd93b-2f33-456e-989a-af4fbfd5788f"
      unitRef="usd">-44367000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="i698d58b2d3b2468cbb119fff40dd7a93_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfNS0xLTEtMS0zNjE1Njk_cb7e1891-4df2-4060-8ba6-405e068a4ef7"
      unitRef="usd">6400162000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i92fca4752e474a7bad54570de210ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfNS0zLTEtMS0zNjE1Njk_cf9bd9ca-e020-4334-b9c6-8b270be2cb36"
      unitRef="usd">646079000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfNS01LTEtMS0zNjE1Njk_2028a240-03bc-4507-8199-74861d0a5c82"
      unitRef="usd">7046241000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i422c6a94a816499c8310fd5a0acc841f_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfNi0xLTEtMS0zNjE1Njk_f82d8328-dd7e-4a51-a499-fed1438e2ed6"
      unitRef="usd">16750000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ie63e40be1b8c44ae852031a36cc0c1d2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfNi0zLTEtMS0zNjE1Njk_b9cd054b-bebe-4039-a8aa-16c0ed42b460"
      unitRef="usd">18019000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfNi01LTEtMS0zNjE1Njk_e7119165-818b-4f3a-943f-55c0a24330a7"
      unitRef="usd">34769000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i422c6a94a816499c8310fd5a0acc841f_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfNy0xLTEtMS0zNjE1Njk_119a59fe-5926-49c5-9a19-b2953d910335"
      unitRef="usd">87000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="ie63e40be1b8c44ae852031a36cc0c1d2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfNy0zLTEtMS0zNjE1Njk_6e7ce42b-5824-485f-bf30-242ce8e14ed5"
      unitRef="usd">3126000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfNy01LTEtMS0zNjE1Njk_de1f31fb-3103-40ef-855b-100e0a81502b"
      unitRef="usd">3213000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i422c6a94a816499c8310fd5a0acc841f_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfOC0xLTEtMS0zNjE1Njk_0b2c3b2e-3923-4966-b40d-3a533050c6f8"
      unitRef="usd">0</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="ie63e40be1b8c44ae852031a36cc0c1d2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfOC0zLTEtMS0zNjE1Njk_943e5876-353b-46a8-95c7-b513c3351474"
      unitRef="usd">-55155000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfOC01LTEtMS0zNjE1Njk_f1bd5ced-1181-4055-b4a0-a25e66cce126"
      unitRef="usd">-55155000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="i7093bff9492a45488822863f8f94a337_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfOS0xLTEtMS0zNjE1Njk_54966761-25fd-4440-8b47-a82eb27728ec"
      unitRef="usd">6416825000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i2d792edae43b4791856eea60df0b33b6_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfOS0zLTEtMS0zNjE1Njk_c1444b93-5a4d-4767-b4f3-54e006405dbb"
      unitRef="usd">605817000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfOS01LTEtMS0zNjE1Njk_3d95bddb-081e-4d9e-a22e-6479e75bc00e"
      unitRef="usd">7022642000</us-gaap:Goodwill>
    <us-gaap:GoodwillGross
      contextRef="i7093bff9492a45488822863f8f94a337_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfMTItMS0xLTEtMzYxNTY5_f644fb4b-90b1-48d6-980d-ded2de2f59e4"
      unitRef="usd">6416825000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="i2d792edae43b4791856eea60df0b33b6_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfMTItMy0xLTEtMzYxNTY5_7340007f-35c6-4c67-8ff7-0bbb5c445df8"
      unitRef="usd">715147000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillGross
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfMTItNS0xLTEtMzYxNTY5_1c2e1145-f122-48d9-aed3-3382b1c910e5"
      unitRef="usd">7131972000</us-gaap:GoodwillGross>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i7093bff9492a45488822863f8f94a337_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfMTMtMS0xLTEtMzYxNTY5_84e21a52-ce7d-48b4-b79b-f1038baa574a"
      unitRef="usd">0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i2d792edae43b4791856eea60df0b33b6_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfMTMtMy0xLTEtMzYxNTY5_a11bc8f8-b426-482d-a467-12bdcfb2495a"
      unitRef="usd">109330000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfMTMtNS0xLTEtMzYxNTY5_b8ff5dff-d508-424d-bc16-1a78d02233c1"
      unitRef="usd">109330000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="i7093bff9492a45488822863f8f94a337_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfMTQtMS0xLTEtMzYxNTY5_9708635e-1fef-4b73-aa9c-56b9f08ce6df"
      unitRef="usd">6416825000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i2d792edae43b4791856eea60df0b33b6_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfMTQtMy0xLTEtMzYxNTY5_136c18cb-0b06-4eec-b5bd-f533a2eedef8"
      unitRef="usd">605817000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RhYmxlOmYwY2ZhNmQ5NzUxODQzODdiODVkMzUxYWI4YjgxYzY5L3RhYmxlcmFuZ2U6ZjBjZmE2ZDk3NTE4NDM4N2I4NWQzNTFhYjhiODFjNjlfMTQtNS0xLTEtMzYxNTY5_4eb7c384-5ca7-4d3b-830f-12d96ed53bd8"
      unitRef="usd">7022642000</us-gaap:Goodwill>
    <us-gaap:NumberOfOperatingSegments
      contextRef="ic52ab49cab0046128e4cd38b93634c67_D20220701-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl80Ni9mcmFnOmVmOGFkMzM1ODE5YjRkZmY5ODliMDdlZWM0MjRkN2EwL3RleHRyZWdpb246ZWY4YWQzMzU4MTliNGRmZjk4OWIwN2VlYzQyNGQ3YTBfMjcwOQ_0c0756e8-4cec-4dd6-8998-ea1790af359f"
      unitRef="segment">0</us-gaap:NumberOfOperatingSegments>
    <us-gaap:LongTermDebtTextBlock
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMzc5OA_0e87895a-b2e5-4491-b749-506d4dd7d9c1">Long-term debt&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt was comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.702%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;As of September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;September 30, &lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Maturity date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Estimated fair value&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Secured Credit Facilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan A&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,531,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,596,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8/12/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LIBOR+1.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan B-1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,667,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,688,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8/12/2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LIBOR+1.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,530,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revolving line of credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8/12/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LIBOR+1.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Notes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.625% Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,750,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,750,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6/1/2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,124,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.75% Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/15/2031&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,068,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition obligations and other notes payable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022-2036&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing lease obligations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023-2038&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt principal outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,128,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,964,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount, premium and deferred financing costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47,520)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56,685)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,081,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,908,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(214,254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(179,030)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,867,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,729,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;For the Company's senior secured credit facilities and senior notes, fair value estimates are based upon bid and ask quotes, typically a level 2 input. For acquisition obligations and other notes payable, the carrying values presented approximate their estimated fair values, based on estimates of their present values using level 2 interest rate inputs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The interest rate presented for acquisition obligations and other notes payable is their weighted average interest rate based on the current fixed and variable interest rate components in effect as of September&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Financing lease obligations are measured at their approximate present values at inception. The interest rate presented is the weighted average discount rate embedded in financing leases outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;As of September&#160;30, 2022, the carrying amount of the Company's senior secured credit facilities have been reduced by a discount of $3,740 and deferred financing costs of $20,891, and the carrying amount of the Company's senior notes have been reduced by deferred financing costs of $37,380 and increased by a debt premium of $14,491. As of December&#160;31, 2021, the carrying amount of the Company's senior secured credit facilities were reduced by a discount of $4,473 and deferred financing costs of $27,207, and the carrying amount of the Company's senior notes were reduced by deferred financing costs of $40,914 and increased by a debt premium of $15,909.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first nine months of 2022, the Company made regularly scheduled mandatory principal payments under its senior secured credit facilities totaling $65,625 on Term Loan A and $20,574 on Term Loan B-1.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2022, the Company's 2019 interest rate cap agreements have the economic effect of capping the Company's maximum exposure to LIBOR variable interest rate changes on equivalent amounts of the Company's floating rate debt, including all of Term Loan B-1 and a portion of Term Loan A. The remaining $698,939 outstanding principal balance of Term Loan A and the $275,000 balance outstanding on the revolving line of credit are subject to LIBOR-based interest rate volatility. These cap agreements are designated as cash flow hedges and, as a result, changes in their fair values are reported in other comprehensive income. The original premiums paid for the caps are amortized to debt expense on a straight-line basis over the term of each cap agreement starting from its effective date. These cap agreements do not contain credit risk-contingent features.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s interest rate cap agreements outstanding as of September&#160;30, 2022 and December&#160;31, 2021, which are classified in "Other long-term assets" on its consolidated balance sheet:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.012%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.012%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.377%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Nine months ended &lt;br/&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;LIBOR maximum rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Effective date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Expiration date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Debt expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Recorded OCI gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;September 30, &lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6/30/2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6/30/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOjMzNDNiOGQxYjAwNzRhZWFhMGYzMWJkOTU1ZWVjYmNiL3RhYmxlcmFuZ2U6MzM0M2I4ZDFiMDA3NGFlYWEwZjMxYmQ5NTVlZWNiY2JfMi05LTEtMS0zNjE1Njk_2f37a18b-1ac9-4872-985b-d24c04e03453"&gt;1,497&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 9 for further details on amounts reclassified from accumulated other comprehensive loss and recorded as debt expense related to the Company&#x2019;s interest rate cap agreements for the three and nine months ended September&#160;30, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of the LIBOR cap from our 2019 interest rate cap agreements, the Company&#x2019;s weighted average effective interest rate on its senior secured credit facilities at the end of the third quarter of 2022 was 4.34%, based on the current margins in effect for its senior secured credit facilities as of September&#160;30, 2022, as detailed in the table above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s overall weighted average effective interest rate for the three and nine months ended September&#160;30, 2022 was 4.28% and 3.78%, and as of September&#160;30, 2022 was 4.39%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2022, the Company&#x2019;s interest rates were fixed and economically fixed on approximately 50% and 89% of its total debt, respectively.&lt;/span&gt;&lt;/div&gt;As of September&#160;30, 2022, the Company had $725,000 available and $275,000 drawn on its $1,000,000 revolving line of credit under its senior secured credit facilities. Credit available under this facility is reduced by the amount of any letters of credit outstanding under this facility, of which there were none as of September&#160;30, 2022. The Company also had approximately $108,002 in letters of credit outstanding under a separate bilateral secured letter of credit facility as of September&#160;30, 2022.</us-gaap:LongTermDebtTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMzc4MA_d523b73b-ea36-45cb-abe3-062327949cc2">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt was comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.702%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;As of September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;September 30, &lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Maturity date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Estimated fair value&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Secured Credit Facilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan A&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,531,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,596,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8/12/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LIBOR+1.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan B-1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,667,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,688,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8/12/2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LIBOR+1.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,530,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revolving line of credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8/12/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;LIBOR+1.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior Notes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.625% Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,750,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,750,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6/1/2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,124,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.75% Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2/15/2031&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,068,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition obligations and other notes payable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022-2036&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing lease obligations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;299,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023-2038&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt principal outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,128,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,964,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount, premium and deferred financing costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47,520)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56,685)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,081,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,908,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(214,254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(179,030)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,867,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,729,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:19.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;For the Company's senior secured credit facilities and senior notes, fair value estimates are based upon bid and ask quotes, typically a level 2 input. For acquisition obligations and other notes payable, the carrying values presented approximate their estimated fair values, based on estimates of their present values using level 2 interest rate inputs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;The interest rate presented for acquisition obligations and other notes payable is their weighted average interest rate based on the current fixed and variable interest rate components in effect as of September&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;Financing lease obligations are measured at their approximate present values at inception. The interest rate presented is the weighted average discount rate embedded in financing leases outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;As of September&#160;30, 2022, the carrying amount of the Company's senior secured credit facilities have been reduced by a discount of $3,740 and deferred financing costs of $20,891, and the carrying amount of the Company's senior notes have been reduced by deferred financing costs of $37,380 and increased by a debt premium of $14,491. As of December&#160;31, 2021, the carrying amount of the Company's senior secured credit facilities were reduced by a discount of $4,473 and deferred financing costs of $27,207, and the carrying amount of the Company's senior notes were reduced by deferred financing costs of $40,914 and increased by a debt premium of $15,909.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:SecuredDebt
      contextRef="i168f0cc4ee2a490ba0df4d0eb3ab2041_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfMy0xLTEtMS0zNjE1Njk_273f00f9-c67d-464c-8c18-c4e8f1d84b9e"
      unitRef="usd">1531250000</us-gaap:SecuredDebt>
    <us-gaap:SecuredDebt
      contextRef="i6f2af1cb259e4765a370d5164540acf9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfMy0zLTEtMS0zNjE1Njk_9e01e9dd-387c-4fda-a8c7-df4980fe2635"
      unitRef="usd">1596875000</us-gaap:SecuredDebt>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="i5fab6e21c9604971bab7725c4bfbac6f_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfMy01LTEtMS0zNjE1Njk_c42d9f11-bfc2-4036-891f-9c6a9a6ff871">2024-08-12</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentDescriptionOfVariableRateBasis
      contextRef="i5fab6e21c9604971bab7725c4bfbac6f_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfMy03LTEtMS0zNjE1Njk_b36c2ca1-392d-45e6-b876-10d35b244c5d">LIBOR+1.75%</us-gaap:DebtInstrumentDescriptionOfVariableRateBasis>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i168f0cc4ee2a490ba0df4d0eb3ab2041_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfMy05LTEtMS0zNjE1Njk_5f41596e-0d8c-49bd-b391-d0c31ce601e6"
      unitRef="usd">1500625000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:SecuredDebt
      contextRef="i302d14b3d5a44d99ac999f078c7fd0c8_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfNC0xLTEtMS0zNjE1Njk_14df7330-060c-4a29-a48d-8e16ed291533"
      unitRef="usd">2667689000</us-gaap:SecuredDebt>
    <us-gaap:SecuredDebt
      contextRef="ib24db8b1544e4594962862573a081569_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfNC0zLTEtMS0zNjE1Njk_8860b2c2-3ce6-4f00-a8e2-a63a5cbde2ac"
      unitRef="usd">2688263000</us-gaap:SecuredDebt>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="i3eac2310025f4fc0a30a0754d743a012_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfNC01LTEtMS0zNjE1Njk_221b48ff-73a6-4bbe-9580-c2c64553b78d">2026-08-12</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentDescriptionOfVariableRateBasis
      contextRef="i3eac2310025f4fc0a30a0754d743a012_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfNC03LTEtMS0zNjE1Njk_72169b61-18fd-4cf6-9f55-8100092aca86">LIBOR+1.75%</us-gaap:DebtInstrumentDescriptionOfVariableRateBasis>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i302d14b3d5a44d99ac999f078c7fd0c8_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfNC05LTEtMS0zNjE1Njk_baa51206-c6ce-462c-a379-a649fba7cc68"
      unitRef="usd">2530970000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:SecuredDebt
      contextRef="i3433a7055306497a9f23d7846a707116_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfNS0xLTEtMS0zNjE1Njk_a4c3ac52-7693-4e4b-842f-9f380040e54c"
      unitRef="usd">275000000</us-gaap:SecuredDebt>
    <us-gaap:SecuredDebt
      contextRef="i6d5c71dc8775496aa1ad4209bbb25af1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfNS0zLTEtMS0zNjE1Njk_af283f06-ec1b-4996-9904-24fe86345e51"
      unitRef="usd">0</us-gaap:SecuredDebt>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="i5034dae68d4445268ca6238ba4f28038_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfNS01LTEtMS0zNjE1Njk_30a048c7-9858-45c4-9caa-5f840adbc844">2024-08-12</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentDescriptionOfVariableRateBasis
      contextRef="i5034dae68d4445268ca6238ba4f28038_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfNS03LTEtMS0zNjE1Njk_c6981def-ce58-415a-b0d4-8066ae062c6e">LIBOR+1.75%</us-gaap:DebtInstrumentDescriptionOfVariableRateBasis>
    <us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding
      contextRef="i3433a7055306497a9f23d7846a707116_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfNS05LTEtMS0zNjE1Njk_bd7f3b65-2273-4f78-932c-df6424357ac0"
      unitRef="usd">275000000</us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding>
    <us-gaap:SeniorNotes
      contextRef="ia085405df9dc49bc9d8a30bf7986f78f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfNy0xLTEtMS0zNjE1Njk_1da7904d-fa31-4a5a-ada8-d2c8618d8b15"
      unitRef="usd">2750000000</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="i09d1f6ddde7148209032eb2224d201eb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfNy0zLTEtMS0zNjE1Njk_1a487735-c119-4e62-9d92-c873ac39f73d"
      unitRef="usd">2750000000</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="i302c47dbb07447f3aa14cc9c0f845e99_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfNy01LTEtMS0zNjE1Njk_c7a06f97-9a59-4ed8-8924-d4cbdf814c6d">2030-06-01</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i302c47dbb07447f3aa14cc9c0f845e99_D20220101-20220930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfNy03LTEtMS0zNjE1Njk_57a7e361-0cd1-439e-85cd-f82943ee0306"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ia085405df9dc49bc9d8a30bf7986f78f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfNy05LTEtMS0zNjE1Njk_a6edab0d-51d6-45b5-a6e3-cbb8f1f62f2c"
      unitRef="usd">2124375000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:SeniorNotes
      contextRef="i5060f8fb53a5401181f83f0a4d6ff2a5_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfOC0xLTEtMS0zNjE1Njk_87572ce0-9f39-4dc4-bb05-af452a0eb86b"
      unitRef="usd">1500000000</us-gaap:SeniorNotes>
    <us-gaap:SeniorNotes
      contextRef="i04752ae989ad4df8860d74e4cad34f15_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfOC0zLTEtMS0zNjE1Njk_04138a16-a017-4fc4-ae13-d5149c9a93f6"
      unitRef="usd">1500000000</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="i64428b0bc4064508aa43d6d7c4cc144b_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfOC01LTEtMS0zNjE1Njk_15192c0f-6bae-48ec-95da-27cbd5446375">2031-02-15</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i64428b0bc4064508aa43d6d7c4cc144b_D20220101-20220930"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfOC03LTEtMS0zNjE1Njk_6c788c3e-abf7-4c95-b659-b80c8879012e"
      unitRef="number">0.0375</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i5060f8fb53a5401181f83f0a4d6ff2a5_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfOC05LTEtMS0zNjE1Njk_888600c3-cc2a-4615-92e3-f4c4264eb7b8"
      unitRef="usd">1068750000</us-gaap:DebtInstrumentFairValue>
    <dva:AcquisitionObligationsAndOtherNotesPayable
      contextRef="ibbe11ca6fc7841578c3e48f6f74461bb_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfOS0xLTEtMS0zNjE1Njk_a29f72e1-db39-47bb-8220-10481ccb7fd8"
      unitRef="usd">125809000</dva:AcquisitionObligationsAndOtherNotesPayable>
    <dva:AcquisitionObligationsAndOtherNotesPayable
      contextRef="ibea5962a62cd4213b61783287c172e38_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfOS0zLTEtMS0zNjE1Njk_195d2158-7828-4640-a9f9-0c03f28c4f0e"
      unitRef="usd">130599000</dva:AcquisitionObligationsAndOtherNotesPayable>
    <us-gaap:DebtInstrumentMaturityDateDescription
      contextRef="i87c41204c9904d789e0b0f9e1ef28d3d_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfOS01LTEtMS0zNjE1Njk_4a097dc1-5fa2-4619-81e6-802aada5a80a">2022-2036</us-gaap:DebtInstrumentMaturityDateDescription>
    <us-gaap:LongtermDebtWeightedAverageInterestRate
      contextRef="ibbe11ca6fc7841578c3e48f6f74461bb_I20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfOS03LTEtMS0zNjE1Njk_01defd52-952f-4c52-ab71-9196f887287e"
      unitRef="number">0.0582</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <dva:AcquisitionObligationsAndOtherNotesPayableFairValue
      contextRef="ibbe11ca6fc7841578c3e48f6f74461bb_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfOS05LTEtMS0zNjE1Njk_df23a34c-aef8-4262-9dcb-fb294718e803"
      unitRef="usd">125809000</dva:AcquisitionObligationsAndOtherNotesPayableFairValue>
    <us-gaap:FinanceLeaseLiability
      contextRef="i00a6d21c50894a1fa91ade6d03f0fffe_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfMTAtMS0xLTEtMzYxNTY5_b9d296a8-6721-4552-a213-b7592fbfdec9"
      unitRef="usd">279213000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i4ebc73ef268843d2a9d4b6d4d487bd9e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfMTAtMy0xLTEtMzYxNTY5_97718614-5992-4b8f-a713-1873ef4b5ecd"
      unitRef="usd">299128000</us-gaap:FinanceLeaseLiability>
    <us-gaap:DebtInstrumentMaturityDateDescription
      contextRef="iaf4852e0d4004e5793b6d25aad62c55c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfMTAtNS0xLTEtMzYxNTY5_ba9304b9-313e-4fb1-b957-1e680eeb2db2">2023-2038</us-gaap:DebtInstrumentMaturityDateDescription>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i00a6d21c50894a1fa91ade6d03f0fffe_I20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfMTAtNy0xLTEtMzYxNTY5_a49783f3-7214-4469-8468-029567cf5cd3"
      unitRef="number">0.0453</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfMTEtMS0xLTEtMzYxNTY5_909de1d4-a374-43f7-8f0c-0a0e1adbe4a1"
      unitRef="usd">9128961000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfMTEtMy0xLTEtMzYxNTY5_3036a0ca-1524-42ed-b88c-4053397ed0d8"
      unitRef="usd">8964865000</us-gaap:DebtInstrumentCarryingAmount>
    <dva:DiscountPremiumAndDeferredFinancingCosts
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfMTItMS0xLTEtMzYxNTY5_cb26637c-4b20-476c-b854-c7cecf6d407e"
      unitRef="usd">47520000</dva:DiscountPremiumAndDeferredFinancingCosts>
    <dva:DiscountPremiumAndDeferredFinancingCosts
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfMTItMy0xLTEtMzYxNTY5_d0a8c326-db66-4134-b095-3aa84595e069"
      unitRef="usd">56685000</dva:DiscountPremiumAndDeferredFinancingCosts>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfMTMtMS0xLTEtMzYxNTY5_e295e888-1bd5-400a-8bc8-0f5f55b751c0"
      unitRef="usd">9081441000</us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfMTMtMy0xLTEtMzYxNTY5_6fad3e92-ce0a-4331-8cb6-f6b6d9d51ef7"
      unitRef="usd">8908180000</us-gaap:LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfMTQtMS0xLTEtMzYxNTY5_fe1e428b-0a86-4e7e-ac9a-0380c76fea02"
      unitRef="usd">214254000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfMTQtMy0xLTEtMzYxNTY5_ff3ac856-a138-4b53-800e-d197401ab8ec"
      unitRef="usd">179030000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfMTUtMS0xLTEtMzYxNTY5_92231fbf-9153-4c97-9a13-a7f36e42b895"
      unitRef="usd">8867187000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOmRhNTI5MTFhMjQyODQ2MThiNGE1NmE5ODZlOTU5YzM5L3RhYmxlcmFuZ2U6ZGE1MjkxMWEyNDI4NDYxOGI0YTU2YTk4NmU5NTljMzlfMTUtMy0xLTEtMzYxNTY5_54fdd840-5e24-4639-97ac-1f362fc4458c"
      unitRef="usd">8729150000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i41f04bf6bfb648ff9ac2bac9337cf616_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfOTUy_5b6763be-97a5-4bc1-9bd0-590acd457432"
      unitRef="usd">3740000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DeferredOfferingCosts
      contextRef="i41f04bf6bfb648ff9ac2bac9337cf616_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfOTg3_3f16c512-34aa-4a42-a0f8-203b3b585288"
      unitRef="usd">20891000</us-gaap:DeferredOfferingCosts>
    <us-gaap:DeferredOfferingCosts
      contextRef="i3c5c02a03c2046a284b5bbc100254ca4_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMTA5NA_a8c70a15-628d-443d-8455-718c9e6fe68f"
      unitRef="usd">37380000</us-gaap:DeferredOfferingCosts>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="i3c5c02a03c2046a284b5bbc100254ca4_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMTEzMg_18154a22-96e0-4821-8c9b-3b41b8e06747"
      unitRef="usd">14491000</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i82d2dee054d74a1a9b9863ec06aedad5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMTI0Ng_2ecf10f6-b81f-4d39-86ee-d642fdf43fcb"
      unitRef="usd">4473000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DeferredOfferingCosts
      contextRef="i82d2dee054d74a1a9b9863ec06aedad5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMTI4MQ_949370a5-366b-48f6-80bb-14117cb1b356"
      unitRef="usd">27207000</us-gaap:DeferredOfferingCosts>
    <us-gaap:DeferredOfferingCosts
      contextRef="i7c55687d402147b5b3598fcd58f4ea18_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMTM4Mw_9c1ea2f5-a5bf-4034-91f7-50fd7802d468"
      unitRef="usd">40914000</us-gaap:DeferredOfferingCosts>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="i7c55687d402147b5b3598fcd58f4ea18_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMTQyMQ_b60bd4be-4fb7-4ce9-81cc-24c8f814113e"
      unitRef="usd">15909000</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="i5fab6e21c9604971bab7725c4bfbac6f_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMTU3Nw_53baa4c9-f68d-4493-b8d4-3622cebb1f78"
      unitRef="usd">65625000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="i3eac2310025f4fc0a30a0754d743a012_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMTU5OQ_a929c97b-6a93-4658-b3af-a692fd117514"
      unitRef="usd">20574000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <dva:SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR
      contextRef="i168f0cc4ee2a490ba0df4d0eb3ab2041_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMTkxOQ_4657231e-1e0c-46b4-9e89-b73a48a8c411"
      unitRef="usd">698939000</dva:SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR>
    <us-gaap:SecuredDebt
      contextRef="i3433a7055306497a9f23d7846a707116_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMTk3NQ_a4c3ac52-7693-4e4b-842f-9f380040e54c"
      unitRef="usd">275000000</us-gaap:SecuredDebt>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMzgwMA_39e61bc7-731d-455b-b204-4dde1dbee8d6">These cap agreements are designated as cash flow hedges and, as a result, changes in their fair values are reported in other comprehensive income. The original premiums paid for the caps are amortized to debt expense on a straight-line basis over the term of each cap agreement starting from its effective date.</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:ScheduleOfDerivativeInstrumentsTextBlock
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMzc3OA_425b9d49-fffb-461a-9924-de76a8d93c7b">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s interest rate cap agreements outstanding as of September&#160;30, 2022 and December&#160;31, 2021, which are classified in "Other long-term assets" on its consolidated balance sheet:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.779%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.012%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.012%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.377%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Nine months ended &lt;br/&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Notional amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;LIBOR maximum rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Effective date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Expiration date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Debt expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Recorded OCI gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;September 30, &lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,500,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6/30/2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6/30/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOjMzNDNiOGQxYjAwNzRhZWFhMGYzMWJkOTU1ZWVjYmNiL3RhYmxlcmFuZ2U6MzM0M2I4ZDFiMDA3NGFlYWEwZjMxYmQ5NTVlZWNiY2JfMi05LTEtMS0zNjE1Njk_2f37a18b-1ac9-4872-985b-d24c04e03453"&gt;1,497&lt;/span&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsTextBlock>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i27a76be1220a42ebb7e508e18f02f881_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOjMzNDNiOGQxYjAwNzRhZWFhMGYzMWJkOTU1ZWVjYmNiL3RhYmxlcmFuZ2U6MzM0M2I4ZDFiMDA3NGFlYWEwZjMxYmQ5NTVlZWNiY2JfMi0xLTEtMS0zNjE1Njk_59eb4c5b-05d1-4194-8515-b0fceab86707"
      unitRef="usd">3500000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i551c354ec3c64e7889df8603ed99c879_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOjMzNDNiOGQxYjAwNzRhZWFhMGYzMWJkOTU1ZWVjYmNiL3RhYmxlcmFuZ2U6MzM0M2I4ZDFiMDA3NGFlYWEwZjMxYmQ5NTVlZWNiY2JfMi0zLTEtMS0zNjE1Njk_ff06c194-04eb-4cc0-9d41-e15d4a648560"
      unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DerivativeInceptionDates
      contextRef="i6dcab18b6e464b478f9e7b926940407a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOjMzNDNiOGQxYjAwNzRhZWFhMGYzMWJkOTU1ZWVjYmNiL3RhYmxlcmFuZ2U6MzM0M2I4ZDFiMDA3NGFlYWEwZjMxYmQ5NTVlZWNiY2JfMi01LTEtMS0zNjE1Njk_e53f7ab8-aba5-46f0-a806-3e93b5de7a87">2020-06-30</us-gaap:DerivativeInceptionDates>
    <us-gaap:DerivativeMaturityDates
      contextRef="i6dcab18b6e464b478f9e7b926940407a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOjMzNDNiOGQxYjAwNzRhZWFhMGYzMWJkOTU1ZWVjYmNiL3RhYmxlcmFuZ2U6MzM0M2I4ZDFiMDA3NGFlYWEwZjMxYmQ5NTVlZWNiY2JfMi03LTEtMS0zNjE1Njk_ad8f197d-d0f4-41f3-bc1d-8a8729c221aa">2024-06-30</us-gaap:DerivativeMaturityDates>
    <us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
      contextRef="ie3bcbd3ed4904f758f13fa1bf235728c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOjMzNDNiOGQxYjAwNzRhZWFhMGYzMWJkOTU1ZWVjYmNiL3RhYmxlcmFuZ2U6MzM0M2I4ZDFiMDA3NGFlYWEwZjMxYmQ5NTVlZWNiY2JfMi05LTEtMS0zNjE1Njk_71913a8e-8fb1-47c5-bd4b-1644f1bcb45a"
      unitRef="usd">1497000</us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i2bd1edc1ab034b47a8b52b57f222a787_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOjMzNDNiOGQxYjAwNzRhZWFhMGYzMWJkOTU1ZWVjYmNiL3RhYmxlcmFuZ2U6MzM0M2I4ZDFiMDA3NGFlYWEwZjMxYmQ5NTVlZWNiY2JfMi0xMS0xLTEtMzYxNTY5_78ab2f9e-0c21-4bfb-a178-cc4c7e83150a"
      unitRef="usd">127460000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i6c1f682df591439fa3b6fcdf674d782e_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOjMzNDNiOGQxYjAwNzRhZWFhMGYzMWJkOTU1ZWVjYmNiL3RhYmxlcmFuZ2U6MzM0M2I4ZDFiMDA3NGFlYWEwZjMxYmQ5NTVlZWNiY2JfMi0xMy0xLTEtMzYxNTY5_0c01526c-ea2d-40d4-94a4-cf2c059a37b1"
      unitRef="usd">139663000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i288ec9efae5e463983828ed73eecc6fa_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RhYmxlOjMzNDNiOGQxYjAwNzRhZWFhMGYzMWJkOTU1ZWVjYmNiL3RhYmxlcmFuZ2U6MzM0M2I4ZDFiMDA3NGFlYWEwZjMxYmQ5NTVlZWNiY2JfMi0xNS0xLTEtMzYxNTY5_9be32091-299d-459c-b5b5-0e821360220f"
      unitRef="usd">12203000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:LongtermDebtWeightedAverageInterestRate
      contextRef="i41f04bf6bfb648ff9ac2bac9337cf616_I20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMjE5OTAyMzI1OTQzNQ_b5630501-f6ad-4a39-b74e-cb1a97e3ba43"
      unitRef="number">0.0434</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMzIyNw_0cf4ba20-8350-4f8c-b4c9-3915a03d796f"
      unitRef="number">0.0428</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMzIzNA_4ed7c9aa-b6ee-40ff-85a3-813f1db93663"
      unitRef="number">0.0378</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:LongtermDebtWeightedAverageInterestRate
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMzI1NQ_c55f8df2-1112-426e-ad76-588b58c3eb28"
      unitRef="number">0.0439</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <us-gaap:LongTermDebtPercentageBearingFixedInterestRate
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMzMyNg_aeecadf3-921e-4d56-af00-4799787b775c"
      unitRef="number">0.50</us-gaap:LongTermDebtPercentageBearingFixedInterestRate>
    <dva:LongTermDebtPercentageBearingEconomicallyFixedInterestRate
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMTY0OTI2NzQ0NzQ5OQ_c091c8d7-3172-42ef-ac74-bb2e41c8b2fa"
      unitRef="number">0.89</dva:LongTermDebtPercentageBearingEconomicallyFixedInterestRate>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="i3433a7055306497a9f23d7846a707116_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMzM3NA_10f39905-cd40-4d54-93cb-93dd9a1e489c"
      unitRef="usd">725000000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:SecuredDebt
      contextRef="i3433a7055306497a9f23d7846a707116_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMzM5MQ_a4c3ac52-7693-4e4b-842f-9f380040e54c"
      unitRef="usd">275000000</us-gaap:SecuredDebt>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i3433a7055306497a9f23d7846a707116_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMzQwNw_1e6d6b83-aa51-438e-a52c-73efa32fec26"
      unitRef="usd">1000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="icf19afd02f534c9c8ffb4475417e4ce0_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMzYxOQ_38600007-f52f-4b79-9d09-439bbb6df4dd"
      unitRef="usd">0</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i6e5742b805d64156889d9a58826bf40d_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81Mi9mcmFnOjJkNTQ2Y2NkOTJkNzRkZjU5NDM4ZTExMzFlOGMyZDhjL3RleHRyZWdpb246MmQ1NDZjY2Q5MmQ3NGRmNTk0MzhlMTEzMWU4YzJkOGNfMzY2Nw_9b277b0c-dd77-4afb-976a-c6828331e686"
      unitRef="usd">108002000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LossContingencyDisclosures
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81NS9mcmFnOjhkYjQxYTc1ODQyNDRhMmU4OTRmODViYWQ3OTJhMzVhL3RleHRyZWdpb246OGRiNDFhNzU4NDI0NGEyZTg5NGY4NWJhZDc5MmEzNWFfMTQ1MDc_9efb60b5-5763-4d91-a03d-46bcd26cadef">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Commitments and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;contingencies&lt;/span&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The majority of the Company&#x2019;s revenues are from government programs and may be subject to adjustment as a result of: (i)&#160;examination by government agencies or contractors, for which the resolution of any matters raised may take extended periods of time to finalize; (ii)&#160;differing interpretations of government regulations by different Medicare contractors or regulatory authorities; (iii)&#160;differing opinions regarding a patient&#x2019;s medical diagnosis or the medical necessity of services provided; and (iv)&#160;retroactive applications or interpretations of governmental requirements. In addition, the Company&#x2019;s revenues from commercial payors may be subject to adjustment as a result of potential claims for refunds, as a result of government actions or as a result of other claims by commercial payors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates in a highly regulated industry and is a party to various lawsuits, demands, claims, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; suits, governmental investigations (which frequently arise from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; suits) and audits (including, without limitation, investigations or other actions resulting from its obligation to self-report suspected violations of law) and other legal proceedings, including, without limitation, those described below. The Company records accruals for certain legal proceedings and regulatory matters to the extent that the Company determines an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. As of September&#160;30, 2022 and December&#160;31, 2021, the Company&#x2019;s total recorded accruals with respect to legal proceedings and regulatory matters, net of anticipated third party recoveries, were immaterial. While these accruals reflect the Company&#x2019;s best estimate of the probable loss for those matters as of the dates of those accruals, the recorded amounts may differ materially from the actual amount of the losses for those matters, and any anticipated third party recoveries for any such losses may not ultimately be recoverable. Additionally, in some cases, no estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made because of the inherently unpredictable nature of legal proceedings and regulatory matters, which also may be impacted by various factors, including, without limitation, that they may involve indeterminate claims for monetary damages or may involve fines, penalties or non-monetary remedies; present novel legal theories or legal uncertainties; involve disputed facts; represent a shift in regulatory policy; are in the early stages of the proceedings; or may result in a change of business practices. Further, there may be various levels of judicial review available to the Company in connection with any such proceeding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a description of certain lawsuits, claims, governmental investigations and audits and other legal proceedings to which the Company is subject.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Certain Governmental Inquiries and Related Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2016 U.S. Attorney Texas Investigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: In February 2016, DaVita Rx, LLC (DaVita Rx), a wholly-owned subsidiary of the Company, received a Civil Investigative Demand (CID) from the U.S. Attorney&#x2019;s Office, Northern District of Texas. The government is conducting a federal False Claims Act (FCA) investigation concerning allegations that DaVita Rx presented or caused to be presented false claims for payment to the government for prescription medications, as well as an investigation into the Company&#x2019;s relationships with pharmaceutical manufacturers. The government&#x2019;s investigation covers the period from January 1, 2006 through December 31, 2018. In December 2017, the Company finalized and executed a settlement agreement that resolved certain of the issues in the government&#x2019;s investigation and that included total monetary consideration of $63,700, as previously disclosed, of which $41,500 was an incremental cash payment and $22,200 was for amounts previously refunded, and all of which was previously accrued. The government&#x2019;s investigation is ongoing with respect to issues related to DaVita Rx&#x2019;s historic relationships with certain pharmaceutical manufacturers, and in July 2018 the Office of Inspector General (OIG) served the Company with a subpoena seeking additional documents and information relating to those relationships. On September 15, 2021, the U.S. Attorney&#x2019;s Office notified the U.S. District Court, Northern District of Texas, of its decision and the decision of 31 states not to elect to intervene at this time in the matter of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;U.S. ex rel. Doe v. DaVita Inc., et al&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The court then unsealed the complaint, which alleges violations of the FCA, by order dated September 17, 2021. The complaint was not served on the Company. In December 2021, the private party relator filed a notice of voluntary dismissal of all claims and the court entered an order dismissing the claims without prejudice. The Company is continuing to cooperate with the government in this investigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2017 U.S. Attorney Colorado Investigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: In November 2017, the U.S. Attorney&#x2019;s Office, District of Colorado informed the Company of an investigation it was conducting into possible federal healthcare offenses involving DaVita Kidney Care, as well as several of the Company&#x2019;s wholly-owned subsidiaries. In addition to DaVita Kidney Care, the matter currently includes an investigation into DaVita Rx, DaVita Laboratory Services, Inc. (DaVita Labs), and RMS Lifeline Inc. (Lifeline). In each of August 2018, May 2019, and July 2021, the Company received a CID pursuant to the FCA from the U.S. Attorney's Office relating to this investigation. In May 2020, the Company sold its interest in Lifeline, but the Company retained certain liabilities of the Lifeline business, including those related to this investigation. The Company is continuing to cooperate with the government in this investigation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2020 U.S. Attorney New Jersey Investigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: In March 2020, the U.S. Attorney&#x2019;s Office, District of New Jersey served the Company with a subpoena and a CID relating to an investigation being conducted by that office and the U.S. Attorney&#x2019;s Office, Eastern District of Pennsylvania. The subpoena and CID request information on several topics, including certain of the Company&#x2019;s joint venture arrangements with physicians and physician groups, medical director agreements, and compliance with its five-year Corporate Integrity Agreement, the term of which expired October 22, 2019. On October 12, 2022, the U.S. Attorney&#x2019;s Office notified the U.S. District Court, Eastern District of Pennsylvania, of its decision not to elect to intervene at this time in the matter of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;U.S. ex rel. Bayne v. DaVita Inc., et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The court then unsealed a complaint, which alleges violations of federal and state False Claims Acts, by order dated October 14, 2022. The Company is continuing to cooperate with the government in this investigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2020 California Department of Insurance Investigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: In April 2020, the California Department of Insurance (CDI) sent the Company an Investigative Subpoena relating to an investigation being conducted by that office. CDI issued a superseding subpoena in September 2020 and an additional subpoena in September 2021. Those subpoenas request information on a number of topics, including but not limited to the Company&#x2019;s communications with patients about insurance plans and financial assistance from the American Kidney Fund (AKF), analyses of the potential impact of patients&#x2019; decisions to change insurance providers, and documents relating to donations or contributions to the AKF. The Company is continuing to cooperate with CDI in this investigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2020 Department of Justice Investigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: In October 2020, the Company received a CID from the Department of Justice pursuant to an FCA investigation concerning allegations that DaVita Medical Group (DMG) may have submitted undocumented or unsupported diagnosis codes in connection with Medicare Advantage beneficiaries. The CID covers the period from January 1, 2015 through June 19, 2019, the date the Company completed the divestiture of DMG to Collaborative Care Holdings, LLC. The Company is continuing to cooperate with the government in this investigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* * *&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although the Company cannot predict whether or when proceedings might be initiated or when these matters may be resolved (other than as may be described above), it is not unusual for inquiries such as these to continue for a considerable period of time through the various phases of document and witness requests and ongoing discussions with regulators and to develop over the course of time. In addition to the inquiries and proceedings specifically identified above, the Company frequently is subject to other inquiries by state or federal government agencies, many of which relate to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; complaints filed by relators. Negative findings or terms and conditions that the Company might agree to accept as part of a negotiated resolution of pending or future government inquiries or relator proceedings could result in, among other things, substantial financial penalties or awards against the Company, substantial payments made by the Company, harm to the Company&#x2019;s reputation, required changes to the Company&#x2019;s business practices, an impact on the Company's various relationships and/or contracts related to the Company's business, exclusion from future participation in the Medicare, Medicaid and other federal health care programs and, if criminal proceedings were initiated against the Company, members of its board of directors or management, possible criminal penalties, any of which could have a material adverse effect on the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2021 Antitrust Indictment and Putative Class Action Suit&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: On July 14, 2021, an indictment was returned by a grand jury in the U.S. District Court, District of Colorado against the Company and its former chief executive officer in the matter of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;U.S. v. DaVita Inc., et al.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; alleging that purported agreements entered into by DaVita's former chief executive officer not to solicit senior-level employees violated Section 1 of the Sherman Act. On April 15, 2022, a jury returned a verdict in the Company&#x2019;s favor, acquitting both the Company and its former chief executive officer on all counts. On April 20, 2022, the court entered judgments of acquittal and closed the case. On August 9, 2021, DaVita and its former chief executive officer were added as defendants in a consolidated putative class action complaint in the matter of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;In re Outpatient Medical Center Employee Antitrust Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the U.S. District Court, Northern District of Illinois. This class action complaint asserts that the defendants violated Section 1 of the Sherman Act and seeks to bring an action on behalf of certain groups of individuals employed by the Company between February 1, 2012 and January 5, 2021. On September 26, 2022, the court denied the Company's motion to dismiss. The Company disputes the allegations in the class action complaint, as well as the asserted violations of the Sherman Act, and intends to defend this action accordingly.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Marietta Memorial Hospital Employee Health Benefit Plan, et al. v. DaVita Inc. et al. No. 20-1641&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: On November 5, 2021, the United States Supreme Court granted certiorari of an appeal by an employer group health plan, the plan sponsor, and the plan&#x2019;s advisor of the U.S. Court of Appeals for the Sixth Circuit (Sixth Circuit) decision in the Company's favor. The questions presented involved whether the health plan violates the Medicare Secondary Payor Act (MSPA) by "taking into account" that plan beneficiaries are eligible for Medicare and/or by "differentiating" between the benefits that the plan offers to patients with dialysis versus others. On December 23, 2021, the Solicitor General on behalf of the United States filed an amicus brief supporting the petitioners' request to overturn the Sixth Circuit decision. On January 19, 2022, the Company filed its brief in support of the Sixth Circuit decision. On June 21, 2022, the United States Supreme Court reversed the Sixth Circuit decision and held that the employee health plan for Marietta Memorial Hospital did not violate the MSPA. The case has been remanded back to the lower court for resolution of the outstanding claims. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, from time to time the Company is subject to other lawsuits, demands, claims, governmental investigations and audits and legal proceedings that arise due to the nature of its business, including, without limitation, contractual disputes, such as with payors, suppliers and others, employee-related matters and professional and general liability claims. From time to time, the Company also initiates litigation or other legal proceedings as a plaintiff arising out of contracts or other matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* * *&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other than as may be described above, the Company cannot predict the ultimate outcomes of the various legal proceedings and regulatory matters to which the Company is or may be subject from time to time, including those described in this Note 7, or the timing of their resolution or the ultimate losses or impact of developments in those matters, which could have a material adverse effect on the Company&#x2019;s revenues, earnings and cash flows. Further, any legal proceedings or regulatory matters involving the Company, whether meritorious or not, are time consuming, and often require management&#x2019;s attention and result in significant legal expense, and may result in the diversion of significant operational resources, may impact the Company's various relationships and/or contracts related to the Company's business or otherwise harm the Company&#x2019;s business, results of operations, financial condition, cash flows or reputation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* * *&lt;/span&gt;&lt;/div&gt;</us-gaap:LossContingencyDisclosures>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i017440e66fea4d42af33e10727d6d8bc_D20171201-20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81NS9mcmFnOjhkYjQxYTc1ODQyNDRhMmU4OTRmODViYWQ3OTJhMzVhL3RleHRyZWdpb246OGRiNDFhNzU4NDI0NGEyZTg5NGY4NWJhZDc5MmEzNWFfMzc5MA_2b470b52-3fea-4bcd-b7b6-0b1fbe1f030f"
      unitRef="usd">63700000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="ifb92eab57e66403ca68107330167cb46_D20171201-20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81NS9mcmFnOjhkYjQxYTc1ODQyNDRhMmU4OTRmODViYWQ3OTJhMzVhL3RleHRyZWdpb246OGRiNDFhNzU4NDI0NGEyZTg5NGY4NWJhZDc5MmEzNWFfMzgyOA_ff6572f5-7d49-473f-924e-260baf0b93c6"
      unitRef="usd">41500000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="ie9078554660b4e04aa85a2b59269458d_D20171201-20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81NS9mcmFnOjhkYjQxYTc1ODQyNDRhMmU4OTRmODViYWQ3OTJhMzVhL3RleHRyZWdpb246OGRiNDFhNzU4NDI0NGEyZTg5NGY4NWJhZDc5MmEzNWFfMzg2Nw_e5f82bed-730f-4fa8-b2bf-58715d97f9d6"
      unitRef="usd">22200000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <dva:CorporateIntegrityAgreementExpirationDate
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81NS9mcmFnOjhkYjQxYTc1ODQyNDRhMmU4OTRmODViYWQ3OTJhMzVhL3RleHRyZWdpb246OGRiNDFhNzU4NDI0NGEyZTg5NGY4NWJhZDc5MmEzNWFfNjM5Mw_9fa68bdf-ffab-423f-acf7-4d07ec944110">2019-10-22</dva:CorporateIntegrityAgreementExpirationDate>
    <us-gaap:CommitmentsDisclosureTextBlock
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81NS9mcmFnOjhkYjQxYTc1ODQyNDRhMmU4OTRmODViYWQ3OTJhMzVhL3RleHRyZWdpb246OGRiNDFhNzU4NDI0NGEyZTg5NGY4NWJhZDc5MmEzNWFfMTQ1MTA_e7b18371-f4cd-497d-8473-67a597f317ee">&lt;div style="margin-top:9pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Commitments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also has certain potential commitments to provide working capital funding, if necessary, to certain nonconsolidated outpatient dialysis businesses that the Company manages and in which the Company owns a noncontrolling equity interest or which are wholly-owned by third parties of approximately $9,431.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, on May&#160;25, 2022, the Company entered into an agreement with Medtronic, Inc. and one of its subsidiaries (collectively, Medtronic) to form a new, independent kidney care-focused medical device company (NewCo). The transaction is expected to close in 2023, subject to customary closing conditions and regulatory approvals. At close, the Company will make a cash payment to Medtronic of approximately $75,000, subject to certain customary adjustments prior to the closing, and will contribute certain other non-cash assets to NewCo valued at approximately $25,000. Additionally, at close, the Company and Medtronic each will contribute approximately $200,000 in cash to launch NewCo. The Company also agreed to pay Medtronic additional consideration of up to $300,000 if certain regulatory and commercial milestones are achieved between 2024 and 2028.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsDisclosureTextBlock>
    <us-gaap:OtherCommitment
      contextRef="i34475a7595b24df1b1183abfd0b8bb6b_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81NS9mcmFnOjhkYjQxYTc1ODQyNDRhMmU4OTRmODViYWQ3OTJhMzVhL3RleHRyZWdpb246OGRiNDFhNzU4NDI0NGEyZTg5NGY4NWJhZDc5MmEzNWFfMTM2NzY_8f4e1c63-2ee5-4997-8792-24f6910d8e77"
      unitRef="usd">9431000</us-gaap:OtherCommitment>
    <dva:BusinessAgreementDate
      contextRef="i234c9227eeee433bb5adf6ea9bcf5b0e_D20220525-20220525"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81NS9mcmFnOjhkYjQxYTc1ODQyNDRhMmU4OTRmODViYWQ3OTJhMzVhL3RleHRyZWdpb246OGRiNDFhNzU4NDI0NGEyZTg5NGY4NWJhZDc5MmEzNWFfMTM2OTY_d8ad2761-ea96-4f67-8edc-a023db19d541">2022-05-25</dva:BusinessAgreementDate>
    <us-gaap:OtherCommitmentDueInNextTwelveMonths
      contextRef="i56c2b0de3ff24b87b529562972a48a8a_I20220525"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81NS9mcmFnOjhkYjQxYTc1ODQyNDRhMmU4OTRmODViYWQ3OTJhMzVhL3RleHRyZWdpb246OGRiNDFhNzU4NDI0NGEyZTg5NGY4NWJhZDc5MmEzNWFfMTQwODE_403b7f1e-c5cf-456d-a774-e08cbe44f1ab"
      unitRef="usd">75000000</us-gaap:OtherCommitmentDueInNextTwelveMonths>
    <dva:OtherNoncashAssetsCommitment
      contextRef="i56c2b0de3ff24b87b529562972a48a8a_I20220525"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81NS9mcmFnOjhkYjQxYTc1ODQyNDRhMmU4OTRmODViYWQ3OTJhMzVhL3RleHRyZWdpb246OGRiNDFhNzU4NDI0NGEyZTg5NGY4NWJhZDc5MmEzNWFfMTQyMzE_cddc85c3-d3fc-4e13-a114-b75b487537d0"
      unitRef="usd">25000000</dva:OtherNoncashAssetsCommitment>
    <dva:AdditionalCashCommitment
      contextRef="i56c2b0de3ff24b87b529562972a48a8a_I20220525"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81NS9mcmFnOjhkYjQxYTc1ODQyNDRhMmU4OTRmODViYWQ3OTJhMzVhL3RleHRyZWdpb246OGRiNDFhNzU4NDI0NGEyZTg5NGY4NWJhZDc5MmEzNWFfMTQzMjA_9458ba34-9924-49e8-b262-3c801b7797b2"
      unitRef="usd">200000000</dva:AdditionalCashCommitment>
    <us-gaap:OtherCommitmentDueAfterFifthYear
      contextRef="i56c2b0de3ff24b87b529562972a48a8a_I20220525"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl81NS9mcmFnOjhkYjQxYTc1ODQyNDRhMmU4OTRmODViYWQ3OTJhMzVhL3RleHRyZWdpb246OGRiNDFhNzU4NDI0NGEyZTg5NGY4NWJhZDc5MmEzNWFfMTQ0MjM_faadfb8a-474f-4971-a9df-7bb68bb1fe94"
      unitRef="usd">300000000</us-gaap:OtherCommitmentDueAfterFifthYear>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RleHRyZWdpb246MmY5NWQ0MThhNDU3NGE3ZDk1OTY4MTlkYjRmMjAwNzNfMTYxMg_e922fdc0-231d-4093-9f66-b8b0ad4401c6">Shareholders' equity&lt;div style="margin-top:9pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock-based compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the nine months ended September&#160;30, 2022, the Company granted 1,129 restricted and performance stock units with an aggregate grant-date fair value of $122,356 and a weighted-average expected life of approximately 3.5 years and 130 stock-settled stock appreciation rights with an aggregate grant-date fair value of $4,573 and a weighted-average expected life of approximately 4.5 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2022, the Company had $182,083 in total estimated but unrecognized stock-based compensation expense under the Company's equity compensation and employee stock purchase plans. The Company expects to recognize this expense over a weighted average remaining period of 1.3 years.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i70a7c2b3d8c3425b83bdbde7adae4aed_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RleHRyZWdpb246MmY5NWQ0MThhNDU3NGE3ZDk1OTY4MTlkYjRmMjAwNzNfMTA2_70f83cfd-0bab-421b-b220-6b0149a763e3"
      unitRef="shares">1129000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <dva:SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted
      contextRef="i70a7c2b3d8c3425b83bdbde7adae4aed_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RleHRyZWdpb246MmY5NWQ0MThhNDU3NGE3ZDk1OTY4MTlkYjRmMjAwNzNfMTkx_8a964f0a-1286-4661-b6e5-99d209547a8d"
      unitRef="usd">122356000</dva:SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i70a7c2b3d8c3425b83bdbde7adae4aed_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RleHRyZWdpb246MmY5NWQ0MThhNDU3NGE3ZDk1OTY4MTlkYjRmMjAwNzNfMjQ4_77a20b36-dd8d-4d66-93f2-944b2aa202e3">P3Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="i8ccb6189ca58495499f4dbbf4481a40c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RleHRyZWdpb246MmY5NWQ0MThhNDU3NGE3ZDk1OTY4MTlkYjRmMjAwNzNfMjU1_a5ddec1b-fe43-47a4-9a58-88bb7ed1b28f"
      unitRef="shares">130000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <dva:SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted
      contextRef="i8ccb6189ca58495499f4dbbf4481a40c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RleHRyZWdpb246MmY5NWQ0MThhNDU3NGE3ZDk1OTY4MTlkYjRmMjAwNzNfMzQx_72a0ea76-e55f-42d1-b26f-8f347917be93"
      unitRef="usd">4573000</dva:SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i8ccb6189ca58495499f4dbbf4481a40c_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RleHRyZWdpb246MmY5NWQ0MThhNDU3NGE3ZDk1OTY4MTlkYjRmMjAwNzNfMzk4_4ac0ea3a-9221-44e0-bf03-dd3f8288f547">P4Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RleHRyZWdpb246MmY5NWQ0MThhNDU3NGE3ZDk1OTY4MTlkYjRmMjAwNzNfNDI4_d1a7680b-2258-42e8-9035-581142039ad8"
      unitRef="usd">182083000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RleHRyZWdpb246MmY5NWQ0MThhNDU3NGE3ZDk1OTY4MTlkYjRmMjAwNzNfNjY1_b54a3d28-6872-4069-b7e9-3844a887f33a">P1Y3M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:TreasuryStockTextBlock
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RleHRyZWdpb246MmY5NWQ0MThhNDU3NGE3ZDk1OTY4MTlkYjRmMjAwNzNfMTYxMw_81097c6d-2b78-43f8-b34e-7730bb3556de">&lt;div style="margin-top:9pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share repurchases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company's common stock repurchases during the three and nine months ended September&#160;30, 2022 and 2021: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.228%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.575%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Open market repurchases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount paid&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;787,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;899,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average paid per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company did not repurchase any shares subsequent to September&#160;30, 2022 through October&#160;27, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is authorized to make purchases from time to time in the open market or in privately negotiated transactions, including without limitation, through accelerated share repurchase transactions, derivative transactions, tender offers, Rule 10b5-1 plans or any combination of the foregoing, depending upon market conditions and other considerations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of October&#160;27, 2022, the Company had a total of $1,596,085 available under the current authorization for additional share repurchases. Although this share repurchase authorization does not have an expiration date, the Company remains subject to share repurchase limitations including under the terms of its current senior secured credit facilities.&lt;/span&gt;&lt;/div&gt;</us-gaap:TreasuryStockTextBlock>
    <us-gaap:ScheduleOfTreasuryStockByClassTextBlock
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RleHRyZWdpb246MmY5NWQ0MThhNDU3NGE3ZDk1OTY4MTlkYjRmMjAwNzNfMTYwOQ_6163ba04-a5e2-4dc6-89c3-f7a1cde9f924">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company's common stock repurchases during the three and nine months ended September&#160;30, 2022 and 2021: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:66.228%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.557%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.575%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Open market repurchases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares repurchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount paid&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;787,854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;899,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average paid per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfTreasuryStockByClassTextBlock>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i0e26a096655c4539b381dad37c3f4def_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RhYmxlOmFhOWQxNDJhZTczNTQ2Y2ViOTdkYTIwYTA3OWMyZTE5L3RhYmxlcmFuZ2U6YWE5ZDE0MmFlNzM1NDZjZWI5N2RhMjBhMDc5YzJlMTlfMy0xLTEtMS0zNjE1Njk_61d5f8d6-805c-4b37-afe4-be94d5fadc77"
      unitRef="shares">2122000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i1bbbb5f9079d4dc2b1bc26bc9197d8c2_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RhYmxlOmFhOWQxNDJhZTczNTQ2Y2ViOTdkYTIwYTA3OWMyZTE5L3RhYmxlcmFuZ2U6YWE5ZDE0MmFlNzM1NDZjZWI5N2RhMjBhMDc5YzJlMTlfMy0zLTEtMS0zNjE1Njk_7e817da5-e1ca-4775-a43c-8dc7e82c962d"
      unitRef="shares">2731000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="id88c7440116645768f677634e0f5e6d1_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RhYmxlOmFhOWQxNDJhZTczNTQ2Y2ViOTdkYTIwYTA3OWMyZTE5L3RhYmxlcmFuZ2U6YWE5ZDE0MmFlNzM1NDZjZWI5N2RhMjBhMDc5YzJlMTlfMy02LTEtMS0zNjE1Njk_ce582b02-351b-4be0-9d94-05c79e9e66a9"
      unitRef="shares">8095000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i75f2b64af109480b978f5c7a64a13687_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RhYmxlOmFhOWQxNDJhZTczNTQ2Y2ViOTdkYTIwYTA3OWMyZTE5L3RhYmxlcmFuZ2U6YWE5ZDE0MmFlNzM1NDZjZWI5N2RhMjBhMDc5YzJlMTlfMy04LTEtMS0zNjE1Njk_03a526b2-2205-43f8-bb21-b26f63486d2b"
      unitRef="shares">7750000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i0e26a096655c4539b381dad37c3f4def_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RhYmxlOmFhOWQxNDJhZTczNTQ2Y2ViOTdkYTIwYTA3OWMyZTE5L3RhYmxlcmFuZ2U6YWE5ZDE0MmFlNzM1NDZjZWI5N2RhMjBhMDc5YzJlMTlfNC0xLTEtMS0zNjE1Njk_7e9d9b29-b5ac-4d69-b838-1fc3169c839b"
      unitRef="usd">184797000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i1bbbb5f9079d4dc2b1bc26bc9197d8c2_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RhYmxlOmFhOWQxNDJhZTczNTQ2Y2ViOTdkYTIwYTA3OWMyZTE5L3RhYmxlcmFuZ2U6YWE5ZDE0MmFlNzM1NDZjZWI5N2RhMjBhMDc5YzJlMTlfNC0zLTEtMS0zNjE1Njk_8ef07d2c-c4cb-4406-8c81-17ab462debc6"
      unitRef="usd">336217000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="id88c7440116645768f677634e0f5e6d1_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RhYmxlOmFhOWQxNDJhZTczNTQ2Y2ViOTdkYTIwYTA3OWMyZTE5L3RhYmxlcmFuZ2U6YWE5ZDE0MmFlNzM1NDZjZWI5N2RhMjBhMDc5YzJlMTlfNC02LTEtMS0zNjE1Njk_83f45aa0-1d07-4d34-8232-ef63e396c43e"
      unitRef="usd">787854000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i75f2b64af109480b978f5c7a64a13687_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RhYmxlOmFhOWQxNDJhZTczNTQ2Y2ViOTdkYTIwYTA3OWMyZTE5L3RhYmxlcmFuZ2U6YWE5ZDE0MmFlNzM1NDZjZWI5N2RhMjBhMDc5YzJlMTlfNC04LTEtMS0zNjE1Njk_f1788890-504f-44ba-b545-9c405cfd7781"
      unitRef="usd">899447000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i0e26a096655c4539b381dad37c3f4def_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RhYmxlOmFhOWQxNDJhZTczNTQ2Y2ViOTdkYTIwYTA3OWMyZTE5L3RhYmxlcmFuZ2U6YWE5ZDE0MmFlNzM1NDZjZWI5N2RhMjBhMDc5YzJlMTlfNS0xLTEtMS0zNjE1Njk_091b6d87-1d53-4c8a-8d12-a6e732030fe7"
      unitRef="usdPerShare">87.10</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i1bbbb5f9079d4dc2b1bc26bc9197d8c2_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RhYmxlOmFhOWQxNDJhZTczNTQ2Y2ViOTdkYTIwYTA3OWMyZTE5L3RhYmxlcmFuZ2U6YWE5ZDE0MmFlNzM1NDZjZWI5N2RhMjBhMDc5YzJlMTlfNS0zLTEtMS0zNjE1Njk_9bd8fbcf-1cda-4ca5-8232-4d0bba294ec2"
      unitRef="usdPerShare">123.14</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="id88c7440116645768f677634e0f5e6d1_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RhYmxlOmFhOWQxNDJhZTczNTQ2Y2ViOTdkYTIwYTA3OWMyZTE5L3RhYmxlcmFuZ2U6YWE5ZDE0MmFlNzM1NDZjZWI5N2RhMjBhMDc5YzJlMTlfNS02LTEtMS0zNjE1Njk_c6daa6e4-df51-4d87-a653-7aa1982cfedd"
      unitRef="usdPerShare">97.33</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i75f2b64af109480b978f5c7a64a13687_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RhYmxlOmFhOWQxNDJhZTczNTQ2Y2ViOTdkYTIwYTA3OWMyZTE5L3RhYmxlcmFuZ2U6YWE5ZDE0MmFlNzM1NDZjZWI5N2RhMjBhMDc5YzJlMTlfNS04LTEtMS0zNjE1Njk_73f9c785-d4fd-472a-a2c2-2d7aee2fc058"
      unitRef="usdPerShare">116.06</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i93d8bfb8799a4eb1a6cac7ed70c03ca0_D20221001-20221027"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RleHRyZWdpb246MmY5NWQ0MThhNDU3NGE3ZDk1OTY4MTlkYjRmMjAwNzNfODI0NjMzNzIxMDA5Mw_908983d4-fbf3-432b-8188-36f9f1d6dd9b"
      unitRef="shares">0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i7d5aa4e5434b4526a0049dce3fe3e153_I20221027"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82MS9mcmFnOjJmOTVkNDE4YTQ1NzRhN2Q5NTk2ODE5ZGI0ZjIwMDczL3RleHRyZWdpb246MmY5NWQ0MThhNDU3NGE3ZDk1OTY4MTlkYjRmMjAwNzNfMTMxOA_c265b599-59b2-495a-beb4-93a62775ced6"
      unitRef="usd">1596085000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RleHRyZWdpb246ZTA3NTA5NmZhZmVmNDg1MGE3YzQxMzMwODk2NTcwMDlfMjYy_67db68c6-9dab-49bc-ae6d-0716c272287c">Accumulated other comprehensive loss&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.251%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.267%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.310%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.468%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.433%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.310%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.474%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Interest&lt;br/&gt;rate cap&lt;br/&gt;agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;currency&lt;br/&gt;translation&lt;br/&gt;adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;other&lt;br/&gt;comprehensive&lt;br/&gt;loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Interest&lt;br/&gt;rate cap&lt;br/&gt;agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;currency&lt;br/&gt;translation&lt;br/&gt;adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;other&lt;br/&gt;comprehensive&lt;br/&gt;loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(167,033)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(111,796)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,178)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(138,069)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(139,247)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66,100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,055)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(95,064)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Related income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,733)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,733)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,800)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,800)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66,100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,788)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(95,064)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification into net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Related income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(344)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(344)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,032)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,032)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(233,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(135,551)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(233,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(135,551)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.251%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.267%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.310%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.468%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.433%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.310%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.474%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Interest&lt;br/&gt;rate cap&lt;br/&gt;agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;currency&lt;br/&gt;translation&lt;br/&gt;adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;other&lt;br/&gt;comprehensive&lt;br/&gt;loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Interest&lt;br/&gt;rate cap&lt;br/&gt;agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;currency&lt;br/&gt;translation&lt;br/&gt;adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;other&lt;br/&gt;comprehensive&lt;br/&gt;loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,577)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58,322)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65,899)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,466)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53,688)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66,154)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized (losses) gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(477)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54,528)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55,005)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59,162)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55,878)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Related income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(818)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(818)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(357)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54,528)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54,885)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59,162)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56,696)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification into net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Related income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(344)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(344)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,032)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,032)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,900)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(112,850)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(119,750)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,900)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(112,850)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(119,750)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The interest rate cap agreement net realized losses reclassified into net income are recorded as debt expense in the corresponding consolidated statements of income. See Note 6 for further details.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RleHRyZWdpb246ZTA3NTA5NmZhZmVmNDg1MGE3YzQxMzMwODk2NTcwMDlfMjUw_379a4a84-4002-4c1f-9c3c-faefc434670a">&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.251%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.267%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.310%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.468%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.433%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.310%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.474%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Interest&lt;br/&gt;rate cap&lt;br/&gt;agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;currency&lt;br/&gt;translation&lt;br/&gt;adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;other&lt;br/&gt;comprehensive&lt;br/&gt;loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Interest&lt;br/&gt;rate cap&lt;br/&gt;agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;currency&lt;br/&gt;translation&lt;br/&gt;adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;other&lt;br/&gt;comprehensive&lt;br/&gt;loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(167,033)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(111,796)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,178)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(138,069)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(139,247)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66,100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,055)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(95,064)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Related income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,733)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,733)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,800)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,800)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66,100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,788)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(95,064)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification into net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Related income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(344)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(344)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,032)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,032)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(233,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(135,551)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(233,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(135,551)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.251%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.267%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.310%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.468%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.433%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.310%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.474%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Interest&lt;br/&gt;rate cap&lt;br/&gt;agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;currency&lt;br/&gt;translation&lt;br/&gt;adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;other&lt;br/&gt;comprehensive&lt;br/&gt;loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Interest&lt;br/&gt;rate cap&lt;br/&gt;agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Foreign&lt;br/&gt;currency&lt;br/&gt;translation&lt;br/&gt;adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;other&lt;br/&gt;comprehensive&lt;br/&gt;loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,577)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58,322)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65,899)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,466)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53,688)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66,154)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized (losses) gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(477)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54,528)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55,005)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59,162)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55,878)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Related income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(818)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(818)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(357)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54,528)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54,885)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59,162)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56,696)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification into net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Related income tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(344)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(344)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,032)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,032)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,900)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(112,850)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(119,750)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,900)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(112,850)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(119,750)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ib8eadbdf6a4545af8abdecc0181aed70_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfMi0xLTEtMS0zNjE1Njk_4ea1f81b-03e4-44f6-8db1-d01c12fd971e"
      unitRef="usd">55237000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i9e8ea0962d7f484ab9b39cd36f1fe019_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfMi0zLTEtMS0zNjE1Njk_cbde8e64-5654-4ed9-b66a-77c8cef47e9e"
      unitRef="usd">-167033000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i0b995987498a46b5abb6da0bb3401211_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfMi01LTEtMS0zNjE1Njk_24879e8f-627c-41c5-a436-b42e3a0c242c"
      unitRef="usd">-111796000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i25695481a54a456da58a8b675ea33615_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfMi03LTEtMS0zNjE1Njk_b47e7a98-ba5d-4c20-b2c5-e3692491b020"
      unitRef="usd">-1178000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i782ad893fc0b4621a76c9a45d98be61d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfMi05LTEtMS0zNjE1Njk_8db85996-1f54-4da7-a554-c570ca01c0e4"
      unitRef="usd">-138069000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i98434fe450004124afb331b74fd63193_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfMi0xMS0xLTEtMzYxNTY5_8e08db28-62d6-424a-967d-76a84fbae457"
      unitRef="usd">-139247000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i8fe95730ae644d9e881c7051751a5a76_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfMy0xLTEtMS0zNjE1Njk_ddb5eed9-866c-42c6-b9b2-3bd834311fde"
      unitRef="usd">55045000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ifd10dfc3a87841eda50c4640b2db4669_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfMy0zLTEtMS0zNjE1Njk_ce8c28d9-8b74-4284-8613-42ff00a9e9f2"
      unitRef="usd">-66100000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ie9b5ae0e296a416d8eddebe00e9bfe22_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfMy01LTEtMS0zNjE1Njk_f220ec00-6a6c-4982-9952-7b383ec29aed"
      unitRef="usd">-11055000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i79b1d5bcdc7c4fb0a917646f4ab14002_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfMy03LTEtMS0zNjE1Njk_326c5006-a490-4d6a-b6e3-62d4cc27fc06"
      unitRef="usd">127460000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i5c0124b9404249c4b64ad373e8c59fb9_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfMy05LTEtMS0zNjE1Njk_2a589ac4-6dfb-446a-9dce-a8f54e867b1d"
      unitRef="usd">-95064000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i7b7464a1b4454319b3b1a6fdfe238cef_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfMy0xMS0xLTEtMzYxNTY5_afc00c72-1f5f-40bd-8241-c78dd83574f9"
      unitRef="usd">32396000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i8fe95730ae644d9e881c7051751a5a76_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfNC0xLTEtMS0zNjE1Njk_4bccb49e-746e-4cb3-93a7-18da7e6eaacb"
      unitRef="usd">13733000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="ifd10dfc3a87841eda50c4640b2db4669_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfNC0zLTEtMS0zNjE1Njk_455245e2-6691-49dd-aa66-6f18bf157ed0"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="ie9b5ae0e296a416d8eddebe00e9bfe22_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfNC01LTEtMS0zNjE1Njk_9b6bdce0-151f-43a6-a7d0-05356920c753"
      unitRef="usd">13733000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i79b1d5bcdc7c4fb0a917646f4ab14002_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfNC03LTEtMS0zNjE1Njk_bc9b2874-b03a-4790-bd9d-34ff0531f4c0"
      unitRef="usd">31800000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i5c0124b9404249c4b64ad373e8c59fb9_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfNC05LTEtMS0zNjE1Njk_79e57aa5-0fa9-46a4-aac7-afaa00484374"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i7b7464a1b4454319b3b1a6fdfe238cef_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfNC0xMS0xLTEtMzYxNTY5_6ce006f8-e770-4bec-9b28-72db25b10aeb"
      unitRef="usd">31800000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i8fe95730ae644d9e881c7051751a5a76_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfNS0xLTEtMS0zNjE1Njk_0b2ec2da-ab0e-4839-a5fd-9cc2d4511df4"
      unitRef="usd">41312000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ifd10dfc3a87841eda50c4640b2db4669_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfNS0zLTEtMS0zNjE1Njk_baae5396-bf3c-4d02-94b3-9234ce2fa0a1"
      unitRef="usd">-66100000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ie9b5ae0e296a416d8eddebe00e9bfe22_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfNS01LTEtMS0zNjE1Njk_ca3abfdf-528f-4be1-88b9-a1d8191cac29"
      unitRef="usd">-24788000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i79b1d5bcdc7c4fb0a917646f4ab14002_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfNS03LTEtMS0zNjE1Njk_059b8ddf-9097-4f83-8977-7f0e07dd6adb"
      unitRef="usd">95660000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i5c0124b9404249c4b64ad373e8c59fb9_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfNS05LTEtMS0zNjE1Njk_b35aa4d3-261a-46e0-9007-ea8590b435c1"
      unitRef="usd">-95064000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i7b7464a1b4454319b3b1a6fdfe238cef_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfNS0xMS0xLTEtMzYxNTY5_7011e013-9401-4a6e-a19f-fa7fdb108dda"
      unitRef="usd">596000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i8fe95730ae644d9e881c7051751a5a76_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfNi0xLTEtMS0zNjE1Njk_b3b0c230-511d-4b2f-a866-9a7072ce7647"
      unitRef="usd">1377000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="ifd10dfc3a87841eda50c4640b2db4669_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfNi0zLTEtMS0zNjE1Njk_025419f8-1858-4bb5-8be4-52748c51b830"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="ie9b5ae0e296a416d8eddebe00e9bfe22_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfNi01LTEtMS0zNjE1Njk_ac9e03fe-ed07-4612-a73f-6ab06375b6e6"
      unitRef="usd">1377000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i79b1d5bcdc7c4fb0a917646f4ab14002_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfNi03LTEtMS0zNjE1Njk_6f075142-cc3c-4d5f-97e5-5228cc487078"
      unitRef="usd">4132000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i5c0124b9404249c4b64ad373e8c59fb9_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfNi05LTEtMS0zNjE1Njk_99fa4cec-b14f-4ecd-bf5b-5174237a451c"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i7b7464a1b4454319b3b1a6fdfe238cef_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfNi0xMS0xLTEtMzYxNTY5_6bfffe1c-deef-47fc-b2e2-6c7d2f106c04"
      unitRef="usd">4132000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i8fe95730ae644d9e881c7051751a5a76_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfNy0xLTEtMS0zNjE1Njk_3a841de1-965a-4749-83c0-5d62136a125f"
      unitRef="usd">344000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="ifd10dfc3a87841eda50c4640b2db4669_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfNy0zLTEtMS0zNjE1Njk_0a119ff7-66da-4e2d-8129-4d932ccc626f"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="ie9b5ae0e296a416d8eddebe00e9bfe22_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfNy01LTEtMS0zNjE1Njk_d14d9605-7a9a-4798-a013-c3a1e4c84a0c"
      unitRef="usd">344000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i79b1d5bcdc7c4fb0a917646f4ab14002_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfNy03LTEtMS0zNjE1Njk_e2cd43b5-e8a2-4415-93ce-07d31642f1ac"
      unitRef="usd">1032000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i5c0124b9404249c4b64ad373e8c59fb9_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfNy05LTEtMS0zNjE1Njk_0d355bea-0d4e-4d39-a09a-da17d4919e11"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i7b7464a1b4454319b3b1a6fdfe238cef_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfNy0xMS0xLTEtMzYxNTY5_03a05493-55aa-4c15-802b-1de6e118c88b"
      unitRef="usd">1032000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i8fe95730ae644d9e881c7051751a5a76_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfOC0xLTEtMS0zNjE1Njk_3b8429cc-ade1-4e1b-a748-d67a73bbfd91"
      unitRef="usd">1033000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ifd10dfc3a87841eda50c4640b2db4669_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfOC0zLTEtMS0zNjE1Njk_61032a90-7127-443b-addc-ec8b0218a7ce"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ie9b5ae0e296a416d8eddebe00e9bfe22_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfOC01LTEtMS0zNjE1Njk_e7345f33-3e5d-45d9-af17-74c07f4a9a9e"
      unitRef="usd">1033000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i79b1d5bcdc7c4fb0a917646f4ab14002_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfOC03LTEtMS0zNjE1Njk_19577d6d-ef95-4dc7-b906-40534a5696c9"
      unitRef="usd">3100000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i5c0124b9404249c4b64ad373e8c59fb9_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfOC05LTEtMS0zNjE1Njk_1ab3868a-af81-46cc-b0d3-72fc7a16e87a"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i7b7464a1b4454319b3b1a6fdfe238cef_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfOC0xMS0xLTEtMzYxNTY5_e5220e9a-6a07-4be5-bb21-8eb9d501dce2"
      unitRef="usd">3100000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i1ddb5952c6014f42bf7ffa4d2e53fd09_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfOS0xLTEtMS0zNjE1Njk_028b080c-58ed-426e-ac37-fbb30eb0b8bf"
      unitRef="usd">97582000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i6f9aa59cbd6641848230a121fb1bcaf3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfOS0zLTEtMS0zNjE1Njk_ebd29b08-4014-4bfe-a83c-8a405d9720c9"
      unitRef="usd">-233133000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i27574f6140c946159e41244ddaeb3b3d_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfOS01LTEtMS0zNjE1Njk_55749388-4aa5-4003-bf30-4f0fe3afecdf"
      unitRef="usd">-135551000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i1ddb5952c6014f42bf7ffa4d2e53fd09_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfOS03LTEtMS0zNjE1Njk_960334fd-e778-4c70-9dcd-2885dacf4896"
      unitRef="usd">97582000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i6f9aa59cbd6641848230a121fb1bcaf3_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfOS05LTEtMS0zNjE1Njk_de5f8414-c288-4046-9a06-7c6b1b869269"
      unitRef="usd">-233133000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i27574f6140c946159e41244ddaeb3b3d_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjZhOTg3ZDY3YzQ3YzRhMDY5ZGQyNjM1MmQ2Yjg4NzEwL3RhYmxlcmFuZ2U6NmE5ODdkNjdjNDdjNGEwNjlkZDI2MzUyZDZiODg3MTBfOS0xMS0xLTEtMzYxNTY5_372cef55-6213-44ec-9da8-9b8fb0e49200"
      unitRef="usd">-135551000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ied2f14238be74cbcab93bfce44bcf2a8_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfMi0xLTEtMS0zNjE1Njk_69a80dc4-7ab8-4cf9-ba92-2d37c75be7c3"
      unitRef="usd">-7577000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i90536d42eb7f4763bfaeebdcb028b4bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfMi0zLTEtMS0zNjE1Njk_7836ff35-1189-4d80-b80d-7709ec0b0ffe"
      unitRef="usd">-58322000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ib9ec694fa011482bba09ae1ec0527b52_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfMi01LTEtMS0zNjE1Njk_4ee2a4fb-01c2-45e4-88db-b645ad5ca422"
      unitRef="usd">-65899000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i4b41eec20f9949888d1d2510c252e563_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfMi03LTEtMS0zNjE1Njk_6b85e20a-91c8-468a-ab37-aa8d784c688c"
      unitRef="usd">-12466000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="id8d33af08bcf4539ad092a661c7d9f23_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfMi05LTEtMS0zNjE1Njk_9306d456-3df1-4170-b3e0-72dc45985463"
      unitRef="usd">-53688000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ibdfd5d445b04452f8439ae6973f8405c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfMi0xMS0xLTEtMzYxNTY5_d91bbe4f-ce2c-4f3e-af4f-e757ea3bd540"
      unitRef="usd">-66154000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ic1ee6b43a5f5462f93097ca6bbd4be00_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfMy0xLTEtMS0zNjE1Njk_3089be24-461b-4c5e-8a82-6e2894358683"
      unitRef="usd">-477000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i23adff93afc54365bb6b4b7000f67792_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfMy0zLTEtMS0zNjE1Njk_c6aad417-a0f3-4f6c-914d-e8f30af3b83f"
      unitRef="usd">-54528000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="id6ae4d7515be40af9b5d0d99dedb6674_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfMy01LTEtMS0zNjE1Njk_a9573828-e3a4-434a-8526-88811ff33765"
      unitRef="usd">-55005000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i3d45a9c325c54f76bedad3d6dc284da2_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfMy03LTEtMS0zNjE1Njk_e43db0a8-dd80-45d2-8a7d-dd62ef0ca6e1"
      unitRef="usd">3284000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i01dd8be0b3174c8ca7f5203f166342a4_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfMy05LTEtMS0zNjE1Njk_8a08433b-1556-4072-8b68-8e1994f3456f"
      unitRef="usd">-59162000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i90261a9edf1e40d0a4d5ecc464319061_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfMy0xMS0xLTEtMzYxNTY5_99e70a7c-2acf-4df0-9f90-2a41c2d15dc6"
      unitRef="usd">-55878000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="ic1ee6b43a5f5462f93097ca6bbd4be00_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfNC0xLTEtMS0zNjE1Njk_0d47d8d0-3d32-4534-80e3-bf1853c6f1cf"
      unitRef="usd">-120000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i23adff93afc54365bb6b4b7000f67792_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfNC0zLTEtMS0zNjE1Njk_f8e2ec0e-4664-4b79-b83b-0b3766afba62"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="id6ae4d7515be40af9b5d0d99dedb6674_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfNC01LTEtMS0zNjE1Njk_918ddf45-75fe-4156-96a8-a00917e68cc3"
      unitRef="usd">-120000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i3d45a9c325c54f76bedad3d6dc284da2_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfNC03LTEtMS0zNjE1Njk_3082c4f0-1074-4107-bc3c-4c877ed0534c"
      unitRef="usd">818000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i01dd8be0b3174c8ca7f5203f166342a4_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfNC05LTEtMS0zNjE1Njk_275c6f35-1499-4216-9955-f52a28c60839"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i90261a9edf1e40d0a4d5ecc464319061_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfNC0xMS0xLTEtMzYxNTY5_1ba23012-f18b-483f-86a8-91ba1eb4b785"
      unitRef="usd">818000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ic1ee6b43a5f5462f93097ca6bbd4be00_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfNS0xLTEtMS0zNjE1Njk_2759a130-6e5b-4ca5-a4c8-e1a7471ef2e7"
      unitRef="usd">-357000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i23adff93afc54365bb6b4b7000f67792_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfNS0zLTEtMS0zNjE1Njk_8e0b63c2-384a-498e-b9d4-247b7701da58"
      unitRef="usd">-54528000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="id6ae4d7515be40af9b5d0d99dedb6674_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfNS01LTEtMS0zNjE1Njk_316b7904-3283-42ed-b741-c9611170eacc"
      unitRef="usd">-54885000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i3d45a9c325c54f76bedad3d6dc284da2_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfNS03LTEtMS0zNjE1Njk_2a98afd5-ca76-4137-bdfb-0dab58f22f15"
      unitRef="usd">2466000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i01dd8be0b3174c8ca7f5203f166342a4_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfNS05LTEtMS0zNjE1Njk_105e2afb-2527-4c18-985f-bdde1bac4afe"
      unitRef="usd">-59162000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i90261a9edf1e40d0a4d5ecc464319061_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfNS0xMS0xLTEtMzYxNTY5_ab312072-4491-4170-b66d-8751d21f827c"
      unitRef="usd">-56696000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="ic1ee6b43a5f5462f93097ca6bbd4be00_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfNi0xLTEtMS0zNjE1Njk_3e04763b-a049-4f90-8b51-e6a9f922aa6c"
      unitRef="usd">1378000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i23adff93afc54365bb6b4b7000f67792_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfNi0zLTEtMS0zNjE1Njk_c8897eea-ef12-4c22-9762-47cf51f8a61b"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="id6ae4d7515be40af9b5d0d99dedb6674_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfNi01LTEtMS0zNjE1Njk_95e27e16-da12-43f3-8a12-bbfdbb6d2d5c"
      unitRef="usd">1378000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i3d45a9c325c54f76bedad3d6dc284da2_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfNi03LTEtMS0zNjE1Njk_7880846b-d4cd-4db2-b038-37817fe704bb"
      unitRef="usd">4132000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i01dd8be0b3174c8ca7f5203f166342a4_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfNi05LTEtMS0zNjE1Njk_7c57ac1b-2102-4602-af10-640bb7c0a98c"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i90261a9edf1e40d0a4d5ecc464319061_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfNi0xMS0xLTEtMzYxNTY5_7e694812-f39f-4d0e-83ac-deb496a67618"
      unitRef="usd">4132000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="ic1ee6b43a5f5462f93097ca6bbd4be00_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfNy0xLTEtMS0zNjE1Njk_b152aaa6-f360-4dc4-9ed4-8a60b1d53c04"
      unitRef="usd">344000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i23adff93afc54365bb6b4b7000f67792_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfNy0zLTEtMS0zNjE1Njk_0e332056-e4cd-4fa4-80f4-f8038cd4d293"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="id6ae4d7515be40af9b5d0d99dedb6674_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfNy01LTEtMS0zNjE1Njk_8c5ec353-d93a-48ea-93a1-060fe85f9f75"
      unitRef="usd">344000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i3d45a9c325c54f76bedad3d6dc284da2_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfNy03LTEtMS0zNjE1Njk_30ddf780-c530-4898-9086-0835504e453e"
      unitRef="usd">1032000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i01dd8be0b3174c8ca7f5203f166342a4_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfNy05LTEtMS0zNjE1Njk_caac3601-4bde-4b43-b1c6-dbf8e3894c40"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i90261a9edf1e40d0a4d5ecc464319061_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfNy0xMS0xLTEtMzYxNTY5_46aaebda-be82-4924-bb83-1bf08b474be8"
      unitRef="usd">1032000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ic1ee6b43a5f5462f93097ca6bbd4be00_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfOC0xLTEtMS0zNjE1Njk_332a3fe4-fa99-4dea-b7b4-1b53a796bc4d"
      unitRef="usd">1034000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i23adff93afc54365bb6b4b7000f67792_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfOC0zLTEtMS0zNjE1Njk_848174a0-174c-420d-bd76-657b35f2387d"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="id6ae4d7515be40af9b5d0d99dedb6674_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfOC01LTEtMS0zNjE1Njk_de7b6102-abd3-4147-b09d-f4f44f48bdcf"
      unitRef="usd">1034000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i3d45a9c325c54f76bedad3d6dc284da2_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfOC03LTEtMS0zNjE1Njk_4245e4d6-9f51-45f7-aad9-1fe3ea1f795b"
      unitRef="usd">3100000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i01dd8be0b3174c8ca7f5203f166342a4_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfOC05LTEtMS0zNjE1Njk_b313d133-691c-4dd2-a8bb-af9a16be2bb1"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i90261a9edf1e40d0a4d5ecc464319061_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfOC0xMS0xLTEtMzYxNTY5_65d77034-f996-4aa8-b498-9b4d16309b33"
      unitRef="usd">3100000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i68f578d19e7645c387c11ed14154d754_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfOS0xLTEtMS0zNjE1Njk_85bbf070-afba-4b10-b538-b38e7475f776"
      unitRef="usd">-6900000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i156a47ec55f944129c986623c6da4e76_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfOS0zLTEtMS0zNjE1Njk_e312cadf-23bc-4d62-8b4b-83fcb16c3c43"
      unitRef="usd">-112850000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i52c9b6f82ebb4d52b32a547426bdefa3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfOS01LTEtMS0zNjE1Njk_ff640bf2-b8c7-439d-ad61-7f433fbc91ab"
      unitRef="usd">-119750000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i68f578d19e7645c387c11ed14154d754_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfOS03LTEtMS0zNjE1Njk_35a5832b-fffe-420c-aa7b-23e4096da527"
      unitRef="usd">-6900000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i156a47ec55f944129c986623c6da4e76_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfOS05LTEtMS0zNjE1Njk_7fb12775-2fbd-420c-8914-0aeadb3f02ca"
      unitRef="usd">-112850000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i52c9b6f82ebb4d52b32a547426bdefa3_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82NC9mcmFnOmUwNzUwOTZmYWZlZjQ4NTBhN2M0MTMzMDg5NjU3MDA5L3RhYmxlOjg3Mjc2OTE0OTgyNDQ1YTNiZjI2NGQxODIyNDEyNTkyL3RhYmxlcmFuZ2U6ODcyNzY5MTQ5ODI0NDVhM2JmMjY0ZDE4MjI0MTI1OTJfOS0xMS0xLTEtMzYxNTY5_6372f58f-e945-4ab4-b990-dfbd2e06ee8b"
      unitRef="usd">-119750000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RleHRyZWdpb246ODFiMWI1Zjc4NDc0NGI5Njg1NWM4YjQ0OTU5MWNjNDVfMjA4OQ_11ff3337-5949-4454-8e4b-87b0fb9aa9f5">Acquisitions and divestitures&lt;div style="margin-top:9pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Routine acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the nine months ended September&#160;30, 2022, the Company acquired dialysis businesses consisting of five dialysis centers located in the U.S. and eight dialysis centers located outside the U.S. for total net cash of $43,811, contingent earn-out obligations of $2,171 and deferred purchase price and liabilities assumed of $11,726. The assets and liabilities for these acquisitions were recorded at their estimated fair values at the dates of the acquisitions and are included in the Company&#x2019;s condensed consolidated financial statements, as are their operating results, from the designated effective dates of the acquisitions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The initial purchase price allocations have been recorded at estimated fair values based on information available to management and will be finalized when certain information arranged to be obtained has been received. In particular, certain income tax amounts are pending final evaluation and quantification of any pre-acquisition tax contingencies. In addition, valuation of intangibles, contingent earn-outs, leases, and certain other working capital items relating to these acquisitions are pending final quantification.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amount of goodwill recognized or adjusted during the nine months ended September&#160;30, 2022 that is deductible for tax purposes was $34,769.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingent earn-out obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has several contingent earn-out obligations associated with acquisitions that could result in the Company paying the former owners of acquired businesses a total of up to approximately $56,815 if certain performance targets or quality margins are met over the next one year to five years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contingent earn-out obligations are remeasured to fair value at each reporting date until the contingencies are resolved with changes in the liability due to the remeasurement recognized in earnings. As of September&#160;30, 2022, the Company estimated the fair value of these contingent earn-out obligations to be $25,771, of which $9,461 is included in other current liabilities and the remaining $16,310 is included in other long-term liabilities in the Company&#x2019;s consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of changes in contingent earn-out obligations: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.093%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.604%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.678%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.679%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;br/&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Nine months ended &lt;br/&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(741)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value remeasurements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(350)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,129)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,085)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,274)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="i95e6e28da1c64a71b6b90cda0a4d622f_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RleHRyZWdpb246ODFiMWI1Zjc4NDc0NGI5Njg1NWM4YjQ0OTU5MWNjNDVfMTM3NDM4OTUzNDkzODQ_395ce8c7-1897-479f-8480-945873cae1ad"
      unitRef="clinic">5</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="ic959e17b2ced48048db8022f4a387ae2_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RleHRyZWdpb246ODFiMWI1Zjc4NDc0NGI5Njg1NWM4YjQ0OTU5MWNjNDVfMTM3NDM4OTUzNDk0NzQ_08483c4e-8649-41c1-a003-5ca9e856c80a"
      unitRef="clinic">8</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ia6e87c344c514ceda105446f9b6fd9f1_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RleHRyZWdpb246ODFiMWI1Zjc4NDc0NGI5Njg1NWM4YjQ0OTU5MWNjNDVfMjE0_780194b9-3a75-404a-9d08-c458aa834e38"
      unitRef="usd">43811000</us-gaap:PaymentsToAcquireBusinessesGross>
    <dva:BusinessCombinationContingentConsiderationAcquisitions
      contextRef="ia6e87c344c514ceda105446f9b6fd9f1_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RleHRyZWdpb246ODFiMWI1Zjc4NDc0NGI5Njg1NWM4YjQ0OTU5MWNjNDVfMjUz_f6e8c0c5-b016-4b0e-999a-f881a03d9c7e"
      unitRef="usd">2171000</dva:BusinessCombinationContingentConsiderationAcquisitions>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred
      contextRef="ia6e87c344c514ceda105446f9b6fd9f1_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RleHRyZWdpb246ODFiMWI1Zjc4NDc0NGI5Njg1NWM4YjQ0OTU5MWNjNDVfMzEx_b8da1f84-997d-4ad8-a29f-0916aef14380"
      unitRef="usd">11726000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <dva:BusinessAcquisitionGoodwillExpectedTaxDeductibleAmountAdjustment
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RleHRyZWdpb246ODFiMWI1Zjc4NDc0NGI5Njg1NWM4YjQ0OTU5MWNjNDVfMTIyOA_6a82b615-25a7-432b-b06f-a3f36cb1d330"
      unitRef="usd">34769000</dva:BusinessAcquisitionGoodwillExpectedTaxDeductibleAmountAdjustment>
    <dva:BusinessCombinationContingentConsiderationAcquisitions
      contextRef="icd5d82e4da8342af95e4f8a9ea99d743_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RleHRyZWdpb246ODFiMWI1Zjc4NDc0NGI5Njg1NWM4YjQ0OTU5MWNjNDVfMTQ2MQ_849b7e67-3dd3-4d1d-b2e7-8df17e5a7a4b"
      unitRef="usd">56815000</dva:BusinessCombinationContingentConsiderationAcquisitions>
    <dva:BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod
      contextRef="i88a8225e4c1e42caaefc9c729b03c373_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RleHRyZWdpb246ODFiMWI1Zjc4NDc0NGI5Njg1NWM4YjQ0OTU5MWNjNDVfMTUzNg_7bb2628d-a7f9-43bc-af5c-1b82fc5fbadf">P1Y</dva:BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod>
    <dva:BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod
      contextRef="ifde433a78f5e48a7bae7190340e2eb48_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RleHRyZWdpb246ODFiMWI1Zjc4NDc0NGI5Njg1NWM4YjQ0OTU5MWNjNDVfMTU0Mg_ecfb01ac-80ef-4454-b50a-8c0b8d7980e0">P5Y</dva:BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ide4330793ff1447187183eb8ef9696b9_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RleHRyZWdpb246ODFiMWI1Zjc4NDc0NGI5Njg1NWM4YjQ0OTU5MWNjNDVfMTg0MA_d5756f19-e88e-4c92-992a-2d62ac824574"
      unitRef="usd">25771000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i01942e9636d34741abd1fb7dae3a5e7a_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RleHRyZWdpb246ODFiMWI1Zjc4NDc0NGI5Njg1NWM4YjQ0OTU5MWNjNDVfMTg1Mw_2ddb91c8-eea4-41b5-a9f0-a442684c3c05"
      unitRef="usd">9461000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i4a9ef1628dd54bbc87ca947161e93f59_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RleHRyZWdpb246ODFiMWI1Zjc4NDc0NGI5Njg1NWM4YjQ0OTU5MWNjNDVfMTkxNQ_9f2b0f41-de6b-4c6f-83b9-296ce1c486c4"
      unitRef="usd">16310000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RleHRyZWdpb246ODFiMWI1Zjc4NDc0NGI5Njg1NWM4YjQ0OTU5MWNjNDVfMjA5NQ_d8d2e5d3-d45e-4bb2-87e0-b135a1b84e6b">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of changes in contingent earn-out obligations: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:79.093%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.604%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.678%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.679%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended&lt;br/&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Nine months ended &lt;br/&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(741)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value remeasurements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(350)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,129)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,085)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,274)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="ic6f218803873471383d0301f439bbb92_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RhYmxlOmJlM2JiMTI5MmNlZjQ0YmNiZDRiZTNkNjU5NzkzOTQ1L3RhYmxlcmFuZ2U6YmUzYmIxMjkyY2VmNDRiY2JkNGJlM2Q2NTk3OTM5NDVfMS0xLTEtMS0zNjE1Njk_77299d3a-84d9-4b13-bde0-4199690a3d05"
      unitRef="usd">29299000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i9c5d44642dc04d7aad80fa984ec18f13_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RhYmxlOmJlM2JiMTI5MmNlZjQ0YmNiZDRiZTNkNjU5NzkzOTQ1L3RhYmxlcmFuZ2U6YmUzYmIxMjkyY2VmNDRiY2JkNGJlM2Q2NTk3OTM5NDVfMS0zLTEtMS0zNjE1Njk_46ac2f99-b7fa-4c75-b226-0bbb2804296a"
      unitRef="usd">33600000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
      contextRef="i200705f0b3544be7a6092cd5a931bd55_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RhYmxlOmJlM2JiMTI5MmNlZjQ0YmNiZDRiZTNkNjU5NzkzOTQ1L3RhYmxlcmFuZ2U6YmUzYmIxMjkyY2VmNDRiY2JkNGJlM2Q2NTk3OTM5NDVfMi0xLTEtMS0zNjE1Njk_e777a436-7c03-4467-b26a-36b59e23bfd8"
      unitRef="usd">1648000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
      contextRef="ia6e87c344c514ceda105446f9b6fd9f1_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RhYmxlOmJlM2JiMTI5MmNlZjQ0YmNiZDRiZTNkNjU5NzkzOTQ1L3RhYmxlcmFuZ2U6YmUzYmIxMjkyY2VmNDRiY2JkNGJlM2Q2NTk3OTM5NDVfMi0zLTEtMS0zNjE1Njk_e61478eb-2b5e-4493-a94b-2172f49ebc9c"
      unitRef="usd">2171000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1>
    <dva:ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations
      contextRef="i200705f0b3544be7a6092cd5a931bd55_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RhYmxlOmJlM2JiMTI5MmNlZjQ0YmNiZDRiZTNkNjU5NzkzOTQ1L3RhYmxlcmFuZ2U6YmUzYmIxMjkyY2VmNDRiY2JkNGJlM2Q2NTk3OTM5NDVfMy0xLTEtMS0zNjE1Njk_5b45b839-da0d-4dae-8a2f-3edc6dc5c3e0"
      unitRef="usd">-741000</dva:ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations>
    <dva:ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations
      contextRef="ia6e87c344c514ceda105446f9b6fd9f1_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RhYmxlOmJlM2JiMTI5MmNlZjQ0YmNiZDRiZTNkNjU5NzkzOTQ1L3RhYmxlcmFuZ2U6YmUzYmIxMjkyY2VmNDRiY2JkNGJlM2Q2NTk3OTM5NDVfMy0zLTEtMS0zNjE1Njk_65019d8a-861b-41bf-a594-04c610947019"
      unitRef="usd">403000</dva:ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations>
    <dva:BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss
      contextRef="i200705f0b3544be7a6092cd5a931bd55_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RhYmxlOmJlM2JiMTI5MmNlZjQ0YmNiZDRiZTNkNjU5NzkzOTQ1L3RhYmxlcmFuZ2U6YmUzYmIxMjkyY2VmNDRiY2JkNGJlM2Q2NTk3OTM5NDVfNC0xLTEtMS0zNjE1Njk_ef5de48d-5d13-4454-8b2e-90074ba85f8f"
      unitRef="usd">350000</dva:BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss>
    <dva:BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss
      contextRef="ia6e87c344c514ceda105446f9b6fd9f1_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RhYmxlOmJlM2JiMTI5MmNlZjQ0YmNiZDRiZTNkNjU5NzkzOTQ1L3RhYmxlcmFuZ2U6YmUzYmIxMjkyY2VmNDRiY2JkNGJlM2Q2NTk3OTM5NDVfNC0zLTEtMS0zNjE1Njk_bc777e12-2591-42b1-8af3-68b753eb0c65"
      unitRef="usd">3129000</dva:BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i200705f0b3544be7a6092cd5a931bd55_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RhYmxlOmJlM2JiMTI5MmNlZjQ0YmNiZDRiZTNkNjU5NzkzOTQ1L3RhYmxlcmFuZ2U6YmUzYmIxMjkyY2VmNDRiY2JkNGJlM2Q2NTk3OTM5NDVfNS0xLTEtMS0zNjE1Njk_600d4830-e5a9-4a0e-9641-9926b7e452a0"
      unitRef="usd">4085000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ia6e87c344c514ceda105446f9b6fd9f1_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RhYmxlOmJlM2JiMTI5MmNlZjQ0YmNiZDRiZTNkNjU5NzkzOTQ1L3RhYmxlcmFuZ2U6YmUzYmIxMjkyY2VmNDRiY2JkNGJlM2Q2NTk3OTM5NDVfNS0zLTEtMS0zNjE1Njk_25a2c74c-02f0-4a00-bfa0-d9ac6d6f1950"
      unitRef="usd">7274000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i7ab035ae8c46470e89b5add1fb9a3684_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RhYmxlOmJlM2JiMTI5MmNlZjQ0YmNiZDRiZTNkNjU5NzkzOTQ1L3RhYmxlcmFuZ2U6YmUzYmIxMjkyY2VmNDRiY2JkNGJlM2Q2NTk3OTM5NDVfNi0xLTEtMS0zNjE1Njk_6373c46a-e7bb-4287-9a5c-e6c74c1a098c"
      unitRef="usd">25771000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i7ab035ae8c46470e89b5add1fb9a3684_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl82Ny9mcmFnOjgxYjFiNWY3ODQ3NDRiOTY4NTVjOGI0NDk1OTFjYzQ1L3RhYmxlOmJlM2JiMTI5MmNlZjQ0YmNiZDRiZTNkNjU5NzkzOTQ1L3RhYmxlcmFuZ2U6YmUzYmIxMjkyY2VmNDRiY2JkNGJlM2Q2NTk3OTM5NDVfNi0zLTEtMS0zNjE1Njk_f27cdf53-5d9c-40f3-b515-073e81db4870"
      unitRef="usd">25771000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:VariableInterestEntityDisclosureTextBlock
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83MC9mcmFnOmNlOTljNTVlYzVjMDQyM2FhMzMxZWFkOGVmZWIzMTNmL3RleHRyZWdpb246Y2U5OWM1NWVjNWMwNDIzYWEzMzFlYWQ4ZWZlYjMxM2ZfNDUz_686e2e11-6b02-4073-b7a8-c5999936570a">Variable interest entities (VIEs)At September&#160;30, 2022, these condensed consolidated financial statements include total assets of consolidated VIEs of $298,477 and total liabilities and noncontrolling interests of consolidated VIEs to third parties of $196,159. There have been no material changes in the nature of the Company's arrangements with VIEs or its judgments concerning them from those described in Note 23 to the Company's consolidated financial statements included in the 2021 10-K.</us-gaap:VariableInterestEntityDisclosureTextBlock>
    <us-gaap:Assets
      contextRef="if32523db73914548b7ef72241eec1f64_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83MC9mcmFnOmNlOTljNTVlYzVjMDQyM2FhMzMxZWFkOGVmZWIzMTNmL3RleHRyZWdpb246Y2U5OWM1NWVjNWMwNDIzYWEzMzFlYWQ4ZWZlYjMxM2ZfMTMy_3e19de16-5fc8-4a8d-95c3-5f9287f06537"
      unitRef="usd">298477000</us-gaap:Assets>
    <us-gaap:Liabilities
      contextRef="if32523db73914548b7ef72241eec1f64_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83MC9mcmFnOmNlOTljNTVlYzVjMDQyM2FhMzMxZWFkOGVmZWIzMTNmL3RleHRyZWdpb246Y2U5OWM1NWVjNWMwNDIzYWEzMzFlYWQ4ZWZlYjMxM2ZfMjE0_bbafc0b1-5f9d-4606-a980-177ecc68d861"
      unitRef="usd">196159000</us-gaap:Liabilities>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83My9mcmFnOjg5YzhhNWVjMTBmOTQ1ZDdiZDA4NzVjODE4MTk1MDg1L3RleHRyZWdpb246ODljOGE1ZWMxMGY5NDVkN2JkMDg3NWM4MTgxOTUwODVfNDM3MQ_5e9fe5c8-fe81-40ff-a352-3a18bbd98213">Fair values of financial instruments&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures the fair value of certain assets, liabilities and noncontrolling interests subject to put provisions (redeemable equity interests classified as temporary equity) based upon certain valuation techniques that include observable or unobservable inputs and assumptions that market participants would use in pricing these assets, liabilities, temporary equity and commitments. The Company has also classified assets, liabilities and temporary equities that are measured at fair value on a recurring basis into the appropriate fair value hierarchy levels as defined by the Financial Accounting Standards Board (FASB).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company&#x2019;s assets, liabilities and temporary equities measured at fair value on a recurring basis as of September&#160;30, 2022:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.251%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.947%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Quoted prices in&lt;br/&gt;active&#160;markets&lt;br/&gt;for identical assets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Significant other&lt;br/&gt;observable&#160;inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;unobservable&lt;br/&gt;inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments in equity securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent earn-out obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Temporary equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests subject to put provisions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,370,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,370,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For reconciliations of changes in contingent earn-out obligations and noncontrolling interests subject to put provisions during the three and nine months ended September&#160;30, 2022, see Note 10 and the consolidated statement of equity, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investments in equity securities represent investments in various open-ended registered investment companies (mutual funds) and common stocks and are recorded at fair value estimated based on reported market prices or redemption prices, as applicable. See Note 4 for further discussion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest rate cap agreements are recorded at fair value estimated from valuation models utilizing the income approach and commonly accepted valuation techniques that use inputs from closing prices for similar assets and liabilities in active markets as well as other relevant observable market inputs at quoted intervals such as current interest rates, forward yield curves, implied volatility and credit default swap pricing. The Company does not believe the ultimate amount that could be realized upon settlement of these interest rate cap agreements would be materially different from the fair value estimates currently reported. See Note 6 for further discussion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value measurements of contingent earn-out obligations are primarily based on unobservable inputs, including projected earnings before interest, taxes, depreciation, and amortization (EBITDA), revenue and certain operating metrics. The estimated fair values of these contingent earn-out obligations are remeasured as of each reporting date and could fluctuate based upon any significant changes in key assumptions, such as changes in the Company's credit risk adjusted rate that is used to discount obligations to present value. See Note 10 for further discussion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of noncontrolling interests subject to put provisions is based principally on the higher of either estimated liquidation value of net assets or a multiple of earnings for each subject dialysis partnership, based on historical earnings, revenue mix, and other performance indicators that can affect future results. The multiples used for these valuations are derived from observed ownership transactions for dialysis businesses between unrelated parties in the U.S. in recent years, and the specific valuation multiple applied to each dialysis partnership is principally determined by its recent and expected revenue mix and contribution margin. As of September&#160;30, 2022, an increase or decrease in the weighted average multiple used in these valuations of one times EBITDA would change the estimated fair value of these noncontrolling interests by approximately $170,000. See Notes 17 and 24 to the Company's consolidated financial statements included in the 2021 10-K for further discussion of the Company&#x2019;s methodology for estimating the fair value of noncontrolling interests subject to put obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's fair value estimates for its senior secured credit facilities and senior notes are based upon bid and ask quotes for these instruments, typically a level 2 input. See Note 6 for further discussion of the Company's debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other financial instruments consist primarily of cash and cash equivalents, restricted cash and cash equivalents, accounts receivable, accounts payable, other accrued liabilities, lease liabilities and debt. The balances of financial instruments other than debt and lease liabilities are presented in these condensed consolidated financial statements at September&#160;30, 2022 at their approximate fair values due to the short-term nature of their settlements.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83My9mcmFnOjg5YzhhNWVjMTBmOTQ1ZDdiZDA4NzVjODE4MTk1MDg1L3RleHRyZWdpb246ODljOGE1ZWMxMGY5NDVkN2JkMDg3NWM4MTgxOTUwODVfNDM2OQ_c8064732-5fc6-4cd2-afa2-7ea7cd942db1">The following table summarizes the Company&#x2019;s assets, liabilities and temporary equities measured at fair value on a recurring basis as of September&#160;30, 2022:&#160;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.251%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.066%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.947%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Quoted prices in&lt;br/&gt;active&#160;markets&lt;br/&gt;for identical assets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Significant other&lt;br/&gt;observable&#160;inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;unobservable&lt;br/&gt;inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments in equity securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent earn-out obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Temporary equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests subject to put provisions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,370,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,370,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="iad68a7dfc7f8430c902a9ff9db916de5_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83My9mcmFnOjg5YzhhNWVjMTBmOTQ1ZDdiZDA4NzVjODE4MTk1MDg1L3RhYmxlOjVhZWJjNmZiNDk5ZjRlMjZiYmFiYzMxZWE3Yzg5OGFmL3RhYmxlcmFuZ2U6NWFlYmM2ZmI0OTlmNGUyNmJiYWJjMzFlYTdjODk4YWZfMi0xLTEtMS0zNjE1Njk_ed63bfc7-863d-4a5c-8927-a4e3fc34df00"
      unitRef="usd">39997000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i37ced70b3e714fa5b27f6d0da83e5d16_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83My9mcmFnOjg5YzhhNWVjMTBmOTQ1ZDdiZDA4NzVjODE4MTk1MDg1L3RhYmxlOjVhZWJjNmZiNDk5ZjRlMjZiYmFiYzMxZWE3Yzg5OGFmL3RhYmxlcmFuZ2U6NWFlYmM2ZmI0OTlmNGUyNmJiYWJjMzFlYTdjODk4YWZfMi0zLTEtMS0zNjE1Njk_9d65326f-4544-4974-93c9-b6272efb8cd5"
      unitRef="usd">39997000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ie85a55a4b6014368afa4c77e630e85e9_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83My9mcmFnOjg5YzhhNWVjMTBmOTQ1ZDdiZDA4NzVjODE4MTk1MDg1L3RhYmxlOjVhZWJjNmZiNDk5ZjRlMjZiYmFiYzMxZWE3Yzg5OGFmL3RhYmxlcmFuZ2U6NWFlYmM2ZmI0OTlmNGUyNmJiYWJjMzFlYTdjODk4YWZfMi01LTEtMS0zNjE1Njk_7d8a198b-a8ed-474a-a821-928fc9588fec"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i861d396ab85f4a41a20715d925fdf77d_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83My9mcmFnOjg5YzhhNWVjMTBmOTQ1ZDdiZDA4NzVjODE4MTk1MDg1L3RhYmxlOjVhZWJjNmZiNDk5ZjRlMjZiYmFiYzMxZWE3Yzg5OGFmL3RhYmxlcmFuZ2U6NWFlYmM2ZmI0OTlmNGUyNmJiYWJjMzFlYTdjODk4YWZfMi03LTEtMS0zNjE1Njk_33f6e64a-3d75-4286-acaf-8ad6f8328ddb"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:DerivativeAssets
      contextRef="ie2281493dee746f3a9ad6ed5affc319f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83My9mcmFnOjg5YzhhNWVjMTBmOTQ1ZDdiZDA4NzVjODE4MTk1MDg1L3RhYmxlOjVhZWJjNmZiNDk5ZjRlMjZiYmFiYzMxZWE3Yzg5OGFmL3RhYmxlcmFuZ2U6NWFlYmM2ZmI0OTlmNGUyNmJiYWJjMzFlYTdjODk4YWZfMy0xLTEtMS0zNjE1Njk_57441924-8696-4e5b-8280-7cdeb11d90a9"
      unitRef="usd">139663000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i942ba5c680184d918b3750ba16f74597_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83My9mcmFnOjg5YzhhNWVjMTBmOTQ1ZDdiZDA4NzVjODE4MTk1MDg1L3RhYmxlOjVhZWJjNmZiNDk5ZjRlMjZiYmFiYzMxZWE3Yzg5OGFmL3RhYmxlcmFuZ2U6NWFlYmM2ZmI0OTlmNGUyNmJiYWJjMzFlYTdjODk4YWZfMy0zLTEtMS0zNjE1Njk_3e24e8f6-8075-467a-8565-3e5f164338a1"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i422c441ffd274e1a8dea60fc1227cd35_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83My9mcmFnOjg5YzhhNWVjMTBmOTQ1ZDdiZDA4NzVjODE4MTk1MDg1L3RhYmxlOjVhZWJjNmZiNDk5ZjRlMjZiYmFiYzMxZWE3Yzg5OGFmL3RhYmxlcmFuZ2U6NWFlYmM2ZmI0OTlmNGUyNmJiYWJjMzFlYTdjODk4YWZfMy01LTEtMS0zNjE1Njk_5bb9192d-fe3d-406e-ba73-88ae150187be"
      unitRef="usd">139663000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i277124343d7e4b49b6103749b88e2648_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83My9mcmFnOjg5YzhhNWVjMTBmOTQ1ZDdiZDA4NzVjODE4MTk1MDg1L3RhYmxlOjVhZWJjNmZiNDk5ZjRlMjZiYmFiYzMxZWE3Yzg5OGFmL3RhYmxlcmFuZ2U6NWFlYmM2ZmI0OTlmNGUyNmJiYWJjMzFlYTdjODk4YWZfMy03LTEtMS0zNjE1Njk_9fc974f6-a414-45e6-9db8-12a46b1e2310"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="iad68a7dfc7f8430c902a9ff9db916de5_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83My9mcmFnOjg5YzhhNWVjMTBmOTQ1ZDdiZDA4NzVjODE4MTk1MDg1L3RhYmxlOjVhZWJjNmZiNDk5ZjRlMjZiYmFiYzMxZWE3Yzg5OGFmL3RhYmxlcmFuZ2U6NWFlYmM2ZmI0OTlmNGUyNmJiYWJjMzFlYTdjODk4YWZfNS0xLTEtMS0zNjE1Njk_2ede372a-cbdf-429c-a7e4-35cef0d31d32"
      unitRef="usd">25771000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i37ced70b3e714fa5b27f6d0da83e5d16_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83My9mcmFnOjg5YzhhNWVjMTBmOTQ1ZDdiZDA4NzVjODE4MTk1MDg1L3RhYmxlOjVhZWJjNmZiNDk5ZjRlMjZiYmFiYzMxZWE3Yzg5OGFmL3RhYmxlcmFuZ2U6NWFlYmM2ZmI0OTlmNGUyNmJiYWJjMzFlYTdjODk4YWZfNS0zLTEtMS0zNjE1Njk_80418dcb-be01-47aa-a929-b6c9f6189210"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ie85a55a4b6014368afa4c77e630e85e9_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83My9mcmFnOjg5YzhhNWVjMTBmOTQ1ZDdiZDA4NzVjODE4MTk1MDg1L3RhYmxlOjVhZWJjNmZiNDk5ZjRlMjZiYmFiYzMxZWE3Yzg5OGFmL3RhYmxlcmFuZ2U6NWFlYmM2ZmI0OTlmNGUyNmJiYWJjMzFlYTdjODk4YWZfNS01LTEtMS0zNjE1Njk_3ee2a9a9-2895-486f-bb58-0b999d2ff176"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i861d396ab85f4a41a20715d925fdf77d_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83My9mcmFnOjg5YzhhNWVjMTBmOTQ1ZDdiZDA4NzVjODE4MTk1MDg1L3RhYmxlOjVhZWJjNmZiNDk5ZjRlMjZiYmFiYzMxZWE3Yzg5OGFmL3RhYmxlcmFuZ2U6NWFlYmM2ZmI0OTlmNGUyNmJiYWJjMzFlYTdjODk4YWZfNS03LTEtMS0zNjE1Njk_b1f78a92-26fe-4c0e-837f-caf3c90c5f31"
      unitRef="usd">25771000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="iad68a7dfc7f8430c902a9ff9db916de5_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83My9mcmFnOjg5YzhhNWVjMTBmOTQ1ZDdiZDA4NzVjODE4MTk1MDg1L3RhYmxlOjVhZWJjNmZiNDk5ZjRlMjZiYmFiYzMxZWE3Yzg5OGFmL3RhYmxlcmFuZ2U6NWFlYmM2ZmI0OTlmNGUyNmJiYWJjMzFlYTdjODk4YWZfNy0xLTEtMS0zNjE1Njk_f57fa670-7106-4a2d-901a-d8cdb6dbf06a"
      unitRef="usd">1370753000</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="i37ced70b3e714fa5b27f6d0da83e5d16_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83My9mcmFnOjg5YzhhNWVjMTBmOTQ1ZDdiZDA4NzVjODE4MTk1MDg1L3RhYmxlOjVhZWJjNmZiNDk5ZjRlMjZiYmFiYzMxZWE3Yzg5OGFmL3RhYmxlcmFuZ2U6NWFlYmM2ZmI0OTlmNGUyNmJiYWJjMzFlYTdjODk4YWZfNy0zLTEtMS0zNjE1Njk_a6f23f09-640c-41ff-9b89-65bdca403059"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="ie85a55a4b6014368afa4c77e630e85e9_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83My9mcmFnOjg5YzhhNWVjMTBmOTQ1ZDdiZDA4NzVjODE4MTk1MDg1L3RhYmxlOjVhZWJjNmZiNDk5ZjRlMjZiYmFiYzMxZWE3Yzg5OGFmL3RhYmxlcmFuZ2U6NWFlYmM2ZmI0OTlmNGUyNmJiYWJjMzFlYTdjODk4YWZfNy01LTEtMS0zNjE1Njk_fffdea71-4bfd-43b3-a01c-1bee246e8456"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="i861d396ab85f4a41a20715d925fdf77d_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83My9mcmFnOjg5YzhhNWVjMTBmOTQ1ZDdiZDA4NzVjODE4MTk1MDg1L3RhYmxlOjVhZWJjNmZiNDk5ZjRlMjZiYmFiYzMxZWE3Yzg5OGFmL3RhYmxlcmFuZ2U6NWFlYmM2ZmI0OTlmNGUyNmJiYWJjMzFlYTdjODk4YWZfNy03LTEtMS0zNjE1Njk_b1f859ff-19e2-41be-a50c-fe08460451d7"
      unitRef="usd">1370753000</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83My9mcmFnOjg5YzhhNWVjMTBmOTQ1ZDdiZDA4NzVjODE4MTk1MDg1L3RleHRyZWdpb246ODljOGE1ZWMxMGY5NDVkN2JkMDg3NWM4MTgxOTUwODVfNDM3NQ_b4540a62-ba37-41e3-84e8-0ff5d9f6ad76">Interest rate cap agreements are recorded at fair value estimated from valuation models utilizing the income approach and commonly accepted valuation techniques that use inputs from closing prices for similar assets and liabilities in active markets as well as other relevant observable market inputs at quoted intervals such as current interest rates, forward yield curves, implied volatility and credit default swap pricing. The Company does not believe the ultimate amount that could be realized upon settlement of these interest rate cap agreements would be materially different from the fair value estimates currently reported. See Note 6 for further discussion.The estimated fair value measurements of contingent earn-out obligations are primarily based on unobservable inputs, including projected earnings before interest, taxes, depreciation, and amortization (EBITDA), revenue and certain operating metrics. The estimated fair values of these contingent earn-out obligations are remeasured as of each reporting date and could fluctuate based upon any significant changes in key assumptions, such as changes in the Company's credit risk adjusted rate that is used to discount obligations to present value.</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <dva:PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83My9mcmFnOjg5YzhhNWVjMTBmOTQ1ZDdiZDA4NzVjODE4MTk1MDg1L3RleHRyZWdpb246ODljOGE1ZWMxMGY5NDVkN2JkMDg3NWM4MTgxOTUwODVfMzI5ODUzNDg4NzczNg_507df271-b51f-4774-94ab-babc97ad213b"
      unitRef="usd">170000000</dva:PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RleHRyZWdpb246NzMwNWFjNzUyNWI3NDk4OGJmNzFmODQ3Mzc1NDRlZDJfMTQ4MA_7f39e421-0234-48ff-be43-e803c6abf483">Segment reporting&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s operating divisions are comprised of its U.S. dialysis and related lab services business (its U.S. dialysis business), its U.S. integrated kidney care business, its U.S. other ancillary services and its international operations (collectively, its ancillary services), as well as its corporate administrative support. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s separate operating segments include its U.S. dialysis and related lab services business, its U.S. integrated kidney care business, its U.S. other ancillary services, its kidney care operations in each foreign sovereign jurisdiction, and its equity method investment in the Asia Pacific joint venture (APAC JV). The U.S. dialysis and related lab services business qualifies as a separately reportable segment, and all other operating segments have been combined and disclosed in the other segments category. See Note 25 to the Company's consolidated financial statements included in the 2021 10-K for further description of how the Company determines and measures results for its operating segments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of segment net revenues, segment operating margin (loss), and a reconciliation of segment operating margin to consolidated income before income taxes:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dialysis patient service revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;External sources&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,674,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,669,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,858,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,874,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. dialysis patient service revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,697,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,691,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,923,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,944,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;External sources&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total U.S. dialysis revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,703,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,698,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,941,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,964,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other&#x2014;Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dialysis patient service revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;513,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other external sources&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total ancillary services revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;815,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;785,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,971,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,960,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,757,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,749,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Elimination of intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,957)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64,516)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74,718)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,948,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,938,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,693,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,674,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment operating margin (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;509,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,230,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,523,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&#x2014;Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,909)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56,689)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36,577)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment operating margin&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,174,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,487,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Reconciliation of segment operating income to&lt;br/&gt;&#160;consolidated income before income taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate administrative support&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,417)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,153)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(91,217)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79,093)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;474,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,082,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,407,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(99,680)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72,829)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(256,057)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(213,167)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (loss) income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,898)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,590)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,968)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;818,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,203,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation and amortization expense by reportable segment was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.175%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.982%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.649%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.653%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;507,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;477,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&#x2014;Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;538,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expenditures for property and equipment by reportable segment were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.005%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.459%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.696%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;363,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;415,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&#x2014;Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;409,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;451,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of assets by reportable segment were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.538%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.542%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.581%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.583%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,223,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,375,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&#x2014;Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,738,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,746,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,961,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,121,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RleHRyZWdpb246NzMwNWFjNzUyNWI3NDk4OGJmNzFmODQ3Mzc1NDRlZDJfMTQ4Nw_438f8843-5009-4d86-af8a-5d908cd9e5b8">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of segment net revenues, segment operating margin (loss), and a reconciliation of segment operating margin to consolidated income before income taxes:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dialysis patient service revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;External sources&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,674,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,669,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,858,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,874,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. dialysis patient service revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,697,197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,691,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,923,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,944,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;External sources&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total U.S. dialysis revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,703,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,698,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,941,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,964,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other&#x2014;Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dialysis patient service revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;513,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other external sources&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total ancillary services revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;815,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;785,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net segment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,971,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,960,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,757,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,749,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Elimination of intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,957)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64,516)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74,718)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,948,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,938,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,693,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,674,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment operating margin (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;509,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,230,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,523,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&#x2014;Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,271)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,909)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56,689)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36,577)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment operating margin&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,174,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,487,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Reconciliation of segment operating income to&lt;br/&gt;&#160;consolidated income before income taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate administrative support&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,417)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,153)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(91,217)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79,093)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;474,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,082,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,407,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(99,680)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72,829)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(256,057)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(213,167)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (loss) income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,898)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,590)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,968)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;818,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,203,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i86e50a7258fd4e0992f2a0577c97a330_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfNS0xLTEtMS0zNjE1Njk_034cc8d6-2bf6-4567-9fc9-0521ba33e50e"
      unitRef="usd">2674240000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i8addd3c7916144679fc2e787249b56d9_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfNS0zLTEtMS0zNjE1Njk_043a2ecd-8725-4644-90a8-5a87e4358035"
      unitRef="usd">2669823000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ide05e52cd7054762b05f224b69c2974e_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfNS01LTEtMS0zNjE1Njk_510c7205-9acb-47b5-bdce-777f660588a6"
      unitRef="usd">7858939000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i819e851e63e848a696a608bae9204746_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfNS03LTEtMS0zNjE1Njk_10722d40-ac58-4b34-abf8-97d8d8ebc638"
      unitRef="usd">7874759000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i96cb1c0878bf49cea8cfa1212cdc7aed_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfNi0xLTEtMS0zNjE1Njk_9256b49f-4c51-4aec-80f3-4c095a408c9c"
      unitRef="usd">22957000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i36100b7124c542bd86b8f36ce7106243_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfNi0zLTEtMS0zNjE1Njk_6aa38015-f741-4978-bb54-550b1a7738b4"
      unitRef="usd">22007000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i73df09631cc34d359a0ce8f26f7d7e45_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfNi01LTEtMS0zNjE1Njk_6912c4e1-aa18-464f-a59d-d6707a1aedc7"
      unitRef="usd">64526000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="if3eb7e259bf141018ef89a58189f8ba2_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfNi03LTEtMS0zNjE1Njk_18282470-0129-405a-b1b2-0d039d2d4361"
      unitRef="usd">70196000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ia8601bd20cd04c22b8e3e448c8c8a4bc_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfOS0xLTEtMS0zNjE1Njk_659c6391-a151-4ade-9f1a-d077e3ed5dd5"
      unitRef="usd">2697197000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i38b206ccc4604608ab1cbaeaa6e878f5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfOS0zLTEtMS0zNjE1Njk_07d1453e-2d1d-4049-bc70-6059c8d89bfe"
      unitRef="usd">2691830000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i5947da8371ba465b929ebd233615c5fc_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfOS01LTEtMS0zNjE1Njk_cb56f162-ab32-4b63-a12b-4fa35b166b38"
      unitRef="usd">7923465000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="icc9f7a8bb84e40e581606e923ee81543_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfOS03LTEtMS0zNjE1Njk_291b76d7-4455-4536-afa3-949a075cbfa0"
      unitRef="usd">7944955000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:OtherIncome
      contextRef="i86e50a7258fd4e0992f2a0577c97a330_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTEtMS0xLTEtMzYxNTY5_1315cf94-9d7e-48ad-a45e-11a952f3628d"
      unitRef="usd">6056000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i8addd3c7916144679fc2e787249b56d9_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTEtMy0xLTEtMzYxNTY5_3d89e3b8-d07e-47b3-a467-f57e0783672c"
      unitRef="usd">6119000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="ide05e52cd7054762b05f224b69c2974e_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTEtNS0xLTEtMzYxNTY5_f1b69fcb-290a-4224-91a9-b1cf0e2556e0"
      unitRef="usd">18134000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i819e851e63e848a696a608bae9204746_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTEtNy0xLTEtMzYxNTY5_da3c2334-a5b8-4547-b371-aad923991628"
      unitRef="usd">19080000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i96cb1c0878bf49cea8cfa1212cdc7aed_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTItMS0xLTEtMzYxNTY5_b4e11dfc-e7d8-4197-803f-5cfbca289caf"
      unitRef="usd">0</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i36100b7124c542bd86b8f36ce7106243_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTItMy0xLTEtMzYxNTY5_efcb7ed1-bfec-40a7-83f5-96eeb6d48627"
      unitRef="usd">97000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i73df09631cc34d359a0ce8f26f7d7e45_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTItNS0xLTEtMzYxNTY5_b6cbb4a6-e81d-471c-90d5-ca295feeb037"
      unitRef="usd">-10000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="if3eb7e259bf141018ef89a58189f8ba2_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTItNy0xLTEtMzYxNTY5_8d7940d5-4d32-4532-a4b5-2c4eb19c83d1"
      unitRef="usd">228000</us-gaap:OtherIncome>
    <us-gaap:Revenues
      contextRef="ia8601bd20cd04c22b8e3e448c8c8a4bc_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTMtMS0xLTEtMzYxNTY5_9dda0074-2a68-4f01-ac25-59844dd9ff6b"
      unitRef="usd">2703253000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i38b206ccc4604608ab1cbaeaa6e878f5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTMtMy0xLTEtMzYxNTY5_7dc45c72-6dfd-4f5d-a265-e3d8f0122965"
      unitRef="usd">2698046000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5947da8371ba465b929ebd233615c5fc_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTMtNS0xLTEtMzYxNTY5_86fc5933-b9c0-40db-b46f-9e2fc29ab4cb"
      unitRef="usd">7941589000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icc9f7a8bb84e40e581606e923ee81543_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTMtNy0xLTEtMzYxNTY5_64e91a21-3a58-4a89-b71c-b40762feb5dc"
      unitRef="usd">7964263000</us-gaap:Revenues>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i068759fddb5d4fbd9e32d6347d1e6d75_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTUtMS0xLTEtMzYxNTY5_128a0af3-c3fa-4f66-b219-7fd89e29c426"
      unitRef="usd">172254000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i6b9dedef3bed43dba87b7821cb677959_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTUtMy0xLTEtMzYxNTY5_fd7bef2f-f186-4c8c-9a4e-0ebc19f7c708"
      unitRef="usd">168117000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i2fd089f25d0742cc93cba789d7beaa24_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTUtNS0xLTEtMzYxNTY5_b80282d3-52a7-4d72-a44b-11925aed9987"
      unitRef="usd">513935000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ib561b1ec046245b58bddae941fc0daf3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTUtNy0xLTEtMzYxNTY5_d2e75275-f9fb-4e99-ac77-d4bd2f80f9b2"
      unitRef="usd">495725000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:OtherIncome
      contextRef="i068759fddb5d4fbd9e32d6347d1e6d75_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTYtMS0xLTEtMzYxNTY5_fb536d34-2a7e-4b32-b573-10b4ba36b3a3"
      unitRef="usd">96144000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i6b9dedef3bed43dba87b7821cb677959_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTYtMy0xLTEtMzYxNTY5_d5b2d7f2-f999-4aa3-b2c3-7edf02dd221b"
      unitRef="usd">94260000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="i2fd089f25d0742cc93cba789d7beaa24_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTYtNS0xLTEtMzYxNTY5_f6fc0486-e0e9-4b35-8932-b85f8aa97633"
      unitRef="usd">301998000</us-gaap:OtherIncome>
    <us-gaap:OtherIncome
      contextRef="ib561b1ec046245b58bddae941fc0daf3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTYtNy0xLTEtMzYxNTY5_f3c783aa-fab3-4dd5-a764-a0616cdfeffc"
      unitRef="usd">285266000</us-gaap:OtherIncome>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ibe0e63e321e945a08099e16de0785d5c_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTctMS0xLTEtMzYxNTY5_4ce1a232-d8f2-41d0-b8b8-df40d5e734c2"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="iee77a72428d248f899e78bbf60ce4cc2_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTctMy0xLTEtMzYxNTY5_3a215330-6892-489f-b13f-a471589cd190"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i283d80459c03449ebbe9a4d7b3746698_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTctNS0xLTEtMzYxNTY5_47f917de-fe6d-4c5b-941a-d5f55ad4e36e"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ibdf9f7a5de6348a2a7d0775d1ab48459_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTctNy0xLTEtMzYxNTY5_7b538fa7-e754-4b71-becf-f4edfaf215a9"
      unitRef="usd">4294000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:Revenues
      contextRef="i068759fddb5d4fbd9e32d6347d1e6d75_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTgtMS0xLTEtMzYxNTY5_b96e5512-9b38-4bac-9133-b231b3f987df"
      unitRef="usd">268398000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6b9dedef3bed43dba87b7821cb677959_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTgtMy0xLTEtMzYxNTY5_0452e888-e0f9-44c4-880d-8ed5d6c7e04e"
      unitRef="usd">262377000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2fd089f25d0742cc93cba789d7beaa24_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTgtNS0xLTEtMzYxNTY5_349d0051-62a4-4882-ae3e-4c3dd236faee"
      unitRef="usd">815933000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib561b1ec046245b58bddae941fc0daf3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTgtNy0xLTEtMzYxNTY5_80078620-8376-4b7b-95e4-30ec8258c9d2"
      unitRef="usd">785285000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id1a93e7f4f5e4e33bffc9621d504b491_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTktMS0xLTEtMzYxNTY5_93bbf992-54af-4205-8e78-3f4eaa3cdf9f"
      unitRef="usd">2971651000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4bcbcc0a834148c8afeb26f2a4556df3_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTktMy0xLTEtMzYxNTY5_08ef173b-e30a-4fb0-8fbc-718fdc513a73"
      unitRef="usd">2960423000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i74c6003e725f4a6c850b011b394744f5_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTktNS0xLTEtMzYxNTY5_9fe31f58-dc3e-4bee-9435-780189bf415a"
      unitRef="usd">8757522000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i700a5ecba5cb45d1ba64cd1d25b5583e_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMTktNy0xLTEtMzYxNTY5_c39d0bdc-bbba-48ca-a251-a18d3e2ec90b"
      unitRef="usd">8749548000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i253b9978247749dcb47c368cdebc35ae_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjAtMS0xLTEtMzYxNTY5_17078c9c-b3e1-42e1-ac3b-20e23659e291"
      unitRef="usd">-22957000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5c321d3f4f114e7a810149cebdfddf89_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjAtMy0xLTEtMzYxNTY5_b5579c7e-eba1-4621-942a-83c2892b984f"
      unitRef="usd">-22104000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4b80df9aa48e4aa9a2eeabbf8c48904e_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjAtNS0xLTEtMzYxNTY5_9a8c5a0f-9ef5-4db0-b746-2b08ecbf83c3"
      unitRef="usd">-64516000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iabe54304a7d4439d88d4c1cbb00ee5ac_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjAtNy0xLTEtMzYxNTY5_293cb48c-b319-44b1-bee3-1829e6525656"
      unitRef="usd">-74718000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjEtMS0xLTEtMzYxNTY5_9eebe2df-dd7c-41c8-ac6f-25a292196ee0"
      unitRef="usd">2948694000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjEtMy0xLTEtMzYxNTY5_54a36c73-b13c-4fff-b1b9-47158808e7ae"
      unitRef="usd">2938319000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjEtNS0xLTEtMzYxNTY5_b0009044-2697-4e93-97e7-0f5a9ea5801e"
      unitRef="usd">8693006000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjEtNy0xLTEtMzYxNTY5_eba44533-b2ed-4fed-86df-247be62a79e7"
      unitRef="usd">8674830000</us-gaap:Revenues>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia8601bd20cd04c22b8e3e448c8c8a4bc_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjMtMS0xLTEtMzYxNTY5_3a45a797-526e-4540-9112-c2fd5a1b74f4"
      unitRef="usd">351474000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i38b206ccc4604608ab1cbaeaa6e878f5_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjMtMy0xLTEtMzYxNTY5_bdba244f-b208-400c-9d2a-f521f54375b1"
      unitRef="usd">509939000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5947da8371ba465b929ebd233615c5fc_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjMtNS0xLTEtMzYxNTY5_79a9eaec-7f23-4adf-9fbb-35e7ba4de8bd"
      unitRef="usd">1230715000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="icc9f7a8bb84e40e581606e923ee81543_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjMtNy0xLTEtMzYxNTY5_d1784739-cb8c-43bc-9e40-e5d2543c8ba9"
      unitRef="usd">1523625000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i068759fddb5d4fbd9e32d6347d1e6d75_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjQtMS0xLTEtMzYxNTY5_6606363e-f0fa-4077-b1d2-231559bec8a8"
      unitRef="usd">-15271000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6b9dedef3bed43dba87b7821cb677959_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjQtMy0xLTEtMzYxNTY5_aec3cb7f-a151-44d4-be8b-87f73bddbf52"
      unitRef="usd">-6909000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2fd089f25d0742cc93cba789d7beaa24_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjQtNS0xLTEtMzYxNTY5_99820d10-fbab-4287-a2ef-59666b82674a"
      unitRef="usd">-56689000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib561b1ec046245b58bddae941fc0daf3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjQtNy0xLTEtMzYxNTY5_8590f310-7b9c-470b-8979-192587a72ad9"
      unitRef="usd">-36577000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id1a93e7f4f5e4e33bffc9621d504b491_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjUtMS0xLTEtMzYxNTY5_5aaf29d2-0621-476b-8ccb-dc6506a95542"
      unitRef="usd">336203000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4bcbcc0a834148c8afeb26f2a4556df3_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjUtMy0xLTEtMzYxNTY5_f591b1cc-7d68-492a-a796-20639e357a2c"
      unitRef="usd">503030000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i74c6003e725f4a6c850b011b394744f5_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjUtNS0xLTEtMzYxNTY5_5a324df3-8238-40ba-8281-0bfb29e72ff5"
      unitRef="usd">1174026000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i700a5ecba5cb45d1ba64cd1d25b5583e_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjUtNy0xLTEtMzYxNTY5_b45df6af-86e1-4903-be7f-ce88ce9fdfa7"
      unitRef="usd">1487048000</us-gaap:OperatingIncomeLoss>
    <dva:SegmentReportingInformationCorporateExpenses
      contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjctMS0xLTEtMzYxNTY5_9292146b-8079-49ab-89b7-3378e00d00f4"
      unitRef="usd">24417000</dva:SegmentReportingInformationCorporateExpenses>
    <dva:SegmentReportingInformationCorporateExpenses
      contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjctMy0xLTEtMzYxNTY5_2066bba6-8d6a-4de7-9f4e-bbb74292ec56"
      unitRef="usd">28153000</dva:SegmentReportingInformationCorporateExpenses>
    <dva:SegmentReportingInformationCorporateExpenses
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjctNS0xLTEtMzYxNTY5_15fa8c87-78b5-4da5-99f0-ef7f4e4206d2"
      unitRef="usd">91217000</dva:SegmentReportingInformationCorporateExpenses>
    <dva:SegmentReportingInformationCorporateExpenses
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjctNy0xLTEtMzYxNTY5_b4b04167-1991-424b-8cc5-b8e5659fbfe3"
      unitRef="usd">79093000</dva:SegmentReportingInformationCorporateExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjgtMS0xLTEtMzYxNTY5_7c724758-ef1d-4c87-838c-155c0c0b9eaa"
      unitRef="usd">311787000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjgtMy0xLTEtMzYxNTY5_c53f7e0d-bf1f-4296-bec4-2ab1f4890094"
      unitRef="usd">474877000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjgtNS0xLTEtMzYxNTY5_0419790b-b0c3-4fca-b33c-c049d0399a35"
      unitRef="usd">1082810000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjgtNy0xLTEtMzYxNTY5_65f1a88d-cea9-481e-831b-3620f46e6800"
      unitRef="usd">1407955000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestAndDebtExpense
      contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjktMS0xLTEtMzYxNTY5_acf2b3c0-36da-4ddc-84ac-7464daf2f4ee"
      unitRef="usd">99680000</us-gaap:InterestAndDebtExpense>
    <us-gaap:InterestAndDebtExpense
      contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjktMy0xLTEtMzYxNTY5_224053f4-c832-4dd6-bec7-7666a0973416"
      unitRef="usd">72829000</us-gaap:InterestAndDebtExpense>
    <us-gaap:InterestAndDebtExpense
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjktNS0xLTEtMzYxNTY5_95ebbffa-67cb-4f0b-8da5-f6d0fb493ca2"
      unitRef="usd">256057000</us-gaap:InterestAndDebtExpense>
    <us-gaap:InterestAndDebtExpense
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMjktNy0xLTEtMzYxNTY5_1228b1a1-e644-44ac-b9e3-70a835ff11d3"
      unitRef="usd">213167000</us-gaap:InterestAndDebtExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMzEtMS0xLTEtMzYxNTY5_f79b079d-dd86-4b37-af8e-e5354d78667f"
      unitRef="usd">-4898000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMzEtMy0xLTEtMzYxNTY5_1c586133-bf6c-4b56-b6c4-37a33e232dd0"
      unitRef="usd">-7590000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMzEtNS0xLTEtMzYxNTY5_7a2e0d57-00ac-4244-8fe4-dd303a95649c"
      unitRef="usd">-7968000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMzEtNy0xLTEtMzYxNTY5_a9473c08-cdfd-4b50-90a0-59d9fda97411"
      unitRef="usd">8766000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMzItMS0xLTEtMzYxNTY5_b63ab107-851b-485c-8f32-2c6d7eff4869"
      unitRef="usd">207209000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMzItMy0xLTEtMzYxNTY5_af97b3af-f96e-49e2-9b2b-1940485f478a"
      unitRef="usd">394458000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMzItNS0xLTEtMzYxNTY5_b2708ec7-2897-4432-bb0c-06b98c15a8ff"
      unitRef="usd">818785000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmExY2U0Y2Y0YjBiYTQ4ZWFiYTQ0YTJiNjRiY2EwNzM2L3RhYmxlcmFuZ2U6YTFjZTRjZjRiMGJhNDhlYWJhNDRhMmI2NGJjYTA3MzZfMzItNy0xLTEtMzYxNTY5_e1cc84e8-4baa-42d3-95e6-68ba66344994"
      unitRef="usd">1203554000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RleHRyZWdpb246NzMwNWFjNzUyNWI3NDk4OGJmNzFmODQ3Mzc1NDRlZDJfMTQ3Nw_6fda0a3f-fc93-458d-bdca-589b7d64ccb3"
      xsi:nil="true"/>
    <us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RleHRyZWdpb246NzMwNWFjNzUyNWI3NDk4OGJmNzFmODQ3Mzc1NDRlZDJfMTQ3MA_3e66edbf-aab7-487b-a4f1-131c4ac983aa">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation and amortization expense by reportable segment was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.175%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.982%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.414%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.649%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.653%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;507,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;477,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&#x2014;Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;538,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock>
    <us-gaap:DepreciationAndAmortization
      contextRef="i138d5ad826a74dd389b7c50d766dce89_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOjcwZDMzYmRjZDZlYzQ1NjM5OTU5ZjU4MjFkNWM2NjFlL3RhYmxlcmFuZ2U6NzBkMzNiZGNkNmVjNDU2Mzk5NTlmNTgyMWQ1YzY2MWVfMi0xLTEtMS0zNjE1Njk_96196e2c-1924-484f-a3b8-c6648217f1fa"
      unitRef="usd">184688000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ia98746ed55ed4291881ac7bb3d451f92_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOjcwZDMzYmRjZDZlYzQ1NjM5OTU5ZjU4MjFkNWM2NjFlL3RhYmxlcmFuZ2U6NzBkMzNiZGNkNmVjNDU2Mzk5NTlmNTgyMWQ1YzY2MWVfMi0zLTEtMS0zNjE1Njk_d80eba49-b64e-4260-83bb-f65f02b7fcc8"
      unitRef="usd">161252000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i422c6a94a816499c8310fd5a0acc841f_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOjcwZDMzYmRjZDZlYzQ1NjM5OTU5ZjU4MjFkNWM2NjFlL3RhYmxlcmFuZ2U6NzBkMzNiZGNkNmVjNDU2Mzk5NTlmNTgyMWQ1YzY2MWVfMi01LTEtMS0zNjE1Njk_66ca77be-5631-40bb-95bc-4812dcabbd29"
      unitRef="usd">507320000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i0cb049c47bd043afa9a8eb3aaf37cb95_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOjcwZDMzYmRjZDZlYzQ1NjM5OTU5ZjU4MjFkNWM2NjFlL3RhYmxlcmFuZ2U6NzBkMzNiZGNkNmVjNDU2Mzk5NTlmNTgyMWQ1YzY2MWVfMi03LTEtMS0zNjE1Njk_36f10d34-b420-42dc-a4f7-a4df2a5df6ee"
      unitRef="usd">477054000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i5743480e6048496ab58c95a14b8aaf6f_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOjcwZDMzYmRjZDZlYzQ1NjM5OTU5ZjU4MjFkNWM2NjFlL3RhYmxlcmFuZ2U6NzBkMzNiZGNkNmVjNDU2Mzk5NTlmNTgyMWQ1YzY2MWVfMy0xLTEtMS0zNjE1Njk_57d5f5c9-224c-42f7-8a1a-f1fb9972f5b6"
      unitRef="usd">9726000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i0162929ca27d43d894768f88369a32f4_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOjcwZDMzYmRjZDZlYzQ1NjM5OTU5ZjU4MjFkNWM2NjFlL3RhYmxlcmFuZ2U6NzBkMzNiZGNkNmVjNDU2Mzk5NTlmNTgyMWQ1YzY2MWVfMy0zLTEtMS0zNjE1Njk_4438b258-85c1-4e6f-9171-fd5ed567ac0f"
      unitRef="usd">9210000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ie63e40be1b8c44ae852031a36cc0c1d2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOjcwZDMzYmRjZDZlYzQ1NjM5OTU5ZjU4MjFkNWM2NjFlL3RhYmxlcmFuZ2U6NzBkMzNiZGNkNmVjNDU2Mzk5NTlmNTgyMWQ1YzY2MWVfMy01LTEtMS0zNjE1Njk_dfdca2d4-add1-45d4-bf85-0712c334a3bd"
      unitRef="usd">31214000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="if7870e39ec59457d85f40917f0be7b4b_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOjcwZDMzYmRjZDZlYzQ1NjM5OTU5ZjU4MjFkNWM2NjFlL3RhYmxlcmFuZ2U6NzBkMzNiZGNkNmVjNDU2Mzk5NTlmNTgyMWQ1YzY2MWVfMy03LTEtMS0zNjE1Njk_a6d96d2c-6772-4c71-8942-5c47c92f4d31"
      unitRef="usd">28798000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOjcwZDMzYmRjZDZlYzQ1NjM5OTU5ZjU4MjFkNWM2NjFlL3RhYmxlcmFuZ2U6NzBkMzNiZGNkNmVjNDU2Mzk5NTlmNTgyMWQ1YzY2MWVfNC0xLTEtMS0zNjE1Njk_51ff5272-22b6-4bed-9771-f26adac102b6"
      unitRef="usd">194414000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i76ab968b4c244e35b71d2baf2def2868_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOjcwZDMzYmRjZDZlYzQ1NjM5OTU5ZjU4MjFkNWM2NjFlL3RhYmxlcmFuZ2U6NzBkMzNiZGNkNmVjNDU2Mzk5NTlmNTgyMWQ1YzY2MWVfNC0zLTEtMS0zNjE1Njk_d1448066-3d19-46e2-a300-482db9b4f9f4"
      unitRef="usd">170462000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOjcwZDMzYmRjZDZlYzQ1NjM5OTU5ZjU4MjFkNWM2NjFlL3RhYmxlcmFuZ2U6NzBkMzNiZGNkNmVjNDU2Mzk5NTlmNTgyMWQ1YzY2MWVfNC01LTEtMS0zNjE1Njk_ce0cd822-e002-437f-823a-98cc623321e1"
      unitRef="usd">538534000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOjcwZDMzYmRjZDZlYzQ1NjM5OTU5ZjU4MjFkNWM2NjFlL3RhYmxlcmFuZ2U6NzBkMzNiZGNkNmVjNDU2Mzk5NTlmNTgyMWQ1YzY2MWVfNC03LTEtMS0zNjE1Njk_6277aafe-9ac2-44ae-aaeb-308dff62a9c2"
      unitRef="usd">505852000</us-gaap:DepreciationAndAmortization>
    <dva:ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RleHRyZWdpb246NzMwNWFjNzUyNWI3NDk4OGJmNzFmODQ3Mzc1NDRlZDJfMTQ5MA_1d49cd1b-fc41-47b9-8307-c2257712dc0b">Expenditures for property and equipment by reportable segment were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.005%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.459%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.696%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.647%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;363,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;415,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&#x2014;Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;409,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;451,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</dva:ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i422c6a94a816499c8310fd5a0acc841f_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmNmZjVlYzJkNWI4ZDRmM2FhNzhiYzBmOWY4MjFhYzFlL3RhYmxlcmFuZ2U6Y2ZmNWVjMmQ1YjhkNGYzYWE3OGJjMGY5ZjgyMWFjMWVfMi01LTEtMS0zNjE1Njk_752f1203-e0bf-4ff4-a83a-ad735d72119e"
      unitRef="usd">363046000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i0cb049c47bd043afa9a8eb3aaf37cb95_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmNmZjVlYzJkNWI4ZDRmM2FhNzhiYzBmOWY4MjFhYzFlL3RhYmxlcmFuZ2U6Y2ZmNWVjMmQ1YjhkNGYzYWE3OGJjMGY5ZjgyMWFjMWVfMi03LTEtMS0zNjE1Njk_1929c4a2-cca0-467c-9662-eb1f18a0d767"
      unitRef="usd">415994000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ie63e40be1b8c44ae852031a36cc0c1d2_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmNmZjVlYzJkNWI4ZDRmM2FhNzhiYzBmOWY4MjFhYzFlL3RhYmxlcmFuZ2U6Y2ZmNWVjMmQ1YjhkNGYzYWE3OGJjMGY5ZjgyMWFjMWVfMy01LTEtMS0zNjE1Njk_410c8cd0-43f2-4af3-9e93-4914876bfd82"
      unitRef="usd">46345000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="if7870e39ec59457d85f40917f0be7b4b_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmNmZjVlYzJkNWI4ZDRmM2FhNzhiYzBmOWY4MjFhYzFlL3RhYmxlcmFuZ2U6Y2ZmNWVjMmQ1YjhkNGYzYWE3OGJjMGY5ZjgyMWFjMWVfMy03LTEtMS0zNjE1Njk_64508723-5038-4835-ade0-67304a97d4c6"
      unitRef="usd">35915000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmNmZjVlYzJkNWI4ZDRmM2FhNzhiYzBmOWY4MjFhYzFlL3RhYmxlcmFuZ2U6Y2ZmNWVjMmQ1YjhkNGYzYWE3OGJjMGY5ZjgyMWFjMWVfNC01LTEtMS0zNjE1Njk_2bb87b46-aa4b-4fa5-b511-2d60104ff47c"
      unitRef="usd">409391000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i00423f61933c4cc68c4ca6dd3c789375_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOmNmZjVlYzJkNWI4ZDRmM2FhNzhiYzBmOWY4MjFhYzFlL3RhYmxlcmFuZ2U6Y2ZmNWVjMmQ1YjhkNGYzYWE3OGJjMGY5ZjgyMWFjMWVfNC03LTEtMS0zNjE1Njk_31b79642-88aa-4b3d-8d6d-a528f17e0f64"
      unitRef="usd">451909000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RleHRyZWdpb246NzMwNWFjNzUyNWI3NDk4OGJmNzFmODQ3Mzc1NDRlZDJfMTQ3Mw_27682729-b422-4058-9ac9-75e89566ed16">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of assets by reportable segment were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.538%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.542%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.581%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.583%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. dialysis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,223,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,375,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&#x2014;Ancillary services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,738,267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,746,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,961,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,121,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock>
    <us-gaap:Assets
      contextRef="i7093bff9492a45488822863f8f94a337_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOjY4NjBmOTUyMDA4YTQ2NjBhYzVlN2U5OGFlNmZkOTQ1L3RhYmxlcmFuZ2U6Njg2MGY5NTIwMDhhNDY2MGFjNWU3ZTk4YWU2ZmQ5NDVfMS0xLTEtMS0zNjE1Njk_717b5cbd-fc53-42ee-95c7-72c0b00e2d8d"
      unitRef="usd">15223532000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i698d58b2d3b2468cbb119fff40dd7a93_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOjY4NjBmOTUyMDA4YTQ2NjBhYzVlN2U5OGFlNmZkOTQ1L3RhYmxlcmFuZ2U6Njg2MGY5NTIwMDhhNDY2MGFjNWU3ZTk4YWU2ZmQ5NDVfMS0zLTEtMS0zNjE1Njk_cfb1b632-ae01-451e-bacc-bdc7c7bbbd02"
      unitRef="usd">15375000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i2d792edae43b4791856eea60df0b33b6_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOjY4NjBmOTUyMDA4YTQ2NjBhYzVlN2U5OGFlNmZkOTQ1L3RhYmxlcmFuZ2U6Njg2MGY5NTIwMDhhNDY2MGFjNWU3ZTk4YWU2ZmQ5NDVfMi0xLTEtMS0zNjE1Njk_fe654f37-d7b3-422a-9fce-d9f2211d6729"
      unitRef="usd">1738267000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i92fca4752e474a7bad54570de210ff8d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOjY4NjBmOTUyMDA4YTQ2NjBhYzVlN2U5OGFlNmZkOTQ1L3RhYmxlcmFuZ2U6Njg2MGY5NTIwMDhhNDY2MGFjNWU3ZTk4YWU2ZmQ5NDVfMi0zLTEtMS0zNjE1Njk_36e0c437-9d5a-454b-bc90-233865d59b38"
      unitRef="usd">1746488000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i50c63cefb9bd4106bee30b310fc866d1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOjY4NjBmOTUyMDA4YTQ2NjBhYzVlN2U5OGFlNmZkOTQ1L3RhYmxlcmFuZ2U6Njg2MGY5NTIwMDhhNDY2MGFjNWU3ZTk4YWU2ZmQ5NDVfMy0xLTEtMS0zNjE1Njk_ed61ca57-bfa2-4849-9976-e5226ee6de18"
      unitRef="usd">16961799000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83Ni9mcmFnOjczMDVhYzc1MjViNzQ5ODhiZjcxZjg0NzM3NTQ0ZWQyL3RhYmxlOjY4NjBmOTUyMDA4YTQ2NjBhYzVlN2U5OGFlNmZkOTQ1L3RhYmxlcmFuZ2U6Njg2MGY5NTIwMDhhNDY2MGFjNWU3ZTk4YWU2ZmQ5NDVfMy0zLTEtMS0zNjE1Njk_7049d100-8c73-4e3a-80df-84aa0a5f6bc6"
      unitRef="usd">17121488000</us-gaap:Assets>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzMTFlOWM1NjY1ODRiZDlhYjVkZmZiYzliOWE2MDViL3NlYzo5MzExZTljNTY2NTg0YmQ5YWI1ZGZmYmM5YjlhNjA1Yl83OS9mcmFnOjhlNDhiNDkxNDgwMjQxNmM5YjIyNDJiZWViMDA5YTMxL3RleHRyZWdpb246OGU0OGI0OTE0ODAyNDE2YzliMjI0MmJlZWIwMDlhMzFfMjA0OA_ea26976f-2fbc-4a67-8c32-ad50fa7161d4">New accounting standards&lt;div style="margin-top:9pt;padding-left:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;New standards not yet adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued ASU No. 2020-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; ASU No. 2020-04 provides optional expedients and exceptions for applying U.S. generally accepted accounting principles to contract modifications and hedging relationships, subject to certain criteria, that reference LIBOR or another rate that is expected to be discontinued. The amendments in this ASU were effective beginning on March 12, 2020, and the Company may elect to apply the amendments prospectively through December 31, 2022. Effective January 1, 2022 certain LIBOR tenors that do not affect the Company, including the one-week and two-month U.S. dollar LIBOR rate, ceased or became non-representative. The remaining U.S. dollar LIBOR tenors will cease or become non-representative effective July 1, 2023. This change will have no impact on the Company's ability to borrow. The Company is currently assessing the other effects this guidance may have on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2021, the FASB issued ASU No. 2021-08, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations (Topic 805): Accounting for Acquired Contract Assets and Contract Liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. ASU 2021-08 requires application of ASC 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, to recognize and measure assets and liabilities from contracts with customers acquired in a business combination. This ASU creates an exception to the general recognition and measurement principle in ASC 805 and will result in recognition of contract assets and contract liabilities consistent with those recorded by the acquiree immediately before the acquisition date. ASU 2021-08 is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Early adoption is permitted for all entities. The Company does not expect the adoption of this standard to have a material impact on the Company's consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>68
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M&X#[_:ZJ[--#,\#A:GW^#U!+ P04    " !6D%Q5HPKS]Y$$  #H$   &
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M(6^A]>N:X(PP!9#?EY2*UX8:H/MS8_H/4$L#!!0    ( %:07%5[T:48V@<
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M1=/7=+6_X\?NCM1QQZ7<O4<,OT,44VII?NEO?B57T)RTS<EQ\RF,_>  >G
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M3]6W;"E@9-960I;05#*>(D'74V-FW<XM6RL4$G\QNI.-;Z1=67'^I </X=3
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MJ'03?:4?6VH@PZ1,S'*L"@U;'VC#BC)S'8IEW]+N1CPHC4L0VQRRI+LU-.K
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M)C-:T'Y1[TYW &^1CUW%* G2U-0X6K&)TIIY4Q!H4(G2%$K3%&T@\;0W']/
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MW$1I%4JK45J#T@1*DRA-H31-T8:ITGNFA=LSG:S><8_WS@?4*T5I-4IK4)I
M:1*E*92F"\M7>V9QD)YH!5[T9FGA-DLGBW?<X[V5CGJ?**U&:0U*$RA-HC2%
MTG0Q]F6CH#C1I[/H[<_"78_I7;SCYGGK?EQ16<:E>3&/NILHK9DS 8&&E"A-
MH31M.1Q%EI\0:>]%%FXO<E:EC9OA+4S+URQFF=D K4*#UBBMF3<%@0:5*$VA
M-&T[(&$9GU!G[SD6;L_1JS+&S?)6Z=CGLI2R5&C0&J4U\Z8@T* 2I2F4IBG:
M4,V]*UFX7<F3%2_N<=[*1>U'E%:CM :E"90F49I":;JP5*<>ES$-]=W[CX7;
M?_1KYNV&>8O>4GJ8%WDQ:DZ/AJU16H/2!$J3A:7-K.T *S2LIF@#29>]U5BZ
MK<:7-_-V@WWEC=(JE%:CM :E"90F2XN%6@2E82\I-*BF:,,,Z%W*TNU2NIMY
M6ZL6#\3C4T4>1&%DK*)\4X[=NC2.LMQH"5*Y]]!;KN.]*XU+XL:R9]W=79R8
M1J)ENR+),K-IE;3$M)\\+<#S,$Y3\[N@M&7#,"N3HV\]'K[?O6573GU1X\MZ
M=-N5,*XP*X,P2$PAH.8<2JMM4RC"TBS<0H,*E"91FD)IFJ(-U=Z[;J7;=7MY
M[VV[WE&/#J55**U&:0U*$RA-EA8?S/:ACYIO%&V8%KU%5[HMNGF]M_7#:B(=
M4",/I57EV/0)XR(MS,KL&@W;H#2!TB1*4RA-4[1A0O1>7NDN9>1Z;Y>HR8?2
M*I16H[0&I0F4)E&:0FF:H@T3I_<7R[FUCM9D0(U%E%:58TLK+J,@-3\>4&,1
MI0F4)E&:0FF:H@U5WON4I=NGG%R\YQ[O+72T+VMI^1[,I(CRD=)1<Q*E"90F
M49I":9JB#97>>YBEV\.<7+SG'N^M=-3++,>^5UB:M:LU&K-!:0*E292F4)JF
M:$.=]UYF.>%ESED7Y69X:QTMIBPMAF@4CL[IJ'^)T@1*DRA-H31-T09:#X/>
MY=R_=JG=:YW5!,Q7]BRN>L(9WY67&P_L:S9LP^($BY,L3K$XC>$,_8='^O\7
M-&N=".*?%VB[UB?<H![>VJ^5#=RP.,'B)(M3+$YC.",SHJ/,>$'?ULD'_Q-4
M_U08F[!9D.2%N;B+C5L_X9QK!6P[E^;=_;.QC$'8-LR3,,H,HK2%/<^"0>W5
MD]QLO5[#,!\UY+%M&>9!7)YH]AH&\9%&T':O,]2#VJ@LKF)Q]1/.6&!@7J\T
M;%C!XB2+4RQ.8S@C19*C%)DP5'T;Q,Y($M1<97$5BZM97,/B!(N33[AAIY8R
MCT<G?]1AQ7!&DJ1'20+UBWT"8=I'75065[.XAL4)%B=9G&)Q&L,9*9(=I<@?
MU3IV@NR?,V-[M#L\<69V[63CUBRN87%B[E&1;%S%XK1M&E$01B?J.<,@/Q+P
M']!%]@DZN"&*XCPU'F>_>=HPG]BPFMA-?U6BWBB+$RQ.LC@U]SW36%Q#O,61
M>-FVLA,\_W,NZH:RN/H)-SQIC.YB43N4Q4D6IUB<QG"&_LLC_7]Y@]D)AK_F
M+3YF68RO,M"R3A;7S)N$8*-*%J=8G,9P0S6'1Z9G.*.-[!?UWYR(X*WU<&Q=
M1GD6FIU1V+ UBVMFSD*P826+4RQ.8SA#[4<69QBZ'ZY\02O.)S:F<];91'$U
MBVM8G&!QDL4I%J<QG)$U1_9GZ+8_)Q?V3@#\4P,MA65Q-8MK6)Q@<9+%*1:G
MGW##N^8H"$ZT+0S#(S\WG/)S)];X3@#\1<\:M"BN9G$-BQ,L3K(XQ>+T$VYX
M:7EJ!4-X9,^&;GO6NU7G!- _ UCW%<75+*YA<8+%21:G6)Q^PLWJ AJ&1]YK
MZ&Y6.VN]^P3$7_7CEJ;G<3QJ4LN&K5E<,W,6@@TK69QB<=IZ4$XV! W#(P<T
M=#N@?DO5W3!_P8Y]L?'2\HJ-6K.X9MXD!!M5LCC%XC2&,V1]Y(N&;E_4KW?B
M!,U?UQ8++BR2T3+2B@U<L[B&Q0D6)Y]PV=115FQ@C>$,=1\9IZ';.'UY&\4)
MLK_260L5Q=4LKF%Q@L7))YQ1H1A%HV1@750*9R3#D8L:NEW4%W14?$).ME2T
M;6CMJ3BQD_[*'<<=5TI8-K*V5;1M:.VK:-O0WEC1NJ6ULZ)M2U=KQ3 ZLAPC
MM^6(-E=\"C;577%BI[S/>2BNML["TF"1#2M8G&1QBL5I#&<(_\A]C"8*+-D^
MBQ/AO*\*4%S%XFH6U[ XP>+D$VZJW2(;5F.XSQERL;UNVUVUW"U?O[I??FC_
MLMQ\N%EM%[?M^PX??)NG9XO-S8?KYU]VZ_LNH<X6[]:[W?KN\>5UN[QJ-_L-
MNK^_7Z]W3[]<=/Q/Z\WOCS%>_S]02P,$%     @ 5I!<54K0C3./!   :0L
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M6&@;V>N&EMHJ6VIE*$3\0#1BH"?(G(XCP(K)<=D#N\C 9H\ ^YD^.QOK0+_
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M"ZR8GL@:!9WD4E7,T%;MIKI6R#*G5)73* @NIA7CPMNLG.Q.;5:R,247>*=
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MC?&X^85'1 JYIPWXOC6@3/="!H;+^^U?4$L#!!0    ( %:07%7#B#45O0@
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MY4'\,@@3R/7YD-U#5P,\J$V2&H*@P>I?NVX7-JZ=LQ,0VO(2)9JU%=>077&
M*ML*#JKA7&Z5?MHH8)!3:HKU%AIGS:1] >P6*R$*=3).J+V!%+/9)Z%ZZ)U)
M&F]_@N9G^(L(6Z,<^D&^FYKX@O&9%L*)3"Z,1*)0C:IEL<I6V!M!AEGAMN8)
M$XNL 6#QN'!MN%6N23J8#.>\F6&>@$P(21I2%&8JYQCFN6=,*P5I#XXE8K2I
MAX:N6FH0H-@AR78S2&6QK^!;GV]<^@.G@*G6X9U#!Q#E6VW'VI837H''B1TF
MO5^?K!K ?M\&EZY*Z$--)J9QTT[^@_"N0#MW!68;,: '",!3GDAZ\\QJR*D4
M1LX:*KXX#W S1^B6##QUYIH,#S]PD,? 7.OU=I!-5T V:C9QU (A=%G>U4R:
M,L0<!_<'-"N\"P>HTG(&P5FMX@TKJW2EV,7_PO$$,X-5_@M,06,*4/ ;X"<0
M+<YP?L/*<TY0 190CQ24(&)"$P_ )W@QWT8 Z+@F)YEJ55/$.;=%,7%X.8!;
MJ3#C@%J-!7=8V07FJ!_GN 8,J;P+G(.$<9KV@Q6SY-SNS@-4,IN.2X-#^M8<
MC[9-;SG4#I"O[4GWR[D$&!#3HN+&R*ETEAI\)E-5_8P('X4U P08@0'%C*ID
M29ZR<ENZ9;A@?VSD08%3/\QM?2<*,PB$$YBXR^$NR%?A[X;"+=#9N\>%U-2S
MN/?[37M_A0RC\8C/=Q_8#.'_U3A*V6L'P1,6K4>AH>^?PE 5^3BJ^?U33#-1
MG*<TNJ1>/*99,\IA9HQH#8I5!,>3CH+EY+;35A.0I0#?J"A=K7*4%AN0D\?Q
MHFAK* Z(Z;Y0J91QO:=>:0WFWG)_+1PUA,6KW6@5978.2W1,\\R0!QP+@:7Z
ML<H+JP3LK(L'D8*JU;^N'MY>T9_UDNO0W&;6.>BOYR7K*E337W;8N=0E3$&0
M!$#!KH+3O4@\C.)3;W_;#F$+.6NS)4<@7R;"P8)+=D6/<=%(TE&>X!-(9"Z%
M["*$&0X+V8N1^I,&=X"$V2F11,,T._6Z&?) [ND@S$]?V&/L]]>NHUN/2:OF
M@D95MXSAM1Y@8#GQG9A9?HH'HUEL?UW@H;<N'#;5TW#?%=UHX^:T%GI&]\.8
M_B"$W25JO]I?0=^XF]?U=G=__:ESE$I,@=0?ILD B@3=";L7JQ9T#SM1UJJ:
M'N<"6D:-&^#[5$%>Z5[P@/YB_OI_4$L#!!0    ( %:07%6[;4WU'18  ')
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M^B<##0O0^49KM__@"_I_6U;_ 5!+ P04    " !6D%Q5@+G "RT$  #+"@
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M,!Y7EO!8XHXH+"W ?&&,WPS(P/;6>?T_4$L#!!0    ( %:07%4/N%R6^0(
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M.!+]%90F-9-4*;K9L7.Q764GD]K4[NQFQYG9AZU]@ A(Q)@D& "4K'S]GFZ
M%&5+RN7!%@4!?3U]NHF+M75W/M<ZB/NRJ/SE( ^A?CT>^RS7I?0C6^L*ORRL
M*V7 5[<<^]IIJ?A068QGD\G9N)2F&EQ=\-I'=W5AFU"82G]TPC=E*=WF1A=V
M?3F8#MJ%W\TR#[0POKJHY5+?ZO!'_='AV[B3HDRI*V]L)9Q>7 ZNIZ]O3FD_
M;_C3Z+7O/0OR9&[M'7WYH"X'$S)(%SH+)$'B8Z7?ZJ(@03#C<Y(YZ%32P?YS
M*_T]^PY?YM+KM[;XCU$AOQR\' BE%[(IPN]V_3>=_'E!\C);>/XOUG'OR=E
M9(T/MDR'84%IJO@I[U,<>@=>3@X<F*4#,[8[*F(KW\D@KRZ<70M'NR&-'MA5
M/@WC3$5)N0T.OQJ<"U?OI7%B)8M&"[L0"U/)*C.R$*;RP36(?O 7XP!%M'V<
M):$W4>CL@-!7XC=;A=R+7RNEU>[Y,0SLK)RU5M[,C@J\U?5(G$R&8C:9S8[(
M.^F\/F%Y)\>\_I.]?F=\5EC?..W%?Z_G\!I ^=\^GZ/(T_TBJ7A>^UIF^G*
MZO#:K?3@ZN>?IF>3-T<,/NT,/CTF_4?3]*U"_4&IXE.NQ5M;UK+:B%++&*B
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M?;SVCU[ WEK."\X++5WU')T<A5&8I8R0?R)F+X;GY].]UG0_?GJ(YW]^/P'
MTN')^61X_N+D@++M[VC1E#<H@1_)4J*E7,(5#G#V%;]^D*54XU)IXP^!CW*
M>E'&'JBI!^Y!SQ"YU@@+LC:=1)A"!M1[6Q@E"5$^X(,R2:[$. [AI:\USS+%
M9O1U%#G-[:@BEMO9ND(AV091PGSW/!KI]-)X<EGU-A,+H<I(UM.R"0T OV@J
MY9]U%(6BP9R2W25Z!*]0)IQZ5%V0:$KV+-(SSW6 ":VT)!J+B+.I=*39M#BD
M0@3Y%"@CD,$(,4WQ.P51.%CEN-84.GKC*3NCX]7Q398NG"U[K:.TBKBM"8#9
MES;QZ!^V3,0HL[P7F )$GF64>W6D_\0VP0V&U=% 0K)3,,@Y;TI32)<HCC7T
M6<ZT\VV*(Y/6&K,NDQ>'Q6$27C$C;;M:"GK;W(+X'*F,@0]["?CD#_HM&#&"
MJ!=0I 2VK8FU-T:CWV'7BE9-B2R1R[:0%*FVGR&G)K1#L_!KY"/UQMW^IBQ\
MJFP0<PTY*\U1QA'.B9 E]8X8NHS[[)P2*9&1MN<C2*'H2B?V77,,"^M6#FE
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M>D18E*XH?U^'/%CX,3/0*D0!5+V"VQD2%*"6"LSGZ/7/B:U$)9G$8R:-ZXV
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MJ0AV+$#^H&%E-H$?7 CDGF %6+J&"D.$W-P-YHMUIXBX!^9-V)<L[4LHP@J
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ME2+)O-CF=NX]=SFDK_?6??$Y41 /96'\S2 /H;H:C[W*J91^9"LR6-E:5\J
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MO=<9,@WW@8_-]%!1ILF$E'UZ4%2EM -8R*HJ#AR0SZ/U2.S(D)-%<>!040Q
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MXPU8WUH;V@$;Z/Z:S/\#4$L#!!0    ( %:07%5'SO9-,P\  *PI   9
M>&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;)U::W/;-A;]*QCO3)O,R++L/)JF
M26;L/&;=9\9.VP\[^P$B(0DU22@$:$7]]7O.!4A"MJQV^R6Q1 *XSW//O="K
MC6MO_,J8H+[45>-?'ZU"6+\\.?'%RM3:3]W:-'BR<&VM SZVRQ._;HTN95%=
MG9S-9L]/:FV;HS>OY+N/[9M7K@N5;<S'5OFNKG6[O3"5V[P^.CWJO[BRRU7@
M%R=O7JWUTER;\.OZ8XM/)\,NI:U-XZUK5&L6KX_.3U]>G,ZX0-[XS9J-S_Y6
M5&7NW T_7):OCV:4R%2F"-Q"X[];\]94%7>"')_3ID?#F5R8_]WO_D&4AS)S
M[<U;5_UNR[!Z??3B2)5FH;LJ7+G-OTU2Z!GW*USEY5^U2>_.CE31^>#JM!@2
MU+:)_^LOR1!_9\%96G F<L>#1,IW.N@WKUJW42W?QF[\0U25U1#.-O3*=6CQ
MU&)=>//6-25L;$I5N,:[RI8ZX(-M@FEMK1:VT4UA=:5\P .X(WBU9\U?+7GT
M$:\5UOC'KTX"Q.;A)T42\2**>/: B-^JGUP35EZ]Q['E[OH3J#OH?-;K?'%V
M<,-KLYZJ)[.).IN=G1W8[\E@PR>RWY,']CLO"M<UP39+U:NI_G,^]Z%%S/UW
MG\)QOZ?[]V,BOO1K79C71\@T;]I;<_3FJW^=/I]]=T#:IX.T3P_M_D\\OD^%
MPX=\6AG5-;HK;8@'_=]!9INBZDIY2X65]8" M6N#TJU1L,H:_Y=JOL4S@X"L
MU[K93M5E(Y_=VC9,>;= JC0 %VXY4;JJE"[_0%+%(QI3&.^!10KHIK1::-LJ
ML7@#.=(&W ]?(<D]/P(.6WGF11) "/&E%Q-+_XFR4W4.T;Q=-G9A"]V$^'81
MU0)R27SAQ*94"*K&ZR**L-*W1LV-:92I+-"!)TT5C1]-E&L!T?8:NC6?.PL-
M,U.IX/#IQBCC@P7RF7BT]L#N=3PYK#1\L5A ^60B>@=ZZCK*BD-;<VN:SOB)
M,E_6- G^PAXFX/_*ZKFM;+#\$H9B]IA&4H='-:[AEZVK*J:5F /">%2/^1]R
MIE/K+D!-=VM9(7Q4NW8^[!CR80TZN*FMMMS^@'5D59$\P7<;Q\T@*^*@JK80
M[=95MZ97%O\7#L?'DI,6=]'.A;&W>EX9*&S:@(H9(^Y65UUFZDF_A*<Q,)$)
MKC8JZ"])B\IYOVNSJ/S^,-T3H@<3K]9;*CEDAX62<ZXI85&64.ZOFZ;#LG0,
M!$UGBR#_+ F47[FN*GD6Z06EQ=H_NB:6[XT-*XFT#%3&C1_T7707UK4&(;,+
M*@-P?/6O%V>GWWSGU7E4ZRI"#4YEY5>GL^,?Q!-<LC6Z58:52+V#A>JY:2,T
M/SF5@G*J'LF_7/1XJCZV%@MA)NL@<H4 E,B,KH$*Y%4,9FY==&W+[$MOYT@4
M'9S$1=I[91@VHCM2PB.'N9(Q&*ANZ[IE-!?M\\^126U@.&61-DQMV)-'#U8D
MH(X@FD,K7RVM+Q"J'=28'JA;SX:Z]>Q@2;F*";:O%AU>^(G.%[3.@0%Q%9,P
M".9X[Z ZS2&!EK(Q1K:<.U&;E2U66>8'(J3'4WR4L/!T)+0E'O2)D.$/!1C1
MRS5+%Z$-%H+=Z1YNM<0?*XW$!A LC5NV>HUSQX>E!>@B3 J^$#\,"(F("2FT
MD*,"H*@4XUIZQ3$7U%IOB2STJX R_,SBZ/$ ]F !2H^BKWE":7""U)A44_1Z
M#;)#0$.HVEI"  =XPSCCI_[<2:\1TVXXX+[>7%TXUY;9(7.8>V&E1/H4QKLF
M!;S!W] +FR@\P&ESZ*C6SEM!*T$!LXS0E<>H."N"=MQ(@/O/$1UV\W&JWB$W
MMMZ.1B(UL\6 _1 R!:F_NR,;AY* L@]U>H5ZNI&5>%JV,/DJJ:5%%!_DG]!.
MO^F$P-S#0SR_D&H%RU%\Z=YH:S>O[#*&R-_0YP&[)'Q*;_M$R5"(RSN:YL[*
M;$/TL3ZDJ&%]@="(R.B61>MJM:0[&^$B,2KJ&GR(V+0RNJ)[*]A(0+GLM1CD
M&60A28BJ^5T 9;O*W*?=.D_(EU.DW1(^:)"K:(#+#L$M-1B"#0<%U*<,YUI3
M"7!4>C[(\)U:N0VA@=4\\(#D*\MTZ<,.>S7T#-$D,S.9E: G64"T!\V>"S55
MOT@>CY&W^WFP<4;#%""JN4>:OZ8,S?&@'$M 5=$(HW]'>( ,T>H961264P(9
M+#L>2;-A*8&N"WU\#8?,.X^D!15,1#*/[](9+P0D*U+WU&/(]:'UM^)RQ__0
M^=?I]?2^KN,!J<;=,YZP1M5:?W,<(UVW+;&M;UKNF):P# BGD#>V; Q D5(]
MNOSA[>/!"CG*"AE,6\=7?[O J_DI4_6K",&8Q,.=9Y,=4PK=I<,Z> ].\ROI
MFL9"3ST&9A-<P%>U(<]CO,;H$2'X2I])@.0*E9L=T]P14HG1Q0IY<Q.-/'R$
M!Y9,LI!*9RX:-.Y:256@.S<34NNR)DIJ5W1BV*XI$XEHCJ,9@T?EJVU7$\IL
MV?,I*3%\"K%MV*I'N[Z1]$+1U&W8/I[$NI_7ATWD#4.5FU!,'MU&^D<+R.OX
M>\=J0;=+-#F'2,_S@?0\/\A=WB/JH(%7'^'P:[IO'_\YO,>%]B 0IM\)61(#
M@? #F8LNPA=@H;3(%6ER3.C;#AU":^==D#J?#-L[,2')1D9?S(54R)N.M#AR
MD+J&R>0\3R@ M6QXQ%3]?G?5@^]FR0B$L=++ *F+&T0 @D=O=%OV'2G4:AR"
M"0G1YG0+$;PP-H",(CX+W7F3VM;"KF-82R\=2Z?% 7B9B,.74'$YU0GJEI##
M?A%$R-/_X%MHG04%T8 OK;2TV[ZE3MGZSE8=1=[G@:B8CTR=[Q$]36RKV<9E
M1A"-C]$]AVK0'\%)#2);:FG/6)*ZAJ+NF$E@G'VLR!)A+)(-HY$FV_1J;<(*
M7.= Z'XSA.XW!\/N>H4>ZIBF$I%^A$OBITL1[L'!TN%=WYDY>0K 0V8'+^_
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M*31>WX.YII)Q-(&DS#8)IE@U]G/7\_E.AHPH-2F].0>*-$V(.;WL;6U!O=-
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M<VAE970R,RYX;6S=5TMSVS80_BL8)9/&,X@%XD&"CJT9VTFG/:3-V$Y[R/0
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MG.F"=E^<_I<4<BF*@X=,1O@.<V4#./8<T5AU3,L\\CE$7<HT6W*)\Y+W$H6
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MYE\_669/%(\M]KY0F#IK+#E,/MX,V1E.RB2DHB#X/)R4&9196!8E;<?A>%K
MK:$N27!$42/U0,L$;+1J@1I"]0@[P2@':9C$&11AG!>0A4F90QZ6T^28^X.E
M+$S'&4&7X32;0CD)DX*V21*.R:^>E#R%XY2)GP1FE/BHC/(I?8I1ZB(S&>4G
M^_\/-/.@V=B#QC[(HW@*M]+R=[YLJ(OW87AGT%KA@KYGNJ;</U>B<^GWD3J4
MG>O];Y*WD% 4*-[$;SJ9@HN<DZ[Z&#%C5$6U3<I[;ILAS!=Q7=D?RO>LWE_9
M6V/%J/S=W9>AH%_1[ZA*M4>R-$E-IU\&BRW:1M6C2ZTB.FOR].BV?I09J%0G
M;=_OC]+CM+SMA\3I>C]J/S&]Y51  C>D&H\F10"Z'U_]QJJ='QEK96D ^65#
M$Q^UNT#G&Z7L8>,,'/]#+/X%4$L#!!0    ( %:07%5X8;4:;0,  ,\'   9
M    >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;)U5;6_;-A#^*X0:%!N@1.^Q
MG-@&DK3%"JQ 4&?;AV$?:.ED$:%(E:3B^M_O2+U$+1P/V!>1/-T]S]WQ[K@Z
M2/6L:P!#OC=<Z+57&]/>!($N:FBHOI(M"/Q32=50@T>U#W2K@);.J.%!'(;7
M04.9\#8K)WM4FY7L#&<"'A717=-0=;P'+@]K+_)&P5>VKXT5!)M52_>P!?-'
M^ZCP%$PH)6M :"8%45"MO;OHYCZU^D[A3P8'/=L3&\E.RF=[^%RNO= Z!!P*
M8Q$H+B_P )Q;('3CVX#I3936<+X?T3^YV#&6'=7P(/E?K#3UVLL]4D)%.VZ^
MRL-O,,236;Q"<NV^Y-#K9LA8=-K(9C#&<\-$O]+O0QYF!GGXAD$\&,3.[Y[(
M>?F!&KI9*7D@RFHCFMVX4)TU.L>$O92M4?B7H9W9?!8OH UFV6C"!,:S,X2*
MDL"WCIDCT5!TBAD&FOSR1'<<]*^KP""OM0Z*@>.^YXC?X%B2+U*86I./HH3R
M1_L _9V<CD>G[^.S@%MHKT@2^B0.X_@,7C(E(7%XR7\GP2<?QA1\[%.P?4W!
MWW<[;106TC^GDM!SI*<Y;'/=Z)86L/:P>S2H%_ V[]]%U^'MF0C2*8+T'/IF
MB\U:=AR(K,@LFE-NG@4Z[>93#>1!-BT5Q_?O\CA:W&JB:ZG,I0'5N&1Q*?;]
MZ><28O/D%A+;61LF]M93I\H$YK3K*[#@5&M6,2@)U:0&7EX:>8F]9V_@^ 8J
M=HRIB9U(C!\1TWK!A"U64E&FR OE'5Z>5*A30M.Z:= +?7( !9:KDASGD[[!
MZVX--#M04X%A112#)'*2J*^1H3Z>I*'\A.0!E,%0"FHLN0VVE9KUJ9&F1CB#
MTVT4:W)!%@L_3Q/<N"3'MW-1G/AQ?/W#OT'T4P<WG>F0O>I$J1U7(9L& \9)
M4CSKR3Q9^LOE8EQ&:9K[V3(?EQG]H'=!HLB*PKE'K]J1G\<IV;Y6QOR6+LAU
M[.=)[$#\=&%A%ZF?A!EN<L1R\*D?YB[>V$^BD/P^E=4<*LK\,(I(C,3(ER9^
MEF36=+E<DB3ULR@CZ1*7]/^&<*HC@]F0;4#MW5.")2L[8?IY.TFGU^JN']*O
MZOU3]X6J/98]X5"A:7BUR#RB^N>C/QC9NI&]DP8? +>ML;Y!607\7TEIQH,E
MF-[PS;]02P,$%     @ 5I!<58__UW=T P  R@<  !D   !X;"]W;W)K<VAE
M971S+W-H965T,C8N>&ULE57;;MLX$/V5@5H4#2!8(G7QI;8!.]E+'XH-XK;[
M4.P#+8UM;BC1)>DX^?L=2K;L%*Z+?9&&ESES#F>&'.^U>;0;1 ?/E:KM)-@X
MMQU%D2TV6 G;TUNL:66E324<#<TZLEN#HFR<*A7Q.,ZC2L@ZF(Z;N7LS'>N=
M4[+&>P-V5U7"O,Q1Z?TD8,%QXD&N-\Y/1-/Q5JQQ@>[+]M[0*.I02EEA;:6N
MP>!J$LS8:)[Z_<V&KQ+W]LP&KV2I]:,??"PG0>P)H<+">01!OR>\1:4\$-'X
M?L ,NI#>\=P^HO_>:"<M2V'Q5JN_9>DVDV 00(DKL5/N0>__Q(.>S.,56MGF
M"_MV;Y8'4.RLT]7!F1A4LF[_XOEP#F<.@_@G#OS@P!O>;:"&Y9UP8CHV>@_&
M[R8T;S12&V\B)VN?E(4SM"K)STW_T+K<2Z7@_6>Q5&AOQI$C6+\8%0>(>0O!
M?P(QA$^Z=AL+O]4EEJ_](Z+3<>)'3G-^%7"!VQXD<0@\YOP*7M)I3!J\Y%<:
M15W"Q]J)>BU)*\RL16?A3MI":;LS"-]F2^L,5<H_EXZAC9)>CN*[9V2WHL!)
M0.UAT3QA,'WWAN7QARL:TDY#>@U]>KLAUFA!UM#)6;[  VZU<3YSL, U-0OI
M^?89GQW,E2X>+\JX&NBRC+/HZ[/HYA3='J/OD<Y16%AI10UO1_"EM^A!*85Z
ML=+"7VZ#!MZ]&7#&/\"L+@B*+@/P@61!(6YU;;62I7!8PEPH41>$Y^ ."ZR6
MY)NPIC!B> MYF,3#<,@'WB:+#5@S.V1DQT.8%=]WTDK?_A:&+!SVAS!@(<\S
M8/TDY&E*R7]"ZZ2C[%MXS\)^FMUT](YCZG_J[IKZT1BLBY>FD'2C1)3_4I.V
MTCNW- V3O']S,J[H:!FG<1RRG'L[S<.8>+Z%?AB3S5/V6@?+PWX6 QN$,1M"
MDH;]?/B#C(&/G82,Y\V?L^3_:\BRD&6DO3/.-%"#NH.(0Y>V(HC:@&=-,K)P
MP/JM",[#/.77_4>GJGZ-U&<4/FV16.)3R.DXBEVU4TV%R&HKI/'<H=@(XXOT
ME#TJB22);\ZL7].\U*O1V?U:(07QKXB%0N]JUUZUW6SW4,W:^_FTO7WE/A%'
M25E4N"+7N-?/ C#MR]$.G-XVM_52.[K[&W-#CRT:OX'65UJ[X\ 'Z)[OZ7]0
M2P,$%     @ 5I!<5=U(=R=N!@  51   !D   !X;"]W;W)K<VAE971S+W-H
M965T,C<N>&ULK5AM<]LV#/XK.*_MDIMJ4Y1D26F2N[RTM][U[9)L^[#;!UJB
M;5XE424I.]FO'T@JBN,Z7K/;ASJ4!#Q\  (@T..U5%_UDG,#MW75Z)/1TICV
M:#+1Q9+73(]ERQO\,I>J9@8?U6*B6\59Z93J:D()F4YJ)IK1Z;%[]T6='LO.
M5*+A7Q3HKJZ9NCOGE5R?C,+1_8LKL5@:^V)R>MRR!;_FYK?VB\*GR8!2BIHW
M6L@&%)^?C,["H_/$RCN!WP5?ZXTU6$MF4GZU#^_+DQ&QA'C%"V,1&/Y9\0M>
M518(:7SK,4?#EE9Q<WV/_L[9CK;,F.87LOI#E&9Y,LI&4/(YZRIS)=>_\MX>
M1["0E7:_L/:R43*"HM-&UKTR,JA%X_^RV]X/&PH9>4*!]@K4\?8;.9:7S+#3
M8R77H*PTHMF%,]5I(SG1V$.Y-@J_"M0SIQ]DLWAMN*K1E)F!@QLVJ[@^/)X8
M!+<BDZ('.O= ] F@'#[*QBPUO&U*7C[6GR"I@1F]9W9.]P)>\W8,$0F $DKW
MX$6#I9'#BY[ N[3V70I=5%)WBL.?9S-M%$;%7[N,]5CQ;BR;*4>Z904_&6$J
M:*Y6?'3ZZJ=P2M[L81H/3.-]Z!MG8CGO8O>C^NY,UTQ#(>M6"<U+D',P2PYS
M66$^BF9Q!&?:OD1W&U[/N!I\OO7JDA?]0^B^A_"1F4X)<P<E,QS>-[@EUP:4
M?7JKC<"<P0WG3"A8L:KC<! >(F@CI,(_!1Y""1?X(PR\8X6HA!%<'\&-9?Y!
ML@;.X 6$08(;TH3X=3X-LC2!;!)2+#PTA@_OSS]?_1*.T^2EER DF-)D ^7\
M=0@TF$[38)KE=I5E 9U& \9T"X/BCB3(4P)7?"6K%3H)K(NMEPI/EZ9)0 B!
M5S]E-*1OGJ1S+]<;_4D::V \1H(O'[W$3=.$.-F'U702(FA$O )X;B&-@P@]
M$+DM'F%XXZWFPXI.PL2"A$X!O(_(-+.;P%GQK1-:N/(H9Y58,+O4P!J,$XP2
M!8T#;MF=+0MP0 \AI$F0D1Q"]%&2YRY27N,&4TC&&?4;]"+O1,.:PKF/8^%\
MM,5!=(C>R0,:1D#S',W*+%1DH3(T.(D0ZD8:5OD@QNA%J!8?\6;1!AE:7*<7
MY-,0[&\<9-/$I;CL&A.@#J]%5SMSL%!S90-N/I JI#9()#[$?VF04(*+9(KA
MD1PB,,G"((X=,,F","/P@6M,I Y1&N0CE7/; 0UCC$X+$J(Y>%J'Z($,F:2H
ME+IU2I$GNMN&/UXE+O\N,"%9<_>S!NV/4/<)T4?8?$@(1[\7<L<1;*84[_,,
MQ;"FV?NIA*Y%8C-1.DVFO\*WSNN9NU84K*KN@.&1K'@%%$33=F;L>+'GA4/@
M#"F84G?6G8Z/!E</&YOXK&V5O'7LK"12YCN* M+RK''3!V-\E4*9'NX>O=,^
MG.ZY;Y8<9XD>NRB]6?*MKP^\YL\W%83N^:S=-6^M6W&%7<O6+H,ISC5]K,S%
M+?>'L6)*>+Q'6K8ZRP9%-7X /I]CRX('M[LLCUWN[,LM&PDUOG7QQ$S/?/,X
MMKR*,IA=N!.JC_?ZSOOA>R^4?=)Y>4NX+*UXLY%OCJC>S-^QR[ZG[I^M^&*U
MVZ"_OYZ1/TLD"3/.;1-9=@7*S&P"#)01\444I#'97RBL&"5!EN/U9P6?0\X'
MTTXB>_>+TB#*/"\\(,5=='GVOBCZ F=%L0S%>3CNO?G=9?U_.7.-8;''CT@B
MC7[ CVE 2?I?_;C-8>]6,5[E8?QC+DRPUN?C/1U<,G1PR=X.[!IGI[*KN#\*
M)5;,SA[8(F''V=4VT7=U=7LQ=_><-YNM'!A76_Q\)?[F>M.)KE5)W^CMTL-:
M8 O%N6/UZ')]J@ Y7^X(L/52%$M7?(J*:2WFPE> T6=74*NA*\6/W.B1+9/"
MV-ZTT;(2I;L89JS"(T0C[$1S!)]LWU7[P8+;P0([Q>'NPZX'"Q:V!'W4N-[+
M#D>BQA/U;:BKI=;WKD=]>]L*Y:JD?W8S ;_%"1=+Z!4OI+);?+YX#PN<9_^U
M :8DS+<]^ *BA^9K3,A+;.,B8IM#,JQBUX7%>>J:I32(IZZ[C7+L4B/W#M,C
M@EV!.-D8]6JN%FZ@M3Y$!_BI;W@[S,QG?E1\$/<#]T>F%@*OBXK/495@>S@"
MY8=8_V!DZP;'F30XAKKE$N=^KJP ?I]+3,?^P6XP_$_"Z3]02P,$%     @
M5I!<56JSWCOE @  :08  !D   !X;"]W;W)K<VAE971S+W-H965T,C@N>&UL
MC57;;MLP#/T5PAMV 8SXFCC)D@!)MV%[Z%8T6?=0[$&QF=BH97F2W+3[^E%R
MZKE &NS%IBB>HT.+I&<'(>]4CJCA@9>5FCNYUO74\U2:(V=J(&JL:&<G)&>:
MEG+OJ5HBRRR(EU[H^R./LZ)R%C/KNY*+F6AT651X)4$UG#/YN,)2'.9.X#PY
MKHM]KHW#6\QJML<UZA_UE:25U[%D!<=*%:("B;NYLPRFJ]C$VX"; @^J9X/)
M9"O$G5E\S>:.;P1AB:DV#(Q>]WB!96F(2,;O(Z?3'6F ??N)_;/-G7+9,H47
MHOQ99#J?.V,',MRQIM37XO %C_D,#5\J2F6?<&ACXZ$#::.TX$<P*>!%U;[9
MP_$[] !C_P5 > 2$5G=[D%7YD6FVF$EQ &FBB<T8-E6+)G%%92YEK27M%H33
MBW7.)-+7K1N9YI2=@M9SW?.\V[!MB>K]S--THL%YZ9%]U;*'+[!/X%)4.E?P
MJ<HP>X[W2&DG-WR2NPK/$JZQ'D#DNQ#Z87B&+^K2CRQ?] +?A@I9-?(1UEJD
M=R[<L+)!N%UNE994,+].I=PRQJ<931--5<U2G#O4)0KE/3J+-Z^"D?_AC-ZX
MTQN?8U]<E$PI$#MX+AQN[17!!A\TK$KRG%1^EONT\DV.L!,E]6Y1[4';4]H&
M+OY0:6C:OA"\9M7C6P6IX)PZ35E)_9K*&FGA%*USB0BLRJ"B\X&W]8&F/H!N
M5R/?HNRNV :2$4QA8X%GXK_]#Y_AZEG?:;A1.\D[&G\]P=.V"U3/1S+<P,#<
M) I@[/J3(21N,O1AR453::A9D<%K",:QFTP2LJ)HY(:!L9)QXHZ',5GCR<2-
MXP26]RAIYK6@F@0JVW44D P"W]"$T2 PB$DRB"+C"$8#?P2G:LCKM3]'N;=#
MSMP&R6HG0>?MYNBR'1__PMLA?,GDOJ@4E+@CJ#](:&S)=K"U"RUJ.TRV0M-H
MLF9._P*4)H#V=T+HIX4YH/N[+/X"4$L#!!0    ( %:07%5L^(/ZS ,  .D)
M   9    >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;+5636_C-A#]*X2V6,@
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MH Z/OH5G8 U ;0:I#;H[68-[/_D_;E;:]""C/\]-WZ.GY]'MUKK6N[(2BP"
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MX4J"QM7,N^E.YK$[7Q_XR7%KCF1PF:1*/3GE6S[S0D<(!6;6(3!:GO$6A7!
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MN8;7;OCH9CPUBE6;>B2DRM* J<6")CIJ=X#V5TK9@^("M/^(Y!]02P,$%
M  @ 5I!<58 OP?DT P  ,@<  !D   !X;"]W;W)K<VAE971S+W-H965T,S$N
M>&ULC551;],P$/XKIX 02&5)TVUE6UMI'2 F,32V @^(!R>YI ;'#O:E9?QZ
MSDD6,B@5+XE]]GWW??;=>;8U]IM;(Q+\*)5V\V!-5)V&H4O76 IW8"K4O)(;
M6PKBJ2U"5UD46>-4JC".HN.P%%('BUECN[:+F:E)28W7%EQ=EL+>+5&9[3P8
M!_>&&UFLR1O"Q:P2!=XB?:BN+<_"'B63)6HGC0:+^3PX'Y\N#_W^9L-'B5LW
M&(-7DACSS4\NLWD0>4*H,"6/(/BWP0M4R@,QC>\=9M"']([#\3WZZT8[:TF$
MPPNC/LF,UO/@10 9YJ)6=&.V;[#3<^3Q4J-<\X5MMS<*(*T=F;)S9@:EU.U?
M_.C.X7\<XLXA;GBW@1J6+P6)Q<R:+5B_F]'\H)':>#,YJ?VEW)+E5<E^M'@M
MI(6-4#6"R2&76NA4"@52.[(UGSXY>+H2B4+W;!821_1^8=JA+UOT^!_H)W!E
M-*T=O-(99@_]0V;:TXWOZ2[CO8"W6!W )!I!',7Q'KQ)+W_2X$WVR?_8R'\I
M7:J,JRTZ^'R>L'S.F"^[-+>0A[LA?16=NDJD. ^X3!S:#0:+)X_&Q]'9'L*'
M/>'#?>B+<^>0W C>2I%()4DR6Z$S6&%9&<ME!:^^UY+NX J%UY*!(!BH](4
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MSGTY\QT=P._W;1O7"S*P^4OEXC]02P,$%     @ 5I!<57M6%AY("@  F6$
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M-!;-39'U733LN\94"]KW0J949*D_LX!T)(D3SZHI0$<3QHV5]<H%))2ID,G
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MW6"9*JM31[="##I$W/E\'@SHJE%>Z,]#/5V_H>L;Z7ZE(DITG'QE- BEALZ
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M)W9O&W8;DJ_+!_8++B5/RY\K2F(J"@/U_SWG\FFC6*!^YS/['U!+ P04
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M1ZT>',E/L.4GL/+SM1!)MDZ12QD6DW0IO\HR6@J9%&68F/Q?(P8[;L4^C.+
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MPQ8+D*)!W*X/PQYHB;:Y2J)+44[R[T=*LF3)#.NX7!\:?=Q[R'O(>W5(<_K
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M.?L^\&WW]!L^F7[]3FJHM@)+K4VM<1F!VV;<PVJ3,"WDOEHQTQ1D9,NZ.YZ
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M5FUOHS@0_BL66ZU:*1M> TDW06I>5K?251<U[=Z'TWYP81)0 ;.V2;;__L9
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MPL2S74L1K<,H\6U8,K9:0V_UBK[EC9O?6W8AOWGW/./+1(#FW(+6!8]213>
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M-=74I*FF(S>S 9R^F0V109O9$.[H9C9M/38U[+$IX'7E-/5]53SHL7U?33V
M<[3$@V2N&QS9SZ:MP:;F#38=M9\-H]0W#  %[&</H;KBGQVZ,6&VZ:C][%&H
M$$(!^]F#L*[@UGK3-V.]Z:C];!BE16W4?O80JANSUH;3U]IP.O:@"0C$@:?9
M\+&,T0C&1O;TV='%#2]6]9G14B9ZEXGFF-KA[N%<ZF5]&E.Y?X7/YABX'^*S
MJ#EUVM(WAV _L6)5U=.4+V57UD=/CKEHSI4V%R+?U@<G[W,A\DW]<<W9@A<5
M0#Y?YKEXNJ@Z.)SNG?T'4$L#!!0    ( %:07%4][:4M+0,  '4)   9
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M7>^3"VEPUZT?"SP7@;(!^'XII;EOV &ZDU;Z"U!+ P04    " !6D%Q5RAL
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MW7<8+ _, A)1C$64=$3;CSV? /YHNO66B*4J']K7<U3>K'C*Z_6C^9NCFU>
M?&Y??&$=OZ)GUQ0X'M.S9/V"#T._?M_([VGYD.65MU#W^E3D5.HQ6KE^A<?Z
M2UVLVG=4W!5U72S;CX\JG:NR >C?[XNB?OO2G&#S(I7+_P-02P,$%     @
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M"#R-.((Y  \8$L?U>W#O?12NWU/AYO]_HS]02P,$%     @ 5I!<59>*NQS
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M2P$"% ,4    " !6D%Q5%D75#.X    K @  $0              @ &O
M9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " !6D%Q5F5R<(Q &  "<)P
M$P              @ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0
M   ( %:07%4WK5M_S04  .(>   8              " @0T(  !X;"]W;W)K
M<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " !6D%Q50H<>4N(&  !F'P
M&               @($0#@  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L!
M A0#%     @ 5I!<5:,*\_>1!   Z!   !@              ("!*!4  'AL
M+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    ( %:07%5[T:48V@<
M %TB   8              " @>\9  !X;"]W;W)K<VAE971S+W-H965T-"YX
M;6Q02P$"% ,4    " !6D%Q5ZX_HMYT#  #,"P  &               @('_
M(0  >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ 5I!<54%6
M[WO'"   \"8  !@              ("!TB4  'AL+W=O<FMS:&5E=',O<VAE
M970V+GAM;%!+ 0(4 Q0    ( %:07%6"B(@D;1@  -9@ 0 8
M  " @<\N  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    " !6
MD%Q52M"-,X\$  !I"P  &               @(%R1P  >&PO=V]R:W-H965T
M<R]S:&5E=#@N>&UL4$L! A0#%     @ 5I!<55N?<^U8"   "18  !@
M         ("!-TP  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0
M   ( %:07%5ZE(.8? 0  %X*   9              " @<54  !X;"]W;W)K
M<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @ 5I!<51<>/I9>!   E@H
M !D              ("!>%D  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q0
M2P$"% ,4    " !6D%Q5'3V+3N<&  #(#P  &0              @($-7@
M>&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( %:07%7#B#45
MO0@  *07   9              " @2ME  !X;"]W;W)K<VAE971S+W-H965T
M,3,N>&UL4$L! A0#%     @ 5I!<5;MM3?4=%@  <D   !D
M ("!'VX  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4    " !6
MD%Q5ART$JCD%  #"#   &0              @(%SA   >&PO=V]R:W-H965T
M<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( %:07%6 N< ++00  ,L*   9
M          " @>.)  !X;"]W;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#
M%     @ 5I!<5?8D!._V!0  @0X  !D              ("!1XX  'AL+W=O
M<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4    " !6D%Q5#[A<EOD"  #$
M!@  &0              @(%TE   >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM
M;%!+ 0(4 Q0    ( %:07%7J.N2BQ@@  )\7   9              " @:27
M  !X;"]W;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @ 5I!<5<^/
MW)15!P  P!(  !D              ("!H:   'AL+W=O<FMS:&5E=',O<VAE
M970R,"YX;6Q02P$"% ,4    " !6D%Q5N9*3OX0%  "F#   &0
M    @($MJ   >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    (
M %:07%5'SO9-,P\  *PI   9              " @>BM  !X;"]W;W)K<VAE
M971S+W-H965T,C(N>&UL4$L! A0#%     @ 5I!<56,^/',L!0  J T  !D
M             ("!4KT  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"
M% ,4    " !6D%Q5V1O-=\@#  !/"   &0              @(&UP@  >&PO
M=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    ( %:07%5X8;4:;0,
M ,\'   9              " @;3&  !X;"]W;W)K<VAE971S+W-H965T,C4N
M>&UL4$L! A0#%     @ 5I!<58__UW=T P  R@<  !D              ("!
M6,H  'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"% ,4    " !6D%Q5
MW4AW)VX&  !5$   &0              @($#S@  >&PO=V]R:W-H965T<R]S
M:&5E=#(W+GAM;%!+ 0(4 Q0    ( %:07%5JL]X[Y0(  &D&   9
M      " @:C4  !X;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%
M  @ 5I!<56SX@_K, P  Z0D  !D              ("!Q-<  'AL+W=O<FMS
M:&5E=',O<VAE970R.2YX;6Q02P$"% ,4    " !6D%Q5C3E$5M\"   O!@
M&0              @(''VP  >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+
M 0(4 Q0    ( %:07%6 +\'Y- ,  #('   9              " @=W>  !X
M;"]W;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#%     @ 5I!<51&F%V=1
M!@  7A$  !D              ("!2.(  'AL+W=O<FMS:&5E=',O<VAE970S
M,BYX;6Q02P$"% ,4    " !6D%Q5>U86'D@*  "980  &0
M@('0Z   >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( %:0
M7%7?OTR01@0  .8.   9              " @4_S  !X;"]W;W)K<VAE971S
M+W-H965T,S0N>&UL4$L! A0#%     @ 5I!<52R?+]=1!   6!8  !D
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M=#,Y+GAM;%!+ 0(4 Q0    ( %:07%7R >G8_04  .0D   9
M  " @:T3 0!X;"]W;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#%     @
M5I!<5?WB9GB1!0  BB,  !D              ("!X1D! 'AL+W=O<FMS:&5E
M=',O<VAE970T,2YX;6Q02P$"% ,4    " !6D%Q5;!=QG@X$   9#@  &0
M            @(&I'P$ >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4
M Q0    ( %:07%7]$]U77 ,  %D*   9              " @>XC 0!X;"]W
M;W)K<VAE971S+W-H965T-#,N>&UL4$L! A0#%     @ 5I!<54D@O1"3 @
MJ04  !D              ("!@2<! 'AL+W=O<FMS:&5E=',O<VAE970T-"YX
M;6Q02P$"% ,4    " !6D%Q5,W=^_+4&  #I*P  &0              @(%+
M*@$ >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4 Q0    ( %:07%4]
M[:4M+0,  '4)   9              " @3<Q 0!X;"]W;W)K<VAE971S+W-H
M965T-#8N>&UL4$L! A0#%     @ 5I!<5<H; (? !0  2B,  !D
M     ("!FS0! 'AL+W=O<FMS:&5E=',O<VAE970T-RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( %:07%619L ]CP,  &L0   9              "
M@2U/ 0!X;"]W;W)K<VAE971S+W-H965T-3(N>&UL4$L! A0#%     @ 5I!<
M565D4#,= P  :0L  !D              ("!\U(! 'AL+W=O<FMS:&5E=',O
M<VAE970U,RYX;6Q02P$"% ,4    " !6D%Q5Z3]!$,$"  #N"0  &0
M        @(%'5@$ >&PO=V]R:W-H965T<R]S:&5E=#4T+GAM;%!+ 0(4 Q0
M   ( %:07%7<E%4@0P,   P4   -              "  3]9 0!X;"]S='EL
M97,N>&UL4$L! A0#%     @ 5I!<59>*NQS     $P(   L
M ( !K5P! %]R96QS+RYR96QS4$L! A0#%     @ 5I!<5:=5[\^S!   020
M  \              ( !EET! 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    (
M %:07%4/E%1(V@$  %D@   :              "  79B 0!X;"]?<F5L<R]W
M;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( %:07%4A7:<FS0$  "0@   3
M              "  8AD 0!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     ^
- #X Z1   (9F 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>311</ContextCount>
  <ElementCount>294</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>67</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/DocumentandEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - CONSOLIDATED STATEMENTS OF INCOME (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF INCOME (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - CONSOLIDATED BALANCE SHEETS (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunauditedParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - CONSOLIDATED STATEMENTS OF EQUITY (unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF EQUITY (unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Disclosure - Condensed consolidated interim financial statements Condensed consolidated interim financial statements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidatedinterimfinancialstatements</Role>
      <ShortName>Condensed consolidated interim financial statements Condensed consolidated interim financial statements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Revenue Recognition Revenue Recognition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/RevenueRecognitionRevenueRecognition</Role>
      <ShortName>Revenue Recognition Revenue Recognition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Earnings per share (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.davita.com/role/EarningspershareNotes</Role>
      <ShortName>Earnings per share (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Investments in debt and equity securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/Investmentsindebtandequitysecurities</Role>
      <ShortName>Investments in debt and equity securities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/Goodwill</Role>
      <ShortName>Goodwill</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Long-term debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/Longtermdebt</Role>
      <ShortName>Long-term debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Shareholders' equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/Shareholdersequity</Role>
      <ShortName>Shareholders' equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Accumulated other comprehensive (loss) income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/Accumulatedothercomprehensivelossincome</Role>
      <ShortName>Accumulated other comprehensive (loss) income</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Acquisitions and divestitures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/Acquisitionsanddivestitures</Role>
      <ShortName>Acquisitions and divestitures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Variable interest entities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/Variableinterestentities</Role>
      <ShortName>Variable interest entities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Fair value of financial instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/Fairvalueoffinancialinstruments</Role>
      <ShortName>Fair value of financial instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Segment reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/Segmentreporting</Role>
      <ShortName>Segment reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - New accounting standards</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/Newaccountingstandards</Role>
      <ShortName>New accounting standards</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Condensed consolidated interim financial statements Condensed consolidaed interim financial statements (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies</Role>
      <ShortName>Condensed consolidated interim financial statements Condensed consolidaed interim financial statements (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Revenue Recognition Segment revenue by major payor (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/RevenueRecognitionSegmentrevenuebymajorpayorTables</Role>
      <ShortName>Revenue Recognition Segment revenue by major payor (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Earnings per share Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/EarningspershareEarningsPerShareTables</Role>
      <ShortName>Earnings per share Earnings Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Investments in debt and equity securities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/InvestmentsindebtandequitysecuritiesTables</Role>
      <ShortName>Investments in debt and equity securities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/Investmentsindebtandequitysecurities</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/GoodwillTables</Role>
      <ShortName>Goodwill (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/Goodwill</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Long-term debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LongtermdebtTables</Role>
      <ShortName>Long-term debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/Longtermdebt</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Share repurchases Share Repurchases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SharerepurchasesShareRepurchasesTables</Role>
      <ShortName>Share repurchases Share Repurchases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Accumulated other comprehensive (loss) income (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/AccumulatedothercomprehensivelossincomeTables</Role>
      <ShortName>Accumulated other comprehensive (loss) income (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/Accumulatedothercomprehensivelossincome</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Acquisitions and divestitures (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/AcquisitionsanddivestituresTables</Role>
      <ShortName>Acquisitions and divestitures (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/Acquisitionsanddivestitures</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Fair value of financial instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/FairvalueoffinancialinstrumentsTables</Role>
      <ShortName>Fair value of financial instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/Fairvalueoffinancialinstruments</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Segment reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SegmentreportingTables</Role>
      <ShortName>Segment reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.davita.com/role/Segmentreporting</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Revenue Recognition Segment Revenue by Payor (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails</Role>
      <ShortName>Revenue Recognition Segment Revenue by Payor (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Earnings per share Earnings per share - Reconciliation of numberators and denominators used to calculate basic and diluted earnings per share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails</Role>
      <ShortName>Earnings per share Earnings per share - Reconciliation of numberators and denominators used to calculate basic and diluted earnings per share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Investments in debt and equity securities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail</Role>
      <ShortName>Investments in debt and equity securities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.davita.com/role/InvestmentsindebtandequitysecuritiesTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Goodwill - Changes in Goodwill by Reportable Segments (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail</Role>
      <ShortName>Goodwill - Changes in Goodwill by Reportable Segments (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Goodwill - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/GoodwillNarrativeDetails</Role>
      <ShortName>Goodwill - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Long-term debt (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LongtermdebtDetail</Role>
      <ShortName>Long-term debt (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.davita.com/role/LongtermdebtTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Long-term debt Schedule of Derivative Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails</Role>
      <ShortName>Long-term debt Schedule of Derivative Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Long-term debt - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LongtermdebtAdditionalInformationDetail</Role>
      <ShortName>Long-term debt - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - Commitments and Contingencies - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail</Role>
      <ShortName>Commitments and Contingencies - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - Long-term incentive compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/LongtermincentivecompensationDetails</Role>
      <ShortName>Long-term incentive compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - Share repurchases Share Repurchase Table (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SharerepurchasesShareRepurchaseTableDetails</Role>
      <ShortName>Share repurchases Share Repurchase Table (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.davita.com/role/SharerepurchasesShareRepurchasesTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - Share repurchases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SharerepurchasesDetails</Role>
      <ShortName>Share repurchases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.davita.com/role/SharerepurchasesShareRepurchasesTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - Accumulated other comprehensive (loss) income (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail</Role>
      <ShortName>Accumulated other comprehensive (loss) income (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.davita.com/role/AccumulatedothercomprehensivelossincomeTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - Acquisitions and divestitures Contingent Earn-out obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/AcquisitionsanddivestituresContingentEarnoutobligationsDetails</Role>
      <ShortName>Acquisitions and divestitures Contingent Earn-out obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - Acquisitions and divestitures - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail</Role>
      <ShortName>Acquisitions and divestitures - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - Variable interest entities - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/VariableinterestentitiesAdditionalInformationDetail</Role>
      <ShortName>Variable interest entities - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - Fair value of financial instruments - Assets, Liabilities and Temporary Equity Measured at Fair Value on Recurring Basis (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail</Role>
      <ShortName>Fair value of financial instruments - Assets, Liabilities and Temporary Equity Measured at Fair Value on Recurring Basis (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - Fair value of financial instruments Fair Value of Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/FairvalueoffinancialinstrumentsFairValueofFinancialInstrumentsDetails</Role>
      <ShortName>Fair value of financial instruments Fair Value of Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - Segment reporting - Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income Before Income Taxes (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail</Role>
      <ShortName>Segment reporting - Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income Before Income Taxes (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - Segment reporting - Summary of Depreciation and Amortization Expense by Segment (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail</Role>
      <ShortName>Segment reporting - Summary of Depreciation and Amortization Expense by Segment (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - Segment reporting - Summary of Expenditures for Property and Equipment by Segment (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail</Role>
      <ShortName>Segment reporting - Summary of Expenditures for Property and Equipment by Segment (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="dva-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - Segment reporting - Summary of Assets by Segment (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.davita.com/role/SegmentreportingSummaryofAssetsbySegmentDetail</Role>
      <ShortName>Segment reporting - Summary of Assets by Segment (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 11 fact(s) appearing in ix:hidden were eligible for transformation: dva:CorporateIntegrityAgreementPeriod, dva:RegulatoryAndCommercialMilestonesBeginningDate, dva:RegulatoryAndCommercialMilestonesEndingDate, us-gaap:CommonStockParOrStatedValuePerShare, us-gaap:CommonStockSharesAuthorized, us-gaap:CommonStockSharesOutstanding, us-gaap:GoodwillImpairmentLoss, us-gaap:PreferredStockParOrStatedValuePerShare, us-gaap:PreferredStockSharesAuthorized, us-gaap:PreferredStockSharesIssued -  dva-20220930.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="dva-20220930.htm">dva-20220930.htm</File>
    <File>dva-20220930.xsd</File>
    <File>dva-20220930_cal.xml</File>
    <File>dva-20220930_def.xml</File>
    <File>dva-20220930_lab.xml</File>
    <File>dva-20220930_pre.xml</File>
    <File>dva-93022ex101xamno1tosour.htm</File>
    <File>dva-93022ex31110xq.htm</File>
    <File>dva-93022ex31210xq.htm</File>
    <File>dva-93022ex32110xq.htm</File>
    <File>dva-93022ex32210xq.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>dva-20220930_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1018">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>74
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "dva-20220930.htm": {
   "axisCustom": 0,
   "axisStandard": 26,
   "contextCount": 311,
   "dts": {
    "calculationLink": {
     "local": [
      "dva-20220930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "dva-20220930_def.xml"
     ]
    },
    "inline": {
     "local": [
      "dva-20220930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "dva-20220930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "dva-20220930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "dva-20220930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 486,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 9,
    "http://www.davita.com/20220930": 3,
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 17
   },
   "keyCustom": 32,
   "keyStandard": 262,
   "memberCustom": 31,
   "memberStandard": 36,
   "nsprefix": "dva",
   "nsuri": "http://www.davita.com/20220930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Document and Entity Information",
     "role": "http://www.davita.com/role/DocumentandEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Earnings per share (Notes)",
     "role": "http://www.davita.com/role/EarningspershareNotes",
     "shortName": "Earnings per share (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Investments in debt and equity securities",
     "role": "http://www.davita.com/role/Investmentsindebtandequitysecurities",
     "shortName": "Investments in debt and equity securities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Goodwill",
     "role": "http://www.davita.com/role/Goodwill",
     "shortName": "Goodwill",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Long-term debt",
     "role": "http://www.davita.com/role/Longtermdebt",
     "shortName": "Long-term debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDisclosures",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Commitments and Contingencies",
     "role": "http://www.davita.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDisclosures",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Shareholders' equity",
     "role": "http://www.davita.com/role/Shareholdersequity",
     "shortName": "Shareholders' equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Accumulated other comprehensive (loss) income",
     "role": "http://www.davita.com/role/Accumulatedothercomprehensivelossincome",
     "shortName": "Accumulated other comprehensive (loss) income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Acquisitions and divestitures",
     "role": "http://www.davita.com/role/Acquisitionsanddivestitures",
     "shortName": "Acquisitions and divestitures",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:VariableInterestEntityDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Variable interest entities",
     "role": "http://www.davita.com/role/Variableinterestentities",
     "shortName": "Variable interest entities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:VariableInterestEntityDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Fair value of financial instruments",
     "role": "http://www.davita.com/role/Fairvalueoffinancialinstruments",
     "shortName": "Fair value of financial instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - CONSOLIDATED STATEMENTS OF INCOME (unaudited)",
     "role": "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited",
     "shortName": "CONSOLIDATED STATEMENTS OF INCOME (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "dva:RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Segment reporting",
     "role": "http://www.davita.com/role/Segmentreporting",
     "shortName": "Segment reporting",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - New accounting standards",
     "role": "http://www.davita.com/role/Newaccountingstandards",
     "shortName": "New accounting standards",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Condensed consolidated interim financial statements Condensed consolidaed interim financial statements (Policies)",
     "role": "http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies",
     "shortName": "Condensed consolidated interim financial statements Condensed consolidaed interim financial statements (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Revenue Recognition Segment revenue by major payor (Tables)",
     "role": "http://www.davita.com/role/RevenueRecognitionSegmentrevenuebymajorpayorTables",
     "shortName": "Revenue Recognition Segment revenue by major payor (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Earnings per share Earnings Per Share (Tables)",
     "role": "http://www.davita.com/role/EarningspershareEarningsPerShareTables",
     "shortName": "Earnings per share Earnings Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Investments in debt and equity securities (Tables)",
     "role": "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesTables",
     "shortName": "Investments in debt and equity securities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Goodwill (Tables)",
     "role": "http://www.davita.com/role/GoodwillTables",
     "shortName": "Goodwill (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Long-term debt (Tables)",
     "role": "http://www.davita.com/role/LongtermdebtTables",
     "shortName": "Long-term debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:TreasuryStockTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Share repurchases Share Repurchases (Tables)",
     "role": "http://www.davita.com/role/SharerepurchasesShareRepurchasesTables",
     "shortName": "Share repurchases Share Repurchases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:TreasuryStockTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Accumulated other comprehensive (loss) income (Tables)",
     "role": "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeTables",
     "shortName": "Accumulated other comprehensive (loss) income (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (unaudited)",
     "role": "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Acquisitions and divestitures (Tables)",
     "role": "http://www.davita.com/role/AcquisitionsanddivestituresTables",
     "shortName": "Acquisitions and divestitures (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Fair value of financial instruments (Tables)",
     "role": "http://www.davita.com/role/FairvalueoffinancialinstrumentsTables",
     "shortName": "Fair value of financial instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Segment reporting (Tables)",
     "role": "http://www.davita.com/role/SegmentreportingTables",
     "shortName": "Segment reporting (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherIncome",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Revenue Recognition Segment Revenue by Payor (Details)",
     "role": "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails",
     "shortName": "Revenue Recognition Segment Revenue by Payor (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "iaf7c25a75aca401a8b6ff5a12f6bd14d_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Earnings per share Earnings per share - Reconciliation of numberators and denominators used to calculate basic and diluted earnings per share (Details)",
     "role": "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails",
     "shortName": "Earnings per share Earnings per share - Reconciliation of numberators and denominators used to calculate basic and diluted earnings per share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesIssuedBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:MarketableSecuritiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i50c63cefb9bd4106bee30b310fc866d1_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:HeldToMaturitySecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Investments in debt and equity securities (Detail)",
     "role": "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail",
     "shortName": "Investments in debt and equity securities (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:MarketableSecuritiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i50c63cefb9bd4106bee30b310fc866d1_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:HeldToMaturitySecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Goodwill - Changes in Goodwill by Reportable Segments (Detail)",
     "role": "http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail",
     "shortName": "Goodwill - Changes in Goodwill by Reportable Segments (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "ibf9e89b4e598444e8b9df2b00849c30a_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "ic52ab49cab0046128e4cd38b93634c67_D20220701-20220930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Goodwill - Narrative (Details)",
     "role": "http://www.davita.com/role/GoodwillNarrativeDetails",
     "shortName": "Goodwill - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "ic52ab49cab0046128e4cd38b93634c67_D20220701-20220930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentInterestRateDuringPeriod",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Long-term debt (Detail)",
     "role": "http://www.davita.com/role/LongtermdebtDetail",
     "shortName": "Long-term debt (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i6dcab18b6e464b478f9e7b926940407a_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInceptionDates",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Long-term debt Schedule of Derivative Instruments (Details)",
     "role": "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails",
     "shortName": "Long-term debt Schedule of Derivative Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i6dcab18b6e464b478f9e7b926940407a_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInceptionDates",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i50c63cefb9bd4106bee30b310fc866d1_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - CONSOLIDATED BALANCE SHEETS (unaudited)",
     "role": "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited",
     "shortName": "CONSOLIDATED BALANCE SHEETS (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i50c63cefb9bd4106bee30b310fc866d1_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i50c63cefb9bd4106bee30b310fc866d1_I20220930",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongtermDebtWeightedAverageInterestRate",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Long-term debt - Additional Information (Detail)",
     "role": "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
     "shortName": "Long-term debt - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i5fab6e21c9604971bab7725c4bfbac6f_D20220101-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentPeriodicPaymentPrincipal",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dva:CorporateIntegrityAgreementExpirationDate",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - Commitments and Contingencies - Additional Information (Detail)",
     "role": "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail",
     "shortName": "Commitments and Contingencies - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dva:CorporateIntegrityAgreementExpirationDate",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i50c63cefb9bd4106bee30b310fc866d1_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - Long-term incentive compensation (Details)",
     "role": "http://www.davita.com/role/LongtermincentivecompensationDetails",
     "shortName": "Long-term incentive compensation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i50c63cefb9bd4106bee30b310fc866d1_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
       "us-gaap:TreasuryStockTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i0e26a096655c4539b381dad37c3f4def_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockSharesAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - Share repurchases Share Repurchase Table (Details)",
     "role": "http://www.davita.com/role/SharerepurchasesShareRepurchaseTableDetails",
     "shortName": "Share repurchases Share Repurchase Table (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
       "us-gaap:TreasuryStockTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i0e26a096655c4539b381dad37c3f4def_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockSharesAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:TreasuryStockTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i93d8bfb8799a4eb1a6cac7ed70c03ca0_D20221001-20221027",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockSharesAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - Share repurchases (Details)",
     "role": "http://www.davita.com/role/SharerepurchasesDetails",
     "shortName": "Share repurchases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:TreasuryStockTextBlock",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i93d8bfb8799a4eb1a6cac7ed70c03ca0_D20221001-20221027",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockSharesAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i1fd70ffb1cb34b3ab8cb29a9176cd4f3_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - Accumulated other comprehensive (loss) income (Detail)",
     "role": "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail",
     "shortName": "Accumulated other comprehensive (loss) income (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "ib8eadbdf6a4545af8abdecc0181aed70_I20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "ic6f218803873471383d0301f439bbb92_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - Acquisitions and divestitures Contingent Earn-out obligations (Details)",
     "role": "http://www.davita.com/role/AcquisitionsanddivestituresContingentEarnoutobligationsDetails",
     "shortName": "Acquisitions and divestitures Contingent Earn-out obligations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "ic6f218803873471383d0301f439bbb92_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesGross",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - Acquisitions and divestitures - Additional Information (Detail)",
     "role": "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail",
     "shortName": "Acquisitions and divestitures - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i50c63cefb9bd4106bee30b310fc866d1_I20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "dva:BusinessAcquisitionGoodwillExpectedTaxDeductibleAmountAdjustment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i50c63cefb9bd4106bee30b310fc866d1_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - Variable interest entities - Additional Information (Detail)",
     "role": "http://www.davita.com/role/VariableinterestentitiesAdditionalInformationDetail",
     "shortName": "Variable interest entities - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "if32523db73914548b7ef72241eec1f64_I20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:MarketableSecuritiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i50c63cefb9bd4106bee30b310fc866d1_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNi",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - Fair value of financial instruments - Assets, Liabilities and Temporary Equity Measured at Fair Value on Recurring Basis (Detail)",
     "role": "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail",
     "shortName": "Fair value of financial instruments - Assets, Liabilities and Temporary Equity Measured at Fair Value on Recurring Basis (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "iad68a7dfc7f8430c902a9ff9db916de5_I20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNi",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i50c63cefb9bd4106bee30b310fc866d1_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentOwnedAccumulatedDepreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical)",
     "role": "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunauditedParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i50c63cefb9bd4106bee30b310fc866d1_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentOwnedAccumulatedDepreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i50c63cefb9bd4106bee30b310fc866d1_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "dva:PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - Fair value of financial instruments Fair Value of Financial Instruments (Details)",
     "role": "http://www.davita.com/role/FairvalueoffinancialinstrumentsFairValueofFinancialInstrumentsDetails",
     "shortName": "Fair value of financial instruments Fair Value of Financial Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i50c63cefb9bd4106bee30b310fc866d1_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "dva:PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherIncome",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - Segment reporting - Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income Before Income Taxes (Detail)",
     "role": "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail",
     "shortName": "Segment reporting - Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income Before Income Taxes (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "dva:SegmentReportingInformationCorporateExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i544651d8c71a4d14b227c293cf80e8ca_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DepreciationAndAmortization",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - Segment reporting - Summary of Depreciation and Amortization Expense by Segment (Detail)",
     "role": "http://www.davita.com/role/SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail",
     "shortName": "Segment reporting - Summary of Depreciation and Amortization Expense by Segment (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i138d5ad826a74dd389b7c50d766dce89_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - Segment reporting - Summary of Expenditures for Property and Equipment by Segment (Detail)",
     "role": "http://www.davita.com/role/SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail",
     "shortName": "Segment reporting - Summary of Expenditures for Property and Equipment by Segment (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i422c6a94a816499c8310fd5a0acc841f_D20220101-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i50c63cefb9bd4106bee30b310fc866d1_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - Segment reporting - Summary of Assets by Segment (Detail)",
     "role": "http://www.davita.com/role/SegmentreportingSummaryofAssetsbySegmentDetail",
     "shortName": "Segment reporting - Summary of Assets by Segment (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i7093bff9492a45488822863f8f94a337_I20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)",
     "role": "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationAmortizationAndAccretionNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "ie15a7e2f621142fbac1d6b1ed5011b9d_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - CONSOLIDATED STATEMENTS OF EQUITY (unaudited)",
     "role": "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited",
     "shortName": "CONSOLIDATED STATEMENTS OF EQUITY (unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "ie15a7e2f621142fbac1d6b1ed5011b9d_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000008 - Disclosure - Condensed consolidated interim financial statements Condensed consolidated interim financial statements",
     "role": "http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidatedinterimfinancialstatements",
     "shortName": "Condensed consolidated interim financial statements Condensed consolidated interim financial statements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - Revenue Recognition Revenue Recognition",
     "role": "http://www.davita.com/role/RevenueRecognitionRevenueRecognition",
     "shortName": "Revenue Recognition Revenue Recognition",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dva-20220930.htm",
      "contextRef": "i9f7fb34a5c0a4a46a7026702ccfd8a13_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 67,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r589"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.davita.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dva_A2019InterestRateCapAgreementsEffectiveJune302020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2019 Interest Rate Cap Agreements Effective June 30, 2020.",
        "label": "2019 Interest Rate Cap Agreements Effective June 30, 2020 [Member]",
        "terseLabel": "2019 Interest Rate Cap Agreements Effective June 30, 2020"
       }
      }
     },
     "localname": "A2019InterestRateCapAgreementsEffectiveJune302020Member",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_AcquisitionObligationsAndOtherNotesPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This represents deferred purchase price obligations associated with acquisitions as well as other notes payable.",
        "label": "Acquisition Obligations And Other Notes Payable",
        "terseLabel": "Acquisition obligations and other notes payable"
       }
      }
     },
     "localname": "AcquisitionObligationsAndOtherNotesPayable",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_AcquisitionObligationsAndOtherNotesPayableFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition Obligations And Other Notes Payable, Fair Value.",
        "label": "Acquisition Obligations And Other Notes Payable, Fair Value",
        "terseLabel": "Acquisition obligations and other notes payable, fair value"
       }
      }
     },
     "localname": "AcquisitionObligationsAndOtherNotesPayableFairValue",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_AdditionalCashCommitment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional Cash Commitment",
        "label": "Additional Cash Commitment",
        "terseLabel": "Additional Cash Commitment"
       }
      }
     },
     "localname": "AdditionalCashCommitment",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_AgreementWithMedtronicMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement with Medtronic, Inc. and one of its subsidiaries (collectively, Medtronic) to form a new, independent kidney care-focused medical device company (NewCo).",
        "label": "Agreement with Medtronic [Member]",
        "terseLabel": "Agreement with Medtronic"
       }
      }
     },
     "localname": "AgreementWithMedtronicMember",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_BilateralSecuredLetterOfCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bilateral Secured Letter Of Credit",
        "label": "Bilateral Secured Letter Of Credit Facility [Member]",
        "terseLabel": "Bilateral Secured Letter Of Credit Facility"
       }
      }
     },
     "localname": "BilateralSecuredLetterOfCreditFacilityMember",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business acquisition contingent consideration revenue earn-out period.",
        "label": "Business Acquisition Contingent Consideration Revenue Earnout Period",
        "terseLabel": "Earn-out consideration payment period"
       }
      }
     },
     "localname": "BusinessAcquisitionContingentConsiderationRevenueEarnoutPeriod",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "dva_BusinessAcquisitionGoodwillExpectedTaxDeductibleAmountAdjustment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Goodwill, Expected Tax Deductible Amount, Adjustment.",
        "label": "Business Acquisition, Goodwill, Expected Tax Deductible Amount, Adjustment",
        "terseLabel": "Business Acquisition, Goodwill, Adjustment To Expected Tax Deductible Amount"
       }
      }
     },
     "localname": "BusinessAcquisitionGoodwillExpectedTaxDeductibleAmountAdjustment",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_BusinessAgreementDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Agreement Date, in YYYY-MM-DD formate",
        "label": "Business Agreement Date",
        "terseLabel": "Business Agreement Date"
       }
      }
     },
     "localname": "BusinessAgreementDate",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "dateItemType"
    },
    "dva_BusinessCombinationContingentConsiderationAcquisitions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination Contingent Consideration Acquisitions, Earn-out Obligations and Assumed Liabilities.",
        "label": "Business Combination Contingent Consideration Acquisitions",
        "verboseLabel": "Contingent earn-out obligations and liabilities assumed associated with acquisitions"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationAcquisitions",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination Contingent Consideration Acquisitions Fair Value Remeasurement Gain Loss",
        "label": "Business Combination Contingent Consideration Acquisitions Fair Value Remeasurement Gain Loss",
        "negatedLabel": "Fair value remeasurements"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationAcquisitionsFairValueRemeasurementGainLoss",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresContingentEarnoutobligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_CashPaidForPortionPreviouslyRefundedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Paid For Amounts Previously Refunded [Member]",
        "label": "Cash Paid For Portion Previously Refunded [Member]",
        "terseLabel": "Cash Paid For Portion Previously Refunded"
       }
      }
     },
     "localname": "CashPaidForPortionPreviouslyRefundedMember",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Certificates of deposit, commercial paper, and money market funds.",
        "label": "Certificates Of Deposit Commercial Paper And Money Market Funds [Member]",
        "terseLabel": "Certificates of deposit and other time deposits"
       }
      }
     },
     "localname": "CertificatesOfDepositCommercialPaperAndMoneyMarketFundsMember",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_CommercialPayorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial Payors in healthcare industry.",
        "label": "Commercial Payors [Member]",
        "terseLabel": "Commercial Payors"
       }
      }
     },
     "localname": "CommercialPayorsMember",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_CommitmentsToProvideOperatingCapitalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commitments to provide operating capital.",
        "label": "Commitments To Provide Operating Capital [Member]",
        "terseLabel": "Commitments to provide operating capital"
       }
      }
     },
     "localname": "CommitmentsToProvideOperatingCapitalMember",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_CorporateIntegrityAgreementExpirationDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate Integrity Agreement Expiration Date, in CCYY-MM-DD format.",
        "label": "Corporate Integrity Agreement Expiration Date",
        "terseLabel": "Corporate Integrity Agreement Expiration Date"
       }
      }
     },
     "localname": "CorporateIntegrityAgreementExpirationDate",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "dateItemType"
    },
    "dva_CorporateIntegrityAgreementPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate Integrity Agreement Period, in PnYnMnDn format.",
        "label": "Corporate Integrity Agreement Period",
        "terseLabel": "Corporate Integrity Agreement Period"
       }
      }
     },
     "localname": "CorporateIntegrityAgreementPeriod",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "dva_DebtExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt expense.",
        "label": "Debt Expense [Member]",
        "terseLabel": "Debt Expense"
       }
      }
     },
     "localname": "DebtExpenseMember",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_DiscountPremiumAndDeferredFinancingCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discount, premium and deferred financing costs.",
        "label": "Discount Premium And Deferred Financing Costs",
        "negatedLabel": "Discount, premium and deferred financing costs"
       }
      }
     },
     "localname": "DiscountPremiumAndDeferredFinancingCosts",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "EBITDA operating income performance targets or quality margins.",
        "label": "E B I T D A Operating Income Performance Targets Or Quality Margins [Member]",
        "terseLabel": "EBITDA or Operating Income Performance Targets or Quality Margins"
       }
      }
     },
     "localname": "EBITDAOperatingIncomePerformanceTargetsOrQualityMarginsMember",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_ExternalSourcesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "External sources.",
        "label": "External Sources [Member]",
        "terseLabel": "External Sources"
       }
      }
     },
     "localname": "ExternalSourcesMember",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_FinanceLeaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease [Member]",
        "label": "Finance Lease [Member]",
        "verboseLabel": "Financing lease obligations"
       }
      }
     },
     "localname": "FinanceLeaseMember",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign Currency Translation Adjustment For Contingent Earn-out Obligations.",
        "label": "Foreign Currency Translation Adjustment For Contingent Earn Out Obligations",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "ForeignCurrencyTranslationAdjustmentForContingentEarnOutObligations",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresContingentEarnoutobligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_ForeignDialysisCentersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign dialysis and other medical businesses.",
        "label": "Foreign Dialysis Centers [Member]",
        "terseLabel": "Foreign Dialysis Centers"
       }
      }
     },
     "localname": "ForeignDialysisCentersMember",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net change during the reporting period in other current receivables and other current assets.",
        "label": "Increase Decrease In Other Current Receivables And Other Current Assets",
        "negatedLabel": "Other receivables and prepaid and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherCurrentReceivablesAndOtherCurrentAssets",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_IncrementalCashPortionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental Cash Portion [Member]",
        "label": "Incremental Cash Portion [Member]",
        "terseLabel": "Incremental Cash Portion"
       }
      }
     },
     "localname": "IncrementalCashPortionMember",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_LongTermDebtPercentageBearingEconomicallyFixedInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long Term Debt Percentage Bearing Economically Fixed Interest Rate.",
        "label": "Long Term Debt Percentage Bearing Economically Fixed Interest Rate",
        "terseLabel": "Long Term Debt Percentage Bearing Economically Fixed Interest Rate"
       }
      }
     },
     "localname": "LongTermDebtPercentageBearingEconomicallyFixedInterestRate",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "dva_MedicaidandManagedMedicaidMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicaid and Managed Medicaid Member.",
        "label": "Medicaid and Managed Medicaid [Member]",
        "terseLabel": "Medicaid and Managed Medicaid"
       }
      }
     },
     "localname": "MedicaidandManagedMedicaidMember",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_MedicareandMedicareAdvantageMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare and Medicare Advantage",
        "label": "Medicare and Medicare Advantage [Member]",
        "terseLabel": "Medicare and Medicare Advantage"
       }
      }
     },
     "localname": "MedicareandMedicareAdvantageMember",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_MutualFundsAndCommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mutual Funds And Common Stock [Member]",
        "label": "Mutual Funds And Common Stock [Member]",
        "terseLabel": "Investments in mutual funds and common stocks"
       }
      }
     },
     "localname": "MutualFundsAndCommonStockMember",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_NoncontrollingInterestChangesFromOther": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest Changes From Other",
        "label": "Noncontrolling Interest Changes From Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "NoncontrollingInterestChangesFromOther",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest, Decrease Due To Acquisitions and Divestitures",
        "label": "Noncontrolling Interest, Decrease Due To Acquisitions and Divestitures",
        "negatedTerseLabel": "Acquisitions and divestitures"
       }
      }
     },
     "localname": "NoncontrollingInterestDecreaseDueToAcquisitionsAndDivestitures",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest, Increase Due To Acquisitions and Divestitures without Put provisions.",
        "label": "Noncontrolling Interest, Increase Due To Acquisitions and Divestitures",
        "terseLabel": "Acquisitions and divestitures"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseDueToAcquisitionsAndDivestitures",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_NoncontrollingInterestIncreaseFromContributions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling interest increase from contributions.",
        "label": "Noncontrolling Interest Increase From Contributions",
        "terseLabel": "Contributions"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseFromContributions",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_OpenMarketPurchasesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Open Market Purchases Member.",
        "label": "Open Market Purchases [Member]",
        "terseLabel": "Open Market Purchases"
       }
      }
     },
     "localname": "OpenMarketPurchasesMember",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/SharerepurchasesShareRepurchaseTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_OtherCompaniesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other companies.",
        "label": "Other Companies [Member]",
        "terseLabel": "Other companies"
       }
      }
     },
     "localname": "OtherCompaniesMember",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_OtherGovernmentPayorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other government payors in healthcare industry.",
        "label": "Other Government Payors [Member]",
        "terseLabel": "Other Government Payors"
       }
      }
     },
     "localname": "OtherGovernmentPayorsMember",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_OtherNoncashAssetsCommitment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Noncash Assets Commitment",
        "label": "Other Noncash Assets Commitment",
        "terseLabel": "Other Noncash Assets Commitment"
       }
      }
     },
     "localname": "OtherNoncashAssetsCommitment",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_OtherReportingUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Reporting Units [Member]",
        "label": "Other Reporting Units [Member]",
        "terseLabel": "Other Health Operations"
       }
      }
     },
     "localname": "OtherReportingUnitsMember",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/GoodwillNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_OtherSourcesofRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other sources of revenue (management fees and revenue from the Company's ancillary services and strategic initiatives).",
        "label": "Other Sources of Revenue [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherSourcesofRevenueMember",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_PatientCareCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patient care costs are costs directly associated with operating and supporting dialysis centers, medical clinics and ancillary operations and consist principally of labor, pharmaceuticals, medical supplies and facility operating costs.",
        "label": "Patient Care Costs",
        "terseLabel": "Patient care costs"
       }
      }
     },
     "localname": "PatientCareCosts",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Potential increase decrease In fair value of Noncontrolling interests related to contractual Put obligations due to the change In Weighted Average EBITDA multiple.",
        "label": "Potential Increase Decrease In Fair Value Of Noncontrolling Interests Due To Change In Weighted Average EBITDA Multiple",
        "terseLabel": "Potential Increase Decrease In Fair Value Of Noncontrolling Interests Due To Change In Weighted Average EBITDA Multiple"
       }
      }
     },
     "localname": "PotentialIncreaseDecreaseInFairValueOfNoncontrollingInterestsDueToChangeInWeightedAverageEBITDAMultiple",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsFairValueofFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reconciliation of capital expenditures for property and equipment from segment to consolidated.",
        "label": "Reconciliation Of Capital Expenditures For Property And Equipment From Segment To Consolidated Table [Text Block]",
        "terseLabel": "Summary of Expenditures for Property and Equipment by Reportable Segment"
       }
      }
     },
     "localname": "ReconciliationOfCapitalExpendituresForPropertyAndEquipmentFromSegmentToConsolidatedTableTextBlock",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/SegmentreportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dva_RegulatoryAndCommercialMilestonesBeginningDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regulatory and Commercial Milestones Beginning Date",
        "label": "Regulatory and Commercial Milestones Beginning Date",
        "terseLabel": "Regulatory and Commercial Milestones Beginning Date"
       }
      }
     },
     "localname": "RegulatoryAndCommercialMilestonesBeginningDate",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "dateItemType"
    },
    "dva_RegulatoryAndCommercialMilestonesEndingDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regulatory and Commercial Milestones Ending Date",
        "label": "Regulatory and Commercial Milestones Ending Date",
        "terseLabel": "Regulatory and Commercial Milestones Ending Date"
       }
      }
     },
     "localname": "RegulatoryAndCommercialMilestonesEndingDate",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "dateItemType"
    },
    "dva_RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue From Contract With Customer Including Assessed Tax Net Of Provision For Uncollectible Accounts",
        "label": "Revenue From Contract With Customer Including Assessed Tax Net Of Provision For Uncollectible Accounts",
        "terseLabel": "Dialysis patient service revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerIncludingAssessedTaxNetOfProvisionForUncollectibleAccounts",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_RevenuesbymajorpayorAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenues by major payor [Abstract]",
        "label": "Revenues by major payor [Abstract]",
        "terseLabel": "Revenues by major payor [Abstract]"
       }
      }
     },
     "localname": "RevenuesbymajorpayorAbstract",
     "nsuri": "http://www.davita.com/20220930",
     "xbrltype": "stringItemType"
    },
    "dva_SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Secured Debt Outstanding Principal Balance Subject To LIBOR-based interest rate volatility.",
        "label": "Secured Debt Outstanding Principal Balance Subject To LIBOR",
        "terseLabel": "Secured Debt Outstanding Principal Balance Subject To LIBOR"
       }
      }
     },
     "localname": "SecuredDebtOutstandingPrincipalBalanceSubjectToLIBOR",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_SegmentReportingInformationCorporateExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of general and administrative support costs, such as labor, benefits and stock-based compensation costs.",
        "label": "Segment Reporting Information Corporate Expenses",
        "negatedLabel": "Corporate administrative support"
       }
      }
     },
     "localname": "SegmentReportingInformationCorporateExpenses",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_SegmentRevenuebyMajorPayorAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Segment Revenue by Major Payor [Abstract]",
        "label": "Segment Revenue by Major Payor [Abstract]",
        "terseLabel": "Segment Revenue by Major Payor [Abstract]"
       }
      }
     },
     "localname": "SegmentRevenuebyMajorPayorAbstract",
     "nsuri": "http://www.davita.com/20220930",
     "xbrltype": "stringItemType"
    },
    "dva_SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes Four Point Six Two Five Percent Due Twenty Thirty member.",
        "label": "Senior Notes Four Point Six Two Five Percent Due Twenty Thirty [Member]",
        "terseLabel": "Senior Notes Four Point Six Two Five Percent Due Twenty Thirty"
       }
      }
     },
     "localname": "SeniorNotesFourPointSixTwoFivePercentDueTwentyThirtyMember",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Notes Three Point Seven Five Percent Due Twenty Thirty One.",
        "label": "Senior Notes Three Point Seven Five Percent Due Twenty Thirty One [Member]",
        "terseLabel": "Senior Notes Three Point Seven Five Percent Due Twenty Thirty One"
       }
      }
     },
     "localname": "SeniorNotesThreePointSevenFivePercentDueTwentyThirtyOneMember",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_SeniorSecuredCreditFacilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior secured credit facilities.",
        "label": "Senior Secured Credit Facilities [Member]",
        "terseLabel": "Senior Secured Credit Facilities"
       }
      }
     },
     "localname": "SeniorSecuredCreditFacilitiesMember",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based compensation arrangement by share-based payment award, grant date fair value of options granted.",
        "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Grant Date Fair Value Of Options Granted",
        "terseLabel": "Aggregate grant-date fair value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardGrantDateFairValueOfOptionsGranted",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/LongtermincentivecompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_TemporaryEquityDecreasePurchaseOfInterests": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Decrease Purchase Of Interests",
        "label": "Temporary Equity, Decrease Purchase Of Interests",
        "negatedTerseLabel": "Partial purchases"
       }
      }
     },
     "localname": "TemporaryEquityDecreasePurchaseOfInterests",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Decrease from Distributions to Noncontrolling Interest Holders",
        "label": "Temporary Equity, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedTerseLabel": "Distributions"
       }
      }
     },
     "localname": "TemporaryEquityDecreasefromDistributionstoNoncontrollingInterestHolders",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Increase due to Acquisitions and Divestitures of the NCI with Put obligations.",
        "label": "Temporary Equity, Increase Due To Acquisitions And Divestitures",
        "terseLabel": "Acquisitions and divestitures"
       }
      }
     },
     "localname": "TemporaryEquityIncreaseDueToAcquisitionsAndDivestitures",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Increase From Contributions From Noncontrolling Interest Holders",
        "label": "Temporary Equity, Increase From Contributions From Noncontrolling Interest Holders",
        "terseLabel": "Contributions"
       }
      }
     },
     "localname": "TemporaryEquityIncreaseFromContributionsFromNoncontrollingInterestHolders",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dva_TemporaryEquityRedeemableNoncontrollingInterestsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable Noncontrolling Interests Temporary Equity [Member]",
        "label": "Temporary Equity Redeemable Noncontrolling Interests [Member]",
        "terseLabel": "Non- controlling interests subject to put provisions"
       }
      }
     },
     "localname": "TemporaryEquityRedeemableNoncontrollingInterestsMember",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_TermLoanAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term loan A.",
        "label": "Term Loan A [Member]",
        "terseLabel": "Term Loan A"
       }
      }
     },
     "localname": "TermLoanAMember",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_TermLoanB1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan B-1.",
        "label": "Term Loan B-1 [Member]",
        "terseLabel": "Term Loan B-1"
       }
      }
     },
     "localname": "TermLoanB1Member",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_TermLoanFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan Facility [Member]",
        "label": "Term Loan Facility [Member]",
        "terseLabel": "Term Loan Facility"
       }
      }
     },
     "localname": "TermLoanFacilityMember",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_USAttorneyPrescriptionDrugInvestigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US Attorney Prescription Drug Investigation [Member]",
        "label": "US Attorney Prescription Drug Investigation [Member]",
        "terseLabel": "US Attorney Prescription Drug Investigation"
       }
      }
     },
     "localname": "USAttorneyPrescriptionDrugInvestigationMember",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_USDialysisAndRelatedLabServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US dialysis \u200band \u200brelated \u200blab\u200b services\u200b.",
        "label": "U S Dialysis And Related Lab Services [Member]",
        "terseLabel": "U.S. dialysis"
       }
      }
     },
     "localname": "USDialysisAndRelatedLabServicesMember",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail",
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentreportingSummaryofAssetsbySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dva_USDialysisAndRelatedServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US Dialysis And Related Services.",
        "label": "US Dialysis And Related Services [Member]",
        "terseLabel": "US Dialysis"
       }
      }
     },
     "localname": "USDialysisAndRelatedServicesMember",
     "nsuri": "http://www.davita.com/20220930",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r110",
      "r232",
      "r237",
      "r245",
      "r398",
      "r399",
      "r404",
      "r405",
      "r477",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.davita.com/role/VariableinterestentitiesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r110",
      "r232",
      "r237",
      "r245",
      "r398",
      "r399",
      "r404",
      "r405",
      "r477",
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.davita.com/role/VariableinterestentitiesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r110",
      "r147",
      "r160",
      "r161",
      "r162",
      "r163",
      "r165",
      "r167",
      "r171",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r239",
      "r240",
      "r242",
      "r244",
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r110",
      "r147",
      "r160",
      "r161",
      "r162",
      "r163",
      "r165",
      "r167",
      "r171",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r239",
      "r240",
      "r242",
      "r244",
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r223",
      "r225",
      "r226",
      "r227",
      "r250",
      "r278",
      "r321",
      "r323",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r492",
      "r555",
      "r556",
      "r585",
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r223",
      "r225",
      "r226",
      "r227",
      "r250",
      "r278",
      "r321",
      "r323",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r492",
      "r555",
      "r556",
      "r585",
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r216",
      "r223",
      "r225",
      "r226",
      "r227",
      "r250",
      "r278",
      "r310",
      "r321",
      "r323",
      "r351",
      "r352",
      "r353",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r492",
      "r555",
      "r556",
      "r585",
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r216",
      "r223",
      "r225",
      "r226",
      "r227",
      "r250",
      "r278",
      "r310",
      "r321",
      "r323",
      "r351",
      "r352",
      "r353",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r492",
      "r555",
      "r556",
      "r585",
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingChangesAndErrorCorrectionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Changes and Error Corrections [Abstract]",
        "terseLabel": "Accounting Changes and Error Corrections [Abstract]"
       }
      }
     },
     "localname": "AccountingChangesAndErrorCorrectionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r31",
      "r480"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r178",
      "r179"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r18",
      "r512",
      "r534"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Income tax payable"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r49",
      "r56",
      "r65",
      "r66",
      "r67",
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r51",
      "r56",
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, including the portion attributable to the noncontrolling interest.",
        "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Including Portion Attributable to Noncontrolling Interest [Member]",
        "terseLabel": "Interest rate cap agreements"
       }
      }
     },
     "localname": "AccumulatedNetGainLossFromCashFlowHedgesIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r25",
      "r53",
      "r55",
      "r56",
      "r537",
      "r561",
      "r562"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail",
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r65",
      "r66",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income Loss [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r52",
      "r56",
      "r65",
      "r66",
      "r67",
      "r111",
      "r112",
      "r113",
      "r403",
      "r473",
      "r557",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r23"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r111",
      "r112",
      "r113",
      "r359",
      "r360",
      "r361",
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r325",
      "r362",
      "r363"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-settled stock-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllOtherSegmentsMember": {
     "auth_ref": [
      "r142",
      "r160",
      "r161",
      "r162",
      "r163",
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating segments classified as other. Excludes intersegment elimination and reconciling items.",
        "label": "Other Segments [Member]",
        "terseLabel": "Other\u2014Ancillary services",
        "verboseLabel": "Other\u2014Ancillary services"
       }
      }
     },
     "localname": "AllOtherSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail",
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentreportingSummaryofAssetsbySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Anti-dilutive stock-settled awards excluded from calculation"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AociIncludingPortionAttributableToNoncontrollingInterestMember": {
     "auth_ref": [
      "r52",
      "r56",
      "r65",
      "r66",
      "r67",
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, including the portion attributable to the noncontrolling interest. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest [Member]",
        "verboseLabel": "Accumulated other comprehensive (loss) income"
       }
      }
     },
     "localname": "AociIncludingPortionAttributableToNoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r15",
      "r106",
      "r155",
      "r162",
      "r169",
      "r188",
      "r232",
      "r233",
      "r234",
      "r236",
      "r237",
      "r238",
      "r239",
      "r241",
      "r243",
      "r245",
      "r246",
      "r398",
      "r404",
      "r450",
      "r478",
      "r480",
      "r510",
      "r533"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Total assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited",
      "http://www.davita.com/role/SegmentreportingSummaryofAssetsbySegmentDetail",
      "http://www.davita.com/role/VariableinterestentitiesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited",
      "http://www.davita.com/role/SegmentreportingSummaryofAssetsbySegmentDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r9",
      "r30",
      "r106",
      "r188",
      "r232",
      "r233",
      "r234",
      "r236",
      "r237",
      "r238",
      "r239",
      "r241",
      "r243",
      "r245",
      "r246",
      "r398",
      "r404",
      "r450",
      "r478",
      "r480"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "verboseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermincentivecompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r419",
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Condensed consolidated interim financial statements"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r320",
      "r322",
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail",
      "http://www.davita.com/role/AcquisitionsanddivestituresContingentEarnoutobligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r320",
      "r322",
      "r377",
      "r378",
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail",
      "http://www.davita.com/role/AcquisitionsanddivestituresContingentEarnoutobligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail",
      "http://www.davita.com/role/AcquisitionsanddivestituresContingentEarnoutobligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred": {
     "auth_ref": [
      "r380",
      "r382",
      "r383",
      "r386"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.",
        "label": "Business Combination, Consideration Transferred, Liabilities Incurred",
        "terseLabel": "Deferred purchase price obligations"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurred",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Contingent Consideration Arrangements [Abstract]",
        "terseLabel": "Business Combination, Contingent Consideration Arrangements [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1": {
     "auth_ref": [
      "r98",
      "r389"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of right to a contingent consideration asset.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresContingentEarnoutobligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r98",
      "r389"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "negatedLabel": "Payments"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresContingentEarnoutobligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": {
     "auth_ref": [
      "r388"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High",
        "periodEndLabel": "Contingent Earn-out Obligations, Ending balance",
        "periodStartLabel": "Contingent Earn-out Obligations, Beginning balance"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresContingentEarnoutobligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r381",
      "r384",
      "r387"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Contingent earn-out obligations",
        "verboseLabel": "Contingent earn-out obligations"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail",
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r6",
      "r11",
      "r101"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r96",
      "r101",
      "r102"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of the period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of the year"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r96",
      "r453"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net (decrease) increase in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfTreasuryStockTable": {
     "auth_ref": [
      "r286",
      "r287",
      "r288",
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table]",
        "terseLabel": "Class of Treasury Stock [Table]"
       }
      }
     },
     "localname": "ClassOfTreasuryStockTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/SharerepurchasesDetails",
      "http://www.davita.com/role/SharerepurchasesShareRepurchaseTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and contingencies:"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsDisclosureTextBlock": {
     "auth_ref": [
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.",
        "label": "Commitments Disclosure [Text Block]",
        "terseLabel": "Noncontrolling interests subject to put provisions and other commitments"
       }
      }
     },
     "localname": "CommitmentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r111",
      "r112",
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (usd per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r21",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Common stock, Ending balance (in shares)",
        "periodStartLabel": "Common stock, Beginning balance (in shares)",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunauditedParenthetical",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r21",
      "r480"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common Stock, Value, Issued"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r61",
      "r63",
      "r64",
      "r76",
      "r525",
      "r549"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income attributable to DaVita Inc."
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r61",
      "r63",
      "r75",
      "r394",
      "r395",
      "r409",
      "r524",
      "r548"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "negatedLabel": "Less: Comprehensive income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r61",
      "r63",
      "r74",
      "r393",
      "r409",
      "r523",
      "r547"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Total comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Comprehensive income:"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r73",
      "r81",
      "r522",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/Accumulatedothercomprehensivelossincome"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]",
        "terseLabel": "Contingent Consideration by Type"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs and Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "CostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r16",
      "r18",
      "r19",
      "r105",
      "r110",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r266",
      "r267",
      "r268",
      "r269",
      "r466",
      "r511",
      "r513",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail",
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "LIBOR plus interest rate margin"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r19",
      "r265",
      "r513",
      "r532"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-Term Debt, Gross",
        "terseLabel": "Total debt principal outstanding"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentDescriptionOfVariableRateBasis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of reference rate used for variable rate of debt instrument.",
        "label": "Debt Instrument, Description of Variable Rate Basis",
        "terseLabel": "Debt Instrument, Description of Variable Rate Basis"
       }
      }
     },
     "localname": "DebtInstrumentDescriptionOfVariableRateBasis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r256",
      "r266",
      "r267",
      "r449"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Debt Instrument, Fair Value Disclosure"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Fair Value Disclosure [Abstract]",
        "terseLabel": "Debt Instrument, table footnotes"
       }
      }
     },
     "localname": "DebtInstrumentFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "auth_ref": [
      "r36",
      "r260",
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average effective interest rate during the reporting period.",
        "label": "Debt Instrument, Interest Rate During Period",
        "terseLabel": "Debt interest rate during period",
        "verboseLabel": "Weighted average effective interest rate during quarter"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "auth_ref": [
      "r37",
      "r250",
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.",
        "label": "Debt Instrument, Maturity Date",
        "terseLabel": "Debt Instrument, Maturity Date"
       }
      }
     },
     "localname": "DebtInstrumentMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DebtInstrumentMaturityDateDescription": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.",
        "label": "Debt Instrument, Maturity Date, Description",
        "terseLabel": "Debt instrument, maturity date, description"
       }
      }
     },
     "localname": "DebtInstrumentMaturityDateDescription",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r38",
      "r105",
      "r110",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r266",
      "r267",
      "r268",
      "r269",
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail",
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": {
     "auth_ref": [
      "r38"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payments applied to principal.",
        "label": "Debt Instrument, Periodic Payment, Principal",
        "terseLabel": "Debt Instrument, Periodic Payment, Principal"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentPrincipal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r38",
      "r105",
      "r110",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r266",
      "r267",
      "r268",
      "r269",
      "r280",
      "r281",
      "r282",
      "r283",
      "r464",
      "r465",
      "r466",
      "r467",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Debt Instrument [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r254",
      "r464",
      "r467"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "terseLabel": "Debt Instrument, Unamortized Discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedPremium": {
     "auth_ref": [
      "r254",
      "r464",
      "r467"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt premium.",
        "label": "Debt Instrument, Unamortized Premium",
        "negatedLabel": "Debt Instrument, Unamortized Premium"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedPremium",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r99",
      "r107",
      "r368",
      "r372",
      "r373",
      "r374"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r365",
      "r366"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredOfferingCosts": {
     "auth_ref": [
      "r192"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.",
        "label": "Deferred Offering Costs",
        "terseLabel": "Deferred Offering Costs"
       }
      }
     },
     "localname": "DeferredOfferingCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAmortizationAndAccretionNet": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Depreciation, Amortization and Accretion, Net",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAmortizationAndAccretionNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r99",
      "r212"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited",
      "http://www.davita.com/role/SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetNotionalAmount": {
     "auth_ref": [
      "r412",
      "r413",
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative asset.",
        "label": "Derivative Asset, Notional Amount",
        "terseLabel": "Notional amounts of interest rate agreements"
       }
      }
     },
     "localname": "DerivativeAssetNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r45",
      "r46",
      "r47",
      "r449"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Interest rate cap agreements"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail",
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r44",
      "r47",
      "r48",
      "r421",
      "r491"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset",
        "terseLabel": "Derivative asset, fair value, gross asset"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInceptionDates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the entity entered into the derivative contract, in YYYY-MM-DD format.",
        "label": "Derivative, Inception Date",
        "terseLabel": "Derivative, effective date"
       }
      }
     },
     "localname": "DerivativeInceptionDates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration": {
     "auth_ref": [
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of income or comprehensive income that includes gain (loss) from effective portion of derivative instrument reclassified from accumulated other comprehensive income (AOCI) into income.",
        "label": "Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "terseLabel": "Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]"
       }
      }
     },
     "localname": "DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r47",
      "r420",
      "r422",
      "r426",
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail",
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r417",
      "r420",
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet": {
     "auth_ref": [
      "r425",
      "r428"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net",
        "verboseLabel": "Amount of debt expense reclassified from accumulated OCI into income"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeMaturityDates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date the derivative contract matures, in YYYY-MM-DD format.",
        "label": "Derivative, Maturity Date",
        "terseLabel": "Derivative, expiration date"
       }
      }
     },
     "localname": "DerivativeMaturityDates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r411",
      "r414",
      "r415",
      "r417",
      "r418",
      "r424",
      "r426",
      "r430",
      "r432",
      "r433",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r109",
      "r411",
      "r414",
      "r417",
      "r418",
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r300",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue [Table Text Block]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionSegmentrevenuebymajorpayorTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r328",
      "r329",
      "r355",
      "r356",
      "r358",
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "Long-term incentive compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/Shareholdersequity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings per share attributable to DaVita Inc.:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r77",
      "r116",
      "r117",
      "r118",
      "r119",
      "r120",
      "r124",
      "r127",
      "r132",
      "r133",
      "r134",
      "r138",
      "r139",
      "r436",
      "r437",
      "r526",
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic net income",
        "verboseLabel": "Basic net income per share attributable to DaVita Inc."
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited",
      "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r77",
      "r116",
      "r117",
      "r118",
      "r119",
      "r120",
      "r127",
      "r132",
      "r133",
      "r134",
      "r138",
      "r139",
      "r436",
      "r437",
      "r526",
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted net income",
        "verboseLabel": "Diluted net income per share attributable to DaVita Inc."
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited",
      "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r135",
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share Reconciliation [Abstract]",
        "terseLabel": "Numerators:"
       }
      }
     },
     "localname": "EarningsPerShareReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r135",
      "r136",
      "r137",
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings Per Share [Text Block]"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/EarningspershareNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r453"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of exchange rate changes on cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued compensation and benefits"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r357"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation cost related to nonvested stock-based compensation arrangements under equity compensation and stock purchase plans"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermincentivecompensationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Unrecognized compensation cost related to nonvested stock-based compensation arrangements under stock-based component of LTIP costs, weighted average remaining period (in years)"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermincentivecompensationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityClassOfTreasuryStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Equity, Class of Treasury Stock [Line Items]",
        "terseLabel": "Equity, Class of Treasury Stock [Line Items]"
       }
      }
     },
     "localname": "EquityClassOfTreasuryStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/SharerepurchasesDetails",
      "http://www.davita.com/role/SharerepurchasesShareRepurchaseTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r65",
      "r66",
      "r67",
      "r111",
      "r112",
      "r113",
      "r115",
      "r121",
      "r123",
      "r141",
      "r189",
      "r279",
      "r284",
      "r359",
      "r360",
      "r361",
      "r369",
      "r370",
      "r435",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r461",
      "r473",
      "r557",
      "r558",
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r8",
      "r17",
      "r447"
     ],
     "calculation": {
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_MarketableSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "verboseLabel": "Investments in equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail",
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r256",
      "r266",
      "r267",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r319",
      "r439",
      "r482",
      "r483",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value, Hierarchy"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r438",
      "r439",
      "r440",
      "r441",
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair value of financial instruments"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/Fairvalueoffinancialinstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r256",
      "r311",
      "r312",
      "r317",
      "r319",
      "r439",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Quoted prices in active\u00a0markets\u00a0for identical assets (Level 1)"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r256",
      "r266",
      "r267",
      "r311",
      "r312",
      "r317",
      "r319",
      "r439",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Significant other observable\u00a0inputs (Level 2)"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r256",
      "r266",
      "r267",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r319",
      "r439",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Significant unobservable inputs (Level 3)"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Fair Value, Measurement Frequency"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r256",
      "r266",
      "r267",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r319",
      "r482",
      "r483",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r443",
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Measurements, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "terseLabel": "Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "auth_ref": [
      "r442",
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "terseLabel": "Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Input Reconciliation [Table]"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r446",
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r469",
      "r471"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "verboseLabel": "Financing lease obligations"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r470",
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "verboseLabel": "Finance lease, weighted average discount rate, percent"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r13",
      "r211"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Intangible assets, accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunauditedParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r12",
      "r193",
      "r195",
      "r202",
      "r207",
      "r480",
      "r509"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited",
      "http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r196",
      "r207"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillDisclosureTextBlock": {
     "auth_ref": [
      "r203",
      "r205",
      "r207",
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill.",
        "label": "Goodwill Disclosure [Text Block]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/Goodwill"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillGross": {
     "auth_ref": [
      "r195",
      "r202",
      "r207"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Gross",
        "terseLabel": "Goodwill, before accumulated impairment charges"
       }
      }
     },
     "localname": "GoodwillGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": {
     "auth_ref": [
      "r195",
      "r202",
      "r207"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impaired, Accumulated Impairment Loss",
        "negatedTerseLabel": "Accumulated impairment charges"
       }
      }
     },
     "localname": "GoodwillImpairedAccumulatedImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r99",
      "r194",
      "r199",
      "r206",
      "r207"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "terseLabel": "Goodwill impairment charges"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/GoodwillNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail",
      "http://www.davita.com/role/GoodwillNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r203",
      "r376"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Translation and Purchase Accounting Adjustments",
        "terseLabel": "Foreign currency and other adjustments"
       }
      }
     },
     "localname": "GoodwillTranslationAndPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit": {
     "auth_ref": [
      "r198",
      "r207"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Written off Related to Sale of Business Unit",
        "negatedLabel": "Divestitures"
       }
      }
     },
     "localname": "GoodwillWrittenOffRelatedToSaleOfBusinessUnit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HealthCareOrganizationRevenueSourcesAxis": {
     "auth_ref": [
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major payor source of revenue for health care organizations.",
        "label": "Health Care Organization, Revenue Sources [Axis]",
        "terseLabel": "Health Care Organization, Revenue Sources [Axis]"
       }
      }
     },
     "localname": "HealthCareOrganizationRevenueSourcesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HealthCareOrganizationRevenueSourcesDomain": {
     "auth_ref": [
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Major payor source of revenue for health care organizations.",
        "label": "Health Care Organization, Revenue Sources [Domain]",
        "terseLabel": "Health Care Organization, Revenue Sources [Domain]"
       }
      }
     },
     "localname": "HealthCareOrganizationRevenueSourcesDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HeldToMaturitySecurities": {
     "auth_ref": [
      "r180",
      "r184",
      "r190",
      "r191"
     ],
     "calculation": {
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_MarketableSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity).",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss",
        "terseLabel": "Debt securities"
       }
      }
     },
     "localname": "HeldToMaturitySecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesCurrent": {
     "auth_ref": [
      "r183",
      "r184",
      "r190"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity), classified as current.",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss, Current",
        "terseLabel": "Debt securities, short-term investments"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesNoncurrent": {
     "auth_ref": [
      "r183",
      "r184",
      "r190"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity), classified as noncurrent.",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, before Allowance for Credit Loss, Noncurrent",
        "terseLabel": "Debt securities, long-term investments"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r70",
      "r155",
      "r161",
      "r165",
      "r168",
      "r171",
      "r506",
      "r520",
      "r527",
      "r551"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Income before income taxes",
        "totalLabel": "Income before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r71",
      "r99",
      "r152",
      "r187",
      "r519",
      "r544"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedLabel": "Equity investment income, net"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r214",
      "r217"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r217"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r108",
      "r122",
      "r123",
      "r153",
      "r367",
      "r371",
      "r375",
      "r552"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "verboseLabel": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesReceivable": {
     "auth_ref": [
      "r22",
      "r516",
      "r543"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.",
        "label": "Income Taxes Receivable, Current",
        "terseLabel": "Income tax receivable"
       }
      }
     },
     "localname": "IncomeTaxesReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Increase (Decrease) in Employee Related Liabilities",
        "terseLabel": "Accrued compensation and benefits"
       }
      }
     },
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEquitySecuritiesFvNi": {
     "auth_ref": [
      "r93",
      "r186"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Increase (Decrease) in Equity Securities, FV-NI",
        "negatedLabel": "Equity investment income, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInEquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities, net of effect of acquisitions and divestitures:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentLiabilities": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in current liabilities classified as other.",
        "label": "Increase (Decrease) in Other Current Liabilities",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedLabel": "Other long-term assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Liabilities",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Temporary Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r128",
      "r129",
      "r130",
      "r134",
      "r327"
     ],
     "calculation": {
      "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Assumed incremental from stock plans"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r209",
      "r210"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestAndDebtExpense": {
     "auth_ref": [
      "r463"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest and debt related expenses associated with nonoperating financing activities of the entity.",
        "label": "Interest and Debt Expense",
        "negatedLabel": "Debt expense"
       }
      }
     },
     "localname": "InterestAndDebtExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCapMember": {
     "auth_ref": [
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract in which the cap writer, in return for a premium, agrees to limit, or cap, the cap holder's risk associated with an increase in interest rates. If rates go above a specified interest-rate-level (the strike price or the cap rate), the cap holder is entitled to receive cash payments equal to the excess of the market rate over the strike price multiplied by the notional principal amount.",
        "label": "Interest Rate Cap [Member]",
        "terseLabel": "Interest rate cap agreements"
       }
      }
     },
     "localname": "InterestRateCapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntersegmentEliminationMember": {
     "auth_ref": [
      "r147",
      "r160",
      "r161",
      "r162",
      "r163",
      "r165",
      "r167",
      "r171"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eliminating entries used in operating segment consolidation.",
        "label": "Intersegment Eliminations [Member]",
        "terseLabel": "Intersegment Elimination",
        "verboseLabel": "Elimination of intersegment revenues"
       }
      }
     },
     "localname": "IntersegmentEliminationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntersubsegmentEliminationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eliminating entries used in subsegment consolidation.",
        "label": "Intersubsegment Eliminations [Member]",
        "terseLabel": "Intersubsegment Eliminations"
       }
      }
     },
     "localname": "IntersubsegmentEliminationsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r7",
      "r29",
      "r480"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentHoldingsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Investment Holdings [Line Items]",
        "terseLabel": "Investment Holdings [Line Items]"
       }
      }
     },
     "localname": "InvestmentHoldingsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentHoldingsTable": {
     "auth_ref": [
      "r564",
      "r574",
      "r577",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The investment holdings table is used for any listing of investments. The \"Investment [Axis]\" identifies the investment for which the line items apply. The other axes are used for categorizing the investments and creating useful subtotals. These axes cover different categorizations. The appropriate axes are expected to be used. Additional axes can be added for alternative categorizations.",
        "label": "Investment Holdings [Table]",
        "terseLabel": "Investment Holdings [Table]"
       }
      }
     },
     "localname": "InvestmentHoldingsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r575",
      "r576",
      "r579",
      "r580",
      "r581",
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r575",
      "r576",
      "r579",
      "r580",
      "r581",
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]",
        "terseLabel": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": {
     "auth_ref": [
      "r15"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate.",
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures",
        "terseLabel": "Equity method and other investments"
       }
      }
     },
     "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r185",
      "r507",
      "r529",
      "r583",
      "r592"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "Investments in debt and equity securities"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/Investmentsindebtandequitysecurities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letters of credit outstanding"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r33",
      "r106",
      "r163",
      "r188",
      "r232",
      "r233",
      "r234",
      "r237",
      "r238",
      "r239",
      "r241",
      "r243",
      "r245",
      "r246",
      "r399",
      "r404",
      "r405",
      "r450",
      "r478",
      "r479"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "terseLabel": "Total liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited",
      "http://www.davita.com/role/VariableinterestentitiesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r28",
      "r106",
      "r188",
      "r450",
      "r480",
      "r515",
      "r540"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r10",
      "r35",
      "r106",
      "r188",
      "r232",
      "r233",
      "r234",
      "r237",
      "r238",
      "r239",
      "r241",
      "r243",
      "r245",
      "r246",
      "r399",
      "r404",
      "r405",
      "r450",
      "r478",
      "r479",
      "r480"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding": {
     "auth_ref": [
      "r449"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of the amount outstanding under the credit facility.",
        "label": "Line of Credit Facility, Fair Value of Amount Outstanding",
        "terseLabel": "Revolving line of credit, fair value of amount outstanding"
       }
      }
     },
     "localname": "LineOfCreditFacilityFairValueOfAmountOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r32"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity on the revolving credit facilities"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r32"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Line of Credit Facility, Remaining Borrowing Capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementAmountAwardedToOtherParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount awarded to other party in judgment or settlement of litigation.",
        "label": "Litigation Settlement, Amount Awarded to Other Party",
        "terseLabel": "Litigation Settlement, Amount Awarded to Other Party"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedToOtherParty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r19"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.davita.com/role/LongtermdebtDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-Term Debt and Lease Obligation",
        "terseLabel": "Long-term debt",
        "verboseLabel": "Total long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited",
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.davita.com/role/LongtermdebtDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as current.",
        "label": "Long-Term Debt and Lease Obligation, Current",
        "negatedLabel": "Less current portion",
        "terseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited",
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/LongtermdebtDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, including portion classified as current.",
        "label": "Long-Term Debt and Lease Obligation, Including Current Maturities",
        "totalLabel": "Carrying amount of long-term debt, net of unamortized discounts"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtPercentageBearingFixedInterestRate": {
     "auth_ref": [
      "r36"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a set, unchanging rate.",
        "label": "Long-Term Debt, Percentage Bearing Fixed Interest, Percentage Rate",
        "terseLabel": "Percentage of debt instruments bearing fixed interest rate"
       }
      }
     },
     "localname": "LongTermDebtPercentageBearingFixedInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LongTermDebtTextBlock": {
     "auth_ref": [
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-term debt.",
        "label": "Long-Term Debt [Text Block]",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/Longtermdebt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r38",
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongtermDebtWeightedAverageInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average interest rate of long-term debt outstanding calculated at point in time.",
        "label": "Long-Term Debt, Weighted Average Interest Rate, at Point in Time",
        "terseLabel": "Long-term debt, weighted average interest rate, at point in time",
        "verboseLabel": "Weighted average effective interest rate at quarter end"
       }
      }
     },
     "localname": "LongtermDebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LossContingencyDisclosures": {
     "auth_ref": [
      "r221",
      "r222",
      "r224",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made.",
        "label": "Contingencies Disclosure [Text Block]",
        "terseLabel": "Contingencies"
       }
      }
     },
     "localname": "LossContingencyDisclosures",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MarketableSecurities": {
     "auth_ref": [
      "r518"
     ],
     "calculation": {
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security.",
        "label": "Marketable Securities",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "MarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as current.",
        "label": "Marketable Securities, Current",
        "terseLabel": "Short-term investments",
        "totalLabel": "Total, short-term investments"
       }
      }
     },
     "localname": "MarketableSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited",
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as noncurrent.",
        "label": "Marketable Securities, Noncurrent",
        "terseLabel": "Long-term investments",
        "totalLabel": "Total, long-term investments"
       }
      }
     },
     "localname": "MarketableSecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited",
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "auth_ref": [
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment classified as marketable security.",
        "label": "Marketable Securities, Policy [Policy Text Block]",
        "terseLabel": "Short-term and Long-term Investments"
       }
      }
     },
     "localname": "MarketableSecuritiesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MarketableSecuritiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.",
        "label": "Marketable Securities [Table Text Block]",
        "terseLabel": "Schedule of Investments"
       }
      }
     },
     "localname": "MarketableSecuritiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": {
     "auth_ref": [
      "r4",
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.",
        "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]",
        "terseLabel": "Acquisitions and divestitures"
       }
      }
     },
     "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/Acquisitionsanddivestitures"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r43",
      "r106",
      "r188",
      "r232",
      "r237",
      "r238",
      "r239",
      "r245",
      "r246",
      "r450",
      "r514",
      "r539"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests not subject to put provisions"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestChangeInRedemptionValue": {
     "auth_ref": [
      "r274",
      "r275",
      "r276",
      "r285"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in noncontrolling interest during the period as a result of a change in the redemption value of redeemable noncontrolling interest.",
        "label": "Noncontrolling Interest, Change in Redemption Value",
        "terseLabel": "Fair value remeasurements"
       }
      }
     },
     "localname": "MinorityInterestChangeInRedemptionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r284"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedLabel": "Distributions"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromRedemptions": {
     "auth_ref": [
      "r284",
      "r396",
      "r397"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).",
        "label": "Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests",
        "negatedLabel": "Partial purchases"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromRedemptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r96",
      "r97",
      "r100"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r3",
      "r59",
      "r62",
      "r67",
      "r72",
      "r100",
      "r106",
      "r114",
      "r116",
      "r117",
      "r118",
      "r119",
      "r122",
      "r123",
      "r131",
      "r155",
      "r161",
      "r165",
      "r168",
      "r171",
      "r188",
      "r232",
      "r233",
      "r234",
      "r237",
      "r238",
      "r239",
      "r241",
      "r243",
      "r245",
      "r246",
      "r437",
      "r450",
      "r521",
      "r545"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net income attributable to DaVita Inc."
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited",
      "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r59",
      "r62",
      "r67",
      "r122",
      "r123",
      "r401",
      "r408"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedLabel": "Less: Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest": {
     "auth_ref": [
      "r273",
      "r401",
      "r402"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.",
        "label": "Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest",
        "terseLabel": "Net income attributable to DaVita Inc."
       }
      }
     },
     "localname": "NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies",
      "http://www.davita.com/role/Newaccountingstandards"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest Items [Abstract]",
        "terseLabel": "Changes in noncontrolling interest from:"
       }
      }
     },
     "localname": "NoncontrollingInterestItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r111",
      "r112",
      "r113",
      "r284",
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Non- controlling interests not subject to put provisions"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NotesPayableOtherPayablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A written promise to pay a note to a third party.",
        "label": "Notes Payable, Other Payables [Member]",
        "terseLabel": "Acquisition obligations and other notes payable"
       }
      }
     },
     "localname": "NotesPayableOtherPayablesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfBusinessesAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of businesses acquired by the entity during the period.",
        "label": "Number of Businesses Acquired",
        "terseLabel": "Number of businesses acquired"
       }
      }
     },
     "localname": "NumberOfBusinessesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of Reportable Segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/GoodwillNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r155",
      "r161",
      "r165",
      "r168",
      "r171"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Operating income (loss)",
        "totalLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r469"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r469"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r468"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r160",
      "r161",
      "r162",
      "r163",
      "r165",
      "r171"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r5",
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidatedinterimfinancialstatements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r14"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.",
        "label": "Other Commitment",
        "terseLabel": "Other potential commitments to provide operating capital to several dialysis centers"
       }
      }
     },
     "localname": "OtherCommitment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitmentDueAfterFifthYear": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of commitment classified as other to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Other Commitment, to be Paid, after Year Five",
        "terseLabel": "Other Commitment, to be Paid, after Year Five"
       }
      }
     },
     "localname": "OtherCommitmentDueAfterFifthYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitmentDueInNextTwelveMonths": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of commitment classified as other to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Other Commitment, to be Paid, Year One",
        "terseLabel": "Other Commitment, to be Paid, Year One"
       }
      }
     },
     "localname": "OtherCommitmentDueInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of other commitment.",
        "label": "Other Commitments [Axis]",
        "terseLabel": "Other Commitments"
       }
      }
     },
     "localname": "OtherCommitmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherCommitmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other future obligation.",
        "label": "Other Commitments [Domain]",
        "terseLabel": "Other Commitments"
       }
      }
     },
     "localname": "OtherCommitmentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherCommitmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Other Commitments [Line Items]",
        "terseLabel": "Commitments and Contingencies:"
       }
      }
     },
     "localname": "OtherCommitmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherCommitmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about obligations resulting from other commitments.",
        "label": "Other Commitments [Table]",
        "terseLabel": "Other Commitments [Table]"
       }
      }
     },
     "localname": "OtherCommitmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax [Abstract]",
        "terseLabel": "Unrealized gains (losses) on interest rate cap agreements:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r50",
      "r53",
      "r451",
      "r452",
      "r454"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax",
        "terseLabel": "Unrealized losses on foreign currency translation:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": {
     "auth_ref": [
      "r56",
      "r65",
      "r66",
      "r455",
      "r457",
      "r461"
     ],
     "calculation": {
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax",
        "terseLabel": "Unrealized gains (losses)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r56",
      "r65",
      "r66",
      "r68",
      "r455",
      "r457",
      "r461"
     ],
     "calculation": {
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "totalLabel": "Unrealized (losses) gains net"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax": {
     "auth_ref": [
      "r54",
      "r65"
     ],
     "calculation": {
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss) before Reclassifications, Tax",
        "negatedLabel": "Related income tax benefit"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r51",
      "r53"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": {
     "auth_ref": [
      "r51",
      "r53"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "terseLabel": "Unrealized gains (losses)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "auth_ref": [
      "r53",
      "r57"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "negatedLabel": "Reclassifications of net realized losses into net income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r60",
      "r63",
      "r65",
      "r66",
      "r68",
      "r73",
      "r279",
      "r455",
      "r460",
      "r461",
      "r522",
      "r546"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Other comprehensive (loss) income",
        "verboseLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive (loss) income, net of tax:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current liabilities.",
        "label": "Other Current Liabilities [Member]",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherIncome": {
     "auth_ref": [
      "r553"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue and income classified as other.",
        "label": "Other Income",
        "terseLabel": "Other revenues"
       }
      }
     },
     "localname": "OtherIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited",
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r34",
      "r480"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLongTermInvestmentsMember": {
     "auth_ref": [
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term investments classified as other.",
        "label": "Other Long-Term Investments [Member]",
        "terseLabel": "Long-term Investments"
       }
      }
     },
     "localname": "OtherLongTermInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedLabel": "Other non-cash charges, net"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent assets.",
        "label": "Other Noncurrent Assets [Member]",
        "terseLabel": "Other Long-term Assets"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtScheduleofDerivativeInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other (loss) income, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Other Receivables, Net, Current",
        "terseLabel": "Other receivables"
       }
      }
     },
     "localname": "OtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.",
        "label": "Parent [Member]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "ParentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Purchase of treasury stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDistributionsToAffiliates": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The distributions of earnings to an entity that is affiliated with the reporting entity by means of direct or indirect ownership.",
        "label": "Payments of Distributions to Affiliates",
        "negatedLabel": "Distributions to noncontrolling interests"
       }
      }
     },
     "localname": "PaymentsOfDistributionsToAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfFinancingCosts": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for loan and debt issuance costs.",
        "label": "Payments of Financing Costs",
        "negatedLabel": "Deferred financing and debt redemption costs"
       }
      }
     },
     "localname": "PaymentsOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "negatedTerseLabel": "Net payments related to stock purchases and awards"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r86",
      "r385"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "negatedLabel": "Acquisitions",
        "verboseLabel": "Cash paid to acquire businesses"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Payments to Acquire Equity Method Investments",
        "negatedLabel": "Purchase of equity method investments"
       }
      }
     },
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireHeldToMaturitySecurities": {
     "auth_ref": [
      "r85",
      "r182"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow through purchase of long-term held-to-maturity securities.",
        "label": "Payments to Acquire Held-to-Maturity Securities",
        "negatedLabel": "Purchase of debt investments held-to-maturity"
       }
      }
     },
     "localname": "PaymentsToAcquireHeldToMaturitySecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Payments to Acquire Intangible Assets",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireOtherInvestments": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to acquire investments classified as other.",
        "label": "Payments to Acquire Other Investments",
        "negatedLabel": "Purchase of other debt and equity investments"
       }
      }
     },
     "localname": "PaymentsToAcquireOtherInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Additions of property and equipment",
        "verboseLabel": "Expenditures for property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited",
      "http://www.davita.com/role/SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToMinorityShareholders": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.",
        "label": "Payments to Noncontrolling Interests",
        "negatedLabel": "Purchases of noncontrolling interests"
       }
      }
     },
     "localname": "PaymentsToMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r20",
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (usd per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunauditedParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r20",
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r20",
      "r480"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred Stock, Value, Issued"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r30"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromContributionsFromAffiliates": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from an entity that is affiliated with the entity by means of direct or indirect ownership.",
        "label": "Proceeds from Contributions from Affiliates",
        "terseLabel": "Contributions from noncontrolling interests"
       }
      }
     },
     "localname": "ProceedsFromContributionsFromAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital": {
     "auth_ref": [
      "r83",
      "r95"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of distribution received from equity method investee for return of investment, classified as investing activities. Excludes distribution for return on investment, classified as operating activities.",
        "label": "Proceeds from Equity Method Investment, Distribution, Return of Capital",
        "terseLabel": "Distributions from equity method investments"
       }
      }
     },
     "localname": "ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-Term Debt",
        "terseLabel": "Borrowings"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMinorityShareholders": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership.",
        "label": "Proceeds from Noncontrolling Interests",
        "terseLabel": "Proceeds from sales of additional noncontrolling interests"
       }
      }
     },
     "localname": "ProceedsFromMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities": {
     "auth_ref": [
      "r82",
      "r182"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from the sale or maturity of long-term held-to-maturity securities.",
        "label": "Proceeds from Sale and Maturity of Held-to-Maturity Securities",
        "terseLabel": "Proceeds from debt investments held-to-maturity"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the sale and maturity (principal being due) of other investments, prepayment and call (request of early payment) of other investments not otherwise defined in the taxonomy.",
        "label": "Proceeds from Sale and Maturity of Other Investments",
        "terseLabel": "Proceeds from sale of other debt and equity investments"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfOtherInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate cash proceeds received from a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.",
        "label": "Proceeds from Sales of Business, Affiliate and Productive Assets",
        "terseLabel": "Proceeds from asset and business sales"
       }
      }
     },
     "localname": "ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r3",
      "r59",
      "r62",
      "r67",
      "r94",
      "r106",
      "r114",
      "r122",
      "r123",
      "r155",
      "r161",
      "r165",
      "r168",
      "r171",
      "r188",
      "r232",
      "r233",
      "r234",
      "r237",
      "r238",
      "r239",
      "r241",
      "r243",
      "r245",
      "r246",
      "r393",
      "r400",
      "r402",
      "r408",
      "r409",
      "r437",
      "r450",
      "r527"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income",
        "totalLabel": "Net income",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEunaudited",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r213",
      "r480",
      "r530",
      "r541"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of depreciation (related to long-lived, depreciable flight assets owned by the entity and used in the entity's principle business operations and capitalized assets classified as property, plant and equipment that are owned by the entity) that has been recognized in the income statement.",
        "label": "Property, Plant, and Equipment, Owned, Accumulated Depreciation",
        "terseLabel": "Property and equipment, accumulated depreciation"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentOwnedAccumulatedDepreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunauditedParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": {
     "auth_ref": [
      "r56",
      "r65",
      "r66",
      "r455",
      "r459",
      "r461"
     ],
     "calculation": {
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax",
        "terseLabel": "Reclassification into net income"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r56",
      "r65",
      "r66",
      "r68",
      "r455",
      "r459",
      "r461"
     ],
     "calculation": {
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "totalLabel": "Reclassification from accumulated other comprehensive income into net income net of tax"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]",
        "terseLabel": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodTax": {
     "auth_ref": [
      "r54",
      "r58",
      "r65"
     ],
     "calculation": {
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Reclassification from AOCI, Current Period, Tax",
        "negatedLabel": "Related income tax"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock": {
     "auth_ref": [
      "r162",
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.",
        "label": "Reconciliation of Assets from Segment to Consolidated [Table Text Block]",
        "terseLabel": "Summary of Assets by Reportable Segment"
       }
      }
     },
     "localname": "ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/SegmentreportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r161",
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Summary of Segment Net Revenues, Segment Operating Income (Loss) and Reconciliation of Segment Income to Consolidated Income Before Income Taxes"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/SegmentreportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r163",
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of each significant reconciling item, other than profit (loss), revenues, or assets, in the reconciliation of totals of such items in reportable segments to the entity's corresponding consolidated amount.",
        "label": "Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Summary of Depreciation and Amortization Expense by Reportable Segment"
       }
      }
     },
     "localname": "ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/SegmentreportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": {
     "auth_ref": [
      "r271",
      "r272",
      "r274",
      "r275"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.",
        "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount",
        "terseLabel": "Noncontrolling interests subject to put provisions"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityFairValue": {
     "auth_ref": [
      "r271",
      "r272",
      "r274",
      "r275"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate fair value as of the reporting date of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.",
        "label": "Redeemable Noncontrolling Interest, Equity, Fair Value",
        "terseLabel": "Noncontrolling interests subject to put provisions"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r318",
      "r474",
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r318",
      "r474",
      "r476",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations": {
     "auth_ref": [],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for short-term and long-term debt and lease obligation.",
        "label": "Repayments of Debt and Lease Obligation",
        "negatedTerseLabel": "Payments on long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalents": {
     "auth_ref": [
      "r11",
      "r101",
      "r102",
      "r508",
      "r536"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents",
        "terseLabel": "Restricted cash and equivalents"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "verboseLabel": "Restricted stock units and Performance stock units"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermincentivecompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r24",
      "r284",
      "r480",
      "r538",
      "r560",
      "r562"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r111",
      "r112",
      "r113",
      "r115",
      "r121",
      "r123",
      "r189",
      "r359",
      "r360",
      "r361",
      "r369",
      "r370",
      "r435",
      "r557",
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": {
     "auth_ref": [
      "r146",
      "r147",
      "r160",
      "r166",
      "r167",
      "r173",
      "r174",
      "r176",
      "r299",
      "r300",
      "r493"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.",
        "label": "Revenue from Contract with Customer, Including Assessed Tax",
        "terseLabel": "Dialysis patient service revenues",
        "verboseLabel": "Patient service revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerIncludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r301",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue Recognition [Text Block]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/RevenueRecognitionRevenueRecognition"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r103",
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CondensedconsolidatedinterimfinancialstatementsCondensedconsolidaedinterimfinancialstatementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r69",
      "r106",
      "r146",
      "r147",
      "r160",
      "r166",
      "r167",
      "r173",
      "r174",
      "r176",
      "r188",
      "r232",
      "r233",
      "r234",
      "r237",
      "r238",
      "r239",
      "r241",
      "r243",
      "r245",
      "r246",
      "r450",
      "r527"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "totalLabel": "Total revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited",
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving line of credit"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r56",
      "r460",
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.",
        "label": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]",
        "terseLabel": "Schedule of Business Acquisitions by Acquisition, Contingent Consideration"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r377",
      "r378",
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule Of Business Acquisitions By Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail",
      "http://www.davita.com/role/AcquisitionsanddivestituresContingentEarnoutobligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r38",
      "r110",
      "r266",
      "r268",
      "r280",
      "r281",
      "r282",
      "r283",
      "r464",
      "r465",
      "r467",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table Text Block]",
        "terseLabel": "Long-term Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": {
     "auth_ref": [
      "r411",
      "r414",
      "r415",
      "r417",
      "r418",
      "r424",
      "r426",
      "r430",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Schedule of Derivative Instruments [Table Text Block]",
        "terseLabel": "Schedule of Derivative Instruments"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/EarningspershareEarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r438",
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Assets, Liabilities and Temporary Equity Measured at Fair Value on a Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r206",
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]",
        "verboseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail",
      "http://www.davita.com/role/GoodwillNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r206",
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Changes in Goodwill by Reportable Segments [Text Block]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/GoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r155",
      "r158",
      "r164",
      "r203"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/SegmentreportingSummaryofAssetsbySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r324",
      "r326",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermincentivecompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfTreasuryStockByClassTextBlock": {
     "auth_ref": [
      "r286",
      "r287",
      "r288",
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table Text Block]",
        "terseLabel": "Class of Treasury Stock [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfTreasuryStockByClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/SharerepurchasesShareRepurchasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredDebt": {
     "auth_ref": [
      "r19",
      "r513",
      "r535"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date, including the current and noncurrent portions, of collateralized debt obligations (with maturities initially due after one year or beyond the operating cycle, if longer). Such obligations include mortgage loans, chattel loans, and any other borrowings secured by assets of the borrower.",
        "label": "Secured Debt",
        "terseLabel": "Secured Debt"
       }
      }
     },
     "localname": "SecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtAdditionalInformationDetail",
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r142",
      "r146",
      "r147",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r160",
      "r161",
      "r162",
      "r163",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r171",
      "r176",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r207",
      "r218",
      "r219",
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail",
      "http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail",
      "http://www.davita.com/role/GoodwillNarrativeDetails",
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentreportingSummaryofAssetsbySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r142",
      "r144",
      "r145",
      "r155",
      "r159",
      "r165",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r175",
      "r176",
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Reporting Disclosure"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/Segmentreporting"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/SegmentreportingSummaryofAssetsbySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SeniorNotes": {
     "auth_ref": [
      "r517",
      "r542"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.",
        "label": "Senior Notes",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermdebtDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember": {
     "auth_ref": [
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the aggregation and reporting of combined amounts of individually immaterial business combinations that were completed during the period.",
        "label": "Series of Individually Immaterial Business Acquisitions [Member]",
        "terseLabel": "Dialysis and other businesses"
       }
      }
     },
     "localname": "SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail",
      "http://www.davita.com/role/AcquisitionsanddivestituresContingentEarnoutobligationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermincentivecompensationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermincentivecompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermincentivecompensationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Equity Award"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermincentivecompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/SharerepurchasesShareRepurchaseTableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/SharerepurchasesShareRepurchaseTableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Weighted-average expected life (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermincentivecompensationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShortTermInvestmentsMember": {
     "auth_ref": [
      "r579",
      "r580",
      "r581",
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments which are not otherwise included in another category or item that the entity has the intent to sell or dispose of within one year from the date of the balance sheet.",
        "label": "Short-Term Investments [Member]",
        "terseLabel": "Short-term Investments"
       }
      }
     },
     "localname": "ShortTermInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/InvestmentsindebtandequitysecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r2",
      "r142",
      "r146",
      "r147",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r160",
      "r161",
      "r162",
      "r163",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r171",
      "r176",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r207",
      "r215",
      "r218",
      "r219",
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AcquisitionsanddivestituresAdditionalInformationDetail",
      "http://www.davita.com/role/GoodwillChangesinGoodwillbyReportableSegmentsDetail",
      "http://www.davita.com/role/GoodwillNarrativeDetails",
      "http://www.davita.com/role/RevenueRecognitionSegmentRevenuebyPayorDetails",
      "http://www.davita.com/role/SegmentreportingSummaryofAssetsbySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofDepreciationandAmortizationExpensebySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofExpendituresforPropertyandEquipmentbySegmentDetail",
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r42",
      "r65",
      "r66",
      "r67",
      "r111",
      "r112",
      "r113",
      "r115",
      "r121",
      "r123",
      "r141",
      "r189",
      "r279",
      "r284",
      "r359",
      "r360",
      "r361",
      "r369",
      "r370",
      "r435",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r461",
      "r473",
      "r557",
      "r558",
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/AccumulatedothercomprehensivelossincomeDetail",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited",
      "http://www.davita.com/role/VariableinterestentitiesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r111",
      "r112",
      "r113",
      "r141",
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited",
      "http://www.davita.com/role/VariableinterestentitiesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period.",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights"
       }
      }
     },
     "localname": "StockAppreciationRightsSARSMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/LongtermincentivecompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r20",
      "r21",
      "r279",
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Stock award plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r20",
      "r21",
      "r284",
      "r346"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Stock award plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r42",
      "r279",
      "r284"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "negatedLabel": "Stock award plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Stock Repurchase Program, Remaining Authorized Repurchase Amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/SharerepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r21",
      "r26",
      "r27",
      "r106",
      "r181",
      "r188",
      "r450",
      "r480"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total DaVita Inc. shareholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r66",
      "r106",
      "r111",
      "r112",
      "r113",
      "r115",
      "r121",
      "r188",
      "r189",
      "r284",
      "r359",
      "r360",
      "r361",
      "r369",
      "r370",
      "r391",
      "r392",
      "r407",
      "r435",
      "r450",
      "r455",
      "r456",
      "r461",
      "r473",
      "r558",
      "r559"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited",
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Equity:"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsegmentsConsolidationItemsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by subsegments, eliminations and reconciling items used in consolidating a reportable segment and its subsegments.",
        "label": "Subsegments Consolidation Items [Axis]",
        "terseLabel": "Subsegments Consolidation Items"
       }
      }
     },
     "localname": "SubsegmentsConsolidationItemsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsegmentsConsolidationItemsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subsegments, eliminations and reconciling items used in consolidating a reportable segment and its subsegments.",
        "label": "Subsegments Consolidation Items [Domain]",
        "terseLabel": "Subsegments Consolidation Items"
       }
      }
     },
     "localname": "SubsegmentsConsolidationItemsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/SegmentreportingSummaryofSegmentNetRevenuesSegmentOperatingIncomeLossandReconciliationofSegmentIncometoConsolidatedIncomeBeforeIncomeTaxesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r462",
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/SharerepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r462",
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/SharerepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r462",
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/SharerepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SummaryOfDerivativeInstrumentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Derivative Instruments [Abstract]",
        "terseLabel": "Summary of Derivative Instruments [Abstract]"
       }
      }
     },
     "localname": "SummaryOfDerivativeInstrumentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity [Abstract]",
        "terseLabel": "Temporary equity"
       }
      }
     },
     "localname": "TemporaryEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/FairvalueoffinancialinstrumentsAssetsLiabilitiesandTemporaryEquityMeasuredatFairValueonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityAccretionToRedemptionValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of accretion of temporary equity to its redemption value during the period.",
        "label": "Temporary Equity, Accretion to Redemption Value",
        "terseLabel": "Fair value remeasurements"
       }
      }
     },
     "localname": "TemporaryEquityAccretionToRedemptionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests": {
     "auth_ref": [
      "r40",
      "r106",
      "r188",
      "r450"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests",
        "periodEndLabel": "Temporary equity, ending balance",
        "periodStartLabel": "Temporary equity, starting balance"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityNetIncome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of net income or loss attributable to temporary equity interest.",
        "label": "Temporary Equity, Net Income",
        "terseLabel": "Net income"
       }
      }
     },
     "localname": "TemporaryEquityNetIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityOtherChanges": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in temporary equity from changes classified as other.",
        "label": "Temporary Equity, Other Changes",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "TemporaryEquityOtherChanges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Text Block [Abstract]",
        "terseLabel": "Text Block [Abstract]"
       }
      }
     },
     "localname": "TextBlockAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TransactionDomain": {
     "auth_ref": [
      "r47"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement between buyer and seller for the exchange of financial instruments.",
        "label": "Transaction [Domain]",
        "terseLabel": "Transaction [Domain]"
       }
      }
     },
     "localname": "TransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransactionTypeAxis": {
     "auth_ref": [
      "r47"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of agreement between buyer and seller for the exchange of financial instruments.",
        "label": "Transaction Type [Axis]",
        "terseLabel": "Transaction Type [Axis]"
       }
      }
     },
     "localname": "TransactionTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CommitmentsandContingenciesAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "auth_ref": [
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.",
        "label": "Treasury Stock Acquired, Average Cost Per Share",
        "terseLabel": "Treasury Stock Acquired, Average Cost Per Share"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/SharerepurchasesShareRepurchaseTableDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TreasuryStockCommonShares": {
     "auth_ref": [
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Shares",
        "terseLabel": "Treasury Stock, Common, Shares"
       }
      }
     },
     "localname": "TreasuryStockCommonShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunauditedParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r41",
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r41",
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "negatedPeriodEndLabel": "Treasury stock, ending balance (in shares)",
        "negatedPeriodStartLabel": "Treasury stock, Beginning balance (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r21",
      "r279",
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "negatedLabel": "Purchase of treasury stock (in shares)",
        "terseLabel": "Repurchase of common stock (in shares)",
        "verboseLabel": "Repurchase of common stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited",
      "http://www.davita.com/role/SharerepurchasesDetails",
      "http://www.davita.com/role/SharerepurchasesShareRepurchaseTableDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockTextBlock": {
     "auth_ref": [
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Treasury Stock [Text Block]",
        "terseLabel": "Share repurchases"
       }
      }
     },
     "localname": "TreasuryStockTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/Shareholdersequity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r41",
      "r286",
      "r289"
     ],
     "calculation": {
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedTerseLabel": "Treasury Stock, Value"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDBALANCESHEETSunaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury Stock, Value [Abstract]",
        "terseLabel": "Treasury Stock, Value [Abstract]"
       }
      }
     },
     "localname": "TreasuryStockValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r279",
      "r284",
      "r286"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedLabel": "Purchase of treasury stock",
        "terseLabel": "Treasury Stock, Value, Acquired, Cost Method"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFEQUITYunaudited",
      "http://www.davita.com/role/SharerepurchasesShareRepurchaseTableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableInterestEntityDisclosureTextBlock": {
     "auth_ref": [
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss.",
        "label": "Variable Interest Entity Disclosure [Text Block]",
        "terseLabel": "Variable interest entities"
       }
      }
     },
     "localname": "VariableInterestEntityDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/Variableinterestentities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": {
     "auth_ref": [
      "r398",
      "r399",
      "r404",
      "r405",
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity.",
        "label": "Variable Interest Entity, Primary Beneficiary [Member]",
        "terseLabel": "Variable Interest Entity"
       }
      }
     },
     "localname": "VariableInterestEntityPrimaryBeneficiaryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/VariableinterestentitiesAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r126",
      "r134"
     ],
     "calculation": {
      "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted average shares for diluted earnings per share calculation"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited",
      "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesIssuedBasic": {
     "auth_ref": [
      "r124",
      "r125"
     ],
     "calculation": {
      "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the weighted average total number of shares issued throughout the period including the first (beginning balance outstanding) and last (ending balance outstanding) day of the period before considering any reductions (for instance, shares held in treasury) to arrive at the weighted average number of shares outstanding. Weighted average relates to the portion of time within a reporting period that common shares have been issued and outstanding to the total time in that period. Such concept is used in determining the weighted average number of shares outstanding for purposes of calculating earnings per share (basic).",
        "label": "Weighted Average Number of Shares Issued, Basic",
        "terseLabel": "Weighted average basic shares outstanding during period"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesIssuedBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/EarningspershareEarningspershareReconciliationofnumberatorsanddenominatorsusedtocalculatebasicanddilutedearningspershareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average shares for earnings per share:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r124",
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.davita.com/role/CONSOLIDATEDSTATEMENTSOFINCOMEunaudited"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 6
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2646-109256"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953401-111524"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26626-111562"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=123583714&loc=SL75117360-209713"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.A)",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=122040515&loc=d3e105025-122735"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/subtopic&trid=2144439"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/subtopic&trid=2127163"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=6397426&loc=d3e17499-108355"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "450",
   "URI": "https://asc.fasb.org/subtopic&trid=2127197"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(3)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "16(c)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/subtopic&trid=2208821"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6405-128476"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(3)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e7008-128479"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613674-111683"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569655-111683"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4616395-111683"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/subtopic&trid=2122178"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.27(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28129-110885"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a-c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "https://asc.fasb.org/subtopic&trid=2176304"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.16)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.4)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62652-112803"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/subtopic&trid=2209399"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.16(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.5(c))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.4)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611133-123010"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-14)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611322-123010"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL34724391-108580"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "https://asc.fasb.org/subtopic&trid=2324412"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691"
  },
  "r587": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r588": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r589": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r590": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r591": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r592": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1403"
  },
  "r593": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "https://asc.fasb.org/topic&trid=2134417"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3444-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=SL94080555-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>75
<FILENAME>0000927066-22-000167-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000927066-22-000167-xbrl.zip
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MS6F$-ZWC%I\#G!=DJ5AC18ZVU,4[% II TK4E=K,&7!E(+N='."<4(F9U9I
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MZZ7?LGU:3 BFL.]$20I*B=THPP@'YTHN&!/DLKH9@R68J7>72*X1VA@,UB$
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M:$%I<@@:;<1BZR14K35Y>^'?W@M<TV&6Y#08- H%0 83"G'S#DIT*GD0*VY
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M!B0EEGPHS<^95=D%11D)= 07I&=23FA%+B)J'6WCH5K(4)H?/LDHC! 21B'
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M%D,VRP8IW>5#="%:UYFBH@4L//S BQB<+R8YY)^DMA>9]89L@KETB"YD \S
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ME>7N92\?@Y8Q&].@(A&- '$)"D/4O8$-DJ]S#YP@7\N$Y$I: FKKH0'FL E
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MR>.*)/CG.M6!:9&M/X?C<:K-/5V50S\Y';J#+TN30Y_J8ZS7<P(*!$?1L;!
M8)(JW' &E#,6N "Q-%QH%VA*>&6P&H#\KWPZL06HKETAR*A>-:JKU6T=MP$S
M"HB6'%#C'5 B6&"@$<%Y)HD0"=4"5OV*C.IM0'7M*D%&]:I17=$+O!4L8(V!
MUC!Z%]I&[P(R#3SCW%.CXQ?<[F!:\#DQRAG6VP#KVJ6"#.M5P[HB&FBD&9::
M 1+MKM1-40(=D )26FQ,-,(02<F\I!"R&ORW%EC_0"YPO?%%7U^E<?KO,T'^
MRV__,D_L>B9V.TLV#RLED992O'D#M]QUBEYE/M_NP,VB]?+F6E^-^>.#M+%.
M-:[KD\]I#.^T1(YK*X#PE@!*) .*FP @04%ZSY"R998])[Q0<.&<F9\"RP8=
MP#U2]-<NCF7T+Q7]5W?0CP-1T806@#,576:E23J0,T!C9AVC CH<$OHI)P6E
M=1W)9?1O!_IK%]$R^I>)_N[=O9\R@[6G<<>G$?/1=!/1LU8"!&RH(XPR['6[
M(PJ.8(UY_1G]VX'^VK6VC/ZEHO_NWA]M_6B7.0T@%P%0Y@V0T8(#%F&.1&!6
MFQ+]F/-"BKJ*Y"T7_8^JD/,T*&>1>)Q'RESU-Y:^69.OQP69O.HCK\.J;&$M
MEDAK"#QC#E#. U#6>>!]=$"AQ$(2WNX0A HAZRKTT0S#I<:SP$<*__J[4F?X
M+QG^=VT7H9.1@C! U-,(?TJ!] 8#8P1DT'LM)&UW:.I"(3+\,_R7JEID^"\9
M_A7A E)A$1,&1.]3@?@# T99"3S45E&DC,'1=4%%- 0*B19N0Y,)8*L(H/Z.
MV)D EDP =_=_1Z$C''F >(" :LR!-,P Q0-!D&D93;Q$ !2*0BU>X'\E!%!3
M#$:3M8L];R8WP1:/J\C(FO.()G[DQY/=@4LKD.L@U4Y1+ZL*1?0F"0L6 Z@\
MB38*4B#ZF I832D*PEF6CE:5*KBL&B@/#UO,><O-!?(24H<RD)<.Y$J,!*:0
MD4"!E00#ZE(S(9\"ICCG&BI!*.+MCHB>!EXD!S #N;E 7D*V4 ;RLH%<40T<
M(H1;[D&0D@*J% :2>@PTA%8Z8K!UJ64]XP5D5=$P(WD;D+R$!*&,Y*4C^>Z6
MC#"6!FD$?%+^*=6IS'^TL@74,AK= 2&74H(0*1!O"))SZDI34E<V,.1C<NI'
MK7_VA^/QOW(IEA5)*.-XO_&[BM:;UJ([' R_U7PS[]?.^R=5324(9:!0#CA7
MUFT@*6!5>N 98=0)R;D([0XMI)+-R 3-"=[-DU0RL-</[(I!9YGDT3T#)G ;
M@<TX,-Q20(0FQ&."G8,I%I6I1;32#.SF KL&B24#>^W KF@N0F,/'1, PNBD
M49P"M8*G<0,GD*1VSE39!.S(Z1G8&P/LM09;9#BO#LYW]VFMJ" 62F!=<&F?
MAD!!#0%33@6GE: (E873>),Z-CV"R(HI"%K&Q\??SS2"UD1_7E)-BZV/$5MR
M+=>G\;-Z@\LX?;/8L>%@_'NY=M._.TXKM_]Y,M)Q!7H#/;HZF/CS<:2]-,K1
ML-\OB6\J/6?.JX_S[)Q4DR0M^V2SX)1J0@(&&ED'&)3,!1Q8_&^[$Y^% L\I
M EMSEMPVILEN/9DLN81L)I/FDDDE<%42H14QD3TP M$4QD!9[0 AA&+O)89!
MM#LD]9UB58\HDTDFDR57KLUDTE@RJ8@K&F,>$+2 ",$ Y8("I:(W9@*SD6:\
MDTQ%;PS)N:4Q,YED,EERO=Q,)LTEDTHY$!@P(Q@#[[!/A0"C91)-$R"DQY8[
MK;SE*:4&0U(P5E>_K:73R2,(#SGXHO8LE%OS&-3H)<DZD<=F^O/O?N!#+W-5
MC5SUOBK)2"DTDIH &M(72BV05$J %81*2<\YU>T.Q05#=>7^Y;.EYJ%Y2;I*
M1O-RT5PM0AI7,$@#L$T)-G$]@29> .*H$,$'15+?#D'GMN/):-X6-"])V,AH
M7BJ:JT5%I?-2&0.TH!Q0P00P<?F 5<(*J((+S$8_@I-"S,FRR7#>%C@O25K(
M<%XNG.]NSL%Q081A@%B) %4< BDL!\Y:%I0W1"J4FFJA N,F[<XYWR;WX-FL
MOWP$44I=/UFD:NVCE^MKEZ]>C(9Q"\T%JVK=1L_VJXJ5DY!2S"6@)F4N*26!
M,IP!*S71R@0CH4Q6<6I.N3':>CZJVV2Q*V-_2=BOF-#"(Q>$!H0:#RB3'F@D
M+! **HL%TRRIU02IZ!%G[&?LKT :R]A?#O:K-6<4YI[H )QA&- 0W6=C(@%8
M39@6S"!'H_O,&2L@SO%^&?LKT-$R]I>$_4JR%(44(2*!H3+E/L8O*B@$F$.$
M<BJC$4?;'<5Q0<C"-:HW+)YFBE*\@QO>*?A//QX_:7W5+5IZ,AGUS.5$F[YO
M38:MP3>Q:O&OIL%JOY9VM;'G FLM;QM7YVO8X>ZM]3D>YDC"9?/>G);"QL"X
MD($# K$!%'(%-#,!*".%M! :0TV[PU1!YI@\.>E[&S!>NUB1,;Y>C%=L&Q(]
M4B]PM&B< !1I$C$N,3!"&T,"LT[IZ-? (CZ2&>-;B?':18F,\;5BO*)=1$.-
MH>AP @537)[G+'XG&,"&.^*Y8Q2I=&:!"T%0!OE6@KQV]2&#?+T@O[N1&QL0
M]U8!SP-*AQ,1[EX$(!5F6,:?C4]I/P(5A)%F@/Q1!4I4!(<]_5=OHEL11#M+
M$X?F\EC3YN@?R[O]1M-W8Z26S,SU,?.<%L>>&Z2]E2!%5 -*H 92* P"D3(H
MS;EA(C(S9 59O-K6AAT=9:;+3+="P2DS7:U,=]<&57')3.KD0'@2C+6B0")$
M@4B%?Z$0(4B5&K,\Q@"9S'29Z58HNV6FJY/IJN% &B.A$ 34)MF<(@^DXQA8
M81V5(5A'HDU'%2ZP6C@Y+C-=9KI-9KKE:H^9Z6IENDI2/Y(,:T@!3[TRJ=,"
MR.!2LRY"E#0A0,_:':%@H<3&,-U,>;P9R,V#34L>J_OLX0'7N'7#)-Z2&UXF
MD?#N'2_R"7F4&S_*K9++Q=Q-95^/!G&HX]:%C^ \U:/ORN9/[HW-6VQ6&K?7
MSF?16D.W\XPM<<8:>8V<_]V4_._-CJS^78][-G6QO"<C?.&XBZ;=\,,]OGEW
MV&C:_)Y3]\*/7J<=N=ZC27S7M[LQ 6X^KGR\OKAQ,+MQ#W#CYC2_0%@QRA@!
M04B?<E@4T-YA@)@EFD=_W&':[J =U*1^/S79Y9F!MIJ!%CPRS RT' :J1)H;
M2*S%&EAN3&0@0X"&EH+@M-6!.61HZO6^0Q=.G\T,E!EHI0RTX%%>9J"E,%#U
MT YR%\T@#S2)E@^UE@!C, -80Q:B"20\2?EL.XVJ?Y<9*#/0CQEHP2.VS$#+
M8:!*US NF-': !5D.D)C&BC"$7#4Z?A(Q>T"AG9'[-!J&DZNP+EU?UG3@<ZF
M"(5[O?[EQ+M?D0JKY\)W#LVV>?_ZR9O?MJUMV0+C[+',F]M/;6X?YO37E280
MS!B0DJ:6F(H"+9T!3B!*O$0V0%U*C-7TLX7#1+Z'B,T)A\ND]EA(;=F:92:U
M7R2UBL5.3*#(<8",X:D^A@=&A0 L-8CB(#EV-JF69 F96YG4&@'O3&H-D4$S
MJ?T:J56$4.*#X-A@X*4TD=08 EH[ 00QFL==B<' DQ *EQ#0FTFM$?#.I-80
M9363VB^2VEU+S?K F*<86!77@A)A@0[( >&1A=%:LU2@I*W")91G7@:IY1R%
M/,J-&^4CR%'XN_S!NY:.@]+O_31/89RRT%J^DK]02XY"(^/'\S46?/2W(>Q[
M^NP_KAK9]QJ1T\E8=NFF&_[9G=)/]_+<^-%1*(W)\='E9#S1@S2CLR/[G!Q;
MD\UY/:="MG30<^4<0($*0+G50$5' ;!H<$8?6UEH6+NC4!'MRP:=Z.?JFK7#
MO/:Z11GFZX-YI:Z1A4KYZ$LZZ B@"DD@O<5 NZ 8<\+$U4\5W&@AU,*'FQGG
M3<;Y@AHWS#!O#,PKLK@7B!FN- B".T"10D"YH(% EIF $ \8QMV<%(JIC/)M
M1OF"HF]&>8-07LE#2JUZJ6$ ,ZH )5@!C9T"P6LH4F,;85.A;,@++EF#8/Y(
MHT474!B^U>FG-U.1ZA\F<FXKT:U*G9BM9H7P,M?5QW5S2D\+8SGW*'HJ-N5<
M>FJ!DD8 A06V2/M M2LM&LQK#LI<&&V;U],T$\P:=9%,,"LAF+O&%*0DI6][
M0.+7%$GDHLO$$+#Q$<34>\JP3<:4*B2I^=P],TQFF!4J,IE@5D$P%4U&8TA<
MJCRJ4N(V-=Z"Z(P+@(1#T3D7!!H<+1A1H#E=C3*_9'[9%"TH\\M*^.6N 1,=
M8*.Q=\!']Q=0YFCD%\8 <=P+A#2$/!DP"!6\[N8\:R.8G-"]GH3NY@UX4_XR
M3VR>V,WZRSRQRYS8?Y?EP.._KO>Q\Y_XY>8=YWKTOC<H-T_^K15J?>I#6[?!
MB>"/+$Z<+,[7WK<&PTF\X&28K$OG!V.?;GE0]C;0Z: C] 9Z8'NZ'P<7?W$>
MQSO^VAGT[HW.+D_3*<[%<-Q+YLB3D>_K2>^C_^U3STU.;ZS=6^^:F1SPZUNT
MB2.(AN>];VG*%*)OI^+VUS3:TOI5!"&O+..<26J<TH:Y$(Q51FD.F7F'>/OF
M3:=?,BLNHA4.S,CK#T"'>(-/=/^3OAJW__WMDQ4?JYM)5SMIVG]VQCK_,:-X
MS3FWL=;IKD2YE].]M_O7P?%NZZ#[]/YGL"EC?7K4?7WTY\'>[O'^7NOU<?SG
M<+][_+IU]*SU].CPQ:O]_^YW7Q_\M9_NYNAPO_'W\\_+@;YTO4@*_VK^6-VP
MW]>C<:LW:$U.AY?Q6FY\_[!O\;.:)C*5?1V^T%/I^MATR8NQ?W+SS6\W&T%O
M4(Z@?--OLVO-."TA\H[74\[1].6O8-V!4\#.]N;9)\]>WBE?NN/'35^C? =A
M?._+< ?=^]KW+HO0#D?JER[[_=<8N?]#&S=8(FD>+"8/NNP/+,L?RH&J\J=S
M-+LIIZQ&M!,/2KLZ/AU%(^H\_MWIN.6C!>5:K_U%M).,'[4(+!Z09[6M4].-
MOWGHS#SPZ=F(^WYXDY>?Z"?6[%M.)UAUW?!#,N"V:>)0'12QI7.3'ZI:'JJM
M2G^>?WC6K:-Z9^[[^ACZOM8>7/IB- R]R>8T?>WV9J>BYW]\.#G^\*F+]\G;
MOP_9X=G+>(U]>OC\93J9_-#]^R5^>WSXZ3!^]M=3T6<?NF?N[/#L]_[1\<'5
MR=E+>'A\>GIR?4CC)[&3X[_.CH[??#[:>\DJIZ+Q>EU\>'7X_$W\K#]ZW;V7
MGX^>/SL[O#X]?YO&%\?0C9_?W>N'P][L1/0UO.Z>[<=Y^/#.24@IYA)0(SF@
M2DF@#&<@1<YK98*14+8[B-."JX5KY>?NUIGE-IGE:H]PS2RW%):[OLMR07CD
M@M" 4.,!9=(#C80%0D%EL6":4=WN$*0*P3++999[U"RW8)1M9KD5L1RJV'(*
M<T]T ,XP#&C@$!@3J<YJPK1@!CF*VAW.6 'Q$BKC999K#-HSR_V0Y1:,]<TL
MMR*6(W=93E-($2(2&"IM:F]K@0H* >80H9S*:)?3=D=Q7!"R<"6F5;%<317E
M?L1)YSWG^GX]V#R:G/I1O+GSBY$_]8-Q[Z-O_;,?X?*OF<A8E.V"AJ$UT9]_
MK9;BCR>E<8SU\(.M99;_S#.V5=>HLWZ$:#:KO!F,?!S%M7>M][HW&$\IQ4=2
MB=M_+YTB^?&D-=(3W[+ZHJ7?C_PTWK*6:JU;CI<EU%'-,[85UUA#!=Q&LDPN
MA[NJ \'2?'QZVWH\**W&Y' ]U>/39_WAI_]Z]]X_CPN4?OF[CUZ8?^5M7X_'
MO1"G,(UY-X5]'^O/V4>KRT?[DL=]6V^'2!EA O BM=+R,  MO0>.<BNHMT%C
MW.Y05!"$&U1W*Y?7>P )_'.U!V;C>+_QNZ7304;\SR"^<L*&=8 ,(@:T@A)0
MC ,P-%@ +4%6(:*U->T.8=4V4Y4]-".](4A?YYE1WNZ;"_[JP9,(03!H ?(J
M=<YT$!@""2#*&@L1BO:?;7<4*WBNC;_%)%#[D4HF@>:20.5<AE-'H=,6>!,0
MH"YXH"0R(+I[B#,C)9*LW<$%7;RX2BZU^ZMHO@N-<3IO2<<N7_2-J;"1I--A
M^<+\ / '<=Z<J=HZSJM!YZC+P\FTMW3:FQ- 39PP$FD%N'$!4,9=I#TI 7)!
M&RL(QTBU.ZB I*ZB=0V*JLDTT#RA(]/ "FB@HG\0$Z2*^T 2/"2(>P(#2@L.
ML$'Q65!!!VZF-%!7?'&F@>;10 TR2*:!#:*!BA)"O(+23?4/#:AG!!B&(= $
M1O](.:]L2C0HXI.5:6!K:: &(233P ;10%4+42RZ@4&#H* !%$<:T'%? %0$
MR9&%+E#2/!JH,ZAC<\+&9H)'1'32#N/ 6O9R-/(#>]6:C.(G]$O<W!\NMI6J
M[\\<\JY> GDV7:BGLW4Z3LLT'>?NP!U_7;0;$MP=]<9Q_O<N1_'KBS@A0]?U
MDZ.0>;!.'KRJBB-2& E-I$!G0F0_1!30VE' E.7.4F:5C03 ^5PBS ?#V\ .
MJU=&,CLTDQTJFHGEUDOL1&2'U(15.084(A"H$*S1AD')8+O#:,'FI"MF=M@&
M=EB]8)+9H9GL4)%2$&>$2AKI $,&*)48&&,@"$@Y[B2F<<\H@TH@KTJJF1VV
M@1U6KZ-D=F@F.U04%N$"$H:G_J:: PJ1! 8Q""162G :&-,VV@ZJ0+P:8;X6
M=J@ST@2S'='PE)D?IOO6T.?Y%ZLU;#0GKB?@))-:W:1V]+0JEP@+/1>: .%,
M=(@8"< 01@%#DJ-H%QLO4@@=*02KMJM_.*EM6.F63 P-%5HR,2R)&"I*"4+,
MQO5E@.EH\M!HDH"XT Q$5T@ZXU%@4$=KAQ22H4P,CX 8FIJ:D^E@"710D48$
M"IY8A0%1*<HD6 ^DYQ8X(A%!3%&,0CI>YJKF/J:9$II+"<T65C(Y+(D<JLJ(
M=Q ZCD&T#6#*Q(7 4*] =!2E59P[YFQI*[ Y[- \6^$15$8['DYT_XY4LH!&
M,IN >U=F [EMG85'YI#9#9'%G_J7:2I?#$>E1CR9C'KFLNQ9=SSL#@=I9*-A
M/][0^X-9+:I,?K61WYS"(]HAX26D +/4XYVD$KAQJP.<>V@@0\@YU.X@"@M%
M5$UIB \#V@8=*CU2YJB]NG]FCN8R1T5BX<AJBT0 BLE4P,08H 6Q0$J&#;9:
M$Q_- \Q9H>#"F7R9.;:*.6J76#)S-)<Y*FJ,%'&Q$?? H!  ]=I%#A$8""$B
MI00"&1>I[+XL!%XX^2\SQU8Q1^TE4S)S-)<Y*E*-<=P)9"V(FX< U% '#'8<
M*,(]DAH3C%+=)!B98_&TX94PQR,KI_*G'X^?M)[.46Y:^A:Z6I-AZS]F]._9
MD@V^@=J7*M7CQU5D9<5!+P^FR4R+*^WP<;R;*'$JY%R??([WQ=YYQHBP3L\D
M;"D@,!)S$ UJ%BF34\A0&=Q'%DH,R!G4S47\*L68C/B5(_[J#N*)038:N1Y(
MF<)Y402[]HP""@G3.'K54*CH0\$"+I0HF!'?7,2O4D3)B%\UXKMW]WBJ)!&:
M*1 W=@6H#@$HZ&"<8$<%0X+3%.N*.(Z^3PTQ;1GR#83\*M6/#/F50_[N)F^@
M48@&![C5"% L,#"I<F*D=^>LD]ZX5"I1H(*PZA'+6B#_"*)/'J1>[.F_>A/=
MBI#:^47!:3JO3TA<"#>\3)>]N;/'VGJU_OEI],;04+DG<WY]G+]?E7*@YQ*Q
MZ-,1PPF@W")@L($ "V/C9N )LJ3=D:C@J&KE+:1PUP"H-9^?96;-S+K!,4Z9
M66MEUKO6-'686>HY8!:*R*R17J6S&F 'M10N!.HBLV*XA("E3*V96C.UKE&_
MS-1:)[56M$GMJ74&,Q",PE-M4AL>@!"0.$U0("Q2*U616E6FUDRMF5JW)THN
M4VNMU'K7:@W00D5] -PSE(YW)9"I6897(D0[%C-,3+LCB"B(W!Y!H)21_UVJ
MJ?%?U_O8^4_\<C/P<SUZWQN4'\^_)3/KT\E$W?A$\$< Q0F@T\E^[7UK,)S$
MRTZ&"94N@L:GG6)03I.>Q!]";Z 'MJ?[<8CQ%^=QU..O.O'=V[WO_CIEB-R]
M;YN-C::0P(OAN%=6Y1[Y5(_MH__M4\]-3F^8Y=:[9HL.O[Y%FSCPR\G];VG*
M_.-OI^+VUS3:DG\40<@KRSAGDAJGM&'1\S-6&:4Y9.9=:CXU>]/IZ.8.+O1[
M#\S(ZP] IWX 3W3_D[X:M__][6,9G\F;25<[:=I_=L;FK>B#'X?E3;>8.]VM
MO=V_#HYW6P?=IS__[*YZL$^/NJ^/_CS8VSW>WVO]OOOG;O?I?NOU?_?WCU\W
M?NS_O!SH2]>+Q/&OYH_5#?M]/1JW]"#N,Z=Z5+9&;$U.AY?QLFY<M/QGZ^.N
M<.%'T]=;D1+U_3=VB^M5:39/C]B^L%6Y$=GTH1=C_^3FF]]<;WS1UU=/>H-R
MC.6;?IM=:T9Q":!W-J%R%J<O?\7N#ISB=W:J.?ODV<L[Y4MW-M;I:P+M8"[O
M?1GNH'M?^]YE$=XA[/Z7OW?9[[_&R*]=]8>#Q0^Z[ ].CG\8'%+]TSG.SA0;
MJ['JQ8\ 4SY6KR,8_+F):""P:"6AX]ZH]NV?C#UO9W.!RKE W\Q%3;D2ZYJ"
MNU[>_"G8??WZ]I[T"V%4/V.<-]KAG>^\U!I1]LBG<T71.NN\Z]3DJS1&;/K&
M_^^R]U'WD[^U2$GC[132ME(*8]!R8GTPRCB*(#?>$V@(@L%*SAUZ=_# PX7X
M^.P.7/IG_^M#M#MYJD>CJSAK?^G^I=\,+>SH]4P+.WOSZ?#\S=7;L_B>O>YI
M]_I5[P0?L.[>7^>'S[MGW6M+#_=>PO3S%RTL7N?H[^YI'-^'+BZUL*N3XP_L
M\.P QL]EA_B/LRY^"4_^/KF^JX7%,;,3O/_Y\.^7Y*34POXX/3K^<'5X]C+>
MXX?K.$[R=N_5Z=NS;CB<TSE:!L<=D0$(CR6@BCD@"9$ ,H:\#MP%"ML=PD7!
MT,)MXN8S79//"3)!->?6?H*@4' "AF"0-80:HHVT!BNMD.#6T4!*@D(($Y0)
MJED$52F)8WAJ:ATH"!110+FT0#-C  F&"H64(]BU.Y2C0BW>Q[)&@EJ"8]4T
MKGGEQY-1SR;QW=Y8A-\Q!K<[Y60-YM/7^9_/4YF8:B.F.6TEB26&*BZ!CP93
M)";"@1(> 4RDPQH*HQ!I=Q0M!%RX;$;.'VLLF.LR-3*85PCF:N$]"CWGD *$
M @/4V.@&(6P I#1(@0F30D0PDP+R+6R6W60CX_7I<#0!$S\Z;_4&'R-(SG_9
MMGBH3[?)=%27;7&H1Q]\><+WVMO+46_2\^-I0[H-25#=!";JSFF_Y CU6HL4
M1"81H PIH'&D(^*\<089S;5J=P0M"*RV7]IX/2;CN&:S(N-X-3BN6!2>>XT)
M1P RE(K)A.@>:&A X#Y A86EJ9@,Q@5IE*[Z"&2+76OC#4S&K9&W/IK7$1M9
MJEBR.7$SYZ^^3'G73S(/U<U#<YH1(&X55@P"%T0 E&L)C/(<. 6QB"Q$M0R1
MAPHH50&1:)!SDY6*9IH4&<LKPG+%IG!06(<9 Y8&"Z@C(A6N\H!2XKU&&GOL
MVQU4*"8*)A=."LM"Q<\@\6#P,0)@.(H&=E8GEFQ.W,SU562>3#FU4<Z<^!!G
M(@EHXX!AV "*F8CF XD_2AN\%)I[DGH905Y(FO6([45N7<9#1NZ2D%L5('30
M1"D%L'(\F@B*I0K_"C#H%7,R8")M0JXHZ)P"UEF!6"+NROZDM^2''"JQ;(.A
MG/&O#LLX>RQ+(*$Y01(R\DP(" (AH]N2M 80]PP(%)&"X" )4M%\( K/;1J?
MM8=MP7%=YD/&\4IP7#$F,#<FKI\""JGD!F@*I(]@CHQL+?/<>B+:'8I%07"3
M</P(=(<7(W^A>ZZ,OAR6AH6=(J*EQV.?0R66;EO,%F#_\T6J2K$[<"5)[9:3
MG\FI9G(ZFA<R8;''PH7HZ:1./8XF<DHA$Q 93B5"*MC4^["0<.'SC2Q1-!;/
M==D8&<^KQ7/5V("4.^P5H"DQC3+"@.%8 VX#Y-!PSP1I=P0NV.+GE5FX^+DS
MCK(P_T1_SL$3JSSM2+-^K#_[6V>NF8)JHZ Y41,4(:AL:K\>I  T> Z4$P9(
M892@4BLJ8+N#4$$7+VN<98O&(KB^4X^,X.4BN&)$4$4,T]0!90P'U,,0O[,$
MF("MYP1JK%-E<E;P1J5GU218;$KOXN/A1/=K%"P6*]N[R5156Z1F]G.6DG0V
MK\6PP]@X+TU\=DQR=+P$2M-H=$!$C%?.:,_:'5+$E2LHQ<MNOCZG^-*F"!N/
M%_>U175FW"\-]Y7ZTQ(RS1@#RC(-J!,)]]H#Z .Q%ENHG4FX1UP4 M=<W'_)
M!:97*("494W7<N(RO(A#NOI2\.(BY:06K8&?M(:AI:V]/+_LET6IG;\81=3H
M$L7QM7^LY7QB.MP7?3V8[ [<_LV(CSX-O-O].MJ]6X/-#% ? T3D/_V6 >+U
M^OZ_KZ[>_NTN#*;\\/J =J]?DL,XII/C0]Q]_JH7/[]_N/>!=/=^[QT]/_P<
M[_E3-QW/GAV^LQY"KS$'*J2B.($0(*DW('HY6@BE,$K'L:Q B!9,J J!E$_N
MSSR+]6GK^5G<IF?Q>O>=5I(0AA%0,"! -8K?(92**'@F E+20M_NT$+PN*&1
M:HQPT1KY\86WJ8)^_^I.G?8L2*UX3\AAN77#[:[3YXF63$(7:=M$X\^Z:/Q!
MKX"W0J2^"=Q[6CI]%-:1&YS5Y<:">>F;:@9SW6"N]+^$AADB&$#01T.,> 0,
MLPC(:'5QXPS$PB<P4Z$*)196<)HG-#=97#Z*J(@&Y.!]J^_UV+?*60'# "[C
M#SDX;C6!]S=K\&=:@E=I,$?AS=B7<E,FI_K(Z:!J:5 O D.I@Z36&-#(--'2
MD Q(J8DWE$/+>$K]%Q@54C8I!RB'QC73TLAH7AV:*Z:&) &+".3(OA'-&'*@
M4ZMM1B)7(R>\EZF@4"%Q]+7E8PZ,6Y<N?#"8Z,'[7FJE-;4NYDK"^GP8AWV]
M5DGX62]^AO^S]]&[KX.>G@#=TN!V;XTT@[L^<!_^4(/KXCC.X[?GW;_CM<Z>
MG<9Q]KM_'UR?X/C?O_^(]_"&=H_??.J>OPIQ;._B6XCSF@!'TH$2CU\4<010
M$9],*Q#%AJ8BZ86:$P&_-C$X/X5;]!2>O7GG88!<QAU**:$ I>E\@CL.L&-.
M8&&0A[C=X; 0I"IK91EX+9'%W\*NZR?[GVW_,LW<\^'0?>KU^QESM6+NKI,&
M0T1,A U <3DC:%"J$RDTX%Y  IFPUI)V!PE5"+1P@94L!C<6TO6%&F=(KQC2
M=STU9!6'+HG"&I)9R44=$(!2X.BM:>=12) 6!5=-RAYX!))P.AJ97+7._>1T
M>#ME.I>67VWQMME<'PQV0^CU>]'.'[^^-..>Z^E40"]2U]"6O]T=N#^&O<'D
MK_CGE]%"S-15'W6]K%HC5CA"620LPFVT1J07P'A.HS6B@Y$4TX!$NX,I*1A;
M.&TB"\:-Q7J=Y=XRUIN!];MFBN.8>.45""BE62/F@:&$ .*-0Y::@*R,6">R
MD'+AFBX;+">O :E_#@?OZ^EY\QA<IV7VO.D.!S;G1-3-1F^JE@<37HNXZ0"5
MC YJN0;:,@BD12(0H[5CD8V2X3$GAC3+(-N"Y67VO<E87A*6[UH6$EO!D3?
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MUJ1'FD$8HOE(N00TY5M*&6QJ*()"L$X*E10G42","EI;TO0FUN:S/C[DH_6
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M*H0]+K%CK9:'^ZCG$%BY;$^G:_+5.4KM!VZ_LELN5F:X^ACN9$YL$]3&8\Z
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MJ]]&/@A=G_WQ^^4XCG \]N/GH^$XZP(U\M*<FH/<0!Z$X$#&!QI0%320A 0
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ME5%E5!F5-2RU=L=AKS\8-C7;)TS@FCK\,$T=[BK<7JG#,JC#R9_3+KO@9<)
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M3>_Y[8JP>8X FSN\ <WL7]4:KMBW$/;].<?$#T"M8YYXZI& =)I8F]^B5ID
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M2>"=#V][*)![Z7_^.'[[5SSR'-3;G<Z'\IR]O]YV=_</#CH[L=OYZ[>/6"]
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M^VESE?;Y<69J?<:&:W41-@7:V)[ET:>M6 CU*XF>I=;RU7BJ)(N^OZA:+NB
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M_OSD[<XN>[/_''8_O/VXN_/R^$U9&37/@/F*GG0^/,=V^/B.1>6Y$9) C(I
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M0::$1MT*U;:F&O4'#'6'PIUI[RC/'D)PGK.H@.<RHV"H"#7:L&907YA"$#Y
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M3R5NX>VAPYN0 7C&2<\X3QDEIBP%, \%^]=Y[UIXNT-X6ZJ[D\$:RI5&V*J
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M(K!##=*<1232WE+.&#;EHR>,=TIY;\"@K9AJ4ZZ_FS%SS93K%J:N#U,KBJ(
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MJ,8@99U".(HHA"T%2:>+Z0Y6I,-YZTQML>(6G:DM5FP45BRJGC(:ST(ZUR0
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M#?U/W*N:1FZO\>?]]\]@'3Z\$SI8[H1%6'B".-$<*4$$LCBZ8*R2)2Y3_;S
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M&?-:P&L!;R,!CRH5G [1!!'2\5Z**:J"+UD(SLEHKM^KKP6\[PMX^TN'8=K
M0#2!^JYUZC"A';+""H2#HH3))+=B4O(Z%-\/O%MQ!M6]ZT3X.H1BOS\.A<[]
M,>)DF.L\?1B;JIM[4$T;3PWGG$UU:PMS[FY:V9.C"S95+C8=3A,HS>ABGXW<
M=*+NOW'C>M=I.X_Q,7R47]-;JK"XJ@(VX<8];&8V[9DR;016I\:GM<E[TI\,
MO]S%K+-RM9>.I#EO6W+Q84W)[Y</!AO7G=+2(4NQV:MJZ(O_3<P0GC=M=%F<
M EG<+,_CZTZXX*N.\!PW1WC^W<Q^NY[\;C/CE-QQ[W,[OKX __TS<7"X?;;W
M>9<<'+[ZO/_JG16288$)BM( BAN6.HGQ@)PE1I>!6</9HR=\BRWW$OQ'9_6!
M636OS1^&E7C[>B1V=7>_C#<)R>HB]DR"N;K<V/['<-^X_W %TZ:&1*G'W[69
M]UM@\^:,*CB7@GCE2F*X)]Q26CJJF8L*Q+Z;AK;+2YQZ2QQ[,1UKGDGKEKIU
M@] 'S+"?=\_V3\&VC-P:BI%B B,>%:A:J24LTT08S'RI94Q,2M4RDV::N-DN
M?U4'E':7OV67/^]OO^-@!SEM#++I4 :.8T1*&(8489%XJYF4 ,5LJURQRYWF
M\,VK^H1\!;MC)YD+T6KK.<'2AL"P901'IZ3TEV1AMW+Y*PB @"QV0D3E(T4$
M+&#$J0S(^%(BH905RK%@J<JR>+FOYS_NF_"[?A_?U>9#<ZK$^>&<TP:^^;S9
M^N-D[9R?\0@?WQGU3P^6!Z1+2=E ^+\%DZ#O>1IHRP0U$^R=[1^],R$XXR-#
MFA) 02\D,A&#U"NU+E5IRU*X1T]6G/W^-9+N&[<X-3B^<GN?S1%EN]5SK6O?
MX(/#7;K_^16&_U)7<X<U<<J7B)$R85^(R+B2(VMIX/"-I=$\>J)6(%_"D61<
MY!,/FH;9L,2#6EWNGMVDE>9F8N7JKGA?[G)W?8PMCLT-#P984Y?GES#9@_@T
M&X+/:SOP[(]IL_+?^L-A;J?VU S@N_'9#^W1_1;@9* ^ F@QK;% SG.<@),C
M,,PL_/!>&Q*XT@"<);VD$;3Y"'9U;4S?])"(MN/W=]MHL??-';_]T)SVIDZ_
M3>'YO;H72,OQUR2$5Z?[I^](D%Y:Q9 Q@B#.%-@+@CI4LA -HS$X*E-:(KZD
MPO+R#N_7/VAHJWC:-(6?X4=]\_BX&DVO.TO'I,\= )<DS_G)<4G^=,,8%*/1
MW!#F^U^N>&(G75IWMTRABE"; S>@9A>)-M%C&@7C3CL5H^6\%)R4@;N KTW-
M]<BG!#UWR,6J(N-LF*#/8=A_P,3[)IUCP91,:E.)H@#LXK;42'NL@8RUM5:F
MDT;\HR>PF6&%K+I*L:F;QD\5&]BU?M9N+EJ"-\$]&43)J558>,F)D*D,51LP
MRJFTD6-_.Y328MV,7"A@G;:T+"UVR/NR1-Q$4&Q*:9"3BBK&  I5PCJL .GH
M,L54O6M!C &@&YCL6+=5BF4.P:288E_]@+G[9^AV-3TNFQS%LK,F[ZEFA 3M
MA)1"<0M$9H4'6'+::B.QL.^$>/1%#\\=M3,O9W;679A(]9(O_YR.Z7;[?><4
MY'YSB(,[2X<1=_/A4*,[9M;]UU-F/?[PYOVK3V\.';SCU=G^SA_'>R=_\H/#
M/TX.X-EO_G[%@(F/]S[_=;S(K <O_JCV=YX?[W_^D^_O[.+]%\_.WAX>B?T7
M;_C^W_\Y?KOC@(F??=[_^WDZ#)+L[;AW.L1T(*1 HI2@HGI-4(I3I..*G*?2
M&1_B8M=VAK&5(5*BH^2TQ-9&&7S*&8^V=$$LM02_"RH'L7)2C9N347K^+DF^
M^#XO7[T.LR-+'.B ,S1;+(N\HJ7_%S?[(G%X[2T8')9YK3A(8D4Y%<$9(D/
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M5F%%?03[.1?<:S/UTOH3->#Q-/DE#P@>S=FUG\6-6F '4\%!7]*(:*$!-YQ
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MDA$? "UJ7G@-AIUDGB*FN47<Z(B<"1Q1KIR"C0Y6Z,4=[&\ XWD!QE*Y[AO
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M//$XCF%[JV;5\V8^FI+H;>:<EVC2\[;X:<R04U)>?EXH6*1 H$S2J7?J08&
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M''27?O&STG*OW[4P9@HM>%9"PK+ KF5JNQE.0#FZ1F#G2W _X(,9.7C)  G
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MXI%Y+-U"7P-4++.O 7FKB>7Y_ (+W)M$^\L[UF_S:WO6)=LM9-XP9ZIF;TT
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M<\=V^#_LV>^KD5_SDT'CLFC8\9OOG^@'_.G_L??MS6T;R;Y?!:5[SKU.%<
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M]K8L]<B13BLF-G/)I1GQ8R$$]BJ-_91G@<BXXCQ6:9+FD77)'9B86,[72F1
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M"-T@[@@K?\?<E\7XJL]O<)SJ=NZW5\Y?^=0R1S02<-7GK\H7<9VANEOIR=,
M)=N!3V4=*!ENQOEH.)KW"MM38->GP-^OEYTL><(R/V'2DS*-/9J%B<?S5'DJ
M"B,JDS2.D_SDE+HI6R[HM7"#1\'9._"Q6,Y^?,Y>TN]$E,8!MB7.8P&<'<5>
M%@OJA0D/0T5"(J5_<IJX$;N/]]1R=H<Y>P<^%\O9C\[9R^V0.%&^C!+/]\%H
MHR"UO317%([PT \YBV+*!'(V"'7+V8?#V8^:D6'Y>7_\O 3ASV@2"C_UA,PE
MGM2^QWSN>Q&3+)><)30(3DY3-XGO#:YE<8)W4&JR'@CGCN!&9FJ+K<YQ1O?+
M.NO<,F[=]6V'"W0TPO\!LEOJ++R?RM$ 2!T.@"FL6Y6F!Z3_#TWJYKJ/2.BO
MOTU*#DM?#'EY\V:B!F,X/'"4Y:C?U\>'\>C;DV-W)\>;9>]-%H<\ ]/<2Z,@
M\V@:"= $0^(1$<L$!#U-8W9R"K3@DA7M7^X%R+8#ENQX4TTKG*UP?OS**2N<
M#T4X+ZGU.4NRD.=>SF+E4::(QS*2>0&C/HCJG"8IUF$RZM)HQVB95CA;X6R%
M\SYRT*QP/@CAO.1#S4CBIYB#2E*6>)2"TIQEOO#\.&.I""*>YOG):1JD;I+N
MJF>S%<Y6.%OAO,>L0BN<#T,X+VK.*A BI2KU:,:Y1XD,/1:IV .[BL=Q2"E#
M[(( >T^Y442/1CQKE_J/$PXOA7]E\?6TGMKY=  ,*,S?PI"RIN&:PZH+=J#O
M?!L7SX=%_[]/)N54+?+4/)#\NUS'C3[ 3(H<9H7 9=7WP"O(/LAY%:;9^..H
M[47_"*/\1W\DOAPFD_35_[R_^>M/>941&L-WU^=__O3Y_._?;\[_?!.>O_I"
MW_W\R^#\[Y\&[U[]!H0N B#^_E^O?LG??OPM/+_^5YQ+[O,0C$/!0@\,0.EE
M4G O0MQ?&8, S$!\*) D5ZK:BF5B  JIJ;J2NA0#*5>C<8';\[Q4?8VL_>*Z
MD)/+6B2W[JIHW9_=PC/8H>ED_2TMBA8*Q>'^3Q:"8PI8P]^&45H_+\MZ-%?\
M0GE9J?@7C^<PV.>\?\UOQB<_SLUI4 SKAS-\^[9S/]4M$^;'\ZA+MM0%0B_9
MJ[,_WGP\<]Z<O^QU?JSG[SZ^_N!\?.>\?'?^ZO7YA]>O\+</[_[YYM791_CC
MIS?G9^<OWYS]T_GP$3YX^_K\XX?_^W]2$I 7SRKYJ.0/G9_FL^F03V4QZ=98
M5W/<,PE*$"_'#A_"87K)01%RBJ$SN1Q-X;%R[#KJFU!P](%^9;YW0-+SY8FM
M9QKS<^&(,^<#3>)8!+G/8DGA=YFE C3$/*6$A+[/LI/=GX3VZ-O]T??V[%^A
MBF,EL]SC/ /3.TTRC],\\((P$)0+EH:<+QU];6FM>_-J-8S5AF$QE+#.STFB
M[=3'X(Y7ZJH$_=]0+'(('R"$Z]_F@PJSP<ENG%)CNZ*.US3AN>; 5&.P*?K]
MT76KF\ZB)&C-/,9SWJB<'MK#]=2K!]?'NU98!?+MU5@]KW]Y4=> %$,]$7W3
MB^KIE4Z BL2"LJI7VGQ='9$LZ@5)A*=DE0A2O;@Z0'OZ %W0O\UWE/982M9^
M[?>"M=_=]M@@Z*5^>*?'WOY=%*>',U@:T(<8;$S9S@<+KR0/LK)QM-G*?B>-
MZ;NYB&SITA4>*W-N[\<SDVS4$>SC9:F4,X#K+L>. NDIG0]P=JM!!H=WZ+L;
M=&PZUJ4YAT\V79D-J>=1G9B+L[YOHZXMO"#=WFC4]'8UX4VZ@AW3P@6[$!!'
MNC:6J'9"5,?5F'.UU/V]]Z'GR(+W;\;%YMG#.X&D[-Q:;!Y%VWK^1Q,D"\)4
M1ERF).8)E3)$;[&(?)G$L10J95OG_K;-UK.A/&L9K4\@R/597/_UZNW?GP;O
M/__UZB]X]V\PQK?1NX^_1W]]_IV^_?S3E_,_WY+SSS_U%X-<YW__X\O;O\^+
MOWX^_W(^^./S^:O?R=N_OT3G'_L#&//-VS]_"S[]_8F\_?./_&U1!;@^^'^?
M?WX-[_CR+Q8'+%9$> $CU*,IS3T>9JDGXIBF)$CR(.<GIT%*W3B]=W;8@>'R
M6L%G!=^"X.,L36BL9!0I20D+TC3@(LFR4-(HR!G9.J_6"K[]"+Z_%P6?3'V5
M<<J\+*;*HR3VO33,,B^/H]PG69(+D8+@BP.71,0*/BOXGK;@HX2(F#/*TR"F
MC(DT#/P<=$"?8XY,D&^=LVH%WWX$7[ H^.)8\"3)E!?%8>!1'V0>BS*!:.Q$
M"IYEDK"3T\A/W) \M4X,5O!9P;>8#RHRGS)!DTSZ-.0Y9SQ56<AY'B8B8]OG
M@UK!MQ_!%RX*OC#. U^&U,LH\3&=4V# /X$?,B<\DGF,0.XT25S__LF<!]9Z
MHM-B2J>X5%E59YC;TN?EC0,/^UJ(9;"#(T?(W:9"/Z$A!3,G]FE*6<RS*!4L
MX@'-4A!?<6Z]=)T473?+7KHHD5$>">810A%J":16R@/NY4&>,9:0/,KBDU/F
M)N3>T"P6\KJ[#.T',6&$"4X224.9,IK$:9ZF8<QX2')JO4\=9>@E[Q.E89J1
M*/722( 1IN+<8T$2>&!2*QG%"1=^C@Q-[M\,SS)T=QE:Q:$""UP%62HHY2J-
MB!\&/(R%\$4@B?6J=)2AE[PJ,I<@EB7U@%Z!H2/X+<O3R/.3@(@PI#S,)':[
M!H[>5:&8Y>@.<G2>I(FO0J9$Q"BH;0BPX8-HSX'+DXQFUEW048Y><A?P6+)8
M$N'%24(\*N!T!H6+>)&@B6"@;<DP.#DEJ9NLP"1_/([>4[K29'3U2,QX+T?,
MZJK:]6Z:)^34O=_2'(T WSFLH17@>Q#@YR]7.$V"/(\(R&Y",NPIH:3'$K2Q
M2,PE%X%/T&D2(/#5_76R'?+28<3 K"2UDG3/&(16DNY'DB[G2@64IGX<>Z$,
MF$=C13P>^KY'4R(SEM&<Y0B$DO@NC7><*V4EJ96D3UZ2[APPT$K2_4C2)3>A
M4+Z0*2&>\GWBT3#)O92$W&.I$#$)0Q*HX.0T"E,W"JU.:B6IE:0=1_>SDG0_
MDG3)/1N3).$\5Q[C@F#?8.5QKC(O]%.9YS'A3!!,8XW<=-?Y^X\B23< Y>L\
M.,T#02/)KWP)%NDEORHFO*\[1\EB,BW5^*=1^6N)G:4F-\"IK_\]+:X0]J8%
MD+2 CX1K_81!DJ*W9_\*)&5"!IF7"QIX-,F8EX9^X@E"HB3!A'$_,R)6(YV=
MH;#C<:Q8%I(PSA*:BX1QL/BY+T64I"%)@T50I?8>H<ATKJI=TOA%JMZG=:!%
MJE3SJ$6+4)5W1S%:B0#VW>GM&_TH9CW?OQ/Z44QZ--H83&>%(M>]%N);P?/$
MO9C%#P!\%--D]UA".-C-((KNBR7T$+MF07@ZD7&]8Q">3O+_L<.36%P7B^NR
M"UR7SG'I[>>Y+<JS17D/5HW\*[^I$'+/!!@<I:HMQ5_[?#AIFXM/P*LS.!_\
M]?D/>.<O7\!,I'^]>C]X2WZZ//_[$L;UC\&[/S^A9P>>N>S5^43^&IS_^<?G
MMX/?@D^?+[^<__SI[T]_O@[!S/S\]N=/$;SSYBV8H.N*DY.(Y 'Q0T_Y6>[1
M/*<>3T/N<9F$D4Q($# 0#6$<NC[=51=B6YQLY6"7)OZ8Q<E6#CZ*'%SR;@=8
MYD4Y\83@OD?C1'@LCHFGLB /4HY(:\G)*0TBES%;J]PAYKUCK7+'57!;W_%@
M%5M6XCZ"Q%U1P$4#7Z1"@K -<^)1.$$]IK G$@MHFL19+E,"$C=V0[JK1HRV
M@*N##+[S B[+X(_"X,L) S3RTX2$7N2'J4?3, *K4OE>G(0^Y2R15,1@6H)&
M%72)P9]H/5='])U=.2=M9IK-3-MSCJ\]=_9_[JQ*^259EH+B$'N<T\RC.8^\
M+ I@%V4,NXDNSD2 8NDS-V3!$22JV91?*UB[)%AWGO)K!>NC"-9E/,<@2UA,
MB9>FV)X["Z67REAZ/")I'B3*SV,*@C4*7.:S(Q"L\QG 2PVX=\J&T49M8Q?6
ML.Z:NL?NIV?CL9J,UZ?P/MWLW?#M];]($J<D(0P13XE'_2C%;'GF)9%*683M
M3X/X\%J<GCGCZ6" ;O51[G!- !OG!M\]%WB_.;U)V(O"]"XYO5':B^@#=#2%
MQZ9WS8>][;N$/4"34!SL?OIN;I3?V;ULN+DL5F?#I,)C78Q72E1K$>BUL'F"
M#Y1W<=3FUE/*.TE -\ORG%%&.(UHFJ:$I'&8I_ 1#\/D7V\V\U$9]>T)F$F?
M/]'SSV .??S]YNVK,_KIXV\$_H9G_-$_)[]'[W[^J0^&U)=W'W\+E@HE/U\0
M-(?./[ZY?OOJ\O+\U2?X&_3 /W\/__KXA7[Z\W<PI'Z+SE_]D8-YM 2#E 1)
M%HE,>KF(0H\2I3P6B<1+B/ SWU=$IO+D-(A<0D(W"FVO(RO=GKATBUDJHS0C
M,D2[*Q59%@0LSW/J2YEP%FKI%@0D#*QTV[-T6X(F$GD69'%(/*Y\Q-T-E >D
M++Q,B@0;\V72)UJZA4GD H4=BG2SN7*VK\<Z^41DPHB27-$PHPD+TBA6BL>^
MS/TL#+/8:E^/))]6]-?-51S1/$P\F62H?1'NL5PH3[*<P!DBXP2[K05N$J8N
MB9,.)9[8S+)=1_A)+CA-(J)H0GF2<1G1*/&E(H&?YZFT:L6CL>V26A'&RA<4
MV);)B(-:03,O$\SW2!BF<20CEH6I9EL:N_3^C;&[ER]FN(_T2-1Q):(=[JFB
M 3L-ZMT:UWM:-N N%NAHI'GDBS@4*L]8)FG@QYE2(:A?(,I%&L<RL$K8(TGS
M%>W3E(P#P:/$RW)./&R&YS&6Q)Z*" '5.98JT+V^71:#2&=[21;8BFT.PT=F
M!:@5H)L+T""7">B]62"RD&8ASU*1$<99D,1"@LEDU>%'$Z!+ZG#B4R9AA[U4
M)&#%JI![J2]S+Z6<^SS*XPQK)X+$#4BP"WVX,P)T ]3%Y4PL3"S19,;"(%!,
M1'$<I323C&>1!(H7+&,\]J/L7PD[N3T;A>TARV9U;E= >V;3EG\^<(X73.!,
M"" '6-*+7\O1$'X52J=<_@H;+&[,SZ[D=KW[4//T9?\<>/C\U9=OYZ\NKM]^
M_NW;N;[VS<WYJU^*O_[\HP"^C3Y]?/MM,;?KW<^_^^]^?N._^_C:?_?J#*Y_
M37!<;S^_\=\.?NG_]2?R;?_R[=\_Y6\_G_GOSOZE.(E!A\D] @3E41XGP)SH
M!Y>1G_,DB -)%Y$90Y[[($]!.^64@L[#PA1XA*M(13P@>;B8"X:DQ)NM  KD
M0\E+.;X=8W$E:N)W7WU;XME</E80]J*'Y K]Q.<('EJ(#;+1\,'-PCC#T<2Y
M41.'R]$5&*2;))QU*+/NS=!YRTMQB4DPONM,+I7ST]F'?SC%> PDY)Q]^-TY
M'_7TMYY/7:>>7C=V @20*A6("N<]G\ /A1J!\^SCZ J$5$K3'YX[/W','9T8
MNASE>H:O\UR)R1C_7/T$N/2G8LB'HN!]^ RS#($8>P\\^5NGNK@5")GZM9#P
M B [F!L,5'V[4K) H6E@5+\)I;\R$*O\ZJI_@SRM,W\NU%"5O-^_06['S##9
M9ONKLH"Y7_7AZ9.1EBAXJCN#D2QR.#C-0_$=ETI>X VEZIM/+XNKL>N,I]EG
M6&%],YRUO!@ZHBPF,'..-,8G<$.][O]\\X]W[QT<('#2I2J=$C="7U2,]9P$
MC@X>E2E'%N-&OO6<C["7<(X,I3XI''C+Y!+NP972>:!*[W/Q5<&M,,PACG14
M$WQ W(KH<2)(%B]' ]C8&V? ;QS5K\:OETU_W7H3K/WXRCQ:?PF:S,6ELYA4
M1GH5I>$(?N$@',L;I_JJ61<S_8D:CLJQF;4<:9G"]:WM@;DP0]&?HES4'X^
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M_C3_+2E!JR:_@1$*$@#.(N/6T*X.='D$OO?;O($)5S\@\;A:+0$[<]Q:8V,
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M=WX0;3_B]0CC&"=F =T3Y\3(1_P-C4WX%Z4_\5]H2>3J/X(7S@DN"EX$"U6
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MR9-2H7:Q7  -P@L=C9/+>DO/AL-I@Y;?AI7[7^V0Q!<@0*MCC(0:[-5 )E:
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M8#7:5EK/.6O6OG^SA,UE!%FM="UC\M;;4P75]/:VN_L9RJG-T@H>9 Z"U_!
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MM+%[8,?A3SHFT41CJHJ:UB&RG'5:"^6:>MJB&!L0S9AU.I^;OJ:,QP4^U,?
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M/6=^/U>>+"43 X6/I_V))N"* 9"<-Y'R;$G^Z!J!AYN5?N+S8@*[(38@LH]
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M?<2H*&@0H[: A%H">MH8NFF.$DBR>T*825?]Q.?%!'A3;"*M3"3,*0977.A
MV2QD9K)?',\1_=%X6IO]O0>AI>\?#WJXSJMIB4,S"&-%*9U_3WF)FP>;C$3@
M.M<*!SXM2Z"42[@5G127,-+AJ!P R56A/TU>YIAP!(>Y8^9/-<]QS_EX"9*W
M^=M!GP>^$GZ?]B>:H!Q-L?^_O7?K<ANYU4#_"I<S27KV4M,B=;=WYJR./<[V
M9&)/;$]R\I15(DLMCBE2PTNW=7[] 5 D15V;5.M"4GB8L=U-%E' !Q0*50#D
MO6/!3Q\<F![\U(^!D#B:I[$2F #\/AL_D+_'3B Q7*+.(>/(<9,;PT#XU+&F
MVE2 $HRE]!*1P"S 8$VU\4*S)0XHJ;8 ?BG[#"A,3#\-45X O:\2/I!;2-Y\
M_-?[M[?&"%X!#,X<JZ6)$#CENO@G#(W#+6N:A?#>HPCL5J*@#\*SZ+.D#8$4
M82J#.>I#D*Y/.,H42; =X2Y")TQ)++94G5=1]N+L8QRLX2N/FU_US_IRCBF*
M4K \2D#+FL'IMI<EZ92<$T9B.;B\*)?1-9#*=X/E6_C4?0&SB:\9YDI!/'S5
MWG=;/7V;7C8SVYBIP;I^)!0F]A;\$1EI\"O\/(X.?X'?!C("K .&7)RF>J6E
M?DG0=H*E'@C+DBZ:'1AL+Z5UP]&_I?8(S(39>V!2E4+Z\\B9P1@DEZU0FOA^
M- <[%V$513^^GZ:_F$G 8$ \>^GG((=L0AE:$0VZBD@-^8HJ#2*9H6<J(@VX
M_4#<AC^E"V)[D,EJ"WS30O@AXBS!_A[M32;;1;=P,PLR\?>40Y=[*_' VLM7
MQ!A<L3C:_<K)G?N" C4':SF;N?]/,V=T#D[^[1CT^^NMF "QKX3[*!;ABY>K
MD 6\I@P<4:YHV=G_0#6CME%4!<THZ8ILGC!<UM585<TM%GJUG,^R\.D6MR1G
M[B>!/Z,'0PE68?-)4'R0&,PG7<"7KX([AG9ZQ6:':L#$TWD$X"7ZCC8!5@=8
M)&"M5@0G PHO&Q.=!J 7'M&UCQ&.8 >@N0$YS4AD[D%5C37] ?D;4RE<]$U@
M79HX4492"PR5C3M$V-_.Y^XB-?Z^^@(L"VBHMES-"D,?+3],]=&!<6GA6K6-
M,(J:"QD955@59@E&K(7.R$2&(3 'OCR1Z5VO56.8K4.PT(16X(QA##$&^Y>N
M=LL)TD(^!^D "3 )?S+!M4LY8DL>..!\!>@@9:LH?G4.[L),6#*FG?(:G*NC
MHGLUX$ %*+5A6U>*HB\;Y?5DN9%;/KFF+[A,!^!TT\_#@U3B.!C?I)4&I_T"
MB"',L+:$9\(%UP?89K^&=Y#DB1.$$6PMW$EB9HR\_B )#TX0Q0#4.;T^CP/P
M=Q'* 4#[7NU85O8,*V1MJ !J:4&U:R6,WZK3NO8>W!7;=J+,!YXXW]!G?H++
MGKP7JNCS<AOU)( 3#J;:;2]_1;-$R!Y@)+;;@M9NVTGF8]V45=!VE%S>"\1\
MEO&4RYN[(GNM1+N.ON+?PZJ-VF#Y]QY,P$X_M.-]/_FM<&6Z"P^E.[FUT;<'
MY2 XS3%H2XI93"/W6],GC&EKBS7-QR-@C^?Z"U(Z(/C]%R3P-U#E7287C!%8
MH0V#NT5/]EJ3ZNG0D0%9E2685&,M"OMDH/605;N5B#;Y1EE_SPGSJ[E6GN&/
M(MQJ_)4&PSQ0*;<KV8H3N0O'H$#..$:.A.E*C8$H1YWG3/ \J*IQD9++P]YR
M"E5:& I%TI:JF!KKHFJ(6B""Q&QMO+^E3<:&$NX,IN4,H@H6R75M6?7QA#:)
M73>_W*P,EQF,P'==/X[2M<<#KJO(-VX %R%,&"'^#[%0+E3UH'HZZ1<WQ.MR
M+VZ%\ZOASBW1?KJ17# K]B.ZQMMV*-MD2J%E6JTM/YC["#@MDM;4 \'<+[(E
M?152N[")%.P"I0IED-M #DWJ-Q!1:L=405"5M'^[DL^K9/KD#AJ3P#)(+@W]
M @0G\+<G@F+KF-_NWU;QE/483%MN$$N[7L\P%ZTM"T9ZLIAZ(NA>8*!A@4<%
M5G*?Y3<?#R0>8 )T1%H]F914N(_KY]S*S_LM#JE'T]IO7Q69;W_]%D@RX?/>
MOAET=<,T#[E]T^GIQN@$;9LZ^G!TBN9"@V&_+L0:NC$\;-1F$=OAMDUH@K8W
MC_BRT3/OBOLVY7LV_=/4-GH/G:%?TY9KSM7FV?:&0L_JV;3S;N2UM\3!K7AI
M-C,GN6_3.5G+?9N>T;?I^IHSK>^)N#53G5N6='J7Z8?!37*N%7'= ;=E8L2=
M<VXWAFD6KX=9/;0UO";,C=G3A^>63T7R5J^A']/=KGAY@]HQE1%:TQ:$;5.L
MMB)V1O5OC,.(JQ/BNH.R_6\9<8RX9WE5PQ(^5?7 UO!R+3?&4.^>6SX5\7D/
MJI5QD5L27*-$9>URC9(=-4K>^8$F* G#LQS7R8KP[+PBA/>^ XGE$!20Y3W>
M]FK!7Z3VXM/*.)38\,'W;O]V=_>+-I."[CF^P MP])FQ=/U'SKI>9ET/ZYYU
M?7F#-X#];V=XT+6PKMX?]HY_'ZBKM]NC4UP+&W7K0JQQF@MW=2/6,/E:V.ZS
MZ0_K=WNO^%;8?[Z\U?(WPY;_-LY].ZQ>%QQ6KH8=Y6;8L6[<[+YN4V,.9[?"
M#+X5QK?"*L9:OA7&M\+X5MB5WI@P6F:'[X4QYLZ+N5[IE@J,.<;<\ZX>C4IT
M2JX>VII^,\P8Z6>_N5>14[*GW6R^ %:]"V#-,>\ULN+@K0[W>ZNG,]E/^ &,
MA\MXDIT^XX'QL+Q@WMOE19P?"5M\MEJZ9GV]?R*F5L0#XWM*?$^)[RF=^IY2
M'<IS;7#G&"7+J);4&6L MJ@0Z;:BU^-%@4JHS1+@WCI>3XAW2TVV([5I:*W6
MA,5QL$BSMJU(\Y.EGU=+-&^O(+NS44*N<./V-@U26-/-:KD;]=*H]BWMM#<@
MM]9A BM("FPI<R^S*NP@^P?'PM*!#Q(;XZR68E^M0)W)>EF0_2HQ6]R2/*.V
MX):RSB(;#Z6Y11J;<-RA ZLUH4_<$82H6JDRFE8OSSV:*SZ^'?EK;0_6.AV<
M6R^V56M?DK=:4WJU[4#L.5'*]@U3]$3-^%U%X@O4L-YF8K8HKV/_Y84SZAB&
M'%F]?K\W[([MD1CW[,ED;(W&(]%O]\;_'0U>/*GQ)U?PC:L"JIPD(OE/?QB:
MAOGZ#CTH5P2+5)IAS:P5MK]3JIGH)+J":?5]L3$[;+ 849/$I>F@_4Q>;2T?
M?C^.0^Q@2'XEX.7!H<KNF48O!_23LL/1HQ]\I:?33H+:';V]P_*UT-91NSD/
M!HQ4460@>)X4:%\V77/ >-RK2L1?'=N3"]48Y.;]W]]\G]'9RLJ?TCN*)TL&
MI(\!Q3?+0O4TV[18,K;P%0&8%9@N?&ZF2M9[N#E$;?<G$15=7GX0E2:ILIHO
M&HO'(?/O6UE#/R0_\$@T\)6EF&I7+5<U5-D"*E5_/Z*JPF0+MW5R-?O#E5Z'
MWPV-?O:#O?TY\.D]:Z*V1!2($ M3DSG'?R5MF5'4J]2,_I@B#.&'^^%5\H$>
MZN4)PG)\NWZBNE/-#M)) B0?839)(]0%M5ZE]J4*MC+I'YHT)J3^#\LNB.H9
MV'6"F7 FH"J <> KC&LM.ZM,XD Y"*N%OU/\)^IKY15(Z8]P8WD[5MZX($7*
M>IM2"Q_<#@G<OVJ>CTZ&6M030_:8-&V$W](.&:@-8PM^'6(]?%K17:EHP64S
MZ0.+W2#0UB5HP;<VR%!NTE:[D\P8EEF'=H .^GU@+]*7P E#G\J5WUJ:O?!
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M5)\R-;@(I]K$]1_K9^7?*1C-P%\#@<"*ZV6.T[K_DZ[5+3204U2\?:Y):XO
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M6J99ML9F6194_ B;H=P4*'?;#&6&<@.@?&,,VZ6##W4!<>-#1Z9^]GZ]E7%
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M'VEA/-/L6&(9FV@JM7D@0Z!64(MG?Z*1'*6=1+!"?75-WS[[CO+RD4T9)E3
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MPF7-;:YPS:IJ[I45HKNSDMNHR;[^RLK.<:FLB@N(FXM77$"L0147$-<=JKB
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MD56 D1\GD]NQ<"D4&4ZEC#01!,*[E^ID' ,.XOX^D/=XS9U..(05Q<+5_#&
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MDP0#9AP0N%3AW@C=I&0B0-3:9#+.M)(;   58:M!Z;OI@/AY8&:>E_";,!8
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MQ>W$MV+<$,S W;0$KCL/CD76!Y5=NP%^O/&_5VL8V!TOQ!P/K&\64N%B"O/
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M/X4';K@@AO2O=-FX.%/WI:37B^-W217A>>!84C%9P$1@FZ(8SYP^-[8UD?P
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MQ'TV\9= AF #D[)1M;&-5Y3.<!G5Z5ZYVKSQ@23M%VQ5N_TH\V;B!S,11=1
M=>6H$I,L+?B @)_8>!Z:5!31P"!]7TV%*E)UKW^!*CM N]YN'];/7C?,WO$+
MXIBZV3E^G1W#U#M=\\1U=IYM8DX#Q08X46@0;$S+F<2!YX13^,=4!A*O,NB'
MVM&F+"7_LY,!_6>O#I>8SR]^H(H;TC5!)]22JZ=TBR57&%%H@?P]EF%$A1IA
M/9@X6)D2KS1&@10179[!I8+J+8XQ63^0-BPS2;6."6$JE',1J$J@B"9U,?''
M-_JFPUY5$S[JZD;//,R"]\W^T4WMJ*<;@V+UUYJB@NNU6VH^G<3:YJK4)->
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M?>KW<NS;"_AC&LW<'_Y_4$L#!!0    ( %:07%4;-&)38!$  '.L   0
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ME2Q=L$GJWT'!9FB@@#EO)V)QXC)>1 ^WB^,?.S2/^KY06AZO1-?F<^Z/A;D
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MNB'^: (F5!R=''F^86X8;8K/,*&P3LZ6>6RB)'!%UZ;B3_ =X2' "HR"?LM
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M9SNYUFDMFOXE0FKHOY+T*^[@P;D?KIKKHK-R*6&S L:M<$ZB/6+:E YTPI+
MN"0Q(FV3R";EVI'4!K#ZETJIP8_:^JC<-7;>$/0;?0?6 @6>++$)#'HNI0=>
MU*5(PE$9(5%5O?G,6B#]2Z[4,1:[RKQOY5(Q&T#$C"#@3&1*'$-CR0DHCM)0
M&=#F/8)RJ1KR&V0;M$E RR70BD@?$W'!.0)2*5#&<L-KM_R[JU*W;T<+.^?8
MW<5B]U)3O6A].)XT<P$L!R64LHEI1QAEK#3K$,1+D0GW6@IMLI6I=I[O.H8^
M96MZ0)6=5-3%Z8 +/](QFY)1Q&L,+:3,2-U  PG440 <*!>U6X[<1%$K._'.
M?RT:7(U-HUI,!$D,+3V1=+E=&;(G&@0762?C=.TN;NN1]&G=W)$#MZ4E=A!]
MW6!US?B24HY[#)-<*6N36I>FV)*5^B-IM$HV=Q.IWD7TWI3VUR!"#>%78\+1
MV?EH\A7@/<S/:ZV!!2$JXUD@V7GTM$,"$ER!I4': %Z'ZK>=WPFJ3[GLRNRH
MJY!Z!G$R_G@"S5FY0GV^]S(_/C[?I#X.H^''Q247*XB^W'HM=2HE"PZIS"B*
M0D04 %"K 62L?GSC7@#[E/BNS)_N%-51@<EJ_%\O1F^%5.!=*74I/8&M),Z"
M(Y$'JKFV733E_"ZB/J7,:]NB>JJHN8/6S"!=RM*LX!@F+'(2XPJ> I%&>.*$
M,(2:&#.43FJY@U/=Z\'T*8]>WU.MH( N8K&!-TEQP%7*Z%+9"E#Z#7M-!)H]
M;[R.*+_N@K .HDIC:111EVMH J["*N+:FY4F%%=F(T-&\UY[1W@[=^H!HJY[
M:?L[!Z^WD777QNY2U6X*@L:,8)(MYW1SS,0['&JTSNB8 H:'M6_8NA-43\.O
MG1A15Q-[]JP'X&FIW8\$="D%9BP1!SP3:D,$*:CRNG;9P&;(>AJ+[;9XU-=)
M9[F;2_SU@;L8RBY8EJ5</ *Q&3B^9!8= LTSJQUVW8ZFIS'6;DM('=E7X\*+
M99?'"U?M,C:8#C(-/$0&Z*!!N=HE2!PK9"*4+XW_7)2LMG=Q!Z2>QE([L:*F
M%A[B.KJ##[^_?'W\9[7.O'<\O,.KY^X82:5.O:6XR+>G\SLF\6G/O_[1%N5?
M^!<'<3K\M*"5I9D%E4J/O%QNZ-::^, $T3Z72D.)7D7M";@YNHHMZ$/2,OM8
M#J8(4=J,"@P,)9"83+#62Q:J]^/O9POZCKCQG>[R]Q%]1<-SWD YM5ZD?%:V
MAO_ME]=1E.P!E)_+TB>LP:BKI D2!EI2LM)AQF8"LNP1,T:=JNVU;@BM3Q'.
MGDC3A=+J54*=^@:>HX.=2KM &+=S:(.@A9(<*-(Y()9"<2=4)EHPB"@"HV)M
M JU'TJ<P9T]\J:"2[CS=92GG<Q@#KH0#'PWW'AC)24/)[3CBRDO&A#0TLD"K
M%_+< :E/\<_>%IAZ2JI985N:V,(+6/S]:KRH;/IV7NCEI[?#@776./P_H:%T
MOXX"%SVF.('$#(7$K:N^9;D9LEZU%]X3D3K06=W\2PG\40X+HB]9/A L@M)4
MD2#*S2LR ;'. =&2YN"T41*J)W)O W//[:D?@C5U--/APG/S9-H@1@?)>HRF
M;2JW]21.'-!(E,816R.#"+4WM#;!=<]3(#\$?:KKJT,FK<Z[E3$[Y86GI7>G
M*IOT\U;=T=C"=<!!:V5"!X=%;@=TST,C/RAWMM70SJ1)G_P:.(M&[(M<]:5S
M<JN34,O?+!N82!IM4#J22-$[PZ@O$"^Y)A:,4D88R<*U'B\W\H&[H]B$1NX'
MH=&>==;APG1A@Z^ \UE16=K3<6,#D30H8BU(HFA$42G((7;O7*^%ME'ND/X@
M-.M2;7MPFY:5\P-0I:V#TKB(,DHD3^5$+U=$&UQHC7;,R?K-)^\ M1&/?K D
M=%U-=1GPWUI3/1!6 ??9X&+)+)$V>.)MIB0GP3F.G\50NWW/??!M1*L?+$W=
MF?ZZ-GM+@WP9'O?& '<*\=!RY8=-Q"7 Z%/EJ'FY2:>#9A\;@MN(6S]82KL;
MS75K^Z[5XJ[6UNR2="DD0AUX(I7@Q-.(S ?O&76!Y^IE@_> MQ&Y?K#T=U?:
MVY^[?GD"9&XA"&6)CKSDS' J6*$=@>1E IDQSJA])O0^^#8BV+XJB?KBMV^K
MOWK7_:(4KO7EN]&W[^H;ES[Y#IKA)-T<Y/($^M&7>.K''^$]^@!'.4.<#J(2
M7E$;"="2UU4\$2_0O\PZ4UR?<3*QVMG3_8YP5WW<0LR7P[$?QZO$S*7128B
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M6>(IH_P,VAH@0A"X",$A132@/<G"Q(<\@ZJ ?@S.'4EA=UDG&K#NQ0S/ZHN
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MD[^FZ:=1[&EEC#2*@HF\U-0D7]J+6M!),<,#=9[YEOS8@.O,B5)#&TWZ/]S
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M]A!FL"Q;$+H;]!(L>!?QG&4JD<P$XJ]N=^R-]OQ(=23--;!F-[MXUCK.\3"
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MO7_YJ:><08T&4Z;\<#PF$@6D,X.L431!NT1B[1J]NBLX_L9;C6VK^^\)5=O
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MP<F(+X21F83:G6CN!?1D;GAWHL*F;@('JZ3)M4R'97%9L V85O-$;@(Y<?>
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MI#@7E><U+^:EVLLG/*_X;C<:]SH3-P>+ :CTF8DN5N!J+/0>8*^J"NT1F[U
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MG?HV<$"*NL51Q@-'%O+!6N+7L;5I'_(G8CLJ==W_NO_@=">__O(_4$L#!!0
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MOQ455U77U-;5-S0V=77W]/;AOO</C(U/3$Y-S^!GYU;7UC<(FUO;.[L'?%$
ME!2_EG_(%SW(UR$J*DHJZ@.^* YY'-Q 3W7XG,B14S<TJ<V<&,Z+/CW**/\Z
MZ4LE#9>8U@K3 ^=.VM/<XF,\JP>L_>3L7V/LV7^)L]\8^SM? \!Q2I 1^D/T
M  P@&/(E/Z']'UQ/1AQ1NZ3;,[UF_U&V:=1?1B?&V>NSTG :MBEO\\MF.&I
M4VOGZH,B*"],=7!:39%1[_D+1LWKA_\_JXQ+POZM,M;U4X^5.V:0,_J"##6>
M^XUD $$&+#/C%)<'D@?JI^]0+DFS3J0&DP';3'F-A_&RDMK6^ 3HCZJ,>3=A
M(WSSAJ:B.]N8(N-="D7&T$J*!X^!1G&*L'$6TB37_@0QB)!9+-GZT7<FD QT
MA+G@8H_,Z4?,1#HM?H=,&1\)_I:OX3RR2X_A.OQRM^Y*/JYJ#)UL(XQU*6'0
MZ#>;K<=<*<^6CDU+#B:TG4P.Y@/^/ZN4S#6(M7H2-1G([7-/\-A4B5ZO''NR
M02 *D(&7R/8SX#)A$\PW,>_K=5V_=*>S3_"1Z)4Q0<\262_[B).!*^Y^-K:!
M82Z;(6Y4:RA^HI1_M']Y8+2B'GV\>^2=-30SS;6R[L^:BDP6+RSL"DL8KZ-C
MILJ"T!,D[]Z]P=K<T!)G;XHYNYA(O7?]/R:CHDP>VH5LWG4UW=_)]DTA U2+
M%1TSL?FQU<SH]V3@B6AQ O\5PQI8?_NT2LZ]4)PYK9=U)OZ#OWQ1[KUA-]Y.
M1>$R,E AT6*Y5"4[B/ @7MOE2RZK;OUW \6_HTHN^A7>Y]L(18@9%-CI1K44
M1VQ20R,.9> :)WC;7V;LNI3X)F"Y?E37Q[QAWM*?2$=_T,A]\'R?,+LDV3YE
M?-A93W1'NVYD$=E\3:(/5_!&9^;#Z-9SU \"&1!KJZ^.R4"T,FUE'THN*@KO
M/-;P&*;E)R XI"3(M!-NQ,8WAZC0EW3SXIE8<AE\^MT/5I=?-WVRFO?,@*ZW
M4$@K&7A][='%3.FR<R/8#R;#90OOWZ^P/R$#L 0%1:;UJ/B,QC;U)0W]:>_5
MX&>:P;F*"5>@<N,2"V=Y\9(Y&5]*91U?>/GY:R9Z.R.JOMKAG3/DFNG>&[:.
M3'6L.15(SN5_#4?))2DRZG]P_I^%ML]?L,A0W(M#AN:W2G,V3W\FG?D\L]X
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MY2@R50=CW2N>Z?> X425A3NL!MT#78/X"S;[*HSM$&%7ZG=>YTTU=K"Y<K3
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M1YDXGXD>!4V(2-?O-V"]4+_':,U5!I*\.:FL>Z? F; XA@V K"32"6[WPFI
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M&'%>H$?'='K7_Z%R"-%D($HB._,!?43+-5'W12*L'?N_JOO.L*:Z;MNMJ-@
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M:P3!X378&Q(O909[G6L:-AFSZ8\Z0F(H=7K!:LT19,:NH^PFQ'-R"7V'9S<
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MH6.%]%& ?[MBK= )/EL-I1)<"L"DTIM+ 62)2@L)%""&3,L=I!Z^B!XW&J$
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MU.9 D*2)2.(L2F.78Z&^SN:VDN]E!7MA!R48Z878;C_E"[B1%]1!F#EO@VS
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M#NQ_;K;M&?N@ M6&_8?D:U/'^G&S;CBOLK?+A@Z/'<6-"/K(/+>7')RQB6]
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M%=;3.4S32#D%ZI[K:&Y3>[^HR5921W^ILXC:7B%>C]/H-X=F+VB<,[="CN+
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MK>BYH(8S3[L[)[[*37VODBYK'M&+OERO32;&U_K/^?HMY?6)YC8DDK,D3,,
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MZ#" $>)*FDP_C%G%7%KU-C<&WLKFF#*M%U [QO0&T\@LN!5+VX):,)^9RFP
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M"9$Q3,)86S64<4A#*:$)\<%A3!E.W"Y"SW8UMS.6O:1@*^K@^YD>@"VO4+W
M-O:UZC#$W*];+X+AZPKV?$?37LM>5/CHJO;R&P-W/0^/R^))RD^R=E]YGU-F
M"OF:M#.- ;O@-$,A2Q5,0Q,0)#,*,T8H# 1*941B1H15!1KK'F=('*4I2V4*
MJ\I5U1PTFC3LK(G$=]T,743<<F?D$\>QMTFMK+!LA 4=:<?8*ME"XVO?=+&_
M:3=1MNH?[:BL7QQ&-EOGN(=\O<]]22G%2B88$M'DEQ"0,1Y!90JB*B2P1%;1
M2'V=S(U2=JZD6R'=*.0DCG:L<2TZ(Q/%$3#>;W3Z /!$!R>[F)0!^I0\G/2]
MSPZN=OE(<]%&&=RN&J_8QMULN\AE',<)2RE,@D":1,(9I 0ED*(@9$Q1@IF3
M66'1Y]Q8H!6YMB6:(CJ\$720"Z<-Z'8<X1G*D2ECB^(V,,J@V=#(ME"%=_O"
M 2!_)3(O]CAUK4Q;"$X4S;1^]1HO$^-R;_*HG\J?^4JJHI2[U%JR^N6[WDWI
M/O(5+9_JX.O3A8 7#&=A:DY[0T[C]D8HBRBD$:8D0S1%"+N<^XXHZ]P.BENW
M#5;K<T6JOC&'-Y6896$0ZRFHM[P(<;TB"<:AR' @:!CQU*W>VUR&=SHGIED/
MK]T".)-!&WGA?!Z[5N<6/YVENAW1?:)(LVE_KA[8ZN?;]6K40?#JNC6.I"_@
M^C4JY*==Q\;M<I@1\7>Y%'?%MBC?_IIYD;$X$'H9,"6Y.438)$="7$'%,Z1(
M0!D*G78NYSJ:&[_7+E)#74#.HFG'R#XP&IE.:WBZCB!&9K@NX%;J&W"[\RA[
M753KFRVQWBZ7Q3>J9RC0?P6O2RERX]):>;S-O82?)R8\V\VD-'9)V4,.NOC\
MP,0(3<&5-AL8IE)('#$8*Y)"))G46X8TTR1"N(P3)3AV8HUGK<^-*@;62'H&
MF!TQ#(9A9#;8UT#REBRM5V5?<?W/VIXV2O^46D<Q]R<?NC9QR=^*0GS+E\LZ
M0'_!HU3J_V$H$Z2W@$EDMH!Z1\@0SJB0+,EPZN;S>:8GE\]U&K?/;NJ+K:AM
M5@M'#XFSX J.D, ,1ED@(!)$0I(1 A,L5,)1FB4L&Y;M93"TDQ#BZ,!:TN7U
M<(U-G$.0NB*;RDD<O&=)>=[+"V4_.:GJ^:PFIQ_W$R*\SRX41B%13&AZE:G>
M306:=QE-% P"22*2,I&E3NF?SO8T-THX%>5JDSG($5\[7O""VLC,,!2PJP.#
MQTJB=+Z?%PT-OICXZ/(+@]U6MVF4WNI]<7Z_:JZ#^-.M^(]-$X[R;L67&U'[
MP95UC&$GKOZN.'T0U&8[I%P%*HE#2*4I-\ED!HD@"<1(IC)-8Q3;9<R<1MRY
MT56K8GM%S9_ NJ2K:MEZP^T4=LT[-.Z0VY'?? 9R9 ;M9K/;CN=65;#7%>R4
M!:VVX/8@?<69T_\1B@%,,SC^'(S'%'9J)^4)@#_AZ#Q%KU?X+YKV&R^%CG]D
MRS>()(B'*($B-4F9LR2&!.L51U",$<U0%$BGW>VE#N>V2#1^-\MB=0]U=P]@
MN1=X@(=C'])VS.X3OY&YN8%N+VO717H$6K5%QJ=+9%]WT[M'6BA_TE72YKVA
M;DL-5WW2[/>:/K9?>IJ&642B!$8"8XA($,*,Q!E4,HM$&/,XH-3-(^5$+W,C
MDIU!46HI :>/@-Z74@ZP,$^#:D<?5T,U,F?L4#(" BWA"$31BX$W!XI3?4SL
M^M"CYK'30M_#PR;_]K3M;V5158N$\$#&3,"$1,@DK460*BY@%B2IY#)"2#F=
MBCUK?6Z3?2O<[D*<=O8I^<,CS<MZ6\*_T/+>U9)XCJO=O!^,ULCS?0]4+9F_
M27Y284^3^WG;DT[JDVH=3N;3#PV;Q+_FJ\+X$&P)XHWDI:25-+Y-GZ20#W7U
MQFH18"Q4E$J(26"N& 6!C! .@RR@*<(RD %VRUIEV;/5QSQI\JJ/5._AZ!(\
MZ@:_:($=I[<MXG83WR>*$^6(.'T0<P.VHC>.G1WA]0<-/K9@FTNV[2L>Z<01
M1D]$8]OKI!3D",4A.;F^/HRV3M0K^$VN/Z@[^GW(6<N""H2#"$DHHRB%*!09
M)%F<0,ED&*.4)013EQ@)S_(YV3^353?@5Q=Z\3V,=ISY@H,S,K?VE'JY 28Y
MCV9/K>7-\/-R?Y0[TBAXHF;?TDU*X2-!>TCU8W4ST#GNB^[J3I8/G4R [=E)
M1D7,31KW).18LSL/((V2%"I,91!&5)#$*6#_?%=SVZC6DC8GVQU9'?VWS@-K
MQ[=^X!J9.AND[@Z0&J-6^$4T?/ERG>]H6G>NBPH?>71=?F,H1]!2OM+6J'C=
M28US6Y;Z2VB.:E\][9_Y2)_,SVZ_T5+4O]SI7F]7XJ/^<'[3GU+K]LTYCH,D
M2V!"$Y-Q->50[Y%- "8GIM!5@*23E\880LZ-E]HLI+7 KFPTPA#:\MC+#LS8
MOA9&2&"D'",$8$3LO/'E"").S+3C@7S,T2/VY5YN^I.\-\?O1?FD6S6Y863)
M<[K\-5_J!:18R>J7E3%'ZR+H6&_UE5 !1)@A_0MF,$MPT+C5!9+B#%O=3SKV
M.S<.WHM>9R#9"P_VTH-&?)?:\XZ#T4^](T(\,IO. UW[>MDCH3Q1)6UO:#L5
MVQZ 64\9;I?6)BO0/4#%;NGN(:]?EQ;TLRR_YER>7IY^*^H-A6S6H*H^QNS^
MNPER_JU8_Q^Y_B1Y<;^J:S7(,B^,:U_[(_-<N$!I$ 5I)F$F4KV&Q*F)MI,I
M9*%( XD9HR0>DF-T&O'GMA3]OBIW C_/6LH+XU+3YN!<%V"UA0#H[X?_"9G!
MZ"#1:<<& 9N5,!7M#I[57]ZJ/@Q]?_?N8]U'=0.^R?S^BVF9?I4EO9>Z6V.4
M&,IXK$$$/^0K\"1I6?TX+('J1-^FW6YFOE_<Z"<]6E-8JPI:NQ1T[-8Z44S[
MC=5:W]2Y#_1/UWKPUV"OZ UH5*V3('24]9\6=MHQ\IQC=B+A7R1A[;0#<R[[
M[<127)/BKLZ'HUN5^=<Z"%@&$8V)B*! H=Z0*1+#+$PPQ(KC!.D5-I5.1_,G
M>YG;<O=NEVE,KS%;(8>D'#M$TX[YK\9H9(+NINT">PE'2(O9BX377%N'?;Q
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MZH7WRX,L[_4:\K>R^+;^8JH>T-73(D5QG"4B@#CCYBX-<TA99%+&,A5PD=#
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M=S@W>MK+"[C)=6UR"<J]N*Y^6Q?0MJ,FGQB.S$@=^%YOX:O_\(L%A@.<L^R
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M_NUAN5!?G\OO4XYQ2C.>0(S-^@DE@D+"E( YEF9OQE!,B=/&[-C#IS:I2_U
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MX2YZ[$X1WJ <:1SA_XS+CG?N5FRQGI<3\WHAOYGW\\%F=%2\::E6_O=S503
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M>3E>/168&B,V^H-;#;99T*\*G;U_:?_<K]>S]S YNF$'!']H/VR#^_($[E>
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ML5-CKY;6O6L =Z'L1ECAL1N8J5H*7X%6,=%V)YAA:P$[X!2^$G"7T+>J ^P
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MMQ_+""T@Y" 5F3#Q2018(LR@IC1C$/,DPUZCIEMDS8T<&F]*ZV!4NO;P+:Y
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M!<E7R])*OKQ>C/9-N^VV)]@757W@RZ6.PA]_[<P_]0[\XUH+JR8,+DB2TJ+
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M;CSSYTKWJ-PK;W9L1GOW8)C'$G1''\<!=NQ70P/3AS*JU8X.>D>UXCUJRCS
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MJ!WQ92'3;H%;#3W;\[9_NA\]U"N[?2AON=X\;V2UA?Y#[KZ;!GL_M&]C?[^
M"2X$4RG@,.8 I8P !H4"<5KD,<MPI@JU6,M'TQS7C3)<13L]$Z1Z)IH*C/=H
MW.L;?;=%R,KV8]V]1D]6:^W%']3VXQ+G=7!CEZ#83L,W>Y7-27JM]#X*5ZD=
M?78 UYML?)$*1#_.8B<E)%\PWE*4]_5]I@>ME^7FSW(GMY_T=\]NGK\M?SW\
M+#^9<9A2?QO7N[L7^?!3__GZ\'VY,?*KR0NID)+)!$@6(X"$WCQ1!0N09UF6
M%Y PA=TJS0:I,3N?R%H265,B8TL=D-#61-J<Z),=TEL9%&F+HLJDJ++)9Z)-
M[X7K/G.>9CG&]K@&K42/Y@\#EL1GU- 42S/9P*%!2_1D[0HV6V@HL*T3AGK?
M?,(Y0T,!.)TV-/AN U*S?U]29@9/+>76[*M>-ALM91$G.<422R!RT^9'J *0
M%&'] N.$(YE!XG?V?5W4W-Y*5;+QZG"FM#HJW2,S^S*Z;JYT&,Q&?G54<#6T
MK+;GE9Z!4[-;L0B9FWU9T/3)V:T&7\S.;K^B'TU4@YKW V>N;0\U.Q0YSC!
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MP)'+-U\$;,-IK .[]0DSXMGZT?N]?>\V<MSV=SDZJY>ODV)I3S&6@2LZ^Y5
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M7O 7G"&Y1!/,G/.H-1BM0IT+*R"4K"'SS(,-1G'1.AW]!$GCUI9T!\.6"NP
MC\1&S7GA:]S\]]UL4V1]-<?S[;??IA/%3>1!(3CRR$$)<M6#L P$9E6[,KF$
MK3LB[$;9N$4IW:%S '4>^E*X71/>^NR$9+F1[<6VFQ@A)/)$7H8OH3H=#AQ#
M!*&S%768B(F#]."]CYAQBUFZ V,;I76!O[O[ZE)H%^U'+B6&69++80I8E6EO
M!1G!^V(AA$3.L%=T$+3V'W>G;MQ:F.X0.I!:NSS7MT,*2>XX_58?\DVT*\79
M*CJA:I6VU!!D$%!LBLH7XP)K74NS"UWCAM]#8>))Z!VHH$[MY+O9-Q+Z?%&[
M(@L?,I:H0?C:/ENG",[Z#-P9F[RH][:M*T\?)6C<"'LTH.VKDE$1EK^%^R2V
M;BNR&0%PM6_JN]'K?W(Q4UJ)G)FIG>D"\Z 89G E!A!!1^]1\LANO26Z<\]]
M.!7CAM,#8^Z%E=2IR;OT>V\P%A*&(',=Y50[*CL=(!B7H2@1I%8L<=\ZL[,C
M:>/&T*.9P</5U"G^;HVCGF"4-DA4$+"^#35&@,_$EW;!:Z4P%][Z<O%)HL8-
ME4?W\?9139=1Q</SA"?>RR!KR9SBOB:9"H)+L?:D0Z>JC4^E]=/=Y] W;B@\
M&@(;*:Q+,%YW)ZXSIIVS19!--\76G'P*X+DPD++7-L1DC6]=EKTS<>.^(!GW
M\#U055UB\.Y<V*VM-S*K@.BAY#K<HDB$R)(!+3SW-9AGMG4-Y#/(&_?UR9@'
M<@-U=8G$6_[M]5UF2(1&\ 3.U[Q2<0*<" DD;3ADJJ!H_J;@.?2-^VZEEX!D
M7X5U ,;=*_$F*F4RZL19\I*VF8SD=-3AV8QK(9)%0V(<K3)\W&1-!_6, RFR
M@^Y_#W!6<Z/+9PB7%6&8)^'*HC1M3)1UTH '5*6.5K$L-&^FT(;R;GH6O<C#
MAB'5VH&])9_EXE;U*/WG^72!#[83FV16))-<0Z$#"E2MO(\Z"9 B!BL3-_9J
M#&>KAP\[4]?EPXA!L7/[8<0PBNPB47F'MU_.E],9+I>X_/.B/@4)S!6>,J.3
MB=$)DC."S]Q#1C18LBU2M78%GJ*IRP<-HP+R$*7U </%/"'FY5L2]^=PBLL/
M9<O342GD<--*M-'HQ_)YE>]%I[N)K5N,R;K?2H+JVM>[^)JH,(S^"!5K/E]T
M3U*[]%I?%+0OH.(>3_V_X&D^GO\:5K76\UK-Y\0Y@SS* IE\)U!(OE40=&!X
M+W1FLGZC]<3FG8D;]_:Q![0.HL8^;.UMUM8ICHUPUW\P29QV54VKF1@R*%N3
M)TP@))VM3]''/+P[>INH<>\F>T3D06KK XFWC@0R_]L-]J$\N.$XXW5T*H).
M0=6<A@&7')T**6!66$IN/G=T+T+'O<OL ;&#J[>'\_XQ)N]L42>5%U9(*,'H
M6DBE(<2H03KE8TI&:1R@P\'N!(Y[\=D[9@]29P]8O7V$W.X</K&,]EZ=Q%6L
MX* 29Q"3]%!$R"5%+F5LWDS[*:+&O03M 9--U=;'R7^;I<V+N%]Q]66>K^^P
M6.\HC(A@C73D75N$H!0#HXDWF61)S3M![DK;N!>B/>*RA1+[@.>U4^!^IEY/
MJ]AG>?EA\7JZW,SAJH+]A'18S.H%ROI2>J)K\D(K"4HX!LJA!\^X!VZ2=<7:
M&$WK>KMFQ(_<6+ 'A(^"@PX\A=UE/^'&4'#) FWN%$%Q6PL4G82@H\-@O61^
MO,O6W2#\W_GR:B!-]ELL<-&$=&?A.F>D+R$"[<[:1%0SXAHS)"MM%EXHSU\(
MO\^DO)OY,B]2+#"D6CLPN-=/FMJ#FWC%#^7]?'9RC(NSUQB)(R&+CB:"M"J#
M\H%#5,%!U,RD.KM)ZM;U@4]3U65QP*!8><1%:*"X#J#X";]>./8?2J7_:)8O
MO)CWM23R0SR=GFP$.-&%T087#+BNH^[(C0=G70934LHIZ*1]ZSX?NU/799G
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M_A@]XUY]-<-2,Y%W )_++-=[.I3?T9?+";GV5N3ZIBUEXL"@JBGU!"DY%[E
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MK&H3E75PLM\[LVZBG,Y&U+;TPC)0H0@(MC[[Y\E8<E183JU?PM]+R+CE&R^
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MP]700:AZQ<8Q_8UU2:&(,N7, AA?S3YGEAS4),'I%)4UQ)$L@P%I2T4O&#I
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M<?\O[@48]Q( ,Z"D.S ]-_.I[RD<78<'$Z^#0Z81-*OM(*+H3:V+0"ECY!0
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MP>6S?H_9P5P5VLU2 [R4Y*M"'[\6Y_9]<9:_A#\FUD5F95UH+YT#A29 M)B
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M7\T2NV3O,W[=%%O4QTKR28ITU@!;5[@I)< [Q8%$&#1WNK#4NJ#V48)>6.G
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M^#%-5SM:K71U=)^OR4TRKJYH\$YE\)D.$XN"<_-4$FSOCW41MA^CR/F04NW
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M1! P#UC-?P069BA"Y0CC0W2R@3Y:AB%#"FX$7!3$'[/'L82/03"8GZ/2S<@
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MAMARY0F"R[BBF8X<<D7=?''2.QPL9HLRKR?%&[6PQFTT_&^<KZ<35\JJUEZ
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M4OZIO(,8X<N2ML4Y61I:+U:^):^19,CC0>MF%[IJ[I4-.M&:QT>$^U:;-:Q
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M0\OF2"MM^D=-_^^,6FHQ3Z1:]+\=R00L^P!S=J,3GGY;M>B&F@4CX]#1RD^
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M^?'L=S3:<87,I2 0<XO[7Z)Y;G$!4.U$R.9&5"A#W$L>227=DG+KOFEIS7E
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MME#;MVP#%ENO-,O?XH+57/4>_0=02P,$%     @ 5I!<5:F*?*-(!0  W10
M !8   !D=F$M.3,P,C)E>#,R,C$P>'$N:'1MU5CI;QHY%/^^?\4KT?:0&.:
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M,#(R,#DS,%]D968N>&UL4$L! A0#%     @ 5I!<50VN2/>)9@  D'X  !,
M             ( !2 D# &1V82TR,#(R,#DS,%]G,2YJ<&=02P$"% ,4
M" !6D%Q5PMLS9D_F    4PD %               @ $"< , 9'9A+3(P,C(P
M.3,P7VQA8BYX;6Q02P$"% ,4    " !6D%Q5L<\\DEN(  !PZP4 %
M        @ &#5@0 9'9A+3(P,C(P.3,P7W!R92YX;6Q02P$"% ,4    " !6
MD%Q59NF)J7Q   #^U ( '@              @ $0WP0 9'9A+3DS,#(R97@Q
M,#%X86UN;S%T;W-O=7(N:'1M4$L! A0#%     @ 5I!<586?*P3V!P  A20
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J82TY,S R,F5X,S(R,3!X<2YH=&U02P4&      P #  A P  "CL%

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
